PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rosenbaum, L				Rosenbaum, Lisa			The March of Science - The True Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Caulfield T., 2017, 2017 LETS TAKE BACK; Funk C., 2017, PUBLIC CONFIDENCE SC; Gilbert DT, 2016, SCIENCE, V351, DOI 10.1126/science.aad7243; Kennedy B, 2016, MANY AM SKEPTICAL SC; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; National Science Board, 2016, PUBL ATT S T GEN SCI; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1992, PERS SOC PSYCHOL B, V18, P504, DOI 10.1177/0146167292184017; Young RS, 2017, NY TIMES	10	8	8	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					188	191		10.1056/NEJMms1706087	http://dx.doi.org/10.1056/NEJMms1706087			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28514226				2022-12-28	WOS:000405282300016
J	Minutti, CM; Jackson-Jones, LH; Garcia-Fojeda, B; Knipper, JA; Sutherland, TE; Logan, N; Rinqvist, E; Guillamat-Prats, R; Ferenbach, DA; Artigas, A; Stamme, C; Chroneos, ZC; Zaiss, DM; Casals, C; Allen, JE				Minutti, Carlos M.; Jackson-Jones, Lucy H.; Garcia-Fojeda, Belen; Knipper, Johanna A.; Sutherland, Tara E.; Logan, Nicola; Rinqvist, Emma; Guillamat-Prats, Raquel; Ferenbach, David A.; Artigas, Antonio; Stamme, Cordula; Chroneos, Zissis C.; Zaiss, Dietmar M.; Casals, Cristina; Allen, Judith E.			Local amplifiers of IL-4R alpha-mediated macrophage activation promote repair in lung and liver	SCIENCE			English	Article							SURFACTANT PROTEIN-A; TISSUE-REPAIR; POLARIZATION; RESPONSES; FIBROSIS; IMMUNITY; ROLES; MICE	The type 2 immune response controls helminth infection and maintains tissue homeostasis but can lead to allergy and fibrosis if not adequately regulated. We have discovered local tissue-specific amplifiers of type 2-mediated macrophage activation. In the lung, surfactant protein A (SP-A) enhanced interleukin-4 (IL-4)-dependent macrophage proliferation and activation, accelerating parasite clearance and reducing pulmonary injury after infection with a lung-migrating helminth. In the peritoneal cavity and liver, C1q enhancement of type 2 macrophage activation was required for liver repair after bacterial infection, but resulted in fibrosis after peritoneal dialysis. IL-4 drives production of these structurally related defense collagens, SP-A and C1q, and the expression of their receptor, myosin 18A. These findings reveal the existence within different tissues of an amplification system needed for local type 2 responses.	[Minutti, Carlos M.; Garcia-Fojeda, Belen; Casals, Cristina] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Minutti, Carlos M.; Garcia-Fojeda, Belen; Guillamat-Prats, Raquel; Artigas, Antonio; Casals, Cristina] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid 28029, Spain; [Minutti, Carlos M.; Jackson-Jones, Lucy H.; Knipper, Johanna A.; Sutherland, Tara E.; Logan, Nicola; Rinqvist, Emma; Ferenbach, David A.; Zaiss, Dietmar M.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FL, Midlothian, Scotland; [Minutti, Carlos M.; Jackson-Jones, Lucy H.; Knipper, Johanna A.; Sutherland, Tara E.; Logan, Nicola; Rinqvist, Emma; Ferenbach, David A.; Zaiss, Dietmar M.; Allen, Judith E.] Univ Edinburgh, Sch Clin Sci, Edinburgh EH9 3FL, Midlothian, Scotland; [Sutherland, Tara E.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Fac Biol Med & Hlth, Manchester M13 9NT, Lancs, England; [Guillamat-Prats, Raquel; Artigas, Antonio] Univ Autonoma Barcelona, Corp Sanitaria Univ Parc Tauli, Crit Care Ctr, Parc Tauli 1, Sabadell 08208, Spain; [Stamme, Cordula] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Cellular Pneumol, D-23845 Borstel, Germany; [Stamme, Cordula] Univ Lubeck, Dept Anesthesiol & Intens Care, D-23538 Lubeck, Germany; [Chroneos, Zissis C.] Penn State Univ, Coll Med, Pulm Immunol & Physiol Lab, Dept Pediat & Microbiol & Immunol, Hershey, PA 17033 USA; [Allen, Judith E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Wellcome Ctr Cell Matrix Res, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Rinqvist, Emma] Karolinska Inst, Dept Med Solna, S-17176 Stockholm, Sweden	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Edinburgh; University of Edinburgh; University of Manchester; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Forschungszentrum Borstel; University of Lubeck; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Manchester; Karolinska Institutet	Casals, C (corresponding author), Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain.; Casals, C (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid 28029, Spain.; Allen, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3FL, Midlothian, Scotland.; Allen, JE (corresponding author), Univ Edinburgh, Sch Clin Sci, Edinburgh EH9 3FL, Midlothian, Scotland.; Allen, JE (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Wellcome Ctr Cell Matrix Res, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England.	ccasalsc@ucm.es; judi.allen@manchester.ac.uk	Allen, Judith E/C-9198-2011; Ringqvist, Emma/AID-6735-2022; Sutherland, Tara/S-1427-2019; Ringqvist, Emma/AAP-1070-2021; Guillamat-Prats, Raquel/D-4475-2016; Casals, Cristina/H-4658-2015; Garcia-Fojeda, Belen/G-4214-2015	Allen, Judith E/0000-0002-3829-066X; Ringqvist, Emma/0000-0001-6303-6076; Sutherland, Tara/0000-0001-9334-8206; Guillamat-Prats, Raquel/0000-0001-6960-0985; Casals, Cristina/0000-0003-2696-0918; antonio, artigas/0000-0002-8029-1017; , Zissis/0000-0002-9841-7917; Knipper, Johanna/0000-0002-9038-0566; Garcia-Fojeda, Belen/0000-0002-9558-3020; Ferenbach, David/0000-0002-9202-1428; Minutti, Carlos/0000-0002-9663-1928; Jackson-Jones, Lucy/0000-0003-0608-8966; Zaiss, Dietmar M.W./0000-0003-3596-7062	Spanish Ministry of Science [FPU-AP2010-1524, Est13/00372]; Institute of Health Carlos III (CIBERES); Wenner-Gren Foundation; Spanish Ministry of Economy and Competitiveness [SAF2012-32728, SAF2015-65307-R]; Institute of Health Carlos III [CIBERES-CB06/06/0002]; Medical Research Council UK [MR/K01207X/1]; Wellcome Centre for Cell-Matrix Research; Medical Research Council [MR/M011755/1]; European Union [CIG-631413]; National Institutes of Health [HL068127, HL128746]; German Research Council (DFG) [609/2-1]; Wellcome Trust Intermediate Fellowship; Wenner Gren Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL128746, R01HL068127] Funding Source: NIH RePORTER; Medical Research Council [MR/K01207X/2, MR/K01207X/1] Funding Source: researchfish; Wellcome Trust [100171/Z/12/Z] Funding Source: researchfish; MRC [MR/K01207X/2, MR/M011755/1, MR/K01207X/1] Funding Source: UKRI	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute of Health Carlos III (CIBERES); Wenner-Gren Foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Centre for Cell-Matrix Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council (DFG)(German Research Foundation (DFG)); Wellcome Trust Intermediate Fellowship(Wellcome Trust); Wenner Gren Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Waterfall for expertise with flow cytometry; M. Botto and M. Gray for providing C1q<SUP>-/-</SUP> mice; C. Benezech for providing IL-4R alpha<SUP>-/-</SUP> mice; S. Walmsley for providing LysM<SUP>Cre/WT</SUP>/HIF1 alpha<SUP>fl/fl</SUP> mice; D. Ruckerl, M. Lorente, and R. Tillu for valuable advice; G. Goodman and M. Rigol-Muxart for veterinary advice; S. Jenkins for critical evaluation of the manuscript; A. Fulton and S. Duncan for excellent technical assistance; and support staff for excellent animal husbandry. The Myo18 neutralizing antibody was provided by Z.C.C. and is covered by a Material Transfer Agreement between Edinburgh University and Pennsylvania State University. C. M. M. was the recipient of fellowships from the Spanish Ministry of Science (FPU-AP2010-1524 and Est13/00372) and Institute of Health Carlos III (CIBERES). E.R. gratefully acknowledges funding support from the Wenner-Gren Foundation. This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2012-32728 and SAF2015-65307-R) and Institute of Health Carlos III (CIBERES-CB06/06/0002) to C. C., Medical Research Council UK (MR/K01207X/1) and Wellcome Centre for Cell-Matrix Research support to J.E.A., Medical Research Council (MR/M011755/1) and European Union (CIG-631413) to D.M.Z., National Institutes of Health grants HL068127 and HL128746 to Z.C.C., German Research Council (DFG) grant 609/2-1 to C. S., a Wellcome Trust Intermediate Fellowship to D.A.F. and a Wenner Gren Foundation Fellowship to E.R. All data to understand and assess the conclusions of this research are available in the main text or supplementary materials. C. M. M. designed and performed research, analyzed and interpreted data, and wrote the manuscript; L.H.J.-J., B.G.-F., T.E.S., J.A.K., N.L., and E.R. performed research, contributed to experimental design, and assisted in manuscript preparation; R.G.-P. performed research; D.A.F., A.A., C.S., and Z.C.C. contributed tools, provided expertise, and edited the manuscript; D.M.Z. contributed to project funding, provided expertise, and edited the manuscript; C.C. and J.E.A funded and designed the research, organized the project and analyses, and wrote the manuscript. All authors reviewed and approved the final version of the manuscript. The authors declare	Atochina EN, 2004, INFECT IMMUN, V72, P6002, DOI 10.1128/IAI.72.10.6002-6011.2004; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; De Masson A, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1127493; Goto H, 2010, AM J RESP CRIT CARE, V181, P1336, DOI 10.1164/rccm.200907-1002OC; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Ikegami M, 2000, AM J PHYSIOL-LUNG C, V279, pL468, DOI 10.1152/ajplung.2000.279.3.L468; Ledford JG, 2010, INNATE IMMUN-LONDON, V16, P183, DOI 10.1177/1753425910368446; Lu JH, 2007, IMMUNOBIOLOGY, V212, P245, DOI 10.1016/j.imbio.2006.11.008; Minutti CM, 2016, J IMMUNOL, V197, P590, DOI 10.4049/jimmunol.1501032; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Petry F, 2001, J IMMUNOL, V167, P4033, DOI 10.4049/jimmunol.167.7.4033; Pletinck A, 2012, NAT REV NEPHROL, V8, P542, DOI 10.1038/nrneph.2012.144; Ruckerl D, 2014, IMMUNOL REV, V262, P113, DOI 10.1111/imr.12221; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7; Thawer S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005461; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wang J, 2013, INT J MOL SCI, V14, P10369, DOI 10.3390/ijms140510369; Watanabe S, 2015, FASEB J, V29, P1003, DOI 10.1096/fj.14-262154; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200	29	119	121	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1076	1080		10.1126/science.aaj2067	http://dx.doi.org/10.1126/science.aaj2067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28495878	Green Submitted, Green Accepted			2022-12-28	WOS:000402871700054
J	Harris, RP; McLean, RM; Qaseem, A				Harris, Russell P.; McLean, Robert M.; Qaseem, Amir			Management of Acute and Recurrent Gout RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Harris, Russell P.] Univ N Carolina, Sch Med, Chapel Hill, NC 27516 USA; [McLean, Robert M.] Yale Sch Med, New Haven, CT USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Yale University; American College of Physicians	Harris, RP (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27516 USA.							Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Kiltz U, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209467; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009	4	1	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					760	760		10.7326/L17-0146	http://dx.doi.org/10.7326/L17-0146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505649				2022-12-28	WOS:000401240200030
J	Lee, CJ; Cheskin, LJ				Lee, Clare J.; Cheskin, Lawrence J.			Bariatric surgery improved HbA(1c) at 5 y more than intensive medical care alone in obese patients with T2DM	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lee, Clare J.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, CJ (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030				Ikramuddin S, 2016, DIABETES CARE, V39, P1510, DOI 10.2337/dc15-2481; Kumar AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032395; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC57	JC57		10.7326/ACPJC-2017-166-10-057	http://dx.doi.org/10.7326/ACPJC-2017-166-10-057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505641				2022-12-28	WOS:000401240200009
J	Sharma, A; Heinze, SD; Wu, YL; Kohlbrenner, T; Morilla, I; Brunner, C; Wimmer, EA; van de Zande, L; Robinson, MD; Beukeboom, LW; Bopp, D				Sharma, Akash; Heinze, Svenia D.; Wu, Yanli; Kohlbrenner, Tea; Morilla, Ian; Brunner, Claudia; Wimmer, Ernst A.; van de Zande, Louis; Robinson, Mark D.; Beukeboom, Leo W.; Bopp, Daniel			Male sex in houseflies is determined by Mdmd, a paralog of the generic splice factor gene CWC22	SCIENCE			English	Article							EXON JUNCTION COMPLEX; MUSCA-DOMESTICA L; DETERMINING MECHANISMS; X-CHROMOSOME; INSECTS; POPULATIONS; RATIO	Across species, animals have diverse sex determination pathways, each consisting of a hierarchical cascade of genes and its associated regulatory mechanism. Houseflies have a distinctive polymorphic sex determination system in which a dominant male determiner, the M-factor, can reside on any of the chromosomes. We identified a gene, Musca domestica male determiner (Mdmd), as the M-factor. Mdmd originated from a duplication of the spliceosomal factor gene CWC22 (nucampholin). Targeted Mdmd disruption results in complete sex reversal to fertile females because of a shift from male to female expression of the downstream genes transformer and doublesex. The presence of Mdmd on different chromosomes indicates that Mdmd translocated to different genomic sites. Thus, an instructive signal in sex determination can arise by duplication and neofunctionalization of an essential splicing regulator.	[Sharma, Akash; Wu, Yanli; van de Zande, Louis; Beukeboom, Leo W.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Post Off Box 11103, NL-9700 CC Groningen, Netherlands; [Sharma, Akash; Heinze, Svenia D.; Kohlbrenner, Tea; Morilla, Ian; Brunner, Claudia; Robinson, Mark D.; Bopp, Daniel] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Wu, Yanli; Wimmer, Ernst A.] Univ Goettingen, Gottingen Ctr Mol Biosci, Dept Dev Biol, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Robinson, Mark D.] Univ Zurich, SIB, Zurich, Switzerland; [Morilla, Ian] Univ Paris 13 Sorbonne, Lab Inflamex, LAGA, INSERM,UMR 1149, Paris, France	University of Groningen; University of Zurich; University of Gottingen; Swiss Institute of Bioinformatics; University of Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bopp, D (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	daniel.bopp@imls.uzh.ch	Bopp, Daniel/L-3517-2018; Robinson, Mark D./O-2254-2019; Morilla, Ian/X-4622-2018; Wimmer, Ernst A./I-3333-2019	Bopp, Daniel/0000-0002-0740-9672; Robinson, Mark D./0000-0002-3048-5518; Morilla, Ian/0000-0002-5100-5990; Wimmer, Ernst A./0000-0002-2480-2804; Beukeboom, Leo/0000-0001-9838-9314; van de Zande, Louis/0000-0001-5687-3220; Sharma, Akash/0000-0003-2432-5486	Netherlands Organisation for Scientific Research [ALW 822.02.009]; Ubbo Emmius grant; U4 Network - DAAD (German Academic Exchange Service "Strategic Partnerships" program); U4 Network - DAAD (German Federal Ministry of Education, and Research); Swiss National Science Foundation [31003A_143883]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Ubbo Emmius grant; U4 Network - DAAD (German Academic Exchange Service "Strategic Partnerships" program); U4 Network - DAAD (German Federal Ministry of Education, and Research); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E. Geuverink and A. H Rensink for technical advice; A. Meccariello and G. Saccone for providing purified Cas9 protein, and M. Hediger for helpful advice on housefly genetics. This work was supported by the Netherlands Organisation for Scientific Research (grant no. ALW 822.02.009) and an Ubbo Emmius grant to L.W.B.; the U4 Network sponsored by the DAAD (German Academic Exchange Service "Strategic Partnerships" program and the German Federal Ministry of Education, and Research to Georg-August-University Gottingen; and the Swiss National Science Foundation (grant no. 31003A_143883) to M.D.R. We thank M. Schenkel; S. Visser; G. Saccone, and the Groningen Evolutionary Genetics group members for fruitful discussion. The nucleotide sequences of Mama genes from different M strains have been deposited in the DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank database (accession numbers KY020047, KY020048, KY020049; and KY020050). Deep sequencing data are available from ArrayExpress (accession number E-MTAB-5080).	Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Bopp D, 2014, SEX DEV, V8, P20, DOI 10.1159/000356458; DENHOLM I, 1983, GENET RES, V42, P311, DOI 10.1017/S0016672300021790; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; FRANCO MG, 1982, GENET RES, V40, P279, DOI 10.1017/S0016672300019157; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; Hamm RL, 2015, G3-GENES GENOM GENET, V5, P371, DOI 10.1534/g3.114.014795; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; HIROYOSHI T, 1964, GENETICS, V50, P373; Kozielska M, 2008, GENET RES, V90, P157, DOI 10.1017/S001667230700907X; Krzywinska E, 2016, SCIENCE, V353, P67, DOI 10.1126/science.aaf5605; Pease JB, 2012, MOL BIOL EVOL, V29, P1645, DOI 10.1093/molbev/mss010; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sauliere J, 2010, NAT STRUCT MOL BIOL, V17, P1269, DOI 10.1038/nsmb.1890; Scott JG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0466-3; Steckelberg AL, 2015, NUCLEIC ACIDS RES, V43, P4687, DOI 10.1093/nar/gkv320; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078; Wang Z, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0551-7	21	72	80	6	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					642	645		10.1126/science.aam5498	http://dx.doi.org/10.1126/science.aam5498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495751	Green Published, Green Accepted			2022-12-28	WOS:000400975200056
J	Gong, HZ; Li, J				Gong, Hui-Zi; Li, Jun			Melanoma of the Foot	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gong, Hui-Zi; Li, Jun] Beijing Union Med Coll Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, J (corresponding author), Beijing Union Med Coll Hosp, Beijing, Peoples R China.	lijun35@hotmail.com							0	0	0	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1867	1867		10.1056/NEJMicm1614877	http://dx.doi.org/10.1056/NEJMicm1614877			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28490004				2022-12-28	WOS:000400891100012
J	Willich, SN				Willich, Stefan N.			The Center Cannot Hold Medicine, Music, and the Mind	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Willich, Stefan N.] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Luisenstr 57, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Willich, SN (corresponding author), Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Luisenstr 57, D-10117 Berlin, Germany.	stefan.willich@charite.de							0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1822	1823		10.1001/jama.2017.4690	http://dx.doi.org/10.1001/jama.2017.4690			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492877				2022-12-28	WOS:000400842400001
J	Mervis, J				Mervis, Jeffrey		Sci News Staff	2017 US BUDGET Congress trumps president in backing science	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					470	471		10.1126/science.356.6337.470	http://dx.doi.org/10.1126/science.356.6337.470			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473540				2022-12-28	WOS:000400545700010
J	Camp, JG; Treutlein, B				Camp, J. Gray; Treutlein, Barbara			HUMAN DEVELOPMENT Advances in mini-brain technology	NATURE			English	Editorial Material									[Camp, J. Gray; Treutlein, Barbara] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Treutlein, Barbara] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Treutlein, Barbara] Tech Univ Munich, Munich, Germany	Max Planck Society; Max Planck Society; Technical University of Munich	Camp, JG (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	gray_camp@eva.mpg.de; barbara_treutlein@eva.mpg.de		Treutlein, Barbara/0000-0002-3299-5597				Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859	9	13	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					39	40		10.1038/545039a	http://dx.doi.org/10.1038/545039a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470206				2022-12-28	WOS:000400480400025
J	Marques, PE; Grinstein, S; Freeman, SA				Marques, Pedro E.; Grinstein, Sergio; Freeman, Spencer A.			SnapShot: Macropinocytosis	CELL			English	Editorial Material							MACROPINOSOMES; PHAGOSOMES		[Marques, Pedro E.; Grinstein, Sergio; Freeman, Spencer A.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Cell Biol, 686 Bay St,19-9800, Toronto, ON M5G 0A4, Canada; [Grinstein, Sergio] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 290 Victoria St, Toronto, ON M5C 1N8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marques, PE (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Cell Biol, 686 Bay St,19-9800, Toronto, ON M5G 0A4, Canada.		Marques, Pedro Elias/U-5740-2019	Marques, Pedro Elias/0000-0002-5613-8012				Buckley CM, 2016, P NATL ACAD SCI USA, V113, pE5906, DOI 10.1073/pnas.1524532113; Egami Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00374; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Veltman DM, 2016, ELIFE, V5, DOI 10.7554/eLife.20085; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153	6	38	39	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					766	+		10.1016/j.cell.2017.04.031	http://dx.doi.org/10.1016/j.cell.2017.04.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475901	Bronze			2022-12-28	WOS:000400560900019
J	Handy, LK; Offit, PA				Handy, Lori K.; Offit, Paul A.			Why Aren't International Travelers Vaccinated for Measles?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RUBELLA; MUMPS		[Handy, Lori K.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Offit, Paul A.] Univ Penn, Philadelphia, PA 19104 USA; [Handy, Lori K.; Offit, Paul A.] Childrens Hosp Philadelphia, Abramson Res Bldg,Room 1202, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Handy, LK (corresponding author), Childrens Hosp Philadelphia, Abramson Res Bldg,Room 1202, Philadelphia, PA 19104 USA.	handyl@email.chop.edu						BLOCH AB, 1985, PEDIATRICS, V76, P524; Centers for Disease Control and Prevention, 2017, MEASL CAS OUTBR; Cocoro N. M., 2011, Morbidity and Mortality Weekly Report, V60, P397; Gastanaduy PA, 2016, NEW ENGL J MED, V375, P1343, DOI 10.1056/NEJMoa1602295; Hyle EP, 2017, ANN INTERN MED, V167, P77, DOI 10.7326/M16-2249; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Rosario-Rosario G, 2015, J TRAVEL MED, V22, P396, DOI 10.1111/jtm.12235; Sukumaran L, 2015, CLIN INFECT DIS, V60, pE58, DOI 10.1093/cid/civ061	9	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					127	+		10.7326/M17-1044	http://dx.doi.org/10.7326/M17-1044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28505661				2022-12-28	WOS:000405573400020
J	Hyle, EP; Rao, SR; Jentes, ES; Fiebelkorn, AP; Hagmann, SHF; Walker, AT; Walensky, RP; Ryan, ET; LaRocque, RC; de Melo, EKS				Hyle, Emily P.; Rao, Sowmya R.; Jentes, Emily S.; Fiebelkorn, Amy Parker; Hagmann, Stefan H. F.; Walker, Allison Taylor; Walensky, Rochelle P.; Ryan, Edward T.; LaRocque, Regina C.; Souto de Melo Junior, Elayne Karine			Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing US Adult Travelers Receiving Pretravel Health Consultations	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; GLOBAL TRAVEPINET; PREVENTABLE DISEASES; INTERNATIONAL TRAVEL; OUTBREAK; CARE; SEROPREVALENCE; CALIFORNIA; HESITANCY; RISKS	Background: Measles outbreaks continue to occur in the United States and are mostly due to infections in returning travelers. Objective: To describe how providers assessed the measles immunity status of departing U.S. adult travelers seeking pretravel consultation and to assess reasons given for nonvaccination among those considered eligible to receive the measles, mumps, rubella (MMR) vaccine. Design: Observational study in U.S. pretravel clinics. Setting: 24 sites associated with Global TravEpiNet (GTEN), a Centers for Disease Control and Prevention-funded consortium. Patients: Adults (born in or after 1957) attending pretravel consultations at GTEN sites (2009 to 2014). Measurements: Structured questionnaire completed by traveler and provider during pretravel consultation. Results: 40 810 adult travelers were included; providers considered 6612 (16%) to be eligible for MMR vaccine at the time of pretravel consultation. Of the MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%) were not vaccinated because of traveler refusal, 966 (28%) because of provider decision, and 822 (24%) because of health systems barriers. Most MMR-eligible travelers who were not vaccinated were evaluated in the South (2262 travelers [65%]) or at nonacademic centers (1777 travelers [51%]). Nonvaccination due to traveler refusal was most frequent in the South (1432 travelers [63%]) and in nonacademic centers (1178 travelers [66%]). Limitation: These estimates could underrepresent the opportunities for MMR vaccination because providers accepted verbal histories of disease and vaccination as evidence of immunity. Conclusion: Of U.S. adult travelers who presented for pretravel consultation at GTEN sites, 16% met criteria for MMR vaccination according to the provider's assessment, but fewer than half of these travelers were vaccinated. An increase in MMR vaccination of eligible U.S. adult travelers could reduce the likelihood of importation and transmission of measles virus.	[Rao, Sowmya R.] Massachusetts Gen Hosp, Biostat Ctr, 50 Staniford St,5th Floor, Boston, MA 02114 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford Street,9th Floor, Boston, MA 02114 USA; [Ryan, Edward T.; LaRocque, Regina C.] Massachusetts Gen Hosp, Div Infect Dis, 55 Fruit Street,Jackson 504, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA; Boston Univ, Boston, MA USA; [Jentes, Emily S.; Walker, Allison Taylor] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Road NE,MS E 03, Atlanta, GA 30333 USA; [Fiebelkorn, Amy Parker] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Road,MS A-34, Atlanta, GA 30333 USA; [Hagmann, Stefan H. F.] Bronx Lebanon Hosp Ctr, Div Pediat Infect Dis, 1650 Selwyn Ave, Bronx, NY 10457 USA; Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Hyle, Emily P.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; BronxCare Health System; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital	Hyle, EP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	ehyle@mgh.harvard.edu; srrao@mgh.harvard.edu; rclarocque@mgh.harvard.edu			Centers for Disease Control and Prevention; National Institutes of Health; Steve and Deborah Gorlin MGH Research Scholars Award; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U19CI000514] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL123349] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steve and Deborah Gorlin MGH Research Scholars Award; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Centers for Disease Control and Prevention, National Institutes of Health, and the Steve and Deborah Gorlin MGH Research Scholars Award.	Blaisdell LL, 2016, MED DECIS MAKING, V36, P479, DOI 10.1177/0272989X15607855; CDC, 2016, REACH HLTH EQ; Centers for Disease Control and Prevention, 2013, CDC VACC PRIC LIST; Centers for Disease Control and Prevention, 2017, IMM INF SYST IIS IIS; Centers for Disease Control and Prevention, 2016, MEASL HLTH CAR PROF; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Coleman MS, 2012, VACCINE, V30, P317, DOI 10.1016/j.vaccine.2011.10.091; Deshpande BR, 2014, AM J TROP MED HYG, V91, P694, DOI 10.4269/ajtmh.14-0062; Fiebelkorn AP, 2015, CLIN INFECT DIS, V61, P615, DOI 10.1093/cid/civ387; Fiebelkorn AP, 2015, MEASLES RUBEOLA; Gastanaduy PA, 2016, NEW ENGL J MED, V375, P1343, DOI 10.1056/NEJMoa1602295; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Jost M, 2015, TRAVEL MED INFECT DI, V13, P10, DOI 10.1016/j.tmaid.2014.10.022; Lammert Sara M, 2016, J Travel Med, V24; LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460; LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839; Liu FC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1766-6; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; McQuillan GM, 2007, J INFECT DIS, V196, P1459, DOI 10.1086/522866; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Ortega-Sanchez IR, 2014, VACCINE, V32, P1311, DOI 10.1016/j.vaccine.2013.10.012; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Perry RT, 2013, MMWR-MORBID MORTAL W, V62, P27; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Rosario-Rosario G, 2015, J TRAVEL MED, V22, P396, DOI 10.1111/jtm.12235; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; Stoney RJ, 2014, AM J TROP MED HYG, V90, P553, DOI 10.4269/ajtmh.13-0479; Sukumaran L, 2015, CLIN INFECT DIS, V60, pE58, DOI 10.1093/cid/civ061; United States Census Bureau, CENS REG DIV US; Wallace G, 2013, MMWR-MORBID MORTAL W, V62, P741; Wendorf KA, 2015, PEDIATR INFECT DIS J, V34, P589, DOI 10.1097/INF.0000000000000682; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	35	19	20	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					77	84		10.7326/M16-2249	http://dx.doi.org/10.7326/M16-2249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28505632	Green Accepted			2022-12-28	WOS:000405573400013
J	Sahuguet, J; Poulet, A; Ali, HB; Parola, P; Kaphan, E				Sahuguet, Julie; Poulet, Antoine; Ali, Hanna Bou; Parola, Philippe; Kaphan, Elsa			Postmalaria Neurologic Syndrome-Autoimmune Encephalitis With Anti-Voltage-Gated Potassium-Channel Antibodies	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sahuguet, Julie; Ali, Hanna Bou; Kaphan, Elsa] AP HM, Marseille, France; [Poulet, Antoine; Parola, Philippe] Inst Hosp Univ Mediterranee Infect, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Sahuguet, J (corresponding author), AP HM, Marseille, France.		Kaphan, Elsa/AAC-7574-2020; Parola, Philippe/AAY-4346-2021	Parola, Philippe/0000-0002-1061-1927; kaphan, elsa/0000-0002-0155-8597				Leypoldt F, 2013, NEUROLOGY, V81, P1637, DOI 10.1212/WNL.0b013e3182a9f531; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Markley JD, 2009, J TRAVEL MED, V16, P424, DOI 10.1111/j.1708-8305.2009.00349.x; Niehusmann P, 2016, NEUROPATHOLOGY, V36, P376, DOI 10.1111/neup.12283; Rey C, 2012, J NEUROL, V259, P1106, DOI 10.1007/s00415-011-6308-2	5	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					70	71		10.7326/L16-0651	http://dx.doi.org/10.7326/L16-0651			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28505668				2022-12-28	WOS:000404591600019
J	Beyar, R; Zeevi, B; Rechavi, G				Beyar, Rafael; Zeevi, Benny; Rechavi, Gideon			Israel: a start-up life science nation	LANCET			English	Editorial Material							EMBRYONIC STEM-CELLS; TECHNOLOGY; NAVIGATION		[Beyar, Rafael] Rambam Hlth Care Campus, IL-3109601 Haifa, Israel; [Beyar, Rafael] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Zeevi, Benny] Tel Aviv Venture Partners, Tel Aviv, Israel; [Zeevi, Benny] Israel Adv Technol Ind, Hertzliya Pituach, Israel; [Rechavi, Gideon] Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Rechavi, Gideon] Sheba Med Ctr, Wohl Inst Translat Res, Ramat Gan, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Beyar, R (corresponding author), Rambam Hlth Care Campus, IL-3109601 Haifa, Israel.	r_beyar@rambam.health.gov.il						[Anonymous], 2017, NATURE, DOI [10.1038/nature.2017.21443, DOI 10.1038/NATURE.2017.21443]; BenHaim SA, 1996, NAT MED, V2, P1393, DOI 10.1038/nm1296-1393; Beyar R, 2006, J AM COLL CARDIOL, V47, P296, DOI 10.1016/j.jacc.2005.09.024; Beyar R., 1997, HDB CORONARY STENTS, P153; Bloomberg The Company, 2015, BLOOMB INN IND; Bradley William G Jr, 2009, J Am Coll Radiol, V6, P510, DOI 10.1016/j.jacr.2009.01.004; Ciechanover Aaron, 2012, Biochem Biophys Res Commun, V425, P565, DOI 10.1016/j.bbrc.2012.08.025; DeFontenai C, 2001, 00040 SIEPR; Ehrlich D., 1986, ME MED DREAMS DEEDS, P104; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; Elzayat EA, 2006, EUR UROL, V49, P87, DOI 10.1016/j.eururo.2005.08.015; Eshhar Z, 2014, CANCER J, V20, P123, DOI 10.1097/PPO.0000000000000027; Gabizon A, 1998, J CONTROL RELEASE, V53, P275, DOI 10.1016/S0168-3659(97)00261-7; Getz D, 2013, OUTPUTS ISRAEL INT C; Getz D, 2013, SCI TECHNOLOGY INNOV; Gwynne P, 2013, NATURE, V503, pS16, DOI 10.1038/503S16a; Israel Academy of Sciences and Humanities, 2008, REP COMM ASS STAT BI; Israel Central Bureau of Statistics, 2014, JER ISR SURV COMM CO; Israel's life sciences industry, 2015, IATI 2015 REP; Jeron A, 2009, EUROINTERVENTION, V5, P552; Johnson Mardikian S., 2008, PHARMADEALS REV, V2008, P1756; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; LOTEM J, 1980, INT J CANCER, V25, P763, DOI 10.1002/ijc.2910250612; Marcus HJ, 2014, EUR SPINE J, V23, P291, DOI 10.1007/s00586-013-2879-1; Office of the chief scientist, 2016, TECHN INC PROGR OCS; Organisation for Economic Co-operation and Development, 2015, EC POL REF 2015 GO G, P223; Organisation for Economic Co-operation and Development, EC POL REF 2015 GO G; Parker JA, 2003, J DIGIT IMAGING, V16, P5, DOI 10.1007/s10278-002-6028-3; RABAU E, 1967, AM J OBSTET GYNECOL, V98, P92, DOI 10.1016/0002-9378(67)90137-8; RAZIN A, 1984, INT REV CYTOL, V92, P159; REISNER Y, 1983, BLOOD, V61, P341; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Revel M, 2003, PHARMACOL THERAPEUT, V100, P49, DOI 10.1016/S0163-7258(03)00085-8; Richter K, 1997, HDB CORONARY STENTS, P137; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schwab K., 2014, GLOBAL COMPETITIVENE; Schwammenthal E, 2007, US Patent, Patent No. [7,201,772, 2007, 7201772]; Senor Dan, 2011, START UP NATION STOR; Soto RG, 2004, ANESTH ANALG, V99, P379; Teitelbaum D, 1997, CELL MOL LIFE SCI, V53, P24, DOI 10.1007/PL00000576; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wallach D, 2013, CYTOKINE, V63, P225, DOI 10.1016/j.cyto.2013.05.027; Weinreb O, 2010, PROG NEUROBIOL, V92, P330, DOI 10.1016/j.pneurobio.2010.06.008; Yonath A, 2004, ANNU REV MICROBIOL, V58, P233, DOI 10.1146/annurev.micro.58.030603.123822	44	6	6	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2563	2569		10.1016/S0140-6736(17)30704-3	http://dx.doi.org/10.1016/S0140-6736(17)30704-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495116				2022-12-28	WOS:000403901800034
J	Pedro-Botet, J; Rubies-Prat, J				Pedro-Botet, Juan; Rubies-Prat, Juan			Statin-associated muscle symptoms: beware of the nocebo effect	LANCET			English	Editorial Material							INTOLERANCE; IMPACT; PANEL		[Pedro-Botet, Juan] Hosp Mar, Lipid & Vasc Risk Unit, E-08003 Barcelona, Spain; [Pedro-Botet, Juan; Rubies-Prat, Juan] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Pedro-Botet, J (corresponding author), Hosp Mar, Lipid & Vasc Risk Unit, E-08003 Barcelona, Spain.; Pedro-Botet, J (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.	jpedrobotet@parcdesalutmar.cat						Banach M, 2015, ARCH MED SCI, V11, P1, DOI 10.5114/aoms.2015.49807; Gupta A, 2017, LANCET; KENNEDY W P, 1961, Med World, V95, P203; Mampuya WM, 2013, AM HEART J, V166, P597, DOI 10.1016/j.ahj.2013.06.004; Matthews A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3283; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Rizos CV, 2017, CURR MED RES OPIN, V33, P327, DOI 10.1080/03007995.2016.1255601; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Tobert JA, 2016, J CLIN LIPIDOL, V10, P739, DOI 10.1016/j.jacl.2016.05.002; Webster RK, 2016, HEALTH PSYCHOL, V35, P1334, DOI 10.1037/hea0000416; Wei MY, 2013, J CLIN LIPIDOL, V7, P472, DOI 10.1016/j.jacl.2013.03.001	11	16	16	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2445	2446		10.1016/S0140-6736(17)31163-7	http://dx.doi.org/10.1016/S0140-6736(17)31163-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28476289	Green Accepted			2022-12-28	WOS:000403901800005
J	Geng, L; Murray, LT; Mickley, LJ; Lin, P; Fu, Q; Schauer, AJ; Alexander, B				Geng, Lei; Murray, Lee T.; Mickley, Loretta J.; Lin, Pu; Fu, Qiang; Schauer, Andrew J.; Alexander, Becky			Isotopic evidence of multiple controls on atmospheric oxidants over climate transitions	NATURE			English	Article							NITRATE; TROPOSPHERE; METHANE; GREENLAND; CHEMISTRY; MODEL; PREINDUSTRIAL; VARIABILITY; CIRCULATION; DELTA-O-17	The abundance of tropospheric oxidants, such as ozone (O-3) and hydroxyl (OH) and peroxy radicals (HO2 + RO2), determines the lifetimes of reduced trace gases such as methane and the production of particulate matter important for climate and human health. The response of tropospheric oxidants to climate change is poorly constrained owing to large uncertainties in the degree to which processes that influence oxidants may change with climate(1) and owing to a lack of palaeo-records with which to constrain levels of atmospheric oxidants during past climate transitions(2). At present, it is thought that temperature-dependent emissions of tropospheric O-3 precursors and water vapour abundance determine the climate response of oxidants, resulting in lower tropospheric O-3 in cold climates while HOx (= OH + HO2 + RO2) remains relatively buffered(3). Here we report observations of oxygen-17 excess of nitrate (a proxy for the relative abundance of atmospheric O-3 and HOx) from a Greenland ice core over the most recent glacial-interglacial cycle and for two Dansgaard-Oeschger events. We find that tropospheric oxidants are sensitive to climate change with an increase in the O-3/HOx ratio in cold climates, the opposite of current expectations. We hypothesize that the observed increase in O-3/HOx in cold climates is driven by enhanced stratosphere-to-troposphere transport of O-3, and that reactive halogen chemistry is also enhanced in cold climates. Reactive halogens influence the oxidative capacity of the troposphere directly as oxidants themselves and indirectly(4) via their influence on O-3 and HOx. The strength of stratosphere-to-troposphere transport is largely controlled by the Brewer-Dobson circulation(5), which may be enhanced in colder climates owing to a stronger meridional gradient of sea surface temperatures(6), with implications for the response of tropospheric oxidants(7) and stratospheric thermal and mass balance(8). These two processes may represent important, yet relatively unexplored, climate feedback mechanisms during major climate transitions.	[Geng, Lei; Fu, Qiang; Alexander, Becky] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Geng, Lei] Univ Grenoble Alpes, Inst Geosci & Environm, F-38508 Grenoble, France; [Geng, Lei] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Anhui, Peoples R China; [Murray, Lee T.] Univ Rochester, Dept Earth & Environm Sci, Rochester, NY USA; [Mickley, Loretta J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lin, Pu] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA; [Schauer, Andrew J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Rochester; Harvard University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of Washington; University of Washington Seattle	Alexander, B (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	beckya@uw.edu	Lin, Pu/D-4393-2014; Murray, Lee/F-2296-2014; Alexander, Becky/N-7048-2013; Geng, Lei/M-3418-2018; Murray, Lee Thomas/AAE-2840-2020; Fu, Qiang/W-5836-2019	Lin, Pu/0000-0003-2577-6094; Murray, Lee/0000-0002-3447-3952; Alexander, Becky/0000-0001-9915-4621; Geng, Lei/0000-0003-2175-2538; Murray, Lee Thomas/0000-0002-3447-3952; Schauer, Andrew/0000-0002-5941-5396	NSF [AGS 1103163, PLR 1106317, PLR 1244817, AGS 1102880]; NASA Postdoctoral Program Fellowship [NNH06CC03B]; NASA [NNX13AN49G]; National Oceanic and Atmospheric Administration, US Department of Commerce [NA14OAR4320106]	NSF(National Science Foundation (NSF)); NASA Postdoctoral Program Fellowship; NASA(National Aeronautics & Space Administration (NASA)); National Oceanic and Atmospheric Administration, US Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA)	We acknowledge financial support from NSF awards AGS 1103163, PLR 1106317 and PLR 1244817 (to B.A.) and AGS 1102880 (to L.J.M. and L.T.M.). L.T.M. was also supported by the NASA Postdoctoral Program Fellowship administered by Oak Ridge Associated Universities (NNH06CC03B). Q.F. is supported by NASA Grant NNX13AN49G. P.L. is supported by NA14OAR4320106 from the National Oceanic and Atmospheric Administration, the US Department of Commerce. The statements, findings, conclusions, and recommendations are those of the author(s) and do not necessarily reflect the views of the National Oceanic and Atmospheric Administration, or the US Department of Commerce. We thank the National Ice Core Laboratory for providing the GISP2 ice-core samples, and the GISP2 team for ice-core drilling. We also thank our laboratory technician B. Vanden Heuvel for measurements of delta<SUP>18</SUP>O(H<INF>2</INF>O).	Alexander B, 2009, ATMOS CHEM PHYS, V9, P5043, DOI 10.5194/acp-9-5043-2009; Alexander B, 2015, CURR POLLUT REP, V1, P57, DOI 10.1007/s40726-015-0006-0; Alexander MJ, 2010, Q J ROY METEOR SOC, V136, P1103, DOI 10.1002/qj.637; Allan W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007369; Alley RB, 2007, ANNU REV EARTH PL SC, V35, P241, DOI 10.1146/annurev.earth.35.081006.131524; BARRIE LA, 1988, NATURE, V334, P138, DOI 10.1038/334138a0; Brook EJ, 1996, SCIENCE, V273, P1087, DOI 10.1126/science.273.5278.1087; Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Butchart N, 2014, REV GEOPHYS, V52, P157, DOI 10.1002/2013RG000448; CLIMAP Project Members, 1976, Science, V191, P1131; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Geng L, 2014, ATMOS CHEM PHYS, V14, P13361, DOI 10.5194/acp-14-13361-2014; Geng L, 2013, RAPID COMMUN MASS SP, V27, P2411, DOI 10.1002/rcm.6703; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Gupta P, 2009, RAPID COMMUN MASS SP, V23, P2534, DOI 10.1002/rcm.4100; Hegglin MI, 2009, NAT GEOSCI, V2, P687, DOI 10.1038/NGEO604; Holmes CD, 2013, ATMOS CHEM PHYS, V13, P285, DOI 10.5194/acp-13-285-2013; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Kaiser J, 2007, ANAL CHEM, V79, P599, DOI 10.1021/ac061022s; Kaplan JO, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002590; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Lin P, 2013, J GEOPHYS RES-ATMOS, V118, P73, DOI 10.1029/2012JD018813; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Miller GH, 2010, QUATERNARY SCI REV, V29, P1779, DOI 10.1016/j.quascirev.2010.02.008; Morin S, 2007, ATMOS CHEM PHYS, V7, P1451, DOI 10.5194/acp-7-1451-2007; Murray LT, 2014, ATMOS CHEM PHYS, V14, P3589, DOI 10.5194/acp-14-3589-2014; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; Olsen MA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008012; Persechino A, 2012, CLIM DYNAM, V39, P1021, DOI 10.1007/s00382-012-1432-y; Pfeiffer M, 2013, GEOSCI MODEL DEV, V6, P643, DOI 10.5194/gmd-6-643-2013; Rind D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037617; Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P20195, DOI 10.1029/2000JD900548; Savarino J, 2013, P NATL ACAD SCI USA, V110, P17668, DOI 10.1073/pnas.1216639110; Schmidt JA, 2016, J GEOPHYS RES-ATMOS, V121, P11819, DOI 10.1002/2015JD024229; Shepherd TG, 2011, J ATMOS SCI, V68, P784, DOI 10.1175/2010JAS3608.1; Sherwen T, 2017, ATMOS CHEM PHYS, V17, P1557, DOI 10.5194/acp-17-1557-2017; Sprenger M, 2007, J ATMOS SCI, V64, P1587, DOI 10.1175/JAS3911.1; Webb RS, 1997, NATURE, V385, P695, DOI 10.1038/385695a0; Xie B, 2016, ADV ATMOS SCI, V33, P819, DOI 10.1007/s00376-016-5193-0	39	28	34	17	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2017	546	7656					133	+		10.1038/nature22340	http://dx.doi.org/10.1038/nature22340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW3CR	28514452				2022-12-28	WOS:000402372800042
J	Jarvis, DE; Ho, YS; Lightfoot, DJ; Schmockel, SM; Li, B; Borm, TJA; Ohyanagi, H; Mineta, K; Michell, CT; Saber, N; Kharbatia, NM; Rupper, RR; Sharp, AR; Dally, N; Boughton, BA; Woo, YH; Gao, G; Schijlen, EGWM; Guo, XJ; Momin, AA; Negrao, S; Al-Babili, S; Gehring, C; Roessner, U; Jung, C; Murphy, K; Arold, ST; Gojobori, T; van der Linden, CG; van Loo, EN; Jellen, EN; Maughan, PJ; Tester, M				Jarvis, David E.; Ho, Yung Shwen; Lightfoot, Damien J.; Schmockel, Sandra M.; Li, Bo; Borm, Theo J. A.; Ohyanagi, Hajime; Mineta, Katsuhiko; Michell, Craig T.; Saber, Noha; Kharbatia, Najeh M.; Rupper, Ryan R.; Sharp, Aaron R.; Dally, Nadine; Boughton, Berin A.; Woo, Yong H.; Gao, Ge; Schijlen, Elio G. W. M.; Guo, Xiujie; Momin, Afaque A.; Negrao, Sonia; Al-Babili, Salim; Gehring, Christoph; Roessner, Ute; Jung, Christian; Murphy, Kevin; Arold, Stefan T.; Gojobori, Takashi; van der Linden, C. Gerard; van Loo, Eibertus N.; Jellen, Eric N.; Maughan, Peter J.; Tester, Mark			The genome of Chenopodium quinoa (vol 542, pg 307, 2017)	NATURE			English	Correction													Mineta, Katsuhiko/A-5455-2012; Negrao, Sonia/F-4787-2016	Mineta, Katsuhiko/0000-0002-4727-045X; Negrao, Sonia/0000-0001-8059-5240; Al-Babili, Salim/0000-0003-4823-2882; Momin, Afaque Ahmad/0000-0002-5058-9445; Boughton, Berin/0000-0001-6342-9814				Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370	1	6	6	12	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					510	510		10.1038/nature22384	http://dx.doi.org/10.1038/nature22384			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY8HE	28489823	Bronze			2022-12-28	WOS:000427104100001
J	Xu, GY; Greene, GH; Yoo, HJ; Liu, LJ; Marques, J; Motley, J; Dong, XN				Xu, Guoyong; Greene, George H.; Yoo, Heejin; Liu, Lijing; Marques, Jorge; Motley, Jonathan; Dong, Xinnian			Global translational reprogramming is a fundamental layer of immune regulation in plants	NATURE			English	Article							ETHYLENE-INSENSITIVE MUTANTS; MESSENGER-RNA; ARABIDOPSIS-THALIANA; IN-VIVO; LANDSCAPE; VECTORS; GENES	In the absence of specialized immune cells, the need for plants to reprogram transcription to transition from growth-related activities to defence is well understood(1,2). However, little is known about translational changes that occur during immune induction. Using ribosome footprinting, here we perform global translatome profiling on Arabidopsis exposed to the microbe-associated molecular pattern elf18. We find that during this pattern-triggered immunity, translation is tightly regulated and poorly correlated with transcription. Identification of genes with altered translational efficiency leads to the discovery of novel regulators of this immune response. Further investigation of these genes shows that messenger RNA sequence features are major determinants of the observed translational efficiency changes. In the 5' leader sequences of transcripts with increased translational efficiency, we find a highly enriched messenger RNA consensus sequence, R-motif, consisting of mostly purines. We show that R-motif regulates translation in response to pattern-triggered immunity induction through interaction with poly(A)-binding proteins. Therefore, this study provides not only strong evidence, but also a molecular mechanism, for global translational reprogramming during pattern-triggered immunity in plants.	[Xu, Guoyong; Greene, George H.; Yoo, Heejin; Liu, Lijing; Marques, Jorge; Motley, Jonathan; Dong, Xinnian] Duke Univ, Dept Biol, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA	Duke University; Howard Hughes Medical Institute	Dong, XN (corresponding author), Duke Univ, Dept Biol, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA.	xdong@duke.edu	Yoo, Heejin/L-3207-2019; Liu, Lijing/ADB-0506-2022	liu, lijing/0000-0003-0260-8493; Yoo, Heejin/0000-0002-9630-8207	National Institutes of Health [5R01 GM069594-11]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754, R01GM069594, R35GM118036, T32GM007184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from National Institutes of Health 5R01 GM069594-11 and the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (through grant GBMF3032) to X. Dong. We thank J. M. Alonso for ein4-1, wei7-4, and ers1-10 seeds; T. Girke, M. Hummel, and J. Bailey-Serres for providing the Ribo-Seq workflow package for data analyses; W. Wang, P. Y. Hsu, and P. N. Benfey for discussing the protocol; R. Zavaliev for the callose staining method; and the Arabidopsis Information Resource for gcn2, erf7, eicbp. b, pab2/4, and pab2/8 seeds. We thank P. Zwack and S. Zebell for comments on the manuscript.	Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dufresne PJ, 2008, J GEN VIROL, V89, P2339, DOI 10.1099/vir.0.2008/002139-0; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Gallie DR, 2014, TRANSLATION, V2, DOI 10.4161/2169074X.2014.959378; Galon Y, 2010, PLANTA, V232, P165, DOI 10.1007/s00425-010-1153-6; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Juntawong P, 2014, P NATL ACAD SCI USA, V111, pE203, DOI 10.1073/pnas.1317811111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei L, 2015, PLANT J, V84, P1206, DOI 10.1111/tpj.13073; Li JT, 2014, GENET MOL RES, V13, P7815, DOI 10.4238/2014.September.26.20; Liu MJ, 2013, PLANT CELL, V25, P3699, DOI 10.1105/tpc.113.114769; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukoszek R, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0915-0; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Miettinen TP, 2015, NUCLEIC ACIDS RES, V43, P1019, DOI 10.1093/nar/gku1310; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; von Arnim AG, 2014, PLANT SCI, V214, P1, DOI 10.1016/j.plantsci.2013.09.006; Wu SJ, 2014, PLANT SCI, V228, P118, DOI 10.1016/j.plantsci.2014.03.001; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2013, P NATL ACAD SCI USA, V110, P5748, DOI 10.1073/pnas.1302659110	38	98	104	16	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					487	+		10.1038/nature22371	http://dx.doi.org/10.1038/nature22371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514447	Green Published, Green Accepted			2022-12-28	WOS:000401906500053
J	Brinker, A				Brinker, Alyson			Scarlet Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brinker, Alyson] Navy Hosp Guam, Yigo, GU 96910 USA		Brinker, A (corresponding author), Navy Hosp Guam, Yigo, GU 96910 USA.	brinker.alyson@gmail.com							0	1	1	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1972	1972		10.1056/NEJMicm1612308	http://dx.doi.org/10.1056/NEJMicm1612308			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514617				2022-12-28	WOS:000401407500011
J	Cahill, KN; Katz, HR; Cui, J; Lai, JY; Kazani, S; Crosby-Thompson, A; Garofalo, D; Castro, M; Jarjour, N; DiMango, E; Erzurum, S; Trevor, JL; Shenoy, K; Chinchilli, VM; Wechsler, ME; Laidlaw, TM; Boyce, JA; Israel, E				Cahill, Katherine N.; Katz, Howard R.; Cui, Jing; Lai, Juying; Kazani, Shamsah; Crosby-Thompson, Allison; Garofalo, Denise; Castro, Mario; Jarjour, Nizar; DiMango, Emily; Erzurum, Serpil; Trevor, Jennifer L.; Shenoy, Kartik; Chinchilli, Vernon M.; Wechsler, Michael E.; Laidlaw, Tanya M.; Boyce, Joshua A.; Israel, Elliot			KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; INNATE LYMPHOID-CELLS; LONG-TERM TREATMENT; AIRWAY HYPERRESPONSIVENESS; MAST-CELLS; INFLAMMATION; QUESTIONNAIRE; ADULTS	BACKGROUND Mast cells are present in the airways of patients who have severe asthma despite glucocorticoid treatment; these cells are associated with disease characteristics including poor quality of life and inadequate asthma control. Stem cell factor and its receptor, KIT, are central to mast-cell homeostasis. We conducted a proof-of-principle trial to evaluate the effect of imatinib, a KIT inhibitor, on airway hyperresponsiveness, a physiological marker of severe asthma, as well as on airway mast-cell numbers and activation in patients with severe asthma. METHODS We conducted a randomized, double-blind, placebo-controlled, 24-week trial of imatinib in patients with poorly controlled severe asthma who had airway hyperresponsiveness despite receiving maximal medical therapy. The primary end point was the change in airway hyperresponsiveness, measured as the concentration of methacholine required to decrease the forced expiratory volume in 1 second by 20% (PC 20). Patients also underwent bronchoscopy. RESULTS Among the 62 patients who underwent randomization, imatinib treatment reduced airway hyperresponsiveness to a greater extent than did placebo. At 6 months, the methacholine PC 20 increased by a mean (+/- SD) of 1.73 +/- 0.60 doubling doses in the imatinib group, as compared with 1.07 +/- 0.60 doubling doses in the placebo group (P = 0.048). Imatinib also reduced levels of serum tryptase, a marker of mast-cell activation, to a greater extent than did placebo (decrease of 2.02 +/- 2.32 vs. 0.56 +/- 1.39 ng per milliliter, P = 0.02). Airway mast-cell counts declined in both groups. Muscle cramps and hypophosphatemia were more common in the imatinib group than in the placebo group. CONCLUSIONS In patients with severe asthma, imatinib decreased airway hyperresponsiveness, mast-cell counts, and tryptase release. These results suggest that KIT-dependent processes and mast cells contribute to the pathobiologic basis of severe asthma. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01097694.)	[Cahill, Katherine N.; Katz, Howard R.; Cui, Jing; Lai, Juying; Crosby-Thompson, Allison; Garofalo, Denise; Laidlaw, Tanya M.; Boyce, Joshua A.; Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Kazani, Shamsah] Novartis Inst BioMed Res, Cambridge, MA USA; [Castro, Mario] Washington Univ, St Louis, MO USA; [Jarjour, Nizar] Univ Wisconsin, Madison, WI 53706 USA; [DiMango, Emily] Columbia Univ, Med Ctr, New York, NY USA; [Erzurum, Serpil] Cleveland Clin, Cleveland, OH USA; [Trevor, Jennifer L.] Univ Alabama Birmingham, Birmingham, AL USA; [Shenoy, Kartik] Temple Univ, Philadelphia, PA 19122 USA; [Chinchilli, Vernon M.] Penn State Univ, Hershey, PA USA; [Wechsler, Michael E.] Natl Jewish Hlth, Denver, CO USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Columbia University; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Jewish Health	Israel, E (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.; Israel, E (corresponding author), Brigham & Womens Hosp, Div Allergy & Immunol, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org	Wechsler, Michael/AAC-5506-2019	Cahill, Katherine/0000-0002-8549-1835	National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [U01 HL102225, RO1 HL117945, RO1 AI078908, R37 AI052353, T32 AI007306-23, K23 AI118804]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL102225, R01HL117945, R01HL136209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078908, U19AI095219, K23AI118804, R37AI052353, T32AI007306] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH U01 HL102225, RO1 HL117945, RO1 AI078908, R37 AI052353, T32 AI007306-23, and K23 AI118804), and by contributions from the Vinik family and the Kaye family. Novartis provided imatinib free of charge.	[Anonymous], 2016, PRESCR INF GLEEV; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Boyd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108649; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Cerny-Reiterer S, 2015, ONCOTARGET, V6, P3071, DOI 10.18632/oncotarget.3074; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Da Silva CA, 2006, FUND CLIN PHARMACOL, V20, P21, DOI 10.1111/j.1472-8206.2005.00390.x; Farha S, 2014, PULM CIRC, V4, P452, DOI 10.1086/677359; Gibson PG, 2000, J ALLERGY CLIN IMMUN, V105, P752, DOI 10.1067/mai.2000.105319; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kraft M, 2003, CHEST, V124, P42, DOI 10.1378/chest.124.1.42; Limb SL, 2005, J ALLERGY CLIN IMMUN, V116, P1213, DOI 10.1016/j.jaci.2005.09.024; Makowska Joanna S, 2009, BMC Pulm Med, V9, P27, DOI 10.1186/1471-2466-9-27; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; MORROW JD, 1995, J INVEST DERMATOL, V104, P937, DOI 10.1111/1523-1747.ep12606209; MORROW JD, 1993, J CHROMATOGR-BIOMED, V612, P179, DOI 10.1016/0378-4347(93)80161-V; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Porsbjerg C, 2007, ANN ALLERG ASTHMA IM, V98, P44, DOI 10.1016/S1081-1206(10)60858-7; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Siddiqui S, 2008, J ALLERGY CLIN IMMUN, V122, P335, DOI 10.1016/j.jaci.2008.05.020; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Ward C, 2001, AM J RESP CRIT CARE, V164, P1718, DOI 10.1164/ajrccm.164.9.2102039; Wenzel S, 2005, AM J RESP CRIT CARE, V172, P149, DOI 10.1164/rccm.200409-1181PP; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	37	125	131	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1911	1920		10.1056/NEJMoa1613125	http://dx.doi.org/10.1056/NEJMoa1613125			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514613	Green Accepted			2022-12-28	WOS:000401407500005
J	Hattori, D; Aso, Y; Swartz, KJ; Rubin, GM; Abbott, LF; Axel, R				Hattori, Daisuke; Aso, Yoshinori; Swartz, Kurtis J.; Rubin, Gerald M.; Abbott, L. F.; Axel, Richard			Representations of Novelty and Familiarity in a Mushroom Body Compartment	CELL			English	Article							DOPAMINERGIC-NEURONS; EXTRINSIC NEURONS; TERM-MEMORY; DROSOPHILA; EXPRESSION; PLASTICITY; BODIES; SLEEP; TEMPERATURE; RETRIEVAL	Animals exhibit a behavioral response to novel sensory stimuli about which they have no prior knowledge. We have examined the neural and behavioral correlates of novelty and familiarity in the olfactory system of Drosophila. Novel odors elicit strong activity in output neurons (MBONs) of the alpha'3 compartment of the mushroom body that is rapidly suppressed upon repeated exposure to the same odor. This transition in neural activity upon familiarization requires odor-evoked activity in the dopaminergic neuron innervating this compartment. Moreover, exposure of a fly to novel odors evokes an alerting response that can also be elicited by optogenetic activation of alpha'3 MBONs. Silencing these MBONs eliminates the alerting behavior. These data suggest that the alpha'3 compartment plays a causal role in the behavioral response to novel and familiar stimuli as a consequence of dopamine-mediated plasticity at the Kenyon cell-MBON alpha'3 synapse.	[Hattori, Daisuke; Swartz, Kurtis J.; Abbott, L. F.; Axel, Richard] Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA.	ra27@columbia.edu	Aso, Yoshinori/ACJ-9439-2022	Axel, Richard/0000-0002-3141-4076	Jane Coffin Childs Memorial Funds; Simons Foundation; Mathers Foundation; Gatsby Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS064929] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Funds; Simons Foundation; Mathers Foundation; Gatsby Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Cori Bargmann, Barbara Noro, Vanessa Ruta, and Woj Wojtowicz for their comments on the manuscript; Melissa Metcalf and Anna Zhukovskaya for technical assistance; Ethan Bromberg-Martin, Kei Ito, Kenta Asahina, Andy Seeds, Steffi Hampel, and members of the Axel and Abbott laboratories for discussions; David Anderson, Anita Devineni, Josh Dubnau, Andre Fiala, Aljoscha Nern, Barret Pfeiffer, and Julie Simpson for fly stocks; and Phyllis Kisloff for assistance in the preparation of the manuscript. This work is supported by Jane Coffin Childs Memorial Funds (D.H.), Simons Foundation (L.F.A. and R.A.), Mathers Foundation (L.F.A. and R.A.), Gatsby Foundation (L.F.A. and R.A.), and Howard Hughes Medical Institute (Y.A., G.M.R., and R.A.). R.A. is an HHMI investigator.	Aso Y., 2016, ELIFE; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04577; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Berry JA, 2015, CELL, V161, P1656, DOI 10.1016/j.cell.2015.05.027; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bracker LB, 2013, CURR BIOL, V23, P1228, DOI 10.1016/j.cub.2013.05.029; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fisek M, 2014, NAT NEUROSCI, V17, P280, DOI 10.1038/nn.3613; Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hampel S, 2015, ELIFE, V4, DOI 10.7554/eLife.08758; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hige T, 2015, NEURON, V88, P985, DOI 10.1016/j.neuron.2015.11.003; Hige T, 2015, NATURE, V526, P258, DOI 10.1038/nature15396; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Hoopfer ED, 2015, ELIFE, V4, DOI 10.7554/eLife.11346; Ito K, 1998, LEARN MEMORY, V5, P52; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Khouri L, 2015, CURR OPIN NEUROBIOL, V35, P142, DOI 10.1016/j.conb.2015.08.003; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kirkhart C, 2015, J NEUROSCI, V35, P5950, DOI 10.1523/JNEUROSCI.3930-14.2015; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Malmierca MS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00019; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; Parnas M, 2013, NEURON, V79, P932, DOI 10.1016/j.neuron.2013.08.006; Perisse E, 2016, NEURON, V90, P1086, DOI 10.1016/j.neuron.2016.04.034; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Placais PY, 2012, NAT NEUROSCI, V15, P592, DOI 10.1038/nn.3055; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Seeds AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02951; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592	61	60	60	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					956	+		10.1016/j.cell.2017.04.028	http://dx.doi.org/10.1016/j.cell.2017.04.028			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV1OM	28502772	Bronze, Green Accepted			2022-12-28	WOS:000401515900019
J	Jain, A; Cifu, AS				Jain, Atul; Cifu, Adam S.			Antithrombotic Therapy for Venous Thromboembolic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; THROMBOSIS		[Jain, Atul] Mayo Clin, Div Consultat Med, Scottsdale, AZ USA; [Jain, Atul] Mayo Clin, Div Prevent Occupat & Aerosp Med, Scottsdale, AZ USA; [Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Carrier M, 2014, THROMB RES, V134, P1214, DOI 10.1016/j.thromres.2014.09.039; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Peiman S, 2016, THROMB RES, V138, P55, DOI 10.1016/j.thromres.2015.12.003; Simes J, 2014, CIRCULATION, V130, P1062, DOI 10.1161/CIRCULATIONAHA.114.008828; Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666	9	7	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					2008	2009		10.1001/jama.2017.1928	http://dx.doi.org/10.1001/jama.2017.1928			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510665				2022-12-28	WOS:000401315500020
J	Barrett, PM; Steinhubl, SR; Muse, ED; Topol, EJ				Barrett, Paddy M.; Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.			Digitising the mind	LANCET			English	Editorial Material									[Barrett, Paddy M.; Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	etopol@scripps.edu			US National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR001114]; Qualcomm Foundation	US National Institutes of Health/National Center for Advancing Translational Sciences; Qualcomm Foundation	The authors are supported by the US National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR001114 and a grant from the Qualcomm Foundation.		0	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1877	1877		10.1016/S0140-6736(17)31218-7	http://dx.doi.org/10.1016/S0140-6736(17)31218-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28513442				2022-12-28	WOS:000400973500013
J	McGann, JP				McGann, John P.			Poor human olfaction is a 19th-century myth	SCIENCE			English	Review							COMPARATIVE MORPHOMETRY; ORBITOFRONTAL CORTEX; ODOR IDENTIFICATION; BULB VOLUME; BRAIN; EVOLUTION; PRIMATES; SYSTEM; DISCRIMINATION; CHEMOSIGNALS	It is commonly believed that humans have a poor sense of smell compared to other mammalian species. However, this idea derives not from empirical studies of human olfaction but from a famous 19th-century anatomist's hypothesis that the evolution of human free will required a reduction in the proportional size of the brain's olfactory bulb. The human olfactory bulb is actually quite large in absolute terms and contains a similar number of neurons to that of other mammals. Moreover, humans have excellent olfactory abilities. We can detect and discriminate an extraordinary range of odors, we are more sensitive than rodents and dogs for some odors, we are capable of tracking odor trails, and our behavioral and affective states are influenced by our sense of smell.	[McGann, John P.] Rutgers State Univ, Behav & Syst Neurosci, Dept Psychol, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	McGann, JP (corresponding author), Rutgers State Univ, Behav & Syst Neurosci, Dept Psychol, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	john.mcgann@rutgers.edu			National Institute of Mental Health [R01 MH101293]; National Institute of Deafness and Other Communication Disorders [R01 DC013090]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013090] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This paper was supported by grants from the National Institute of Mental Health (R01 MH101293) and National Institute of Deafness and Other Communication Disorders (R01 DC013090). Photos of capybara and human in Fig. 3 are courtesy of L. Joseph at Silver Moon Photography, and the photo of the star-nosed mole is courtesy of K. Catania. I thank D. Glendinning for providing the human brain specimen, I. Defalco for assistance with graphics, and the members of the McGann Laboratory for helpful discussion and photographic assistance. I am especially grateful to the anonymous donor who generously donated their body for scientific purposes.	ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Ahs F, 2013, BIOL PSYCHOL, V92, P135, DOI 10.1016/j.biopsycho.2012.11.004; AMOORE JE, 1977, CHEM SENS FLAV, V2, P267, DOI 10.1093/chemse/2.3.267; BARON G, 1988, J HIRNFORSCH, V29, P509; Baum MJ, 2015, HORM BEHAV, V68, P53, DOI 10.1016/j.yhbeh.2014.06.003; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Broca P, 1879, REVUE DANTHROPOLOGIE, P385; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Cadiou H, 2014, J NEUROSCI, V34, P4857, DOI 10.1523/JNEUROSCI.0688-13.2014; Cometto-Muniz JE, 2008, PHARMACOL BIOCHEM BE, V89, P279, DOI 10.1016/j.pbb.2007.12.023; Croy I, 2013, CHEM SENSES, V38, P679, DOI 10.1093/chemse/bjt037; Cummings DM, 1997, J NEUROSCI, V17, P7433; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; DOTY RL, 1981, CHEM SENSES, V6, P351, DOI 10.1093/chemse/6.4.351; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; Finlay BL, 2011, PHILOS T R SOC B, V366, P2111, DOI 10.1098/rstb.2010.0344; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Freud S., 1905, DREI ABHANDLUNGEN ZU; Freud S., 1891, ZUR AUFFASSUNG DER A; Freud S., 1900, GW, V2; Freud Sigmund, 1909, GESAM MELTE WERKE, Vvii; Frumin I, 2015, ELIFE, V4, DOI 10.7554/eLife.05154; Gheusi Gilles, 2013, Curr Top Behav Neurosci, V15, P49, DOI 10.1007/7854_2012_228; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Golgi C., 1875, RIV SPERIMENTALE FRE, V1, P405; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gottfried JA, 2011, ANN NY ACAD SCI, V1239, P138, DOI 10.1111/j.1749-6632.2011.06268.x; GROSS EA, 1982, J ANAT, V135, P83; Guven SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034301; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; He W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00110; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herrick C. J., 1924, NEUROLOGICAL FOUNDAT; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; HINDS JW, 1981, J COMP NEUROL, V203, P441, DOI 10.1002/cne.902030308; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; Huart C, 2013, MOLECULES, V18, P11586, DOI 10.3390/molecules180911586; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Joussain P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00113; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Kass MD, 2013, J NEUROSCI, V33, P6594, DOI 10.1523/JNEUROSCI.1442-12.2013; Kavoi BM, 2011, INT J MORPHOL, V29, P939, DOI 10.4067/S0717-95022011000300047; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2005, EXP BRAIN RES, V160, P302, DOI 10.1007/s00221-004-2012-0; Laska M, 2005, CHEM SENSES, V30, P171, DOI 10.1093/chemse/bji013; Lassek A. M., 1957, THE HUMAN BRAIN FROM; Latchney SE, 2014, J APPL PHYSIOL, V116, P1593, DOI 10.1152/japplphysiol.01174.2013; Le Guerer A., 1992, THE MYSTERIOUS AND E; Leydig F., 1857, LEHRBUCH DER HISTOLO; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Li W, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00098; Lioy P., 2011, DUST THE INSIDE STOR; Loos HM, 2014, CHEM SENSES, V39, P693, DOI 10.1093/chemse/bju041; Lubke KT, 2015, HORM BEHAV, V68, P134, DOI 10.1016/j.yhbeh.2014.10.001; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Meister M, 2015, ELIFE, V4, DOI 10.7554/eLife.07865; Milinski M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2889; Mirich JM, 2002, J COMP NEUROL, V454, P361, DOI 10.1002/cne.10426; Moulton D. G., 1969, TASTE AND SMELL IN V, P227; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Mutic S, 2016, CHEM SENSES, V41, P35, DOI 10.1093/chemse/bjv058; NEGUS V, 1958, COMPARATIVE ANATOMY; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nummela S, 2013, J COMP PHYSIOL A, V199, P1077, DOI 10.1007/s00359-013-0846-2; Olender T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2960-3; Oliveira-Pinto AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111733; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Prieto-Godino LL, 2016, NATURE, V539, P93, DOI 10.1038/nature19824; Ribeiro PFM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00023; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sarrafchi A, 2017, PERCEPTION, V46, P333, DOI 10.1177/0301006616653136; Sarrafchi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080621; Schaal B., 1996, REV INT PSYCHOPATHOL, V22, P387; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135; Schiller F., 1979, PAUL BROCA; Secundo L, 2015, P NATL ACAD SCI USA, V112, P8750, DOI 10.1073/pnas.1424826112; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Shepherd GM, 2011, BRAIN RES REV, V66, P92, DOI 10.1016/j.brainresrev.2010.09.009; Smeets MAM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00096; Sorokin SP, 1988, CELL TISSUE BIOL TXB, P751; Spehr M, 2006, CELL MOL LIFE SCI, V63, P1476, DOI 10.1007/s00018-006-6109-4; Stephan H., 1988, P1; Turner W, 1890, J Anat Physiol, V25, P105; Walker J. C., 1991, THE HUMAN SENSE OF S, P261; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zwaardemaker H., 1895, DIE PHYSIOLOGIE DE G; Zwaardemaker H., 1898, ANN PSYCHOL, V5, P202, DOI [10.3406/psy.1898.3051, DOI 10.3406/PSY.1898.3051]	100	225	228	11	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338							eaam7263	10.1126/science.aam7263	http://dx.doi.org/10.1126/science.aam7263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495701	Green Accepted			2022-12-28	WOS:000400975200045
J	Wakeford, HR; Sing, DK; Kataria, T; Deming, D; Nikolov, N; Lopez, ED; Tremblin, P; Amundsen, DS; Lewis, NK; Mandell, AM; Fortney, JJ; Knutson, H; Benneke, B; Evans, TM				Wakeford, Hannah R.; Sing, David K.; Kataria, Tiffany; Deming, Drake; Nikolov, Nikolay; Lopez, Eric D.; Tremblin, Pascal; Amundsen, David S.; Lewis, Nikole K.; Mandell, Avi M.; Fortney, Jonathan J.; Knutson, Heather; Benneke, Bjorn; Evans, Thomas M.			HAT-P-26b: A Neptune-mass exoplanet with a well-constrained heavy element abundance	SCIENCE			English	Article							ATMOSPHERIC CIRCULATION; TRANSMISSION SPECTRUM; HOT; WATER; FRAMEWORK; METHANE; MODELS; CLOUDS; CLEAR	A correlation between giant-planet mass and atmospheric heavy elemental abundance was first noted in the past century from observations of planets in our own Solar System and has served as a cornerstone of planet-formation theory. Using data from the Hubble and Spitzer Space Telescopes from 0.5 to 5 micrometers, we conducted a detailed atmospheric study of the transiting Neptune-mass exoplanet HAT-P-26b. We detected prominent H2O absorption bands with a maximum base-to-peak amplitude of 525 parts per million in the transmission spectrum. Using the water abundance as a proxy for metallicity, we measured HAT-P-26b's atmospheric heavy element content (4.8(-4.0)(+21.5) times solar). This likely indicates that HAT-P-26b's atmosphere is primordial and obtained its gaseous envelope late in its disk lifetime, with little contamination from metal-rich planetesimals.	[Wakeford, Hannah R.; Lopez, Eric D.; Mandell, Avi M.] NASA, Goddard Space Flight Ctr, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA; [Sing, David K.; Nikolov, Nikolay; Evans, Thomas M.] Univ Exeter, Astrophys Grp, Phys Bldg,Stocker Rd, Exeter EX4 4QL, Devon, England; [Kataria, Tiffany] NASA, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Deming, Drake] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Lopez, Eric D.] Univ Edinburgh, Inst Astron, Royal Observ Edinburgh, Blackford Hill, Edinburgh, Midlothian, Scotland; [Tremblin, Pascal] Univ Paris Saclay, Univ Paris Sud, Maison Simulat,CEA, Univ Versailles St Quentin En Yvelines UVSQ,CNRS, F-91191 Gif Sur Yvette, France; [Amundsen, David S.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10025 USA; [Amundsen, David S.] NASA, Goddard Inst Space Studies, 2880 Broadway, New York, NY 10025 USA; [Lewis, Nikole K.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Fortney, Jonathan J.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Knutson, Heather; Benneke, Bjorn] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Exeter; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University System of Maryland; University of Maryland College Park; University of Edinburgh; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Space Telescope Science Institute; University of California System; University of California Santa Cruz; California Institute of Technology	Wakeford, HR (corresponding author), NASA, Goddard Space Flight Ctr, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA.	hannah.wakeford@nasa.gov	Wakeford, Hannah/H-7883-2018; Mandell, Avi M/F-9361-2012; Nikolov, Nikolay/H-6183-2015	Wakeford, Hannah/0000-0003-4328-3867; Mandell, Avi M/0000-0002-8119-3355; Kataria, Tiffany/0000-0003-3759-9080; Sing, David/0000-0001-6050-7645; Evans, Thomas/0000-0001-5442-1300; Nikolov, Nikolay/0000-0002-6500-3574; Tremblin, Pascal/0000-0001-6172-3403	NASA [NAS 5-26555]; NASA from the StSci [HST-GO-14260]; European Research Council under the European Union [336192, 313014, 247060 PEPS];  [GO-14110];  [GO-14260];  [90092]	NASA(National Aeronautics & Space Administration (NASA)); NASA from the StSci; European Research Council under the European Union(European Research Council (ERC)); ; ; 	This work 6 based on observations made with the NASA/European Space Agency (ESA) Hubble Space Telescope, obtained at the Space Telescope Science Institute (STScl), which 6 operated by the Association of Universities for Research in Astronomy Under NASA contract NAS 5-26555. The HST and Spitzer data are available at http://maststsci.edu under project numbers GO-14110 (PI:Sing) and GO-14260 (PI:Deming) and at http://sha.ipac.caltech.edu under project number 90092 (P.I. Jean-Michel Desert). The combined transmission spectrum is available in Table 1. Support for this work was provided by NASA through grants under the HST-GO-14260 program from the StSci. H.R.W. acknowledges support from the NASA Postdoctoral Progam, administered by Universgies Space Research Association, through a contract with NASA. Several authors acknowledge funding from the European Research Council under the European Union Seventh Framework Program: D.K.S., T.K., N.N. and T.M.E. under grant 336192; E.D.L. under grant 313014; and P.T. and D.S.A. under grant 247060 PEPS. The authors thank J. Goyal and B. Drummond for their contribritions to the ATMO model framework. the authors thank the anonymous reviewers for their contribution to this paper, including the statistical re:viewer who provided an interesting expansion and discussion.	Amundsen DS, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201323169; Batalha NM, 2014, P NATL ACAD SCI USA, V111, P12647, DOI 10.1073/pnas.1304196111; Bostroem K., 2011, STIS DATA HDB STSCI; Dressel L, 2017, WIDE FIELD CAMERA 3; Fletcher LN, 2009, ICARUS, V199, P351, DOI 10.1016/j.icarus.2008.09.019; Fortney JJ, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/80; Fraine J, 2014, NATURE, V513, P526, DOI 10.1038/nature13785; Hartman JD, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/138; Karkoschka E, 2011, ICARUS, V211, P780, DOI 10.1016/j.icarus.2010.08.013; Kataria T, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/1/9; Kataria T, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/86; Knutson HA, 2014, NATURE, V505, P66, DOI 10.1038/nature12887; Kreidberg L, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/1/66; Kreidberg L, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L27; Lee EJ, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/2/90; Lewis NK, 2010, ASTROPHYS J, V720, P344, DOI 10.1088/0004-637X/720/1/344; Line MR, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/137; Lopez ED, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/1; Lopez ED, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/2; Mordasini C, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201117350; Morley CV, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/172; Moses JI, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/34; Nikolov N, 2015, MON NOT R ASTRON SOC, V447, P463, DOI 10.1093/mnras/stu2433; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Sromovsky LA, 2011, ICARUS, V215, P292, DOI 10.1016/j.icarus.2011.06.024; Stevenson KB, 2016, ASTROPHYS J LETT, V817, DOI 10.3847/2041-8205/817/2/L16; Tremblin P, 2016, ASTROPHYS J LETT, V817, DOI 10.3847/2041-8205/817/2/L19; Tremblin P, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/1/L17; Venot O, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219310; Wakeford HR, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/10	33	132	132	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					628	+		10.1126/science.aah4668	http://dx.doi.org/10.1126/science.aah4668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495748	Green Accepted, Green Submitted			2022-12-28	WOS:000400975200052
J	Hayward, NK; Wilmott, JS; Waddell, N; Johansson, PA; Field, MA; Nones, K; Patch, AM; Kakavand, H; Alexandrov, LB; Burke, H; Jakrot, V; Kazakoff, S; Holmes, O; Leonard, C; Sabarinathan, R; Mularoni, L; Wood, S; Xu, QY; Waddell, N; Tembe, V; Pupo, GM; De Paoli-Iseppi, R; Vilain, RE; Shang, P; Lau, LMS; Dagg, RA; Schramm, SJ; Pritchard, A; Dutton-Regester, K; Newell, F; Fitzgerald, A; Shang, CA; Grimmond, SM; Pickett, HA; Yang, JY; Stretch, JR; Behren, A; Kefford, RF; Hersey, P; Long, GV; Cebon, J; Shackleton, M; Spillane, AJ; Saw, RPM; Lopez-Bigas, N; Pearson, JV; Thompson, JF; Scolyer, RA; Mann, GJ				Hayward, Nicholas K.; Wilmott, James S.; Waddell, Nicola; Johansson, Peter A.; Field, Matthew A.; Nones, Katia; Patch, Ann-Marie; Kakavand, Hojabr; Alexandrov, Ludmil B.; Burke, Hazel; Jakrot, Valerie; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Sabarinathan, Radhakrishnan; Mularoni, Loris; Wood, Scott; Xu, Qinying; Waddell, Nick; Tembe, Varsha; Pupo, Gulietta M.; De Paoli-Iseppi, Ricardo; Vilain, Ricardo E.; Shang, Ping; Lau, Loretta M. S.; Dagg, Rebecca A.; Schramm, Sarah-Jane; Pritchard, Antonia; Dutton-Regester, Ken; Newell, Felicity; Fitzgerald, Anna; Shang, Catherine A.; Grimmond, Sean M.; Pickett, Hilda A.; Yang, Jean Y.; Stretch, Jonathan R.; Behren, Andreas; Kefford, Richard F.; Hersey, Peter; Long, Georgina V.; Cebon, Jonathan; Shackleton, Mark; Spillane, Andrew J.; Saw, Robyn P. M.; Lopez-Bigas, Nuria; Pearson, John V.; Thompson, John F.; Scolyer, Richard A.; Mann, Graham J.			Whole-genome landscapes of major melanoma subtypes	NATURE			English	Article							TERT PROMOTER MUTATIONS; FREQUENT SOMATIC MUTATIONS; ACTIVATING MUTATIONS; RECURRENT MUTATIONS; MALIGNANT-MELANOMA; GENERAL FRAMEWORK; CANCER; SIGNATURES; REVEALS; INFERENCE	Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout the world. Here we report analysis of whole-genome sequences from cutaneous, acral and mucosal subtypes of melanoma. The heavily mutated landscape of coding and non-coding mutations in cutaneous melanoma resolved novel signatures of mutagenesis attributable to ultraviolet radiation. However, acral and mucosal melanomas were dominated by structural changes and mutation signatures of unknown aetiology, not previously identified in melanoma. The number of genes affected by recurrent mutations disrupting non-coding sequences was similar to that affected by recurrent mutations to coding sequences. Significantly mutated genes included BRAF, CDKN2A, NRAS and TP53 in cutaneous melanoma, BRAF, NRAS and NF1 in acral melanoma and SF3B1 in mucosal melanoma. Mutations affecting the TERT promoter were the most frequent of all; however, neither they nor ATRX mutations, which correlate with alternative telomere lengthening, were associated with greater telomere length. Most melanomas had potentially actionable mutations, most in components of the mitogen-activated protein kinase and phosphoinositol kinase pathways. The whole-genome mutation landscape of melanoma reveals diverse carcinogenic processes across its subtypes, some unrelated to sun exposure, and extends potential involvement of the non-coding genome in its pathogenesis.	[Hayward, Nicholas K.; Wilmott, James S.; Burke, Hazel; Jakrot, Valerie; Stretch, Jonathan R.; Kefford, Richard F.; Hersey, Peter; Long, Georgina V.; Spillane, Andrew J.; Saw, Robyn P. M.; Thompson, John F.; Scolyer, Richard A.; Mann, Graham J.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia; [Hayward, Nicholas K.; Waddell, Nicola; Johansson, Peter A.; Nones, Katia; Patch, Ann-Marie; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Wood, Scott; Xu, Qinying; Pritchard, Antonia; Dutton-Regester, Ken; Newell, Felicity; Pearson, John V.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Wilmott, James S.; Kakavand, Hojabr; De Paoli-Iseppi, Ricardo; Vilain, Ricardo E.; Shang, Ping; Scolyer, Richard A.] Univ Sydney, Sydney Med Sch, Discipline Pathol, Sydney, NSW 2006, Australia; [Waddell, Nicola; Nones, Katia; Patch, Ann-Marie; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Wood, Scott; Xu, Qinying; Waddell, Nick; Pearson, John V.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4072, Australia; [Field, Matthew A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld 4878, Australia; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Sabarinathan, Radhakrishnan; Mularoni, Loris; Lopez-Bigas, Nuria] Univ Pompeu Fabra, IMIM Hosp Mar, Med Res Inst, Res Program Biomed Informat, Barcelona 08003, Catalonia, Spain; [Sabarinathan, Radhakrishnan; Mularoni, Loris; Lopez-Bigas, Nuria] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Tembe, Varsha; Pupo, Gulietta M.; Schramm, Sarah-Jane; Mann, Graham J.] Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW 2145, Australia; [Lau, Loretta M. S.; Pickett, Hilda A.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW 2145, Australia; [Dagg, Rebecca A.] Univ Sydney, Childrens Hosp Westmead, Sydney, NSW 2145, Australia; [Fitzgerald, Anna; Shang, Catherine A.] Bioplatforms Australia, Sydney, NSW 2109, Australia; [Grimmond, Sean M.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic 3052, Australia; [Yang, Jean Y.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Behren, Andreas; Cebon, Jonathan] La Trobe Univ, Austin Hlth, Olivia Newton John Canc Res Inst, Melbourne, Vic 3084, Australia; [Kefford, Richard F.] Macquarie Univ, Sydney, NSW 2109, Australia; [Hersey, Peter] Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia; [Long, Georgina V.] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW 2065, Australia; [Shackleton, Mark] Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; [Shackleton, Mark] Univ Melbourne, Melbourne, Vic 3000, Australia; [Lopez-Bigas, Nuria] ICREA, Barcelona 08010, Spain; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW 2050, Australia	Melanoma Institute Australia; University of Sydney; QIMR Berghofer Medical Research Institute; University of Sydney; University of Queensland; James Cook University; United States Department of Energy (DOE); Los Alamos National Laboratory; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Sydney; Westmead Institute for Medical Research; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney; University of Melbourne; University of Sydney; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Macquarie University; University of Sydney; Centenary Institute; Royal North Shore Hospital; Peter Maccallum Cancer Center; University of Melbourne; ICREA; University of Sydney	Mann, GJ (corresponding author), Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia.; Mann, GJ (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW 2145, Australia.	graham.mann@sydney.edu.au	Grimmond, Sean/K-3246-2019; Patch, Ann-Marie/C-4201-2018; Lau, Loretta MS/B-1565-2008; Yang, Jean YH/D-2920-2015; Wilmott, James/AGA-8227-2022; Pritchard, Antonia/F-4288-2010; Pearson, John/AAT-4211-2020; Alexandrov, Ludmil/AAS-1454-2021; hayward, nick/AAV-8802-2020; Leonard, Conrad/AAD-2587-2020; Jakrot, Valerie/AAH-2291-2019; Long, Georgina V/C-1771-2013; Newell, Felicity/AAN-1253-2020; Nones, Katia/AAX-6453-2021; Behren, Andreas/ABZ-2615-2022; Scolyer, Richard/AAE-8511-2019; Lopez-Bigas, Nuria/F-6193-2011; Waddell, Nicola/H-4929-2015; hayward, nicholas/C-1367-2015; Mann, Graham/G-4758-2014; Stretch AM D.Phil(Oxon), FRACS, Jonathan/M-7532-2014; Johansson, Peter/K-1053-2014	Grimmond, Sean/0000-0002-8102-7998; Patch, Ann-Marie/0000-0001-6121-4019; Lau, Loretta MS/0000-0002-3172-0970; Yang, Jean YH/0000-0002-5271-2603; Wilmott, James/0000-0002-6750-5244; Pritchard, Antonia/0000-0001-5336-0454; Alexandrov, Ludmil/0000-0003-3596-4515; Leonard, Conrad/0000-0002-4131-2065; Long, Georgina V/0000-0001-8894-3545; Nones, Katia/0000-0003-1925-5196; Scolyer, Richard/0000-0002-8991-0013; Lopez-Bigas, Nuria/0000-0003-4925-8988; Waddell, Nicola/0000-0002-3950-2476; hayward, nicholas/0000-0003-4760-1033; Kakavand, Hojabr/0000-0002-3458-7853; Mann, Graham/0000-0003-1301-405X; Behren, Andreas/0000-0001-5329-280X; Field, Matthew/0000-0003-0788-6513; Thompson, John/0000-0002-2816-2496; Jakrot, Valerie/0000-0002-8578-5964; Stretch AM D.Phil(Oxon), FRACS, Jonathan/0000-0002-2556-2005; Johansson, Peter/0000-0001-7015-5452; Cebon, Jonathan/0000-0002-3898-950X; De Paoli-Iseppi, Ricardo/0000-0001-7724-9144; Dagg, Rebecca/0000-0002-3023-9616; Dutton-Regester, Ken/0000-0002-8884-6355; Kefford, Richard/0000-0001-9251-9229; Pearson, John/0000-0003-0904-4598	Melanoma Institute Australia; Bioplatforms Australia; New South Wales Ministry of Health; Cancer Council NSW; National Health and Medical Research Council of Australia (NHMRC); Cancer Institute NSW; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy; NHMRC Fellowships; Keith Boden Fellowship; University of Sydney Medical Foundation; Pfizer Australia; Victorian Endowment for Knowledge, Science and Innovation; NHMRC; J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; European Research Council [682398]; Victorian Cancer Agency; Victorian Cancer Biobank; Victorian State Government Operational Infrastructure Support Program; Melanoma Research Alliance; Melbourne Melanoma Project; National Nuclear Security Administration of the US Department of Energy; Los Alamos National Laboratory Institutional Computing Program [DE-AC52-06NA25396]; ICREA Funding Source: Custom	Melanoma Institute Australia; Bioplatforms Australia; New South Wales Ministry of Health; Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Keith Boden Fellowship; University of Sydney Medical Foundation(University of Sydney); Pfizer Australia(PfizerPfizer Australia); Victorian Endowment for Knowledge, Science and Innovation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; European Research Council(European Research Council (ERC)European Commission); Victorian Cancer Agency; Victorian Cancer Biobank; Victorian State Government Operational Infrastructure Support Program; Melanoma Research Alliance; Melbourne Melanoma Project; National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); Los Alamos National Laboratory Institutional Computing Program(United States Department of Energy (DOE)Los Alamos National Laboratory); ICREA(ICREA)	This work was supported by Melanoma Institute Australia, Bioplatforms Australia, the New South Wales Ministry of Health, Cancer Council NSW, National Health and Medical Research Council of Australia (NHMRC), Cancer Institute NSW, Australian Cancer Research Foundation and the National Collaborative Research Infrastructure Strategy. N.K.H., Nicola W., R.A.S., J.S.W. and K.D.-R. were supported by NHMRC Fellowships, K.N. by a Keith Boden Fellowship, G.V.L. by the University of Sydney Medical Foundation, M.S. by Pfizer Australia, the Victorian Endowment for Knowledge, Science and Innovation and NHMRC, L.B.A. by a J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory, and N.L.-B. by the European Research Council (Consolidator Grant 682398). Biobanking was supported by Melanoma Institute Australia, the Victorian Cancer Agency, Victorian Cancer Biobank, Victorian State Government Operational Infrastructure Support Program, Melanoma Research Alliance and the Melbourne Melanoma Project, and the efforts of patients, clinicians and other staff at health services across Australia. Cell lines were provided via the ABN-Oncology group, supported by NHMRC. Research at Los Alamos National Laboratory was under the auspices of the National Nuclear Security Administration of the US Department of Energy; the Los Alamos National Laboratory Institutional Computing Program was supported by contract DE-AC52-06NA25396. We acknowledge the support of colleagues at Melanoma Institute Australia, Royal Prince Alfred Hospital, NSW Health Pathology, Westmead Institute for Medical Research, Peter MacCallum Cancer Centre and Olivia Newton-John Cancer Research Institute. We thank D. Stetner for computing assistance.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Arafeh R, 2015, NAT GENET, V47, P1408, DOI 10.1038/ng.3427; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chi ZH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-85; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Ding L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111153; Dutton-Regester K, 2014, ONCOTARGET, V5, P2912, DOI 10.18632/oncotarget.2048; Dutton-Regester K, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12153; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Fu Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0480-5; Furney SJ, 2014, PIGM CELL MELANOMA R, V27, P835, DOI 10.1111/pcmr.12279; Furney SJ, 2013, J PATHOL, V230, P261, DOI 10.1002/path.4204; Griewank KG, 2014, MODERN PATHOL, V27, P502, DOI 10.1038/modpathol.2013.168; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Kinsella M, 2012, J COMPUT BIOL, V19, P662, DOI 10.1089/cmb.2012.0020; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lau LMS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks781; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liau JY, 2014, J CUTAN PATHOL, V41, P504, DOI 10.1111/cup.12323; Mardin BR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156505; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mularoni L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0994-0; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Ramamoorthy M, 2015, CANCER CELL, V28, P357, DOI 10.1016/j.ccell.2015.08.003; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Shain AH, 2015, NAT GENET, V47, P1194, DOI 10.1038/ng.3382; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	54	682	693	5	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					175	180		10.1038/nature22071	http://dx.doi.org/10.1038/nature22071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467829	Green Accepted, Green Submitted			2022-12-28	WOS:000400963800025
J	Myers, J				Myers, Julia			SPOT DIAGNOSIS A young man with elbow pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Myers, Julia] Frenchay Brain Injury Rehabil Ctr, Frenchay Pk Rd, Bristol, Avon, England		Myers, J (corresponding author), Frenchay Brain Injury Rehabil Ctr, Frenchay Pk Rd, Bristol, Avon, England.	julia.myers@nbt.nhs.uk						Hacking C, HETEROTOPIC OSSIFICA; Moreta J, 2014, TRAUMATIC BRAIN INJU, DOI [10.5772/57343, DOI 10.5772/57343]; Pek CH, 2014, SINGAP MED J, V55, pE119, DOI 10.11622/smedj.2014107; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2017	357								j1820	10.1136/bmj.j1820	http://dx.doi.org/10.1136/bmj.j1820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UK	28495850				2022-12-28	WOS:000401170200001
J	Tollefson, J				Tollefson, Jeff			Satellite images reveal gaps in global population data	NATURE			English	News Item																			0	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					141	142		10.1038/545141a	http://dx.doi.org/10.1038/545141a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492271	Bronze			2022-12-28	WOS:000400963800005
J	Lidington, I				Lidington, Iona			Jonathan Hildebrand Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		HILDEBRAND J, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2194	10.1136/bmj.j2194	http://dx.doi.org/10.1136/bmj.j2194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483793				2022-12-28	WOS:000401412700017
J	Buxton, RT; McKenna, MF; Mennitt, D; Fristrup, K; Crooks, K; Angeloni, L; Wittemyer, G				Buxton, Rachel T.; McKenna, Megan F.; Mennitt, Daniel; Fristrup, Kurt; Crooks, Kevin; Angeloni, Lisa; Wittemyer, George			Noise pollution is pervasive in US protected areas	SCIENCE			English	Article							EXPOSURE	Anthropogenic noise threatens ecological systems, including the cultural and biodiversity resources in protected areas. Using continental-scale sound models, we found that anthropogenic noise doubled background sound levels in 63% of U.S. protected area units and caused a 10-fold or greater increase in 21%, surpassing levels known to interfere with human visitor experience and disrupt wildlife behavior, fitness, and community composition. Elevated noise was also found in critical habitats of endangered species, with 14% experiencing a 10-fold increase in sound levels. However, protected areas with more stringent regulations had less anthropogenic noise. Our analysis indicates that noise pollution in protected areas is closely linked with transportation, development, and extractive land use, providing insight into where mitigation efforts can be most effective.	[Buxton, Rachel T.; Crooks, Kevin; Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [McKenna, Megan F.; Fristrup, Kurt] Natl Pk Serv, Nat Sounds & Night Skies Div, 1201 Oakridge Dr, Ft Collins, CO 80525 USA; [Mennitt, Daniel] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80525 USA; [Angeloni, Lisa] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; United States Department of the Interior; Colorado State University; Colorado State University	Buxton, RT (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	rachel.buxton@colostate.edu	Wittemyer, George/AFQ-1840-2022		National Park Service	National Park Service	This project was funded by the National Park Service. We thank E. Brown, D. Joyce, and numerous park and Colorado State University staff for acoustic data collection and analysis. We thank B. Noon and J. Berger for comments, T. Hefley for statistical advice, and staff of the USGS GAP project for assistance with PAD-US data. All data are publicly available at https://irma.nps.gov/DataStore/Reference/Profile/2239783.	[Anonymous], 2008, TECHNICAL SERIES CON, V36; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Benfield J.A., 2014, ECOPSYCHOLOGY, V6, P183, DOI [10.1089/eco.2014.0028, DOI 10.1089/ECO.2014.0028]; Brumm H., 2013, ANIMAL COMMUNICATION, V2; Coad L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0281; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; Francis CD, 2013, FRONT ECOL ENVIRON, V11, P305, DOI 10.1890/120183; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; Hatch LT, 2009, MAR ECOL PROG SER, V395, P223, DOI 10.3354/meps07945; Hobbs Richard J., 2003, Ecological Management & Restoration, V4, pS39, DOI 10.1046/j.1442-8903.4.s.5.x; Ising H, 2004, Noise Health, V6, P5; Krause B. L, 2002, WILD SOUNDSCAPES DIS; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lynch E, 2011, LANDSCAPE ECOL, V26, P1297, DOI 10.1007/s10980-011-9643-x; Mennitt DJ, 2016, NOISE CONTROL ENG J, V64, P342, DOI 10.3397/1/376384; Morley EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2683; National Research Council, 2010, TECHN QUIET AM; Rapoza A, 2015, J ACOUST SOC AM, V138, P2090, DOI 10.1121/1.4929934; Shamble PS, 2016, CURR BIOL, V26, P2913, DOI 10.1016/j.cub.2016.08.041; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	27	148	152	11	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					531	533		10.1126/science.aah4783	http://dx.doi.org/10.1126/science.aah4783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473587				2022-12-28	WOS:000400545700036
J	Baker, M				Baker, Monya			DISKS BACK FROM THE DEAD	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					117	118		10.1038/545117a	http://dx.doi.org/10.1038/545117a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470220	Bronze			2022-12-28	WOS:000400480400043
J	Forslund, K; Hildebrand, F; Nielsen, T; Falony, G; Le Chatelier, E; Sunagawa, S; Prifti, E; Vieira-Silva, S; Gudmundsdottir, V; Pedersen, HK; Arumugam, M; Kristiansen, K; Voigt, AY; Vestergaard, H; Hercog, R; Costea, PI; Kultima, JR; Li, JH; Jorgensen, T; Levenez, F; Dore, J; Nielsen, HB; Brunak, S; Raes, J; Hansen, T; Wang, J; Ehrlich, SD; Bork, P; Pedersen, O				Forslund, Kristoffer; Hildebrand, Falk; Nielsen, Trine; Falony, Gwen; Le Chatelier, Emmanuelle; Sunagawa, Shinichi; Prifti, Edi; Vieira-Silva, Sara; Gudmundsdottir, Valborg; Pedersen, Helle Krogh; Arumugam, Manimozhiyan; Kristiansen, Karsten; Voigt, Anita Yvonne; Vestergaard, Henrik; Hercog, Rajna; Costea, Paul Igor; Kultima, Jens Roat; Li, Junhua; Jorgensen, Torben; Levenez, Florence; Dore, Joel; Nielsen, H. Bjorn; Brunak, Soren; Raes, Jeroen; Hansen, Torben; Wang, Jun; Ehrlich, S. Dusko; Bork, Peer; Pedersen, Oluf		MetaHIT Consortium	Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota (vol 528, pg 262, 2015)	NATURE			English	Correction													Vieira-Silva, Sara/ABE-1247-2021; Bork, Peer/F-1813-2013; Li, Junhua/AAG-3919-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Pedersen, Oluf/AAG-8015-2020; Sunagawa, Shinichi/Q-5950-2019; Prifti, Edi/F-3967-2019; Dore, Joel/ABA-8921-2020; Arumugam, Manimozhiyan/E-1211-2011; LE CHATELIER, Emmanuelle/O-1243-2017; Kristiansen, Karsten/J-5148-2014; Falony, Gwen/AAN-5011-2020; Raes, Jeroen/D-7835-2018	Vieira-Silva, Sara/0000-0002-4616-7602; Bork, Peer/0000-0002-2627-833X; Li, Junhua/0000-0001-6784-1873; Arumugam, Manimozhiyan/0000-0002-0886-9101; Sunagawa, Shinichi/0000-0003-3065-0314; Prifti, Edi/0000-0001-8861-1305; Arumugam, Manimozhiyan/0000-0002-0886-9101; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Kristiansen, Karsten/0000-0002-6024-0917; Falony, Gwen/0000-0003-2450-0782; Hansen, Torben/0000-0001-8748-3831; Voigt, Anita Yvonne/0000-0002-6794-0385; Costea, Paul Igor/0000-0003-1645-3947; Pedersen, Oluf/0000-0002-3321-3972; Nielsen, Trine/0000-0002-2066-7895; Jorgensen, Torben/0000-0001-9453-2830; Raes, Jeroen/0000-0002-1337-041X; Vestergaard, Henrik/0000-0003-3090-269X; Gudmundsdottir, Valborg/0000-0002-7459-1603	Steno Diabetes Center Copenhagen (SDCC) [SDCC 3.A Complications] Funding Source: researchfish	Steno Diabetes Center Copenhagen (SDCC)		Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766	1	33	38	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					116	116		10.1038/nature22318	http://dx.doi.org/10.1038/nature22318			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ4ZG	28470190	Bronze			2022-12-28	WOS:000427600300001
J	Leach, JE; Triplett, LR; Argueso, CT; Trivedi, P				Leach, Jan E.; Triplett, Lindsay R.; Argueso, Cristiana T.; Trivedi, Pankaj			Communication in the Phytobiome	CELL			English	Review							HOMOSERINE LACTONE; SALICYLIC-ACID; FUNGAL COMMUNITIES; PLANT DEFENSES; SOIL ALGAE; BACTERIAL; MICROBIOME; BIODIVERSITY; DIVERSITY; INFECTION	The phytobiome is composed of plants, their environment, and diverse interacting microscopic and macroscopic organisms, which together influence plant health and productivity. These organisms form complex networks that are established and regulated through nutrient cycling, competition, antagonism, and chemical communication mediated by a diverse array of signaling molecules. Integration of knowledge of signaling mechanisms with that of phytobiome members and their networks will lead to a new understanding of the fate and significance of these signals at the ecosystem level. Such an understanding could lead to new biological, chemical, and breeding strategies to improve crop health and productivity.	[Leach, Jan E.; Argueso, Cristiana T.; Trivedi, Pankaj] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Triplett, Lindsay R.] Connecticut Agr Expt Stn, Dept Plant Pathol & Ecol, New Haven, CT 06511 USA	Colorado State University; Connecticut Agricultural Experiment Station	Leach, JE (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	jan.leach@colostate.edu	Trivedi, Pankaj/AAE-7135-2021		Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2014-67013-21564]; Colorado Agricultural Experiment Station	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture; Colorado Agricultural Experiment Station	The authors thank Alejandra Huerta and Stephen Cohen for reviewing the manuscript. This work was partially supported by the Agriculture and Food Research Initiative competitive grant no. 2014-67013-21564 to J.E.L. and L.R.T. from the USDA National Institute of Food and Agriculture, and the Colorado Agricultural Experiment Station to J.E.L., C.T.A., and P.T. We also thank the American Phytopathological Society for their vision in promoting the study of phytobiomes as a system. The authors apologize for the inability to cite all relevant literature due to space constraints.	Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Andersen KS, 2004, BIOL FERT SOILS, V40, P230, DOI 10.1007/s00374-004-0774-y; Andujar C, 2015, MOL ECOL, V24, P3603, DOI 10.1111/mec.13195; Asghar A, 2012, PROTIST, V163, P25, DOI 10.1016/j.protis.2010.12.002; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; Baca B., 2007, ASSOCIATIVE ENDOPHYT, P113; Bacon C.W., 2016, J AGR FOOD CHEM; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Berens M., 2017, ANN REV PHY IN PRESS, V55; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Bodenhausen N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004283; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Casteel CL., 2016, CURRENT RES TOPICS P, P217, DOI [10.1007/978-3-319-32919-2_9, DOI 10.1007/978-3-319-32919-2_9]; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Corral-Lugo A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa8271; de Souza RSC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28774; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Delalande L, 2005, FEMS MICROBIOL ECOL, V52, P13, DOI 10.1016/j.femsec.2004.10.005; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Fonseca-Garcia C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00150; Fu SF, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1048052; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gopal M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00355; Grossmann L, 2016, ISME J, V10, P2269, DOI 10.1038/ismej.2016.10; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hansen RA, 2001, PLANT SOIL, V236, P139, DOI 10.1023/A:1012705231992; Hartmann A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00131; Hatano E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0188-3; Hol WHG, 2013, J CHEM ECOL, V39, P1193, DOI 10.1007/s10886-013-0338-4; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; Hsueh YP, 2013, CURR BIOL, V23, P83, DOI 10.1016/j.cub.2012.11.035; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Jones SE, 2017, ELIFE, V6, DOI 10.7554/eLife.21738; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Kaiser R, 2006, SCIENCE, V311, P806, DOI 10.1126/science.1119499; Kanchiswamy CN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00151; Kergunteuil A, 2016, INSECTS, V7, DOI 10.3390/insects7040070; Khaitov B, 2015, ECOL EVOL, V5, P3756, DOI 10.1002/ece3.1654; KHAN ZR, 1985, ENVIRON ENTOMOL, V14, P297, DOI 10.1093/ee/14.3.297; Kong P, 2010, FEMS MICROBIOL LETT, V303, P55, DOI 10.1111/j.1574-6968.2009.01861.x; Kreuzer K, 2006, SOIL BIOL BIOCHEM, V38, P1665, DOI 10.1016/j.soilbio.2005.11.027; Kudoyarova GR, 2015, SUSTAIN DEV BIODIVER, V12, P69, DOI 10.1007/978-3-319-24654-3_4; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lee JH, 2015, TRENDS MICROBIOL, V23, P707, DOI 10.1016/j.tim.2015.08.001; Leveau JHJ, 2005, APPL ENVIRON MICROB, V71, P2365, DOI 10.1128/AEM.71.5.2365-2371.2005; Li NX, 2016, FUNGAL BIOL REV, V30, P134, DOI 10.1016/j.fbr.2016.06.004; Lin CS, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-41; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Manosalva P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8795; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Martinez-Medina A, 2017, NEW PHYTOL, V213, P1363, DOI 10.1111/nph.14251; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Morrien E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14349; Muller H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00138; Phytobiomes Roadmap, 2016, PHYT ROADM RES TRANS, P15; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Proenca DN, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.415; Qu TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159680; Radhika V, 2015, PLANT PHYSIOL, V169, P1118, DOI 10.1104/pp.15.00787; Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Remus-Emsermann MNP, 2012, ISME J, V6, P756, DOI 10.1038/ismej.2011.209; Richard B, 2012, EUR J SOIL BIOL, V53, P62, DOI 10.1016/j.ejsobi.2012.08.005; Rojas X, 2016, MICROB ECOL, V72, P197, DOI 10.1007/s00248-016-0750-8; Roossinck MJ, 2015, MOL PLANT PATHOL, V16, P331, DOI 10.1111/mpp.12241; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Salvaudon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2959; Schaefer AL, 2013, APPL ENVIRON MICROB, V79, P5745, DOI 10.1128/AEM.01417-13; Schmidt R, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01495; Shanks CM, 2016, MOL PLANT MICROBE IN, V29, P57, DOI 10.1094/MPMI-07-15-0156-R; Shigenaga AM, 2016, SEMIN CELL DEV BIOL, V56, P174, DOI 10.1016/j.semcdb.2016.06.005; Shikano I., 2017, ANNU REV PH IN PRESS, V55; Siles JA, 2016, MICROB ECOL, V72, P207, DOI 10.1007/s00248-016-0748-2; Smith DL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00722; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Szabo Z, 2002, MOL GENET GENOMICS, V268, P362, DOI 10.1007/s00438-002-0756-4; Tait K, 2005, ENVIRON MICROBIOL, V7, P229, DOI 10.1111/j.1462-2920.2004.00706.x; Teplitski M, 2011, CHEM REV, V111, P100, DOI 10.1021/cr100045m; Trivedi P, 2016, ISME J, V10, P2593, DOI 10.1038/ismej.2016.65; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Vayssieres A, 2015, PLANT PHYSIOL, V169, P890, DOI 10.1104/pp.114.255620; Vikram A, 2010, J APPL MICROBIOL, V109, P515, DOI 10.1111/j.1365-2672.2010.04677.x; Vos IA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00639; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Werner S, 2016, APPL MICROBIOL BIOT, V100, P8651, DOI 10.1007/s00253-016-7792-1; Williams TR, 2014, MBIO, V5, DOI 10.1128/mBio.01564-14; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Wubs ERJ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.107, 10.1038/nplants.2016.107]; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zancan S, 2006, AGR ECOSYST ENVIRON, V112, P1, DOI 10.1016/j.agee.2005.06.018; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	107	134	137	10	156	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					587	596		10.1016/j.cell.2017.04.025	http://dx.doi.org/10.1016/j.cell.2017.04.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475891	Bronze			2022-12-28	WOS:000400560900006
J	Mendelson, M; Balasegaram, M; Jinks, T; Pulcini, C; Sharland, M				Mendelson, Marc; Balasegaram, Manica; Jinks, Tim; Pulcini, Celine; Sharland, Mike			Antibiotic resistance has a language problem	NATURE			English	Editorial Material									[Mendelson, Marc] Univ Cape Town, Infect Dis, Rondebosch, South Africa; [Mendelson, Marc] Univ Cape Town, Div Infect Dis, Rondebosch, South Africa; [Mendelson, Marc] Univ Cape Town, Groote Schuur Hosp, HIV Med, Rondebosch, South Africa; [Balasegaram, Manica] Global Antibiot Res & Dev Partnership, Drugs Neglected Dis Initiat, Geneva, Switzerland; [Jinks, Tim] Wellcome Trust Res Labs, Drug Resistant Infect Program, London, England; [Pulcini, Celine] Nancy Univ Hosp, Infect Dis, Nancy, France; [Pulcini, Celine] Univ Lorraine, APEMAC, EA 4360, Nancy, France; [Sharland, Mike] Univ London, St Georges Hosp, Inst Infect & Immun, Paediat Infect Dis, London, England	University of Cape Town; University of Cape Town; University of Cape Town; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; St Georges University London; University of London	Mendelson, M (corresponding author), Univ Cape Town, Infect Dis, Rondebosch, South Africa.; Mendelson, M (corresponding author), Univ Cape Town, Div Infect Dis, Rondebosch, South Africa.; Mendelson, M (corresponding author), Univ Cape Town, Groote Schuur Hosp, HIV Med, Rondebosch, South Africa.	marc.mendelson@uct.ac.za		sharland, mike/0000-0001-8626-8291; Mendelson, Marc/0000-0001-6668-3893				[Anonymous], 2016, REV ANT RES TACKL DR; [Anonymous], 2016, VIET NAM NEWS; Lineman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138996; Wellcome Trust, 2015, EXPLORING CONSUMER P, P47; WHO, 2015, ANT RES MULT PUBL AW; [No title captured]	6	53	54	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					23	25		10.1038/545023a	http://dx.doi.org/10.1038/545023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470219	Bronze, Green Accepted			2022-12-28	WOS:000400480400012
J	Sacks, CA; Avorn, J; Kesselheim, AS				Sacks, Chana A.; Avorn, Jerry; Kesselheim, Aaron S.			The Failure of Solanezumab - How the FDA Saved Taxpayers Billions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Sacks, Chana A.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, CA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA.							[Anonymous], 1996, AR DON HYDR PRESCR I; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004	3	38	39	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1706	1708		10.1056/NEJMp1701047	http://dx.doi.org/10.1056/NEJMp1701047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6ZH	28467878				2022-12-28	WOS:000400442300003
J	Dabora, MC; Turaga, N; Schulman, K				Dabora, Matan C.; Turaga, Namrata; Schulman, KevinA.			Financing and Distribution of Pharmaceuticals in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dabora, Matan C.; Turaga, Namrata; Schulman, KevinA.] Harvard Sch Business, Boston, MA USA; [Schulman, KevinA.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA	Harvard University; Duke University	Schulman, K (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu			Amylin; Janssen; Merck; Verizon; Banner Health; Cytokinetics; Genentech; NeuroCog Trials; Novartis; Nutrition Science Initiative; Sanofi Aventis	Amylin; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Verizon; Banner Health; Cytokinetics; Genentech(Roche HoldingGenentech); NeuroCog Trials; Novartis(Novartis); Nutrition Science Initiative; Sanofi Aventis(Sanofi-Aventis)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Schulman reported receiving grants from Amylin, Janssen, Merck, and Verizon; receiving consulting fees from Banner Health, Cytokinetics, Genentech, NeuroCog Trials, Novartis, Nutrition Science Initiative, and Sanofi Aventis; serving as senior associate editor for Health Services Research; serving on the board of directors for, and holding equity in, Cancer Consultants Inc, Faculty Connection LLC, and Physician Education Leadership Institute; serving as a managing member of, and holding equity in, Bivarus Inc; and serving on the board of directors for Anthelio Healthcare Solutions Inc and Cue Biologics. No other authors reported disclosures.	[Anonymous], 2007, PRESCR DRUG PRIC PRI; Centers for Disease Control and Prevention (CDC), HLTH US 2015 PRESCR; Centers for Medicare & Medicaid Services (CMS), NAT HLTH EXP DAT PRO; Hirsch BR, 2014, HEALTH AFFAIR, V33, P1714, DOI 10.1377/hlthaff.2014.0558; Modern Distribution Management (MDM), 2017, 2016 MDM MARK LEAD T; QuintilesIMS Institute, 2016, MED US SPEND US REV; SK&A, 2016, NAT PHARM MARK SUMM; Warraich HJ, 2016, NEW ENGL J MED, V374, P1005, DOI 10.1056/NEJMp1515769	8	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					21	22		10.1001/jama.2017.5607	http://dx.doi.org/10.1001/jama.2017.5607			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28505252				2022-12-28	WOS:000404717700007
J	Capretta, JC				Capretta, James C.			Building a Broader Consensus for Health Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBAMACARE		[Capretta, James C.] Amer Enterprise Inst Publ Policy Res, 1789 Massachusetts Ave,NW, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Capretta, JC (corresponding author), Amer Enterprise Inst Publ Policy Res, 1789 Massachusetts Ave,NW, Washington, DC 20036 USA.	jcapretta@aei.org						Butler SM, 2017, JAMA-J AM MED ASSOC, V317, P244, DOI 10.1001/jama.2016.19918; Carroll AE, 2017, JAMA-J AM MED ASSOC, V317, P348, DOI 10.1001/jama.2016.19913; Chatterjee P, 2017, JAMA-J AM MED ASSOC, V317, P1007, DOI 10.1001/jama.2017.0901; Herzlinger RE, 2017, JAMA-J AM MED ASSOC, V317, P1409, DOI 10.1001/jama.2017.1475; Levitt L, 2017, JAMA-J AM MED ASSOC, V317, P795, DOI 10.1001/jama.2017.0661	5	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2273	2274		10.1001/jama.2017.6689	http://dx.doi.org/10.1001/jama.2017.6689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28505254				2022-12-28	WOS:000403149900007
J	Ahern, AL; Wheeler, GM; Aveyard, P; Boyland, EJ; Halford, JCG; Mander, AP; Woolston, J; Thomson, AM; Tsiountsioura, M; Cole, D; Mead, BR; Irvine, L; Turner, D; Suhrcke, M; Pimpin, L; Retat, L; Jaccard, A; Webber, L; Cohn, SR; Jebb, SA				Ahern, Amy L.; Wheeler, Graham M.; Aveyard, Paul; Boyland, Emma J.; Halford, Jason C. G.; Mander, Adrian P.; Woolston, Jennifer; Thomson, Ann M.; Tsiountsioura, Melina; Cole, Darren; Mead, Bethan R.; Irvine, Lisa; Turner, David; Suhrcke, Marc; Pimpin, Laura; Retat, Lise; Jaccard, Abbygail; Webber, Laura; Cohn, Simon R.; Jebb, Susan A.			Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial	LANCET			English	Article							MINIMAL INTERVENTION CONTROL; COMMERCIAL PROVIDER; MANAGEMENT PROGRAMS; COST-EFFECTIVENESS; CLINICAL-TRIALS; SELF-HELP; METAANALYSIS; IMPACT; REDUCTION; OBESITY	Background Evidence exist that primary care referral to an open-group behavioural programme is an effective strategy for management of obesity, but little evidence on optimal intervention duration is available. We aimed to establish whether 52-week referral to an open-group weight-management programme would achieve greater weight loss and improvements in a range of health outcomes and be more cost-effective than the current practice of 12-week referrals. Methods In this non-blinded, parallel-group, randomised controlled trial, we recruited participants who were aged 18 years or older and had body-mass index (BMI) of 28 kg/m(2) or higher from 23 primary care practices in England. Participants were randomly assigned (2: 5: 5) to brief advice and self-help materials, a weight-management programme (Weight Watchers) for 12 weeks, or the same weight-management programme for 52 weeks. We followed-up participants over 2 years. The primary outcome was weight at 1 year of follow-up, analysed with mixed-effects models according to intention-to-treat principles and adjusted for centre and baseline weight. In a hierarchical closed-testing procedure, we compared combined behavioural programme arms with brief intervention, then compared the 12-week programme and 52-week programme. We did a within-trial cost-effectiveness analysis using person-level data and modelled outcomes over a 25-year time horizon using microsimulation. This study is registered with Current Controlled Trials, number ISRCTN82857232. Findings Between Oct 18, 2012, and Feb 10, 2014, we enrolled 1269 participants. 1267 eligible participants were randomly assigned to the brief intervention (n=211), the 12-week programme (n=528), and the 52-week programme (n=528). Two participants in the 12-week programme had been found to be ineligible shortly after randomisation and were excluded from the analysis. 823 (65%) of 1267 participants completed an assessment at 1 year and 856 (68%) participants at 2 years. All eligible participants were included in the analyses. At 1 year, mean weight changes in the groups were -3.26 kg (brief intervention), -4.75 kg (12-week programme), and -6.76 kg (52-week programme). Participants in the behavioural programme lost more weight than those in the brief intervention (adjusted difference -2.71 kg, 95% CI -3.86 to -1.55; p<0.0001). The 52-week programme was more effective than the 12-week programme (-2.14 kg, -3.05 to -1.22; p<0.0001). Differences between groups were still significant at 2 years. No adverse events related to the intervention were reported. Over 2 years, the incremental cost-effectiveness ratio (ICER; compared with brief intervention) was 159 pound per kg lost for the 52-week programme and 91 pound per kg for the 12-week programme. Modelled over 25 years after baseline, the ICER for the 12-week programme was dominant compared with the brief intervention. The ICER for the 52-week programme was cost-effective compared with the brief intervention (2394 pound per quality-adjusted life-year [ QALY]) and the 12-week programme (3804 pound per QALY). Interpretation For adults with overweight or obesity, referral to this open-group behavioural weight-loss programme for at least 12 weeks is more effective than brief advice and self-help materials. A 52-week programme produces greater weight loss and other clinical benefits than a 12-week programme and, although it costs more, modelling suggests that the 52-week programme is cost-effective in the longer term. Funding National Prevention Research Initiative, Weight Watchers International (as part of an UK Medical Research Council Industrial Collaboration Award). Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Ahern, Amy L.; Woolston, Jennifer; Thomson, Ann M.; Tsiountsioura, Melina; Jebb, Susan A.] MRC Human Nutr Res, Cambridge, England; [Ahern, Amy L.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Wheeler, Graham M.; Mander, Adrian P.] Univ Cambridge, MRC Biostat Hub Trials Methodol Res, Cambridge, England; [Wheeler, Graham M.] UCL, Canc Res UK, London, England; [Wheeler, Graham M.] UCL, UCL Canc Trials Ctr, London, England; [Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Boyland, Emma J.; Halford, Jason C. G.; Mead, Bethan R.] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Irvine, Lisa; Turner, David; Suhrcke, Marc] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Suhrcke, Marc] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Pimpin, Laura; Webber, Laura] UK Hlth Forum, London, England; [Jaccard, Abbygail; Webber, Laura] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; Cancer Research UK; University of London; University College London; University of London; University College London; University of Oxford; University of Liverpool; University of East Anglia; University of York - UK; University of London; London School of Hygiene & Tropical Medicine	Ahern, AL (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Box 285 Inst Metab Sci,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ala34@cam.ac.uk	Irvine, Lisa/ABH-5953-2020; Turner, David A/E-1847-2013; Laro, Suzanne/AAK-5428-2020; Suhrcke, Marc/AAE-9024-2019; Mead, Bethan/F-6134-2019; Mead, Bethan/AAR-1046-2020	Turner, David A/0000-0002-1689-4147; Mead, Bethan/0000-0002-9294-517X; Mead, Bethan/0000-0002-9294-517X; Irvine, Lisa/0000-0003-1936-3584; Jebb, Susan/0000-0001-9190-2920; Halford, Jason/0000-0003-1629-3189; Turner, David/0000-0002-0789-3601; Boyland, Emma/0000-0001-8384-4994; Suhrcke, Marc/0000-0001-7263-8626; Ahern, Amy/0000-0001-5069-4758; Aveyard, Paul/0000-0002-1802-4217; Jaccard, Abbygail/0000-0002-7903-5956; Pimpin, Laura/0000-0001-5021-0143	National Prevention Research Initiative, Weight Watchers International (as part of an UK Medical Research Council Industrial Collaboration Award); MRC [MC_UU_00002/3, MC_U105960384, MC_U105960389, MC_UP_1302/2, MC_EX_MR/J000493/1, MC_UU_12015/4] Funding Source: UKRI; Cancer Research UK [15953] Funding Source: researchfish; Medical Research Council [MC_U105960389, MC_UP_1302/2, MC_U105960384, MC_UU_00002/3, MC_EX_MR/J000493/1, MC_UU_12015/4] Funding Source: researchfish	National Prevention Research Initiative, Weight Watchers International (as part of an UK Medical Research Council Industrial Collaboration Award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	National Prevention Research Initiative, Weight Watchers International (as part of an UK Medical Research Council Industrial Collaboration Award).	Ahern AL, 2016, BRIT J GEN PRACT, V66, pE258, DOI 10.3399/bjgp16X684337; Ahern AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-620; Ahern AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-434; Allen JT, 2015, BRIT J GEN PRACT, V65, pE248, DOI 10.3399/bjgp15X684409; ANDERSON AS, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G1823; Aveyard P, 2016, LANCET, V388, P2492, DOI 10.1016/S0140-6736(16)31893-1; British Heart Foundation, 2005, SO YOU WANT LOS WEIG; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Butland B, 2007, TACKL OB FUT CHOIC P; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Dolan P, 1995, SOCIAL TARIFF EUROQO; DPP Research Group, 2015, LANCET DIABETES ENDO; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Fuller NR, 2013, INT J OBESITY, V37, P828, DOI 10.1038/ijo.2012.139; Gudzune KA, 2015, ANN INTERN MED, V162, P501, DOI 10.7326/M14-2238; Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220; Hartmann-Boyce J, 2014, OBES REV, V15, P598, DOI 10.1111/obr.12165; Hartmann-Boyce J, 2015, AM J PUBLIC HEALTH, V105, pE43, DOI 10.2105/AJPH.2014.302389; Herman WH, 2003, DIABETES CARE, V26, P36; Hunt K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-50; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Johns DJ, 2016, OBESITY, V24, P772, DOI 10.1002/oby.21255; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McPherson K, 2007, TACKLING OBESITIES F; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; NatCen Social Research, HLTH SURV ENGL 2003; National Instiute of Health and Clinical Excellence, 2014, MAN OV OB AD LIF WEI; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Office for National Statistics, 2016, POP EST UK ENGL WAL; Public Health England, 2015, NAT MAPP WEIGHT MAN; Ridyard CH, 2010, VALUE HEALTH, V13, P867, DOI 10.1111/j.1524-4733.2010.00788.x; Stevens G, 2009, B WORLD HEALTH ORGAN, V87, P646, DOI 10.2471/BLT.09.070565; Zomer E, 2016, OBES REV, V17, P1001, DOI 10.1111/obr.12433	35	121	121	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2214	2225		10.1016/S0140-6736(17)30647-5	http://dx.doi.org/10.1016/S0140-6736(17)30647-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5JC	28478041	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000402540800029
J	Guibentif, C; Gottgens, B				Guibentif, Carolina; Gottgens, Berthold			BLOOD Education for stem cells	NATURE			English	Editorial Material							HEMATOPOIETIC SPECIFICATION; AORTIC ENDOTHELIUM		[Guibentif, Carolina] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge; University of Cambridge	Guibentif, C (corresponding author), Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge CB2 0XY, England.	cim30@cam.ac.uk; bg200@cam.ac.uk		Gottgens, Berthold/0000-0001-6302-5705	Cancer Research UK [21762] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Lis R, 2017, NATURE, V545, P439, DOI 10.1038/nature22326; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Slukvin II, 2016, FEBS LETT, V590, P4126, DOI 10.1002/1873-3468.12283; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Wilkinson AC, 2014, DEVELOPMENT, V141, P4018, DOI 10.1242/dev.115709; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x	13	2	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					415	417		10.1038/nature22496	http://dx.doi.org/10.1038/nature22496			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV6TH	28514445				2022-12-28	WOS:000401906500037
J	Bourzac, K				Bourzac, Katherine			MOSAIC MATERIALS Capitalizing on carbon capture	NATURE			English	Editorial Material																			0	6	6	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S15	S16		10.1038/545S15a	http://dx.doi.org/10.1038/545S15a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514415	Bronze			2022-12-28	WOS:000401466500013
J	West, JB				West, John B.			Physiological Effects of Chronic Hypoxia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HIGH-ALTITUDE; NEONATAL-MORTALITY; INDUCIBLE FACTORS; ADAPTATION; DISEASE		[West, John B.] Univ Calif San Diego, Dept Med, 0623A,9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	West, JB (corresponding author), Univ Calif San Diego, Dept Med, 0623A,9500 Gilman Dr, La Jolla, CA 92093 USA.	jwest@ucsd.edu						Barcroft J., 1925, RESP FUNCTION BLOO 1; Beall CM, 2000, HUM BIOL, V72, P201; Elsner RW, 1964, PHYSL EFFECTS HIGH A, P217; FAVIER R, 1995, J APPL PHYSIOL, V78, P1868, DOI 10.1152/jappl.1995.78.5.1868; GROVES BM, 1993, J APPL PHYSIOL, V74, P312, DOI 10.1152/jappl.1993.74.1.312; Hogan AM, 2010, DEVELOPMENTAL SCI, V13, P533, DOI 10.1111/j.1467-7687.2009.00909.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; MAZESS RB, 1965, AM J PHYS ANTHROPOL, V23, P209, DOI 10.1002/ajpa.1330230310; Ministry of Health The Republic of Uganda/World Health Organization, 2005, HLTH EV NETW HEN REP, P2; Priestley J., 1776, EXPT OBSERVATIONS DI, V2; RAHN H, 1949, AM J PHYSIOL, V157, P445, DOI 10.1152/ajplegacy.1949.157.3.445; Resar JR, 2005, CHEST, V128, P787, DOI 10.1378/chest.128.2.787; Rimoldi SF, 2016, J PEDIATR-US, V169, P238, DOI 10.1016/j.jpeds.2015.10.009; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Simonson TS, 2015, HIGH ALT MED BIOL, V16, P125, DOI 10.1089/ham.2015.0033; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; West JB, 2015, J PERINATOL, V35, P900, DOI 10.1038/jp.2015.108; WEST JB, 1995, RESP PHYSIOL, V99, P225, DOI 10.1016/0034-5687(94)00094-G; West JB, 2016, PHYSIOLOGY, V31, P216, DOI 10.1152/physiol.00057.2015; Wheaton AG, 2015, MMWR-MORBID MORTAL W, V64, P289; Wilson DF, 2005, HIGH ALT MED BIOL, V6, P97, DOI 10.1089/ham.2005.6.97; Yan XD, 2014, HIGH ALT MED BIOL, V15, P141, DOI 10.1089/ham.2014.1009; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x	27	75	81	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1965	1971		10.1056/NEJMra1612008	http://dx.doi.org/10.1056/NEJMra1612008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514605				2022-12-28	WOS:000401407500010
J	Aiken, ARA; Digol, I; Trussell, J; Gomperts, R				Aiken, Abigail R. A.; Digol, Irena; Trussell, James; Gomperts, Rebecca			Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREGNANCY; TERMINATION; MISOPROSTOL; VISITS; PILLS; HOME	OBJECTIVES To assess self reported outcomes and adverse events after self sourced medical abortion through online telemedicine. DESIGN Population based study. SETTING Republic of Ireland and Northern Ireland, where abortion is unavailable through the formal healthcare system except in a few restricted circumstances. POPULATION 1000 women who underwent self sourced medical abortion through Women on Web (WoW), an online telemedicine service, between 1 January 2010 and 31 December 2012. MAIN OUTCOME MEASURES Successful medical abortion: the proportion of women who reported ending their pregnancy without surgical intervention. Rates of adverse events: the proportion who reported treatment for adverse events, including receipt of antibiotics and blood transfusion, and deaths reported by family members, friends, or the authorities. Care seeking for symptoms of potential complications: the frequency with which women reported experiencing symptoms of a potentially serious complication and the proportion who reported seeking medical attention as advised. RESULTS In 2010-12, abortion medications (mifepristone and misoprostol) were sent to 1636 women and follow-up information was obtained for 1158 (71%). Among these, 1023 women confirmed use of the medications, and follow-up information was available for 1000. At the time women requested help from WoW, 781 (78%) were <7 weeks pregnant and 219 (22%) were 7-9 weeks pregnant. Overall, 94.7% (95% confidence interval 93.1% to 96.0%) reported successfully ending their pregnancy without surgical intervention. Seven women (0.7%, 0.3% to 1.5%) reported receiving a blood transfusion, and 26 (2.6%, 1.7% to 3.8%) reported receiving antibiotics (route of administration (IV or oral) could not be determined). No deaths resulting from the intervention were reported by family, friends, the authorities, or the media. Ninety two women (9.3%, 7.6% to 11.3%) reported experiencing any symptom for which they were advised to seek medical advice, and, of these, 87 (95%, 87.8% to 98.2%) sought attention. None of the five women who did not seek medical attention reported experiencing an adverse outcome. CONCLUSIONS Self sourced medical abortion using online telemedicine can be highly effective, and outcomes compare favourably with in clinic protocols. Reported rates of adverse events are low. Women are able to self identify the symptoms of potentially serious complications, and most report seeking medical attention when advised. Results have important implications for women worldwide living in areas where access to abortion is restricted.	[Aiken, Abigail R. A.] Univ Texas Austin, LBJ Sch Publ Affairs, Austin, TX 78713 USA; [Aiken, Abigail R. A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78713 USA; [Digol, Irena; Gomperts, Rebecca] Women Web Int Fdn, Amsterdam, Netherlands; [Digol, Irena] Ctr Reprod Hlth & Med Genet, Kishinev, Moldova; [Trussell, James] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Trussell, James] Univ Edinburgh, Chalmers Ctr, Edinburgh EH3 9ES, Midlothian, Scotland	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Princeton University; University of Edinburgh	Aiken, ARA (corresponding author), Univ Texas Austin, LBJ Sch Publ Affairs, Austin, TX 78713 USA.; Aiken, ARA (corresponding author), Univ Texas Austin, Populat Res Ctr, Austin, TX 78713 USA.	araa2@utexas.edu			Society of Family Planning [SFPRF10-JI2]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH [R24HD04284, P2C HD047879]	Society of Family Planning; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH	This study was funded by a grant from the Society of Family Planning (SFPRF10-JI2) and was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH through grant R24HD04284 to the population research centre at the University of Texas at Austin, and in part by grant P2C HD047879 to the office of population research at Princeton University. The funders played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The authors are completely independent from the funding sources. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the Society of Family Planning or the National Institutes of Health.	Aiken A, 2016, BJOG; Biggs MA, 2017, JAMA PSYCHIAT, V74, P169, DOI 10.1001/jamapsychiatry.2016.3478; Cleland K, 2013, OBSTET GYNECOL, V121, P166, DOI [http://10.1097/AOG.0b013e3182755763, 10.1097/AOG.0b013e3182755763]; Costa SH, 1998, INT J GYNECOL OBSTET, V63, pS131, DOI 10.1016/S0020-7292(98)00195-7; Creinin MD, 2016, CONTRACEPTION, V94, P97, DOI 10.1016/j.contraception.2016.04.013; Daniels Pauline, 2013, Br J Nurs, V22, P326; Department of Health, 2015, AB STAT ENGL WAL; Dyer C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i629; Fenton S., 2016, INDEPENDENT; Friedman MA, 2009, HEALTH AFFAIR, V28, P393, DOI 10.1377/hlthaff.28.2.393; Gatter M, 2015, CONTRACEPTION, V91, P269, DOI 10.1016/j.contraception.2015.01.005; Gomperts RJ, 2008, BJOG-INT J OBSTET GY, V115, P1171, DOI 10.1111/j.1471-0528.2008.01787.x; Gomperts R, 2014, CONTRACEPTION, V89, P129, DOI 10.1016/j.contraception.2013.11.005; Gomperts R, 2012, ACTA OBSTET GYN SCAN, V91, P226, DOI 10.1111/j.1600-0412.2011.01285.x; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Grossman D, 2004, OBSTET GYNECOL, V103, P738, DOI 10.1097/01.AOG.0000115511.14004.19; Irish Citizens' Assembly, 8 AM CONST; Kassebaum NJ, 2014, LANCET, V384, P956; Knight M, 2014, IMPROVING MOTHERS CA; McDonald H., 2016, GUARDIAN; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Oppegaard KS, 2015, LANCET, V385, P698, DOI 10.1016/S0140-6736(14)61054-0; Redden M., 2016, GUARDIAN; Roberts SCM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0144-z; Rowlands S, 2012, J FAM PLAN REPROD H, V38, P117, DOI 10.1136/jfprhc-2011-100232; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Schonberg D, 2014, CONTRACEPTION, V90, P480, DOI 10.1016/j.contraception.2014.07.004; Sheldon S, 2016, REPROD HEALTH MATTER, V24, P90, DOI 10.1016/j.rhm.2016.10.002; United Nations News Centre, 2016, IR UN EXP URG AM AB; Upadhyay UD, 2015, OBSTET GYNECOL, V125, P175, DOI 10.1097/AOG.0000000000000603; Wainwright Megan, 2016, Reprod Health Matters, V24, P155, DOI 10.1016/j.rhm.2016.06.008; Wicks E, 2011, HUM RIGHTS LAW REV, V11, P556, DOI 10.1093/hrlr/ngr015; World Health Organization, 2010, MOD LIST ESS MED; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, LIST ESS MED	35	90	90	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j2011	10.1136/bmj.j2011	http://dx.doi.org/10.1136/bmj.j2011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512085	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000401898900003
J	DeLancey, JO; Softcheck, J; Chung, JW; Barnard, C; Dahlke, AR; Bilimoria, KY				DeLancey, John O.; Softcheck, Jeffrey; Chung, Jeanette W.; Barnard, Cynthia; Dahlke, Allison R.; Bilimoria, Karl Y.			Associations Between Hospital Characteristics, Measure Reporting, and the Centers for Medicare & Medicaid Services Overall Hospital Quality Star Ratings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[DeLancey, John O.; Chung, Jeanette W.; Dahlke, Allison R.; Bilimoria, Karl Y.] Northwestern Univ, Feinberg Sch Med, Surg Outcomes & Qual Improvement Ctr, Chicago, IL 60611 USA; [Softcheck, Jeffrey; Barnard, Cynthia] Northwestern Mem HealthCare, Div Qual, Chicago, IL USA	Northwestern University; Feinberg School of Medicine	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, SOQIC, Dept Surg, 633 St Clair St,20th Floor, Chicago, IL 60611 USA.; Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, 633 St Clair St,20th Floor, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu			Agency for Healthcare Research and Quality [R21HS021857]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS021857] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work is supported by grant R21HS021857 from the Agency for Healthcare Research and Quality (Dr Bilimoria).	Bilimoria KY, 2016, JAMA-J AM MED ASSOC, V316, P1761, DOI 10.1001/jama.2016.13679; Quality Net, STAT ANAL SYST SAS P; Quality Net, 2016, COMPR METH REP V2 0; US Government Publishing Office, FED REG 2015 RUL REG	4	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					2015	2017		10.1001/jama.2017.3148	http://dx.doi.org/10.1001/jama.2017.3148			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510670	Green Published, Bronze			2022-12-28	WOS:000401315500023
J	Sun, HT; Mei, L; Liang, JF; Zhao, ZP; Lee, C; Fei, HL; Ding, MN; Lau, J; Li, MF; Wang, C; Xu, X; Hao, GL; Papandrea, B; Shakir, I; Dunn, B; Huang, Y; Duan, XF				Sun, Hongtao; Mei, Lin; Liang, Junfei; Zhao, Zipeng; Lee, Chain; Fei, Huilong; Ding, Mengning; Lau, Jonathan; Li, Mufan; Wang, Chen; Xu, Xu; Hao, Guolin; Papandrea, Benjamin; Shakir, Imran; Dunn, Bruce; Huang, Yu; Duan, Xiangfeng			Three-dimensional holey-graphene/niobia composite architectures for ultrahigh-rate energy storage	SCIENCE			English	Article							IMPEDANCE SPECTROSCOPY; ELECTRODE MATERIALS; HOLLOW SPHERES; HIGH-CAPACITY; HIGH-POWER; LITHIUM; OXIDE; NANOWIRES; ANODES; NB2O5	Nanostructured materials have shown extraordinary promise for electrochemical energy storage but are usually limited to electrodes with rather low mass loading (similar to 1 milligram per square centimeter) because of the increasing ion diffusion limitations in thicker electrodes. We report the design of a three-dimensional (3D) holey-graphene/niobia (Nb2O5) composite for ultrahigh-rate energy storage at practical levels of mass loading (> 10 milligrams per square centimeter). The highly interconnected graphene network in the 3D architecture provides excellent electron transport properties, and its hierarchical porous structure facilitates rapid ion transport. By systematically tailoring the porosity in the holey graphene backbone, charge transport in the composite architecture is optimized to deliver high areal capacity and high-rate capability at high mass loading, which represents a critical step forward toward practical applications.	[Sun, Hongtao; Mei, Lin; Lee, Chain; Fei, Huilong; Li, Mufan; Xu, Xu; Hao, Guolin; Papandrea, Benjamin; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Mei, Lin] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Liang, Junfei; Zhao, Zipeng; Ding, Mengning; Lau, Jonathan; Wang, Chen; Dunn, Bruce; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Ding, Mengning; Dunn, Bruce; Huang, Yu; Duan, Xiangfeng] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Shakir, Imran] King Saud Univ, Coll Engn, Sustainable Energy Technol Ctr, Riyadh 11421, Saudi Arabia	University of California System; University of California Los Angeles; Hunan University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; King Saud University	Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Duan, XF (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA.	xduan@chem.ucla.edu	Fei, Huilong/X-2378-2018; MEI, LIN/E-6382-2017; Duan, Xiangfeng/E-7522-2011; Zhao, Zipeng/H-4983-2014; Ding, Mengning/P-6354-2014; Duan, Xiangfeng/AAQ-9674-2020; Ding, Mengning/AAQ-8606-2020; Wang, Chen/S-9478-2018; Huang, Yu/AAZ-9747-2020; SHAKIR, IMRAN/AAE-2559-2019; Sun, Hongtao/N-6597-2013	Fei, Huilong/0000-0002-4216-5810; Duan, Xiangfeng/0000-0002-4321-6288; Zhao, Zipeng/0000-0003-1135-6742; Ding, Mengning/0000-0001-6581-3385; Duan, Xiangfeng/0000-0002-4321-6288; Ding, Mengning/0000-0001-6581-3385; Wang, Chen/0000-0003-4192-8430; Huang, Yu/0000-0003-1793-0741; SHAKIR, IMRAN/0000-0003-3385-4363; Sun, Hongtao/0000-0003-3259-6091; Liang, Junfei/0000-0002-9058-4411; Lau, Jonathan/0000-0003-3599-030X	Deanship of Scientific Research at King Saud University [PEJP-17-01]; U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0008055]; National Science Foundation [DMR-1437263]; Office of Naval Research [N00014-16-1-2164]; Chinese Scholar Council scholarship; Hunan University	Deanship of Scientific Research at King Saud University(King Saud University); U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Chinese Scholar Council scholarship; Hunan University	H.S., H.F., and I.S. extend sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through grant PEJP-17-01 (material preparation and electrochemical studies). X.D. and M.L. thank the U.S. Department of Energy (DOE) Office of Basic Energy Sciences, Division of Materials Science and Engineering, award DE-SC0008055 (structural characterizations). Y.H. M.D. and Z.Z. appreciate the support from the National Science Foundation through award DMR-1437263 (ion transport studies). B.D. and J.L. greatly appreciate the support by the Office of Naval Research (N00014-16-1-2164) (impedance analysis). L.M., J.L., X.X., and G.H. thank the Chinese Scholar Council scholarship for the financial support (materials preparation of electrochemical studies). L.M. also thanks a postdoctoral fellowship from Hunan University. Holy-graphene/niobia composite are available from the University of California, Los Angeles (UCLA) under a materials transfer agreement with the University. A provisional patent application has been filed by UCLA (UCLA Case 2017-216) that covers the subject described here.	An QY, 2015, NANO RES, V8, P481, DOI 10.1007/s12274-014-0638-1; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Beguin F, 2014, ADV MATER, V26, P2219, DOI 10.1002/adma.201304137; Billaud J, 2016, NAT ENERGY, V1, DOI [10.1038/nenergy.2016.97, 10.1038/NENERGY.2016.97]; Chiang YM, 2010, SCIENCE, V330, P1485, DOI 10.1126/science.1198591; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Come J, 2014, J ELECTROCHEM SOC, V161, pA718, DOI 10.1149/2.040405jes; Cui LF, 2009, NANO LETT, V9, P3370, DOI 10.1021/nl901670t; Erickson K, 2010, ADV MATER, V22, P4467, DOI 10.1002/adma.201000732; Gallagher KG, 2016, J ELECTROCHEM SOC, V163, pA138, DOI 10.1149/2.0321602jes; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Kim TY, 2011, ACS NANO, V5, P436, DOI 10.1021/nn101968p; Kong LP, 2015, ACS NANO, V9, P11200, DOI 10.1021/acsnano.5b04737; Li XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5105; Li YZ, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.29; Lim E, 2015, ACS NANO, V9, P7497, DOI 10.1021/acsnano.5b02601; Lim E, 2014, ACS NANO, V8, P8968, DOI 10.1021/nn501972w; Liu N, 2014, NAT NANOTECHNOL, V9, P187, DOI [10.1038/nnano.2014.6, 10.1038/NNANO.2014.6]; Mkhoyan KA, 2009, NANO LETT, V9, P1058, DOI 10.1021/nl8034256; Moshtev R, 2000, J POWER SOURCES, V91, P86, DOI 10.1016/S0378-7753(00)00458-4; Ogihara N, 2015, J PHYS CHEM C, V119, P4612, DOI 10.1021/jp512564f; Ogihara N, 2012, J ELECTROCHEM SOC, V159, pA1034, DOI 10.1149/2.057207jes; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Poizot P, 2000, NATURE, V407, P496, DOI 10.1038/35035045; Rahman MM, 2013, J MATER CHEM A, V1, P11019, DOI 10.1039/c3ta12149f; Salanne M, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.70, 10.1038/nenergy.2016.70]; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Singh M, 2015, J ELECTROCHEM SOC, V162, pA1196, DOI 10.1149/2.0401507jes; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Sun HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5526; Sun HT, 2014, J PHYS CHEM C, V118, P2263, DOI 10.1021/jp408021m; Taberna PL, 2003, J ELECTROCHEM SOC, V150, pA292, DOI 10.1149/1.1543948; Wang HL, 2010, J AM CHEM SOC, V132, P7472, DOI 10.1021/ja102267j; Wang JY, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2016.50; Wang X, 2015, NANO ENERGY, V11, P765, DOI 10.1016/j.nanoen.2014.11.020; Wu H, 2012, NAT NANOTECHNOL, V7, P309, DOI [10.1038/nnano.2012.35, 10.1038/NNANO.2012.35]; Wu RB, 2014, ACS NANO, V8, P6297, DOI 10.1021/nn501783n; Xu YX, 2015, NANO LETT, V15, P4605, DOI 10.1021/acs.nanolett.5b01212; Xu YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5554; Zhang F, 2013, ENERG ENVIRON SCI, V6, P1623, DOI 10.1039/c3ee40509e; Zhang N, 2015, NANO RES, V8, P3384, DOI 10.1007/s12274-015-0838-3; Zhao YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5565	44	1016	1026	76	1723	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					599	604		10.1126/science.aam5852	http://dx.doi.org/10.1126/science.aam5852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495745				2022-12-28	WOS:000400975200047
J	Adinolfi, V; Sargent, EH				Adinolfi, Valerio; Sargent, Edward H.			Photovoltage field-effect transistors (vol 542, pg 324, 2017)	NATURE			English	Correction													Sargent, Edward H./O-9520-2014	Sargent, Edward H./0000-0003-0396-6495				Adinolfi V, 2017, NATURE, V542, P324, DOI 10.1038/nature21050; Aqua T, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940230; Neubauer A, 2015, SENSOR ACTUAT A-PHYS, V229, P166, DOI 10.1016/j.sna.2015.03.031	3	5	5	10	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					252	252		10.1038/nature22347	http://dx.doi.org/10.1038/nature22347			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ4YX	28492256	Bronze			2022-12-28	WOS:000427599400001
J	Thomou, T; Mori, MA; Dreyfuss, JM; Konishi, M; Sakaguchi, M; Wolfrum, C; Rao, TN; Winnay, JN; Garcia-Martin, R; Grinspoon, SK; Gorden, P; Kahn, CR				Thomou, Thomas; Mori, Marcelo A.; Dreyfuss, Jonathan M.; Konishi, Masahiro; Sakaguchi, Masaji; Wolfrum, Christian; Rao, Tata Nageswara; Winnay, Jonathon N.; Garcia-Martin, Ruben; Grinspoon, Steven K.; Gorden, Phillip; Kahn, C. Ronald			Adipose-derived circulating miRNAs regulate gene expression in other tissues (vol 542, pg 450, 2017)	NATURE			English	Correction													Mori, Marcelo A/R-2881-2018; Martin, Ruben Garcia/AAA-8538-2021; Kahn, Ronald/AAY-2435-2021	Mori, Marcelo A/0000-0001-7112-5263; Martin, Ruben Garcia/0000-0003-2049-4960; Kahn, Ronald/0000-0002-7583-9228; Tata, Nageswara Rao/0000-0002-9928-5944	NIDDK NIH HHS [P30 DK036836] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, P30DK036836] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365	1	14	14	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					252	252		10.1038/nature22319	http://dx.doi.org/10.1038/nature22319			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492253	Bronze			2022-12-28	WOS:000400963800040
J	Kragholm, K; Wissenberg, M; Mortensen, RN; Hansen, SM; Hansen, CM; Thorsteinsson, K; Rajan, S; Lippert, F; Folke, F; Gislason, G; Kober, L; Fonager, K; Jensen, SE; Gerds, TA; Torp-Pedersen, C; Rasmussen, BS				Kragholm, Kristian; Wissenberg, Mads; Mortensen, Rikke N.; Hansen, Steen M.; Hansen, Carolina Malta; Thorsteinsson, Kristinn; Rajan, Shahzleen; Lippert, Freddy; Folke, Fredrik; Gislason, Gunnar; Kober, Lars; Fonager, Kirsten; Jensen, Svend E.; Gerds, Thomas A.; Torp-Pedersen, Christian; Rasmussen, Bodil S.			Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOPULMONARY-RESUSCITATION; SURVIVAL; LIFE; REGISTER; INTERVENTION; ASSOCIATION; TRENDS; COHORT; RATES	BACKGROUND The effect of bystander interventions on long-term functional outcomes among survivors of out-of-hospital cardiac arrest has not been extensively studied. METHODS We linked nationwide data on out-of-hospital cardiac arrests in Denmark to functional outcome data and reported the 1-year risks of anoxic brain damage or nursing home admission and of death from any cause among patients who survived to day 30 after an out-of-hospital cardiac arrest. We analyzed risks according to whether bystander cardiopulmonary resuscitation (CPR) or defibrillation was performed and evaluated temporal changes in bystander interventions and outcomes. RESULTS Among the 2855 patients who were 30-day survivors of an out-of-hospital cardiac arrest during the period from 2001 through 2012, a total of 10.5% had brain damage or were admitted to a nursing home and 9.7% died during the 1-year follow-up period. During the study period, among the 2084 patients who had cardiac arrests that were not witnessed by emergency medical services (EMS) personnel, the rate of bystander CPR increased from 66.7% to 80.6% (P<0.001), the rate of bystander defibrillation increased from 2.1% to 16.8% (P<0.001), the rate of brain damage or nursing home admission decreased from 10.0% to 7.6% (P<0.001), and all-cause mortality decreased from 18.0% to 7.9% (P = 0.002). In adjusted analyses, bystander CPR was associated with a risk of brain damage or nursing home admission that was significantly lower than that associated with no bystander resuscitation (hazard ratio, 0.62; 95% confidence interval [CI], 0.47 to 0.82), as well as a lower risk of death from any cause (hazard ratio, 0.70; 95% CI, 0.50 to 0.99) and a lower risk of the composite end point of brain damage, nursing home admission, or death (hazard ratio, 0.67; 95% CI, 0.53 to 0.84). The risks of these outcomes were even lower among patients who received bystander defibrillation as compared with no bystander resuscitation. CONCLUSIONS In our study, we found that bystander CPR and defibrillation were associated with risks of brain damage or nursing home admission and of death from any cause that were significantly lower than those associated with no bystander resuscitation.	[Kragholm, Kristian; Rasmussen, Bodil S.] Aalborg Univ Hosp, Dept Anesthesiol & Intens Care Med, Sdr Skovvej 15, DK-9000 Aalborg, Denmark; [Mortensen, Rikke N.; Hansen, Steen M.; Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Thorsteinsson, Kristinn] Aalborg Univ Hosp, Dept Cardiothorac Surg, Aalborg, Denmark; [Fonager, Kirsten] Aalborg Univ Hosp, Dept Social Med, Aalborg, Denmark; [Jensen, Svend E.] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Kragholm, Kristian; Rasmussen, Bodil S.] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Hansen, Steen M.; Fonager, Kirsten; Jensen, Svend E.; Torp-Pedersen, Christian; Rasmussen, Bodil S.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Kragholm, Kristian; Rasmussen, Bodil S.] Aarhus Univ, Clin Inst Med, Aarhus, Denmark; [Wissenberg, Mads] Copenhagen Univ Hosp, Emergency Med Serv Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Kober, Lars] Copenhagen Univ Hosp, Emergency Med Serv Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Wissenberg, Mads; Lippert, Freddy; Folke, Fredrik] Univ Copenhagen, Copenhagen, Denmark; [Hansen, Carolina Malta; Rajan, Shahzleen; Folke, Fredrik; Gislason, Gunnar] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Copenhagen, Denmark; [Gislason, Gunnar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Gerds, Thomas A.] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Hansen, Carolina Malta] Duke Clin Res Inst, Durham, NC USA	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; University of Copenhagen; Duke University	Kragholm, K (corresponding author), Aalborg Univ Hosp, Dept Anesthesiol & Intens Care Med, Sdr Skovvej 15, DK-9000 Aalborg, Denmark.	kdks@rn.dk	Gislason, Gunnar/B-7561-2009; Folke, Fredrik/P-3601-2014	Gislason, Gunnar/0000-0002-0548-402X; Gerds, Thomas Alexander/0000-0002-5955-816X; Fonager, Kirsten/0000-0001-9641-992X; Folke, Fredrik/0000-0002-2284-7857; Lippert, Freddy/0000-0002-2356-8809; Kober, Lars/0000-0002-6635-1466; Rasmussen, Bodil Steen/0000-0003-2190-145X; Kragholm, Kristian/0000-0001-9629-8670	TrygFonden; Danish Heart Foundation	TrygFonden; Danish Heart Foundation	Funded by TrygFonden and the Danish Heart Foundation.	Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Bartlett JW, 2015, STAT METHODS MED RES, V24, P462, DOI 10.1177/0962280214521348; Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Beesems SG, 2014, RESUSCITATION, V85, P1269, DOI 10.1016/j.resuscitation.2014.05.027; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bunch TJ, 2003, NEW ENGL J MED, V348, P2626, DOI 10.1056/NEJMoa023053; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; Hansen CM, 2014, CIRCULATION, V130, P1859, DOI 10.1161/CIRCULATIONAHA.114.008850; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Jacobsen A., 2016, DANMARKS STAT; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kragholm K, 2015, CIRCULATION, V131, P1682, DOI 10.1161/CIRCULATIONAHA.114.011366; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; . R: A Language and Environment for Statistical Computing, 2012, R LANG ENV STAT COMP; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408; Smith K, 2015, CIRCULATION, V131, P174, DOI 10.1161/CIRCULATIONAHA.114.011200; Stiell I, 2003, CIRCULATION, V108, P1939, DOI 10.1161/01.CIR.0000095028.95929.B0; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Houwelingen HC, 2007, SCAND J STAT, V34, P70, DOI 10.1111/j.1467-9469.2006.00529.x; Verbunt JA, 2009, RESUSCITATION, V80, P297; Vest MT, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-9; Wilson JTL, 2005, STROKE, V36, P777, DOI 10.1161/01.STR.0000157596.13234.95; Wissenberg M, 2015, CIRCULATION, V131, P1536, DOI 10.1161/CIRCULATIONAHA.114.013122; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	34	203	214	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1737	1747		10.1056/NEJMoa1601891	http://dx.doi.org/10.1056/NEJMoa1601891			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28467879				2022-12-28	WOS:000400442300007
J	Lu, X; Horner, JW; Paul, E; Shang, XY; Troncoso, P; Deng, PN; Jiang, S; Chang, Q; Spring, DJ; Sharma, P; Zebala, JA; Maeda, DY; Wang, YA; DePinho, RA				Lu, Xin; Horner, James W.; Paul, Erin; Shang, Xiaoying; Troncoso, Patricia; Deng, Pingna; Jiang, Shan; Chang, Qing; Spring, Denise J.; Sharma, Padmanee; Zebala, John A.; Maeda, Dean Y.; Wang, Y. Alan; DePinho, Ronald A.			Effective combinatorial immunotherapy for castration-resistant prostate cancer (vol 543, pg 728, 2017)	NATURE			English	Correction													Maeda, Dean/AAB-8973-2020	Maeda, Dean/0000-0002-9304-6846				Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676	1	5	5	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					116	116		10.1038/nature22348	http://dx.doi.org/10.1038/nature22348			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ4ZG	28470201	Bronze			2022-12-28	WOS:000427600300002
J	Robbiani, DF; Bozzacco, L; Keeffe, JR; Khouri, R; Olsen, PC; Gazumyan, A; Schaefer-Babajew, D; Avila-Rios, S; Nogueira, L; Patel, R; Azzopardi, SA; Uhl, LFK; Saeed, M; Sevilla-Reyes, EE; Agudelo, M; Yao, KH; Golijanin, J; Gristick, HB; Lee, YE; Hurley, A; Caskey, M; Pai, J; Oliveira, T; Wunder, EA; Sacramento, G; Nery, N; Orge, C; Costa, F; Reis, MG; Thomas, NM; Eisenreich, T; Weinberger, DM; de Almeida, ARP; West, AP; Rice, CM; Bjorkman, PJ; Reyes-Teran, G; Ko, AI; MacDonald, MR; Nussenzweig, MC				Robbiani, Davide F.; Bozzacco, Leonia; Keeffe, Jennifer R.; Khouri, Ricardo; Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Avila-Rios, Santiago; Nogueira, Lilian; Patel, Roshni; Azzopardi, Stephanie A.; Uhl, Lion F. K.; Saeed, Mohsan; Sevilla-Reyes, Edgar E.; Agudelo, Marianna; Yao, Kai-Hui; Golijanin, Jovana; Gristick, Harry B.; Lee, Yu E.; Hurley, Arlene; Caskey, Marina; Pai, Joy; Oliveira, Thiago; Wunder, Elsio A., Jr.; Sacramento, Gielson; Nery, Nivison, Jr.; Orge, Cibele; Costa, Federico; Reis, Mitermayer G.; Thomas, Neena M.; Eisenreich, Thomas; Weinberger, Daniel M.; de Almeida, Antonio R. P.; West, Anthony P., Jr.; Rice, Charles M.; Bjorkman, Pamela J.; Reyes-Teran, Gustavo; Ko, Albert I.; MacDonald, Margaret R.; Nussenzweig, Michel C.			Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico	CELL			English	Article							DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; MEDIATED NEUTRALIZATION; CROSS-REACTIVITY; DOMAIN-III; HIV-1; ENHANCEMENT; BROAD; GLYCOPROTEIN	Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and Mexico for ZIKV envelope domain III (ZEDIII) binding and neutralization. We find that serologic reactivity to dengue 1 virus (DENV1) EDIII before ZIKV exposure is associated with increased ZIKV neutralizing titers after exposure. Antibody cloning shows that donors with high ZIKV neutralizing antibody titers have expanded clones of memory B cells that express the same immunoglobulin VH3-23/VK1-5 genes. These recurring antibodies cross-react with DENV1, but not other flaviviruses, neutralize both DENV1 and ZIKV, and protect mice against ZIKV challenge. Structural analyses reveal the mechanism of recognition of the ZEDIII lateral ridge by VH3-23/VK1-5 antibodies. Serologic testing shows that antibodies to this region correlate with serumneutralizing activity to ZIKV. Thus, high neutralizing responses to ZIKV are associated with pre-existing reactivity to DENV1 in humans.	[Robbiani, Davide F.; Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Nogueira, Lilian; Patel, Roshni; Uhl, Lion F. K.; Agudelo, Marianna; Yao, Kai-Hui; Golijanin, Jovana; Hurley, Arlene; Caskey, Marina; Pai, Joy; Oliveira, Thiago; Thomas, Neena M.; Eisenreich, Thomas; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Bozzacco, Leonia; Azzopardi, Stephanie A.; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Keeffe, Jennifer R.; Gristick, Harry B.; Lee, Yu E.; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Khouri, Ricardo; Wunder, Elsio A., Jr.; Sacramento, Gielson; Nery, Nivison, Jr.; Orge, Cibele; Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil; [Avila-Rios, Santiago; Sevilla-Reyes, Edgar E.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Mexico City 14080, DF, Mexico; [Wunder, Elsio A., Jr.; Costa, Federico; Reis, Mitermayer G.; Weinberger, Daniel M.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med Bahia, BR-40296710 Salvador, BA, Brazil; [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, BR-40296710 Salvador, BA, Brazil; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rockefeller University; California Institute of Technology; Yale University; Universidade Federal da Bahia; Universidade Federal da Bahia; Howard Hughes Medical Institute; Rockefeller University	Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; MacDonald, MR (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	drobbiani@rockefeller.edu; macdonm@rockefeller.edu; nussen@rockefeller.edu	Saeed, Mohsan/AAM-8375-2021; Khouri, Ricardo/M-3184-2018; Reis, Mitermayer/AAO-9742-2020; Avila-Rios, Santiago/AAB-4383-2020; Costa, Federico/G-1838-2015; Nussenzweig, Michel/AAE-7292-2019; Wunder, Elsio Augusto/C-2733-2013; Oliveira, Thiago Y/ABF-5186-2020; Olsen, Priscilla C/I-8994-2012; Ko, Albert/P-2343-2015; Sevilla, Edgar/AAS-3300-2021; Oliveira, Thiago Y/HGA-3848-2022; Robbiani, Davide F./AAF-7662-2019	Khouri, Ricardo/0000-0001-5664-4436; Reis, Mitermayer/0000-0002-3051-9060; Costa, Federico/0000-0001-6951-2336; Wunder, Elsio Augusto/0000-0002-5239-8511; Oliveira, Thiago Y/0000-0002-2654-0879; Olsen, Priscilla C/0000-0002-8795-037X; Ko, Albert/0000-0001-9023-2339; Sevilla, Edgar/0000-0002-7047-0222; Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Machado Orge, Cibele/0000-0002-8157-3657; Reyes-Teran, Gustavo/0000-0002-4115-4888; Schaefer-Babajew, Dennis/0000-0002-5380-2950; Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602; Caskey, Marina/0000-0003-1727-8693; Uhl, Lion/0000-0003-1729-9857; Bozzacco, Leonia/0000-0001-9817-0443; Azzopardi, Stephanie/0000-0002-9585-9234	NIH [U19AI111825, UL1TR001866, R01AI037526, UM1AI100663, R01AI121207, R01TW009504, R25TW009338, U01AI088752, R01AI124690, U19AI057229]; Molecular Observatory at Caltech - Gordon and Betty Moore Foundation; Robertson Therapeutic Development Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Studienstiftung des deutschen Volkes; Austrian Marshall Plan Foundation; Red INMUNOCANEI-Conacyt; FOGARTY INTERNATIONAL CENTER [R01TW009504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001866, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111825, R01AI037526, T32AI070084, U01AI088752, R01AI124690, R01AI121207, R21AI112602, UM1AI100663, R37AI037526] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Observatory at Caltech - Gordon and Betty Moore Foundation; Robertson Therapeutic Development Fund; Pew Latin American Fellows Program in the Biomedical Sciences; Studienstiftung des deutschen Volkes; Austrian Marshall Plan Foundation; Red INMUNOCANEI-Conacyt; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would especially like to thank the members of the Santa Maria Mixtequilla and Pau da Lima communities who agreed to participate in this study, as well as the Fiocruz community research team and staff of Hospital Geral Roberto Santos for their assistance with the clinical protocols. We thank members of the Nussenzweig and Rice labs for helpful discussions and suggestions. A particular thank you to Lotta von Boehmer, Christian Mayer, Yotam Bar-On, Irina Shimeliovich, and Julio Cetrulo Lorenzi for sharing expertise, protocols, and reagents. We thank Ted Pierson for plasmids pWNVII-Rep-REN-IB and pZIKV/HPF/CprME, Aaron Brault (CDC) for ZIKV PRVABC59, Bob Tesh for DENV1 PUO-359, Matt Evans for ZIKV MR766 cDNA, and Greg Ebel, James Weger, and Brian Geiss for ZIKV PRVABC59 cDNA. We are grateful to Laura Kramer (NYSDOH) and Robert Lanciotti (CDC) for PRNT advice and protocols, Kimberly Dowd for RVP advice, and Muhammad Arshad for cloning assistance. We thank Barbara Johnson, Ann Powers, Christin Goodman, Claire Huang, Brandy Russell (CDC), and Claudia Duarte dos Santos for sharing ZIKV information early on. Moreover, we are thankful to Mary Ellen Castillo for facilitating virus work in the cell culture core, Alison Ashbrook for help with PRNT assays, Natalia Frias-Staheli for generation of the DENV1 stock, Corrine Quirk for assistance with mouse colonies, Tiffany Luong, Alisa Voll, and the Caltech Protein Expression Center for cloning, expression, and purification of proteins for crystallography, and Christopher Barnes and Beth Stadtmueller for help with crystallographic methods. This work was supported by NIH pilot awards U19AI111825 (to D.F.R.) and UL1TR001866 (to D.F.R. and L.B.), grants R01AI037526, UM1AI100663, U19AI111825, and UL1TR001866 (to M.C.N.), grants R01AI121207, R01TW009504, R25TW009338, and U01AI088752 (to A.I.K.), grants R01AI124690 (to C.M.R.) and U19AI057229 (CCHI Opportunity Fund Project to C.M.R. and M.R.M.), donors to the Zika Fund at Rockefeller University and anonymous donors (to C.M.R.), and the Molecular Observatory at Caltech supported by the Gordon and Betty Moore Foundation (P.J.B.). Operations at the Stanford Synchrotron Radiation Lightsource are supported by the US Department of Energy and the NIH. Support was also provided by the Robertson Therapeutic Development Fund (to D.F.R. and M.C.N.). P.C.O. is supported by the Pew Latin American Fellows Program in the Biomedical Sciences, D.S.-B. by Studienstiftung des deutschen Volkes, L.F.K.U. by the Austrian Marshall Plan Foundation, and E.E.S.-R. is partly supported by Red INMUNOCANEI-Conacyt. M.C.N. is an HHMI Investigator. In connection with this work, D.F.R. and M.C.N. have a provisional patent application with the U.S. Patent and Trademark Office (62/483,001). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies or individuals.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275; Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774; SABIN AB, 1950, BACTERIOL REV, V14, P225; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	73	189	193	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					597	609		10.1016/j.cell.2017.04.024	http://dx.doi.org/10.1016/j.cell.2017.04.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475892	Bronze, Green Accepted			2022-12-28	WOS:000400560900007
J	Szewczak, L				Szewczak, Lara			The Right Tool for the Job	CELL			English	Editorial Material																		Boswell SA, 2017, NAT CHEM BIOL, V13, P501, DOI [10.1038/NCHEMBIO.2317, 10.1038/nchembio.2317]; Jones L. H., 2017, ACS CHEM BIOL, V16, P285; Shields BC, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2161	3	0	0	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					561	561		10.1016/j.cell.2017.04.029	http://dx.doi.org/10.1016/j.cell.2017.04.029			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475886	Bronze			2022-12-28	WOS:000400560900001
J	Greenway, T; Ross, JS				Greenway, Tyler; Ross, Joseph S.			US drug marketing: how does promotion correspond with health value?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greenway, Tyler] Yale Univ, Sch Med, New Haven, CT USA; [Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA	Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA.; Ross, JS (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, 333 Cedar St, New Haven, CT 06520 USA.; Ross, JS (corresponding author), Yale Univ, Dept Hlth Policy & Management, Sch Publ Hlth, New Haven, CT 06520 USA.; Ross, JS (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.	joseph.ross@yale.edu		Ross, Joseph/0000-0002-9218-3320				Agency for Healthcare Research and Quality US Department of Health and Human Services, NAT GUID CLEAR; Agrawal S, 2016, NEW ENGL J MED, V374, P906, DOI 10.1056/NEJMp1509103; Avorn J, 2011, NEW ENGL J MED, V364, P1185, DOI 10.1056/NEJMp1011713; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Centers for Medicare and Medicaid Services, OPEN PAYM; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Epstein AJ, 2013, MED CARE, V51, P199, DOI 10.1097/MLR.0b013e318277eb19; Fleischman W, 2016, J EPIDEMIOL COMMUNIT; Fleischman W, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4189; IMS Health, 2014, MED US SPEND US REV; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Lanthier M, 2013, HEALTH AFFAIR, V32, P1433, DOI 10.1377/hlthaff.2012.0541; Ornstein C, 2014, WHAT WEVE LEARNED 4; Prescrire International, PRESCR ENGL; ProPublica, OP PAYM EXPL; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709	17	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j1855	10.1136/bmj.j1855	http://dx.doi.org/10.1136/bmj.j1855			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465309				2022-12-28	WOS:000400889500001
J	Papp, K; Thaci, D; Marcoux, D; Weibel, L; Philipp, S; Ghislain, PD; Landells, I; Hoeger, P; Kotkin, C; Unnebrink, K; Seyger, M; Williams, D				Papp, Kim; Thaci, Diamant; Marcoux, Danielle; Weibel, Lisa; Philipp, Sandra; Ghislain, Pierre-Dominique; Landells, Ian; Hoeger, Peter; Kotkin, Carol; Unnebrink, Kristina; Seyger, Marieke; Williams, David			Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial	LANCET			English	Article							ETANERCEPT TREATMENT; MODERATE	Background Adalimumab is indicated for the treatment of moderate to severe psoriasis in adults. We assessed the efficacy and safety of adalimumab in children and adolescents with severe plaque psoriasis. Methods This randomised, double-blind, multiperiod, phase 3 trial was done at 38 clinics in 13 countries. Patients (aged >= 4 to <18 years) with severe plaque psoriasis who had not responded to topical therapy were randomly assigned with an interactive voice or web-response system (1: 1: 1) to receive adalimumab 0.8 mg/kg or 0.4 mg/kg subcutaneously at week 0, then every other week starting at week 1, or oral methotrexate once weekly (0.1-0.4 mg/kg) for 16 weeks. Randomisation was stratified by history of etanercept treatment, with a block size of three. Responders were withdrawn from treatment (for up to 36 weeks) and re-treated with adalimumab (for 16 weeks) if disease became uncontrolled. Ranked primary efficacy endpoints were the proportion of patients who achieved at least 75% improvement from baseline in Psoriasis Area and Severity Index (PASI75) score and clear or minimal physician global assessment (PGA) score at week 16, comparing adalimumab 08 mg/kg with methotrexate. Efficacy analysis was by intention to treat, and safety analysis included all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials. gov, number NCT01251614, and has been completed. Findings Between Dec 14, 2010, and Feb 5, 2015, 114 patients were randomly assigned to adalimumab 0.8 mg/kg (n=38), adalimumab 0.4 mg/kg (n=39) or methotrexate (n=37). At week 16, PASI75 was achieved in 22 (58%) of 38 patients in the adalimumab 0.8 mg/kg group compared with 12 (32%) of 37 patients in the methotrexate group (p=0.027). 23 (61%) of 38 patients in the adalimumab 0.8 mg/kg group and 15 (41%) of 37 in the methotrexate group achieved clear or minimal PGA (p=0083). In the adalimumab 04 mg/kg group, 17 (44%) of 39 patients achieved PASI75 and 16 (41%) achieved clear or minimal PGA. The most frequent adverse events were infections (17 [45%] of 38 in the adalimumab 0.8 mg/kg group during initial treatment; 22 [56%] of 39 in the adalimumab 0.4 mg/kg group; 21 [57%] of 37 in the methotrexate group). Three serious adverse events were reported, all in patients in the adalimumab 0.4 mg/kg group, and were not judged to be related to study drug. Interpretation Treatment with adalimumab 0.8 mg/kg in children and adolescents with severe plaque psoriasis provided significant improvements in PASI75 and a non-significant increase in the proportion of patients who achieved clear or minimal PGA compared with methotrexate. No new safety risks were identified.	[Papp, Kim] Prob Med Res, Waterloo, ON, Canada; [Thaci, Diamant] Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Marcoux, Danielle] CHU St Justine, Montreal, PQ, Canada; [Weibel, Lisa] Univ Childrens Hosp, Paediat Dermatol Dept, Zurich, Switzerland; [Weibel, Lisa] Univ Zurich Hosp, Dermatol Dept, Zurich, Switzerland; [Philipp, Sandra] Charite, Berlin, Germany; [Ghislain, Pierre-Dominique] UCL St Luc, Brussels, Belgium; [Landells, Ian] Nexus Clin Res, St John, NF, Canada; [Landells, Ian] Mem Univ Newfoundland, St John, NF, Canada; [Hoeger, Peter] Catholic Childrens Hosp, Dept Paediat Dermatol, Hamburg, Germany; [Kotkin, Carol; Williams, David] AbbVie, N Chicago, IL USA; [Unnebrink, Kristina] AbbVie Deutschland, Ludwigshafen, Germany; [Seyger, Marieke] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands; [Seyger, Marieke] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands	University of Lubeck; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University Children's Hospital Zurich; University of Zurich; University Zurich Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite Catholique Louvain; Memorial University Newfoundland; AbbVie; AbbVie; Radboud University Nijmegen; Radboud University Nijmegen	Papp, K (corresponding author), Prob Med Res, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com	Thaci, Diamant/AAE-7310-2022; Seyger, M.M.B./L-4648-2015	Thaci, Diamant/0000-0001-8513-550X; Weibel, Lisa/0000-0002-8696-8164; Papp, Kim A./0000-0001-9557-3642	AbbVie	AbbVie(AbbVie)	We would like to acknowledge Monika Hobel and Hui Ding of AbbVie for statistical programming support. Editorial and medical writing support was provided by Katherine Groschwitz (Complete Publication Solutions, North Wales, PA, USA) and funded by AbbVie.	AbbVie Ltd. Humira (adalimumab), SUMMARY PRODUCT CHAR; Augustin M, 2010, BRIT J DERMATOL, V162, P633, DOI 10.1111/j.1365-2133.2009.09593.x; Bronckers IMGJ, 2015, PEDIATR DRUGS, V17, P373, DOI 10.1007/s40272-015-0137-1; Calvet X, 2014, REUMATOL CLIN, V10, P353, DOI 10.1016/j.reuma.2014.06.001; Collin B, 2009, CLIN EXP DERMATOL, V34, P295, DOI 10.1111/j.1365-2230.2008.02907.x; Cordoro K M, 2008, Skin Therapy Lett, V13, P1; de Jager MEA, 2010, J AM ACAD DERMATOL, V62, P1013, DOI 10.1016/j.jaad.2009.06.048; den Broeder AA, 2002, ANN RHEUM DIS; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Janssen- Cilag International NV, STEL UST SUMM PROD C; Klotsche J, 2016, ANN RHEUM DIS; Langley RG, 2011, J AM ACAD DERMATOL, V64, P64, DOI 10.1016/j.jaad.2010.02.060; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Paller AS, 2008, NEW ENGL J MED, V358, P241, DOI 10.1056/NEJMoa066886; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Pfizer Limited, SUMMARY PRODUCT CHAR; Ramanan AV, 2003, ARCH DIS CHILD, V88, P197, DOI 10.1136/adc.88.3.197; Raychaudhuri SP, 2000, PEDIATR DERMATOL, V17, P174, DOI 10.1046/j.1525-1470.2000.01746.x; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P3131, DOI 10.1002/art.27670; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Silverberg Nanette B, 2009, Ther Clin Risk Manag, V5, P849; Thaci D, 2010, BR J DERMATOL; Tollefson MM, 2010, J AM ACAD DERMATOL, V62, P979, DOI 10.1016/j.jaad.2009.07.029; van Geel MJ, 2015, J DERMATOL TREAT, V26, P406, DOI 10.3109/09546634.2014.996515; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; WHO, 2013, PSOR REP SECR	28	92	103	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					40	49		10.1016/S0140-6736(17)31189-3	http://dx.doi.org/10.1016/S0140-6736(17)31189-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ0LK	28478975				2022-12-28	WOS:000404396300026
J	Balicer, RD; Afek, A				Balicer, Ran D.; Afek, Arnon			Digital health nation: Israel's global big data innovation hub	LANCET			English	Editorial Material									[Balicer, Ran D.] Clalit Hlth Serv, Clalit Res Inst, IL-6209804 Tel Aviv, Israel; [Balicer, Ran D.] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel; [Afek, Arnon] Israel Minist Hlth, Jerusalem, Israel; [Afek, Arnon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Clalit Health Services; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Balicer, RD (corresponding author), Clalit Hlth Serv, Clalit Res Inst, IL-6209804 Tel Aviv, Israel.; Balicer, RD (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel.	rbalicer@clalit.org.il	owoyele, babajide/AAD-7054-2020	owoyele, babajide/0000-0002-3688-5248				[Anonymous], 2017, NEW ENGLAND J MED; [Anonymous], 2015, PWC ISR EX REP 2015; Beyar R, 2017, LANCET; Bloomberg, 2014, BLOOMBERG; Dagan N, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6755; Elenko E, 2015, NAT BIOTECHNOL, V33, P456, DOI 10.1038/nbt.3222; Graham JR, 2015, FORBES; Lopez-Claros A, 2015, ISRAEL FACTORS EMERG; Organisation for Economic Co-operation and Development, 2011, SCI TECHN IND SCOR 2; Organisation for Economic Co-operation and Development, 2012, OECD REV HLTH CAR QU; Press Y, 2009, INT J DISABIL HUM DE, V8, P259, DOI 10.1515/IJDHD.2009.8.3.259; Senor Dan, 2009, START UP NATION STOR; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; The World Bank, RES DEV EXP GDP; Topol EJ, 2012, CREATIVE DESTRUCTION; WHO, WHO GLOB HLTH OBS DA; WHO, 2015, CAN INN DAT DRIV APP	17	21	21	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2451	2453		10.1016/S0140-6736(17)30876-0	http://dx.doi.org/10.1016/S0140-6736(17)30876-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495105				2022-12-28	WOS:000403901800009
J	See, P; Dutertre, CA; Chen, JM; Gunther, P; McGovern, N; Irac, SE; Gunawan, M; Beyer, M; Handler, K; Duan, K; Bin Sumatoh, HR; Ruffin, N; Jouve, M; Gea-Mallorqui, E; Hennekam, RCM; Lim, T; Yip, CC; Wen, M; Malleret, B; Low, I; Shadan, NB; Fen, CFS; Tay, A; Lum, J; Zolezzi, F; Larbi, A; Poidinger, M; Chan, JKY; Chen, QF; Renia, L; Haniffa, M; Benaroch, P; Schlitzer, A; Schultze, JL; Newell, EW; Ginhoux, F				See, Peter; Dutertre, Charles-Antoine; Chen, Jinmiao; Gunther, Patrick; McGovern, Naomi; Irac, Sergio Erdal; Gunawan, Merry; Beyer, Marc; Handler, Kristian; Duan, Kaibo; Bin Sumatoh, Hermi Rizal; Ruffin, Nicolas; Jouve, Mabel; Gea-Mallorqui, Ester; Hennekam, Raoul C. M.; Lim, Tony; Yip, Chan Chung; Wen, Ming; Malleret, Benoit; Low, Ivy; Shadan, Nurhidaya Binte; Fen, Charlene Foong Shu; Tay, Alicia; Lum, Josephine; Zolezzi, Francesca; Larbi, Anis; Poidinger, Michael; Chan, Jerry K. Y.; Chen, Qingfeng; Renia, Laurent; Haniffa, Muzlifah; Benaroch, Philippe; Schlitzer, Andreas; Schultze, Joachim L.; Newell, Evan W.; Ginhoux, Florent			Mapping the human DC lineage through the integration of high-dimensional techniques	SCIENCE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; INFLUENZA-VIRUS; T-CELLS; RNA-SEQ; EXPRESSION; PROGENITOR; SUBSETS; TRAJECTORIES; MACROPHAGES	Dendritic cells (DC) are professional antigen-presenting cells that orchestrate immune responses. The human DC population comprises two main functionally specialized lineages, whose origins and differentiation pathways remain incompletely defined. Here, we combine two high-dimensional technologies-single-cell messenger RNA sequencing (scmRNAseq) and cytometry by time-of-flight (CyTOF)-to identify human blood CD123(+)CD33(+)CD45RA(+)DC precursors (pre-DC). Pre-DC share surface markers with plasmacytoid DC (pDC) but have distinct functional properties that were previously attributed to pDC. Tracing the differentiation of DC from the bone marrow to the peripheral blood revealed that the pre-DC compartment contains distinct lineage-committed subpopulations, including one early uncommitted CD123(high) pre-DC subset and two CD45RA(+)CD123(low) lineage-committed subsets exhibiting functional differences. The discovery of multiple committed pre-DC populations opens promising new avenues for the therapeutic exploitation of DC subset-specific targeting.	[See, Peter; Dutertre, Charles-Antoine; Chen, Jinmiao; McGovern, Naomi; Duan, Kaibo; Bin Sumatoh, Hermi Rizal; Malleret, Benoit; Low, Ivy; Shadan, Nurhidaya Binte; Tay, Alicia; Lum, Josephine; Zolezzi, Francesca; Larbi, Anis; Poidinger, Michael; Chan, Jerry K. Y.; Renia, Laurent; Schlitzer, Andreas; Newell, Evan W.; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 4, Singapore 138648, Singapore; [Dutertre, Charles-Antoine; Irac, Sergio Erdal; Wen, Ming] Duke NUS Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore; [Gunther, Patrick; Beyer, Marc; Handler, Kristian; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-32115 Bonn, Germany; [Gunawan, Merry; Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Beyer, Marc; Schultze, Joachim L.] German Ctr Neurodegenerat Dis, Platform Single Cell Genom & Epigen, D-53175 Bonn, Germany; [Beyer, Marc; Schultze, Joachim L.] Univ Bonn, D-53175 Bonn, Germany; [Ruffin, Nicolas; Jouve, Mabel; Gea-Mallorqui, Ester; Benaroch, Philippe] PSL Res Univ, INSERM, U932, Inst Curie, F-75005 Paris, France; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Lim, Tony] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore; [Yip, Chan Chung] Singapore Gen Hosp, Dept Hlth Promot Board HPB & Transplant Surg, Singapore, Singapore; [Malleret, Benoit] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Fen, Charlene Foong Shu] Singapore Hlth Serv Flow Cytometry Core Platform, 20 Coll Rd,Discovery Tower Level 10, Singapore 169856, Singapore; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Div Obstet & Gynaecol, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Singapore, Singapore; [Chen, Qingfeng] ASTAR, Humanized Mouse Unit, Inst Mol & Cell Biol, Singapore, Singapore; [Chen, Qingfeng] Univ Bonn, Myeloid Cell Biol Life & Med Sci LIMES Inst, D-53115 Bonn, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Bonn; Newcastle University - UK; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; Singapore General Hospital; Singapore General Hospital; National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Bonn	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 4, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Renia, Laurent/E-2117-2011; Newell, Evan W/F-9711-2012; Malleret, Benoit/E-9159-2011; Larbi, Anis/ABE-5868-2020; Irac, Sergio Erdal/G-6690-2014; Beyer, Marc/ABE-1408-2021; Chen, Jinmiao/ABE-5601-2021; Schultze, Joachim L./ABA-8176-2020; Schlitzer, Andreas/R-2237-2016	Renia, Laurent/0000-0003-0349-1557; Newell, Evan W/0000-0002-2889-243X; Malleret, Benoit/0000-0001-9658-7528; Irac, Sergio Erdal/0000-0001-5622-1409; Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Schlitzer, Andreas/0000-0001-7662-3712; Jouve San Roman, Mabel Juana/0000-0002-3115-4681; Handler, Kristian/0000-0001-5273-5277; Dutertre, Charles-Antoine/0000-0001-7950-3652; See, Peter/0000-0003-4428-7763; Ruffin, Nicolas/0000-0002-3698-5505; Gea-Mallorqui, Ester/0000-0002-6915-074X; McGovern, Naomi/0000-0001-5200-2698; Benaroch, Philippe/0000-0002-2655-0129; Gunther, Patrick/0000-0002-9135-7819; Poidinger, Michael/0000-0002-1047-2277; chen, jinmiao/0000-0001-7547-6423; Haniffa, Muzlifah/0000-0002-3927-2084	Singapore Immunology Network core funding; Agency for Science, Technology and Research (A*STAR), Singapore; A*STAR Graduate Scholarship; Wellcome Trust [WT 107931/Z/15/Z]; National Research Foundation Singapore [NMRC/BNIG/2026/2014]; French National Research Agency [ANR-10-INSB-04, ANR-10-IDEX-0001-02 PSL, ANR-11-LABX-0043]; Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS); Emmy-Noether fellowship of the German Research Foundation [SCHL 2116/1-1]; Biomedical Research Council Singapore;  [Sonderforschungsbereich 645];  [704]	Singapore Immunology Network core funding; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); National Research Foundation Singapore(National Research Foundation, Singapore); French National Research Agency(French National Research Agency (ANR)); Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Emmy-Noether fellowship of the German Research Foundation; Biomedical Research Council Singapore(Agency for Science Technology & Research (A*STAR)); ; 	We thank L. Robinson of Insight Editing London for critical review and editing of the manuscript; P. Y. J. Ai from the SingHealth Flow Cytometry Core Platform; and M. L. Ng, S. H. Tan, and T. B. Lu from the Electron Microscope Unit of NUS for their assistance. This work was supported by Singapore Immunology Network core funding (F.G. and E.W.N.); Agency for Science, Technology and Research (A*STAR), Singapore; the A*STAR Graduate Scholarship (P. S.); the Wellcome Trust (WT 107931/Z/15/Z) (M. H.); and the National Research Foundation Singapore under its cooperative basic research grant new investigator grant (NMRC/BNIG/2026/2014) and administered by the Singapore Ministry of Health's National Medical Research Council (C.-A.D). This work was supported by the French National Research Agency through the "Investments for the Future" program (France-BioImaging, ANR-10-INSB-04), LABEX DCBIOL (ANR-10-IDEX-0001-02 PSL and ANR-11-LABX-0043), and grants from Agence Nationale de Recherche contre le SIDA et les hepatites virales (ANRS) (P.B., N.R., M.J., and E.G.-M.). J. L. S., M. B., and A. S. are members of the Excellence Cluster ImmunoSensation. J. L. S. is funded by Sonderforschungsbereich 645 and 704. A.S. is funded by an Emmy-Noether fellowship (SCHL 2116/1-1) of the German Research Foundation and a Young Investigator Award of the Biomedical Research Council Singapore. F.G. and P.S. are inventors on patent application 10201607246S held by A*STAR, which covers the methods for the identification, targeting, and isolation of human dendritic cell (DC) precursors ("preDC") and their use as biomarkers of inflammatory diseases. The MARS-seq, microfluidic scmRNAseq, and microarray data sets are deposited in the Gene Expression Omnibus under accession numbers GSE98052, GSE98011, and GSE80171, respectively.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11988; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7432, DOI 10.1073/pnas.0500896102; de Winter CF, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0422-2; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; GRIFFIN JD, 1985, BLOOD, V66, P788; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hahsler M, 2017, DBSCAN DENSITY BASED; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu HS, 2015, PROTEIN CELL, V6, P297, DOI 10.1007/s13238-015-0140-x	61	321	324	8	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI				eaag3009	10.1126/science.aag3009	http://dx.doi.org/10.1126/science.aag3009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28473638	Green Accepted, Green Submitted			2022-12-28	WOS:000402871700045
J	Lebreton, F; Manson, AL; Saavedra, JT; Straub, TJ; Earl, AM; Gilmore, MS				Lebreton, Francois; Manson, Abigail L.; Saavedra, Jose T.; Straub, Timothy J.; Earl, Ashlee M.; Gilmore, Michael S.			Tracing the Enterococci from Paleozoic Origins to the Hospital	CELL			English	Article							LACTIC-ACID BACTERIA; MELISSOCOCCUS-PLUTON; EUROPEAN FOULBROOD; GENOME SEQUENCE; CARNOBACTERIUM; VIRULENCE; EVOLUTION; GENUS; MICROBIOTA; PERMAFROST	We examined the evolutionary history of leading multidrug resistant hospital pathogens, the enterococci, to their origin hundreds of millions of years ago. Our goal was to understand why, among the vast diversity of gut flora, enterococci are so well adapted to the modern hospital environment. Molecular clock estimation, together with analysis of their environmental distribution, phenotypic diversity, and concordance with host fossil records, place the origins of the enterococci around the time of animal terrestrialization, 425-500 mya. Speciation appears to parallel the diversification of hosts, including the rapid emergence of new enterococcal species following the End Permian Extinction. Major drivers of speciation include changing carbohydrate availability in the host gut. Life on land would have selected for the precise traits that now allow pathogenic enterococci to survive desiccation, starvation, and disinfection in the modern hospital, foreordaining their emergence as leading hospital pathogens.	[Lebreton, Francois; Gilmore, Michael S.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA; [Lebreton, Francois; Gilmore, Michael S.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02114 USA; [Lebreton, Francois; Saavedra, Jose T.; Gilmore, Michael S.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Lebreton, Francois; Manson, Abigail L.; Straub, Timothy J.; Earl, Ashlee M.; Gilmore, Michael S.] Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gilmore, MS (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA.; Gilmore, MS (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02114 USA.; Gilmore, MS (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.; Earl, AM; Gilmore, MS (corresponding author), Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.	aearl@broadinstitute.org; michael_gilmore@meei.harvard.edu	Lebreton, Francois/AAH-5958-2020		DHHS/NIH/NIAID [AI072360, AI083214];  [HHSN272200900018C];  [U19AI110818]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110818, R01AI072360, P01AI083214] Funding Source: NIH RePORTER	DHHS/NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Richard Losick, Daria Van Tyne, Melissa Martin, Andrew Knoll, Eric Alm, Gregory Fournier, and other members of the Gilmore Lab for helpful discussions during the development of this project and preparation of the manuscript. The authors thank Charlie Innis, Meghan May, and Julia Schwartzman for the collection and/or typing of marine isolates. This project has been funded in part by DHHS/NIH/NIAID grants AI072360 and AI083214 (Harvard-wide Program on Antibiotic Resistance) (M.S.G.) and contract HHSN272200900018C and grant U19AI110818 to the Broad fInstitute.	Aarestrup FM, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P55; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Baele M, 2002, J APPL MICROBIOL, V92, P348, DOI 10.1046/j.1365-2672.2002.01537.x; BAILEY L, 1983, J APPL BACTERIOL, V55, P65, DOI 10.1111/j.1365-2672.1983.tb02648.x; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; Borgo F, 2013, J BASIC MICROB, V53, P20, DOI 10.1002/jobm.201100464; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Buller N. B., 2014, BACTERIA FUNGI FISH, P400; Bursell, 1967, ADV INSECT PHYSIOL, V4, P33, DOI [10.1016/S0065-2806(08)60207-6, DOI 10.1016/S0065-2806(08)60207-6]; CAI J, 1994, INT J SYST BACTERIOL, V44, P365, DOI 10.1099/00207713-44-2-365; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; COLLINS MD, 1987, INT J SYST BACTERIOL, V37, P310, DOI 10.1099/00207713-37-4-310; COLLINS MD, 1989, J APPL BACTERIOL, V67, P453, DOI 10.1111/j.1365-2672.1989.tb02516.x; COLLINS MD, 1990, FEMS MICROBIOL LETT, V70, P255, DOI 10.1016/S0378-1097(05)80004-7; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FRANZMANN PD, 1991, ARCH MICROBIOL, V156, P255, DOI 10.1007/BF00262994; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; Hoffman PF, 2000, SCI AM, V282, P68, DOI 10.1038/scientificamerican0100-68; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; ISENBERG HD, 1970, APPL MICROBIOL, V20, P433, DOI 10.1128/AEM.20.3.433-436.1970; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Krumins JA, 2013, BIOSCIENCE, V63, P35, DOI 10.1525/bio.2013.63.1.8; Lam MMC, 2012, J BACTERIOL, V194, P2334, DOI 10.1128/JB.00259-12; Lebreton F., 2013, GENOME ANNOUNC, V1; Lebreton F, 2013, MBIO, V4, DOI 10.1128/mBio.00534-13; Leisner JJ, 2012, INT J FOOD MICROBIOL, V152, P107, DOI 10.1016/j.ijfoodmicro.2011.05.012; Loren JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088805; MARTIN JD, 1972, APPL MICROBIOL, V24, P575, DOI 10.1128/AEM.24.4.575-580.1972; MEAD GC, 1974, J GEN MICROBIOL, V82, P421, DOI 10.1099/00221287-82-2-421; Michel C, 2007, APPL ENVIRON MICROB, V73, P2947, DOI 10.1128/AEM.01852-06; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; MUNDT JO, 1963, APPL MICROBIOL, V11, P136, DOI 10.1128/AEM.11.2.136-140.1963; Nicholson WL, 2013, P NATL ACAD SCI USA, V110, P666, DOI 10.1073/pnas.1209793110; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Okumura K, 2011, J BACTERIOL, V193, P4029, DOI 10.1128/JB.05151-11; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pikuta EV, 2005, INT J SYST EVOL MICR, V55, P473, DOI 10.1099/ijs.0.63384-0; Podulka S., 2004, HDB BIRD BIOL; Raven KE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.33, 10.1038/nmicrobiol.2015.33]; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shepard B D, 1995, Methods Mol Biol, V47, P217; Sinton LW, 2007, APPL ENVIRON MICROB, V73, P7917, DOI 10.1128/AEM.01620-07; Srivastava M, 2011, J BACTERIOL, V193, P1643, DOI 10.1128/JB.01063-10; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Svanevik CS, 2011, INT J FOOD MICROBIOL, V151, P164, DOI 10.1016/j.ijfoodmicro.2011.08.016; Swofford D. L., 2001, VERSION 4 0 BETA VER; Valentino MD, 2014, MBIO, V5, DOI 10.1128/mBio.01729-14; Van Tyne D, 2014, ANNU REV MICROBIOL, V68, P337, DOI 10.1146/annurev-micro-091213-113003; WALLBANKS S, 1990, INT J SYST BACTERIOL, V40, P224, DOI 10.1099/00207713-40-3-224; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Yapo BM, 2011, POLYM REV, V51, P391, DOI 10.1080/15583724.2011.615962; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804	68	113	116	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					849	+		10.1016/j.cell.2017.04.027	http://dx.doi.org/10.1016/j.cell.2017.04.027			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV1OM	28502769	Bronze, Green Accepted			2022-12-28	WOS:000401515900011
J	Murphy, F				Murphy, Flynn			China's Silicon Valley	NATURE			English	Editorial Material																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S29	S31		10.1038/545S29a	http://dx.doi.org/10.1038/545S29a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514437	Bronze			2022-12-28	WOS:000401466500025
J	Moon, T				Moon, Twila			CLIMATE CHANGE Saying goodbye to glaciers	SCIENCE			English	Editorial Material							GREENLAND ICE-SHEET; TRENDS		[Moon, Twila] Univ Colorado, Cooperat Inst Res Environm Sci, Natl Snow & Ice Data Ctr, 449 UCB, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Moon, T (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Natl Snow & Ice Data Ctr, 449 UCB, Boulder, CO 80309 USA.	twila.science@gmail.com	Moon, Twila/AAZ-9302-2021	Moon, Twila/0000-0003-0968-7008				Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Clarke GKC, 2015, NAT GEOSCI, V8, P372, DOI [10.1038/ngeo2407, 10.1038/NGEO2407]; Durkin WJ, 2017, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00021; Huss M., 2016, FRONT EARTH SCI, V4, P248; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Kapnick SB, 2014, NAT GEOSCI, V7, P834, DOI 10.1038/NGEO2269; Martin-Espanol A, 2016, J GEOPHYS RES-EARTH, V121, P182, DOI 10.1002/2015JF003550; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Rignot E., 2014, GEOPHYS RES LETT, DOI [10.1002/(ISSN)1944-8007, DOI 10.1002/(ISSN)1944-8007]; Roe GH, 2017, NAT GEOSCI, V10, P95, DOI [10.1038/NGEO2863, 10.1038/ngeo2863]; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Shugar DH, 2017, NAT GEOSCI, V10, P370, DOI [10.1038/ngeo2932, 10.1038/NGEO2932]; Tedesco M, 2016, CRYOSPHERE, V10, P477, DOI 10.5194/tc-10-477-2016; van den Broeke MR, 2016, CRYOSPHERE, V10, P1933, DOI 10.5194/tc-10-1933-2016	15	12	12	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					580	581		10.1126/science.aam9625	http://dx.doi.org/10.1126/science.aam9625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495713				2022-12-28	WOS:000400975200020
J	Symonds, RL				Symonds, R. L.			Cesar Wahby OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2017	357								j2186	10.1136/bmj.j2186	http://dx.doi.org/10.1136/bmj.j2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UA	28487298				2022-12-28	WOS:000401169100005
J	Ginsburg, S; Levinson, W				Ginsburg, Shiphra; Levinson, Wendy			Is There a Conflict of Interest?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ginsburg, Shiphra] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON, Canada; [Levinson, Wendy] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Levinson, W (corresponding author), St Michaels Hosp, Dept Med Res, 250 Yonge St,Sixth Floor,Room 648, Toronto, ON M5B 1W8, Canada.	wendy.levinson@utoronto.ca	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650				Austad KE, 2011, JAMA-J AM MED ASSOC, V306, P991, DOI 10.1001/jama.2011.1233; Cram P, 2007, JAMA-J AM MED ASSOC, V297, P998, DOI 10.1001/jama.297.9.998; Creswell J, 2015, NY TIMES; Levinson W, 2015, UNDERSTANDING MED PR, P85; Lo B, 2009, CONFLICT INTEREST ME, V1; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	6	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1796	1797		10.1001/jama.2017.2233	http://dx.doi.org/10.1001/jama.2017.2233			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464145				2022-12-28	WOS:000400440700037
J	Duong, TA; Valeyrie-Allanore, L; Wolkenstein, P; Chosidow, O				Tu Anh Duong; Valeyrie-Allanore, Laurence; Wolkenstein, Pierre; Chosidow, Olivier			Severe cutaneous adverse reactions to drugs	LANCET			English	Review							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; GENERALIZED EXANTHEMATOUS PUSTULOSIS; LONG-TERM SEQUELAE; REGULATORY T-CELLS; SYSTEMIC SYMPTOMS DRESS; INTRAVENOUS IMMUNOGLOBULIN; RISK-FACTORS; HYPERSENSITIVITY REACTIONS; RETROSPECTIVE ANALYSIS	During the past decade, major advances have been made in the accurate diagnosis of severe cutaneous adverse reactions (SCARs) to drugs, management of their manifestations, and identification of their pathogenetic mechanisms and at-risk populations. Early recognition and diagnosis of SCARs are key in the identification of culprit drugs. SCARS are potentially life threatening, and associated with various clinical patterns and morbidity during the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis, drug reactions with eosinophilia and systemic symptoms, and acute generalised exanthematous pustulosis. Early drug withdrawal is mandatory in all SCARs. Physicians' knowledge is essential to the improvement of diagnosis and management, and in the limitation and prevention of long-term sequelae. This Seminar provides the tools to help physicians in their clinical approach and investigations of SCARs.	[Tu Anh Duong; Valeyrie-Allanore, Laurence; Wolkenstein, Pierre; Chosidow, Olivier] Hop Henri Mondor, AP HP, Dept Dermatol, Creteil, France; [Tu Anh Duong; Valeyrie-Allanore, Laurence; Wolkenstein, Pierre; Chosidow, Olivier] Ctr Reference Dermatoses Bulleuses Tox, Creteil, France; [Wolkenstein, Pierre; Chosidow, Olivier] Univ Paris Est Creteil Val de Marne, EpiDermE Epidemiol Dermatol & Evaluat Therapeut E, Creteil, France; [Chosidow, Olivier] French Satellite Cochrane Skin Grp, Creteil, France; [Chosidow, Olivier] INSERM, Ctr Invest Clin 1430, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm)	Duong, TA (corresponding author), Hop Henri Mondor, Dept Dermatol, F-94010 Creteil, France.	tu-anh.duong@aphp.fr			Janssen Cilag; Novartis; Roche; Sanofi-Aventis; Abbvie; GlaxoSmithKline; Bailleul; Astellas; Galderma; Bayer; Pierre Fabre; Expanscience; Cephalon; Boehringer Ingelheim	Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Abbvie(AbbVie); GlaxoSmithKline(GlaxoSmithKline); Bailleul; Astellas(Astellas Pharmaceuticals); Galderma; Bayer(Bayer AG); Pierre Fabre; Expanscience; Cephalon; Boehringer Ingelheim(Boehringer Ingelheim)	LV-A has received personal fees from Janssen Cilag for a booklet on cutaneous adverse reactions to telaprevir and educational presentations, Cephalon for review of phosphoglucinol in cutaneous adverse reactions, Pinnacle Biologics for expertise regarding cutaneous reactions to amifostine, Boehringer Ingelheim for expert consultancy on severe cutaneous adverse reactions, and Pierre Fabre for educational presentations. PW is a principal investigator of a clinical trial (NCT01412892) on neurofibromatosis funded by Novartis and has received personal fees from Pierre Fabre and Expanscience for his expertise on isotretinoin for acne. OC has received personal fees from Roche for a trial assessing the preventive role of doxycycline in cutaneous-related anti-EGFR toxicities, and Jansen Cilag for a meeting dedicated to the Centocor registry for ustekinumab side-effects, as well as personal fees from Sanofi-Aventis, Novartis, Abbvie, GlaxoSmithKline, Bailleul, Astellas, and Galderma for being on a scientific board. OC has also received a grant from GlaxoSmithKline and consultant and speaker fees from Bayer. TAD declares no competing interests.	Adam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095339; Anna AEBPPS, 2012, BRIT J OPHTHALMOL, V96, P234, DOI 10.1136/bjo.2010.199901; Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Bachot N, 2003, ARCH DERMATOL, V139, P33, DOI 10.1001/archderm.139.1.33; Barbaud A, 2013, BRIT J DERMATOL, V168, P555, DOI 10.1111/bjd.12125; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BEGAUD B, 1985, THERAPIE, V40, P111; Bequignon E, 2015, JAMA DERMATOL, V151, P302, DOI 10.1001/jamadermatol.2014.4844; Bocquet H, 1996, SEMIN CUTAN MED SURG, V15, P250, DOI 10.1016/S1085-5629(96)80038-1; Bouvresse S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-72; Carr DF, 2013, CLIN INFECT DIS, V56, P1330, DOI 10.1093/cid/cit021; Chanal J, 2013, BRIT J DERMATOL, V169, P1041, DOI 10.1111/bjd.12488; Chaponda M, 2011, BRIT J CLIN PHARMACO, V71, P659, DOI 10.1111/j.1365-2125.2010.03784.x; Chen JB, 2010, EUR J DERMATOL, V20, P743, DOI 10.1684/ejd.2010.1077; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chen YC, 2013, J AM ACAD DERMATOL, V68, P459, DOI 10.1016/j.jaad.2012.08.009; Chen YC, 2010, ARCH DERMATOL, V146, P1373, DOI 10.1001/archdermatol.2010.198; Cheng CY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/565320; Cho YT, 2014, J AM ACAD DERMATOL, V70, P539, DOI 10.1016/j.jaad.2013.11.015; Choi MJ, 2010, ANN DERMATOL, V22, P163, DOI 10.5021/ad.2010.22.2.163; Chung WH, 2015, J INVEST DERMATOL, V135, P2237, DOI 10.1038/jid.2015.165; Chung WH, 2014, JAMA-J AM MED ASSOC, V312, P525, DOI 10.1001/jama.2014.7859; Chung WH, 2013, J INFECT DIS, V208, P1968, DOI 10.1093/infdis/jit383; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Creamer D, 2016, BRIT J DERMATOL, V174, P1194, DOI 10.1111/bjd.14530; de Araujo E, 2011, EXP DERMATOL, V20, P107, DOI 10.1111/j.1600-0625.2010.01176.x; de Prost N, 2014, CRIT CARE MED, V42, P118, DOI 10.1097/CCM.0b013e31829eb94f; de Prost N, 2010, MEDICINE, V89, P28, DOI 10.1097/MD.0b013e3181ca4290; de Sica-Chapman A, 2010, BRIT J DERMATOL, V162, P860, DOI 10.1111/j.1365-2133.2009.09585.x; Descamps V, 2001, ARCH DERMATOL, V137, P301; Duong TA, 2015, BRIT J DERMATOL, V172, P400, DOI 10.1111/bjd.13505; Eshki M, 2009, ARCH DERMATOL, V145, P67, DOI 10.1001/archderm.145.1.67; Fili L, 2014, ALLERGOL INT, V63, P129, DOI 10.2332/allergolint.13-LE-0582; Finkelstein Y, 2014, JAMA-J AM MED ASSOC, V311, P2231, DOI 10.1001/jama.2014.839; Firoz BF, 2012, J AM ACAD DERMATOL, V67, P630, DOI 10.1016/j.jaad.2011.12.014; Fujita Y, 2011, J AM ACAD DERMATOL, V65, P65, DOI 10.1016/j.jaad.2010.04.042; Funck-Brentano E, 2015, J AM ACAD DERMATOL, V72, P246, DOI 10.1016/j.jaad.2014.10.032; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Gaultier F, 2009, ARCH DERMATOL, V145, P1332, DOI 10.1001/archdermatol.2009.233; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; Guegan S, 2006, J INVEST DERMATOL, V126, P272, DOI 10.1038/sj.jid.5700068; Gueudry J, 2009, ARCH DERMATOL, V145, P157, DOI 10.1001/archdermatol.2009.540; Haddad C, 2017, J INVEST DERMATOL, V137, P1179, DOI 10.1016/j.jid.2016.11.041; Haddad C, 2013, DRUG SAFETY, V36, P681, DOI 10.1007/s40264-013-0070-6; Hanafusa T, 2012, J DERMATOL SCI, V65, P213, DOI 10.1016/j.jdermsci.2011.12.002; Hashizume H, 2013, ALLERGY, V68, P681, DOI 10.1111/all.12138; Hotz C, 2013, BRIT J DERMATOL, V169, P1223, DOI 10.1111/bjd.12502; Huang YC, 2012, BRIT J DERMATOL, V167, P424, DOI 10.1111/j.1365-2133.2012.10965.x; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Ingen-Housz-Oro S, 2015, BRIT J DERMATOL, V172, P1455, DOI 10.1111/bjd.13540; Ishida T, 2014, ALLERGY, V69, P798, DOI 10.1111/all.12410; Isvy-Joubert A, 2014, DERMATOLOGY, V228, P338, DOI 10.1159/000358295; Joly P, 2012, ARCH DERMATOL, V148, P543, DOI [10.1001/archdermatol.2011.1937, 10.1001/archderm.148.4.dlt120002-c]; Kaffenberger BH, 2014, J AM ACAD DERMATOL, V71, P195, DOI 10.1016/j.jaad.2013.12.048; Kaniwa N, 2010, EPILEPSIA, V51, P2461, DOI 10.1111/j.1528-1167.2010.02766.x; Kano Y, 2007, ALLERGY, V62, P1439, DOI 10.1111/j.1398-9995.2007.01553.x; Kano Y, 2006, BRIT J DERMATOL, V155, P301, DOI 10.1111/j.1365-2133.2006.07238.x; Kano Y, 2010, MED CLIN N AM, V94, P743, DOI 10.1016/j.mcna.2010.03.004; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Kardaun SH, 2013, BRIT J DERMATOL, V169, P1071, DOI 10.1111/bjd.12501; Kardaun SH, 2010, J CUTAN PATHOL, V37, P1220, DOI 10.1111/j.1600-0560.2010.01612.x; Ketter TA, 2006, J CLIN PSYCHIAT, V67, P400, DOI 10.4088/JCP.v67n0310; Kim SK, 2015, J INVEST DERMATOL, V135, P2021, DOI 10.1038/jid.2015.90; Kirchhof MG, 2014, J AM ACAD DERMATOL, V71, P941, DOI 10.1016/j.jaad.2014.07.016; Klimas NK, 2017, JAMA DERMATOL, V153, P461, DOI 10.1001/jamadermatol.2016.4809; Knight L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135501; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P785, DOI 10.1001/jama.2013.276938; Lebargy F, 1997, INTENS CARE MED, V23, P1237, DOI 10.1007/s001340050492; Lebrun-Vignes B, 2012, BRIT J DERMATOL, V166, P1333, DOI 10.1111/j.1365-2133.2012.10845.x; Lee HY, 2013, BRIT J DERMATOL, V169, P1304, DOI 10.1111/bjd.12607; Lee HY, 2012, BRIT J DERMATOL, V167, P555, DOI 10.1111/j.1365-2133.2012.11074.x; Levi N, 2009, PEDIATRICS, V123, pE297, DOI 10.1542/peds.2008-1923; Lew TT, 2015, BRIT J DERMATOL, V172, P836, DOI 10.1111/bjd.13375; Lin A, 2011, J BURN CARE RES, V32, P547, DOI 10.1097/BCR.0b013e31822b0f29; Liu JB, 2011, AM J OPHTHALMOL, V152, P739, DOI 10.1016/j.ajo.2011.03.037; Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Morel E, 2011, ALLERGY, V66, P360, DOI 10.1111/j.1398-9995.2010.02484.x; Morito H, 2014, CLIN EXP DERMATOL, V39, P284, DOI 10.1111/ced.12246; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Natkunarajah J, 2011, EUR J DERMATOL, V21, P385, DOI 10.1684/ejd.2011.1300; Navarini AA, 2015, JAMA DERMATOL, V151, P452, DOI 10.1001/jamadermatol.2014.3848; Navarini AA, 2013, J INVEST DERMATOL, V133, P1904, DOI 10.1038/jid.2013.44; Nicoletti P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131038; Nomura Y, 2011, J DERMATOL, V38, P1076, DOI 10.1111/j.1346-8138.2010.01170.x; Ortonne N, 2015, BRIT J DERMATOL, V173, P50, DOI 10.1111/bjd.13683; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Padovan E, 1996, EUR J IMMUNOL, V26, P42, DOI 10.1002/eji.1830260107; Palmieri TL, 2002, J BURN CARE REHABIL, V23, P87, DOI 10.1097/00004630-200203000-00004; Paradisi A, 2014, J AM ACAD DERMATOL, V71, P278, DOI 10.1016/j.jaad.2014.04.044; PHOENIX G, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E4955; Picard D, 2015, J EUR ACAD DERMATOL, V29, P801, DOI 10.1111/jdv.12419; Picard D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001116; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; Pirmohamed M, 2011, CLIN PHARMACOL THER, V89, P784, DOI 10.1038/clpt.2011.30; Polak ME, 2013, BRIT J DERMATOL, V168, P539, DOI 10.1111/bjd.12109; Porebski G, 2013, CLIN EXP ALLERGY, V43, P1027, DOI 10.1111/cea.12145; Rajaratnam R, 2010, CLIN EXP DERMATOL, V35, P853, DOI 10.1111/j.1365-2230.2010.03826.x; Raucci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068231; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Roujeau JC, 2013, JAMA DERMATOL, V149, P152, DOI 10.1001/jamadermatol.2013.938; Saag M, 2008, CLIN INFECT DIS, V46, P1111, DOI 10.1086/529382; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Schlapbach C, 2011, ALLERGY, V66, P1469, DOI 10.1111/j.1398-9995.2011.02677.x; Schneck J, 2008, J AM ACAD DERMATOL, V58, P33, DOI 10.1016/j.jaad.2007.08.039; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Sekula P, 2011, J BURN CARE RES, V32, P237, DOI 10.1097/BCR.0b013e31820aafbc; Shiohara T, 2007, BRIT J DERMATOL, V156, P1083, DOI 10.1111/j.1365-2133.2007.07807.x; Shiohara Tetsuo, 2006, Allergol Int, V55, P1, DOI 10.2332/allergolint.55.1; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x; Srinoulprasert Y, 2014, INT ARCH ALLERGY IMM, V163, P198, DOI 10.1159/000358491; Stern RS, 2014, JAMA-J AM MED ASSOC, V312, P1590, DOI 10.1001/jama.2014.10777; Stern RS, 2012, NEW ENGL J MED, V366, P2492, DOI 10.1056/NEJMcp1104080; Struck MF, 2010, J BURN CARE RES, V31, P816, DOI 10.1097/BCR.0b013e3181eed441; Struck MF, 2010, INTENS CARE MED, V36, P22, DOI 10.1007/s00134-009-1659-1; Su SC, 2017, J INVEST DERMATOL, V137, P1065, DOI 10.1016/j.jid.2016.11.034; Takahashi R, 2009, J IMMUNOL, V182, P8071, DOI 10.4049/jimmunol.0804002; Tohyama M, 2007, BRIT J DERMATOL, V157, P934, DOI 10.1111/j.1365-2133.2007.08167.x; Tohyama M, 2012, BRIT J DERMATOL, V166, P322, DOI 10.1111/j.1365-2133.2011.10649.x; Tomaino J, 2012, PEDIATR TRANSPLANT, V16, pE74, DOI 10.1111/j.1399-3046.2010.01424.x; Tougeron-Brousseau B, 2009, AM J OPHTHALMOL, V148, P852, DOI 10.1016/j.ajo.2009.07.006; Ushigome Y, 2013, J AM ACAD DERMATOL, V68, P721, DOI 10.1016/j.jaad.2012.10.017; Valeyrie-Allanore L, 2010, BRIT J DERMATOL, V163, P847, DOI 10.1111/j.1365-2133.2010.09863.x; Valeyrie-Allanore L, 2008, RADIOTHER ONCOL, V87, P300, DOI 10.1016/j.radonc.2008.01.021; Valeyrie-Allanore L, 2013, J AM ACAD DERMATOL, V68, pE29, DOI 10.1016/j.jaad.2011.10.007; Viard-Leveugle I, 2013, J INVEST DERMATOL, V133, P489, DOI 10.1038/jid.2012.330; Wang CW, 2013, J ALLERGY CLIN IMMUN, V132, P713, DOI 10.1016/j.jaci.2013.04.036; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Weinand C, 2013, BURNS, V39, P1449, DOI 10.1016/j.burns.2013.03.011; Wolkenstein P, 2005, J INVEST DERMATOL, V125, P1080, DOI 10.1111/j.0022-202X.2005.23939.x; Wolkenstein P, 1998, LANCET, V352, P1586, DOI 10.1016/S0140-6736(98)02197-7; Wu J, 2015, BRIT J DERMATOL, V173, P1224, DOI 10.1111/bjd.14052; Yang CW, 2016, ACTA DERM-VENEREOL, V96, P525, DOI 10.2340/00015555-2295; Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536; Yoshioka N, 2013, CLIN IMMUNOL, V148, P89, DOI 10.1016/j.clim.2013.04.002; Ziemer M, 2012, BRIT J DERMATOL, V166, P575, DOI 10.1111/j.1365-2133.2011.10705.x	143	190	200	5	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2017	390	10106					1996	2011		10.1016/S0140-6736(16)30378-6	http://dx.doi.org/10.1016/S0140-6736(16)30378-6			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK9HW	28476287				2022-12-28	WOS:000413823200035
J	Kivelevitch, D; Menter, A				Kivelevitch, Dario; Menter, Alan			Adalimumab in paediatric psoriasis	LANCET			English	Editorial Material							METHOTREXATE; TRIAL		[Kivelevitch, Dario; Menter, Alan] Baylor Univ, Med Ctr, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center	Menter, A (corresponding author), Baylor Univ, Med Ctr, Dallas, TX 75246 USA.	amderm@gmail.com	Kivelevitch, Dario/M-6918-2019					Klotsche J, 2016, ANN RHEUM DIS, V75, P855, DOI 10.1136/annrheumdis-annrheumdis-2014-206747; Mansouri B, 2016, JAMA DERMATOL, V152, P1244, DOI 10.1001/jamadermatol.2016.2907; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Paller AS, 2008, NEW ENGL J MED, V358, P241, DOI 10.1056/NEJMoa066886; PAPP K, 2017, LANCET; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Ramanan AV, 2003, ARCH DIS CHILD, V88, P197, DOI 10.1136/adc.88.3.197; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Silverberg Nanette B, 2009, Ther Clin Risk Manag, V5, P849; Tollefson MM, 2010, J AM ACAD DERMATOL, V62, P979, DOI 10.1016/j.jaad.2009.07.029; van Geel MJ, 2015, J DERMATOL TREAT, V26, P406, DOI 10.3109/09546634.2014.996515	12	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					5	+		10.1016/S0140-6736(17)31190-X	http://dx.doi.org/10.1016/S0140-6736(17)31190-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28478969				2022-12-28	WOS:000404396300005
J	Schweigler, T; Kasper, V; Erne, S; Mazets, I; Rauer, B; Cataldini, F; Langen, T; Gasenzer, T; Berges, J; Schmiedmayer, J				Schweigler, Thomas; Kasper, Valentin; Erne, Sebastian; Mazets, Igor; Rauer, Bernhard; Cataldini, Federica; Langen, Tim; Gasenzer, Thomas; Berges, Juergen; Schmiedmayer, Joerg			Experimental characterization of a quantum many-body system via higher-order correlations	NATURE			English	Article							SINE-GORDON EQUATION; FERMION SYSTEM; SOLITONS; MODEL	Quantum systems can be characterized by their correlations(1,2). Higher-order (larger than second order) correlations, and the ways in which they can be decomposed into correlations of lower order, provide important information about the system, its structure, its interactions and its complexity(3,4). The measurement of such correlation functions is therefore an essential tool for reading, verifying and characterizing quantum simulations(5). Although higher-order correlation functions are frequently used in theoretical calculations, so far mainly correlations up to second order have been studied experimentally. Here we study a pair of tunnel-coupled one-dimensional atomic superfluids and characterize the corresponding quantum many-body problem by measuring correlation functions. We extract phase correlation functions up to tenth order from interference patterns and analyse whether, and under what conditions, these functions factorize into correlations of lower order. This analysis characterizes the essential features of our system, the relevant quasiparticles, their interactions and topologically distinct vacua. From our data we conclude that in thermal equilibrium our system can be seen as a quantum simulator of the sine-Gordon model(6-10), relevant for diverse disciplines ranging from particle physics to condensed matter(11,12). The measurement and evaluation of higher-order correlation functions can easily be generalized to other systems and to study correlations of any other observable such as density, spin and magnetization. It therefore represents a general method for analysing quantum many-body systems from experimental data.	[Schweigler, Thomas; Erne, Sebastian; Mazets, Igor; Rauer, Bernhard; Cataldini, Federica; Langen, Tim; Schmiedmayer, Joerg] TU Wien, Vienna Ctr Quantum Sci & Technol, Atominst, Stadionallee 2, A-1020 Vienna, Austria; [Kasper, Valentin; Erne, Sebastian; Berges, Juergen] Heidelberg Univ, Inst Theoret Phys, Philosophenweg 16, D-69120 Heidelberg, Germany; [Mazets, Igor] Wolfgang Pauli Inst, A-1090 Vienna, Austria; [Langen, Tim] Univ Stuttgart, Phys Inst 5, D-70569 Stuttgart, Germany; [Langen, Tim] Univ Stuttgart, Ctr Integrated Quantum Sci & Technol IQST, D-70569 Stuttgart, Germany; [Gasenzer, Thomas] Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany	Technische Universitat Wien; Ruprecht Karls University Heidelberg; University of Stuttgart; University of Stuttgart; Ruprecht Karls University Heidelberg	Schmiedmayer, J (corresponding author), TU Wien, Vienna Ctr Quantum Sci & Technol, Atominst, Stadionallee 2, A-1020 Vienna, Austria.	schmiedmayer@atomchip.org	Schmiedmayer, Jörg/M-9669-2019; Mazets, Igor/T-6610-2019; Berges, Jürgen/AAW-6472-2020; Kasper, Valentin/ABH-8709-2020; Schmiedmayer, Jörg/B-4717-2008; Langen, Tim/I-6357-2012; Mazets, Igor E./D-4862-2011; Kasper, Valentin/AAP-3287-2020; Rauer, Bernhard/U-8788-2019	Schmiedmayer, Jörg/0000-0001-7799-5614; Mazets, Igor/0000-0002-3769-8313; Schmiedmayer, Jörg/0000-0001-7799-5614; Langen, Tim/0000-0003-2561-0326; Mazets, Igor E./0000-0002-3769-8313; Rauer, Bernhard/0000-0001-5180-3100; Erne, Sebastian/0000-0003-2836-8993; Schweigler, Thomas/0000-0002-8447-2683	EU [640800]; ERC; Austrian Science Fund (FWF) through the doctoral programme CoQuS [W1210]; SFB-FoQuS; German Research Foundation (DFG) [SFB 1225]; FWF; Max Planck Society; Alexander von Humboldt Foundation; University of Heidelberg (Center for Quantum Dynamics); Helmholtz Association [HA216/EMMI]	EU(European Commission); ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF) through the doctoral programme CoQuS(Austrian Science Fund (FWF)); SFB-FoQuS(Austrian Science Fund (FWF)); German Research Foundation (DFG)(German Research Foundation (DFG)); FWF(Austrian Science Fund (FWF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); University of Heidelberg (Center for Quantum Dynamics); Helmholtz Association(Helmholtz Association)	We acknowledge discussions with E. Demler and J. M. Pawlowski. This work was supported by the EU through the EU-FET Proactive grant AQuS, Project No. 640800 and the ERC advanced grant QuantumRelax, and by the Austrian Science Fund (FWF) through the doctoral programme CoQuS (W1210) (T.S., B.R. and F.C.) and the SFB-FoQuS. This work is in part supported by the SFB 1225 'ISOQUANT' financed by the German Research Foundation (DFG) and the FWF. V.K. acknowledges support from the Max Planck Society through the doctoral programme IMPRS-QD. T.L. acknowledges support by the Alexander von Humboldt Foundation through a Feodor Lynen Research Fellowship. T.G. and J.B. acknowledge support by the University of Heidelberg (Center for Quantum Dynamics) and the Helmholtz Association (HA216/EMMI).	[Anonymous], 1947, J PHYS-USSR; Betz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020407; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Cuevas-Maraver J., 2014, NONLINEAR SYSTEMS CO; Dall RG, 2013, NAT PHYS, V9, P341, DOI [10.1038/nphys2632, 10.1038/NPHYS2632]; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Endres M, 2013, APPL PHYS B-LASERS O, V113, P27, DOI 10.1007/s00340-013-5552-9; FADDEEV LD, 1978, PHYS REP, V42, P1, DOI 10.1016/0370-1573(78)90058-3; FOGEL MB, 1977, PHYS REV B, V15, P1578, DOI 10.1103/PhysRevB.15.1578; Gardiner C, 2009, STOCHASTIC METHODS H; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Grisins P, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013629; Gritsev V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174511; Hodgman SS, 2011, SCIENCE, V331, P1046, DOI 10.1126/science.1198481; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; MANDELSTAM S, 1975, PHYS REV D, V11, P3026, DOI 10.1103/PhysRevD.11.3026; Manz S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.031610; MATTIS DC, 1965, J MATH PHYS, V6, P304, DOI 10.1063/1.1704281; Peskin M., 1995, INTRO QUANTUM FIELD; Schumm T, 2005, NAT PHYS, V1, P57, DOI 10.1038/nphys125; SCHWINGER J, 1951, P NATL ACAD SCI USA, V37, P452, DOI 10.1073/pnas.37.7.452; SCHWINGER J, 1951, P NATL ACAD SCI USA, V37, P455, DOI 10.1073/pnas.37.7.455; Shiryaev A. N., 2016, PROBABILITY, P349; SKLYANIN EK, 1979, THEOR MATH PHYS+, V40, P688, DOI 10.1007/BF01018718; Smith DA, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/7/075011; Stimming HP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015301; Whitlock NK, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.053609; WICK GC, 1950, PHYS REV, V80, P268, DOI 10.1103/PhysRev.80.268; Zinn-Justin J, 2002, QUANTUM FIELD THEORY	36	112	112	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					323	+		10.1038/nature22310	http://dx.doi.org/10.1038/nature22310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516933	Green Submitted			2022-12-28	WOS:000401466500057
J	de Leeuw, PW				de Leeuw, Peter W.			Review: Targeting SBP lowering to < 140 mm Hg reduces MACE more than targeting SBP to >= 140 in hypertensive patients >= 65 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[de Leeuw, Peter W.] Maastricht Univ, Med Ctr, Maastricht, Netherlands	Maastricht University	de Leeuw, PW (corresponding author), Maastricht Univ, Med Ctr, Maastricht, Netherlands.		de Leeuw, Peter W./J-4552-2016	de Leeuw, Peter W./0000-0002-4949-5812				Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC55	JC55		10.7326/ACPJC-2017-166-10-055	http://dx.doi.org/10.7326/ACPJC-2017-166-10-055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505639				2022-12-28	WOS:000401240200007
J	Miloslavsky, EM; Stone, JH; Moy, AP				Miloslavsky, Eli M.; Stone, John H.; Moy, Andrea P.			Case 14-2017: A 20-Year-Old Man with Pain and Swelling of the Left Calf and a Purpuric Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HENOCH-SCHONLEIN PURPURA; INFLAMMATORY BOWEL DISEASES; CUTANEOUS VASCULITIS UPDATE; SMALL-VESSEL VASCULITIS; ALPHA ANTAGONISTS; THERAPY; MANIFESTATIONS; GRANULOMATOSIS; EPIDEMIOLOGY; INVOLVEMENT		[Miloslavsky, Eli M.; Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Moy, Andrea P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Miloslavsky, Eli M.; Stone, John H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Moy, Andrea P.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Miloslavsky, EM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Miloslavsky, EM (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; Calvo-Rio V, 2014, MEDICINE, V93, P106, DOI 10.1097/MD.0000000000000019; Carlson JA, 2006, AM J DERMATOPATH, V28, P486, DOI 10.1097/01.dad.0000246646.45651.a2; Carlson JA, 2007, AM J DERMATOPATH, V29, P44, DOI 10.1097/01.dad.0000245195.35106.3c; Carlson JA, 2005, AM J DERMATOPATH, V27, P504, DOI 10.1097/01.dad.0000181109.54532.c5; Chen KR, 2008, AM J CLIN DERMATOL, V9, P71, DOI 10.2165/00128071-200809020-00001; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Eloy P, 2007, EUR ARCH OTO-RHINO-L, V264, P103, DOI 10.1007/s00405-006-0146-3; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Gupta S, 2009, INDIAN J DERMATOL VE, V75, P356, DOI 10.4103/0378-6323.53130; HARRIST TJ, 1979, HUM PATHOL, V10, P625, DOI 10.1016/S0046-8177(79)80109-4; Hawryluk EB, 2012, J CUTAN PATHOL, V39, P481, DOI 10.1111/j.1600-0560.2012.01894.x; Hocevar A, 2014, BRIT J DERMATOL, V171, P524, DOI 10.1111/bjd.12946; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hung TY, 2009, PEDIATR EMERG CARE, V25, P31, DOI 10.1097/PEC.0b013e318191dafe; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Linskey KR, 2012, J AM ACAD DERMATOL, V66, P813, DOI 10.1016/j.jaad.2011.06.012; Mahr AD, 2006, CLIN EXP RHEUMATOL, V24, pS82; Marques I, 2012, J CROHNS COLITIS, V6, P796, DOI 10.1016/j.crohns.2012.02.019; Marzano AV, 2014, INFLAMM BOWEL DIS, V20, P213, DOI 10.1097/01.MIB.0000436959.62286.f9; Miyazawa T, 2010, JCR-J CLIN RHEUMATOL, V16, P338, DOI 10.1097/RHU.0b013e3181f4de99; Pagnoux C, 2006, CLIN EXP RHEUMATOL, V24, pS71; Paydary K, 2015, IRAN J PEDIATR, V25, DOI 10.5812/ijp.2177; Poon SH, 2011, SEMIN ARTHRITIS RHEU, V41, P434, DOI 10.1016/j.semarthrit.2011.05.009; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; Russell JP, 2006, INT J DERMATOL, V45, P3, DOI 10.1111/j.1365-4632.2005.02898.x; Shet A, 2002, PEDIATR INFECT DIS J, V21, P420, DOI 10.1097/00006454-200205000-00014; Sy A, 2016, SEMIN ARTHRITIS RHEU, V45, P475, DOI 10.1016/j.semarthrit.2015.07.006; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; Weiss PF, 2010, J RHEUMATOL, V37, P2587, DOI 10.3899/jrheum.100364; Xu LY, 2009, SEMIN ARTHRITIS RHEU, V38, P348, DOI 10.1016/j.semarthrit.2008.01.007	32	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1868	1877		10.1056/NEJMcpc1616397	http://dx.doi.org/10.1056/NEJMcpc1616397			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28489991				2022-12-28	WOS:000400891100014
J	de Vladar, HP; Szathmary, E				de Vladar, Harold P.; Szathmary, Eors			Beyond Hamilton's rule	SCIENCE			English	Editorial Material							KIN SELECTION; EVOLUTION		[de Vladar, Harold P.; Szathmary, Eors] Inst Adv Studies Koszeg, 14 Chernel Utca, H-9730 Koszeg, Hungary; [Szathmary, Eors] Evolutionary Syst Res Grp, MTA Ctr Ecol Res, Klebelsberg Kuno U 3, H-8237 Tihany, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	de Vladar, HP (corresponding author), Inst Adv Studies Koszeg, 14 Chernel Utca, H-9730 Koszeg, Hungary.	harold.vladar@parmenides-foundation.org; szathmary.eors@gmail.com	Szathmary, Eors/AAS-1202-2021	Szathmary, Eors/0000-0001-5227-2997				Allen B, 2013, P NATL ACAD SCI USA, V110, P20135, DOI 10.1073/pnas.1317588110; Birch J, 2015, BIOSCIENCE, V65, P22, DOI 10.1093/biosci/biu196; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Okasha S, 2016, BRIT J PHILOS SCI, V67, P435, DOI 10.1093/bjps/axu047; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; Simon B, 2014, J THEOR BIOL, V349, P22, DOI 10.1016/j.jtbi.2014.01.030; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; van Veelen M, 2017, J THEOR BIOL, V414, P176, DOI 10.1016/j.jtbi.2016.08.019; van Veelen M, 2011, J THEOR BIOL, V270, P189, DOI 10.1016/j.jtbi.2010.11.011	12	6	6	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					485	486		10.1126/science.aam6322	http://dx.doi.org/10.1126/science.aam6322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473547	Green Accepted			2022-12-28	WOS:000400545700016
J	Shindell, D; Borgford-Parnell, N; Brauer, M; Haines, A; Kuylenstierna, JCI; Leonard, SA; Ramanathan, V; Ravishankara, A; Amann, M; Srivastava, L				Shindell, D.; Borgford-Parnell, N.; Brauer, M.; Haines, A.; Kuylenstierna, J. C. I.; Leonard, S. A.; Ramanathan, V.; Ravishankara, A.; Amann, M.; Srivastava, L.			A climate policy pathway for near- and long-term benefits	SCIENCE			English	Editorial Material									[Shindell, D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Borgford-Parnell, N.] Inst Governance & Sustainable Dev, Washington, DC 20008 USA; [Brauer, M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Haines, A.] London Sch Hyg & Trop Med, London WC1H 9SH, England; [Kuylenstierna, J. C. I.] Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England; [Leonard, S. A.] United Nations Environm Programme, F-75015 Paris, France; [Ramanathan, V.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ravishankara, A.] Colorado State Univ, Ft Collins, CO 80523 USA; [Amann, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Srivastava, L.] TERI Univ, New Delhi 110070, India	Duke University; University of British Columbia; University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of California System; University of California San Diego; Scripps Institution of Oceanography; Colorado State University; International Institute for Applied Systems Analysis (IIASA); TERI University	Shindell, D (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	drew.shindell@duke.edu	Leonard, Sunday/ABC-9822-2020; Brauer, Michael/Y-2810-2019; Shindell, Drew/D-4636-2012	Brauer, Michael/0000-0002-9103-9343; Shindell, Drew/0000-0003-1552-4715; Srivastava, Leena/0000-0002-4252-5863; Haines, Andy/0000-0002-8053-4605				Climate and Clean Air Coalition, 2016, MARR COMM QUE CLIM C; Harmsen MJHM, 2016, CLIMATIC CHANGE, V136, P203, DOI 10.1007/s10584-016-1603-7; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Ramanathan V, 2010, P NATL ACAD SCI USA, V107, P8055, DOI 10.1073/pnas.1002293107; Rogelj J, 2014, P NATL ACAD SCI USA, V111, P16325, DOI 10.1073/pnas.1415631111; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Tignor M., 2013, CLIMATE CHANGE 2013; UN Environment Programme/World Meteorological Organization, 2011, INT ASS BLACK CARB T; UNEP, 2015, EM GAP REP 2015; Victor DG, 2015, NAT CLIM CHANGE, V5, P796, DOI 10.1038/nclimate2703; Xu Y, 2013, ATMOS CHEM PHYS, V13, P6083, DOI 10.5194/acp-13-6083-2013	11	66	68	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					493	494		10.1126/science.aak9521	http://dx.doi.org/10.1126/science.aak9521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473553				2022-12-28	WOS:000400545700022
J	Gottlieb, JD; Bressler, NM				Gottlieb, Julie D.; Bressler, Neil M.			How Should Journals Handle the Conflict of Interest of Their Editors? Who Watches the "Watchers"?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gottlieb, Julie D.; Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University	Bressler, NM (corresponding author), Johns Hopkins Univ Hosp, Off Maumenee 752, 600 N Wolfe St, Baltimore, MD 21287 USA.	nbressler@jhmi.edu			Bayer; Novartis; Roche/Genentech; Samsung	Bayer(Bayer AG); Novartis(Novartis); Roche/Genentech(Roche HoldingGenentech); Samsung(Samsung)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Gottlieb reports being associate dean for policy coordination at the Johns Hopkins University School of Medicine, which oversees review of outside interests, including financial conflict of interest. Dr Bressler reports receiving grants from Bayer, Novartis, Roche/Genentech, and Samsung to his institution; and previously serving as chair of the Johns Hopkins University School of Medicine's committee on outside interests, which reviews financial conflict of interest. He was not involved in the editorial evaluation or decision to accept this article for publication.	Iverson C, 2009, AMA MANUAL STYLE GUI	1	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1757	1758		10.1001/jama.2017.2207	http://dx.doi.org/10.1001/jama.2017.2207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464152				2022-12-28	WOS:000400440700028
J	Gachter, S				Gachter, Simon			BEHAVIOURAL ECONOMICS Occasional errors can benefit coordination	NATURE			English	Editorial Material							GAMES		[Gachter, Simon] Univ Nottingham, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England	University of Nottingham	Gachter, S (corresponding author), Univ Nottingham, Ctr Decis Res & Expt Econ, Nottingham NG7 2RD, England.	simon.gaechter@nottingham.ac.uk	Gachter, Simon/C-9787-2009	Gachter, Simon/0000-0002-7182-8505				Bowles S., 2003, MICROECONOMICS BEHAV; Buskens V, 2016, DYN GAMES APPL, V6, P477, DOI 10.1007/s13235-015-0144-4; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; CRAWFORD VP, 1995, ECONOMETRICA, V63, P103, DOI 10.2307/2951699; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Shirado H, 2017, NATURE, V545, P370, DOI 10.1038/nature22332; Turchin Peter, 2016, ULTRA SOC 10000 YEAR; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Weidenholzer S, 2010, GAMES-BASEL, V1, P551; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	13	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					297	298		10.1038/545297a	http://dx.doi.org/10.1038/545297a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28516921	Green Accepted			2022-12-28	WOS:000401466500052
J	Liu, KH; Niu, YJ; Konishi, M; Wu, Y; Du, H; Chung, HS; Li, L; Boudsocq, M; McCormack, M; Maekawa, S; Ishida, T; Zhang, C; Shokat, K; Yanagisawa, S; Sheen, J				Liu, Kun-hsiang; Niu, Yajie; Konishi, Mineko; Wu, Yue; Du, Hao; Chung, Hoo Sun; Li, Lei; Boudsocq, Marie; McCormack, Matthew; Maekawa, Shugo; Ishida, Tetsuya; Zhang, Chao; Shokat, Kevan; Yanagisawa, Shuichi; Sheen, Jen			Discovery of nitrate-CPK-NLP signalling in central nutrient-growth networks	NATURE			English	Article							TRANSIENT GENE-EXPRESSION; TRANSCRIPTION FACTORS; ARABIDOPSIS ROOTS; PROTEIN-KINASES; CALCIUM; GLUCOSE; STRESS; TRANSLATION; PROTOPLASTS; METABOLISM	Nutrient signalling integrates and coordinates gene expression, metabolism and growth. However, its primary molecular mechanisms remain incompletely understood in plants and animals. Here we report unique Ca2+ signalling triggered by nitrate with live imaging of an ultrasensitive biosensor in Arabidopsis leaves and roots. A nitrate-sensitized and targeted functional genomic screen identifies subgroup III Ca2+-sensor protein kinases (CPKs) as master regulators that orchestrate primary nitrate responses. A chemical switch with the engineered mutant CPK10(M141G) circumvents embryo lethality and enables conditional analyses of cpk10 cpk30 cpk32 triple mutants to define comprehensive nitrate-associated regulatory and developmental programs. Nitrate-coupled CPK signalling phosphorylates conserved NIN-LIKE PROTEIN (NLP) transcription factors to specify the reprogramming of gene sets for downstream transcription factors, transporters, nitrogen assimilation, carbon/nitrogen metabolism, redox, signalling, hormones and proliferation. Conditional cpk10 cpk30 cpk32 and nlp7 mutants similarly impair nitrate-stimulated system-wide shoot growth and root establishment. The nutrient-coupled Ca2+ signalling network integrates transcriptome and cellular metabolism with shoot-root coordination and developmental plasticity in shaping organ biomass and architecture.	[Liu, Kun-hsiang; Niu, Yajie; Wu, Yue; Du, Hao; Chung, Hoo Sun; Li, Lei; Boudsocq, Marie; McCormack, Matthew; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Liu, Kun-hsiang; Niu, Yajie; Wu, Yue; Du, Hao; Chung, Hoo Sun; Li, Lei; Boudsocq, Marie; McCormack, Matthew; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Liu, Kun-hsiang; Niu, Yajie; Wu, Yue; Du, Hao; Chung, Hoo Sun; Li, Lei; Boudsocq, Marie; McCormack, Matthew; Sheen, Jen] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Liu, Kun-hsiang] Fujian Agr & Forestry Univ, Basic Forestry & Prote Res Ctr, Fuzhou 350002, Fujian, Peoples R China; [Konishi, Mineko; Maekawa, Shugo; Ishida, Tetsuya; Yanagisawa, Shuichi] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan; [Boudsocq, Marie] Univ Paris Saclay, Univ Paris Sud, Univ Evry Val Essonne,Sorbonne Paris Cite, Inst Plant Sci Paris Saclay IPS2,CNRS,INRA,Univ P, Batiment 630, F-91405 Orsay, France; [Zhang, Chao; Shokat, Kevan] UCSF, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94143 USA; [Zhang, Chao; Shokat, Kevan] UCSF, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Fujian Agriculture & Forestry University; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Liu, KH; Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Liu, KH; Sheen, J (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Liu, KH; Sheen, J (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.; Liu, KH (corresponding author), Fujian Agr & Forestry Univ, Basic Forestry & Prote Res Ctr, Fuzhou 350002, Fujian, Peoples R China.; Yanagisawa, S (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	khliu@molbio.mgh.harvard.edu; asyanagi@mail.ecc.u-tokyo.ac.jp; sheen@molbio.mgh.harvard.edu	Boudsocq, Marie/J-6074-2019; Li, Lei/F-9826-2015; Du, Hao/U-4853-2019	Boudsocq, Marie/0000-0001-8945-6773; Wu, Yue/0000-0001-7770-9331; Maekawa, Shugo/0000-0002-6021-505X	NIH; NSF; WJC Special Project RDA-Korea [PJ009106]; JST [CREST-JPMJCR15O5]; JSPS-KAKENHI [25252014/26221103, 15H05616]; NSFC [31670246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567, R01GM060493] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25252014] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); WJC Special Project RDA-Korea; JST(Japan Science & Technology Agency (JST)); JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Asai for the pNLP7-NLP7-GFP and pNLP7-NLP7(S205A)-GFP constructs, X. Y. Liu and R. Q. Ye for the pUBQ10-NLS-TdTomato construct, X. C. Zhang and M. R. Knight for the aequorin transgenic line, J. Bush for management of the plant facilities, Q. Hall for advice on embryo analysis, ABRC, NASC and the Salk Institute for T-DNA insertion lines, K. Holton and H. Lee for advice on statistics analyses, and L. Shi, J. Bush and A. Diener for comments. K.S. thanks F. Rutaganira for help with characterization of 3MBiP. The Research is supported by the NIH, NSF and WJC Special Project (PJ009106) RDA-Korea to J.S., and by CREST-JPMJCR15O5, JST and JSPS-KAKENHI grants 25252014/26221103 to S.Y. and 15H05616 to M.K., and the NSFC grant 31670246 to K.L.	Aki T, 2008, PLANT CELL PHYSIOL, V49, P767, DOI 10.1093/pcp/pcn049; Aki T, 2009, J PROTEOME RES, V8, P3912, DOI 10.1021/pr900187e; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bouguyon E, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.15, 10.1038/NPLANTS.2015.15]; Brandt B, 2015, ELIFE, V4, DOI 10.7554/eLife.03599; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Charpentier M, 2016, SCIENCE, V352, P1102, DOI 10.1126/science.aae0109; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Gan YB, 2012, PLANT CELL PHYSIOL, V53, P1003, DOI 10.1093/pcp/pcs050; Giehl RFH, 2014, J EXP BOT, V65, P769, DOI 10.1093/jxb/ert421; Guan PZ, 2014, P NATL ACAD SCI USA, V111, P15267, DOI 10.1073/pnas.1411375111; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Kato Y, 2010, BIOCHEM BIOPH RES CO, V397, P673, DOI 10.1016/j.bbrc.2010.06.001; Kiba T, 2016, PLANT CELL PHYSIOL, V57, P707, DOI 10.1093/pcp/pcw052; Kiba T, 2013, DEV CELL, V27, P452, DOI 10.1016/j.devcel.2013.10.004; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Konishi M, 2014, J EXP BOT, V65, P5589, DOI 10.1093/jxb/eru267; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; Leran S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4829; Liu KH, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-12; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Medici A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7274; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Obertello M, 2015, PLANT PHYSIOL, V168, P1830, DOI 10.1104/pp.114.255877; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Riveras E, 2015, PLANT PHYSIOL, V169, P1397, DOI 10.1104/pp.15.00961; Sakakibara H, 1997, PLANT CELL PHYSIOL, V38, P837, DOI 10.1093/oxfordjournals.pcp.a029242; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sheen J, 2014, J PLANT BIOL, V57, P67, DOI 10.1007/s12374-014-0902-7; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Soyano T, 2015, PLANT CELL PHYSIOL, V56, P368, DOI 10.1093/pcp/pcu168; Suzuki W, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25975; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Vidal EA, 2015, CURR OPIN PLANT BIOL, V27, P125, DOI 10.1016/j.pbi.2015.06.010; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593; Zhang C, 2013, ACS CHEM BIOL, V8, P1931, DOI 10.1021/cb400376p	67	259	280	33	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					311	+		10.1038/nature22077	http://dx.doi.org/10.1038/nature22077			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489820	Green Accepted			2022-12-28	WOS:000401466500055
J	Zar, FA				Zar, Fred Arthur			In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VANCOMYCIN; METRONIDAZOLE; FIDAXOMICIN		[Zar, Fred Arthur] Univ Illinois, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zar, FA (corresponding author), Univ Illinois, Chicago, IL 60607 USA.							Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Nathwani D, 2014, J ANTIMICROB CHEMOTH, V69, P2901, DOI 10.1093/jac/dku257; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC53	JC53		10.7326/ACPJC-2017-166-10-053	http://dx.doi.org/10.7326/ACPJC-2017-166-10-053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505637				2022-12-28	WOS:000401240200005
J	Kupferschmidt, K				Kupferschmidt, Kai			INFECTIOUS DISEASE Fears of Ebola resurgence quickly dispelled in Liberia	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					574	574		10.1126/science.356.6338.575	http://dx.doi.org/10.1126/science.356.6338.575			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495711				2022-12-28	WOS:000400975200018
J	Haarhuis, JHI; van der Weide, RH; Blomen, VA; Yanez-Cuna, JO; Amendola, M; van Ruiten, MS; Krijger, PHL; Teunissen, H; Medema, RH; van Steensel, B; Brummelkamp, TR; de Wit, E; Rowland, BD				Haarhuis, Judith H. I.; van der Weide, Robin H.; Blomen, Vincent A.; Yanez-Cuna, J. Omar; Amendola, Mario; van Ruiten, Marjon S.; Krijger, Peter H. L.; Teunissen, Hans; Medema, Rene H.; van Steensel, Bas; Brummelkamp, Thijn R.; de Wit, Elzo; Rowland, Benjamin D.			The Cohesin Release Factor WAPL Restricts Chromatin Loop Extension	CELL			English	Article							READ ALIGNMENT; DNA; GENOME; CHROMOSOME; BINDING; ORGANIZATION; CTCF; RESOLUTION; REVEALS; DOMAINS	The spatial organization of chromosomes influences many nuclear processes including gene expression. The cohesin complex shapes the 3D genome by looping together CTCF sites along chromosomes. We show here that chromatin loop size can be increased and that the duration with which cohesin embraces DNA determines the degree to which loops are enlarged. Cohesin's DNA release factor WAPL restricts this loop extension and also prevents looping between incorrectly oriented CTCF sites. We reveal that the SCC2/SCC4 complex promotes the extension of chromatin loops and the formation of topologically associated domains (TADs). Our data support the model that cohesin structures chromosomes through the processive enlargement of loops and that TADs reflect polyclonal collections of loops in the making. Finally, we find that whereas cohesin promotes chromosomal looping, it rather limits nuclear compartmentalization. We conclude that the balanced activity of SCC2/SCC4 and WAPL enables cohesin to correctly structure chromosomes.	[Haarhuis, Judith H. I.; van Ruiten, Marjon S.; Medema, Rene H.; Rowland, Benjamin D.] Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [van der Weide, Robin H.; Yanez-Cuna, J. Omar; Amendola, Mario; Teunissen, Hans; van Steensel, Bas; de Wit, Elzo] Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Blomen, Vincent A.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Krijger, Peter H. L.] Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Brummelkamp, Thijn R.] Canc Genom Ctr, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Amendola, Mario] Genethon, UMR S951, F-91000 Evry, France	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); UDICE-French Research Universities; Universite Paris Saclay	Rowland, BD (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; de Wit, E (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	e.d.wit@nki.nl; b.rowland@nki.nl	van der Weide, Robin Harm/AAA-4474-2020; amendola, mario/I-1728-2017; van der Weide, Robin H./GLV-1335-2022; blomen, vincent/AAE-1477-2020	van der Weide, Robin Harm/0000-0002-6466-7280; amendola, mario/0000-0002-1188-8856; Medema, Rene/0000-0002-6754-0381; Krijger, Peter/0000-0003-1702-348X; de Wit, Elzo/0000-0003-2883-1415	Dutch Cancer Society (KWF) [NKI 2010-4706, NKI 2011-5103, NKI 2015-7657]; European Research Council (ERC) [637587 HAP-PHEN, 293662]; Cancer Genomics Center (CGC.nl); EMBO	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); European Research Council (ERC)(European Research Council (ERC)); Cancer Genomics Center (CGC.nl); EMBO(European Molecular Biology Organization (EMBO))	We are grateful to the Medema laboratory and Ahmed Elbatsh for helpful discussions, Kim Nasmyth for encouragement, Wouter de Laat for support, Max van Osch for technical assistance, Bram van den Broek, Suzan Stelloo, and Sandra de Vries for technical advice, Tao Chen for antibodies, and the NKI Genomics Core and Digital Microscopy facilities for assistance. This work was funded by grants from the Dutch Cancer Society (KWF) (NKI 2010-4706, NKI 2011-5103, and NKI 2015-7657 to B.D.R.), the European Research Council (ERC Starting Grant 637587 HAP-PHEN to E.d.W. and ERC Advanced Grant 293662 to B.v.S.), the Cancer Genomics Center (CGC.nl to T.R.B.), and an EMBO Long Term Fellowship (to J.O.Y.-C.). T.R.B. is a co-founder of Haplogen and Scenic Biotech.	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Beckouet F, 2016, MOL CELL, V61, P563, DOI 10.1016/j.molcel.2016.01.026; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Eisinga R, 2013, FEBS LETT, V587, P677, DOI 10.1016/j.febslet.2013.01.037; Elbatsh AMO, 2016, MOL CELL, V61, P575, DOI 10.1016/j.molcel.2016.01.025; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Haarhuis JHI, 2013, CURR BIOL, V23, P2071, DOI 10.1016/j.cub.2013.09.003; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Heidinger-Pauli JM, 2010, CURR BIOL, V20, P957, DOI 10.1016/j.cub.2010.04.018; Hinshaw SM, 2015, ELIFE, V4, DOI 10.7554/eLife.06057; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kanke M, 2016, EMBO J, V35, P2686, DOI 10.15252/embj.201695756; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koziol JA, 2010, FEBS LETT, V584, P4481, DOI 10.1016/j.febslet.2010.10.012; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Levy-Leduc C, 2014, BIOINFORMATICS, V30, pI386, DOI 10.1093/bioinformatics/btu443; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pindyurin AV, 2016, NUCLEIC ACIDS RES, V44, P5646, DOI 10.1093/nar/gkw176; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287	72	375	381	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					693	707		10.1016/j.cell.2017.04.013	http://dx.doi.org/10.1016/j.cell.2017.04.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475897	hybrid, Green Published			2022-12-28	WOS:000400560900014
J	Julia-Hernandez, F; Moragas, T; Cornella, J; Martin, R				Julia-Hernandez, Francisco; Moragas, Toni; Cornella, Josep; Martin, Ruben			Remote carboxylation of halogenated aliphatic hydrocarbons with carbon dioxide	NATURE			English	Article							NI-CATALYZED CARBOXYLATION; C-H BONDS; NICKEL CATALYSIS; ALKYL BROMIDES; FUNCTIONALIZATION; OLEFINS; CO2; ISOMERIZATION; PHOTOREDOX; ARYLATION	Catalytic carbon-carbon bond formation has enabled the streamlining of synthetic routes when assembling complex molecules(1). It is particularly important when incorporating saturated hydrocarbons, which are common motifs in petrochemicals and biologically relevant molecules. However, cross-coupling methods that involve alkyl electrophiles result in catalytic bond formation only at specific and previously functionalized sites(2). Here we describe a catalytic method that is capable of promoting carboxylation reactions at remote and unfunctionalized aliphatic sites with carbon dioxide at atmospheric pressure. The reaction occurs via selective migration of the catalyst along the hydrocarbon side-chain(3) with excellent regio- and chemoselectivity, representing a remarkable reactivity relay when compared with classical cross-coupling reactions. Our results demonstrate that site-selectivity can be switched and controlled, enabling the functionalization of less-reactive positions in the presence of a priori more reactive ones. Furthermore, we show that raw materials obtained in bulk from petroleum processing, such as alkanes and unrefined mixtures of olefins, can be used as substrates. This offers an opportunity to integrate a catalytic platform en route to valuable fatty acids by transforming petroleum-derived feedstocks directly(4).	[Julia-Hernandez, Francisco; Moragas, Toni; Cornella, Josep; Martin, Ruben] Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avinguda Paisos Catalans 16, Tarragona 43007, Spain; [Martin, Ruben] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Universitat Rovira i Virgili; Institute of Chemical Research of Catalonia; ICREA	Martin, R (corresponding author), Barcelona Inst Sci & Technol, Inst Chem Res Catalonia ICIQ, Avinguda Paisos Catalans 16, Tarragona 43007, Spain.	rmartinromo@iciq.es	Julia-Hernandez, Francisco/G-4687-2015; Julia-Hernandez, Francisco/AGR-4686-2022; Martin, Ruben/M-2905-2014	Julia-Hernandez, Francisco/0000-0001-5311-0957; Julia-Hernandez, Francisco/0000-0001-5311-0957; Martin, Ruben/0000-0002-2543-0221; Cornella, Josep/0000-0003-4152-7098	ICIQ; European Research Council [ERC-StG-277883, ERC-2015-PoC-713577]; MINECO [CTQ2015-65496-R]; MINECO (Severo Ochoa Excellence Accreditation) [SEV-2013-0319]; Cellex Foundation; Marie Curie Actions for an Intra-European Fellowship [FP7-PEOPLE-2012-IEF-328381]; ICREA Funding Source: Custom	ICIQ(Foundation CELLEX); European Research Council(European Research Council (ERC)European Commission); MINECO(Spanish Government); MINECO (Severo Ochoa Excellence Accreditation)(Spanish Government); Cellex Foundation(Foundation CELLEX); Marie Curie Actions for an Intra-European Fellowship; ICREA(ICREA)	We are grateful for financial support provided by ICIQ, the European Research Council (ERC-StG-277883 and ERC-2015-PoC-713577), MINECO (CTQ2015-65496-R and Severo Ochoa Excellence Accreditation 2014-2018, SEV-2013-0319) and the Cellex Foundation. F.J.-H. and J.C. thank COFUND and Marie Curie Actions for an Intra-European Fellowship (FP7-PEOPLE-2012-IEF-328381).	Bair JS, 2014, J AM CHEM SOC, V136, P13098, DOI 10.1021/ja505579f; Behr A, 2003, J MOL CATAL A-CHEM, V206, P179, DOI 10.1016/S1381-1169(03)00461-8; Choi GJ, 2016, NATURE, V539, P268, DOI 10.1038/nature19811; Chou R. T., 2013, WO patent, Patent No. [WO/2013/101891, 2013101891]; Chu JCK, 2016, NATURE, V539, P272, DOI 10.1038/nature19810; Colacot TJ, 2015, RSC CATAL SER, P1; Correa A, 2014, J AM CHEM SOC, V136, P1062, DOI 10.1021/ja410883p; Devasagayaraj A, 1995, ANGEW CHEM INT EDIT, V34, P2723; Dupuy S, 2016, ANGEW CHEM INT EDIT, V55, P14793, DOI 10.1002/anie.201608535; He YL, 2017, J AM CHEM SOC, V139, P1061, DOI 10.1021/jacs.6b11962; JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Kambe N, 2011, CHEM SOC REV, V40, P4937, DOI 10.1039/c1cs15129k; Liu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6933; Liu Y, 2014, J AM CHEM SOC, V136, P11212, DOI [10.1021/ja05064586, 10.1021/ja5064586]; Mei TS, 2014, NATURE, V508, P340, DOI 10.1038/nature13231; Moragas T, 2014, J AM CHEM SOC, V136, P17702, DOI 10.1021/ja509077a; Netherton MR, 2001, J AM CHEM SOC, V123, P10099, DOI 10.1021/ja011306o; Owston NA, 2010, J AM CHEM SOC, V132, P11908, DOI 10.1021/ja105924f; Singh S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14200; Szilagyi M., 2012, PATTYS TOXICOLOGY, V3; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Vasseur A, 2016, NAT CHEM, V8, P209, DOI [10.1038/NCHEM.2445, 10.1038/nchem.2445]; Vasseur A, 2015, CHEM SCI, V6, P2770, DOI 10.1039/c5sc00445d; White MC, 2012, SCIENCE, V335, P807, DOI 10.1126/science.1207661; Wu XF, 2014, ACCOUNTS CHEM RES, V47, P1041, DOI 10.1021/ar400222k; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	26	281	283	18	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					84	+		10.1038/nature22316	http://dx.doi.org/10.1038/nature22316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470192				2022-12-28	WOS:000400480400035
J	Nissen, SE				Nissen, Steven E.			Conflicts of Interest and Professional Medical Associations Progress and Remaining Challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INDUSTRY		[Nissen, Steven E.] Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,J2-230, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave,J2-230, Cleveland, OH 44195 USA.	nissens@ccf.org			AstraZeneca; Amgen; Esperion; AbbVie; Eli Lilly; Medicines Company; Medtronic; Orexigen; Cerenis; Novo Nordisk; Pfizer	AstraZeneca(AstraZeneca); Amgen(Amgen); Esperion; AbbVie(AbbVie); Eli Lilly(Eli Lilly); Medicines Company; Medtronic(Medtronic); Orexigen; Cerenis; Novo Nordisk(Novo Nordisk); Pfizer(Pfizer)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported receiving grants from AstraZeneca, Amgen, Esperion, AbbVie, Eli Lilly, The Medicines Company, Medtronic, Orexigen, Cerenis, Novo Nordisk, and Pfizer and serving as former president of the American College of Cardiology.	Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Desai NR, 2015, JAMA-J AM MED ASSOC, V314, P2045, DOI 10.1001/jama.2015.13764; Institute of Medicine, 2009, CONFLICT INTEREST ME; Kassirer JP, 2007, PERSPECT BIOL MED, V50, P7, DOI 10.1353/pbm.2007.0006; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; NESTLE M, 2009, ATLANTIC; Nissen SE, 2014, JAMA INTERN MED, V174, P1972, DOI 10.1001/jamainternmed.2014.3278; Ornstein C, 2011, FINANCIAL TIES BIND; Rosenberg A, 2015, JAMA INTERN MED, V175, P1913, DOI 10.1001/jamainternmed.2015.5441; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407	10	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1737	1738		10.1001/jama.2017.2516	http://dx.doi.org/10.1001/jama.2017.2516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464156				2022-12-28	WOS:000400440700018
J	Sox, HC				Sox, Harold C.			Conflict of Interest in Practice Guidelines Panels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sox, Harold C.] Patient Ctr Outcomes Res Inst, 1818 L St NW,Ste 900, Washington, DC 20036 USA		Sox, HC (corresponding author), Patient Ctr Outcomes Res Inst, 1818 L St NW,Ste 900, Washington, DC 20036 USA.	hsox@pcori.org						Institute of Medicine, 2009, CONFLICT INTEREST ME; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037413	4	40	43	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1739	1740		10.1001/jama.2017.2701	http://dx.doi.org/10.1001/jama.2017.2701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464160				2022-12-28	WOS:000400440700019
J	Jotkowitz, AB; Agbaria, R; Glick, SM				Jotkowitz, Alan B.; Agbaria, Riad; Glick, Shimon M.			Medical ethics in Israel-bridging religious and secular values	LANCET			English	Editorial Material							LAW		[Jotkowitz, Alan B.] Ben Gurion Univ Negev, Jakobovits Ctr Jewish Med Eth, Fac Med, IL-84105 Beer Sheva, Israel; [Jotkowitz, Alan B.] Ben Gurion Univ Negev, Dept Med, Fac Hlth Sci, Beer Sheva, Israel; [Glick, Shimon M.] Ben Gurion Univ Negev, Moshe Prywes Ctr Med Educ, Fac Hlth Sci, Beer Sheva, Israel; [Jotkowitz, Alan B.; Agbaria, Riad; Glick, Shimon M.] Soroka Univ, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Jotkowitz, AB (corresponding author), Ben Gurion Univ Negev, Jakobovits Ctr Jewish Med Eth, Fac Med, IL-84105 Beer Sheva, Israel.	ajotkowitz@hotmail.com						Assiag Anat, 2008, J HLTH LAW BIOETHICS, V1, P160; Beauchamp TL, 2008, PRINCIPLES BIOMEDICA, V6th; Berger P, 1974, THE HOMELESS MIND, P196; Cover Robert, 1987, J RELIG, V5, P65; Glick S, 2012, HAREFUAH, V151, P63; Glick Shimon, 2012, Harefuah, V151, P12; Glick SM, 1997, NEW ENGL J MED, V336, P954, DOI 10.1056/NEJM199703273361312; Granek L, 2017, LANCET; Gruenbaum BF, 2010, TRANSPL P, V42, P4475, DOI 10.1016/j.transproceed.2010.09.146; Jotkowitz A, 2006, AM J BIOETHICS, V6, P17, DOI 10.1080/15265160600857205; Rimon-Zarfaty N, 2012, J MED ETHICS, V38, P26, DOI 10.1136/jme.2009.032797; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Steinberg A, 2002, ISRAEL MED ASSOC J, V4, P1139	13	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2584	2586		10.1016/S0140-6736(17)30700-6	http://dx.doi.org/10.1016/S0140-6736(17)30700-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EY3VF	28495111				2022-12-28	WOS:000403901800038
J	Thul, PJ; Akesson, L; Wiking, M; Mahdessian, D; Geladaki, A; Blal, HA; Alm, T; Asplund, A; Bjork, L; Breckels, LM; Backstrom, A; Danielsson, F; Fagerberg, L; Fall, J; Gatto, L; Gnann, C; Hober, S; Hjelmare, M; Johansson, F; Lee, S; Lindskog, C; Mulder, J; Mulvey, CM; Nilsson, P; Oksvold, P; Rockberg, J; Schutten, R; Schwenk, JM; Sivertsson, A; Sjostedt, E; Skogs, M; Stadler, C; Sullivan, DP; Tegel, H; Winsnes, C; Zhang, C; Zwahlen, M; Mardinoglu, A; Ponten, F; von Feilitzen, K; Lilley, KS; Uhlen, M; Lundberg, E				Thul, Peter J.; Akesson, Lovisa; Wiking, Mikaela; Mahdessian, Diana; Geladaki, Aikaterini; Blal, Hammou Ait; Alm, Tove; Asplund, Anna; Bjork, Lars; Breckels, Lisa M.; Backstrom, Anna; Danielsson, Frida; Fagerberg, Linn; Fall, Jenny; Gatto, Laurent; Gnann, Christian; Hober, Sophia; Hjelmare, Martin; Johansson, Fredric; Lee, Sunjae; Lindskog, Cecilia; Mulder, Jan; Mulvey, Claire M.; Nilsson, Peter; Oksvold, Per; Rockberg, Johan; Schutten, Rutger; Schwenk, Jochen M.; Sivertsson, Asa; Sjostedt, Evelina; Skogs, Marie; Stadler, Charlotte; Sullivan, Devin P.; Tegel, Hanna; Winsnes, Casper; Zhang, Cheng; Zwahlen, Martin; Mardinoglu, Adil; Ponten, Fredrik; von Feilitzen, Kalle; Lilley, Kathryn S.; Uhlen, Mathias; Lundberg, Emma			A subcellular map of the human proteome	SCIENCE			English	Article							SIGNAL PEPTIDES; HUMAN PROTEINS; LOCALIZATION; SINGLE; IMMUNOFLUORESCENCE; VALIDATION; PREDICTION; SELECTION; DYNAMICS; RESOURCE	Resolving the spatial distribution of the human proteome at a subcellular level can greatly increase our understanding of human biology and disease. Here we present a comprehensive image-based map of subcellular protein distribution, the Cell Atlas, built by integrating transcriptomics and antibody-based immunofluorescence microscopy with validation by mass spectrometry. Mapping the in situ localization of 12,003 human proteins at a single-cell level to 30 subcellular structures enabled the definition of the proteomes of 13 major organelles. Exploration of the proteomes revealed single-cell variations in abundance or spatial distribution and localization of about half of the proteins to multiple compartments. This subcellular map can be used to refine existing protein-protein interaction networks and provides an important resource to deconvolute the highly complex architecture of the human cell.	[Thul, Peter J.; Akesson, Lovisa; Wiking, Mikaela; Mahdessian, Diana; Blal, Hammou Ait; Alm, Tove; Bjork, Lars; Backstrom, Anna; Danielsson, Frida; Fagerberg, Linn; Fall, Jenny; Gnann, Christian; Hjelmare, Martin; Johansson, Fredric; Lee, Sunjae; Nilsson, Peter; Oksvold, Per; Schutten, Rutger; Schwenk, Jochen M.; Sivertsson, Asa; Skogs, Marie; Stadler, Charlotte; Sullivan, Devin P.; Winsnes, Casper; Zhang, Cheng; Zwahlen, Martin; Mardinoglu, Adil; von Feilitzen, Kalle; Uhlen, Mathias; Lundberg, Emma] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Geladaki, Aikaterini; Breckels, Lisa M.; Gatto, Laurent; Mulvey, Claire M.; Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge Ctr Prote, Tennis Court Rd, Cambridge CB2 1QR, England; [Geladaki, Aikaterini] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Asplund, Anna; Lindskog, Cecilia; Sjostedt, Evelina; Ponten, Fredrik] Uppsala Univ, Sci Life Lab, Genet & Pathol, Dept Immunol, SE-75185 Uppsala, Sweden; [Breckels, Lisa M.; Gatto, Laurent] Univ Cambridge, Dept Biochem, Computat Prote Unit, Tennis Court Rd, Cambridge CB2 1QR, England; [Hober, Sophia; Rockberg, Johan; Tegel, Hanna] KTH Royal Inst Technol, Sch Biotechnol, Dept Prote, SE-10691 Stockholm, Sweden; [Mulder, Jan] Karolinska Inst, Dept Neurosci, Sci Life Lab, SE-17177 Stockholm, Sweden	Royal Institute of Technology; University of Cambridge; University of Cambridge; Uppsala University; University of Cambridge; Royal Institute of Technology; Karolinska Institutet	Uhlen, M; Lundberg, E (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se; emma.lundberg@scilifelab.se	Schwenk, Jochen/AAS-4164-2021; Zhang, Cheng/L-7906-2016; Mulder, Jan/G-3909-2011; Lindskog, Cecilia/AAO-2441-2021; Lindskog, Cecilia/AAE-5462-2019; Mulder, Jan/AAG-9761-2021; Schwenk, Jochen M/F-1730-2010; Lee, Sunjae/H-9815-2019; Nilsson, Peter/E-4547-2010; Lilley, Kathryn/ABF-5787-2020; Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Mardinoglu, Adil/AAS-6360-2021; Lundberg, Emma S K/F-3891-2010	Schwenk, Jochen/0000-0001-8141-8449; Zhang, Cheng/0000-0002-3721-8586; Mulder, Jan/0000-0003-3717-5018; Schwenk, Jochen M/0000-0001-8141-8449; Lee, Sunjae/0000-0002-6428-5936; Nilsson, Peter/0000-0002-4657-8532; Lilley, Kathryn/0000-0003-0594-6543; Uhlen, Mathias/0000-0002-4858-8056; Mulvey, Claire/0000-0002-2989-2052; Geladaki, Aikaterini/0000-0002-0530-4252; Bjork, Lars/0000-0002-8116-882X; Sullivan, Devin/0000-0001-6176-108X; /0000-0002-6107-1465; Schutten, Rutger/0000-0001-8787-8868; Kaller Lundberg, Emma/0000-0001-7034-0850; Lindskog, Cecilia/0000-0001-5611-1015; Breckels (Simpson), Lisa/0000-0001-8918-7171; Winsnes, Casper/0000-0002-0028-5865	Knut and Alice Wallenberg Foundation; Erling Persson Foundation; Science for Life Laboratory; Wellcome Trust [108441/Z/15/Z]; Alexander S. Onassis Public Benefit Foundation; Foundation for Education and European Culture; Embiricos Trust Scholarship of Jesus College Cambridge; BBSRC [BB/K00137X/1, BB/G024618/1, BB/H024247/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H024247/1, BB/K00137X/1, BB/G024618/1] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Erling Persson Foundation; Science for Life Laboratory; Wellcome Trust(Wellcome TrustEuropean Commission); Alexander S. Onassis Public Benefit Foundation; Foundation for Education and European Culture; Embiricos Trust Scholarship of Jesus College Cambridge; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We acknowledge the staff of the Human Protein Atlas program and Science for Life Laboratory for valuable contributions. We also acknowledge support from these facilities of the Science for Life Laboratory: the National Genomics Infrastructure and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure, the National Laboratories for Chemical Biology at Karolinska Institutet for access to imaging infrastructure, and the Advanced Light Microscopy facility for superresolution microscopy. We acknowledge H. Masai (Tokyo Metropolitan Institute of Medical Science) for providing the stable U-2 OS FUCCI cell line; A. Hyman (Max Planck Institute) for HeLa cells expressing GFP-tagged proteins; A. Falk (Karolinska Institute) for the AF22 cells; Evercyte for the ASC TERT1, HUVEC TERT2, HBF TERT88, HTCEpi, LHCN-M2, and RPTEC TERT cells; Horizon Discoveries for the Hap1 CRISPR knockout cells; and R. Pepperkok and B. Neumann for prepared solid-phase siRNA plates. We acknowledge CCP Games and MMOS Srl for the creation of Project Discovery and the players of EVE Online for classification of protein patterns in images through Project Discovery. Funding was provided by the Knut and Alice Wallenberg Foundation and the Erling Persson Foundation to M.U. and the Science for Life Laboratory to E.L. C.M.M. and L.M.B. were funded by Wellcome Trust grant 108441/Z/15/Z. A.G. was funded through the Alexander S. Onassis Public Benefit Foundation, the Foundation for Education and European Culture, and the Embiricos Trust Scholarship of Jesus College Cambridge. M.U., F.P., P.N., and S. H. are cofounders and M.U. and F.P. are on the board of Atlas Antibodies. All antibodies are available from various commercial providers, including Atlas Antibodies. The data are available in the supplementary materials. Images and Cell Atlas transcriptome and proteome data are available in the Human Protein Atlas (www.proteinatlas.org/humancell).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Breckels LM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004920; Chapple CE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8412; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Christoforou A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9992; Covini G, 2012, ANTIVIR THER, V17, P805, DOI 10.3851/IMP1993; Crosswell LC, 2012, TRENDS BIOTECHNOL, V30, P241, DOI 10.1016/j.tibtech.2012.02.002; Danielsson F, 2013, J PROTEOME RES, V12, P299, DOI 10.1021/pr3009308; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fagerberg L, 2011, J PROTEOME RES, V10, P3766, DOI 10.1021/pr200379a; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Gatto L, 2014, BIOINFORMATICS, V30, P1322, DOI 10.1093/bioinformatics/btu013; Gaudet P, 2015, NUCLEIC ACIDS RES, V43, pD764, DOI 10.1093/nar/gku1178; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Jadot M, 2017, MOL CELL PROTEOMICS, V16, P194, DOI 10.1074/mcp.M116.064527; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laurila K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-122; Lee SY, 2016, CELL REP, V15, P1837, DOI 10.1016/j.celrep.2016.04.064; Lindskog M, 2005, BIOTECHNIQUES, V38, P723, DOI 10.2144/05385ST02; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Min KW, 2016, CANCER LETT, V370, P108, DOI 10.1016/j.canlet.2015.09.022; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Ochsner SA, 2010, MOL ENDOCRINOL, V24, P2065, DOI 10.1210/me.2010-0216; Park S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.29; Peplow M, 2016, NAT BIOTECHNOL, V34, P452, DOI 10.1038/nbt0516-452c; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Skogs M, 2017, J PROTEOME RES, V16, P147, DOI 10.1021/acs.jproteome.6b00821; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Stadler C, 2012, J PROTEOMICS, V75, P2236, DOI 10.1016/j.jprot.2012.01.030; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Vroling B, 2012, NUCLEIC ACIDS RES, V40, pD377, DOI 10.1093/nar/gkr960; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157	62	1312	1327	20	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2017	356	6340							eaal3321	10.1126/science.aal3321	http://dx.doi.org/10.1126/science.aal3321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV7LP	28495876				2022-12-28	WOS:000401957900032
J	Friedrich, MJ				Friedrich, M. J.			Freeze-dried Rotavirus Vaccine Shows Promise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1941	1941		10.1001/jama.2017.5482	http://dx.doi.org/10.1001/jama.2017.5482			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510686				2022-12-28	WOS:000401315500004
J	Gostin, LO				Gostin, Lawrence O.			Hunger, Health, and Compassion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA; [Gostin, Lawrence O.] WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.; Gostin, LO (corresponding author), WHO, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1939	1940		10.1001/jama.2017.5336	http://dx.doi.org/10.1001/jama.2017.5336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510667	Bronze			2022-12-28	WOS:000401315500002
J	Rabe, KF; Watz, H				Rabe, Klaus F.; Watz, Henrik			Chronic obstructive pulmonary disease	LANCET			English	Review							RESPIRATORY SOCIETY STATEMENT; INHALED FLUTICASONE FUROATE; LUNG-VOLUME REDUCTION; AIR-FLOW LIMITATION; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; DOUBLE-BLIND; SMOKING-CESSATION; COPD EXACERBATIONS; PNEUMONIA RISK	Chronic obstructive pulmonary disease (COPD) kills more than 3 million people worldwide every year. Despite progress in the treatment of symptoms and prevention of acute exacerbations, few advances have been made to ameliorate disease progression or affect mortality. A better understanding of the complex disease mechanisms resulting in COPD is needed. Smoking cessation programmes, increasing physical activity, and early detection and treatment of comorbidities are further key components to reduce the burden of the disease. However, without a global political and economic effort to reduce tobacco use, to regulate environmental exposure, and to find alternatives to the massive use of biomass fuel, COPD will remain a major health-care problem for decades to come.	[Watz, Henrik] German Ctr Lung Res, Pulm Res Inst, Airway Res Ctr North, Grosshansdorf, Germany; [Rabe, Klaus F.] German Ctr Lung Res, LungenClin Grosshansdorf, Airway Res Ctr North, Grosshansdorf, Germany; [Rabe, Klaus F.] Christian Albrechts Univ Kiel, Dept Med, Kiel, Germany	Grosshansdorf Hospital; University of Kiel	Rabe, KF (corresponding author), LungenClin Grosshansdorf, D-22927 Grosshansdorf, Germany.	k.f.rabe@lungenclinic.de	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401	AstraZeneca; Takeda; Chiesi; Novartis; Boehringer Ingelheim; Sanofi Aventis; Berlin Chemie; Teva; GlaxoSmithKline; AstraZeneca; Takeda; Chiesi; Novartis; Boehringer Ingelheim; Sanofi Aventis; Berlin Chemie; Teva; GlaxoSmithKline	AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); Chiesi(Chiesi Pharmaceuticals Inc); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi Aventis(Sanofi-Aventis); Berlin Chemie; Teva(Teva Pharmaceutical Industries); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); Chiesi(Chiesi Pharmaceuticals Inc); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi Aventis(Sanofi-Aventis); Berlin Chemie; Teva(Teva Pharmaceutical Industries); GlaxoSmithKline(GlaxoSmithKline)	KFR has received personal fees from AstraZeneca, Takeda, Chiesi, Novartis, Boehringer Ingelheim, Sanofi Aventis, Berlin Chemie, and Teva, and grants from Chiesi. HW has received personal fees from AstraZeneca, Takeda, Chiesi, Novartis, Boehringer Ingelheim, GlaxoSmithKline, and Berlin Chemie.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Albert RK, 2016, NEW ENGL J MED, V375, P1617, DOI 10.1056/NEJMoa1604344; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Beeh KM, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-209; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Brusselle GG, 2015, LANCET RESP MED, V3, P737, DOI 10.1016/S2213-2600(15)00360-4; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Burney PGJ, 2015, EUR RESPIR J, V45, P1239, DOI 10.1183/09031936.00142414; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Celli BR, 2015, EUR RESPIR REV, V24, P159, DOI 10.1183/16000617.00000315; Chapman KR, 2015, LANCET, V386, P360, DOI 10.1016/S0140-6736(15)60860-1; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Crim C, 2015, ANN AM THORAC SOC, V12, P27, DOI 10.1513/AnnalsATS.201409-413OC; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; de-Torres JP, 2016, CHEST, V149, P936, DOI 10.1378/chest.15-1868; De-Torres JP, 2015, AM J RESP CRIT CARE, V191, P285, DOI 10.1164/rccm.201407-1210OC; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Decramer ML, 2013, LANCET RESP MED, V1, P524, DOI 10.1016/S2213-2600(13)70158-9; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Demeyer H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154587; Durham AL, 2015, LUNG CANCER, V90, P121, DOI 10.1016/j.lungcan.2015.08.017; Ekstrom M, 2016, NEW ENGL J MED, V375, P1683, DOI 10.1056/NEJMe1611742; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Finney L, 2014, LANCET RESP MED, V2, P919, DOI 10.1016/S2213-2600(14)70169-9; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Franciosi LG, 2013, LANCET RESP MED, V1, P714, DOI 10.1016/S2213-2600(13)70187-5; Franssen FME, 2016, AM J RESP CRIT CARE, V194, P568, DOI 10.1164/rccm.201512-2480OC; Fuchs O, 2016, LANCET RESP MED; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gross NJ, 2017, AM J RESP CRIT CARE, V195, P159, DOI 10.1164/rccm.201610-2074PP; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Herth FJF, 2016, RESPIRATION, V91, P241, DOI 10.1159/000444090; Herth FJF, 2016, LANCET RESP MED, V4, P185, DOI 10.1016/S2213-2600(16)00045-X; Hoffman EA, 2016, J MAGN RESON IMAGING, V43, P544, DOI 10.1002/jmri.25010; Hoogendoorn M, 2010, THORAX, V65, P711, DOI 10.1136/thx.2009.131631; Houben-Wilkes S, 2017, AM J RESP CRIT CARE, V195, P189, DOI 10.1164/rccm.201602-0354OC; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hurst JR, 2015, EUR RESPIR J, V45, P310, DOI 10.1183/09031936.00170014; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Jimenez-Ruiz CA, 2015, EUR RESPIR J, V46, P61, DOI 10.1183/09031936.00092614; Kohnlein T, 2014, LANCET RESP MED, V2, P698, DOI 10.1016/S2213-2600(14)70153-5; Lahousse L, 2016, LANCET RESP MED, V4, P149, DOI 10.1016/S2213-2600(15)00518-4; Lamprecht B, 2015, CHEST, V148, P971, DOI 10.1378/chest.14-2535; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Leuppi JD, 2013, JAMA-J AM MED ASSOC, V309, P2223, DOI 10.1001/jama.2013.5023; Luoto JA, 2016, EUR RESPIR J, V47, P461, DOI 10.1183/13993003.00635-2015; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; MacDonald MI, 2016, LANCET RESP MED, V4, P138, DOI 10.1016/S2213-2600(15)00509-3; MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Martinez FJ, 2016, AM J RESP CRIT CARE, V194, P559, DOI 10.1164/rccm.201607-1349OC; Martinez FJ, 2015, LANCET, V385, P857, DOI 10.1016/S0140-6736(14)62410-7; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Mercado N, 2015, THORAX, V70, P482, DOI 10.1136/thoraxjnl-2014-206084; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; O'Donnell Denis E, 2006, Proc Am Thorac Soc, V3, P180, DOI 10.1513/pats.200508-093DO; O'Donnell DE, 2016, RESPIROLOGY, V21, P211, DOI 10.1111/resp.12619; Obeidat M, 2015, LANCET RESP MED, V3, P782, DOI 10.1016/S2213-2600(15)00380-X; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pascoe SJ, 2016, EUR RESPIR J, V48, P320, DOI 10.1183/13993003.02165-2015; Pavord ID, 2016, LANCET RESP MED, V4, P731, DOI 10.1016/S2213-2600(16)30148-5; Poole PJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002733.pub2; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Puhan MA, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005305.pub4, 10.1002/14651858.CD005305.pub3]; Rabe KF, 2014, LANCET RESP MED, V2, P44, DOI 10.1016/S2213-2600(13)70248-0; Ramirez-Venegas A, 2014, AM J RESP CRIT CARE, V190, P996, DOI 10.1164/rccm.201404-0720OC; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; Rennard SI, 2015, AM J RESP CRIT CARE, V191, P1001, DOI 10.1164/rccm.201405-0992OC; Rochester CL, 2015, AM J RESP CRIT CARE, V192, P1373, DOI 10.1164/rccm.201510-1966ST; Rohde GGU, 2015, BMC PULM MED, V15, DOI 10.1186/1471-2466-15-5; Romieu I, 2009, AM J RESP CRIT CARE, V180, P649, DOI 10.1164/rccm.200810-1556OC; Roversi S, 2016, AM J RESP CRIT CARE, V194, P1319, DOI 10.1164/rccm.201604-0690SO; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sanchez-Salcedo P, 2015, AM J RESP CRIT CARE, V191, P924, DOI 10.1164/rccm.201410-1848OC; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Sciurba FC, 2016, JAMA-J AM MED ASSOC, V315, P2178, DOI 10.1001/jama.2016.6261; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Shah PL, 2017, LANCET RESP MED, V5, P147, DOI 10.1016/S2213-2600(16)30221-1; Siddiqui SH, 2015, AM J RESP CRIT CARE, V192, P523, DOI 10.1164/rccm.201502-0235LE; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Sorheim IC, 2010, THORAX; Spruit MA, 2015, AM J RESP CRIT CARE, V192, P924, DOI 10.1164/rccm.201505-0929CI; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Stone IS, 2016, AM J RESP CRIT CARE, V193, P717, DOI 10.1164/rccm.201508-1647OC; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Tsuji T, 2004, AM J RESP CELL MOL, V31, P643, DOI 10.1165/rcmb.2003-0290OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Vanfleteren LEGW, 2016, LANCET RESP MED, V4, P911, DOI 10.1016/S2213-2600(16)00097-7; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Walters JAE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001390.pub3; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Waschki B, 2015, AM J RESP CRIT CARE, V192, P295, DOI 10.1164/rccm.201501-0081OC; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Watz H, 2016, LANCET RESP MED; Watz H, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0256-7; Watz H, 2014, EUR RESPIR J, V44, P1521, DOI 10.1183/09031936.00046814; Watz H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-158; Watz H, 2014, LANCET RESP MED, V2, P63, DOI 10.1016/S2213-2600(13)70200-5; Watz H, 2013, PULM PHARMACOL THER, V26, P588, DOI 10.1016/j.pupt.2013.05.004; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wedzicha JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00791-2016; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Wedzicha JA, 2013, LANCET RESP MED, V1, P199, DOI 10.1016/S2213-2600(13)70052-3; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; White WB, 2013, CHEST, V144, P758, DOI 10.1378/chest.12-2332; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; World Health Organization, GLOB HLTH OBS DAT PR; World Health Organization, BURD COPD; World Health Organization, WORLD HLTH STAT 2016; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Young RP, 2015, AM J RESP CRIT CARE, V192, P1060, DOI 10.1164/rccm.201505-0894OC; Zheng JP, 2014, LANCET RESP MED, V2, P187, DOI 10.1016/S2213-2600(13)70286-8	140	472	500	22	208	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1931	1940		10.1016/S0140-6736(17)31222-9	http://dx.doi.org/10.1016/S0140-6736(17)31222-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU4AZ	28513453				2022-12-28	WOS:000400973500029
J	Gordon, V				Gordon, Vernita			BIOFILMS Coupling and sharing when life is hard	SCIENCE			English	Editorial Material							COMPETITION		[Gordon, Vernita] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Gordon, Vernita] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Gordon, V (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.; Gordon, V (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	gordon@chaos.utexas.edu		Gordon, Vernita/0000-0002-5989-9378				Coyte KZ, 2017, P NATL ACAD SCI USA, V114, pE161, DOI 10.1073/pnas.1525228113; GOEL NS, 1971, REV MOD PHYS, V43, P231, DOI 10.1103/RevModPhys.43.231; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Liu JT, 2017, SCIENCE, V356, P638, DOI 10.1126/science.aah4204; Nadell CD, 2016, NAT REV MICROBIOL, V14, P589, DOI 10.1038/nrmicro.2016.84	7	2	2	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					583	584		10.1126/science.aan3886	http://dx.doi.org/10.1126/science.aan3886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495715				2022-12-28	WOS:000400975200022
J	Gooneratne, IK; Wimalaratna, M; Ranaweera, AKP; Wimalaratna, S				Gooneratne, Inuka Kishara; Wimalaratna, Mayurika; Ranaweera, A. K. Probhodana; Wimalaratna, Sunil			10-MINUTE CONSULTATION Contraception advice for women with epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gooneratne, Inuka Kishara] Kettering & Dist Gen Hosp, Dept Neurol, Kettering, England; [Wimalaratna, Mayurika] Wendover Hlth Ctr, Aylesbury, Bucks, England; [Ranaweera, A. K. Probhodana] Univ Colombo, Fac Med, Dept Obstet & Gynaecol, Colombo, Sri Lanka; [Wimalaratna, Sunil] Oxford Univ Hosp, John Radcliffe Hosp, Neurol Dept, Oxford, England	University of Colombo; University of Oxford	Gooneratne, IK (corresponding author), Kettering & Dist Gen Hosp, Dept Neurol, Kettering, England.	kishig@gmail.com	Gooneratne, Inuka/AAW-7672-2021					Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305; Bromley R, 2014, COCHRANE DB SYST REV, V357; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Gooneratne IK, 2016, POSTGRAD MED J, V92, P554, DOI 10.1136/postgradmedj-2016-134191; Kinney MO, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2880; O'Brien MD, 2005, POSTGRAD MED J, V81, P278, DOI 10.1136/pgmj.2004.030221; Patsalos PN, 2002, EPILEPSIA, V43, P365, DOI 10.1046/j.1528-1157.2002.13001.x; Royal College of Obstetricians and Gynaecologists, 2016, CLIN GREEN TOP GUID; Sabers A, 2001, EPILEPSY RES, V47, P151, DOI 10.1016/S0920-1211(01)00305-9; Shoupe D, 2016, CONTRACEP REPROD MED, V1, DOI 10.1186/s40834-016-0011-8; Thomas SV, 2015, ANN INDIAN ACAD NEUR, V18, P278, DOI 10.4103/0972-2327.162261; Tomson T, 2015, LANCET NEUROL, V357, pS1474; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021	13	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2017	357								j2010	10.1136/bmj.j2010	http://dx.doi.org/10.1136/bmj.j2010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UK	28495788				2022-12-28	WOS:000401170200003
J	van Rijswijk, JB; Dubach, P				van Rijswijk, Jeroen B.; Dubach, Patrick			Binaural Tympanic-Membrane Perforations after Blast Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[van Rijswijk, Jeroen B.; Dubach, Patrick] Burgerspital, Solothurn, Switzerland		Dubach, P (corresponding author), Burgerspital, Solothurn, Switzerland.	patrick.dubach@spital.so.ch							0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					E41	E41		10.1056/NEJMicm1612629	http://dx.doi.org/10.1056/NEJMicm1612629			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28490003				2022-12-28	WOS:000400891100013
J	Chevrier, S; Levine, JH; Zanotelli, VRT; Silina, K; Schulz, D; Bacac, M; Ries, CH; Ailles, L; Jewett, MAS; Moch, H; van den Broek, M; Beisel, C; Stadler, MB; Gedye, C; Reis, B; Pe'er, D; Bodenmiller, B				Chevrier, Stephane; Levine, Jacob Harrison; Zanotelli, Vito Riccardo Tomaso; Silina, Karina; Schulz, Daniel; Bacac, Marina; Ries, Carola Hermine; Ailles, Laurie; Jewett, Michael Alexander Spencer; Moch, Holger; van den Broek, Maries; Beisel, Christian; Stadler, Michael Beda; Gedye, Craig; Reis, Bernhard; Pe'er, Dana; Bodenmiller, Bernd			An Immune Atlas of Clear Cell Renal Cell Carcinoma	CELL			English	Article							TUMOR-ASSOCIATED MACROPHAGES; T-CELLS; GLIOMA PROGRESSION; CANCER; POLARIZATION; EXPRESSION; ACTIVATION; REVEALS; CD38; MECHANISMS	Immune cells in the tumor microenvironment modulate cancer progression and are attractive therapeutic targets. Macrophages and T cells are key components of the microenvironment, yet their phenotypes and relationships in this ecosystem and to clinical outcomes are ill defined. We used mass cytometry with extensive antibody panels to perform in-depth immune profiling of samples from 73 clear cell renal cell carcinoma (ccRCC) patients and five healthy controls. In 3.5 million measured cells, we identified 17 tumor-associated macrophage phenotypes, 22 T cell phenotypes, and a distinct immune composition correlated with progression-free survival, thereby presenting an in-depth human atlas of the immune tumor microenvironment in this disease. This study revealed potential biomarkers and targets for immunotherapy development and validated tools that can be used for immune profiling of other tumor types.	[Chevrier, Stephane; Zanotelli, Vito Riccardo Tomaso; Schulz, Daniel; Bodenmiller, Bernd] Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Levine, Jacob Harrison; Pe'er, Dana] Sloan Kettering Inst, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10065 USA; [Zanotelli, Vito Riccardo Tomaso] ETH, Syst Biol PhD Program, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland; [Zanotelli, Vito Riccardo Tomaso] Univ Zurich, CH-8057 Zurich, Switzerland; [Silina, Karina; van den Broek, Maries] Univ Zurich, Inst Expt Immunol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Bacac, Marina] Roche Innovat Ctr Zurich, Roche Pharma Res & Early Dev, Wagistr 18, CH-8952 Schlieren, Switzerland; [Ries, Carola Hermine] Roche Innovat Ctr Zurich, Roche Pharma Res & Early Dev, Nonnenwald 2, D-82377 Penzberg, Germany; [Ailles, Laurie] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Ailles, Laurie; Jewett, Michael Alexander Spencer] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Moch, Holger] Univ Hosp Zurich, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland; [Beisel, Christian] ETH, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland; [Stadler, Michael Beda] Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Stadler, Michael Beda] Swiss Inst Bioinformat, Mattenstr 26, CH-4058 Basel, Switzerland; [Gedye, Craig] Univ Newcastle, Hunter Med Res Inst, Sch Biomed Sci & Pharm, Newcastle, NSW 2035, Australia; [Reis, Bernhard] Roche Innovat Ctr Basel, Pharmaceut Sci, Roche Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland	University of Zurich; Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Roche Holding; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research; Swiss Institute of Bioinformatics; Hunter Medical Research Institute; University of Newcastle; Roche Holding	Bodenmiller, B (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bernd.bodenmiller@imls.uzh.ch	van den Broek, Maries/L-6532-2019; wang, edwin/G-5372-2010; van den Broek, Maries/G-4128-2016	Gedye, Craig/0000-0002-1629-4352; Reis, Bernhard/0000-0001-7611-8222; Pe'er, Dana/0000-0002-9259-8817; Beisel, Christian/0000-0001-5360-2193; Silina, Karina/0000-0003-3947-2710; Zanotelli, Vito Riccardo Tomaso/0000-0001-7268-311X; van den Broek, Maries/0000-0002-9489-3692	SNSF; SystemsX Transfer Project "Friends and Foes"; SystemsX MetastasiX grant; European Research Council (ERC) under the European Union/ERC [336921]; Roche; EMBO - European Commission [ALTF 970-2014, GA-2013-609409]; RACP CSL Fellowship; CIHR/KCC SHOPP Fellowship; NHMRC [628939]; NIH [DP1-HD084071, R01CA164729]; SNSF [31003A_152851]; Zurich Cancer League grant; Stiftung fur Forschung in der Onkologie grant; University Research Priority Project "Translational Cancer Research" grant; MSK Cancer Center [P30 CA008748]; F. Hoffmann-La Roche AG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA164729, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER	SNSF(Swiss National Science Foundation (SNSF)); SystemsX Transfer Project "Friends and Foes"; SystemsX MetastasiX grant; European Research Council (ERC) under the European Union/ERC(European Research Council (ERC)); Roche(Roche Holding); EMBO - European Commission; RACP CSL Fellowship; CIHR/KCC SHOPP Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNSF(Swiss National Science Foundation (SNSF)); Zurich Cancer League grant; Stiftung fur Forschung in der Onkologie grant; University Research Priority Project "Translational Cancer Research" grant; MSK Cancer Center; F. Hoffmann-La Roche AG(Hoffmann-La Roche); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful for the generous donation of tumor samples by patients undergoing surgery that was collected through the University Health Network Biobank and Cooperative Health Tissue Network. We thank Manfred Kopf, Luigi Tortola, Sabine Hoves, Sylvia Herter, and the Bodenmiller lab for fruitful discussions; Andrew Evans for pathological analysis of tissue samples; Andrea Jacobs and Stefanie Engler for technical support; Christina Ewald for cell sorting; the CyTOF facility and the Center for Microscopy and Image Analysis (University of Zurich); and the Genomics Facility Basel. B.B.'s research is funded by a SNSF R'Equip grant, a SNSF Assistant Professorship grant, the SystemsX Transfer Project "Friends and Foes," the SystemsX MetastasiX grant, and the European Research Council (ERC) under the European Union's Seventh Framework Program (FP/2007-2013/ERC grant agreement no. 336921). This work was funded by a Roche Postdoctoral Fellowship (to S.C.); an EMBO fellowship (ALTF 970-2014) co-funded by the European Commission (LTFCOFUND2013, GA-2013-609409) (to D.S.); an RACP CSL Fellowship (to C.G.); a CIHR/KCC SHOPP Fellowship (to C.G.), an NHMRC Early Career Fellowship (628939 to C.G.), NIH grants (DP1-HD084071 and R01CA164729), a SNSF grant (31003A_152851 to M.v.d.B.), a Zurich Cancer League grant (to M.v.d.B. and K.S.), a Stiftung fur Forschung in der Onkologie grant (to M.v.d.B.), a University Research Priority Project "Translational Cancer Research" grant (to M.v.d.B.), and a MSK Cancer Center Support Grant/Core Grant (P30 CA008748) (to D.P.). This work was in part supported by a fellowship from F. Hoffmann-La Roche AG. M.B., C.R., and B.R. are employees for F. Hoffmann-La Roche AG.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Behbehani GK, 2014, CYTOM PART A, V85A, P1011, DOI 10.1002/cyto.a.22573; Blacher E, 2015, INT J CANCER, V136, P1422, DOI 10.1002/ijc.29095; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Catena R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1006-0; Dannenmann SR, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23562; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Davidson-Pilon C., 2016, LIFELINES, DOI DOI 10.5281/ZENODO.3620921; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Gedye C., 2013, BASIC CELL CULTURE P; Geissler K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.985082; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hardle W., 2003, TECHNOMETRICS, V47, P486, DOI DOI 10.1198/TECH.2005.S319; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Joseph RW, 2017, UROL ONCOL-SEMIN ORI, V35, P142, DOI 10.1016/j.urolonc.2017.01.017; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Karakasheva TA, 2015, CANCER RES, V75, P4074, DOI 10.1158/0008-5472.CAN-14-3639; Komohara Y, 2013, CANCER SCI, V104, P945, DOI 10.1111/cas.12167; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Levy A, 2012, NEURO-ONCOLOGY, V14, P1037, DOI 10.1093/neuonc/nos121; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Maus MV, 2016, CLIN CANCER RES, V22, P1875, DOI 10.1158/1078-0432.CCR-15-1433; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Overgaard NH, 2015, J LEUKOCYTE BIOL, V97, P31, DOI 10.1189/jlb.1RU0814-382; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; R Development Core Team, 2011, R FDN STAT COMP; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Shinohara N, 2015, INT J UROL, V22, P888, DOI 10.1111/iju.12858; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu L, 2014, ANN SURG ONCOL, V21, P3142, DOI 10.1245/s10434-014-3601-1; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang L, 2015, ONCOTARGET, V6, P10592, DOI 10.18632/oncotarget.3547; Zivanovic N, 2014, CURR TOP MICROBIOL, V377, P95, DOI 10.1007/82_2013_335; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	70	541	563	9	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					736	749		10.1016/j.cell.2017.04.016	http://dx.doi.org/10.1016/j.cell.2017.04.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475899	Green Published, hybrid			2022-12-28	WOS:000400560900017
J	McWilliams, JM				McWilliams, J. Michael			MACRA: Big Fix or Big Problem?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIAN PRACTICES; INTEGRATION; PRICES		[McWilliams, J. Michael] Harvard Med Sch, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McWilliams, JM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			Laura and John Arnold Foundation; National Institute on Aging of the National Institutes of Health [P01 AG032952]; NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER	Laura and John Arnold Foundation; National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By grants from the Laura and John Arnold Foundation and the National Institute on Aging of the National Institutes of Health (P01 AG032952).	Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; JM McWilliams, 2016, JAMA-J AM MED ASSOC, V316, P1711, DOI [10.1001/jama.2016.12049, DOI 10.1001/JAMA.2016.12049]; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; McWilliams JM, 2016, ANN INTERN MED, V165, P873, DOI 10.7326/M16-1846; Neprash HT, 2015, JAMA INTERN MED, V175, P1932, DOI 10.1001/jamainternmed.2015.4610; Newhouse JP, 2014, MILBANK Q, V92, P351, DOI 10.1111/1468-0009.12061; Rose S, 2016, HEALTH AFFAIR, V35, P440, DOI 10.1377/hlthaff.2015.1026	9	18	18	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					122	+		10.7326/M17-0230	http://dx.doi.org/10.7326/M17-0230			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28505630	Green Accepted			2022-12-28	WOS:000405573400018
J	Welcher, CM; Kirk, LM; Hawkins, RE				Welcher, Catherine M.; Kirk, Lynne M.; Hawkins, Richard E.			Alternative Pathways to Board Recertification To What End?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CERTIFICATION; MAINTENANCE; ASSOCIATION		[Welcher, Catherine M.; Hawkins, Richard E.] Amer Med Assoc, Med Educ Outcomes, 330 N Wabash,Ste 39300, Chicago, IL 60611 USA; [Kirk, Lynne M.] Univ Texas Southwestern Med Ctr Dallas, Southwestern Med Sch, Dallas, TX 75390 USA	American Medical Association; University of Texas System; University of Texas Southwestern Medical Center Dallas	Welcher, CM (corresponding author), Amer Med Assoc, Med Educ Outcomes, 330 N Wabash,Ste 39300, Chicago, IL 60611 USA.	catherine.welcher@ama-assn.org			American Medical Association	American Medical Association	The preparation of this article was funded by the American Medical Association.	Fiks AG, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0675; Gray BM, 2014, JAMA-J AM MED ASSOC, V312, P2348, DOI 10.1001/jama.2014.12716; Hawkins RE, 2016, ACAD MED, V91, P1509, DOI 10.1097/ACM.0000000000001291; Hayes J, 2014, JAMA-J AM MED ASSOC, V312, P2358, DOI 10.1001/jama.2014.13992; Rose S, 2015, GASTROENTEROLOGY, V149, P1609, DOI 10.1053/j.gastro.2015.08.009; Teirstein PS, 2015, JAMA-J AM MED ASSOC, V313, P1809, DOI 10.1001/jama.2015.3576; Wiggins RE, 2016, JAMA OPHTHALMOL, V134, P967, DOI 10.1001/jamaophthalmol.2016.1848	7	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2279	2280		10.1001/jama.2017.6120	http://dx.doi.org/10.1001/jama.2017.6120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28494065				2022-12-28	WOS:000403149900010
J	Brody, H				Brody, Herb			UNIVERSITY SPIN-OFFS	NATURE			English	Editorial Material																			0	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S1	S1		10.1038/545S1a	http://dx.doi.org/10.1038/545S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514413	Bronze			2022-12-28	WOS:000401466500001
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			A 21st-Century Health IT System - Creating a Real-World Information Economy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mandl, Kenneth D.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA; [Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA.							American Medical Association, 2016, DIG HLTH STUD PHYS M; Bloomfield RA, 2017, INT J MED INFORM, V99, P1, DOI 10.1016/j.ijmedinf.2016.12.005; Califf RM, 2016, NEW ENGL J MED, V375, P2395, DOI 10.1056/NEJMsb1610128; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411	4	27	27	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1905	1907		10.1056/NEJMp1700235	http://dx.doi.org/10.1056/NEJMp1700235			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514623				2022-12-28	WOS:000401407500003
J	Schauer, PR; Bhatt, DL; Kashyap, SR				Schauer, Philip R.; Bhatt, Deepak L.; Kashyap, Sangeeta R.			Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Schauer, Philip R.] Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44106 USA; [Bhatt, Deepak L.] Brigham & Womens Heart & Vasc Ctr, Boston, MA USA; [Kashyap, Sangeeta R.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Schauer, PR (corresponding author), Cleveland Clin, Bariatr & Metab Inst, Cleveland, OH 44106 USA.	schauep@ccf.org		Kashyap, Sangeeta/0000-0002-7489-6650				Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218; Frias JP, 2016, LANCET DIABETES ENDO, V4, P1004, DOI 10.1016/S2213-8587(16)30267-4; Mechanick JI, 2013, OBESITY, V21, pS1, DOI 10.1002/oby.20461; Rubin JK, 2016, DIABETES CARE, V39, P954, DOI 10.2337/dc15-2781; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236	5	33	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1997	1997						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514616				2022-12-28	WOS:000401407500027
J	Wechsler, ME; Akuthota, P; Jayne, D; Khoury, P; Klion, A; Langford, CA; Merkel, PA; Moosig, F; Specks, U; Cid, MC; Luqmani, R; Brown, J; Mallett, S; Philipson, R; Yancey, SW; Steinfeld, J; Weller, PF; Gleich, GJ				Wechsler, M. E.; Akuthota, P.; Jayne, D.; Khoury, P.; Klion, A.; Langford, C. A.; Merkel, P. A.; Moosig, F.; Specks, U.; Cid, M. C.; Luqmani, R.; Brown, J.; Mallett, S.; Philipson, R.; Yancey, S. W.; Steinfeld, J.; Weller, P. F.; Gleich, G. J.		EGPA Mepolizumab Study Team	Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHURG-STRAUSS-SYNDROME; TERM-FOLLOW-UP; ASTHMA CONTROL; TASK-FORCE; VASCULITIS; RECOMMENDATIONS; MANAGEMENT; OUTCOMES; PATHOGENESIS; PROGNOSIS	BACKGROUND Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti-interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment of eosinophilic granulomatosis with polyangiitis. METHODS In this multicenter, double-blind, parallel-group, phase 3 trial, we randomly assigned participants with relapsing or refractory eosinophilic granulomatosis with polyangiitis who had received treatment for at least 4 weeks and were taking a stable prednisolone or prednisone dose to receive 300 mg of mepolizumab or placebo, administered subcutaneously every 4 weeks, plus standard care, for 52 weeks. The two primary end points were the accrued weeks of remission over a 52-week period, according to categorical quantification, and the proportion of participants in remission at both week 36 and week 48. Secondary end points included the time to first relapse and the average daily glucocorticoid dose (during weeks 48 through 52). The annualized relapse rate and safety were assessed. RESULTS A total of 136 participants underwent randomization, with 68 participants assigned to receive mepolizumab and 68 to receive placebo. Mepolizumab treatment led to significantly more accrued weeks of remission than placebo (28% vs. 3% of the participants had >= 24 weeks of accrued remission; odds ratio, 5.91; 95% confidence interval [CI], 2.68 to 13.03; P<0.001) and a higher percentage of participants in remission at both week 36 and week 48 (32% vs. 3%; odds ratio, 16.74; 95% CI, 3.61 to 77.56; P<0.001). Remission did not occur in 47% of the participants in the mepolizumab group versus 81% of those in the placebo group. The annualized relapse rate was 1.14 in the mepolizumab group, as compared with 2.27 in the placebo group (rate ratio, 0.50; 95% CI, 0.36 to 0.70; P<0.001). A total of 44% of the participants in the mepolizumab group, as compared with 7% of those in the placebo group, had an average daily dose of prednisolone or prednisone of 4.0 mg or less per day during weeks 48 through 52 (odds ratio, 0.20; 95% CI, 0.09 to 0.41; P<0.001). The safety profile of mepolizumab was similar to that observed in previous studies. CONCLUSIONS In participants with eosinophilic granulomatosis with polyangiitis, mepolizumab resulted in significantly more weeks in remission and a higher proportion of participants in remission than did placebo, thus allowing for reduced glucocorticoid use. Even so, only approximately half the participants treated with mepolizumab had protocol-defined remission. (Funded by GlaxoSmithKline and the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT02020889.)	[Wechsler, M. E.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Akuthota, P.] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92093 USA; [Akuthota, P.; Weller, P. F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Jayne, D.] Univ Cambridge, Dept Med, Cambridge, MA USA; [Luqmani, R.] Univ Oxford, Dept Orthopaed Rheumatol & Musculoskeletal Sci, Botnar Res Ctr, Oxford, England; [Brown, J.] GlaxoSmithKline, Res & Dev Immunoinflammat Therapy Area Unit, Uxbridge, Middx, England; [Mallett, S.] GlaxoSmithKline, Res & Dev, Stat Programming & Data Stand, Uxbridge, Middx, England; [Philipson, R.] Trizell, Oxford, England; [Khoury, P.; Klion, A.] NIAID, Human Eosinophil Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Langford, C. A.] Cleveland Clin, Ctr Vasculitis Care & Res, Cleveland, OH 44106 USA; [Merkel, P. A.] Univ Penn, Div Rheumatol, Philadelphia, PA 19104 USA; [Merkel, P. A.] Univ Penn, Dept Biostat & Clin Epidemiol, Philadelphia, PA 19104 USA; [Steinfeld, J.] GlaxoSmithKline, Resp Therapy Area Unit, Philadelphia, PA USA; [Steinfeld, J.] GlaxoSmithKline, Flexible Discovery Unit, Philadelphia, PA USA; [Moosig, F.] Schleswig Holstein Mitte, Rheumazentrum, Neumunster, Germany; [Specks, U.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Cid, M. C.] Hosp Clin Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Dept Autoimmune Dis, Vasculitis Res Unit, Barcelona, Spain; [Yancey, S. W.] GlaxoSmithKline, Resp Therapeut Area, Res Triangle Pk, NC USA; [Gleich, G. J.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Gleich, G. J.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA	National Jewish Health; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center; University of Oxford; GlaxoSmithKline; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline; GlaxoSmithKline; Mayo Clinic; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; GlaxoSmithKline; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Wechsler, ME (corresponding author), Wechsler Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80230 USA.	mikewechsler@gmail.com	Baldini, Chiara/K-9829-2016; KAHN, Jean-Emmanuel/S-8509-2018; Puéchal, Xavier/P-1555-2017; Wechsler, Michael/AAC-5506-2019; Pagnoux, Christian/C-4612-2015; Cid, Maria C./J-4553-2016; Khoury, Paneez/ABH-1951-2020; Hernandez-Rodriguez, Jose/L-2073-2017	Baldini, Chiara/0000-0002-4454-1824; KAHN, Jean-Emmanuel/0000-0002-9565-6074; Puéchal, Xavier/0000-0003-3573-9203; Cid, Maria C./0000-0002-4730-0938; Khoury, Paneez/0000-0003-1800-0079; Denson, Joshua/0000-0002-8654-7765; chanez, pascal/0000-0003-4059-0917; Jayne, David/0000-0002-1712-0637; Hernandez-Rodriguez, Jose/0000-0002-2357-2015; Wardlaw, Andrew/0000-0001-6583-0791; Mallett, Stephen/0000-0003-1053-958X; Jayne, David/0000-0002-8725-3283; Moosig, Frank/0000-0002-7341-9844	GlaxoSmithKline [115921]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [U01 AI097073]; Division of Intramural Research, NIAID, National Institutes of Health; Astra-Zeneca; Boston Scientific; Novartis; Vectura Group; Sunovion; Regeneron; Ambit BioScience; Meda Pharmaceuticals; Mylan; GliaCure; Tunitas Therapeutics; Genentech; Theravance Bio-pharma; Neurotronics; Boehringer Ingelheim; Sanofi; Sentien Biotechnologies; Teva Pharmaceutical Industries; Ambrx; AstraZeneca; Bristol-Myers Squibb; ChemoCentryx; Genentech/Roche; Celgene; MedImmune/AstraZeneca; Boston Pharmaceuticals; GlaxoSmithKline; InflaRx; Seattle Genetics; Roche; Chugai Pharmaceuticals; Eli Lilly; SmithKline; Glaxo-Smith-Kline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020241, U01AI097073, R01AI020241, ZIAAI001130] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Astra-Zeneca(AstraZeneca); Boston Scientific(Boston Scientific); Novartis(Novartis); Vectura Group; Sunovion; Regeneron(Regeneron); Ambit BioScience; Meda Pharmaceuticals; Mylan; GliaCure; Tunitas Therapeutics; Genentech(Roche HoldingGenentech); Theravance Bio-pharma; Neurotronics; Boehringer Ingelheim(Boehringer Ingelheim); Sanofi; Sentien Biotechnologies; Teva Pharmaceutical Industries(Teva Pharmaceutical Industries); Ambrx; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); ChemoCentryx; Genentech/Roche(Roche HoldingGenentech); Celgene(Bristol-Myers SquibbCelgene Corporation); MedImmune/AstraZeneca(AstraZeneca); Boston Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); InflaRx; Seattle Genetics; Roche(Roche Holding); Chugai Pharmaceuticals; Eli Lilly(Eli Lilly); SmithKline(GlaxoSmithKline); Glaxo-Smith-Kline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from GlaxoSmithKline (115921) and the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (U01 AI097073), and by the Division of Intramural Research, NIAID, National Institutes of Health.; Dr. Wechsler reports receiving consulting fees from Astra-Zeneca, Boston Scientific, Novartis, Vectura Group, Sunovion, Regeneron, Ambit BioScience, Meda Pharmaceuticals, Mylan, GliaCure, Tunitas Therapeutics, Genentech, Theravance Bio-pharma, Neurotronics, and Boehringer Ingelheim, grant support and consulting fees from Sanofi, fees for serving on a data and safety monitoring board from Sentien Biotechnologies, and consulting fees and fees for serving on an advisory board from Teva Pharmaceutical Industries; Dr. Akuthota, receiving consulting fees from Ambrx and travel fees paid by AstraZeneca; Dr. Langford, receiving grant support from Bristol-Myers Squibb and Genentech and serving as an unpaid consultant for Bristol-Myers Squibb; Dr. Merkel, receiving grant support and consulting fees from Bristol-Myers Squibb, ChemoCentryx, and Genentech/Roche, grant support from Celgene and MedImmune/AstraZeneca, and consulting fees from Boston Pharmaceuticals, GlaxoSmithKline, InflaRx, and Seattle Genetics; Dr. Moosig, receiving grant support and consulting fees from Roche and consulting fees from Chugai Pharmaceuticals, Eli Lilly, and SmithKline; Dr. Cid, receiving consulting fees from Glaxo-Smith-Kline, Novartis, Roche, and Boehringer Ingelheim; Dr. Luqmani, receiving grant support from Roche and consulting fees from Roche and GlaxoSmithKline; Dr. Brown, Mr. Mallett, Mr. Yancey, and Dr. Steinfeld, being an employee of and owning stock in GlaxoSmithKline; Dr. Philipson, being an employee of Trizell; and Dr. Gleich, receiving consulting fees from Genentech. No other potential conflict of interest relevant to this article was reported.	Akuthota P, 2012, SEMIN HEMATOL, V49, P113, DOI 10.1053/j.seminhematol.2012.01.005; Annapureddy N, 2016, CLIN RHEUMATOL, V35, P395, DOI 10.1007/s10067-015-2921-2; Baldini C, 2010, RHEUM DIS CLIN N AM, V36, P527, DOI 10.1016/j.rdc.2010.05.003; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; CHURG J, 1951, AM J PATHOL, V27, P277; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Comarmond C, 2013, ARTHRITIS RHEUM-US, V65, P270, DOI 10.1002/art.37721; Cottin V, 2016, EUR RESPIR J, V48, P1429, DOI 10.1183/13993003.00097-2016; Dejaco C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121737; Dunogue B, 2011, SEMIN RESP CRIT CARE, V32, P298, DOI 10.1055/s-0031-1279826; Grayson PC, 2015, RHEUMATOLOGY, V54, P1351, DOI 10.1093/rheumatology/keu427; Groh M, 2015, EUR J INTERN MED, V26, P545, DOI 10.1016/j.ejim.2015.04.022; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hellmich B, 2005, ANN NY ACAD SCI, V1051, P121, DOI 10.1196/annals.1361.053; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kahn JE, 2010, J ALLERGY CLIN IMMUN, V125, P267, DOI 10.1016/j.jaci.2009.10.014; Khoury P, 2014, NAT REV RHEUMATOL, V10, P474, DOI 10.1038/nrrheum.2014.98; Kim S, 2010, J ALLERGY CLIN IMMUN, V125, P1336, DOI 10.1016/j.jaci.2010.03.028; Mahr A, 2014, CURR OPIN RHEUMATOL, V26, P16, DOI 10.1097/BOR.0000000000000015; Mohammad AJ, 2016, ANN RHEUM DIS, V75, P396, DOI 10.1136/annrheumdis-2014-206095; Moosig F, 2011, ANN INTERN MED, V155, P341, DOI 10.7326/0003-4819-155-5-201109060-00026; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Ribi C, 2008, ARTHRITIS RHEUM-US, V58, P586, DOI 10.1002/art.23198; Samson M, 2013, J AUTOIMMUN, V43, P60, DOI 10.1016/j.jaut.2013.03.003; Sarnes E, 2011, CLIN THER, V33, P1413, DOI 10.1016/j.clinthera.2011.09.009; Strehl C, 2016, ANN RHEUM DIS, V75, P952, DOI 10.1136/annrheumdis-2015-208916; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133	33	435	449	3	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1921	1932		10.1056/NEJMoa1702079	http://dx.doi.org/10.1056/NEJMoa1702079			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514601	Green Published, Green Accepted			2022-12-28	WOS:000401407500006
J	Tsugawa, Y; Newhouse, JP; Zaslavsky, AM; Blumenthal, DM; Jena, AB				Tsugawa, Yusuke; Newhouse, Joseph P.; Zaslavsky, Alan M.; Blumenthal, Daniel M.; Jena, Anupam B.			Physician age and outcomes in elderly patients in hospital in the US: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GEOGRAPHIC-VARIATION; SEX-DIFFERENCES; HEALTH-CARE; MORTALITY; EXPERIENCE; MODELS; VOLUME; THERAPY; QUALITY; RATES	OBJECTIVES To investigate whether outcomes of patients who were admitted to hospital differ between those treated by younger and older physicians. DESIGN Observational study. SETTING US acute care hospitals. PARTICIPANTS 20% random sample of Medicare fee-for-service beneficiaries aged >= 65 admitted to hospital with a medical condition in 2011-14 and treated by hospitalist physicians to whom they were assigned based on scheduled work shifts. To assess the generalizability of findings, analyses also included patients treated by general internists including both hospitalists and non-hospitalists. MAIN OUTCOME MEASURES 30 day mortality and readmissions and costs of care. RESULTS 736 537 admissions managed by 18 854 hospitalist physicians (median age 41) were included. Patients' characteristics were similar across physician ages. After adjustment for characteristics of patients and physicians and hospital fixed effects (effectively comparing physicians within the same hospital), patients' adjusted 30 day mortality rates were 10.8% for physicians aged <40 (95% confidence interval 10.7% to 10.9%), 11.1% for physicians aged 40-49 (11.0% to 11.3%), 11.3% for physicians aged 50-59 (11.1% to 11.5%), and 12.1% for physicians aged >= 60 (11.6% to 12.5%). Among physicians with a high volume of patients, however, there was no association between physician age and patient mortality. Readmissions did not vary with physician age, while costs of care were slightly higher among older physicians. Similar patterns were observed among general internists and in several sensitivity analyses. CONCLUSIONS Within the same hospital, patients treated by older physicians had higher mortality than patients cared for by younger physicians, except those physicians treating high volumes of patients.	[Tsugawa, Yusuke; Newhouse, Joseph P.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Boston, MA 02138 USA; [Tsugawa, Yusuke] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Newhouse, Joseph P.; Zaslavsky, Alan M.; Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Newhouse, Joseph P.] Harvard Kennedy Sch, Cambridge, MA USA; [Newhouse, Joseph P.; Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Blumenthal, Daniel M.] Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02114 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; National Bureau of Economic Research; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Tsugawa, Y (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 42 Church St, Boston, MA 02138 USA.	ytsugawa@hsph.harvard.edu	Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022	Tsugawa, Yusuke/0000-0002-1937-4833	Social Science Research Council; Japan Foundation Center for Global Partnership; Office of the Director, National Institutes of Health (NIH Early Independence Award) [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Social Science Research Council; Japan Foundation Center for Global Partnership; Office of the Director, National Institutes of Health (NIH Early Independence Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	YT is supported in part by the Abe Fellowship (Social Science Research Council and the Japan Foundation Center for Global Partnership). ABJ is supported by the Office of the Director, National Institutes of Health (NIH Early Independence Award, grant 1DP5OD017897-01). The research conducted was independent of any involvement from the sponsors of the study. Study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	ARELLANO M, 1987, OXFORD B ECON STAT, V49, P431; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; CZAJA R, 1994, ANN INTERN MED, V120, P602, DOI 10.7326/0003-4819-120-7-199404010-00012; D'Ascenzo F, 2015, AM J CARDIOL, V115, P1185, DOI 10.1016/j.amjcard.2015.02.003; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1596; Fehrenbach SN, 2001, AM J MANAG CARE, V7, P717; Fitzmaurice GM., 2012, APPL LONGITUDINAL AN, V2nd; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hinami K, 2012, J HOSP MED, V7, P402, DOI 10.1002/jhm.1907; HLATKY MA, 1988, AM J CARDIOL, V61, P510, DOI 10.1016/0002-9149(88)90755-2; Institute of Medicine, 2013, VARIATION HLTH CARE; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Joynt KE, 2013, CIRC-HEART FAIL, V6, P890, DOI 10.1161/CIRCHEARTFAILURE.112.000064; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Moscucci M, 2005, J AM COLL CARDIOL, V46, P625, DOI 10.1016/j.jacc.2005.05.048; Nallamothu BK, 2011, JAMA-J AM MED ASSOC, V306, P1338, DOI 10.1001/jama.2011.1357; Newhouse JP, 2013, JAMA-J AM MED ASSOC, V310, P1227, DOI 10.1001/jama.2013.278139; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Research Data Assistance Center (ResDAC), 2016, DEATH INF RES ID MED; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; SCHWARTZ JS, 1991, ANN INTERN MED, V114, P46, DOI 10.7326/0003-4819-114-1-46; Southern WN, 2011, AM J MED, V124, P868, DOI 10.1016/j.amjmed.2011.04.011; Streja DA, 1999, ARCH INTERN MED, V159, P294, DOI 10.1001/archinte.159.3.294; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Temple RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2240; The Centers for Medicare & Medicaid Services, 2016, NOT PROP RUL MAK QUA; Tsugawa Y, 2017, JAMA INTERN MED, V177, P675, DOI 10.1001/jamainternmed.2017.0059; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Tsugawa Y, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j273; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Wachter RM, 2016, NEW ENGL J MED, V375, P1009, DOI 10.1056/NEJMp1607958; Wachter RM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e652; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209	44	76	77	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j1797	10.1136/bmj.j1797	http://dx.doi.org/10.1136/bmj.j1797			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512089	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000401898900001
J	Hughes, TR; Lambert, SA				Hughes, Timothy R.; Lambert, Samuel A.			Transcription factors read epigenetics	SCIENCE			English	Editorial Material							ZINC-FINGER PROTEINS; FUNCTIONAL DIVERSITY; DNA METHYLATION		[Hughes, Timothy R.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Hughes, Timothy R.; Lambert, Samuel A.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.; Hughes, TR (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada.	t.hughes@utoronto.ca	Lambert, Samuel/ABA-7732-2021	Lambert, Samuel/0000-0001-8222-008X				Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Deans C, 2015, GENETICS, V199, P887, DOI 10.1534/genetics.114.173492; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Schmitges FW, 2016, GENOME RES, V26, P1742, DOI 10.1101/gr.209643.116; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Takahashi Y, 2017, SCIENCE, V356, P503, DOI 10.1126/science.aag3260; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239	13	9	9	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					489	490		10.1126/science.aan2927	http://dx.doi.org/10.1126/science.aan2927			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473550				2022-12-28	WOS:000400545700019
J	Thornton, JP				Thornton, Joseph P.			Conflict of Interest and Legal Issues for Investigators and Authors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Thornton, Joseph P.] JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA		Thornton, JP (corresponding author), JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA.	joseph.thornton@jamanetwork.org	Thornton, Joseph/GSN-4190-2022					Goldner JA, 2000, J LAW MED ETHICS, V28, P379; Kesselheim AS, 2015, JAMA INTERN MED, V175, P1955, DOI 10.1001/jamainternmed.2015.5610	2	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1761	1762		10.1001/jama.2017.4235	http://dx.doi.org/10.1001/jama.2017.4235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464169				2022-12-28	WOS:000400440700030
J	Shalev, SA; Zlotogora, J; Shalata, A; Levy-Lahad, E				Shalev, Satvit A.; Zlotogora, Joel; Shalata, Adel; Levy-Lahad, Ephrat			Medical genetics in Israel's diverse population	LANCET			English	Editorial Material							MUTATIONS		[Shalev, Satvit A.] Emek Med Ctr, Genet Inst, Afula, Israel; [Shalev, Satvit A.] Technion, Rappaport Fac Med, Haifa, Israel; [Zlotogora, Joel; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Shalata, Adel] Bnai Zion Med Ctr, Simon Winter Inst Human Genet, Haifa, Israel; [Shalata, Adel] Bar Ilan Univ, Ramat Gan, Israel; [Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel	Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Bnai Zion Medical Center; Bar Ilan University; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Levy-Lahad, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.; Levy-Lahad, E (corresponding author), Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Zlotogora, Joel/0000-0001-6293-2979				Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Basset C, 2016, NATL CONSULTATIVE ET; Central Bureau of Statistics, 2016, STAT ABSTR ISR; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Gabai-Kapara E, 2014, P NATL ACAD SCI USA, V111, P14205, DOI 10.1073/pnas.1415979111; Javaher P, 2010, PUBLIC HEALTH GENOM, V13, P524, DOI 10.1159/000294998; Koren A, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.012; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Public Health England, CURR UK NSC REC; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Vardi-Saliternik R, 2002, ANN HUM BIOL, V29, P422, DOI 10.1080/03014460110100928; Zlotogora J, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0100-z; Zlotogora J, 2016, GENET MED, V18, P203, DOI 10.1038/gim.2015.55; Zlotogora J, 2014, HUM HERED, V77, P10, DOI 10.1159/000357945; Zlotogora J, 2014, MOL GENET GENOM MED, V2, P85, DOI 10.1002/mgg3.73	17	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2453	2455		10.1016/S0140-6736(17)30875-9	http://dx.doi.org/10.1016/S0140-6736(17)30875-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495108				2022-12-28	WOS:000403901800010
J	Ly, KN; Jiles, RB; Teshale, EH; Foster, MA; Pesano, RL; Holmberg, SD				Ly, Kathleen N.; Jiles, Ruth B.; Teshale, Eyasu H.; Foster, Monique A.; Pesano, Rick L.; Holmberg, Scott D.			Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014	ANNALS OF INTERNAL MEDICINE			English	Article							VERTICAL TRANSMISSION; VIRAL-HEPATITIS; KENTUCKY; RISK	Background: In the United States, hepatitis C virus (HCV) infection has increased among young persons who inject drugs, but the extent of this epidemic among reproductive-aged women and their children is unknown. Objective: To estimate numbers and describe characteristics of reproductive-aged women with HCV infection and of their offspring. Design: Analysis of the National Notifiable Diseases Surveillance System (NNDSS) from 2006 to 2014 and the Quest Diagnostics Health Trends national database from 2011 to 2014. Setting: United States. Participants: 171 801 women (aged 15 to 44 years) and 1859 children (aged 2 to 13 years) with HCV infection reported to the NNDSS; 2.1 million reproductive-aged women and 56 684 children who had HCV testing by Quest Diagnostics. Measurements: NNDSS HCV case reports and Quest laboratory data regarding unique reproductive-aged women and children who were tested for HCV infection. Results: The number of reproductive-aged women with acute and past or present HCV infection in the NNDSS doubled, from 15 550 in 2006 to 31 039 in 2014. Of 581 255 pregnant women tested by Quest from 2011 to 2014, 4232 (0.73% [95% CI, 0.71% to 0.75%]) had HCV infection. Of children tested by Quest, 0.76% (CI, 0.69% to 0.83%) had HCV infection, but the percentage was 3.2-fold higher among children aged 2 to 3 years (1.62% [CI, 1.34% to 1.96%]) than those aged 12 to 13 years (0.50% [CI, 0.41% to 0.62%]). Applying the Quest HCV infection rate to annual live births from 2011 to 2014 resulted in an estimated average of 29 000 women (CI, 27 400 to 30 900 women) with HCV infection, who gave birth to 1700 infants (CI, 1200 to 2200 infants) with the infection each year. Limitations: Only a fraction of HCV infections is detected and reported to the NNDSS. Quest data are potentially biased, because women who are asymptomatic, do not access health care, or have unreported risks may be less likely to be tested for HCV infection. Conclusion: These data suggest a recent increase in HCV infection among reproductive-aged women and may inform deliberations regarding a role for routine HCV screening during pregnancy. Primary Funding Source: Centers for Disease Control and Prevention.	[Ly, Kathleen N.; Jiles, Ruth B.; Teshale, Eyasu H.; Foster, Monique A.; Holmberg, Scott D.] Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd Northeast,Mailstop G-37, Atlanta, GA 30333 USA; Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA; [Pesano, Rick L.] Quest Diagnost Nichols Inst SJC, 33608 Ortega Highway, San Juan Capistrano, CA 92675 USA	Centers for Disease Control & Prevention - USA; Nichols Institute; Nichols Institute	Ly, KN (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd Northeast,Mailstop G-37, Atlanta, GA 30333 USA.	KathleenLy@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2016, HCV GUID REC TEST MA; Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447; Centers for Disease Control and Prevention, 2016, SURV VIR HEP US 2014; Cottrell EB, 2013, ANN INTERN MED, V158, P109, DOI 10.7326/0003-4819-158-2-201301150-00575; Delotte J, 2014, J MATERN-FETAL NEO M, V27, P664, DOI 10.3109/14767058.2013.829813; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Hamilton Brady E, 2015, Natl Vital Stat Rep, V64, P1; Jonas MM, 2002, HEPATOLOGY, V36, pS173, DOI 10.1053/jhep.2002.36799; Klevens RM, 2014, AM J PUBLIC HEALTH, V104, P482, DOI 10.2105/AJPH.2013.301601; Koneru A, 2016, MMWR-MORBID MORTAL W, V65, P705, DOI 10.15585/mmwr.mm6528a2; Kuncio DE, 2016, CLIN INFECT DIS, V62, P980, DOI 10.1093/cid/ciw026; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Pembrey L, 2005, CLIN INFECT DIS, V41, P45, DOI 10.1086/430601; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	20	86	86	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					775	+		10.7326/M16-2350	http://dx.doi.org/10.7326/M16-2350			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28492929				2022-12-28	WOS:000402700200004
J	Brindal, E				Brindal, Emily			Weight management programmes of extended duration	LANCET			English	Editorial Material							LOSS MAINTENANCE; STRATEGIES; ADULTS; TRIAL		[Brindal, Emily] CSIRO, Food & Nutr, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Brindal, E (corresponding author), CSIRO, Food & Nutr, Canberra, ACT, Australia.	emily.brindal@csiro.au	Brindal, Emily/H-9280-2013					Ahern AL, 2017, LANCET; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Astrup A, 2000, Obes Rev, V1, P17, DOI 10.1046/j.1467-789x.2000.00004.x; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; French SA, 1999, INT J OBESITY, V23, P320, DOI 10.1038/sj.ijo.0800822; Hartmann-Boyce J, 2013, WEIGHT REGAIN BEHAV; Heshka S, 2003, JAMA-J AM MED ASSOC, V289, P1792, DOI 10.1001/jama.289.14.1792; National Institute of Health and Clinical Excellence, 2014, MAN OV OB AD LIF WEI; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; World Health Organization, 2016, FISC POL DIET PREV N	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2168	2170		10.1016/S0140-6736(17)31042-5	http://dx.doi.org/10.1016/S0140-6736(17)31042-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28478042	hybrid			2022-12-28	WOS:000402540800007
J	Ting, DSW; Wong, TY				Ting, Daniel Shu Wei; Wong, Tien Yin			Proliferative diabetic retinopathy: laser or eye injection?	LANCET			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; MAJOR RISK-FACTORS; GLOBAL PREVALENCE; FACTOR THERAPY		[Wong, Tien Yin] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore	Wong, TY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Bidwai, Pooja Vishal/0000-0002-3077-4395	Abbott; Allergan; Bayer; Novartis; Roche; Pfizer	Abbott(Abbott Laboratories); Allergan(AbbVieAllergan); Bayer(Bayer AG); Novartis(Novartis); Roche(Roche Holding); Pfizer(Pfizer)	TYW is on advisory boards for Abbott, Allergan, Bayer, Novartis, Roche, and Pfizer and has received honoraria for travel, service on advisory boards, and research support from these companies, outside the area discussed in this Comment. TYW has provided expert testimony to Novartis for clinical use of ranibizumab for the treatment of age-related macular degeneration. DSWT declares no competing interests.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1978, Ophthalmology, V85, P82; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1931, DOI 10.1097/IAE.0000000000000723; Sivaprasad S, 2017, LANCET; Ting DSW, 2016, CLIN EXP OPHTHALMOL, V44, P260, DOI 10.1111/ceo.12696; Weidle UH, 2012, CANCER GENOM PROTEOM, V9, P357; Wong TY, 2009, DIABETES CARE, V32, P2307, DOI 10.2337/dc09-0615; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	12	15	15	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2165	2166		10.1016/S0140-6736(17)31194-7	http://dx.doi.org/10.1016/S0140-6736(17)31194-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW5JC	28494921				2022-12-28	WOS:000402540800005
J	Tsai, CJ; Standfuss, J; Glaeser, RM				Tsai, Ching-Ju; Standfuss, Joerg; Glaeser, Robert M.			Structural biology Signalling under the microscope	NATURE			English	Editorial Material							PHASE-CONTRAST		[Tsai, Ching-Ju; Standfuss, Joerg] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Glaeser, Robert M.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of California System; University of California Berkeley	Tsai, CJ (corresponding author), Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland.	ching-ju.tsai@psi.ch; joerg.standfuss@psi.ch; rmglaeser@lbl.gov	Standfuss, Joerg/G-5126-2011					Danev R, 2017, ELIFE, V6, DOI 10.7554/eLife.23006; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Khoshouei M., 2016, PREPRINT AT BIORXIV; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345	12	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2017	546	7656					36	37		10.1038/nature22491	http://dx.doi.org/10.1038/nature22491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW3CR	28467826				2022-12-28	WOS:000402372800021
J	Lis, R; Karrasch, CC; Poulos, MG; Kunar, B; Redmond, D; Duran, JGB; Badwe, CR; Schachterle, W; Ginsberg, M; Xiang, J; Tabrizi, AR; Shido, K; Rosenwaks, Z; Elemento, O; Speck, NA; Butler, JM; Scandura, JM; Rafii, S				Lis, Raphael; Karrasch, Charles C. .; Poulos, Michael G.; Kunar, Balvir; Redmond, David; Duran, Jose G. Barcia; Badwe, Chaitanya R.; Schachterle, William; Ginsberg, Michael; Xiang, Jenny; Tabrizi, Arash Rafii; Shido, Koji; Rosenwaks, Zev; Elemento, Olivier; Speck, Nancy A. .; Butler, Jason M. .; Scandura, Joseph M. .; Rafii, Shahin			Conversion of adult endothelium to immunocompetent haematopoietic stem cells	NATURE			English	Article							HEMOGENIC ENDOTHELIUM; VASCULAR NICHE; SELF-RENEWAL; DIFFERENTIATION; INDUCTION; FIBROBLASTS; MAINTENANCE; GENERATION; REVEALS; RUNX1	Developmental pathways that orchestrate the fleeting transition of endothelial cells into haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully reprogramming adult mouse endothelial cells to haematopoietic stem cells (rEC-HSCs) through transient expression of the transcription-factor-encoding genes Fosb, Gfi1, Runx1, and Spi1 (collectively denoted hereafter as FGRS) and vascular-niche-derived angiocrine factors. The induction phase (days 0-8) of conversion is initiated by expression of FGRS in mature endothelial cells, which results in endogenous Runx1 expression. During the specification phase (days 8-20), RUNX1(+) FGRS-transduced endothelial cells commit to a haematopoietic fate, yielding rEC-HSCs that no longer require FGRS expression. The vascular niche drives a robust self-renewal and expansion phase of rEC-HSCs (days 20-28). rEC-HSCs have a transcriptome and long-term self-renewal capacity similar to those of adult haematopoietic stem cells, and can be used for clonal engraftment and serial primary and secondary multi-lineage reconstitution, including antigen-dependent adaptive immune function. Inhibition of TGF beta and CXCR7 or activation of BMP and CXCR4 signalling enhanced generation of rEC-HSCs. Pluripotency-independent conversion of endothelial cells into autologous authentic engraftable haematopoietic stem cells could aid treatment of haematological disorders.	[Lis, Raphael; Karrasch, Charles C. .; Poulos, Michael G.; Kunar, Balvir; Duran, Jose G. Barcia; Badwe, Chaitanya R.; Schachterle, William; Shido, Koji; Butler, Jason M. .; Rafii, Shahin] Weill Cornell Med, Ansary Stem Cell Inst, Div Regenerat Med, Dept Med, New York, NY 10065 USA; [Lis, Raphael; Karrasch, Charles C. .; Rosenwaks, Zev] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Poulos, Michael G.; Butler, Jason M. .] Weill Cornell Med, Dept Surg, Dept Med, New York, NY 10065 USA; [Redmond, David; Elemento, Olivier] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA; [Redmond, David; Elemento, Olivier] Weill Cornell Med, Inst Precis Med, New York, NY 10065 USA; [Ginsberg, Michael] Angiocrine Biosci, San Diego, CA 92130 USA; [Xiang, Jenny] Weill Cornell Med, Genom Resources Core Facil, New York, NY 10065 USA; [Tabrizi, Arash Rafii] Weill Cornell Med Qatar, Qatar Fdn, Dept Obstet & Gynecol, Stem Cell & Microenvironm Lab, POB 24144, Doha, Qatar; [Speck, Nancy A. .] Univ Penn, Abramson Family Canc Res Inst, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Speck, Nancy A. .] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Scandura, Joseph M. .] Weill Cornell Med, Dept Med Hematol Oncol, New York, NY 10065 USA; [Scandura, Joseph M. .] New York Presbyterian Hosp, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Cornell University; NewYork-Presbyterian Hospital	Rafii, S (corresponding author), Weill Cornell Med, Ansary Stem Cell Inst, Div Regenerat Med, Dept Med, New York, NY 10065 USA.	srafii@med.cornell.edu		Scandura, Joseph/0000-0002-9525-143X; Barcia Duran, Jose Gabriel/0000-0003-4764-5503	Ansary Stem Cell Institute (ASCI); New York State Department of Health grants (NYSDOH) [C026878, C028117, C029156, C030160]; NIH-R01 [DK095039, HL119872, HL128158, HL115128, HL099997]; Starr foundation TRI-Institution stem cell core project; Tri-Institutional Stem Cell Initiative [2013-032, 2014-023, 2016-013]; Qatar National Priorities Research Program [NPRP 8-1898-3-392, NPRP 6-131-3-268]; NIH [T32 HD060600, CA204308, HL133021, RO1 HL091724]; ASCI; TRI-SCI [2014-023, 2013-022, 2014-004, 2016-024]; Leukemia & Lymphoma Society (LLS) [0859-15]; Taub Foundation; LLS grant [2299-14]; NYSDOH [C029156, C030160]; NIH R01 [HL119872, HL128158]; Cancer Research & Treatment Fund (CRT);  [U54 CA163167]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA163167, R01CA204308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133021, R01HL128158, R01HL091724, U01HL099997, R01HL115128, R01HL119872, R01HL097797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	Ansary Stem Cell Institute (ASCI); New York State Department of Health grants (NYSDOH); NIH-R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr foundation TRI-Institution stem cell core project; Tri-Institutional Stem Cell Initiative; Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCI; TRI-SCI; Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Taub Foundation; LLS grant; NYSDOH; NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research & Treatment Fund (CRT); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Downing at St Jude Hospital for providing the Runx1-IRES-GFP reporter mice. Floxed Cxcr4 mice were provided by Y.-R. Zou (the Feinstein Institute for Medical Research). We are grateful to V. Sandler for constructive discussions. R.L., W.S., K.S., and S.R. are supported by Ansary Stem Cell Institute (ASCI), New York State Department of Health grants (NYSDOH) (C026878, C028117, C029156, C030160), NIH-R01 (DK095039, HL119872, HL128158, HL115128, HL099997) and U54 CA163167, the Starr foundation TRI-Institution stem cell core project, Tri-Institutional Stem Cell Initiative grants (TRI-SCI#2013-032, #2014-023, #2016-013, and fellowships), R.L., A.R.T., and S.R. by the Qatar National Priorities Research Program (NPRP 8-1898-3-392, NPRP 6-131-3-268), B.K. by NIH-T32 HD060600. J.M.B. is supported by the ASCI, TRI-SCI #2013-022 and #2014-004, Leukemia & Lymphoma Society (LLS) grant 0859-15, and NIH-R01 (CA204308, HL133021); J.M.S. by the ASCI, Taub Foundation Grants Program, TRI-SCI#2014-023 and #2016-024, LLS grant 2299-14, (NYSDOH) C029156, C030160, ECRIP, and NIH R01 (HL119872, HL128158) and by Cancer Research & Treatment Fund (CR&T), J.M.S. and S.R. by the ECRIP and NYSDOH, and N.A.S. by NIH-RO1 HL091724.	Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Butler Jason M, 2012, Methods Mol Biol, V904, P221, DOI 10.1007/978-1-61779-943-3_18; Butler JM, 2012, BLOOD, V120, P1344, DOI 10.1182/blood-2011-12-398115; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Gritz E, 2016, CELL MOL LIFE SCI, V73, P1547, DOI 10.1007/s00018-016-2134-0; Hirschi KK, 2012, BLOOD, V119, P4823, DOI 10.1182/blood-2011-12-353466; Israely E, 2014, STEM CELLS, V32, P177, DOI 10.1002/stem.1521; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kinkel SA, 2015, BLOOD, V125, P1890, DOI 10.1182/blood-2014-10-603969; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Lis Raphael, 2017, PROTOC EXCH; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Ng ES, 2016, NAT BIOTECHNOL, V34, P1168, DOI 10.1038/nbt.3702; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Pulecio J, 2014, STEM CELLS, V32, P2923, DOI 10.1002/stem.1800; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Rafii S, 2013, BLOOD, V121, P770, DOI 10.1182/blood-2012-07-444208; Redmond D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0335-7; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Roden MM, 1999, J IMMUNOL METHODS, V226, P29, DOI 10.1016/S0022-1759(99)00039-3; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sasine JP, 2017, STEM CELL TRANSL MED, V6, P482, DOI 10.5966/sctm.2016-0254; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Slukvin II, 2016, FEBS LETT, V590, P4126, DOI 10.1002/1873-3468.12283; Souilhol C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10784; Sturgeon CM, 2013, NAT BIOTECHNOL, V31, P416, DOI 10.1038/nbt.2571; Tashiro K, 2012, STEM CELL RES, V8, P300, DOI 10.1016/j.scr.2011.09.001; Wahlster L, 2016, NAT CELL BIOL, V18, P1111, DOI 10.1038/ncb3419; Yzaguirre AD, 2017, ADV EXP MED BIOL, V962, P47, DOI 10.1007/978-981-10-3233-2_4; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	43	133	139	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					439	+		10.1038/nature22326	http://dx.doi.org/10.1038/nature22326			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514438	Green Accepted			2022-12-28	WOS:000401906500044
J	Huch, M; Rawlins, EL				Huch, Meritxell; Rawlins, Emma L.			CANCER Tumours build their niche	NATURE			English	Editorial Material							NEUROENDOCRINE CELLS; NOTCH		[Huch, Meritxell; Rawlins, Emma L.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Huch, Meritxell; Rawlins, Emma L.] Wellcome Trust Res Labs, MRC, Stem Cell Inst, Cambridge, England	University of Cambridge; Wellcome Trust Sanger Institute	Huch, M (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.; Huch, M (corresponding author), Wellcome Trust Res Labs, MRC, Stem Cell Inst, Cambridge, England.	m.huch@gurdon.cam.ac.uk; e.rawlins@gurdon.cam.ac.uk		Rawlins, Emma Louise/0000-0001-7426-3792	Medical Research Council [MR/P009581/1] Funding Source: Medline; MRC [MR/P009581/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Guha A, 2017, CELL REP, V19, P246, DOI 10.1016/j.celrep.2017.03.051; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lim JS, 2017, NATURE, V545, P360, DOI 10.1038/nature22323; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Noguchi M, 2015, CELL REP, V13, P2679, DOI 10.1016/j.celrep.2015.11.058; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334	12	5	5	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					292	293		10.1038/nature22494	http://dx.doi.org/10.1038/nature22494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28489827				2022-12-28	WOS:000401466500048
J	Edelson, DP; Churpek, MM				Edelson, Dana P.; Churpek, Matthew M.			Inpatient Notes: Predicting Codes-A Future With Fewer In-Hospital Cardiac Arrests	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Edelson, Dana P.; Churpek, Matthew M.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Edelson, DP (corresponding author), Univ Chicago, Med Ctr, Sect Hosp Med, 5841 South Maryland Ave,MC 5000, Chicago, IL 60637 USA.	dperes@uchicago.edu		Churpek, Matthew/0000-0002-4030-5250	Philips Healthcare and EarlySense	Philips Healthcare and EarlySense	Dr. Edelson reports research support from Philips Healthcare and EarlySense and an ownership interest in Quant HC, which is developing products for risk stratification of hospitalized patients. Both Dr. Edelson and Dr. Churpek have a patent pending for risk stratification algorithms for hospitalized patients. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0920.	Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; Galhotra S, 2006, CRIT CARE MED, V34, P1700, DOI 10.1097/01.CCM.0000218418.16472.8B; Kronick SL, 2015, CIRCULATION, V132, pS397, DOI 10.1161/CIR.0000000000000258; Smith GB, 2016, CRIT CARE MED, V44, P2171, DOI 10.1097/CCM.0000000000002000; Solomon RS, 2016, J HOSP MED, V11, P438, DOI 10.1002/jhm.2554	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					HO2	HO3		10.7326/M17-0920	http://dx.doi.org/10.7326/M17-0920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505657				2022-12-28	WOS:000401240200001
J	Shafazand, S				Shafazand, Shirin			Guideline: Insufficient evidence exists on screening for obstructive sleep apnea in asymptomatic adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shafazand, Shirin] Univ Miami, Miami, FL 33124 USA	University of Miami	Shafazand, S (corresponding author), Univ Miami, Miami, FL 33124 USA.							Jonas DE, 2017, JAMA-J AM MED ASSOC, V317, P415, DOI 10.1001/jama.2016.19635; Netzer NC, 2003, CHEST, V124, P1406, DOI 10.1378/chest.124.4.1406	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC50	JC50		10.7326/ACPJC-2017-166-10-050	http://dx.doi.org/10.7326/ACPJC-2017-166-10-050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505634				2022-12-28	WOS:000401240200002
J	Baron, JM; Dighe, AS; Flood, JG				Baron, Jason M.; Dighe, Anand S.; Flood, James G.			Case 3-2017: A Man with Cardiac Sarcoidosis and New Diplopia and Weakness Reply	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							SUBARACHNOID HEMORRHAGE; VISUAL INSPECTION; XANTHOCHROMIA; SPECTROPHOTOMETRY		[Baron, Jason M.; Dighe, Anand S.; Flood, James G.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Baron, JM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758				Chu K, 2014, ANN EMERG MED, V64, P256, DOI 10.1016/j.annemergmed.2014.01.023; Chu KH, 2015, EMERG MED AUSTRALAS, V27, P267, DOI 10.1111/1742-6723.12398; Cruickshank A, 2008, ANN CLIN BIOCHEM, V45, P238, DOI 10.1258/acb.2008.007257; Edlow JA, 2002, ARCH PATHOL LAB MED, V126, P413	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1897	1897						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28490000	Green Published			2022-12-28	WOS:000400891100033
J	Scharifker, B				Scharifker, Benjamin			Science struggles on in my ravaged country	NATURE			English	Editorial Material									[Scharifker, Benjamin] Metropolitan Univ, Caracas, Venezuela		Scharifker, B (corresponding author), Metropolitan Univ, Caracas, Venezuela.	bscharifker@unimet.edu.ve	Scharifker, Benjamin/B-9501-2008	Scharifker, Benjamin/0000-0003-2351-6432					0	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					135	135		10.1038/545135a	http://dx.doi.org/10.1038/545135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU3XG	28492261	Bronze			2022-12-28	WOS:000400963800004
J	Moberly, T				Moberly, Tom			UK GENERAL ELECTION 2017 Five health issues that have dominated general elections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com						McCartney M, 2016, BMJ-BRIT MED J, V357, pi5482; Wise J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3254	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2017	357								j2251	10.1136/bmj.j2251	http://dx.doi.org/10.1136/bmj.j2251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UE	28490525				2022-12-28	WOS:000401169600010
J	Fardet, L; Nazareth, I; Petersen, I				Fardet, Laurence; Nazareth, Irwin; Petersen, Irene			Association Between Long-term Quinine Exposure and All-Cause Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Fardet, Laurence] Univ Paris Est Creteil, EA EpiDermE 7379, Creteil, France; [Nazareth, Irwin; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of London; University College London	Fardet, L (corresponding author), Hop Henri Mondor, 51 Ave Marechal Lattre de Tassigny, F-94010 Creteil, France.	laurence.fardet@aphp.fr		Nazareth, Irwin/0000-0003-2146-9628	National Institute for Health Research [NF-SI-0515-10041] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Blak Betina T, 2011, Inform Prim Care, V19, P251; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; Feas X, 2009, REV ESP NUTR COMUNIT, V15, P97; Gjesing A, 2015, PHARMACOEPIDEM DR S, V24, P310, DOI 10.1002/pds.3746; Katzberg HD, 2010, NEUROLOGY, V74, P691, DOI 10.1212/WNL.0b013e3181d0ccca	5	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1907	1909		10.1001/jama.2017.2332	http://dx.doi.org/10.1001/jama.2017.2332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492890	Green Submitted, Green Published			2022-12-28	WOS:000400842400021
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Only data can say if new is better	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEART-FAILURE; ENALAPRIL					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bavishi C, 2015, EUR HEART J, V36, P1967, DOI 10.1093/eurheartj/ehv142; Brannstrom M, 2014, EUR J HEART FAIL, V16, P1142, DOI 10.1002/ejhf.151; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; National Institute for Health and Care Excellence, 2016, SAC VALS TREAT CHRON; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2191	10.1136/bmj.j2191	http://dx.doi.org/10.1136/bmj.j2191			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483792	Bronze, Green Published			2022-12-28	WOS:000401412700016
J	Kim, K; Schulze, MW; Arora, A; Lewis, RM; Hillmyer, MA; Dorfman, KD; Bates, FS				Kim, Kyungtae; Schulze, Morgan W.; Arora, Akash; Lewis, Ronald M., III; Hillmyer, Marc A.; Dorfman, Kevin D.; Bates, Frank S.			Thermal processing of diblock copolymer melts mimics metallurgy	SCIENCE			English	Article							FRANK-KASPER PHASES; BLOCK-COPOLYMERS; MICROPHASE SEPARATION; PACKING; ORDER; DISCOVERY; SYMMETRY; POLYMERS; DISORDER; LATTICE	Small-angle x-ray scattering experiments conducted with compositionally asymmetric low molar mass poly(isoprene)-b-poly(lactide) diblock copolymers reveal an extraordinary thermal history dependence. The development of distinct periodic crystalline or aperiodic quasicrystalline states depends on how specimens are cooled from the disordered state to temperatures below the order-disorder transition temperature. Whereas direct cooling leads to the formation of documented morphologies, rapidly quenched samples that are then heated from low temperature form the hexagonal C14 and cubic C15 Laves phases commonly found in metal alloys. Self-consistent mean-field theory calculations show that these, and other associated Frank-Kasper phases, have nearly degenerate free energies, suggesting that processing history drives the material into long-lived metastable states defined by self-assembled particles with discrete populations of volumes and polyhedral shapes.	[Kim, Kyungtae; Schulze, Morgan W.; Arora, Akash; Lewis, Ronald M., III; Dorfman, Kevin D.; Bates, Frank S.] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA; [Hillmyer, Marc A.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Schulze, Morgan W.] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara	Dorfman, KD; Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	dorfman@umn.edu; bates001@umn.edu	Kim, Kyungtae/F-5790-2013; Dorfman, Kevin/A-7726-2008	Kim, Kyungtae/0000-0002-3206-8494; Lewis, Ronald/0000-0002-7388-4439; Hillmyer, Marc/0000-0001-8255-3853; Dorfman, Kevin/0000-0003-0065-5157; Arora, Akash/0000-0002-2260-269X; Bates, Morgan/0000-0002-8939-2682	National Science Foundation [DMR-1104368, DMR-1333669]; U.S. Department of Energy, Office of Science [DE-AC02-06CH11357]; E. I. DuPont de Nemours and Co.; Dow Chemical Company; Northwestern University; Direct For Mathematical & Physical Scien [1333669, 1104368] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); E. I. DuPont de Nemours and Co.; Dow Chemical Company; Northwestern University; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation under grants DMR-1104368 and DMR-1333669. Use of the Advanced Photon Source (APS) at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, under contract DE-AC02-06CH11357. Portions were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of the APS, supported by E. I. DuPont de Nemours and Co., The Dow Chemical Company, and Northwestern University. K.K. and F.S.B. designed the research on PI-PLA. K.K. synthesized the PI-PLA samples and acquired and analyzed SAXS data. M.W.S., R.M.L., and M.A.H. designed the research on poly(ethylethylene)-b-poly(+/-)-lactide (PEE-PLA). M.W.S. and R.M.L. synthesized the PEE-PLA samples and performed SAXS experiments. M.W.S. conceived of and demonstrated the liquid nitrogen thermal processing technique with the PEE-PLA and initially identified the C14 phase. A. A. and K.D.D. designed, executed, and interpreted SCFT calculations. F.S.B. supervised the overall project and drafted the initial manuscript. All authors reviewed and edited the manuscript and supplementary materials.	Arora A, 2016, MACROMOLECULES, V49, P4675, DOI 10.1021/acs.macromol.6b00107; Bates FS, 2012, SCIENCE, V336, P434, DOI 10.1126/science.1215368; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Berger RF, 2011, CHEM REV, V111, P4522, DOI 10.1021/cr1001222; De Graef M., 2012, STRUCTURE MAT INTRO; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; FREDRICKSON GH, 1987, J CHEM PHYS, V87, P697, DOI 10.1063/1.453566; Gillard TM, 2016, P NATL ACAD SCI USA, V113, P5167, DOI 10.1073/pnas.1601692113; Grason GM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058304; Han CD, 2000, MACROMOLECULES, V33, P3767, DOI 10.1021/ma991862r; HECKER S.S., 2000, CHALLENGES PLUTONIUM, V26, P290; Hobbs D, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014407; Huang MJ, 2015, SCIENCE, V348, P424, DOI 10.1126/science.aaa2421; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KOPPI KA, 1994, J RHEOL, V38, P999, DOI 10.1122/1.550600; Lee S, 2014, P NATL ACAD SCI USA, V111, P17723, DOI 10.1073/pnas.1408678111; Lee S, 2013, AICHE J, V59, P3502, DOI 10.1002/aic.14023; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Lee S, 2013, CHEM-EUR J, V19, P10244, DOI 10.1002/chem.201203758; LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047; Lifshitz R, 2014, P NATL ACAD SCI USA, V111, P17698, DOI 10.1073/pnas.1420121111; Liu MJ, 2016, ACS MACRO LETT, V5, P1167, DOI 10.1021/acsmacrolett.6b00685; Medapuram P, 2015, MACROMOLECULES, V48, P819, DOI 10.1021/ma5017264; Rappolt M, 2013, SOFT MATTER, V9, P6291, DOI 10.1039/c3sm50308a; Seddon JM, 2000, PHYS CHEM CHEM PHYS, V2, P4485, DOI 10.1039/b004916f; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Sikiric MD, 2010, ACTA CRYSTALLOGR A, V66, P602, DOI 10.1107/S0108767310022932; Ungar G, 2005, SOFT MATTER, V1, P95, DOI 10.1039/b502443a; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; Xie N, 2014, ACS MACRO LETT, V3, P906, DOI 10.1021/mz500445v	31	178	179	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					520	+		10.1126/science.aam7212	http://dx.doi.org/10.1126/science.aam7212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473585				2022-12-28	WOS:000400545700033
J	Ramsey, BW; Nepom, GT; Lonial, S				Ramsey, Bonnie W.; Nepom, Gerald T.; Lonial, Sagar			Academic, Foundation, and Industry Collaboration in Finding New Therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							REFRACTORY MULTIPLE-MYELOMA; LOW-DOSE DEXAMETHASONE; CYSTIC-FIBROSIS; THERAPEUTICS DEVELOPMENT; COMBINATION THERAPY; DIABETES-MELLITUS; GENE-TRANSFER; NOD MICE; LENALIDOMIDE; ELOTUZUMAB		[Ramsey, Bonnie W.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Ramsey, Bonnie W.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Seattle, WA USA; [Nepom, Gerald T.] Immune Tolerance Network, Seattle, WA USA; [Nepom, Gerald T.] Benaroya Res Inst, Seattle, WA USA; [Lonial, Sagar] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Lonial, Sagar] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Immune Tolerance Network; Benaroya Research Institute; Emory University; Emory University	Ramsey, BW (corresponding author), Seattle Childrens Res Inst, POB 5371,M-S CW8-5B, Seattle, WA 98145 USA.	bonnie.ramsey@seattlechildrens.org			NIDDK NIH HHS [P30 DK089507] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashlock MA, 2011, ANNU REV MED, V62, P107, DOI 10.1146/annurev-med-061509-131034; Bluestone JA, 2015, IMMUNITY, V42, P779, DOI 10.1016/j.immuni.2015.05.002; Buckner JH, 2016, J AUTOIMMUN, V71, P44, DOI 10.1016/j.jaut.2016.02.009; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Ferkol T, 2015, AM J RESP CRIT CARE, V192, P658, DOI 10.1164/rccm.201507-1428ED; Gill RG, 2016, DIABETES, V65, P1310, DOI 10.2337/db15-0492; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hanson S, 2009, VENTURE PHILANTHROPY; Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935; Hayden EC, 2016, NATURE, V534, P305, DOI 10.1038/534305a; Higgins RF, 2007, HARVARD BUSINESS SCH; Jakubowiak AJ, 2012, J CLIN ONCOL, V30, P1960, DOI 10.1200/JCO.2011.37.7069; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kowalski J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1503; Long SA, 2013, CLIN IMMUNOL, V149, P324, DOI 10.1016/j.clim.2013.02.005; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Lonial S, 2012, J CLIN ONCOL, V30, P1953, DOI 10.1200/JCO.2011.37.2649; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Pinckney A, 2016, CLIN THER, V38, P1327, DOI 10.1016/j.clinthera.2016.04.032; Rabinovitch A, 2002, DIABETES, V51, P638, DOI 10.2337/diabetes.51.3.638; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Rigby MR, 2015, J CLIN INVEST, V125, P3285, DOI 10.1172/JCI81722; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rowe SM, 2012, THORAX, V67, P882, DOI 10.1136/thoraxjnl-2012-202550; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Welsh MJ, 1999, J CLIN INVEST, V104, P1165, DOI 10.1172/JCI8634; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	39	43	44	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1762	1769		10.1056/NEJMra1612575	http://dx.doi.org/10.1056/NEJMra1612575			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28467868	Green Accepted			2022-12-28	WOS:000400442300009
J	Schmitt, AR; Wetter, DA; Camilleri, MJ; Khan, SP; Tollefson, MM				Schmitt, Adam R.; Wetter, David A.; Camilleri, Michael J.; Khan, Shakila P.; Tollefson, Megha M.			Langerhans cell histiocytosis presenting as a blueberry muffin rash	LANCET			English	Editorial Material									[Schmitt, Adam R.; Wetter, David A.; Camilleri, Michael J.; Tollefson, Megha M.] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA; [Camilleri, Michael J.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Khan, Shakila P.; Tollefson, Megha M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Khan, Shakila P.] Mayo Clin, Div Pediat Hematol Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Tollefson, MM (corresponding author), Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA.	tollfeson.megha@mayo.edu							0	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					155	155		10.1016/S0140-6736(17)30564-0	http://dx.doi.org/10.1016/S0140-6736(17)30564-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28478970				2022-12-28	WOS:000404976600032
J	Bhatia, J; Tobey, R; Hochman, M				Bhatia, Jay; Tobey, Rachel; Hochman, Michael			Value-Based Payment Models for Community Health Centers Time to (Cautiously) Take the Plunge?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhatia, Jay] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Tobey, Rachel] John Snow Inc, San Francisco, CA USA; [Hochman, Michael] Univ Southern Calif, Keck Sch Med, Gehr Family Ctr Implementat Sci, 2020 Zonal Ave,IRD 320, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Hochman, M (corresponding author), Univ Southern Calif, Keck Sch Med, Gehr Family Ctr Implementat Sci, 2020 Zonal Ave,IRD 320, Los Angeles, CA 90033 USA.	mhochman@med.usc.edu			Blue Shield of California Foundation	Blue Shield of California Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hochman reports being a former employee and a current consultant for a large community health center. Ms Tobey reports receipt of grant support from Blue Shield of California Foundation to support the California Primary Care Association and the California Association of Public Hospitals. Mr Bhatia reported no disclosures.	Health Care Payment Learning and Action Network Alternative Payment Model Framework and Progress Tracking (APM FPT) Work Group, 2016, ALT PAYM MOD APM FRA; Hostetler C, 2017, FRONTIERS HEALTHCARE; Lefkowitz B., 2007, COMMUNITY HLTH CTR M; Nocon RS, 2016, AM J PUBLIC HEALTH, V106, P1981, DOI 10.2105/AJPH.2016.303341; Schneider EC, 2017, NEW ENGL J MED, V376, P708, DOI 10.1056/NEJMp1613876	5	8	8	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2275	2276		10.1001/jama.2017.5174	http://dx.doi.org/10.1001/jama.2017.5174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28472226				2022-12-28	WOS:000403149900008
J	Huttlin, EL; Bruckner, RJ; Paulo, JA; Cannon, JR; Ting, L; Baltier, K; Colby, G; Gebreab, F; Gygi, MP; Parzen, H; Szpyt, J; Tam, S; Zarraga, G; Pontano-Vaites, L; Swarup, S; White, AE; Schweppe, DK; Rad, R; Erickson, BK; Obar, RA; Guruharsha, KG; Li, K; Rtavanis-Tsakonas, SA; Gygi, SP; Harper, JW				Huttlin, Edward L.; Bruckner, Raphael J.; Paulo, Joao A. .; Cannon, Joe R.; Ting, Lily; Baltier, Kurt; Colby, Greg; Gebreab, Fana; Gygi, Melanie P.; Parzen, Hannah; Szpyt, John; Tam, Stanley; Zarraga, Gabriela; Pontano-Vaites, Laura; Swarup, Sharan; White, Anne E.; Schweppe, Devin K.; Rad, Ramin; Erickson, Brian K.; Obar, Robert A. .; Guruharsha, K. G.; Li, Kejie; Rtavanis-Tsakonas, Spyros A.; Gygi, Steven P.; Harper, J. Wade			Architecture of the human interactome defines protein communities and disease networks	NATURE			English	Article							SCALE MAP; REGULATORS; LANDSCAPE; COMPLEXES; PEPTIDES	The physiology of a cell can be viewed as the product of thousands of proteins acting in concert to shape the cellular response. Coordination is achieved in part through networks of protein-protein interactions that assemble functionally related proteins into complexes, organelles, and signal transduction pathways. Understanding the architecture of the human proteome has the potential to inform cellular, structural, and evolutionary mechanisms and is critical to elucidating how genome variation contributes to disease(1-3). Here we present BioPlex 2.0 (Biophysical Interactions of ORFeome-derived complexes), which uses robust affinity purification-mass spectrometry methodology(4) to elucidate protein interaction networks and co-complexes nucleated by more than 25% of protein-coding genes from the human genome, and constitutes, to our knowledge, the largest such network so far. With more than 56,000 candidate interactions, BioPlex 2.0 contains more than 29,000 previously unknown co-associations and provides functional insights into hundreds of poorly characterized proteins while enhancing network-based analyses of domain associations, subcellular localization, and co-complex formation. Unsupervised Markov clustering(5) of interacting proteins identified more than 1,300 protein communities representing diverse cellular activities. Genes essential for cell fitness(6,7) are enriched within 53 communities representing central cellular functions. Moreover, we identified 442 communities associated with more than 2,000 disease annotations, placing numerous candidate disease genes into a cellular framework. BioPlex 2.0 exceeds previous experimentally derived interaction networks in depth and breadth, and will be a valuable resource for exploring the biology of incompletely characterized proteins and for elucidating larger-scale patterns of proteome organization.	[Huttlin, Edward L.; Bruckner, Raphael J.; Paulo, Joao A. .; Cannon, Joe R.; Ting, Lily; Baltier, Kurt; Colby, Greg; Gebreab, Fana; Gygi, Melanie P.; Parzen, Hannah; Szpyt, John; Tam, Stanley; Zarraga, Gabriela; Pontano-Vaites, Laura; Swarup, Sharan; White, Anne E.; Schweppe, Devin K.; Rad, Ramin; Erickson, Brian K.; Rtavanis-Tsakonas, Spyros A.; Gygi, Steven P.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Obar, Robert A. .; Guruharsha, K. G.; Li, Kejie; Rtavanis-Tsakonas, Spyros A.] Biogen Inc, 250 Binney St, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Biogen	Huttlin, EL; Gygi, SP; Harper, JW (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	edward_huttlin@hms.harvard.edu; steven_gygi@hms.harvard.edu; wade_harper@hms.harvard.edu	Paulo, Joao/AAO-3981-2020; Kuthethur, Guruharsha/Z-2605-2019	Paulo, Joao/0000-0002-4291-413X; Kuthethur, Guruharsha/0000-0001-7292-4868; Cannnon, Joe/0000-0002-3010-0964; Huttlin, Edward/0000-0002-1822-1173; Erickson, Brian/0000-0002-1150-5042; Harper, Jeffrey/0000-0002-6944-7236; Schweppe, Devin/0000-0002-3241-6276; Zarraga, Gabriela/0000-0003-4344-7008; Parzen, Hannah/0000-0002-5944-3696	National Institutes of Health [U41 HG006673]; Biogen; Canadian Institutes for Health Research;  [K01DK098285]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biogen(Biogen); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Vidal and D. Hill for ORFeome 8.1, and the Nikon Imaging Center (Harvard Medical School) for imaging support. This work was supported by the National Institutes of Health (U41 HG006673 to S.P.G., J.W.H., and E.L.H.) and Biogen (S.P.G., J.W.H.). J.A.P. is supported by K01DK098285, and S.S. was supported by the Canadian Institutes for Health Research.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gallegos LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27114; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pinero J., 2015, DATABASE-OXFORD, V2015, DOI DOI 10.1093/database/bav028; Pratt D, 2015, CELL SYST, V1, P302, DOI 10.1016/j.cels.2015.10.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Ryan CJ, 2013, NAT REV GENET, V14, P865, DOI 10.1038/nrg3574; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	50	761	774	11	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					505	+		10.1038/nature22366	http://dx.doi.org/10.1038/nature22366			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514442	Green Submitted, Green Accepted			2022-12-28	WOS:000401906500057
J	Wang, B; Jie, ZL; Joo, DH; Ordureau, A; Liu, P; Gan, WJ; Guo, JP; Zhang, JF; North, BJ; Dai, XP; Cheng, XH; Bian, XW; Zhang, LQ; Harper, JW; Sun, SC; Wei, WY				Wang, Bin; Jie, Zuliang; Joo, Donghyun; Ordureau, Alban; Liu, Pengda; Gan, Wenjian; Guo, Jianping; Zhang, Jinfang; North, Brian J.; Dai, Xiangpeng; Cheng, Xuhong; Bian, Xiuwu; Zhang, Lingqiang; Harper, J. Wade; Sun, Shao-Cong; Wei, Wenyi			TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling	NATURE			English	Article							RAG GTPASES; PROTEIN-PHOSPHORYLATION; COMPLEX INTEGRITY; GAP ACTIVITY; CANCER; RAPTOR; AKT; ACTIVATION; GROWTH; RICTOR	The mechanistic target of rapamycin (mTOR) has a key role in the integration of various physiological stimuli to regulate several cell growth and metabolic pathways(1). mTOR primarily functions as a catalytic subunit in two structurally related but functionally distinct multi-component kinase complexes, mTOR complex 1 (mTORC1) and mTORC2 (refs 1, 2). Dysregulation of mTOR signalling is associated with a variety of human diseases, including metabolic disorders and cancer(1). Thus, both mTORC1 and mTORC2 kinase activity is tightly controlled in cells. mTORC1 is activated by both nutrients(3-6) and growth factors(7), whereas mTORC2 responds primarily to extracellular cues such as growth-factor-triggered activation of PI3K signalling(8-10). Although both mTOR and G beta L (also known as MLST8) assemble into mTORC1 and mTORC2 (refs 11-15), it remains largely unclear what drives the dynamic assembly of these two functionally distinct complexes. Here we show, in humans and mice, that the K63-linked polyubiquitination status of G beta L dictates the homeostasis of mTORC2 formation and activation. Mechanistically, the TRAF2 E3 ubiquitin ligase promotes K63-linked polyubiquitination of G beta L, which disrupts its interaction with the unique mTORC2 component SIN1 (refs 12-14) to favour mTORC1 formation. By contrast, the OTUD7B deubiquitinase removes polyubiquitin chains from G beta L to promote G beta L interaction with SIN1, facilitating mTORC2 formation in response to various growth signals. Moreover, loss of critical ubiquitination residues in G beta L, by either K305R/K313R mutations or a melanoma-associated G beta L(Delta W297) truncation, leads to elevated mTORC2 formation, which facilitates tumorigenesis, in part by activating AKT oncogenic signalling. In support of a physiologically pivotal role for OTUD7B in the activation of mTORC2/AKT signalling, genetic deletion of Otud7b in mice suppresses Akt activation and Kras-driven lung tumorigenesis in vivo. Collectively, our study reveals a G beta L-ubiquitination-dependent switch that fine-tunes the dynamic organization and activation of the mTORC2 kinase under both physiological and pathological conditions.	[Wang, Bin] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Gastroenterol, Chongqing 400042, Peoples R China; [Wang, Bin; Liu, Pengda; Gan, Wenjian; Guo, Jianping; Zhang, Jinfang; North, Brian J.; Dai, Xiangpeng; Wei, Wenyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Jie, Zuliang; Joo, Donghyun; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St,Box 902, Houston, TX 77030 USA; [Ordureau, Alban; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Minist Educ China, Inst Pathol, Chongqing 400038, Peoples R China; [Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Minist Educ China, Southwest Canc Ctr, Chongqing 400038, Peoples R China; [Bian, Xiuwu] Third Mil Med Univ, Southwest Hosp, Minist Educ China, Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China; [Zhang, Lingqiang] Beijing Inst Radiat Med, Collaborat Innovat Ctr Canc Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China	Army Medical University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Army Medical University; Ministry of Education, China; Army Medical University; Ministry of Education, China; Army Medical University; Ministry of Education, China; Academy of Military Medical Sciences - China	Wei, WY (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.; Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, 7455 Fannin St,Box 902, Houston, TX 77030 USA.	ssun@mdanderson.org; wwei2@bidmc.harvard.edu	Bian, Xiu-Wu/D-4736-2017; Ordureau, Alban/C-7558-2012; Wang, Bin/W-9917-2019	Bian, Xiu-Wu/0000-0003-4383-0197; Ordureau, Alban/0000-0002-4924-8520; Wang, Bin/0000-0001-5574-1760; Harper, Jeffrey/0000-0002-6944-7236; Gan, Wenjian/0000-0001-7599-5020	Edward R. and Anne G. Lefler Center; NIH [R01CA177910, R01GM094777, R37AI064639, R01GM084459, AG011085, GM095567]; National Natural Science Foundation of China [81472294, 81521064];  [ROOCA181342];  [1K99CA207867]; NATIONAL CANCER INSTITUTE [K99CA207867, R01CA200651, P30CA016672, R01CA177910, R00CA181342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459, R01GM089763, R01GM095567, R01GM094777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Edward R. and Anne G. Lefler Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Jacks and the NCI Mouse Repository for providing the Kras<SUP>LA2</SUP> mice. We thank P. P. Pandolfi (Harvard), B. D. Manning (Harvard), and A. Toker (Harvard) for their insightful suggestions and critiques during the preparation of this manuscript. We also thank all Wei laboratory members for critical reading of the manuscript. W.W. is a LLS research scholar. P.L. is supported by ROOCA181342. W.G. is supported by 1K99CA207867. A.O. was supported by an Edward R. and Anne G. Lefler Center postdoctoral fellowship. This work was supported by NIH grants (W.W., R01CA177910 and R01GM094777; S.-C.S., R37AI064639 and R01GM084459; J.W.H., AG011085 and GM095567) and the National Natural Science Foundation of China (B.W., 81472294, L.Z., 81521064).	Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bremm A, 2014, EMBO REP, V15, P1268, DOI 10.15252/embr.201438850; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Deng L, 2015, MOL CELL, V58, P804, DOI 10.1016/j.molcel.2015.03.033; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jin GX, 2015, MOL CELL, V58, P989, DOI 10.1016/j.molcel.2015.05.010; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Wei WY, 2003, MOL CELL BIOL, V23, P2859, DOI 10.1128/MCB.23.8.2859-2870.2003; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	45	93	100	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					365	+		10.1038/nature22344	http://dx.doi.org/10.1038/nature22344			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489822	Green Accepted			2022-12-28	WOS:000401466500066
J	Witze, A				Witze, Alexandra			POLITICS How Trump's science cuts could hurt his supporters	NATURE			English	News Item																			0	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					273	274		10.1038/545273a	http://dx.doi.org/10.1038/545273a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516935	Bronze			2022-12-28	WOS:000401466500032
J	Zhang, XF; Yan, CY; Hang, J; Finci, LI; Lei, JL; Shi, YG				Zhang, Xiaofeng; Yan, Chuangye; Hang, Jing; Finci, Lorenzo I.; Lei, Jianlin; Shi, Yigong			An Atomic Structure of the Human Spliceosome	CELL			English	Article							CRYO-EM STRUCTURE; METAL-ION CATALYSIS; BEAM-INDUCED MOTION; STEP-I SPLICEOSOME; MESSENGER-RNA; CONFORMATIONAL REARRANGEMENT; BINDING-PROTEIN; SPLICING FACTOR; EXON; COMPLEX	Mechanistic understanding of pre-mRNA splicing requires detailed structural information on various states of the spliceosome. Here we report the cryo electron microscopy (cryo-EM) structure of the human spliceosome just before exon ligation (the C* complex) at an average resolution of 3.76 angstrom. The splicing factor Prp17 stabilizes the active site conformation. The step II factor Slu7 adopts an extended conformation, binds Prp8 and Cwc22, and is poised for selection of the 3'-splice site. Remarkably, the intron lariat traverses through a positively charged central channel of RBM22; this unusual organization suggests mechanisms of intron recruitment, confinement, and release. The protein PRKRIP1 forms a 100-angstrom a helix linking the distant U2 snRNP to the catalytic center. A 35-residue fragment of the ATPase/helicase Prp22 latches onto Prp8, and the quaternary exon junction complex (EJC) recognizes upstream 5'-exon sequences and associates with Cwc22 and the GTPase Snu114. These structural features reveal important mechanistic insights into exon ligation.	[Zhang, Xiaofeng; Yan, Chuangye; Hang, Jing; Finci, Lorenzo I.; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Sch Life Sci, Key Lab Prot Sci, Minist Educ,Technol Ctr Prot Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, CY; Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	yancy05@mails.tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Zhang, Xiaofeng/0000-0002-9658-5917; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	National Natural Science Foundation of China [31430020, 31621092]; Ministry of Science and Technology [2016YFA0501100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank Jingyi Hui for providing the MINX plasmid and Robin Reed for providing the MBP-MS2 expression plasmid. We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for the cryo-EM facility and the computational facility support on the cluster of Bio-Computing Platform. This work was supported by funds from the National Natural Science Foundation of China (31430020 and 31621092) and the Ministry of Science and Technology (2016YFA0501100 to J.L.). The atomic coordinates have been deposited with the accession code PDB: 5XJC, and the EM maps have been deposited with the accession code EMDB: EMB-6721. None of the authors of this manuscript has a financial interest related to this work. Correspondence and requests for materials should be addressed to C.Y. (yancy05@mails.tsinghua.edu.cn) or Y.S. (shi-lab@tsinghua.edu.cn).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov A, 2012, P NATL ACAD SCI USA, V109, P21313, DOI 10.1073/pnas.1219725110; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Barbosa I, 2012, NAT STRUCT MOL BIOL, V19, P983, DOI 10.1038/nsmb.2380; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Boehm V, 2016, TRENDS GENET, V32, P724, DOI 10.1016/j.tig.2016.09.003; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; DeLano W.L, PYMOL MOL GRAPHICS S; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Moore M.J., 1993, SPLICING PRECURSORS; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Noble CG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000303; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Steckelberg AL, 2012, CELL REP, V2, P454, DOI 10.1016/j.celrep.2012.08.017; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sun LF, 2015, P NATL ACAD SCI USA, V112, P6003, DOI 10.1073/pnas.1506242112; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Umen JG, 1996, GENETICS, V143, P723; UMEN JG, 1995, RNA, V1, P584; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wolf E, 2009, EMBO J, V28, P2283, DOI 10.1038/emboj.2009.171; Xu DM, 1998, MOL CELL BIOL, V18, P2055, DOI 10.1128/MCB.18.4.2055; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yin Z, 2003, J BIOL CHEM, V278, P22838, DOI 10.1074/jbc.M212969200; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou ZL, 2002, P NATL ACAD SCI USA, V99, P12203, DOI 10.1073/pnas.182427099	78	134	145	8	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					918	+		10.1016/j.cell.2017.04.033	http://dx.doi.org/10.1016/j.cell.2017.04.033			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV1OM	28502770	Bronze			2022-12-28	WOS:000401515900016
J	Friedrich, MJ				Friedrich, M. J.			Scarcity of Safe Water a Looming Threat to Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1941	1941		10.1001/jama.2017.4810	http://dx.doi.org/10.1001/jama.2017.4810			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510685				2022-12-28	WOS:000401315500003
J	Chan, SW; Tulloch, E; Cooper, ES; Smith, A; Wojcik, W; Norman, JE				Chan, Sarah W.; Tulloch, Ed; Cooper, E. Sarah; Smith, Andrew; Wojcik, Wojtek; Norman, Jane E.			Montgomery and informed consent: where are we now?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chan, Sarah W.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Tulloch, Ed] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Cooper, E. Sarah] Royal Infirm Edinburgh NHS Trust, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Smith, Andrew] Compass Chambers, Edinburgh, Midlothian, Scotland; [Wojcik, Wojtek] Royal Infirm Edinburgh NHS Trust, Dept Psychol Med, Edinburgh, Midlothian, Scotland; [Norman, Jane E.] Univ Edinburgh, Ctr Reprod Hlth, MRC, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Chan, SW (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.	sarah.chan@ed.ac.uk	Kozbakova, Ainur/K-5077-2018	Kozbakova, Ainur/0000-0002-5213-4882; Norman, Jane/0000-0001-6031-6953				British Medical Association, 1981, HDB MED ETH; BYRNE DJ, 1988, BRIT MED J, V296, P839, DOI 10.1136/bmj.296.6625.839; Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1414; Edozien LC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2877; Farrell AM, 2016, J MED ETHICS, V42, P85, DOI 10.1136/medethics-2015-102861; Foster C., 2015, NEW LAW J, V357, P1; General Medical Council, 1995, GOOD MED PRACTICE; Heywood R, 2015, MED LAW REV, V23, P455, DOI 10.1093/medlaw/fwv024; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; Montgomery J, 2016, J MED ETHICS, V42, P89, DOI 10.1136/medethics-2015-102862; Scottish Office, 1993, PAT CHART WHAT US TH; Sokol DK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1481; Sundar S., BMJ; Sundar S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1787; Tyler F., 2015, SUPREME COURT DECISI; Weston A, 2015, BRIT DENT J, V219, P304, DOI 10.1038/sj.bdj.2015.764	16	135	135	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2017	357								j2224	10.1136/bmj.j2224	http://dx.doi.org/10.1136/bmj.j2224			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UL	28500035	Green Published, hybrid			2022-12-28	WOS:000401170300002
J	Vogel, G				Vogel, Gretchen			WHERE HAVE ALL THE INSECTS GONE?	SCIENCE			English	Editorial Material																			0	103	106	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					576	579		10.1126/science.356.6338.576	http://dx.doi.org/10.1126/science.356.6338.576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495712				2022-12-28	WOS:000400975200019
J	Fung, JJ				Fung, John J.			Thomas Earl Starzl (1926-2017)	SCIENCE			English	Biographical-Item									[Fung, John J.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago	Fung, JJ (corresponding author), Univ Chicago, Dept Surg, Chicago, IL 60637 USA.	jfung@surgery.bsd.uchicago.edu	FUNG, John Julian/A-2679-2012	FUNG, John Julian/0000-0002-3038-0441					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					491	491		10.1126/science.aan4732	http://dx.doi.org/10.1126/science.aan4732			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473551				2022-12-28	WOS:000400545700020
J	Sohail, M; Vakhrusheva, OA; Sul, JH; Pulit, SL; Francioli, LC; van den Berg, LH; Veldink, JH; de Bakker, PIW; Bazykin, GA; Kondrashov, AS; Sunyaev, SR				Sohail, Mashaal; Vakhrusheva, Olga A.; Sul, Jae Hoon; Pulit, Sara L.; Francioli, Laurent C.; van den Berg, Leonard H.; Veldink, Jan H.; de Bakker, Paul I. W.; Bazykin, Georgii A.; Kondrashov, Alexey S.; Sunyaev, Shamil R.		Genome Netherlands Consortium; Alzheimers Dis Neuroimaging Initia	Negative selection in humans and fruit flies involves synergistic epistasis	SCIENCE			English	Article							EVOLUTIONARY ADVANTAGE; DELETERIOUS MUTATIONS; POPULATION; RECOMBINATION; INSIGHTS; FITNESS; LOAD; SEX	Negative selection against deleterious alleles produced by mutation influences within-population variation as the most pervasive form of natural selection. However, it is not known whether deleterious alleles affect fitness independently, so that cumulative fitness loss depends exponentially on the number of deleterious alleles, or synergistically, so that each additional deleterious allele results in a larger decrease in relative fitness. Negative selection with synergistic epistasis should produce negative linkage disequilibrium between deleterious alleles and, therefore, an underdispersed distribution of the number of deleterious alleles in the genome. Indeed, we detected underdispersion of the number of rare loss-of-function alleles in eight independent data sets from human and fly populations. Thus, selection against rare protein-disrupting alleles is characterized by synergistic epistasis, which may explain how human and fly populations persist despite high genomic mutation rates.	[Sohail, Mashaal] Harvard Med Sch, Syst Biol PhD Program, Boston, MA USA; [Sohail, Mashaal; Sunyaev, Shamil R.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sohail, Mashaal; Sunyaev, Shamil R.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Vakhrusheva, Olga A.; Bazykin, Georgii A.] Russian Acad Sci, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow, Russia; [Sul, Jae Hoon] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Pulit, Sara L.; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Pulit, Sara L.; Francioli, Laurent C.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bazykin, Georgii A.] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Kondrashov, Alexey S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Kondrashov, Alexey S.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; University of California System; University of California Los Angeles; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University; University of Michigan System; University of Michigan	Sunyaev, SR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA.; Sunyaev, SR (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Kondrashov, AS (corresponding author), Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia.; Kondrashov, AS (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	kondrash@umich.edu; ssunyaev@rics.bwh.harvard.edu	Vakhrusheva, Olga/AAP-3270-2021; Bazykin, Georgii/E-4601-2012; Suchiman, H. Eka D./F-5024-2017	Bazykin, Georgii/0000-0003-2334-2751; Pulit, Sara/0000-0002-2502-3669; Vakhrusheva, Olga/0000-0002-9617-2303; Hehir-Kwa, Jayne/0000-0003-0837-304X; Willemsen, Gonneke/0000-0003-3755-0236; Van den Berg, Leonard/0000-0002-6559-3965; Van Duijn, Cornelia/0000-0002-2374-9204; Suchiman, H. Eka D./0000-0002-7168-5516; Karssen, Lennart C./0000-0002-1959-342X; Palamara, Pier Francesco/0000-0002-7999-1972	NIH [R01GM078598, R01GM105857, R01MH101244, U01HG009088]; Russian Science Foundation [14-50-00150]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857, R01GM078598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to L. Mirny, G. McVean, and I. Adzhubey for scientific discussions; all members of the Sunyaev lab and two anonymous reviewers for comments that improved the manuscript; D. Jordan for providing SLiM 2.0 simulation runs; C. Cassa, D. Jordan, D. Weghorn, and D. Balick for providing genic selection estimates for humans; J. Fan for helping with analyses as a summer student; and J. Lack for help with D. melanogaster inversion data. This project was supported by NIH grants R01GM078598, R01GM105857, R01MH101244, and U01HG009088. Analysis of fruit fly data was performed at IITP RAS and supported by the Russian Science Foundation (grant no. 14-50-00150). Data sets used in this study can be accessed as follows: GoNL: www.nlgenome.nl/; ADNI: http://adni.loni.usc.edu/; Project MinE: www.projectmine.com; The 1000 Genomes Phase I Project: ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/; DGRP and DPGP3: www.johnpool.net/genomes.html.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; Besenbacher S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6969; BULMER MG, 1976, GENET RES, V28, P101, DOI 10.1017/S0016672300016797; Bulmer MG, 1980, MATH THEORY QUANTITA; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Charlesworth B, 2013, EVOLUTION, V67, P3354, DOI 10.1111/evo.12195; Chiu HC, 2012, P ROY SOC B-BIOL SCI, V279, P4156, DOI 10.1098/rspb.2012.1449; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; FELSENSTEIN J, 1974, GENETICS, V78, P737; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1995, GENET RES, V65, P113, DOI 10.1017/S0016672300033139; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lack JB, 2015, GENETICS, V199, P1229, DOI 10.1534/genetics.115.174664; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Lesecque Y, 2012, GENETICS, V191, P1321, DOI 10.1534/genetics.112.140343; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; SHNOL EE, 1993, GENETICS, V134, P995; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; Yang RC, 2000, GENETICS, V155, P1449	26	31	31	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					539	542		10.1126/science.aah5238	http://dx.doi.org/10.1126/science.aah5238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473589	Green Submitted, Green Accepted			2022-12-28	WOS:000400545700038
J	Sushkevich, VL; Palagin, D; Ranocchiari, M; van Bokhoven, JA				Sushkevich, Vitaly L.; Palagin, Dennis; Ranocchiari, Marco; van Bokhoven, Jeroen A.			Selective anaerobic oxidation of methane enables direct synthesis of methanol	SCIENCE			English	Article							LOW-TEMPERATURE; CONTAINING ZEOLITES; ACTIVE-SITES; CONVERSION; MORDENITE; CATALYSTS; CLUSTERS; ZSM-5; MONOOXYGENASE; STABILITY	Direct functionalization of methane in natural gas remains a key challenge. We present a direct stepwise method for converting methane into methanol with high selectivity (similar to 97%) over a copper-containing zeolite, based on partial oxidation with water. The activation in helium at 673 kelvin (K), followed by consecutive catalyst exposures to 7 bars of methane and then water at 473 K, consistently produced 0.204 mole of CH3OH per mole of copper in zeolite. Isotopic labeling confirmed water as the source of oxygen to regenerate the zeolite active centers and renders methanol desorption energetically favorable. On the basis of in situ x-ray absorption spectroscopy, infrared spectroscopy, and density functional theory calculations, we propose a mechanism involving methane oxidation at Cu-II oxide active centers, followed by Cu-I reoxidation by water with concurrent formation of hydrogen.	[Sushkevich, Vitaly L.; Palagin, Dennis; Ranocchiari, Marco; van Bokhoven, Jeroen A.] Paul Scherrer Inst, Lab Catalysis & Sustainable Chem, CH-5232 Villigen, Switzerland; [van Bokhoven, Jeroen A.] ETH, Inst Chem & Bioengn, Vladimir Prelog Weg 1, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sushkevich, VL; van Bokhoven, JA (corresponding author), Paul Scherrer Inst, Lab Catalysis & Sustainable Chem, CH-5232 Villigen, Switzerland.; van Bokhoven, JA (corresponding author), ETH, Inst Chem & Bioengn, Vladimir Prelog Weg 1, CH-8093 Zurich, Switzerland.	vitaly.sushkevich@psi.ch; jeroen.vanbokhoven@chem.ethz.ch	Sushkevich, Vitaly/Z-4603-2019; MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; Ranocchiari, Marco/C-3931-2011; Palagin, Dennis/E-1726-2015; li, shangkun/AAB-3035-2019; van Bokhoven, Jeroen A/B-1677-2014	Sushkevich, Vitaly/0000-0002-3788-8969; Ranocchiari, Marco/0000-0002-4460-8742; Palagin, Dennis/0000-0001-5251-3471; van Bokhoven, Jeroen A/0000-0002-4166-2284	Energy System Integration platform of the Paul Scherrer Institute	Energy System Integration platform of the Paul Scherrer Institute	The authors acknowledge the use of the computing facilities of the Swiss National Supercomputer Center and are grateful for the Swiss Light Source and SuperXAS beamline for providing beamtime for XAS measurements. We thank the Energy System Integration platform of the Paul Scherrer Institute for financial support. Experimental data are available in supplementary materials. All authors are inventors on a patent application submitted by the Paul Scherrer Institut that covers the process described in the manuscript.	Aasberg-Petersen K, 2011, J NAT GAS SCI ENG, V3, P423, DOI 10.1016/j.jngse.2011.03.004; Ahlquist M, 2009, J AM CHEM SOC, V131, P17110, DOI 10.1021/ja903930e; Alayon EM, 2012, CHEM COMMUN, V48, P404, DOI 10.1039/c1cc15840f; Alayon EMC, 2015, PHYS CHEM CHEM PHYS, V17, P7681, DOI 10.1039/c4cp03226h; Alayon EMC, 2014, ACS CATAL, V4, P16, DOI 10.1021/cs400713c; Borfecchia E, 2015, CHEM SCI, V6, P548, DOI 10.1039/c4sc02907k; Chan SI, 2008, ACCOUNTS CHEM RES, V41, P969, DOI 10.1021/ar700277n; Giordanino F, 2013, DALTON T, V42, P12741, DOI 10.1039/c3dt50732g; Groothaert MH, 2005, J AM CHEM SOC, V127, P1394, DOI 10.1021/ja047158u; Grundner S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8546; Guo XG, 2014, SCIENCE, V344, P616, DOI 10.1126/science.1253150; Hammond C, 2012, CHEMSUSCHEM, V5, P1668, DOI 10.1002/cssc.201200299; Hashiguchi BG, 2014, SCIENCE, V343, P1232, DOI 10.1126/science.1249357; Li GN, 2016, J CATAL, V338, P305, DOI 10.1016/j.jcat.2016.03.014; Malakoff D, 2014, SCIENCE, V344, P1464, DOI 10.1126/science.344.6191.1464; Mitsudome T, 2008, ANGEW CHEM INT EDIT, V47, P7938, DOI 10.1002/anie.200802761; Morejudo S. H., 2014, SCIENCE, V344, P563; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Olivos-Suarez AI, 2016, ACS CATAL, V6, P2965, DOI 10.1021/acscatal.6b00428; Palagin D, 2017, NANOSCALE, V9, P1144, DOI 10.1039/c6nr07723d; Palkovits R, 2009, ANGEW CHEM INT EDIT, V48, P6909, DOI 10.1002/anie.200902009; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Rosenzweig AC, 2008, BIOCHEM SOC T, V36, P1134, DOI 10.1042/BST0361134; Schlogl R, 2015, ANGEW CHEM INT EDIT, V54, P3465, DOI 10.1002/anie.201410738; Schwarz H, 2011, ANGEW CHEM INT EDIT, V50, P10096, DOI 10.1002/anie.201006424; SHILOV AE, 1978, PURE APPL CHEM, V50, P725, DOI 10.1351/pac197850080725; Smeets PJ, 2008, J CATAL, V256, P183, DOI 10.1016/j.jcat.2008.03.008; Snyder BER, 2016, NATURE, V536, P317, DOI 10.1038/nature19059; Tomkins P, 2017, ACCOUNTS CHEM RES, V50, P418, DOI 10.1021/acs.accounts.6b00534; Tomkins P, 2016, ANGEW CHEM INT EDIT, V55, P5467, DOI 10.1002/anie.201511065; Trout BL, 1996, J PHYS CHEM-US, V100, P4173, DOI 10.1021/jp9524744; Van Bokhoven J.A., 2016, XRAY ABSORPTION XRAY; Vanelderen P, 2015, J AM CHEM SOC, V137, P6383, DOI 10.1021/jacs.5b02817; Woertink JS, 2009, P NATL ACAD SCI USA, V106, P18908, DOI 10.1073/pnas.0910461106	36	442	450	61	1147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					523	+		10.1126/science.aam9035	http://dx.doi.org/10.1126/science.aam9035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473586				2022-12-28	WOS:000400545700034
J	Yin, YM; Morgunova, E; Jolma, A; Kaasinen, E; Sahu, B; Khund-Sayeed, S; Das, PK; Kivioja, T; Dave, K; Zhong, F; Nitta, KR; Taipale, M; Popov, A; Ginno, PA; Domcke, S; Yan, J; Schubeler, D; Vinson, C; Taipale, J				Yin, Yimeng; Morgunova, Ekaterina; Jolma, Arttu; Kaasinen, Eevi; Sahu, Biswajyoti; Khund-Sayeed, Syed; Das, Pratyush K.; Kivioja, Teemu; Dave, Kashyap; Zhong, Fan; Nitta, Kazuhiro R.; Taipale, Minna; Popov, Alexander; Ginno, Paul A.; Domcke, Silvia; Yan, Jian; Schubeler, Dirk; Vinson, Charles; Taipale, Jussi			Impact of cytosine methylation on DNA binding specificities of human transcription factors	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; CPG METHYLATION; GENE-EXPRESSION; SEQUENCING DATA; READ ALIGNMENT; RECOGNITION; CHROMATIN; PROTEINS; PROMOTER; DOMAIN	The majority of CpG dinucleotides in the human genome are methylated at cytosine bases. However, active gene regulatory elements are generally hypomethylated relative to their flanking regions, and the binding of some transcription factors (TFs) is diminished by methylation of their target sequences. By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment), we found that there are also many TFs that prefer CpG-methylated sequences. Most of these are in the extended homeodomain family. Structural analysis showed that homeodomain specificity for methylcytosine depends on direct hydrophobic interactions with the methylcytosine 5-methyl group. This study provides a systematic examination of the effect of an epigenetic DNA modification on human TF binding specificity and reveals that many developmentally important proteins display preference for mCpG-containing sequences.	[Yin, Yimeng; Morgunova, Ekaterina; Jolma, Arttu; Kaasinen, Eevi; Dave, Kashyap; Zhong, Fan; Nitta, Kazuhiro R.; Taipale, Minna; Yan, Jian; Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Div Funct Genom & Syst Biol, SE-14183 Stockholm, Sweden; [Sahu, Biswajyoti; Das, Pratyush K.; Kivioja, Teemu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, POB 63, FI-00014 Helsinki, Finland; [Khund-Sayeed, Syed; Vinson, Charles] NCI, Lab Metab, NIH, Room 3128,Bldg 37, Bethesda, MD 20892 USA; [Popov, Alexander] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Ginno, Paul A.; Domcke, Silvia; Schubeler, Dirk] Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Domcke, Silvia; Schubeler, Dirk] Univ Basel, Fac Sci, Peterspl 1, CH-4003 Basel, Switzerland	Karolinska Institutet; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); European Synchrotron Radiation Facility (ESRF); Friedrich Miescher Institute for Biomedical Research; University of Basel	Taipale, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Funct Genom & Syst Biol, SE-14183 Stockholm, Sweden.; Taipale, J (corresponding author), Univ Helsinki, Genome Scale Biol Program, POB 63, FI-00014 Helsinki, Finland.	jussi.taipale@ki.se	Popov, Alexander/A-8827-2008; Jolma, Arttu/AAK-9649-2021; Yan, Jian/B-2631-2018; Khund Sayeed, Syed/AAB-3149-2022; Morgunova, Ekaterina/G-2479-2018; Sahu, Biswajyoti/U-6724-2017; Dave, Kashyap/D-3290-2014	Yan, Jian/0000-0002-1267-2870; Khund Sayeed, Syed/0000-0002-0404-4233; Morgunova, Ekaterina/0000-0002-7754-9021; Sahu, Biswajyoti/0000-0001-6576-5440; Kaasinen, Eevi/0000-0002-1333-8049; Nitta, Kazuhiro/0000-0003-3151-0962; Das, Pratyush Kumar/0000-0003-2822-9619; Dave, Kashyap/0000-0003-0332-8362; Domcke, Silvia/0000-0002-4102-7774; Jolma, Arttu/0000-0002-2543-7490; Popov, Alexander/0000-0002-3058-8912	Academy of Finland Center of Excellence in Cancer Genetics; European Research Area SynBio project MirrorBio; Center for Innovative Medicine at Karolinska Institutet; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Vetenskapsradet; NATIONAL CANCER INSTITUTE [ZIABC005271] Funding Source: NIH RePORTER	Academy of Finland Center of Excellence in Cancer Genetics(Academy of Finland); European Research Area SynBio project MirrorBio; Center for Innovative Medicine at Karolinska Institutet; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Vetenskapsradet(Swedish Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Linnarsson, N. Zielke, B. Schmierer, F. Zhu, and J. Zhang for critical review of the manuscript; S. Augsten and the Karolinska Institutet Protein Science Facility for protein production and the opportunity to run ITC experiments; and L. Hu, A. Zetterlund, and M. Hoh for technical assistance. Illumina sequencing reads were deposited in the European Nucleotide Archive under accession number PRJEB9797. The experimental data and atomic coordinates have been submitted to the Protein Data Bank with accession codes 5HOD (LHX4), 5EF6 (HOXB13_methDNA), 5EGO (HOXB13: MEIS1_methDNA), 5LUX (CDX1_methDNA), and 5LTX (CDX2_methDNA). This work was supported by the Academy of Finland Center of Excellence in Cancer Genetics, the European Research Area SynBio project MirrorBio, the Center for Innovative Medicine at Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Goran Gustafsson Foundation, and Vetenskapsradet. Y.Y., A.J., K.R.N., and J.T. designed the experiments. Y.Y. performed the HT-SELEX, methyl-SELEX, and bisulfite-SELEX experiments. Y.Y. and B.S. performed the ChIP-seq experiment, K.D. performed the ChIP-exo and ATAC-seq experiments, and B.S. performed the whole-genome bisulfite sequencing experiments. S.K.-S. performed the protein-binding microarray experiment. P.K.D. purified proteins for crystallography, E.M. and A.P. performed the x-ray crystallography experiments, and E.M. solved the protein structures. P.A.G. and S.D. generated Tet-TKO ES cells. Y.Y., E.K., K.R.N., A.J., F.Z., T.K., and J.T. contributed to computational analysis. Y.Y., E.K., and K.R.N. prepared the illustrations. Y.Y. and J.T. wrote the manuscript. All authors contributed to data analysis and reviewed the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bardet AF, 2012, NAT PROTOC, V7, P45, DOI 10.1038/nprot.2011.420; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogani D, 2013, MOL CELL BIOL, V33, P3936, DOI 10.1128/MCB.00498-13; Bourenkov GP, 2006, ACTA CRYSTALLOGR D, V62, P58, DOI 10.1107/S0907444905033998; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Chatterjee R, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-35; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Dragan AI, 2006, BIOCHEMISTRY-US, V45, P141, DOI 10.1021/bi051705m; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; GASTON K, 1995, NUCLEIC ACIDS RES, V23, P901, DOI 10.1093/nar/23.6.901; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Hashimoto H, 2014, GENE DEV, V28, P2304, DOI 10.1101/gad.250746.114; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Huff JT, 2014, CELL, V156, P1286, DOI 10.1016/j.cell.2014.01.029; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Khrapunov S, 2014, BIOCHEMISTRY-US, V53, P3379, DOI 10.1021/bi500424z; Khund-Sayeed S, 2016, INTEGR BIOL-UK, V8, P936, DOI 10.1039/c6ib00079g; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Korhonen J, 2009, BIOINFORMATICS, V25, P3181, DOI 10.1093/bioinformatics/btp554; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YW, 2014, NUCLEIC ACIDS RES, V42, P4859, DOI 10.1093/nar/gku134; Looney TJ, 2014, GENOME RES, V24, P267, DOI 10.1101/gr.143891.112; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon AP, 2000, GENE DEV, V14, P2261, DOI 10.1101/gad.840800; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nitta KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04837; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; OLIPHANT AR, 1988, NUCLEIC ACIDS RES, V16, P7673, DOI 10.1093/nar/16.15.7673; Orenstein Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku117; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stormo GD, 2015, BRIEF FUNCT GENOMICS, V14, P30, DOI 10.1093/bfgp/elu043; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Wang H, 2013, AASRI PROC, V5, P228, DOI 10.1016/j.aasri.2013.10.083; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069	94	513	521	17	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337							eaaj2239	10.1126/science.aaj2239	http://dx.doi.org/10.1126/science.aaj2239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473536	Green Accepted			2022-12-28	WOS:000400545700029
J	Barnes, B				Barnes, Barbara			Financial Conflicts of Interest in Continuing Medical Education Implications and Accountability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT-ADVOCACY ORGANIZATIONS		[Barnes, Barbara] Univ Pittsburgh, Continuing Educ & Ind Relationships, 600 Grant St,58th Floor, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barnes, B (corresponding author), Univ Pittsburgh, Continuing Educ & Ind Relationships, 600 Grant St,58th Floor, Pittsburgh, PA 15219 USA.	barnesbe@upmc.edu						Barnes BE, 2007, J CONTIN EDUC HEALTH, V27, P234, DOI 10.1002/chp.143; Cervero RM, IS THERE RELATIONSHI; Lo B, 2013, JAMA-J AM MED ASSOC, V310, P1019, DOI 10.1001/jama.2013.221227; McCoy MS, 2017, NEW ENGL J MED, V376, P880, DOI 10.1056/NEJMsr1610625; Nissen SE, 2015, JAMA-J AM MED ASSOC, V313, P1813, DOI 10.1001/jama.2015.4138; Rose SL, 2017, JAMA INTERN MED, V177, P344, DOI 10.1001/jamainternmed.2016.8443	6	11	12	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1741	1742		10.1001/jama.2017.2981	http://dx.doi.org/10.1001/jama.2017.2981			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464161				2022-12-28	WOS:000400440700020
J	Lo, B; Grady, D				Lo, Bernard; Grady, Deborah			Payments to Physicians Does the Amount of Money Make a Difference?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lo, Bernard] Greenwall Fdn, One Penn Plaza,Ste 4726, New York, NY 10119 USA; [Grady, Deborah] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lo, B (corresponding author), Greenwall Fdn, One Penn Plaza,Ste 4726, New York, NY 10119 USA.	bernardlo@greenwall.org	Abdullah, Bawadi/N-1421-2017	Abdullah, Bawadi/0000-0002-5908-5876				Accreditation Council for Continuing Medical Education, STAND COMM SUPP STAN; Centres for Medicare & Medicaid Services, OP PAYM DAT; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Lo B, 2009, CONFLICT INTEREST ME; Lo B, 2013, JAMA-J AM MED ASSOC, V310, P1019, DOI 10.1001/jama.2013.221227; ProPublica, DOLL DOCS; Sah S, 2013, J LAW MED ETHICS, V41, P665, DOI 10.1111/jlme.12076	7	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1719	1720		10.1001/jama.2017.1872	http://dx.doi.org/10.1001/jama.2017.1872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464150				2022-12-28	WOS:000400440700009
J	McKinney, RE; Pierce, HH				McKinney, Ross E., Jr.; Pierce, Heather H.			Strategies for Addressing a Broader Definition of Conflicts of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS		[McKinney, Ross E., Jr.; Pierce, Heather H.] Assoc Amer Med Coll, Washington, DC 20001 USA; [McKinney, Ross E., Jr.] Duke Univ, Sch Med, Durham, NC USA	Association of American Medical Colleges; Duke University	McKinney, RE (corresponding author), Assoc Amer Med Coll, Washington, DC 20001 USA.	rmckinney@aamc.org		Pierce, Heather/0000-0002-2042-7664	American Medical Colleges	American Medical Colleges	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McKinney reports receipt of personal fees from Gilead Sciences, the National Football League Players Association, and Janssen outside the submitted work. The Association of American Medical Colleges (which employs Ms Pierce and Dr McKinney) is sponsoring the development and use of Convey, a subscription, fee-based vehicle for disclosing conflict of interest. Neither author reports having a personal financial interest in Convey, although it was the eventual result of an Institute of Medicine-convened committee cochaired by Dr McKinney.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Centers for Medicare & Medicaid Services, FACTS OP PAYM; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Ioannidis JPA, 2017, JAMA-J AM MED ASSOC, V317, P1019, DOI 10.1001/jama.2017.0549; Ornstein C, 2016, PROPUBLICA; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779	7	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1727	1728		10.1001/jama.2017.3857	http://dx.doi.org/10.1001/jama.2017.3857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464167				2022-12-28	WOS:000400440700013
J	Johnson, TE; Brown, M; Gardiner, NJ; Kirkland, CL; Smithies, RH				Johnson, Tim E.; Brown, Michael; Gardiner, Nicholas J.; Kirkland, Christopher L.; Smithies, R. Hugh			Earth's first stable continents did not form by subduction (vol 543, pg 239, 2017)	NATURE			English	Correction							CRUST											Condie K. C., 1981, ARCHAEAN GREENSTONE, V434; Green ECR, 2016, J METAMORPH GEOL, V34, P845, DOI 10.1111/jmg.12211; Johnson TE, 2017, NATURE, V543, P239, DOI 10.1038/nature21383; Palin RM, 2016, PRECAMBRIAN RES, V287, P73, DOI 10.1016/j.precamres.2016.11.001; Smithies RH, 2009, EARTH PLANET SC LETT, V281, P298, DOI 10.1016/j.epsl.2009.03.003	5	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2017	543	7644					510	510		10.1038/nature22385	http://dx.doi.org/10.1038/nature22385			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY8HB	28489824	Bronze			2022-12-28	WOS:000427103700002
J	Liu, Y; Liu, JY; Du, SY; Shan, C; Nie, KX; Zhang, R; Li, XF; Zhang, R; Wang, T; Qin, CF; Wang, P; Shi, PY; Cheng, G				Liu, Yang; Liu, Jianying; Du, Senyan; Shan, Chao; Nie, Kaixiao; Zhang, Rudian; Li, Xiao-Feng; Zhang, Renli; Wang, Tao; Qin, Cheng-Feng; Wang, Penghua; Shi, Pei-Yong; Cheng, Gong			Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes	NATURE			English	Article							FLAVIVIRUS NS1 PROTEIN; SERA	Zika virus (ZIKV) remained obscure until the recent explosive outbreaks in French Polynesia (2013-2014) and South America (2015-2016)(1-3). Phylogenetic studies have shown that ZIKV has evolved into African and Asian lineages. The Asian lineage of ZIKV was responsible for the recent epidemics in the Americas(1,3). However, the underlying mechanisms through which ZIKV rapidly and explosively spread from Asia to the Americas are unclear. Non-structural protein 1 (NS1) facilitates flavivirus acquisition by mosquitoes from an infected mammalian host and subsequently enhances viral prevalence in mosquitoes(4). Here we show that NS1 antigenaemia determines ZIKV infectivity in its mosquito vector Aedes aegypti, which acquires ZIKV via a blood meal. Clinical isolates from the most recent outbreak in the Americas were much more infectious in mosquitoes than the FSS13025 strain, which was isolated in Cambodia in 2010. Further analyses showed that these epidemic strains have higher NS1 antigenaemia than the FSS13025 strain because of an alanine-to-valine amino acid substitution at residue 188 in NS1. ZIKV infectivity was enhanced by this amino acid substitution in the ZIKV FSS13025 strain in mosquitoes that acquired ZIKV from a viraemic C57BL/6 mouse deficient in type I and II interferon (IFN) receptors (AG6 mouse). Our results reveal that ZIKV evolved to acquire a spontaneous mutation in its NS1 protein, resulting in increased NS1 antigenaemia. Enhancement of NS1 antigenaemia in infected hosts promotes ZIKV infectivity and prevalence in mosquitoes, which could have facilitated transmission during recent ZIKV epidemics.	[Liu, Yang; Liu, Jianying; Du, Senyan; Nie, Kaixiao; Zhang, Rudian; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Yang; Zhang, Rudian] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Yang; Liu, Jianying; Zhang, Renli; Wang, Tao; Cheng, Gong] Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China; [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Wang, Tao] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Guangdong, Peoples R China; [Wang, Penghua] New York Med Coll, Sch Med, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	Tsinghua University; Tsinghua University; Shenzhen Center for Disease Control & Prevention (SZCDC); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Beijing Institute of Microbiology & Epidemiology; Southern University of Science & Technology; New York Medical College	Cheng, G (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Cheng, G (corresponding author), Shenzhen Ctr Dis Control & Prevent, SZCDC SUSTech Joint Key Lab Trop Dis, Shenzhen 518055, Guangdong, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.	peshi@utmb.edu; gongcheng@mail.tsinghua.edu.cn	Qin, Cheng-Feng/I-6839-2019; li, xiaofeng/GXF-9442-2022; Zhang, Rudian/D-2513-2017; li, xiao/GSN-6181-2022; Shan, Chao/AAN-8190-2021	Qin, Cheng-Feng/0000-0002-0632-2807; Zhang, Rudian/0000-0003-2214-4892; Shan, Chao/0000-0002-3953-3782	National Key Research and Development Plan of China [2016YFD0500400, 2016ZX10004001-008, 2017ZX09101-005, 2016YFC1201000, 2016YFD0500300]; National Natural Science Foundation of China [81422028, 81571975, 81522025, 31300600]; National Key Basic Research Program of China [2013CB911500, SZSTI-JCYJ2016033111585 3521]; National Institutes of Health of the United States [R01AI087856, AI103807]; Shenzhen San-Ming Project; Academy of Medical Sciences; Newton Fund; University of Texas Medical Branch (UTMB); University of Texas STARs Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103807, R01AI087856] Funding Source: NIH RePORTER; Academy of Medical Sciences (AMS) [AMS-NAF1-Cheng] Funding Source: researchfish	National Key Research and Development Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shenzhen San-Ming Project; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Newton Fund; University of Texas Medical Branch (UTMB); University of Texas STARs Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This work was funded by grants from the National Key Research and Development Plan of China (2016YFD0500400, 2016ZX10004001-008, 2017ZX09101-005, 2016YFC1201000, 2016YFD0500300), the National Natural Science Foundation of China (81422028, 81571975, 81522025, 31300600), the National Key Basic Research Program of China (2013CB911500, SZSTI-JCYJ2016033111585 3521), the National Institutes of Health of the United States (R01AI087856, AI103807), and Shenzhen San-Ming Project for prevention and research on vector-borne diseases. G.C. is a Newton Advanced Fellow awarded by the Academy of Medical Sciences and the Newton Fund. G.C. is also a Janssen Investigator at Tsinghua University. P.-Y.S. was supported by a University of Texas Medical Branch (UTMB) startup award and a University of Texas STARs Award. We thank the core facilities of the Center for Life Sciences and Center of Biomedical Analysis (Tsinghua University) for technical assistance.	Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268; Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009; Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7; Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]; Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931; Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Oehler E, 2014, EUROSURVEILLANCE, V19, P4; Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004; Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213; Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000; Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	30	237	251	12	126	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					482	+		10.1038/nature22365	http://dx.doi.org/10.1038/nature22365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514450	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000401906500052
J	Richter, MF; Drown, BS; Riley, AP; Garcia, A; Shirai, T; Svec, RL; Hergenrother, PJ				Richter, Michelle F.; Drown, Bryon S.; Riley, Andrew P.; Garcia, Alfredo; Shirai, Tomohiro; Svec, Riley L.; Hergenrother, Paul J.			Predictive compound accumulation rules yield a broad - spectrum antibiotic	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATION; DRUG-LIKE MOLECULES; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; RING-DISTORTION; OUTER-MEMBRANE; OMPF PORIN; POLY(ADP-RIBOSE) GLYCOHYDROLASE; DIVERSE COMPOUNDS; FREE-ENERGY	Most small molecules are unable to rapidly traverse the outer membrane of Gram-negative bacteria and accumulate inside these cells, making the discovery of much-needed drugs against these pathogens challenging. Current understanding of the physicochemical properties that dictate small-molecule accumulation in Gram-negative bacteria is largely based on retrospective analyses of antibacterial agents, which suggest that polarity and molecular weight are key factors. Here we assess the ability of over 180 diverse compounds to accumulate in Escherichia coli. Computational analysis of the results reveals major differences from the retrospective studies, namely that the small molecules that are most likely to accumulate contain an amine, are amphiphilic and rigid, and have low globularity. These guidelines were then applied to convert deoxynybomycin, a natural product that is active only against Gram-positive organisms, into an antibiotic with activity against a diverse panel of multi-drug-resistant Gram-negative pathogens. We anticipate that these findings will aid in the discovery and development of antibiotics against Gram-negative bacteria.	[Richter, Michelle F.; Drown, Bryon S.; Riley, Andrew P.; Garcia, Alfredo; Shirai, Tomohiro; Svec, Riley L.; Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Richter, Michelle F.; Drown, Bryon S.; Riley, Andrew P.; Garcia, Alfredo; Shirai, Tomohiro; Svec, Riley L.; Hergenrother, Paul J.] Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hergenrother, PJ (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Hergenrother, PJ (corresponding author), Inst Genom Biol, Urbana, IL 61801 USA.	hergenro@illinois.edu		Richter, Michelle/0000-0002-6113-6820; SHIRAI, TOMOHIRO/0000-0001-6278-4021; Drown, Bryon/0000-0002-5631-512X; Svec, Riley/0000-0003-1277-4575	UIUC through the Office of Technology Management Proof-of-Concept award; NIH [NRSA 1-T32-GM070421]; Kao Corporation; NSF [TG-CHE160050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI129363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER	UIUC through the Office of Technology Management Proof-of-Concept award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kao Corporation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Li (Metabolomics Center, Roy J. Carver Biotechnology Center, UIUC) for LC-MS/MS analysis, L. Zechiedrich (Baylor College of Medicine) for the E. coli clinical isolates, C. Vanderpool (UIUC) for E. coli MG1655, and W. van der Donk (UIUC) for E. cloacae. We also thank K. Hull, S. Denmark, K. Morrison, R. Hicklin, H. Roth, B. Nakamura, A. Deets and A. Keyes for providing valuable compounds for the test set, and we thank M. Lambrecht for NMR expertise. This work was funded by the UIUC, including funds obtained through the Office of Technology Management Proof-of-Concept award. M.F.R. is a NSF predoctoral fellow. M.F.R., A.G., and R.L.S. are members of the NIH Chemistry-Biology Interface Training Grant (NRSA 1-T32-GM070421). A.P.R. is an NIH postdoctoral fellow. T.S. was supported by the Kao Corporation. Computer time was provided by the Texas Advanced Computing Center through Grant TG-CHE160050 funded by the NSF.	Adler M, 2013, J ANTIMICROB CHEMOTH, V68, P51, DOI 10.1093/jac/dks368; BAZILE S, 1992, ANTIMICROB AGENTS CH, V36, P2622, DOI 10.1128/AAC.36.12.2622; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DG, 2014, J MED CHEM, V57, P10144, DOI 10.1021/jm501552x; BROWN DM, 1961, BRIT MED J, V2, P197, DOI 10.1136/bmj.2.5246.197; Cai HL, 2009, ANAL BIOCHEM, V385, P321, DOI 10.1016/j.ab.2008.10.041; Carpenter TS, 2016, J PHYS CHEM LETT, V7, P3446, DOI 10.1021/acs.jpclett.6b01399; CHAPMAN JS, 1988, ANTIMICROB AGENTS CH, V32, P438, DOI 10.1128/AAC.32.4.438; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Danelon C, 2003, BIOPHYS CHEM, V104, P591, DOI 10.1016/S0301-4622(03)00062-0; Davis TD, 2014, ACS CHEM BIOL, V9, P2535, DOI 10.1021/cb5003015; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Firth NC, 2012, J CHEM INF MODEL, V52, P2516, DOI 10.1021/ci300293f; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fornace ME, 2015, J CHEM THEORY COMPUT, V11, P568, DOI 10.1021/ct5011032; Garcia A, 2016, ORG LETT, V18, P4852, DOI 10.1021/acs.orglett.6b02333; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hajjar E, 2010, BIOPHYS J, V98, P569, DOI 10.1016/j.bpj.2009.10.045; Hicklin RW, 2014, ANGEW CHEM INT EDIT, V53, P9880, DOI 10.1002/anie.201404765; Hiramatsu K, 2012, INT J ANTIMICROB AG, V39, P478, DOI 10.1016/j.ijantimicag.2012.02.007; Huigens RW, 2013, NAT CHEM, V5, P195, DOI [10.1038/nchem.1549, 10.1038/NCHEM.1549]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuenemann MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23815; Kuenemann MA, 2014, J CHEM INF MODEL, V54, P3067, DOI 10.1021/ci500487q; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; LUGTENBERG EJJ, 1976, BIOCHIM BIOPHYS ACTA, V441, P38, DOI 10.1016/0005-2760(76)90279-4; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mannhold R., 2006, MOL INTERACTION FIEL, V27; MASSEY EH, 1974, J MED CHEM, V17, P105, DOI 10.1021/jm00247a018; MORTIMER PGS, 1993, J ANTIMICROB CHEMOTH, V32, P195, DOI 10.1093/jac/32.2.195; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Parkinson EI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7947; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rafferty RJ, 2014, ANGEW CHEM INT EDIT, V53, P220, DOI 10.1002/anie.201308743; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Sauer WHB, 2003, J CHEM INF COMP SCI, V43, P987, DOI 10.1021/ci025599w; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Silver LL, 2016, BIOORGAN MED CHEM, V24, P6379, DOI 10.1016/j.bmc.2016.06.044; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; SLAMA JT, 1995, J MED CHEM, V38, P4332, DOI 10.1021/jm00021a023; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Varma S, 2006, BIOPHYS J, V90, P112, DOI 10.1529/biophysj.105.059329; WEISS RL, 1976, J BACTERIOL, V128, P668, DOI 10.1128/JB.128.2.668-670.1976; Williams KJ, 1998, J ANTIMICROB CHEMOTH, V42, P597, DOI 10.1093/jac/42.5.597; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; Zhou Y, 2015, ANAL CHEM, V87, P3579, DOI 10.1021/ac504880r; Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014	63	449	461	15	242	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					299	+		10.1038/nature22308	http://dx.doi.org/10.1038/nature22308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489819	Green Accepted			2022-12-28	WOS:000401466500053
J	Erk, D				Erk, David			Management of Acute and Recurrent Gout	ANNALS OF INTERNAL MEDICINE			English	Letter									[Erk, David] Sage Primary Care, Casper, WY 82601 USA		Erk, D (corresponding author), Sage Primary Care, Casper, WY 82601 USA.							Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					759	760		10.7326/L17-0145	http://dx.doi.org/10.7326/L17-0145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505648				2022-12-28	WOS:000401240200029
J	Sharples, JM; Oxman, AD; Mahtani, KR; Chalmers, I; Oliver, S; Collins, K; Austvoll-Dahlgren, A; Hoffmann, T				Sharples, Jonathan M.; Oxman, Andrew D.; Mahtani, Kamal R.; Chalmers, Iain; Oliver, Sandy; Collins, Kevan; Austvoll-Dahlgren, Astrid; Hoffmann, Tammy			ESSAY Critical thinking in healthcare and education	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPETENCES		[Sharples, Jonathan M.; Oliver, Sandy] UCL Dept Social Sci, EPPI Ctr, London, England; [Oxman, Andrew D.; Austvoll-Dahlgren, Astrid] Norwegian Inst Publ Hlth, Global Hlth Unit, Oslo, Norway; [Mahtani, Kamal R.] Univ Oxford, Ctr Evidence Based Med, Oxford, England; [Chalmers, Iain] James Lind Initiat, Oxford, England; [Collins, Kevan] Educ Endowment Fdn, London, England; [Hoffmann, Tammy] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Australia	University of London; University College London; UCL Institute of Education; Norwegian Institute of Public Health (NIPH); University of Oxford; Bond University	Sharples, JM (corresponding author), UCL Dept Social Sci, EPPI Ctr, London, England.	Jonathan.Sharples@eefoundation.org.uk	Hoffmann, Tammy/E-8029-2010; Oxman, Andrew/Y-3004-2019	Hoffmann, Tammy/0000-0001-5210-8548; Oxman, Andrew/0000-0002-5608-5061; Oliver, Sandy/0000-0001-9571-269X	Economic and Social Research Council [ES/P010059/1] Funding Source: researchfish; National Institute for Health Research [CL-2011-13-006] Funding Source: researchfish; ESRC [ES/P010059/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Abrami PC, 2015, REV EDUC RES, V85, P275, DOI 10.3102/0034654314551063; Austvoll-Dahlgren A, BMJ OPEN IN PRESS; Austvoll-Dahlgren A, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0389-z; Austvoll-Dahlgren Astrid, 2015, J Evid Based Med, V8, P112, DOI 10.1111/jebm.12160; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Castle JC, PLOS ONE IN PRESS; Centre for Evidence Based Medicine, EINST TAK EBM SCH; Clark DB, 2016, REV EDUC RES, V86, P79, DOI 10.3102/0034654315582065; Dewey J., 1910, WE THINK; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Edwards A., 2009, SHARED DECISION MAKI, V2; Facione P.A., 1990, CRITICAL THINKING ST; General Medical Council, 2013, GOOD MED PRACTICE; General Medical Council, 1993, TOMORROWS DOCTORS; Glenton Claire, 2005, BMC Med Inform Decis Mak, V5, P7, DOI 10.1186/1472-6947-5-7; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hanley P, 2015, THINKING DOING TALKI; Harden RM, 1999, MED TEACH, V21, P141, DOI 10.1080/01421599979752; Higgins S., 2015, SUTTON TRUST ED ENDO; Huang GC, 2014, TEACH LEARN MED, V26, P95, DOI 10.1080/10401334.2013.857335; Informed Health Choices Group, INF HLTH CHOIC; Krupat E, 2011, MED EDUC, V45, P625, DOI 10.1111/j.1365-2923.2010.03910.x; Lundh A, 2012, COCHRANE DB SYST REV, V357; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Nordheim L, 2016, HEALTH EDUC, V116, P449, DOI 10.1108/HE-04-2015-0016; Oxman AD, 1993, JAMA-J AM MED ASSOC, V357, P2093, DOI [10.1001/jama.1993.03510170083036, DOI 10.1001/JAMA.1993.03510170083036]; Pintrich PR, 2003, J EDUC PSYCHOL, V95, P667, DOI 10.1037/0022-0663.95.4.667; Ross D, 2016, FAM MED, V48, P121; Ross D, 2013, ACAD MED, V88, P724, DOI 10.1097/ACM.0b013e31828b0823; Rynearson E H, 1940, Cal West Med, V52, P257; SACKETT DL, 1981, CAN MED ASSOC J, V124, P555; Sandoval WA, 2014, EDUC PSYCHOL-US, V49, P139, DOI 10.1080/00461520.2014.917589; Thistlethwaite J, 2010, MED TEACH, V32, P880, DOI 10.3109/0142159X.2010.519068; Voogt J, 2012, J CURRICULUM STUD, V44, P299, DOI 10.1080/00220272.2012.668938; Vosniadou, 2013, INT HDB RES CONCEPTU, DOI 10.4324/9780203154472; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	36	22	22	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j2234	10.1136/bmj.j2234	http://dx.doi.org/10.1136/bmj.j2234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV6RJ	28512135	Green Published, Green Submitted			2022-12-28	WOS:000401898900006
J	Bastin, JF; Berrahmouni, N; Grainger, A; Maniatis, D; Mollicone, D; Moore, R; Patriarca, C; Picard, N; Sparrow, B; Abraham, EM; Aloui, K; Atesoglu, A; Attorre, F; Bassullu, C; Bey, A; Garzuglia, M; Garcia-Montero, LG; Groot, N; Guerin, G; Laestadius, L; Lowe, AJ; Mamane, B; Marchi, G; Patterson, P; Rezende, M; Ricci, S; Salcedo, I; Diaz, ASP; Stolle, F; Surappaeva, V; Castro, R				Bastin, Jean-Francois; Berrahmouni, Nora; Grainger, Alan; Maniatis, Danae; Mollicone, Danilo; Moore, Rebecca; Patriarca, Chiara; Picard, Nicolas; Sparrow, Ben; Abraham, Elena Maria; Aloui, Kamel; Atesoglu, Ayhan; Attorre, Fabio; Bassullu, Caglar; Bey, Adia; Garzuglia, Monica; Garcia-Montero, Luis G.; Groot, Nikee; Guerin, Greg; Laestadius, Lars; Lowe, Andrew J.; Mamane, Bako; Marchi, Giulio; Patterson, Paul; Rezende, Marcelo; Ricci, Stefano; Salcedo, Ignacio; Diaz, Alfonso Sanchez-Paus; Stolle, Fred; Surappaeva, Venera; Castro, Rene			The extent of forest in dryland biomes	SCIENCE			English	Article							BIODIVERSITY; WOODLANDS; IMAGERY	Dryland biomes cover two-fifths of Earth's land surface, but their forest area is poorly known. Here, we report an estimate of global forest extent in dryland biomes, based on analyzing more than 210,000 0.5-hectare sample plots through a photo-interpretation approach using large databases of satellite imagery at (i) very high spatial resolution and (ii) very high temporal resolution, which are available through the Google Earth platform. We show that in 2015, 1327 million hectares of drylands had more than 10% tree-cover, and 1079 million hectares comprised forest. Our estimate is 40 to 47% higher than previous estimates, corresponding to 467 million hectares of forest that have never been reported before. This increases current estimates of global forest cover by at least 9%.	[Bastin, Jean-Francois; Berrahmouni, Nora; Mollicone, Danilo; Patriarca, Chiara; Picard, Nicolas; Bey, Adia; Garzuglia, Monica; Marchi, Giulio; Rezende, Marcelo; Ricci, Stefano; Castro, Rene] Food & Agr Org United Nat, Vialle Terme Caracalla, I-00153 Rome, Italy; [Bastin, Jean-Francois] Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, CP264-2, B-1050 Brussels, Belgium; [Grainger, Alan; Groot, Nikee] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Maniatis, Danae] Sch Geog & Environm, Environm Change Inst, South Parks Rd, Oxford OX1 3QY, England; [Maniatis, Danae] United Nat Dev Programme, Bur Policy & Programme Support, New York, NY 10017 USA; [Moore, Rebecca; Guerin, Greg] Google, Mountain View, CA USA; [Sparrow, Ben] Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide, SA 5005, Australia; [Abraham, Elena Maria] Consejo Nacl Invest Cient & Tecn, Inst Argentino Invest Zonas Aridas, Mendoza, Argentina; [Aloui, Kamel] Minist Agr, Gen Directorate Forests Inventory Serv, Tunis, Tunisia; [Atesoglu, Ayhan] Bartin Univ, Dept Forest Engn, Fac Forestry, Bartin, Turkey; [Attorre, Fabio] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Bassullu, Caglar] Food & Agr Org United Nat, Subreg Off Cent Asia, Ankara, Turkey; [Garcia-Montero, Luis G.] Tech Univ Madrid UPM, Dept Forest & Environm Engn & Management, Escuela Tecn Super Ingn Montes, Ciudad Univ, Madrid 28040, Spain; [Laestadius, Lars] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden; [Lowe, Andrew J.] Univ Adelaide, Environm Inst, North Terrace, Adelaide, SA 5005, Australia; [Lowe, Andrew J.] Univ Adelaide, Sch Biol Sci, North Terrace, Adelaide, SA 5005, Australia; [Mamane, Bako] Ctr Reg AGRHYMET, BP 11011, Niamey, Niger; [Patterson, Paul] US Forest Serv, Interior West Forest Inventory & Anal, USDA, Ft Collins, CO USA; [Salcedo, Ignacio] Inst Nacl Semiarido, BR-10067 Bairro Serrotao, Brazil; [Stolle, Fred] World Resources Inst, 10 G St NE, Washington, DC 20002 USA; [Surappaeva, Venera] Dept Forest & Hunting Inventory Kyrgyztan, Bishkek, Kyrgyzstan	Food & Agriculture Organization of the United Nations (FAO); Universite Libre de Bruxelles; University of Leeds; University of Oxford; Google Incorporated; University of Adelaide; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Bartin University; Sapienza University Rome; FAO Turkey; Food & Agriculture Organization of the United Nations (FAO); Universidad Politecnica de Madrid; Swedish University of Agricultural Sciences; University of Adelaide; University of Adelaide; United States Department of Agriculture (USDA); United States Forest Service	Bastin, JF; Castro, R (corresponding author), Food & Agr Org United Nat, Vialle Terme Caracalla, I-00153 Rome, Italy.; Bastin, JF (corresponding author), Univ Libre Bruxelles, Landscape Ecol & Plant Prod Syst Unit, CP264-2, B-1050 Brussels, Belgium.	bastin.jf@gmail.com; castro@fao.org	ateşoğlu, ayhan/AAL-2898-2021; Guerin, Greg R./R-8955-2019; Sparrow, Ben/O-9308-2016; ATEŞOĞLU, AYHAN/W-1601-2017; Aloui, Kamel/AAJ-3912-2021; Attorre, Fabio/H-5351-2012; Picard, Nicolas/T-2447-2018; patriarca, carlo/AAC-7470-2022	Sparrow, Ben/0000-0003-2566-1895; ATEŞOĞLU, AYHAN/0000-0002-4030-7782; Attorre, Fabio/0000-0002-7744-2195; Picard, Nicolas/0000-0001-5548-9171; patriarca, carlo/0000-0001-5490-1830; Maniatis, Danae/0000-0002-1453-8595; Crowther, Thomas/0000-0001-5674-8913; Groot, Nikee/0000-0003-3594-4311; Abraham, Elena Maria/0000-0003-0808-6737; Lowe, Andrew/0000-0003-1139-2516; Guerin, Greg/0000-0002-2104-6695; Bastin, Jean-Francois/0000-0003-2602-7247	International Climate Initiative of the Federal Ministry for the Environment; Nature Conservation, Building and Nuclear Safety of Germany; Action Against Desertification, an initiative of Africa, Caribbean, and Pacific (ACP) group of states; European Union	International Climate Initiative of the Federal Ministry for the Environment; Nature Conservation, Building and Nuclear Safety of Germany; Action Against Desertification, an initiative of Africa, Caribbean, and Pacific (ACP) group of states; European Union(European Commission)	We thank the 239 operators who participated in the Global Drylands Assessment; all FAO staff who supported it; R. Golder for help in English editing; R. D'Annunzio and E. Lindquist for the use of RSS 2010 data; and F. Achard for guidance in finalizing this paper. We thank the Google Earth Engine team for their prompt response to our requests and J. Agostini for the final editing of the main figures. We thank the Terrestrial Ecosystem Research Network of Australia for supplying the field data set. The data used in the present study are available in a zipped file as Database S1 in the supplementary materials. This work was conducted under the Global Forest Survey project of FAO, supported by the International Climate Initiative of the Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety of Germany, and under Action Against Desertification, an initiative of Africa, Caribbean, and Pacific (ACP) group of states, implemented by FAO and funded by the European Union in support of Africa's Great Green Wall and the United Nations Convention to Combat Desertification action programmes and south-south cooperation in ACP countries. J.-F.B., D.Ma., and D.Mo. conceived and designed the paper. J.-F.B., D.Mo., A.G., and R.C. wrote the paper, and J.-F.B. and N.P. did the statistical analyses. C.P and S.R coordinated the data cleansing procedure. B.S., A.L., and G.G. coordinated the field data collection. N.B., A.G., D.Ma., D.Mo., C.P., B.S., E.M.A., K.A., A. A., F. A., C.B., A.B., M.G., L.G.G.-M., N.G., G.G., L.L., A.L., B.M., G.M., P.P., M.R., S.R., I.S., A.S.-P.D., F.S., and V.S. coordinated the data collection through Collect Earth. All authors assisted editing the manuscript. The authors declare no competing financial interests.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Belward AS, 2015, ISPRS J PHOTOGRAMM, V103, P115, DOI 10.1016/j.isprsjprs.2014.03.009; Bey A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100807; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; FAO, 2001, GLOB FOR RES ASS 200; Goodwin N, 2005, AUST J BOT, V53, P337, DOI 10.1071/BT04085; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/NCLIMATE2837, 10.1038/nclimate2837]; Intergovernmental Panel on Climate Change (IPCC), 2007, SYNTHESIS REPORT, V446; Janzen D.H., 1988, P130; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Johansen K., 2015, REMOTE SENS APPL SOC, V1, P36, DOI [10.1016/j.rsase.2015.06.002, DOI 10.1016/J.RSASE.2015.06.002]; Karlson M, 2014, SENSORS-BASEL, V14, P22643, DOI 10.3390/s141222643; Lindquist E.J., 2010, GLOBAL FOREST LAND U; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naesset E, 2016, REMOTE SENS ENVIRON, V175, P282, DOI 10.1016/j.rse.2016.01.006; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Popkin G, 2015, NATURE, V523, P20, DOI 10.1038/523020a; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; RINGROSE S, 1989, REMOTE SENS ENVIRON, V30, P1, DOI 10.1016/0034-4257(89)90043-6; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sorensen L., 2009, SPATIAL ANAL APPROAC; Van Bogaert E., 2012, GLOBAL LAND COVER MA	30	222	234	18	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					635	+		10.1126/science.aam6527	http://dx.doi.org/10.1126/science.aam6527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495750	Green Accepted			2022-12-28	WOS:000400975200054
J	Solomon, RA; Connolly, ES				Solomon, Robert A.; Connolly, E. Sander, Jr.			Arteriovenous Malformations of the Brain	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VOLUME-STAGED RADIOSURGERY; GAMMA-KNIFE RADIOSURGERY; STEREOTACTIC RADIOSURGERY; RANDOMIZED-TRIAL; FOLLOW-UP; EMBOLIZATION; MULTICENTER; HEMORRHAGE; OUTCOMES; SURGERY		Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; New York Presbyterian Hosp, Dept Neurol Surg, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital	Solomon, RA (corresponding author), 710 W 168th St, New York, NY 10032 USA.	ras5@columbia.edu						Ajiboye N, 2014, SCI WORLD J, V2014; Alexander MD, 2016, INTERV NEURORADIOL, V22, P445, DOI 10.1177/1591019916641316; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Bervini D, 2014, J NEUROSURG, V121, P878, DOI 10.3171/2014.7.JNS132691; Chen JCT, 2016, J CLIN NEUROSCI, V29, P155, DOI 10.1016/j.jocn.2015.12.006; Cockroft KM, 2012, STROKE, V43, P1979, DOI 10.1161/STROKEAHA.112.652032; Cohen-Inbar O, 2015, J NEUROSURG, V123, P945, DOI 10.3171/2014.10.JNS142264; Ding DL, 2017, J NEUROSURG, V126, P859, DOI 10.3171/2016.1.JNS152564; Friedlander RM, 2007, NEW ENGL J MED, V356, P2704, DOI 10.1056/NEJMcp067192; Fukuda K, 2016, J NEUROINTERV SURG; Gross BA, 2013, J NEUROSURG, V118, P437, DOI 10.3171/2012.10.JNS121280; Hanakita S, 2016, WORLD NEUROSURG, V87, P242, DOI 10.1016/j.wneu.2015.12.020; Kretzer RM, 2010, J NEUROSURG, V112, P1182, DOI 10.3171/2009.7.JNS09737; Lee CC, 2015, J NEUROSURG, V123, P126, DOI 10.3171/2014.12.JNS141437; Lindvall P, 2015, J CLIN NEUROSCI, V22, P955, DOI 10.1016/j.jocn.2014.12.015; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Mohr JP, 2014, LANCET, V383, P614, DOI 10.1016/S0140-6736(13)62302-8; Morgan MK, 2017, J NEUROSURG, V126, P338, DOI 10.3171/2016.3.JNS16634; Nagy G, 2016, NEUROSURGERY; Pierot L, 2013, EUR RADIOL, V23, P2838, DOI 10.1007/s00330-013-2870-6; Pollock BE, 2017, J NEUROSURG, V126, P852, DOI 10.3171/2015.11.JNS151300; Potts MB, 2015, J NEUROSURG, V122, P912, DOI 10.3171/2014.12.JNS14938; Saatci I, 2011, J NEUROSURG, V115, P78, DOI 10.3171/2011.2.JNS09830; Sahlein DH, 2014, STROKE, V45, P1964, DOI 10.1161/STROKEAHA.114.005170; Seymour ZA, 2016, J NEUROSURG, V124, P163, DOI 10.3171/2014.12.JNS141308; SPETZLER RF, 1986, J NEUROSURG, V65, P476, DOI 10.3171/jns.1986.65.4.0476; Spetzler RF, 2011, J NEUROSURG, V114, P842, DOI 10.3171/2010.8.JNS10663; Stapf C, 2001, Neurosurg Focus, V11, pe1; Stapf C, 2006, NEUROLOGY, V66, P1350, DOI 10.1212/01.wnl.0000210524.68507.87; Starke RM, 2017, J NEUROSURG, V126, P36, DOI 10.3171/2015.9.JNS151311; Starke RM, 2009, STROKE, V40, P2783, DOI 10.1161/STROKEAHA.108.539775; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Yamamoto M, 2012, J NEUROSURG, V117, P126, DOI 10.3171/2012.6.GKS12757; Young WL, 1996, NEUROSURGERY, V38, P1085, DOI 10.1097/00006123-199606000-00005	34	103	112	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1859	1866		10.1056/NEJMra1607407	http://dx.doi.org/10.1056/NEJMra1607407			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28489992				2022-12-28	WOS:000400891100011
J	Saunders, M				Saunders, Maggie			Arthur Courtenay Saunders Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SAUNDERS AC, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2182	10.1136/bmj.j2182	http://dx.doi.org/10.1136/bmj.j2182			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483967				2022-12-28	WOS:000401412700012
J	Ong, ACM				Ong, Albert C. M.			Making sense of polycystic kidney disease	LANCET			English	Editorial Material							CYST FORMATION; LIVER-DISEASE; PRIMARY CILIA; MUTATIONS		[Ong, Albert C. M.] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Ong, ACM (corresponding author), Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400	Otsuka	Otsuka(Otsuka Pharmaceutical)	I have received consultancy fees from Otsuka. The views expressed in this Comment represent the author's alone.	Belmonte JM, 2016, MOL BIOL CELL, V27, P3673, DOI 10.1091/mbc.E16-01-0059; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Kim S, 2016, NAT CELL BIOL, V18, P752, DOI 10.1038/ncb3363; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Ong ACM, 2015, KIDNEY INT, V88, P699, DOI 10.1038/ki.2015.207; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Porath B, 2016, AM J HUM GENET, V98, P1193, DOI 10.1016/j.ajhg.2016.05.004; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9	12	7	7	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1780	1782		10.1016/S0140-6736(17)30928-5	http://dx.doi.org/10.1016/S0140-6736(17)30928-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495155				2022-12-28	WOS:000400549300008
J	Khelifi, A; Saadaoui, F				Khelifi, Anis; Saadaoui, Faycel			Traumatic Spondylolisthesis of the Axis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khelifi, Anis; Saadaoui, Faycel] Natl Inst Orthoped MT Kassab, Ksar Said, Tunisia	Universite de Tunis-El-Manar; Institut Mohamed Kassab d'Orthopedie	Khelifi, A (corresponding author), Natl Inst Orthoped MT Kassab, Ksar Said, Tunisia.	khelifianis@yahoo.fr							0	0	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1782	1782		10.1056/NEJMicm1405867	http://dx.doi.org/10.1056/NEJMicm1405867			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6ZH	28467872				2022-12-28	WOS:000400442300011
J	Moore, SJ; Sowa, ST; Schuchardt, C; Deery, E; Lawrence, AD; Ramos, JV; Billig, S; Birkemeyer, C; Chivers, PT; Howard, MJ; Rigby, SEJ; Layer, G; Warren, MJ				Moore, Simon J.; Sowa, Sven T.; Schuchardt, Christopher; Deery, Evelyne; Lawrence, Andrew D.; Ramos, Jose Vazquez; Billig, Susan; Birkemeyer, Claudia; Chivers, Peter T.; Howard, Mark J.; Rigby, Stephen E. J.; Layer, Gunhild; Warren, Martin J.			Elucidation of the biosynthesis of the methane catalyst coenzyme F-430 (vol 543, pg 78, 2017)	NATURE			English	Correction														Chivers, Peter/0000-0002-8779-1452				Moore SJ, 2017, NATURE, V543, P78, DOI 10.1038/nature21427; Zheng KY, 2016, SCIENCE, V354, P339, DOI 10.1126/science.aag2947	2	3	3	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					116	116		10.1038/nature22317	http://dx.doi.org/10.1038/nature22317			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470207	Bronze			2022-12-28	WOS:000400480400042
J	Sommers, BD; Simon, K				Sommers, Benjamin D.; Simon, Kosali			Health Insurance and Emergency Department Use - A Complex Relationship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COVERAGE		[Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Simon, Kosali] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Simon, Kosali] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Indiana University System; Indiana University Bloomington; National Bureau of Economic Research	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Sommers, BD (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Antwi YA, 2015, ANN EMERG MED, V65, P664, DOI 10.1016/j.annemergmed.2015.01.010; Finkelstein AN, 2016, NEW ENGL J MED, V375, P1505, DOI 10.1056/NEJMp1609533; Ghosh A., 2015, 21580 NAT BUR EC RES, DOI [10.3386/w21580, DOI 10.3386/W21580]; Miller S, 2012, J PUBLIC ECON, V96, P893, DOI 10.1016/j.jpubeco.2012.07.004; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419	5	37	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1708	1711		10.1056/NEJMp1614378	http://dx.doi.org/10.1056/NEJMp1614378			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6ZH	28467870				2022-12-28	WOS:000400442300004
J	Nunn, A; Jahn, N; Hewes, J; Wong, C				Nunn, Adam; Jahn, Nina; Hewes, James; Wong, Christopher			CASE REVIEW Gastric perforation in a 16 year old girl	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunn, Adam; Hewes, James; Wong, Christopher] Southmead Hosp, Bristol, Avon, England; [Jahn, Nina] Munro Ctr, London, England	Southmead Hospital	Nunn, A (corresponding author), Southmead Hosp, Bristol, Avon, England.	adam.nunn@doctors.org.uk		Nunn, Adam/0000-0002-2993-9922				Aybar A, 2011, GASTROINTEST ENDOSC, V74, P435, DOI 10.1016/j.gie.2010.11.019; Benatta MA, 2016, GASTROENTEROL REP, V4, P251, DOI 10.1093/gastro/gov013; Bhatia M S, 1991, J Indian Med Assoc, V89, P137; Bouwer C, 1998, PSYCHOSOM MED, V60, P658, DOI 10.1097/00006842-199809000-00025; Ersoy YE, 2009, ACTA CHIR BELG, V109, P198; Grant JE, 2016, AM J PSYCHIAT, V173, P868, DOI 10.1176/appi.ajp.2016.15111432; Hamidi H, 2016, INT J SURG CASE REP, V28, P127, DOI 10.1016/j.ijscr.2016.09.039; Kanetaka Kengo, 2003, J Pediatr Surg, V38, pe7, DOI 10.1053/jpsu.2003.50067; Nirasawa Y, 1998, J PEDIATR SURG, V33, P663, DOI 10.1016/S0022-3468(98)90342-6; Ogawa K, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/7456242; Ripolles T, 2001, AM J ROENTGENOL, V177, P65, DOI 10.2214/ajr.177.1.1770065; Rothbart R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007662.pub2; Sinzig M, 1998, PEDIATR RADIOL, V28, P296, DOI 10.1007/s002470050356	13	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j1859	10.1136/bmj.j1859	http://dx.doi.org/10.1136/bmj.j1859			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468771				2022-12-28	WOS:000400889600003
J	Armstrong, K; Freiberg, AA				Armstrong, Katrina; Freiberg, Andrew A.			Challenges and Opportunities in Disclosing Financial Interests to Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRUST; PHYSICIANS		[Armstrong, Katrina; Freiberg, Andrew A.] Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA; [Armstrong, Katrina; Freiberg, Andrew A.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Armstrong, K (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA.	karmstrong6@mgh.harvard.edu			Zimmer Biomet	Zimmer Biomet	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Armstrong reported serving as a consultant to GlaxoSmithKline. Dr Freiberg reported receiving consulting fees and royalties from Zimmer Biomet; holding stock in ArthroSurface; and that he is owner of Orthopaedic Technology Group.	Association of American Medical Colleges, 2012, INT PAT REP TASK FOR; Bal BS, 2012, CLIN ORTHOP RELAT R, V470, P1346, DOI 10.1007/s11999-011-2232-0; Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Cillizza C., 2014, WASHINGTON POST; Grande D, 2012, J GEN INTERN MED, V27, P274, DOI 10.1007/s11606-011-1760-3; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Wolston M, 2011, HEALTH AFFAIR, V30, P2449, DOI [10.1377/HLTHAFF.2011.0094, 10.1377/hlthaff.2011.0094]	8	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1743	1744		10.1001/jama.2017.2656	http://dx.doi.org/10.1001/jama.2017.2656			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464159				2022-12-28	WOS:000400440700021
J	Lichter, AS				Lichter, Allen S.			Conflict of Interest and the Integrity of the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERSPECTIVE; INDUSTRY		[Lichter, Allen S.] 2410 Harbourside Dr,Apt 123, Longboat Key, FL 34228 USA		Lichter, AS (corresponding author), 2410 Harbourside Dr,Apt 123, Longboat Key, FL 34228 USA.	allen.lichter@gmail.com						[Anonymous], OP PAYM; Avorn J, 2017, JAMA-J AM MED ASSOC, V317, P361, DOI 10.1001/jama.2016.16036; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Kahneman D., 2011, THINKING FAST SLOW; Lo B, 2013, JAMA-J AM MED ASSOC, V310, P1019, DOI 10.1001/jama.2013.221227; Ornstein Charles, 2016, NOW THERES PROOF DOC; Podolsky SH, 2008, JAMA-J AM MED ASSOC, V300, P831, DOI 10.1001/jama.300.7.831; RELMAN AS, 1991, NEW ENGL J MED, V325, P854, DOI 10.1056/NEJM199109193251205; Rosenbaum L, 2015, NEW ENGL J MED, V372, P2064, DOI 10.1056/NEJMms1502498; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9	10	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1725	1726		10.1001/jama.2017.3191	http://dx.doi.org/10.1001/jama.2017.3191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464163				2022-12-28	WOS:000400440700012
J	Strowd, LC; Feldman, SR				Strowd, Lindsay C.; Feldman, Steven R.			Dupilumab for atopic dermatitis	LANCET			English	Editorial Material							QUALITY		[Strowd, Lindsay C.; Feldman, Steven R.] Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27104 USA	Wake Forest University	Feldman, SR (corresponding author), Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27104 USA.	sfeldman@wakehealth.edu	Feldman, Steven R./AAH-6971-2021	Feldman, Steven R./0000-0002-0090-6289				Blauvelt A, 2017, LANCET; Kiebert G, 2002, INT J DERMATOL, V41, P151, DOI 10.1046/j.1365-4362.2002.01436.x; Langenbruch A, 2014, J EUR ACAD DERMATOL, V28, P719, DOI 10.1111/jdv.12154; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Wetzels GEC, 2004, J HYPERTENS, V22, P1849, DOI 10.1097/00004872-200410000-00002	5	10	10	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2265	2266		10.1016/S0140-6736(17)31192-3	http://dx.doi.org/10.1016/S0140-6736(17)31192-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28478973				2022-12-28	WOS:000402872700005
J	Vesely, R; Richardson, P				Vesely, Richard; Richardson, Peter			The switch to infliximab biosimilars	LANCET			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE		[Vesely, Richard] European Med Agcy, Sci & Regulatory Management Dept, London E14 5EU, England; [Richardson, Peter] European Med Agcy, Specialised Sci Disciplines Dept, London E14 5EU, England		Vesely, R (corresponding author), European Med Agcy, Sci & Regulatory Management Dept, London E14 5EU, England.	richard.vesely@ema.europa.eu						Braun J, 2016, BIOLOGICALS, V44, P257, DOI 10.1016/j.biologicals.2016.03.006; Danese S, 2017, J CROHNS COLITIS, V11, P26, DOI 10.1093/ecco-jcc/jjw198; European Medicines Agency, 2017, EUR PUBL ASS REP SOL; European Medicines Agency, 2015, EUR PUBL ASS REP BEN; European Medicines Agency, 2016, COMM MED PROD HUM US; European Medicines Agency, 2006, OMN EPAR SUMM PUBL; European Medicines Agency, 2014, GUID SIM BIOL MED PR; European Medicines Agency, MARK AUTH SIM BIOL M; European Medicines Agency, BIOS MED AUTH VIA AG; European Medicines Agency, 2017, EUR PUBL ASS REP AMG; European Medicines Agency, 2013, EUR PUBL ASS REP REM; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; JORGENSEN K. K., 2017, LANCET; Kolar M, 2016, J CROHNS COLITIS, V10, pS45; Moore B, 2016, YOU KNOW BUNJI BOORI	15	0	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2266	2268		10.1016/S0140-6736(17)31258-8	http://dx.doi.org/10.1016/S0140-6736(17)31258-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EW9XM	28502608				2022-12-28	WOS:000402872700006
J	Bailey-Serres, J; Ma, W				Bailey-Serres, Julia; Ma, Wenbo			PLANT BIOLOGY An immunity boost combats crop disease	NATURE			English	Editorial Material									[Bailey-Serres, Julia; Ma, Wenbo] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bailey-Serres, J (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	serres@ucr.edu; wenbo.ma@ucr.edu	Bailey-Serres, Julia/A-2470-2010					Espinas NA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01201; FAO, 2013, FAO STAT YB 2013 WOR; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Li B, 2016, CELL HOST MICROBE, V19, P641, DOI 10.1016/j.chom.2016.04.011; Meteignier L.-V., 2017, J EXP BOT; Nalley L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167295; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Roy Bijoyita, 2013, Arabidopsis Book, V11, pe0165, DOI 10.1199/tab.0165; Staiger D, 2013, NEW PHYTOL, V197, P394, DOI 10.1111/nph.12022; Xu GY, 2017, NATURE, V545, P491, DOI 10.1038/nature22372; Xu GY, 2017, NATURE, V545, P487, DOI 10.1038/nature22371	11	4	7	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					420	421		10.1038/nature22497	http://dx.doi.org/10.1038/nature22497			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV6TH	28514444				2022-12-28	WOS:000401906500040
J	Gordon, SR; Aute, RLM; Dulken, BW; Hutter, G; George, BM; Ccracken, MNM; Gupta, R; Tsai, JM; Sinha, R; Corey, D; Ring, AM; Connolly, AJ; Weissman, IL				Gordon, Sydney R.; Aute, Roy L. M.; Dulken, Ben W.; Hutter, Gregor; George, Benson M. .; Ccracken, Melissa N. M.; Gupta, Rohit; Tsai, Jonathan M. .; Sinha, Rahul; Corey, Daniel; Ring, Aaron M. .; Connolly, Andrew J.; Weissman, Irving L.			PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity	NATURE			English	Article							NF-KAPPA-B; ANTI-PD-1 ANTIBODY; PD-1/PD-L1 AXIS; CELL; MELANOMA; RECEPTOR; PATHWAY; SAFETY; PROGRESSION; POPULATION	Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor that is upregulated on activated T cells for the induction of immune tolerance(1,2). Tumour cells frequently overexpress the ligand for PD-1, programmed cell death ligand 1 (PD-L1), facilitating their escape from the immune system(3,4). Monoclonal antibodies that block the interaction between PD-1 and PD-L1, by binding to either the ligand or receptor, have shown notable clinical efficacy in patients with a variety of cancers, including melanoma, colorectal cancer, non-small-cell lung cancer and Hodgkin's lymphoma(5-9). Although it is well established that PD-1-PD-L1 blockade activates T cells, little is known about the role that this pathway may have in tumour-associated macrophages (TAMs). Here we show that both mouse and human TAMs express PD-1. TAM PD-1 expression increases over time in mouse models of cancer and with increasing disease stage in primary human cancers. TAM PD-1 expression correlates negatively with phagocytic potency against tumour cells, and blockade of PD-1-PD-L1 in vivo increases macrophage phagocytosis, reduces tumour growth and lengthens the survival of mice in mouse models of cancer in a macrophage-dependent fashion. This suggests that PD-1-PD-L1 therapies may also function through a direct effect on macrophages, with substantial implications for the treatment of cancer with these agents.	[Gordon, Sydney R.; Aute, Roy L. M.; Dulken, Ben W.; Hutter, Gregor; George, Benson M. .; Ccracken, Melissa N. M.; Tsai, Jonathan M. .; Sinha, Rahul; Corey, Daniel; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gordon, Sydney R.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Gordon, Sydney R.; Aute, Roy L. M.; George, Benson M. .; Ccracken, Melissa N. M.; Tsai, Jonathan M. .; Sinha, Rahul; Corey, Daniel; Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Gordon, Sydney R.; Aute, Roy L. M.; George, Benson M. .; Ccracken, Melissa N. M.; Tsai, Jonathan M. .; Sinha, Rahul; Corey, Daniel; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Gordon, Sydney R.; Aute, Roy L. M.; George, Benson M. .; Ccracken, Melissa N. M.; Tsai, Jonathan M. .; Sinha, Rahul; Corey, Daniel; Connolly, Andrew J.; Weissman, Irving L.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Dulken, Ben W.] Stanford Univ, Stanford Med Scientist Training Program, Stanford, CA 94305 USA; [Hutter, Gregor] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Hutter, Gregor] Univ Hosp Basel, Dept Neurosurg, CH-4031 Basel, Switzerland; [Gupta, Rohit] Stanford Univ, Sch Med, Human Immune Monitoring Ctr Biobank, Palo Alto, CA 94304 USA; [Ring, Aaron M. .] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06519 USA	Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; University of Basel; Stanford University; Yale University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Weissman, IL (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	irv@stanford.edu	Hutter, Gregor/Q-6698-2019; Hutter, Gregor/A-1254-2011	Hutter, Gregor/0000-0002-7570-3902; Hutter, Gregor/0000-0002-7570-3902; Tsai, Jonathan/0000-0001-5868-2305; Gupta, Rohit/0000-0002-6897-7083; Ring, Aaron/0000-0003-3699-2446	D. K. Ludwig Fund for Cancer Research; A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program [NIH-GM07365]; Cancer Research Institute Irvington Fellowship; Swiss National Science Foundation [P300P3_155336]; ARRA Award from the National Center for Research Resources (NCRR) [1S10RR026780-01]; NATIONAL CANCER INSTITUTE [T32CA009302, P30CA124435, R01CA086017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG047126] Funding Source: NIH RePORTER	D. K. Ludwig Fund for Cancer Research; A.P. Giannini Foundation; Stanford Dean's Fellowship; Stanford Medical Scientist Training Program; Cancer Research Institute Irvington Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ARRA Award from the National Center for Research Resources (NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank S. Karten for assistance in editing the manuscript; and A. McCarty, T. Storm and T. Naik for technical support. Research reported in this publication was supported by the D. K. Ludwig Fund for Cancer Research (to I.L.W.); the A.P. Giannini Foundation and the Stanford Dean's Fellowship (to M.N.M.); the Stanford Medical Scientist Training Program NIH-GM07365 (to B.M.G., B.W.D. and J.M.T.); a Cancer Research Institute Irvington Fellowship (to R.L.M.); and a Swiss National Science Foundation fellowship P300P3_155336 (to G.H.). The project described was supported, in apart, by ARRA Award Number 1S10RR026780-01 from the National Center for Research Resources (NCRR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the National Institutes of Health.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Bally APR, 2015, J IMMUNOL, V194, P4545, DOI 10.4049/jimmunol.1402550; Benson DM, 2010, BLOOD, V116, P2286, DOI 10.1182/blood-2010-02-271874; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen W, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.33; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Karyampudi L, 2016, CANCER RES, V76, P239, DOI 10.1158/0008-5472.CAN-15-0748; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Maruyama C, 2002, EXP ANIM TOKYO, V51, P391, DOI 10.1538/expanim.51.391; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Reichel J, 2015, BLOOD, V125, P1061, DOI 10.1182/blood-2014-11-610436; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Shen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38362; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Zhen A, 2014, J VIROL, V88, P9934, DOI 10.1128/JVI.00616-14; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	32	1009	1051	28	546	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					495	+		10.1038/nature22396	http://dx.doi.org/10.1038/nature22396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514441	Green Submitted, Green Accepted			2022-12-28	WOS:000401906500055
J	Modi, N				Modi, Neena			PERSONAL VIEW Brexit is bad for health, and doctors should say so	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Modi, Neena] Royal Coll Paediat & Child Hlth, London, England		Modi, N (corresponding author), Royal Coll Paediat & Child Hlth, London, England.	n.modi@imperial.ac.uk							0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2017	357								j2265	10.1136/bmj.j2265	http://dx.doi.org/10.1136/bmj.j2265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UK	28495663				2022-12-28	WOS:000401170200009
J	Bally, M; Dendukuri, N; Rich, B; Nadeau, L; Helin-Salmivaara, A; Garbe, E; Brophy, JM				Bally, Michele; Dendukuri, Nandini; Rich, Benjamin; Nadeau, Lyne; Helin-Salmivaara, Arja; Garbe, Edeltraut; Brophy, James M.			Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; PARTICIPANT DATA METAANALYSIS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; SWITCHING-PATTERNS; COX-2 INHIBITORS; PREDICTIVE-VALUE; ROFECOXIB; CELECOXIB	OBJECTIVE To characterise the determinants, time course, and risks of acute myocardial infarction associated with use of oral non-steroidal anti-inflammatory drugs (NSAIDs). DESIGN Systematic review followed by a one stage bayesian individual patient data meta-analysis. DATA SOURCES Studies from Canadian and European healthcare databases. REVIEW METHODS Eligible studies were sourced from computerised drug prescription or medical databases, conducted in the general or an elderly population, documented acute myocardial infarction as specific outcome, studied selective cyclo-oxygenase-2 inhibitors (including rofecoxib) and traditional NSAIDs, compared risk of acute myocardial infarction in NSAID users with non-users, allowed for time dependent analyses, and minimised effects of confounding and misclassification bias. EXPOSURE AND OUTCOMES Drug exposure was modelled as an indicator variable incorporating the specific NSAID, its recency, duration of use, and dose. The outcome measures were the summary adjusted odds ratios of first acute myocardial infarction after study entry for each category of NSAID use at index date (date of acute myocardial infarction for cases, matched date for controls) versus non-use in the preceding year and the posterior probability of acute myocardial infarction. RESULTS A cohort of 446 763 individuals including 61 460 with acute myocardial infarction was acquired. Taking any dose of NSAIDs for one week, one month, or more than a month was associated with an increased risk of myocardial infarction. With use for one to seven days the probability of increased myocardial infarction risk (posterior probability of odds ratio >1.0) was 92% for celecoxib, 97% for ibuprofen, and 99% for diclofenac, naproxen, and rofecoxib. The corresponding odds ratios (95% credible intervals) were 1.24 (0.91 to 1.82) for celecoxib, 1.48 (1.00 to 2.26) for ibuprofen, 1.50 (1.06 to 2.04) for diclofenac, 1.53 (1.07 to 2.33) for naproxen, and 1.58 (1.07 to 2.17) for rofecoxib. Greater risk of myocardial infarction was documented for higher dose of NSAIDs. With use for longer than one month, risks did not appear to exceed those associated with shorter durations. CONCLUSIONS All NSAIDs, including naproxen, were found to be associated with an increased risk of acute myocardial infarction. Risk of myocardial infarction with celecoxib was comparable to that of traditional NSAIDS and was lower than for rofecoxib. Risk was greatest during the first month of NSAID use and with higher doses.	[Bally, Michele] Ctr Hosp Univ Montreal, Dept Pharm, Montreal, PQ H2X 1N4, Canada; [Bally, Michele] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H2X 1N4, Canada; [Bally, Michele; Brophy, James M.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Dendukuri, Nandini] McGill Univ, Hlth Ctr, Technol Assessment Unit, Montreal, PQ, Canada; [Dendukuri, Nandini; Rich, Benjamin; Nadeau, Lyne; Brophy, James M.] McGill Univ, Div Clin Epidemiol, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Helin-Salmivaara, Arja] Hosp Dist Helsinki & Uusimaa, Unit Primary Care, Helsinki, Finland; [Garbe, Edeltraut] Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Clin Epidemiol, Bremen, Germany; [Brophy, James M.] McGill Univ, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University; McGill University; University of Helsinki; Helsinki University Central Hospital; Leibniz Institute for Prevention Research & Epidemiology (BIPS); McGill University	Bally, M (corresponding author), Ctr Hosp Univ Montreal, Dept Pharm, Montreal, PQ H2X 1N4, Canada.; Bally, M (corresponding author), Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H2X 1N4, Canada.; Bally, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	michele.bally.chum@ssss.gouv.qc.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	McGill University Health Centre Research Institute	McGill University Health Centre Research Institute	This study is part of MB's doctoral research thesis in epidemiology. MB received grants from the McGill University Health Centre Research Institute during the conduct of the study.	Abraham NS, 2007, ALIMENT PHARM THER, V25, P913, DOI 10.1111/j.1365-2036.2007.03292.x; Abrahamowicz M, 2006, J CLIN EPIDEMIOL, V59, P393, DOI 10.1016/j.jclinepi.2005.01.021; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bueno H, 2010, AM J CARDIOL, V105, P1102, DOI 10.1016/j.amjcard.2009.12.008; Chan CC, 2009, J HYPERTENS, V27, P2332, DOI 10.1097/HJH.0b013e3283310dc9; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Daniels MJ, 1999, CAN J STAT, V27, P567, DOI 10.2307/3316112; Debray TPA, 2015, RES SYNTH METHODS, V6, P293, DOI 10.1002/jrsm.1160; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Eichler HG, 2011, NAT REV DRUG DISCOV, V10, P495, DOI [10.1038/nrd3501, 10.1038/nrd3348]; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Fortier I, 2011, INT J EPIDEMIOL, V40, P1314, DOI 10.1093/ije/dyr106; Fortier I, 2011, AM J EPIDEMIOL, V174, P261, DOI 10.1093/aje/kwr194; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Girvin B, 2004, PHARMACOEPIDEM DR S, V13, P153, DOI 10.1002/pds.866; Gore M, 2011, CLIN THER, V33, P1914, DOI 10.1016/j.clinthera.2011.10.019; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; GREENLAND S, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431660; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Hall AJ, 2016, EUR J PREV CARDIOL, V23, P938, DOI 10.1177/2047487315610663; Hammad TA, 2008, PHARMACOEPIDEM DR S, V17, P1197, DOI 10.1002/pds.1672; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Helin-Salmivaara A, 2005, J CLIN PHARM THER, V30, P145, DOI 10.1111/j.1365-2710.2005.00627.x; Helin-Salmivaara A, 2006, EUR HEART J, V27, P1657, DOI 10.1093/eurheartj/ehl053; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; Jolani S, 2015, STAT MED, V34, P1841, DOI 10.1002/sim.6451; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; Langman M, 2001, PHARMACOEPIDEM DR S, V10, P517, DOI 10.1002/pds.653; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Little RJA, 2002, STAT ANAL MISSING 1; Mamdani M, 2002, CAN MED ASSOC J, V167, P1125; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Plummer M, 2014, PACKAGE CODA OUTPUT; Plummer M, 2014, PACKAGE RJAGS BAYESI; R Development Core Team, 2009, R LANG ENV STAT COMP; Rawson NSB, 2011, J POPUL THER CLIN PH, V18, pE245; Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Sauer BC, 2013, PHARMACOEPIDEM DR S, V22, P1139, DOI 10.1002/pds.3506; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Sift R, 1997, PHARMACOEPIDEM DR S, V6, P263, DOI 10.1002/(SICI)1099-1557(199707)6:4<263::AID-PDS286>3.0.CO;2-Z; Simmonds MC, 2007, STAT MED, V26, P2982, DOI 10.1002/sim.2768; Solomon DH, 2004, CIRCULATION, V109, P2068, DOI 10.1161/01.CIR.0000127578.21885.3E; Spiegelhalter DJ, 2004, PRIOR DISTRIBUTIONS, P139, DOI [10.1002/0470092602.ch5.(SICI)1097-0258(19961230)15:24&LT;2733::AID-SIM562&GT;3.0.CO;2-0., DOI 10.1002/0470092602.CH5.(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0]; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; Sylvestre MP, 2009, STAT MED, V28, P3437, DOI 10.1002/sim.3701; Taichman DB, 2016, LANCET, V387, pE9, DOI 10.1016/S0140-6736(15)01279-9; TAMBLYN R, 1995, J CLIN EPIDEMIOL, V48, P999, DOI 10.1016/0895-4356(94)00234-H; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; van der Linden MW, 2009, ANN RHEUM DIS, V68, P668, DOI 10.1136/ard.2007.087254; Varas-Lorenzo C, 2008, PHARMACOEPIDEM DR S, V17, P842, DOI 10.1002/pds.1619; Varas-Lorenzo C, 2013, PHARMACOEPIDEM DR S, V22, P559, DOI 10.1002/pds.3437; Varas-Lorenzo C, 2009, PHARMACOEPIDEM DR S, V18, P1016, DOI 10.1002/pds.1815; Warren FC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-64; Welton NJ, 2012, EVIDENCE SYNTHESIS D, P17, DOI [10.1002/9781119942986.ch2., DOI 10.1002/9781119942986.CH2]; Wettermark B, 2013, PHARMACOEPIDEM DR S, V22, P691, DOI 10.1002/pds.3457; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	74	246	254	4	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2017	357								j1909	10.1136/bmj.j1909	http://dx.doi.org/10.1136/bmj.j1909			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UA	28487435	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000401169100002
J	Gebhardt, S				Gebhardt, Stefan			Case Report Comment Tailored genetic testing provides answer to fetal anomaly	LANCET			English	Editorial Material									[Gebhardt, Stefan] Stellenbosch Univ, Dept Obstet & Gynaecol, Stellenbosch, South Africa	Stellenbosch University	Gebhardt, S (corresponding author), POB 19125, ZA-7505 Tygerberg, South Africa.	gsgeb@sun.ac.za		Gebhardt, Gabriel/0000-0001-8999-8193				Kroisel PM, 2017, LANCET, V389, P1857, DOI 10.1016/S0140-6736(17)31049-8; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Radhakrishnan N, 2011, J PEDIAT HEMATOL ONC, V33, P74, DOI 10.1097/MPH.0b013e3181fd2aae; UniProt database, HMOX1 HEM OX 1 HOM S	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1858	1858		10.1016/S0140-6736(17)31050-4	http://dx.doi.org/10.1016/S0140-6736(17)31050-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495171				2022-12-28	WOS:000400549300036
J	Liu, QL; Tabuchi, M; Liu, S; Kodama, L; Horiuchi, W; Daniels, J; Chiu, L; Baldoni, D; Wu, MN				Liu, Qili; Tabuchi, Masashi; Liu, Sha; Kodama, Lay; Horiuchi, Wakako; Daniels, Jay; Chiu, Lucinda; Baldoni, Daniel; Wu, Mark N.			Branch-specific plasticity of a bifunctional dopamine circuit encodes protein hunger	SCIENCE			English	Article							AMINO-ACIDS; DROSOPHILA; NEURONS; MELANOGASTER; APPETITE; MARKER; RATS	Free-living animals must not only regulate the amount of food they consume but also choose which types of food to ingest. The shifting of food preference driven by nutrient-specific hunger can be essential for survival, yet little is known about the underlying mechanisms. We identified a dopamine circuit that encodes protein-specific hunger in Drosophila. The activity of these neurons increased after substantial protein deprivation. Activation of this circuit simultaneously promoted protein intake and restricted sugar consumption, via signaling to distinct downstream neurons. Protein starvation triggered branch-specific plastic changes in these dopaminergic neurons, thus enabling sustained protein consumption. These studies reveal a crucial circuit mechanism by which animals adjust their dietary strategy to maintain protein homeostasis.	[Liu, Qili; Tabuchi, Masashi; Liu, Sha; Kodama, Lay; Horiuchi, Wakako; Daniels, Jay; Chiu, Lucinda; Baldoni, Daniel; Wu, Mark N.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Wu, Mark N.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wu, MN (corresponding author), Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA.; Wu, MN (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA.	marknwu@jhmi.edu		Tabuchi, Masashi/0000-0002-8734-6922; Horiuchi, Wakako/0000-0001-6795-0850; Liu, Sha/0000-0002-7168-330X; Daniels, Jay/0000-0003-4022-6795	National Institute of Neurological Disorders and Stroke (NINDS) Center Grant [NS05027]; Japan Society for the Promotion of Science; NIH [R01NS079584, R21NS088521]; Burroughs-Wellcome Career Award for Medical Scientists; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079584, R21NS088521] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) Center Grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pankratz, H. Amrein, Y.-N. Jan, C. Potter, B. Zhang, B. Dickson, M. Murthy, S. Sigrist, K. Scott, S. Birman, E. Kravitz, J. Wang, O. Shafer, and G. Rubin for sharing reagents. We also thank the Bloomington Stock Center for fly lines. We thank J. Schulze in the Proteomics Core of the Genome Center at the University of California, Davis, for the amino acid analysis. We thank A. Branch for comments on the manuscript and G. Suh and M. Kanai for discussion of unpublished data. This work was supported by a National Institute of Neurological Disorders and Stroke (NINDS) Center Grant (NS05027) for use of the Core Machine Shop, a Japan Society for the Promotion of Science fellowship (M.T.), and NIH grants R01NS079584 and R21NS088521 and a Burroughs-Wellcome Career Award for Medical Scientists (M.N.W.). Data are stored on a password-protected computer and backed up on a hard drive located in the Department of Neurology at Johns Hopkins University. Data will be made available upon request.	Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bjordal M, 2014, CELL, V156, P510, DOI 10.1016/j.cell.2013.12.024; Bohm RA, 2010, P NATL ACAD SCI USA, V107, P16378, DOI 10.1073/pnas.1004669107; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Corrales-Carvajal VM, 2016, ELIFE, V5, DOI 10.7554/eLife.19920; DEUTSCH JA, 1989, PHYSIOL BEHAV, V46, P619, DOI 10.1016/0031-9384(89)90341-7; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fauth M, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00075; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Liu S, 2016, CELL, V165, P1347, DOI 10.1016/j.cell.2016.04.013; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Nern A, 2015, P NATL ACAD SCI USA, V112, pE2967, DOI 10.1073/pnas.1506763112; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Richter CP, 1936, AM J PHYSIOL, V115, P155, DOI 10.1152/ajplegacy.1936.115.1.155; Richter CP., 1943, HARVEY LECTURES SERI, V38, P63; Ro J, 2016, ELIFE, V5, DOI 10.7554/eLife.16843; ROSE WILLIAM C., 1932, YALE JOUR BIOL AND MED, V4, P519; Simpson S.J., 2012, NATURE NUTR; Toshima N, 2012, J EXP BIOL, V215, P2827, DOI 10.1242/jeb.069146; Vargas MA, 2010, CURR BIOL, V20, P1006, DOI 10.1016/j.cub.2010.04.009; Walker SJ, 2015, CURR BIOL, V25, P2621, DOI 10.1016/j.cub.2015.08.043; White BD, 2000, PHYSIOL BEHAV, V68, P673, DOI 10.1016/S0031-9384(99)00229-2; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	30	55	57	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					534	+		10.1126/science.aal3245	http://dx.doi.org/10.1126/science.aal3245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473588	Green Accepted			2022-12-28	WOS:000400545700037
J	Wadman, M				Wadman, Meredith			ANIMAL RESEARCH Mauritius invites primate research labs to set up shop	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					472	473		10.1126/science.356.6337.472	http://dx.doi.org/10.1126/science.356.6337.472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473542				2022-12-28	WOS:000400545700012
J	Sandborn, WJ; Su, CY; Sands, BE; D'Haens, GR; Vermeire, S; Schreiber, S; Danese, S; Feagan, BG; Reinisch, W; Niezychowski, W; Friedman, G; Lawendy, N; Yu, DH; Woodworth, D; Mukherjee, A; Zhang, HY; Healey, P; Panes, J				Sandborn, William J.; Su, Chinyu; Sands, Bruce E.; D'Haens, Geert R.; Vermeire, Severine; Schreiber, Stefan; Danese, Silvio; Feagan, Brian G.; Reinisch, Walter; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Mukherjee, Arnab; Zhang, Haiying; Healey, Paul; Panes, Julian		OCTAVE Induction 1 OCTAVE Inductio	Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JANUS KINASE INHIBITOR; RHEUMATOID-ARTHRITIS; OPEN-LABEL; EFFICACY; PHARMACOKINETICS; VEDOLIZUMAB; ACTIVATION; DISCOVERY; ADULTS	BACKGROUND Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial. We further evaluated the efficacy of tofacitinib as induction and maintenance therapy. METHODS We conducted three phase 3, randomized, double-blind, placebo-controlled trials of tofacitinib therapy in adults with ulcerative colitis. In the OCTAVE Induction 1 and 2 trials, 598 and 541 patients, respectively, who had moderately to severely active ulcerative colitis despite previous conventional therapy or therapy with a tumor necrosis factor antagonist were randomly assigned to receive induction therapy with tofacitinib (10 mg twice daily) or placebo for 8 weeks. The primary end point was remission at 8 weeks. In the OCTAVE Sustain trial, 593 patients who had a clinical response to induction therapy were randomly assigned to receive maintenance therapy with tofacitinib (either 5 mg or 10 mg twice daily) or placebo for 52 weeks. The primary end point was remission at 52 weeks. RESULTS In the OCTAVE Induction 1 trial, remission at 8 weeks occurred in 18.5% of the patients in the tofacitinib group versus 8.2% in the placebo group (P = 0.007); in the OCTAVE Induction 2 trial, remission occurred in 16.6% versus 3.6% (P<0.001). In the OCTAVE Sustain trial, remission at 52 weeks occurred in 34.3% of the patients in the 5-mg tofacitinib group and 40.6% in the 10-mg tofacitinib group versus 11.1% in the placebo group (P<0.001 for both comparisons with placebo). In the OCTAVE Induction 1 and 2 trials, the rates of overall infection and serious infection were higher with tofacitinib than with placebo. In the OCTAVE Sustain trial, the rate of serious infection was similar across the three treatment groups, and the rates of overall infection and herpes zoster infection were higher with tofacitinib than with placebo. Across all three trials, adjudicated nonmelanoma skin cancer occurred in five patients who received tofacitinib and in one who received placebo, and adjudicated cardiovascular events occurred in five who received tofacitinib and in none who received placebo; as compared with placebo, tofacitinib was associated with increased lipid levels. CONCLUSIONS In patients with moderately to severely active ulcerative colitis, tofacitinib was more effective as induction and maintenance therapy than placebo.	[Sandborn, William J.] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Su, Chinyu; Niezychowski, Wojciech; Friedman, Gary; Lawendy, Nervin; Yu, Dahong; Woodworth, Deborah; Zhang, Haiying] Pfizer, Collegeville, PA USA; [Sands, Bruce E.] Icahn Sch Med Mt Sinai, Janowitz Div Gastroenterol, New York, NY 10029 USA; [D'Haens, Geert R.] Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Vermeire, Severine] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Campus Kiel, Kiel, Germany; [Danese, Silvio] Humanitas Res Hosp, Dept Gastroenterol, Inflammatory Bowel Dis Ctr, Milan, Italy; [Feagan, Brian G.] Western Univ, Robarts Clin Trials, Robarts Res Inst, London, ON, Canada; McMaster Univ, Hamilton, ON, Canada; [Mukherjee, Arnab; Healey, Paul] Pfizer Inc, Groton, CT 06340 USA; [Panes, Julian] Hosp Clin Barcelona, Networking Biomed Res Ctr Hepat & Digest Dis CIBE, August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain	University of California System; University of California San Diego; Pfizer; Icahn School of Medicine at Mount Sinai; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; University Hospital Leuven; University of Kiel; Schleswig Holstein University Hospital; Western University (University of Western Ontario); McMaster University; Pfizer; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sandborn, WJ (corresponding author), Univ Calif San Diego, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Panes, J (corresponding author), Hosp Clin Barcelona, IDIBAPS, CIBERehd, E-08036 Barcelona, Spain.	wsandborn@ucsd.edu; jpanes@clinic.cat	Danese, Silvio/ABH-9571-2020; Feagan, Brian/G-3292-2011; Sands, Bruce/R-7887-2019; Fediv, Oleksandr/D-1560-2017; Sandborn, William/ABE-8342-2020	Danese, Silvio/0000-0001-7341-1351; Sands, Bruce/0000-0001-5762-5042; Fediv, Oleksandr/0000-0003-0108-2565; Vermeire, Severine/0000-0001-9942-3019; Guardiola, Jordi/0000-0002-0464-241X	Pfizer; OCTAVE Induction 1 [NCT01465763]; OCTAVE Induction 2 [NCT01458951]; OCTAVE Sustain [NCT01458574]	Pfizer(Pfizer); OCTAVE Induction 1; OCTAVE Induction 2; OCTAVE Sustain	Funded by Pfizer; OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain ClinicalTrials.gov numbers, NCT01465763, NCT01458951, and NCT01458574, respectively.)	Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Bissonnette R, 2015, BRIT J DERMATOL, V172, P1395, DOI 10.1111/bjd.13551; Boland BS, 2014, GASTROENTEROL CLIN N, V43, P603, DOI 10.1016/j.gtc.2014.05.011; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; D'Haens G, 2016, J CROHNS COLITIS, V10, pS58; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Danese S, 2016, AM J PHYSIOL-GASTR L, V310, pG155, DOI 10.1152/ajpgi.00311.2015; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Dowty ME, 2014, DRUG METAB DISPOS, V42, P759, DOI 10.1124/dmd.113.054940; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Hommel G, 2007, STAT MED, V26, P4063, DOI 10.1002/sim.2873; Hutmacher MM, 2008, J PHARMACOKINET PHAR, V35, P139, DOI 10.1007/s10928-007-9080-2; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Mukherjee A, 2014, GASTROENTEROLOGY, V146, pS367; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Schulze-Koops H, 2016, ARTHRITIS RHEUMATOL, V68; Wollenhaupt J, 2014, J RHEUMATOL, V41, P837, DOI 10.3899/jrheum.130683; Yamanaka H, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0932-2	24	784	811	4	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1723	1736		10.1056/NEJMoa1606910	http://dx.doi.org/10.1056/NEJMoa1606910			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28467869	Green Published			2022-12-28	WOS:000400442300006
J	Dwolatzky, T; Brodsky, J; Azaiza, F; Clarfield, AM; Jacobs, JM; Litwin, H				Dwolatzky, Tzvi; Brodsky, Jenny; Azaiza, Faisal; Clarfield, A. Mark; Jacobs, Jeremy M.; Litwin, Howard			Coming of age: health-care challenges of an ageing population in Israel	LANCET			English	Article							HOLOCAUST SURVIVORS; ARAB POPULATION; EMOTIONAL DISTRESS; EXPERIENCE; LIFE; PREVALENCE; DIMENSIONS; COMMUNITY; PROFILE; SOCIETY	Although Israel is still young in years, with relatively high birth rates and older people (individuals aged 65 years or older) constituting only about 11% of its population, the absolute number of older people is growing rapidly. Life expectancy is high, and increasing numbers of people are living to advanced old age (older than 85 years). A wide spectrum of geriatric care is provided within a universal system providing health services to all citizens. Community and institutional care is available, and many innovative programmes are being developed. The unique demographic characteristics of the ageing society in Israel reflect cultural and multiethnic diversity, in addition to a high rate of immigration of older people. To meet the growing challenges, address disparities, and search for innovation will require planning and development of adequate services at the highest level.	[Dwolatzky, Tzvi] Rambam Hlth Care Campus, Geriatr Unit, POB 9602, Haifa, Israel; [Dwolatzky, Tzvi] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Brodsky, Jenny] Ctr Res Ageing, Myers JDC Brookdale Inst, Jerusalem, Israel; [Azaiza, Faisal] Univ Haifa, Sch Social Work, Fac Social Welf & Hlth Sci, Haifa, Israel; [Clarfield, A. Mark] Ben Gurion Univ Negev, Med Sch Int Hlth, Fac Hlth Sci, Beer Sheva, Israel; [Jacobs, Jeremy M.] Hadassah Hebrew Univ, Med Ctr, Dept Geriatr & Rehabil, Jerusalem, Israel; [Jacobs, Jeremy M.] Hebrew Univ Jerusalem, Hadassah Med Sch, Jerusalem, Israel; [Litwin, Howard] Hebrew Univ Jerusalem, Paul Baerwald Sch Social Work & Social Welf, Jerusalem, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Haifa; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Dwolatzky, T (corresponding author), Rambam Hlth Care Campus, Geriatr Unit, POB 9602, Haifa, Israel.	t_dwolatzky@rambam.health.gov.il	Dwolatzky, Tzvi/P-4752-2019	Dwolatzky, Tzvi/0000-0002-3861-2278; Jacobs, Jeremy Michael/0000-0002-7001-7815; LITWIN, HOWARD/0000-0003-1323-4562; Azaiza, Faisal/0000-0002-3094-7575				ANTONOVSKY A, 1971, SOC PSYCHIATR, V6, P186, DOI 10.1007/BF00578367; Azaiza F, 1999, J GERONTOL SOC WORK, V31, P65, DOI 10.1300/J083v31n03_05; Azaiza F, 2003, ISR MED ASSOC J, V5, P383; Azaiza F, 2013, INT J SOC WELF, V22, P15, DOI 10.1111/j.1468-2397.2011.00866.x; Ben-David D., SINGER SERIES STATE; Bergman YS, 2013, INT PSYCHOGERIATR, V25, P6, DOI 10.1017/S1041610212001548; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Brick Y, 2007, ARCH GERONTOL GERIAT, V44, P225, DOI 10.1016/j.archger.2006.05.002; Brodsky J, 1993, J Cross Cult Gerontol, V8, P375, DOI 10.1007/BF00972565; Brodsky J., 2015, ELDERLY ISRAEL STAT; Brodsky J, 2004, RECIPIENTS LONG TERM; Brodsky J, HOLOCAUST SURVIVORS; Brodsky J., 2011, EXAMINING ISSUES FAM; Brodsky J, 2000, LONG TERM CARE 5 DEV; Chernichovsky D, 2005, ECON HUM BIOL, V3, P121, DOI 10.1016/j.ehb.2005.01.002; Clarfield AM, 2000, J AM GERIATR SOC, V48, P980, DOI 10.1111/j.1532-5415.2000.tb06899.x; Clarfield AM, 2004, ISR MED ASSOC J, V6, P516; Clarfield AM, 2003, J AM GERIATR SOC, V51, P1149, DOI 10.1046/j.1532-5415.2003.51364.x; Clarfield AM, 2001, J AM GERIATR SOC, V49, P1714, DOI 10.1046/j.1532-5415.2001.49285.x; Clarfield AM, 2017, LANCET; Foldes AJ, 2003, J BONE MINER RES, V18, pS53; FRIEDLANDER D, 1984, POPUL BULL, V39, P3; Jacobs JM, 2014, REJUV RES, V17, P499, DOI 10.1089/rej.2014.1587; Jacobs JM, 2006, ANN INTERN MED, V144, P456, DOI 10.7326/0003-4819-144-6-200603210-00023; Jotkowitz AB, 2017, LANCET; Katz R, 2009, J CROSS-CULT GERONTO, V24, P77, DOI 10.1007/s10823-009-9092-z; Litwin H, 2006, J CROSS-CULT GERONTO, V21, P25, DOI 10.1007/s10823-006-9019-x; Litwin H, 2008, INT MIGR REV, V42, P903, DOI 10.1111/j.1747-7379.2008.00152.x; Marcus EL, 2007, OSTEOPOROSIS INT, V18, P1501, DOI 10.1007/s00198-007-0389-x; Muhsen K, 2017, LANCET; National Insurance Institute of Israel, 2013, ANN REPORT; OECD, 2013, GOOD LIFE OLD AGE MO; Press Yan, 2008, Harefuah, V147, P120; Sharon A, 2009, BRIT J PSYCHIAT, V195, P331, DOI 10.1192/bjp.bp.108.058784; Shemesh AA, 2006, INT J GERIATR PSYCH, V21, P64, DOI 10.1002/gps.1426; Shemesh AA, 2008, ARCH GERONTOL GERIAT, V47, P63, DOI 10.1016/j.archger.2007.07.001; Shemesh AA, 2008, ISR J PSYCHIATR REL, V45, P230; Shmotkin D., 2008, BITAHON SOCIALI, V197, P224; Staetsky L, 2009, DEMOGR RES, V20, P209, DOI 10.4054/DemRes.2009.20.11; Sternberg SA, 2014, ISR J HEALTH POLICY, V3, DOI 10.1186/2045-4015-3-44; UN, WORLD POP PROSP 2015; World Health Organization, WORLD HLTH STAT 2016; Zucker I, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-27	43	36	36	3	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2542	2550		10.1016/S0140-6736(17)30789-4	http://dx.doi.org/10.1016/S0140-6736(17)30789-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495114				2022-12-28	WOS:000403901800032
J	Roberts, KM; Conwell, D				Roberts, Kristen M.; Conwell, Darwin			Acute Pancreatitis: How Soon Should We Feed Patients?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ENTERAL NUTRITION; SUPPORT		[Roberts, Kristen M.; Conwell, Darwin] Ohio State Univ, 395 West 12th Ave,Second Floor, Columbus, OH 43210 USA	Ohio State University	Roberts, KM (corresponding author), Ohio State Univ, 395 West 12th Ave,Second Floor, Columbus, OH 43210 USA.	Kristen.Roberts@osumc.edu						Cao YF, 2008, ANN NUTR METAB, V53, P268, DOI 10.1159/000189382; Chang YS, 2013, CRIT CARE, V17, DOI 10.1186/cc12790; Chokkalingam A, 1998, SYSTEMATIC REV EVIDE; Lasztity N, 2005, CLIN NUTR, V24, P198, DOI 10.1016/j.clnu.2004.12.008; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; McClave SA, 2006, JPEN-PARENTER ENTER, V30, P143, DOI 10.1177/0148607106030002143; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; Vaughn VM, 2017, ANN INTERN MED, V166, P883, DOI 10.7326/M16-2533; Wang GL, 2013, J SURG RES, V183, P592, DOI 10.1016/j.jss.2012.12.010	9	3	3	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					903	+		10.7326/M17-1123	http://dx.doi.org/10.7326/M17-1123			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28505666				2022-12-28	WOS:000403579000022
J	Blauvelt, A; de Bruin-Weller, M; Gooderham, M; Cather, JC; Weisman, J; Pariser, D; Simpson, EL; Papp, KA; Hong, HCH; Rubel, D; Foley, P; Prens, E; Griffiths, CEM; Etoh, T; Pinto, PH; Pujol, RM; Szepietowski, JC; Ettler, K; Kemeny, L; Zhu, XP; Akinlade, B; Hultsch, T; Mastey, V; Gadkari, A; Eckert, L; Amin, N; Graham, NMH; Pirozzi, G; Stahl, N; Yancopoulos, GD; Shumel, B				Blauvelt, Andrew; de Bruin-Weller, Marjolein; Gooderham, Melinda; Cather, Jennifer C.; Weisman, Jamie; Pariser, David; Simpson, Eric L.; Papp, Kim A.; Hong, H. Chih-Ho; Rubel, Diana; Foley, Peter; Prens, Errol; Griffiths, Christopher E. M.; Etoh, Takafumi; Pinto, Pedro Herranz; Pujol, Ramon M.; Szepietowski, Jacek C.; Ettler, Karel; Kemeny, Lajos; Zhu, Xiaoping; Akinlade, Bolanle; Hultsch, Thomas; Mastey, Vera; Gadkari, Abhijit; Eckert, Laurent; Amin, Nikhil; Graham, Neil M. H.; Pirozzi, Gianluca; Stahl, Neil; Yancopoulos, George D.; Shumel, Brad			Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial	LANCET			English	Article							COATED MYCOPHENOLATE SODIUM; DAILY PRACTICE COHORT; ADULT PATIENTS; PERSISTENT ASTHMA; CLINICAL-TRIAL; CYCLOSPORINE-A; DRUG SURVIVAL; GUIDELINES; ECZEMA; THERAPY	Background Dupilumab (an anti-interleukin-4-receptor-alpha monoclonal antibody) blocks signalling of interleukin 4 and interleukin 13, type 2/Th2 cytokines implicated in numerous allergic diseases ranging from asthma to atopic dermatitis. Previous 16-week monotherapy studies showed that dupilumab substantially improved signs and symptoms of moderate-to-severe atopic dermatitis with acceptable safety, validating the crucial role of interleukin 4 and interleukin 13 in atopic dermatitis pathogenesis. We aimed to evaluate the long-term efficacy and safety of dupilumab with medium-potency topical corticosteroids versus placebo with topical corticosteroids in adults with moderate-to-severe atopic dermatitis. Methods In this 1-year, randomised, double-blinded, placebo-controlled, phase 3 study (LIBERTY AD CHRONOS), adults with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids were enrolled at 161 hospitals, clinics, and academic institutions in 14 countries in Europe, Asia-Pacific, and North America. Patients were randomly assigned (3: 1: 3) to subcutaneous dupilumab 300 mg once weekly (qw), dupilumab 300 mg every 2 weeks (q2w), or placebo via a central interactive voice/web response system, stratified by severity and global region. All three groups were given concomitant topical corticosteroids with or without topical calcineurin inhibitors where inadvisable for topical corticosteroids. Topical corticosteroids could be tapered, stopped, or restarted on the basis of disease activity. Coprimary endpoints were patients (%) achieving Investigator's Global Assessment (IGA) 0/1 and 2-point or higher improvement from baseline, and Eczema Area and Severity Index 75% improvement from baseline (EASI-75) at week 16. Week 16 efficacy and week 52 safety analyses included all randomised patients; week 52 efficacy included patients who completed treatment by US regulatory submission cutoff. This study is registered with ClinicalTrials.gov, NCT02260986. Findings Between Oct 3, 2014, and July 31, 2015, 740 patients were enrolled: 319 were randomly assigned to dupilumab qw plus topical corticosteroids, 106 to dupilumab q2w plus topical corticosteroids, and 315 to placebo plus topical corticosteroids. 623 (270, 89, and 264, respectively) were evaluable for week 52 efficacy. At week 16, more patients who received dupilumab plus topical corticosteroids achieved the coprimary endpoints of IGA 0/1 (39% [125 patients] who received dupilumab plus topical corticosteroids qw and 39% [41 patients] who received dupilumab q2w plus topical corticosteroids vs 12% [39 patients] who received placebo plus topical corticosteroids; p < 0.0001) and EASI-75 (64% [204] and 69% [73] vs 23% [73]; p < 0.0001). Week 52 results were similar. Adverse events were reported in 261 (83%) patients who received dupilumab qw plus topical corticosteroids, 97 (88%) patients who received dupilumab q2w, and 266 (84%) patients who received placebo, and serious adverse events in nine (3%), four (4%), and 16 (5%) patients, respectively. No significant dupilumab-induced laboratory abnormalities were noted. Injection-site reactions and conjunctivitis were more common in patients treated with dupilumab plus topical corticosteroids-treated patients than in patients treated with placebo plus topical corticosteroids. Interpretation Dupilumab added to standard topical corticosteroid treatment for 1 year improved atopic dermatitis signs and symptoms, with acceptable safety.	[Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA; [de Bruin-Weller, Marjolein] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Gooderham, Melinda] Queens Univ, SKiN Ctr Dermatol, Peterborough, ON, Canada; [Gooderham, Melinda] Prob Med Res, Peterborough, ON, Canada; [Cather, Jennifer C.] Modern Dermatol & Modern Res Associates, Dallas, TX USA; [Cather, Jennifer C.] Prob Med Res, Dallas, TX USA; [Weisman, Jamie] Adv Med Res PC, Atlanta, GA USA; [Pariser, David] Eastern Virginia Med Sch, Norfolk, VA 23501 USA; [Pariser, David] Virginia Clinical Res Inc, Norfolk, VA USA; [Simpson, Eric L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Papp, Kim A.] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada; [Hong, H. Chih-Ho] Univ British Columbia, Dept Dermatol & Skin Sci, Surrey, BC, Canada; [Hong, H. Chih-Ho] Prob Med Res, Surrey, BC, Canada; [Rubel, Diana] Australian Natl Univ, Phillip, ACT, Australia; [Rubel, Diana] Prob Med Res, Phillip, ACT, Australia; [Foley, Peter] Univ Melbourne, Parkville, Vic, Australia; [Foley, Peter] Skin & Canc Fdn, Carlton, Vic, Australia; [Foley, Peter] Prob Med Res, Carlton, Vic, Australia; [Prens, Errol] Erasmus Univ, Med Ctr Rotterdam, Rotterdam, Netherlands; [Griffiths, Christopher E. M.] Univ Manchester, Dermatol Ctr, Salford Royal Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Etoh, Takafumi] Tokyo Teishin Postal Serv Agcy Hosp, Tokyo, Japan; [Pinto, Pedro Herranz] La Paz Univ Hosp, Dept Dermatol, Madrid, Spain; [Pujol, Ramon M.] Hosp del Mar, Dept Dermatol, Barcelona, Spain; [Szepietowski, Jacek C.] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland; [Ettler, Karel] Dermatol & Venereol, Hradec Kralove, Czech Republic; [Kemeny, Lajos] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary; [Zhu, Xiaoping] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA; [Akinlade, Bolanle; Gadkari, Abhijit; Amin, Nikhil; Graham, Neil M. H.; Stahl, Neil; Yancopoulos, George D.; Shumel, Brad] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Hultsch, Thomas] Sanofi, Cambridge, MA USA; [Eckert, Laurent] Sanofi, Chilly Mazarin, France; [Pirozzi, Gianluca] Sanofi, Bridgewater, NJ USA	Utrecht University; Utrecht University Medical Center; Queens University - Canada; Eastern Virginia Medical School; Oregon Health & Science University; University of British Columbia; Australian National University; University of Melbourne; SKIN & CANCER FOUNDATION AUSTRALIA; Erasmus University Rotterdam; Erasmus MC; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Hospital Universitario La Paz; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Wroclaw Medical University; Szeged University; Regeneron; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Blauvelt, A (corresponding author), Oregon Med Res Ctr, Portland, OR 97223 USA.	ablauvelt@oregonmedicalresearch.com	Ettler, Karel/M-4762-2017; Kemeny, Lajos/ABF-1339-2021; Griffiths, Christopher/P-5448-2014	Ettler, Karel/0000-0002-7986-4885; Kemeny, Lajos/0000-0002-2119-9501; Ettler, Karel/0000-0002-3747-2947; Papp, Kim A./0000-0001-9557-3642; Szepietowski, Jacek/0000-0003-0766-6342; PUJOL, RAMON M/0000-0002-5622-6055; Griffiths, Christopher/0000-0001-5371-4427	Sanofi; Regeneron Pharmaceuticals Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals Inc.(Regeneron)	Sanofi and Regeneron Pharmaceuticals Inc.	Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Basra MKA, 2015, DERMATOLOGY, V230, P27, DOI 10.1159/000365390; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; BerthJones J, 1997, BRIT J DERMATOL, V136, P76, DOI 10.1046/j.1365-2133.1997.d01-1146.x; Bieber T, 2015, ALLERGY, V70, P6, DOI 10.1111/all.12498; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Decani S, 2014, J DERMATOL TREAT, V25, P495, DOI 10.3109/09546634.2012.755252; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Gandhi NA, 2016, NAT REV DRUG DISCOV, V15, P35, DOI 10.1038/nrd4624; Garritsen FM, 2014, BRIT J DERMATOL, V170, P501, DOI 10.1111/bjd.12645; Granlund H, 2001, ACTA DERM-VENEREOL, V81, P22, DOI 10.1080/000155501750208137; Haeck IM, 2011, J AM ACAD DERMATOL, V64, P1074, DOI 10.1016/j.jaad.2010.04.027; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Jacob SE, 2006, J AM ACAD DERMATOL, V54, P723, DOI 10.1016/j.jaad.2005.12.028; Katayama I, 2016, ALLERGOL INT; Kim JE, 2016, DERMATOL THER, V29, P120, DOI 10.1111/dth.12333; Politiek K, 2016, BRIT J DERMATOL, V174, P201, DOI 10.1111/bjd.13961; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Sanchez-Perez J, 2013, ACTAS DERMO-SIFILOGR, V104, P44, DOI 10.1016/j.ad.2012.03.008; Schram ME, 2012, ALLERGY, V67, P99, DOI 10.1111/j.1398-9995.2011.02719.x; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P1218, DOI 10.1016/j.jaad.2014.08.038; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Silverberg JI, 2016, J DERMATOL TREAT, V27, P568, DOI 10.1080/09546634.2016.1174765; Silverberg JI, 2015, J INVEST DERMATOL, V135, P56, DOI 10.1038/jid.2014.325; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Simpson E, 2017, AM AC DERM 75 ANN M; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Simpson EL, 2016, J AM ACAD DERMATOL, V75, P506, DOI 10.1016/j.jaad.2016.04.054; Simpson EL, 2016, J AM ACAD DERMATOL, V74, P491, DOI 10.1016/j.jaad.2015.10.043; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; van der Schaft J, 2016, BRIT J DERMATOL, V175, P199, DOI 10.1111/bjd.14398; van der Schaft J, 2015, BRIT J DERMATOL, V172, P1621, DOI 10.1111/bjd.13730; van Velsen SGA, 2010, J AM ACAD DERMATOL, V63, P911, DOI 10.1016/j.jaad.2009.12.048; von Kobyletzki LB, 2017, ACTA DERM-VENEREOL, V97, P86, DOI 10.2340/00015555-2480; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Zonneveld IM, 1996, BRIT J DERMATOL, V135, P15, DOI 10.1111/j.1365-2133.1996.tb00704.x	41	625	646	5	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2287	2303		10.1016/S0140-6736(17)31191-1	http://dx.doi.org/10.1016/S0140-6736(17)31191-1			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW9XM	28478972	Green Submitted			2022-12-28	WOS:000402872700024
J	Silverman, M; Povitz, M; Sontrop, JM; Li, LH; Richard, L; Cejic, S; Shariff, SZ				Silverman, Michael; Povitz, Marcus; Sontrop, Jessica M.; Li, Lihua; Richard, Lucie; Cejic, Sonny; Shariff, Salimah Z.			Antibiotic Prescribing for Nonbacterial Acute Upper Respiratory Infections in Elderly Persons	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; TRACT INFECTIONS; GENERAL-PRACTITIONERS; ADMINISTRATIVE DATA; SORE THROAT; ADULTS; PERCEPTIONS; POPULATION; INCENTIVES; PREDICTORS	Background: Reducing inappropriate antibiotic prescribing for acute upper respiratory tract infections (AURIs) requires a better understanding of the factors associated with this practice. Objective: To determine the prevalence of antibiotic prescribing for nonbacterial AURIs and whether prescribing rates varied by physician characteristics. Design: Retrospective analysis of linked administrative health care data. Setting: Primary care physician practices in Ontario, Canada (January-December 2012). Patients: Patients aged 66 years or older with nonbacterial AURIs. Patients with cancer or immunosuppressive conditions and residents of long-term care homes were excluded. Measurements: Antibiotic prescriptions for physician-diagnosed AURIs. A multivariable logistic regression model with generalized estimating equations was used to examine whether prescribing rates varied by physician characteristics, accounting for clustering of patients among physicians and adjusting for patient-level covariates. Results: The cohort included 8990 primary care physicians and 185 014 patients who presented with a nonbacterial AURI, including the common cold (53.4%), acute bronchitis (31.3%), acute sinusitis (13.6%), or acute laryngitis (1.6%). Forty-six percent of patients received an antibiotic prescription; most prescriptions were for broad-spectrum agents (69.9% [95% CI, 69.6% to 70.2%]). Patients were more likely to receive prescriptions from mid- and late-career physicians than early-career physicians (rate difference, 5.1 percentage points [CI, 3.9 to 6.4 percentage points] and 4.6 percentage points [CI, 3.3 to 5.8 percentage points], respectively), from physicians trained outside of Canada or the United States (3.6 percentage points [CI, 2.5 to 4.6 percentage points]), and from physicians who saw 25 to 44 patients per day or 45 or more patients per day than those who saw fewer than 25 patients per day (3.1 percentage points [CI, 2.1 to 4.0 percentage points] and 4.1 percentage points [CI, 2.7 to 5.5 percentage points], respectively). Limitation: Physician rationale for prescribing was unknown. Conclusion: In this low-risk elderly cohort, 46% of patients with a nonbacterial AURI were prescribed antibiotics. Patients were more likely to receive prescriptions from mid-or late-career physicians with high patient volumes and from physicians who were trained outside of Canada or the United States. Primary Funding Source: Ontario Ministry of Health and Longterm Care, Academic Medical Organization of Southwestern Ontario, Schulich School of Medicine and Dentistry, Western University, and Lawson Health Research Institute.	[Silverman, Michael] St Josephs Hlth Care, Schulich Sch Med & Dent, Dept Med, Div Infect Dis, Room B3-404,268 Grosvenor St, London, ON N6A 4V2, Canada; [Povitz, Marcus; Sontrop, Jessica M.; Richard, Lucie; Shariff, Salimah Z.] Victoria Hosp, Inst Clin Evaluat Sci Western, Room ELL 215,800 Commissioners Rd East, London, ON, Canada; [Cejic, Sonny] Byron Family Med Ctr, 1228 Commissioners Rd West, London, ON N6K 1C7, Canada	Western University (University of Western Ontario); University of Victoria; Western University (University of Western Ontario)	Silverman, M (corresponding author), St Josephs Hosp, Schulich Sch Med & Dent, Dept Med, Div Infect Dis, Room B3-404 268 Grosvenor, London, ON N6A 4V2, Canada.	Michael.Silverman@sjhc.london.on.ca	Silverman, Michael/J-3776-2014; Povitz, Marcus/F-6615-2018	Silverman, Michael/0000-0002-0389-7656; Shariff, Salimah/0000-0002-1219-6763; Sontrop, Jessica M./0000-0001-7784-2028; Richard, Lucie/0000-0001-6577-5067; Li, Lihua/0000-0003-3154-9576	Ontario Ministry of Health and Longterm Care; Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry; Western University; Lawson Health Research Institute	Ontario Ministry of Health and Longterm Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry; Western University; Lawson Health Research Institute	Ontario Ministry of Health and Longterm Care, Academic Medical Organization of Southwestern Ontario, Schulich School of Medicine and Dentistry, Western University, and Lawson Health Research Institute.	[Anonymous], 2016, ANT RES; Aspinall SL, 2005, CLIN THER, V27, P258, DOI 10.1016/j.clinthera.2005.02.002; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bagger K, 2015, EUR J GEN PRACT, V21, P118, DOI 10.3109/13814788.2014.1001361; Barnett ML, 2014, JAMA INTERN MED, V174, P138, DOI 10.1001/jamainternmed.2013.11673; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cadieux G, 2008, HEALTH SERV RES, V43, P2223, DOI 10.1111/j.1475-6773.2008.00873.x; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Carthy P, 2000, FAM PRACT, V17, P36, DOI 10.1093/fampra/17.1.36; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Daneman N, 2015, JAMA INTERN MED, V175, P1331, DOI 10.1001/jamainternmed.2015.2770; Daneman N, 2013, JAMA INTERN MED, V173, P673, DOI 10.1001/jamainternmed.2013.3029; De Sutter AI, 2001, FAM PRACT, V18, P209, DOI 10.1093/fampra/18.2.209; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Dempsey PP, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0194-5; Ebell MH, 2015, AM J MANAG CARE, V21, pE567; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gill PS, 2001, J CLIN PHARM THER, V26, P195, DOI 10.1046/j.1365-2710.2001.00345.x; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Harris AM, 2016, ANN INTERN MED, V164, P425, DOI 10.7326/M15-1840; Hersh AL, 2016, JAMA INTERN MED, V176, P1870, DOI 10.1001/jamainternmed.2016.6625; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Jones BE, 2015, ANN INTERN MED, V163, P73, DOI 10.7326/M14-1933; Kiran T, 2012, DIABETES CARE, V35, P1038, DOI 10.2337/dc11-1402; Kozyrskyj AL, 2004, CAN MED ASSOC J, V171, P139, DOI 10.1503/cmaj.1031629; Kralj B, 2009, MEASURING RURALITY P; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Little P, 1997, BRIT MED J, V315, P350; Maserejian NN, 2014, ARTHRIT CARE RES, V66, P147, DOI 10.1002/acr.22143; Mazzaglia G, 2003, EUR J CLIN PHARMACOL, V59, P651, DOI 10.1007/s00228-003-0669-0; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Steele Leah S, 2013, Open Med, V7, pe9; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2009, AM J MANAG CARE, V15, P861; Tell D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008096; Tonkin-Crine S, 2011, J ANTIMICROB CHEMOTH, V66, P2215, DOI 10.1093/jac/dkr279; U. S. Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; U. S. Food and Drug Administration, 2016, FDA DRUG SAF COMM AZ; US Food and Drug Administration. 2015. Biaxin Filmtab (clarithromycin tablets USP), 2015, BIAX FILMT CLAR TABL; Wilkins, 2010, AUTOMATED GEOGRAPHIC; Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1499; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717	57	63	65	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					765	+		10.7326/M16-1131	http://dx.doi.org/10.7326/M16-1131			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28492914				2022-12-28	WOS:000402700200003
J	Smaglik, P				Smaglik, Paul			The genetic microscope	NATURE			English	Editorial Material																			0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S25	S27		10.1038/545S25a	http://dx.doi.org/10.1038/545S25a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514433	Bronze			2022-12-28	WOS:000401466500024
J	Kearns, P				Kearns, Patrick			Patient-Centered Medical Homes and Adherence to Chronic Disease Medications	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kearns, Patrick] Santa Clara Valley Med Ctr, Los Gatos, CA 95032 USA	Santa Clara Valley Medical Center	Kearns, P (corresponding author), Santa Clara Valley Med Ctr, Los Gatos, CA 95032 USA.							Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Lauffenburger JC, 2017, ANN INTERN MED, V166, P81, DOI 10.7326/M15-2659; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					760	761		10.7326/L17-0157	http://dx.doi.org/10.7326/L17-0157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505650				2022-12-28	WOS:000401240200031
J	Sacks, HS				Sacks, Henry S.			Review: In children and adults, vitamin D-3 supplementation reduces risk for acute respiratory tract infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE; D DEFICIENCY		[Sacks, Henry S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Sacks, HS (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; LeFevre ML, 2015, ANN INTERN MED, V162, P133, DOI 10.7326/M14-2450; Manson JE, 2015, JAMA-J AM MED ASSOC, V313, P1311, DOI 10.1001/jama.2015.1353; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC51	JC51		10.7326/ACPJC-2017-166-10-051	http://dx.doi.org/10.7326/ACPJC-2017-166-10-051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505635				2022-12-28	WOS:000401240200003
J	Voelker, R				Voelker, Rebecca			A First in HCV Drugs for Youths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1942	1942		10.1001/jama.2017.5542	http://dx.doi.org/10.1001/jama.2017.5542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510663				2022-12-28	WOS:000401315500008
J	Jones, DS				Jones, David S.			CABG at 50 (or 107?) - The Complex Course of Therapeutic Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jones, David S.] Harvard Med Sch, Dept Global Hlth & Social Med, Cambridge, MA 02115 USA; [Jones, David S.] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA	Harvard University	Jones, DS (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Cambridge, MA 02115 USA.; Jones, DS (corresponding author), Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA.				NATIONAL LIBRARY OF MEDICINE [G13LM012053] Funding Source: NIH RePORTER; NLM NIH HHS [G13 LM012053] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Captur G, 2004, TEX HEART I J, V31, P47; Jones DS, 2017, TECHNOLOGICAL CHANGE, P185; Konstantinov IE, 2000, ANN THORAC SURG, V69, P1966, DOI 10.1016/S0003-4975(00)01264-9; Konstantinov IE, 2004, TEX HEART I J, V31, P349; Mueller RL, 1997, ANN THORAC SURG, V63, P869, DOI 10.1016/S0003-4975(96)01375-6	5	14	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1809	1811		10.1056/NEJMp1702718	http://dx.doi.org/10.1056/NEJMp1702718			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28489988	Green Accepted			2022-12-28	WOS:000400891100004
J	Iacobucci, G				Iacobucci, Gareth			UK GENERAL ELECTION 2017 Conservatives and Labour trade blows on NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com						[Anonymous], 2017, QUEST TIM; [Anonymous], 2017, TODAY; Ashworth J., 2017, HUFFINGTON POST; Campbell D, 2017, GUARDIAN; Full Fact, 2017, NUMB DOCT NURS NHS E; Ham C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1678; NHS England, 2017, A E ATT EM ADM 2016; Show Andrew Marr, 2017, J HUNT PLEDG END MEN	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2017	357								j2246	10.1136/bmj.j2246	http://dx.doi.org/10.1136/bmj.j2246			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UE	28490475				2022-12-28	WOS:000401169600009
J	Cyrus, KD				Cyrus, Kali D.			Medical Education and the Minority Tax	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACADEMIC MEDICINE		[Cyrus, Kali D.] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University	Cyrus, KD (corresponding author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.	kali.cyrus@yale.edu						Amodio DM, 2014, NAT REV NEUROSCI, V15, P670, DOI 10.1038/nrn3800; Fnais N, 2014, ACAD MED, V89, P817, DOI 10.1097/ACM.0000000000000200; Grbic D, 2010, ANAL BRIEF AAMC, V9; Guevara JP, 2013, JAMA-J AM MED ASSOC, V310, P2297, DOI 10.1001/jama.2013.282116; Nivet M., 2014, DIVERSITY PHYS WORKF; Nivet MA, 2008, MT SINAI J MED, V75, P491, DOI 10.1002/msj.20079; Roberts LW, 2014, ACAD PSYCHIATR, V38, P394, DOI 10.1007/s40596-014-0175-y; Rodriguez JE, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0290-9	8	39	39	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1833	1834		10.1001/jama.2017.0196	http://dx.doi.org/10.1001/jama.2017.0196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492902				2022-12-28	WOS:000400842400010
J	Montgomery, MW; Yawetz, S; Levy, BD; Loscalzo, J				Montgomery, Mary W.; Yawetz, Sigal; Levy, Bruce D.; Loscalzo, Joseph			Back to the History	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COCCIDIOIDOMYCOSIS		Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg,77 Ave Louis Pasteur,HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Brown Jennifer, 2013, Clin Epidemiol, V5, P185, DOI 10.2147/CLEP.S34434; Crum NF, 2004, MEDICINE, V83, P149, DOI 10.1097/01.md.0000126762.91040.fd; Durkin M, 2008, CLIN INFECT DIS, V47, pE69, DOI 10.1086/592073; Galgiani JN, 2000, ANN INTERN MED, V133, P676, DOI 10.7326/0003-4819-133-9-200011070-00009; Galgiani JN, 2005, CLIN INFECT DIS, V41, P1217, DOI 10.1086/496991; Galgiani JN, 2016, CLIN INFECT DIS, V63, pE112, DOI 10.1093/cid/ciw360; Kakarla UK, 2011, J NEUROSURG-SPINE, V15, P441, DOI 10.3171/2011.5.SPINE10596; Martirosyan Nikolay L, 2015, Surg Neurol Int, V6, P107, DOI 10.4103/2152-7806.158979; Mirochnik BD, 2014, RADIOLOGY, V272, P914, DOI 10.1148/radiol.14112328; Nguyen C, 2013, CLIN MICROBIOL REV, V26, P505, DOI 10.1128/CMR.00005-13; STEVENS DA, 1995, NEW ENGL J MED, V332, P1077, DOI 10.1056/NEJM199504203321607; Stevens DA, 2009, CLIN INFECT DIS, V49, P919, DOI 10.1086/605441; Valdivia L, 2006, EMERG INFECT DIS, V12, P958	13	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1783	1788		10.1056/NEJMcps1607608	http://dx.doi.org/10.1056/NEJMcps1607608			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6ZH	28467866				2022-12-28	WOS:000400442300013
J	Davis, MC; Miller, BJ; Kalsi, JK; Birkner, T; Mathis, MV				Davis, Michael C.; Miller, Brian J.; Kalsi, Jasmeet K.; Birkner, Thomas; Mathis, Mitchell V.			Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUG-DEVELOPMENT		[Davis, Michael C.; Miller, Brian J.; Kalsi, Jasmeet K.; Mathis, Mitchell V.] Ctr Drug Evaluat & Res, Div Psychiat Prod, Silver Spring, MD 20993 USA; [Birkner, Thomas] Ctr Drug Evaluat & Res, Div Biometr 1, Silver Spring, MD USA; [Miller, Brian J.] Univ N Carolina, Kenan Flagler Sch Business, Chapel Hill, NC USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); University of North Carolina; University of North Carolina Chapel Hill	Davis, MC (corresponding author), Ctr Drug Evaluat & Res, Div Psychiat Prod, Silver Spring, MD 20993 USA.		Davis, Michael C/L-8920-2013	Davis, Michael C/0000-0003-2293-5694				Hauser RA, 2017, AM J PSYCHIAT, V174, P476, DOI 10.1176/appi.ajp.2017.16091037; McReynolds Connie J., 2002, J APPL REHABILITATIO, V33, P32; Moscicki RA, 2017, NEW ENGL J MED, V376, P469, DOI 10.1056/NEJMra1510070; Sherman RE, 2013, NEW ENGL J MED, V369, P1877, DOI 10.1056/NEJMp1311439; Woods SW, 2010, J CLIN PSYCHIAT, V71, P463, DOI 10.4088/JCP.07m03890yel	5	18	20	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2503	2506		10.1056/NEJMp1704898	http://dx.doi.org/10.1056/NEJMp1704898			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28489481				2022-12-28	WOS:000404259200002
J	Kroenke, K; Cheville, A				Kroenke, Kurt; Cheville, Andrea			Management of Chronic Pain in the Aftermath of the Opioid Backlash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Kroenke, Kurt] Indiana Univ Sch Med, VA Hlth Serv Res & Dev Serv, Ctr Hlth Informat & Commun, Indianapolis, IN 46202 USA; [Kroenke, Kurt] Regenstrief Inst Inc, Indianapolis, IN USA; [Cheville, Andrea] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Mayo Clinic	Kroenke, K (corresponding author), Regenstrief Inst Hlth Care, RF 221,1101 W 10th St, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org		Kroenke, Kurt/0000-0002-0114-4669				Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Enthoven WTM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012087; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Quinn PD, 2017, PAIN, V158, P140, DOI 10.1097/j.pain.0000000000000730; Reuben DB, 2015, ANN INTERN MED, V162, P295, DOI 10.7326/M14-2775; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251	9	39	38	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2365	2366		10.1001/jama.2017.4884	http://dx.doi.org/10.1001/jama.2017.4884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28494058				2022-12-28	WOS:000403654600004
J	Forster, P				Forster, Piers			In Retrospect Half a century of robust climate models	NATURE			English	Editorial Material							CARBON-DIOXIDE; THERMAL-EQUILIBRIUM; CO2 CONCENTRATION; ATMOSPHERE		[Forster, Piers] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Forster, P (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	p.m.forster@leeds.ac.uk	Forster, Piers M/F-9829-2010	Forster, Piers M/0000-0002-6078-0171				Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Callendar GS, 1938, Q J ROY METEOR SOC, V64, P223, DOI 10.1002/qj.49706427503; Forster PM, 2016, ANNU REV EARTH PL SC, V44, P85, DOI 10.1146/annurev-earth-060614-105156; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; MANABE S, 1975, J ATMOS SCI, V32, P3, DOI 10.1175/1520-0469(1975)032<0003:TEODTC>2.0.CO;2; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MANABE S, 1964, J ATMOS SCI, V21, P361, DOI 10.1175/1520-0469(1964)021<0361:TEOTAW>2.0.CO;2; MANABE S, 1969, J ATMOS SCI, V26, P786, DOI 10.1175/1520-0469(1969)026<0786:CCWACO>2.0.CO;2; MOLLER F, 1963, J GEOPHYS RES, V68, P3877; RAMANATHAN V, 1981, J ATMOS SCI, V38, P918, DOI 10.1175/1520-0469(1981)038<0918:TROOAI>2.0.CO;2; Silvers LG, 2016, J ADV MODEL EARTH SY, V8, P1330, DOI 10.1002/2016MS000629; Tyndall J, 1861, PHILOS MAG, V22, P273, DOI DOI 10.1098/RSTL.1861.0001; Tyndall J., 1861, PHILOS MAG, V22, DOI [DOI 10.1080/14786446108643138, 10.1080/14786446108643138]	14	4	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					296	297		10.1038/545296a	http://dx.doi.org/10.1038/545296a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28516918				2022-12-28	WOS:000401466500051
J	Marchini, M; Giglio, E				Marchini, Michele; Giglio, Elisabetta			Tuberous Sclerosis Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marchini, Michele; Giglio, Elisabetta] Univ Pisa, Pisa, Italy	University of Pisa	Marchini, M (corresponding author), Univ Pisa, Pisa, Italy.	m.marchini@ao-pisa.toscana.it		Marchini, Michele/0000-0002-6179-8971					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					E42	E42		10.1056/NEJMicm1610501	http://dx.doi.org/10.1056/NEJMicm1610501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514607				2022-12-28	WOS:000401407500012
J	Shen, NT; Maw, A; Schneider, Y; Rosenblatt, RE				Shen, Nicole T.; Maw, Anna; Schneider, Yecheskel; Rosenblatt, Russell Evan			Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years	ANNALS OF INTERNAL MEDICINE			English	Letter									[Shen, Nicole T.; Schneider, Yecheskel; Rosenblatt, Russell Evan] Weill Cornell Med Coll, New York, NY 10065 USA; [Maw, Anna] Univ Colorado, Denver, CO 80202 USA	Cornell University; University of Colorado System; University of Colorado Denver	Shen, NT (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.		Rosenblatt, Russell/W-6845-2019	Rosenblatt, Russell/0000-0003-3981-7053; Shen, Nicole/0000-0002-2951-7930				American Cancer Society, 2015, COL CANC WHAT AR SUR; Garcia-Albeniz X, 2017, ANN INTERN MED, V166, P18, DOI 10.7326/M16-0758; National Institutes of Health (NIH) NCI . Surveillance Epidemiology and End Results (SEER), 2010, SEER STAT FACT SHEET; The Henry J. Kaiser Family Foundation, 2016, PROFILE MED BENEFICI; United States Census Bureau, 2017, 2010 2015 AM COMM SU	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					758	758		10.7326/L17-0137	http://dx.doi.org/10.7326/L17-0137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505645				2022-12-28	WOS:000401240200026
J	Niiranen, TJ; McCabe, EL; Larson, MG; Henglin, M; Lakdawala, NK; Vasan, RS; Cheng, S				Niiranen, Teemu J.; McCabe, Elizabeth L.; Larson, Martin G.; Henglin, Mir; Lakdawala, Neal K.; Vasan, Ramachandran S.; Cheng, Susan			Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the Framingham Heart Study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; FAMILY-HISTORY; SECONDARY HYPERTENSION; INCIDENT HYPERTENSION; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; PARENTAL HISTORY; AGE; GUIDELINES; MANAGEMENT	OBJECTIVE To determine the role of early onset versus late onset hypertension as a risk factor for hypertension in offspring and cardiovascular death. Design Multigenerational, prospective cohort study. Setting Framingham Heart Study. Participants Two generations of community dwelling participants with blood pressure measurements performed at serial examinations spanning six decades: 3614 first generation participants with mortality data and 1635 initially non-hypertensive second generation participants with data available on parental blood pressure. Main outcome measures The main outcome measures were relation of parental early onset hypertension (age <55 years) with incidence of hypertension in offspring, using regression analyses, and relation of age at hypertension onset with cause specific mortality using a case (cardiovascular death) versus control (non-cardiovascular death) design. Results In second generation participants, having one or both parents with late onset hypertension did not increase the risk of hypertension compared with having parents with no hypertension; by contrast, the hazard ratios of hypertension were 2.0 (95% confidence interval 1.2 to 3.5) and 3.5 (1.9 to 6.1) in participants with one and both parents with early onset hypertension, respectively. In first generation decedents, 1151 cardiovascular deaths occurred (including 630 coronary deaths). The odds of cardiovascular death increased linearly with decreasing age of hypertension onset (P<0.001 for trend). Compared with non-hypertensive participants, hypertension onset at age <45 years conferred an odds ratios of 2.2 (1.8 to 2.7) for cardiovascular death and 2.3 (1.8 to 2.9) for coronary death, whereas hypertension onset at age >= 65 years conferred a lower magnitude odds ratios of 1.5 (1.2 to 1.9) for cardiovascular death and 1.4 (0.98 to 1.9) for coronary death (P <= 0.002 for differences in odds ratios between hypertension onset at age <45 and age >= 65). Conclusions Early onset and not late onset hypertension in parents was strongly associated with hypertension in offspring. In turn, early onset compared with late onset hypertension was associated with greater odds of cardiovascular, and particularly coronary, death. These findings suggest it may be important to distinguish between early onset and late onset hypertension as a familial trait when assessing an individual's risk for hypertension, and as a specific type of blood pressure trait when estimating risk for cardiovascular outcomes in adults with established hypertension.	[Niiranen, Teemu J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan] Natl Heart Blood & Lung Inst, Framingham, MA 01702 USA; [Niiranen, Teemu J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan] Boston Univ, Framingham Heart Study, Framingham, MA 01702 USA; [McCabe, Elizabeth L.; Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Henglin, Mir; Lakdawala, Neal K.; Cheng, Susan] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; Framingham Heart Study; Boston University; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Boston University	Niiranen, TJ (corresponding author), Natl Heart Blood & Lung Inst, Framingham, MA 01702 USA.; Niiranen, TJ (corresponding author), Boston Univ, Framingham Heart Study, Framingham, MA 01702 USA.	teemu.niiranen@thl.fi	Ramachandran, Vasan/Y-2527-2019; Niiranen, Teemu/R-1507-2017	Ramachandran, Vasan/0000-0001-7357-5970; Niiranen, Teemu/0000-0002-7394-7487; Cheng, Susan/0000-0002-4977-036X	American Heart Association; National Heart, Lung and Blood Institute's Framingham Heart Study [N01HC25195, HHSN268201500001I]; National Institutes of Health [T32GM74905, R01HL093328, R01HL107385, R01HL126136, R00HL107642, R01HL131532, R01HL134168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074905] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association (SC) and the National Heart, Lung and Blood Institute's Framingham Heart Study (contracts N01HC25195 and HHSN268201500001I), and the following National Institutes of Health grants: T32GM74905 (ELM), R01HL093328 (RSV), R01HL107385 (RSV), R01HL126136 (RSV), R00HL107642 (SC), R01HL131532 (SC), and R01HL134168 (SC). The funders played no role in the design of the study; the collection, analysis, and interpretation of the data; and the decision to approve publication of the finished manuscript. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Alegre-Diaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368; Bensen JT, 1999, GENET EPIDEMIOL, V17, P141, DOI 10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q; BUCK C, 1987, HYPERTENSION, V9, P204, DOI 10.1161/01.HYP.9.2.204; Burke V, 1998, J HYPERTENS, V16, P269, DOI 10.1097/00004872-199816030-00003; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Fava C, 2015, EUR J HUM GENET, V23, P969, DOI 10.1038/ejhg.2014.212; Fava C, 2013, HYPERTENSION, V61, P319, DOI 10.1161/HYPERTENSIONAHA.112.202655; FRIEDMAN GD, 1988, PREV MED, V17, P387, DOI 10.1016/0091-7435(88)90038-2; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Juhola J, 2012, CIRCULATION, V126, P402, DOI 10.1161/CIRCULATIONAHA.111.085977; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kannel W., 1987, FRAMINGHAM HEART STU; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kishi S, 2015, J AM COLL CARDIOL, V65, P2679, DOI 10.1016/j.jacc.2015.04.042; KRAUSE T, 2011, BRIT MED J, V343, DOI DOI 10.1136/BMJ.D4891; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; LAUER MS, 1991, J AM COLL CARDIOL, V18, P1287, DOI 10.1016/0735-1097(91)90549-O; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LIN DY, 1994, STAT MED, V13, P2233, DOI 10.1002/sim.4780132105; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Mitchell BD, 2003, ANN EPIDEMIOL, V13, P128, DOI 10.1016/S1047-2797(02)00255-7; Moser Marvin, 2006, J Clin Hypertens (Greenwich), V8, P15, DOI 10.1111/j.1524-6175.2006.05836.x; Niinikoski H, 2009, HYPERTENSION, V53, P918, DOI 10.1161/HYPERTENSIONAHA.109.130146; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; SHEAR CL, 1986, PEDIATRICS, V77, P862; Shook RP, 2012, HYPERTENSION, V59, P1220, DOI 10.1161/HYPERTENSIONAHA.112.191676; SIGURDSSON JA, 1983, EUR HEART J, V4, P424, DOI 10.1093/oxfordjournals.eurheartj.a061489; Siven SSE, 2015, SCAND J PUBLIC HEALT, V43, P246, DOI 10.1177/1403494815571031; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Toren P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2109; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; Viera AJ, 2010, AM FAM PHYSICIAN, V82, P1471; Wallace ML, 2015, J GEN INTERN MED, V30, P768, DOI 10.1007/s11606-015-3202-0; Wang NY, 2008, ARCH INTERN MED, V168, P643, DOI 10.1001/archinte.168.6.643; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3; Zhao Q, 2013, CURR HYPERTENS REP, V15, P676, DOI 10.1007/s11906-013-0388-6	46	44	44	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2017	357								j1949	10.1136/bmj.j1949	http://dx.doi.org/10.1136/bmj.j1949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UL	28500036	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000401170300001
J	Voelker, R				Voelker, Rebecca			Medicaid's Impact on Overdose Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1827	1827		10.1001/jama.2017.5101	http://dx.doi.org/10.1001/jama.2017.5101			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492907				2022-12-28	WOS:000400842400007
J	Barrie, M				Barrie, Michael			Herbert Barrie Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BARRIE H, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2187	10.1136/bmj.j2187	http://dx.doi.org/10.1136/bmj.j2187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483973				2022-12-28	WOS:000401412700015
J	Hofmann, B; Skolbekken, JA				Hofmann, Bjorn; Skolbekken, John-Arne			Surge in publications on early detection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hofmann, Bjorn] Norwegian Univ Sci & Technol, Dept Hlth Sci Gjovik, Trondheim, Norway; [Skolbekken, John-Arne] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hofmann, B (corresponding author), Norwegian Univ Sci & Technol, Dept Hlth Sci Gjovik, Trondheim, Norway.	b.m.hofmann@medisin.uio.no	Hofmann, Bjørn/AAI-7121-2020	Hofmann, Bjørn/0000-0001-6709-4265	Commonwealth Fund through Harkness Fellowship at The Dartmouth Institute of Health Policy and Clinical Practice (TDI); Commonwealth Fund through Harkness Fellowship at The Dartmouth Institute of Health Policy and Clinical Practice (TDI)	Commonwealth Fund through Harkness Fellowship at The Dartmouth Institute of Health Policy and Clinical Practice (TDI); Commonwealth Fund through Harkness Fellowship at The Dartmouth Institute of Health Policy and Clinical Practice (TDI)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author). We have read and understood BMJ policy on competing interests and declare that BH has received funding from the Commonwealth Fund through the Harkness Fellowship at The Dartmouth Institute of Health Policy and Clinical Practice (TDI) for the initial part of the research. The views presented here are those of the author and not necessarily those of the Commonwealth Fund their directors, officers, or staff or of TDI.	Arnold H D, 1907, Trans Am Climatol Assoc, V23, P289; Aronowitz RA, 2009, MILBANK Q, V87, P417, DOI 10.1111/j.1468-0009.2009.00563.x; Chisholm C., 1822, MANUAL CLIMATE DIS T; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57; Gardner Kirsten E., 2006, EARLY DETECTION WOME; Halpin SFS, 2009, BRIT J RADIOL, V82, P982, DOI 10.1259/bjr/61782960; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Highsmith J., 2014, BIOMARKERS TECHNOLOG; Hoffmann TC, 2017, JAMA INTERN MED, V177, P407, DOI 10.1001/jamainternmed.2016.8254; Krogsboll Lasse T, 2012, BMJ, V345, pe7191, DOI 10.1136/bmj.e7191; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Saquib N, 2015, INT J EPIDEMIOL, V44, P264, DOI 10.1093/ije/dyu140; Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487; Welch H, 2011, OVERDIAGNOSED MAKING; Wilson AD, 2015, METABOLITES, V5, P140, DOI 10.3390/metabo5010140; Wu L, 2015, CHEM SOC REV, V44, P2963, DOI 10.1039/c4cs00370e	20	10	10	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2102	10.1136/bmj.j2102	http://dx.doi.org/10.1136/bmj.j2102			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483750	Green Published			2022-12-28	WOS:000401412700002
J	Wigglesworth, D				Wigglesworth, David			William McIntyre Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MCINTYRE W, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2184	10.1136/bmj.j2184	http://dx.doi.org/10.1136/bmj.j2184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483789				2022-12-28	WOS:000401412700014
J	Rochon, PA; Gurwitz, JH				Rochon, Paula A.; Gurwitz, Jerry H.			The prescribing cascade revisited	LANCET			English	Editorial Material							CHOLINESTERASE-INHIBITORS; DRUG-THERAPY		[Rochon, Paula A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Rochon, Paula A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rochon, Paula A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Gurwitz, Jerry H.] Meyers Primary Care Inst, Worcester, MA USA; [Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Dept Med, Div Geriatr Med, Worcester, MA USA	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Massachusetts System; University of Massachusetts Worcester	Rochon, PA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada.; Rochon, PA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Rochon, PA (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	paula.rochon@wchospital.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151	Canadian Institutes of Health Research; US National Institute on Aging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We declare no competing interests. PAR holds the Retired Teachers of Ontario/Les enseignantes et enseignants retraites de l'Ontario (RTO/ERO) Chair in Geriatric Medicine at the University of Toronto and receives funding from the Canadian Institutes of Health Research. JHG receives funding from the US National Institute on Aging.	Ball R, 2016, CLIN PHARMACOL THER, V99, P265, DOI 10.1002/cpt.320; Canadian Institute for Health Information, 2013, ADV DRUG REACT REL H; Choosing Wisely Australia, 2016, 5 THINGS CLIN CONS S; Gill SS, 2005, ARCH INTERN MED, V165, P808, DOI 10.1001/archinte.165.7.808; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Greater Manchester Shared Services National Health Service, 2016, POL DEPR TOOLK VERS; GURWITZ JH, 1994, JAMA-J AM MED ASSOC, V272, P781, DOI 10.1001/jama.272.10.781; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; ROCHON PA, 1995, LANCET, V346, P32, DOI 10.1016/S0140-6736(95)92656-9; Rosenberg J, 2014, J AM GERIATR SOC, V62, P580, DOI 10.1111/jgs.12714; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324	12	100	102	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1778	1780		10.1016/S0140-6736(17)31188-1	http://dx.doi.org/10.1016/S0140-6736(17)31188-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495154				2022-12-28	WOS:000400549300007
J	Ocko, IB; Hamburg, SP; Jacob, DJ; Keith, DW; Keohane, NO; Oppenheimer, M; Roy-Mayhew, JD; Schrag, DP; Pacala, SW				Ocko, Ilissa B.; Hamburg, Steven P.; Jacob, Daniel J.; Keith, David W.; Keohane, Nathaniel O.; Oppenheimer, Michael; Roy-Mayhew, Joseph D.; Schrag, Daniel P.; Pacala, Stephen W.			Unmask temporal trade-offs in climate policy debates	SCIENCE			English	Editorial Material							POLLUTANTS; POTENTIALS		[Ocko, Ilissa B.; Hamburg, Steven P.; Keohane, Nathaniel O.] Environm Def Fund, New York, NY 10010 USA; [Jacob, Daniel J.; Keith, David W.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Roy-Mayhew, Joseph D.] Harvard Univ, Off Technol Dev, Cambridge, MA 02138 USA; [Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Environmental Defense Fund; Harvard University; Princeton University; Princeton University; Harvard University; Harvard University; Princeton University	Ocko, IB (corresponding author), Environm Def Fund, New York, NY 10010 USA.; Pacala, SW (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	iocko@edf.org; pacala@princeton.edu		Oppenheimer, Michael/0000-0002-9708-5914	Robertson Foundation; Kravis Scientific Research Fund; High Meadows Foundation	Robertson Foundation; Kravis Scientific Research Fund; High Meadows Foundation	This work was partially funded by the Robertson Foundation, the Kravis Scientific Research Fund, and the High Meadows Foundation. We are very appreciative of B. O'Neill and M. Levi for discussions and for reviewing earlier versions of the manuscript. We thank J. Decicco and J. Greene for providing insight into other fields with similar strategies, and two anonymous reviewers for helpful feedback.	Allen MR, 2016, NAT CLIM CHANGE, V6, P773, DOI [10.1038/nclimate2998, 10.1038/NCLIMATE2998]; Alvarez RA, 2012, P NATL ACAD SCI USA, V109, P6435, DOI 10.1073/pnas.1202407109; Bowerman NHA, 2013, NAT CLIM CHANGE, V3, P1021, DOI [10.1038/nclimate2034, 10.1038/NCLIMATE2034]; Chapin III F. S., 2014, COMMUNICATION; Collins WJ, 2013, ATMOS CHEM PHYS, V13, P2471, DOI 10.5194/acp-13-2471-2013; Daniel JS, 2012, CLIMATIC CHANGE, V111, P241, DOI 10.1007/s10584-011-0136-3; Goodland R, 2009, WORLD WATCH; Hughes JD, 2011, LIFE CYCLE GREENHOUS; Lowell D., 2012, CLEAN DIESEL VERSUS; Myhre G., 2013, PHYS SCI BASIS CONTR; Plattner G-K, 2009, IPCC EXP M SCI ALT M; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shoemaker JK, 2013, SCIENCE, V342, P1323, DOI 10.1126/science.1240162; Tol RSJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044006	14	59	59	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					492	493		10.1126/science.aaj2350	http://dx.doi.org/10.1126/science.aaj2350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473552				2022-12-28	WOS:000400545700021
J	Gupta, A; Thompson, D; Whitehouse, A; Collier, T; Dahlof, B; Poulter, N; Collins, R; Sever, P				Gupta, Ajay; Thompson, David; Whitehouse, Andrew; Collier, Tim; Dahlof, Bjorn; Poulter, Neil; Collins, Rory; Sever, Peter		ASCOT Investigators	Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase	LANCET			English	Article							CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; PREVENTION; RISK; PARTICIPANTS; INTOLERANCE; MANAGEMENT	Background In blinded randomised controlled trials, statin therapy has been associated with few adverse events (AEs). By contrast, in observational studies, larger increases in many different AEs have been reported than in blinded trials. Methods In the Lipid-Lowering Arm of the Anglo-Scandinavian Cardiac Outcomes Trial, patients aged 40-79 years with hypertension, at least three other cardiovascular risk factors, and fasting total cholesterol concentrations of 6.5 mmol/L or lower, and who were not taking a statin or fibrate, had no history of myocardial infarction, and were not being treated for angina were randomly assigned to atorvastatin 10 mg daily or matching placebo in a randomised double-blind placebo-controlled phase. In a subsequent non-randomised non-blind extension phase (initiated because of early termination of the trial because efficacy of atorvastatin was shown), all patients were offered atorvastatin 10 mg daily open label. We classified AEs using the Medical Dictionary for Regulatory Activities. We blindly adjudicated all reports of four prespecified AEs of interest-muscle-related, erectile dysfunction, sleep disturbance, and cognitive impairment-and analysed all remaining AEs grouped by system organ class. Rates of AEs are given as percentages per annum. Results The blinded randomised phase was done between February, 1998, and December, 2002; we included 101 80 patients in this analysis (5101 [50%] in the atorvastatin group and 5079 [50%] in the placebo group), with a median follow-up of 3.3 years (IQR 2.7-3.7). The non-blinded non-randomised phase was done between December, 2002, and June, 2005; we included 9899 patients in this analysis (6409 [65%] atorvastatin users and 3490 [35%] nonusers), with a median follow-up of 2.3 years (2.2-2.4). During the blinded phase, muscle-related AEs (298 [2.03% per annum] vs 283 [2.00% per annum]; hazard ratio 1.03 [95% CI 0.88-1.21]; p= 0.72) and erectile dysfunction (272 [1.86% per annum] vs 302 [2.14% per annum]; 0.88 [0.75-1.04]; p= 0.13) were reported at a similar rate by participants randomly assigned to atorvastatin or placebo. The rate of reports of sleep disturbance was significantly lower among participants assigned atorvastatin than assigned placebo (149 [1.00% per annum] vs 210 [1.46% per annum]; 0.69 [0.56-0.85]; p= 0.0005). Too few cases of cognitive impairment were reported for a statistically reliable analysis (31 [0.20% per annum] vs 32 [0.22% per annum]; 0.94 [057-1.54]; p= 0.81). We observed no significant differences in the rates of all other reported AEs, with the exception of an excess of renal and urinary AEs among patients assigned atorvastatin (481 [1.87%] per annum vs 392 [1.51%] per annum; 1.23 [1.08-1.41]; p= 0.002). By contrast, during the non-blinded non-randomised phase, muscle-related AEs were reported at a significantly higher rate by participants taking statins than by those who were not (161 [1.26% per annum] vs 124 [1.00% per annum]; 1.41 [1.10-1.79]; p= 0.006). We noted no significant differences between statin users and non-users in the rates of other AEs, with the exception of musculoskeletal and connective tissue disorders (992 [8.69% per annum] vs 831 [7.45% per annum]; 1.17 [1.06-1.29]; p= 0.001) and blood and lymphatic system disorders (114 [0.88% per annum] vs 80 [0.64% per annum]; 1.40 [1.04-1.88]; p= 0.03), which were reported more commonly by statin users than by non-users. Interpretation These analyses illustrate the so-called nocebo effect, with an excess rate of muscle-related AE reports only when patients and their doctors were aware that statin therapy was being used and not when its use was blinded. These results will help assure both physicians and patients that most AEs associated with statins are not causally related to use of the drug and should help counter the adverse effect on public health of exaggerated claims about statin-related side-effects.	[Gupta, Ajay; Thompson, David; Whitehouse, Andrew; Sever, Peter] Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England; [Gupta, Ajay] Royal London Hosp, Barts Hlth NHS Trust, London, England; [Gupta, Ajay] Queen Mary Univ London, William Harvey Res Inst, London, England; [Collier, Tim] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Dahlof, Bjorn] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Poulter, Neil] Imperial Coll London, Imperial Clin Trials Unit, London, England; [Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Oxford, England; [Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Nuffield Dept Populat Hlth, Oxford, England	Imperial College London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; University of Gothenburg; Imperial College London; University of Oxford; University of Oxford	Sever, P (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England.	p.sever@imperial.ac.uk	Collins, Rory/ABA-8487-2020; Gupta, Ajay/AAG-9859-2020; Whitehouse, Andrew J.O./AGJ-2519-2022	Gupta, Ajay/0000-0001-5807-8503; Whitehouse, Andrew J.O./0000-0001-8722-1575; Thompson, David/0000-0002-0850-7784	Pfizer; Servier Research Group; Leo Laboratories; National Institute for Health Research [NF-SI-0513-10059] Funding Source: researchfish	Pfizer(Pfizer); Servier Research Group; Leo Laboratories; National Institute for Health Research(National Institute for Health Research (NIHR))	Pfizer, Servier Research Group, and Leo Laboratories.	ABC1, 2013, HEART MATT 2; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], 2014, INTR GUID MEDDRA VER; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; ASCOT Study, TABL 1 ADV EV LEAD P; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Desai CS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3743; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; Guyton JR, 2014, J CLIN LIPIDOL, V8, pS72, DOI 10.1016/j.jacl.2014.03.002; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Matthews A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3283; Medicines and Healthcare Products Regulatory Agency, 2009, MHRA PUBL ASS REP ST; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; National Institute for Health and Care Excellence, 2014, CARD DIS RISK ASS RE; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Sever PS, 2008, EUR HEART J, V29, P499, DOI 10.1093/eurheartj/ehm583; Sever PS, 2001, J HYPERTENS, V19, P1139, DOI 10.1097/00004872-200106000-00020; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Thompson R, 2014, LATEST NICE DRAFT GU; Tobert JA, 2016, J CLIN LIPIDOL, V10, P739, DOI 10.1016/j.jacl.2016.05.002; Tuccori M, 2014, CNS DRUGS, V28, P249, DOI 10.1007/s40263-013-0135-1; US Food and Drug Administration, 2016, FDA DRUG SAF COMM IM; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	31	200	206	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2473	2481		10.1016/S0140-6736(17)31075-9	http://dx.doi.org/10.1016/S0140-6736(17)31075-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY3VF	28476288	Green Accepted, Green Submitted			2022-12-28	WOS:000403901800026
J	Kiziltan, B; Baumgardt, H; Loeb, A				Kiziltan, Blent; Baumgardt, Holger; Loeb, Abraham			An intermediate-mass black hole in the centre of the globular cluster 47 Tucanae (vol 542, pg 203, 2017)	NATURE			English	Correction														Kiziltan, Bulent/0000-0002-7109-6391					1	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					510	510		10.1038/nature22320	http://dx.doi.org/10.1038/nature22320			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28467823	Bronze			2022-12-28	WOS:000401906500058
J	Xu, GY; Uan, MY; Ai, CR; Liu, LJ; Zhuang, E; Karapetyan, S; Wang, S; Dong, XN				Xu, Guoyong; Uan, Meng Y.; Ai, Chaoren; Liu, Lijing; Zhuang, Edward; Karapetyan, Sargis; Wang, Shiping; Dong, Xinnian			uORF-mediated translation allows engineered plant disease resistance without fitness costs	NATURE			English	Article							MOLECULAR-PATTERNS; IMMUNE-SYSTEM; RICE; ARABIDOPSIS; DEFENSE; GENE; TRANSFORMATION; EXPRESSION; PROTEIN; DISSECTION	Controlling plant disease has been a struggle for humankind since the advent of agriculture. Studies of plant immune mechanisms have led to strategies of engineering resistant crops through ectopic transcription of plants' own defence genes, such as the master immune regulatory gene NPR1 (ref. 1). However, enhanced resistance obtained through such strategies is often associated with substantial penalties to fitness(2), making the resulting products undesirable for agricultural applications. To remedy this problem, we sought more stringent mechanisms of expressing defence proteins. On the basis of our latest finding that translation of key immune regulators, such as TBF1 (ref. 3), is rapidly and transiently induced upon pathogen challenge (see accompanying paper(4)), we developed a 'TBF1-cassette' consisting of not only the immune-inducible promoter but also two pathogen-responsive upstream open reading frames (uORFs(TBF1)) of the TBF1 gene. Here we demonstrate that inclusion of uORFs(TBF1)-mediated translational control over the production of snc1-1 (an autoactivated immune receptor) in Arabidopsis thaliana and AtNPR1 in rice enables us to engineer broad-spectrum disease resistance without compromising plant fitness in the laboratory or in the field. This broadly applicable strategy may lead to decreased pesticide use and reduce the selective pressure for resistant pathogens.	[Xu, Guoyong; Liu, Lijing; Zhuang, Edward; Karapetyan, Sargis; Dong, Xinnian] Duke Univ, Dept Biol, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA; [Uan, Meng Y.; Ai, Chaoren; Wang, Shiping] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China	Duke University; Howard Hughes Medical Institute; Huazhong Agricultural University	Dong, XN (corresponding author), Duke Univ, Dept Biol, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Durham, NC 27708 USA.	xdong@duke.edu	Liu, Lijing/ADB-0506-2022; Yuan, Meng/E-4949-2013	Yuan, Meng/0000-0003-1381-9202; Karapetyan, Sargis/0000-0003-0020-310X; liu, lijing/0000-0003-0260-8493	National Institutes of Health [5R01 GM069594-11]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3032]; National Natural Science Foundation of China [31371926]; National Key Research and Development Program of China [2016YFD0100903]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594, R35GM118036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from National Institutes of Health 5R01 GM069594-11 and Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (through grant GBMF3032) to X.D., National Natural Science Foundation of China (31371926) to M.Y., and the National Key Research and Development Program of China (2016YFD0100903) to S.W. We thank J. Motley, J. Marques, P. Zwack and S. Zebell for comments on this manuscript.	Benedetti M, 2015, P NATL ACAD SCI USA, V112, P5533, DOI 10.1073/pnas.1504154112; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bouwmeester K, 2014, PLANT BIOTECHNOL J, V12, P10, DOI 10.1111/pbi.12111; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chern Maw-Sheng, 2001, Plant Journal, V27, P101, DOI 10.1046/j.1365-313x.2001.01070.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Fitzgerald HA, 2004, MOL PLANT MICROBE IN, V17, P140, DOI 10.1094/MPMI.2004.17.2.140; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Johnson K C M, 2012, Cold Spring Harb Symp Quant Biol, V77, P259, DOI 10.1101/sqb.2013.77.014738; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang HX, 2016, MOL PLANT PATHOL, V17, P959, DOI 10.1111/mpp.12340; Kim SH, 2016, SCIENCE, V351, P684, DOI 10.1126/science.aad3436; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lawless C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-7; Li X, 2001, MOL PLANT MICROBE IN, V14, P1131, DOI 10.1094/MPMI.2001.14.10.1131; Li YQ, 2007, MOL PLANT MICROBE IN, V20, P1449, DOI 10.1094/MPMI-20-11-1449; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Molla KA, 2016, PLANT SCI, V250, P105, DOI 10.1016/j.plantsci.2016.06.005; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Pajerowska-Mukhtar KM, 2012, CURR BIOL, V22, P103, DOI 10.1016/j.cub.2011.12.015; Quilis J, 2008, MOL PLANT MICROBE IN, V21, P1215, DOI 10.1094/MPMI-21-9-1215; Rahmani F, 2009, PLANT PHYSIOL, V150, P1356, DOI 10.1104/pp.109.136036; Schwessinger B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004809; Xu G., 2017, NATURE; Xu GY, 2012, PLANT J, V72, P57, DOI 10.1111/j.1365-313X.2012.05053.x; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Yi H, 2007, PLANT CELL, V19, P2929, DOI 10.1105/tpc.107.051821; Yuan M, 2016, ELIFE, V5, DOI 10.7554/eLife.19605; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x	33	164	175	22	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					491	+		10.1038/nature22372	http://dx.doi.org/10.1038/nature22372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514448	Green Accepted			2022-12-28	WOS:000401906500054
J	Mansour, MK; Letourneau, AR; Wallace, ZS; Fintelmann, FJ; Foreman, RK				Mansour, Michael K.; Letourneau, Alyssa R.; Wallace, Zachary S.; Fintelmann, Florian J.; Foreman, Ruth K.			Case 15-2017: A 27-Year-Old Woman with Anemia, Thrombocytosis, and Skin Lesions after Travel Abroad	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL ARTERITIS; TAKAYASU ARTERITIS; POLYMYALGIA-RHEUMATICA; LIVER		[Mansour, Michael K.; Letourneau, Alyssa R.; Wallace, Zachary S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fintelmann, Florian J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Foreman, Ruth K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mansour, Michael K.; Letourneau, Alyssa R.; Wallace, Zachary S.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Fintelmann, Florian J.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Foreman, Ruth K.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mansour, MK (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Mansour, MK (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.				McKesson Health Solutions	McKesson Health Solutions	Dr. Fintelmann reports receiving consulting fees from McKesson Health Solutions. No other potential conflict of interest relevant to this article was reported.	AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Bateman Helen, 2009, Curr Rheumatol Rep, V11, P422; COHEN CD, 1980, S AFR MED J, V57, P1076; Gilden D, 2016, J INFECT DIS, V213, P1866, DOI 10.1093/infdis/jiw101; Hartlage GR, 2014, JACC-CARDIOVASC IMAG, V7, P605, DOI 10.1016/j.jcmg.2014.04.002; HOFFMAN GS, 1994, ARTHRITIS RHEUM, V37, P578, DOI 10.1002/art.1780370420; KYLE V, 1991, BAILLIERE CLIN RHEUM, V5, P475, DOI 10.1016/S0950-3579(05)80066-4; Mekinian A, 2015, CIRCULATION, V132, P1693, DOI 10.1161/CIRCULATIONAHA.114.014321; Molloy ES, 2008, CURR OPIN RHEUMATOL, V20, P29, DOI 10.1097/BOR.0b013e3282f1dcf2; Noris M, 1999, CIRCULATION, V100, P55, DOI 10.1161/01.CIR.100.1.55; Pascual-Lopez M, 2004, DERMATOLOGY, V208, P10, DOI 10.1159/000075039; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750	12	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1973	1981		10.1056/NEJMcpc1616396	http://dx.doi.org/10.1056/NEJMcpc1616396			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514603				2022-12-28	WOS:000401407500013
J	Tammela, T; Sanchez-Rivera, FJ; Cetinbas, NM; Wu, K; Joshi, NS; Helenius, K; Park, Y; Azimi, R; Kerper, NR; Wesselhoeft, RAL; Gu, X; Schmidt, L; Cornwall-Brady, M; Yilmaz, OH; Xue, W; Katajisto, P; Bhutkar, A; Jacks, T				Tammela, Tuomas; Sanchez-Rivera, Francisco J.; Cetinbas, Naniye Malli; Wu, Katherine; Joshi, Nikhil S.; Helenius, Katja; Park, Yoona; Azimi, Roxana; Kerper, Natanya R.; Wesselhoeft, R. A. Lexander; Gu, Xin; Schmidt, Leah; Cornwall-Brady, Milton; Yilmaz, Omer H.; Xue, Wen; Katajisto, Pekka; Bhutkar, Arjun; Jacks, Tyler			A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma	NATURE			English	Article							BETA-CATENIN; TRANSCRIPTIONAL ACTIVATION; TUMOR INITIATION; CANCER; CELL; CRISPR-CAS9; GENERATION; IDENTIFICATION; TUMORIGENESIS; INACTIVATION	The heterogeneity of cellular states in cancer has been linked to drug resistance, cancer progression and the presence of cancer cells with properties of normal tissue stem cells(1,2). Secreted Wnt signals maintain stem cells in various epithelial tissues, including in lung development and regeneration(3-5). Here we show that mouse and human lung adenocarcinomas display hierarchical features with two distinct subpopulations, one with high Wnt signalling activity and another forming a niche that provides the Wnt ligand. The Wnt responder cells showed increased tumour propagation ability, suggesting that these cells have features of normal tissue stem cells. Genetic perturbation of Wnt production or signalling suppressed tumour progression. Small-molecule inhibitors targeting essential posttranslational modification of Wnt reduced tumour growth and markedly decreased the proliferative potential of lung cancer cells, leading to improved survival of tumour-bearing mice. These results indicate that strategies for disrupting pathways that maintain stem-like and niche cell phenotypes can translate into effective anti-cancer therapies.	[Tammela, Tuomas; Sanchez-Rivera, Francisco J.; Cetinbas, Naniye Malli; Wu, Katherine; Joshi, Nikhil S.; Helenius, Katja; Park, Yoona; Azimi, Roxana; Kerper, Natanya R.; Wesselhoeft, R. A. Lexander; Gu, Xin; Schmidt, Leah; Cornwall-Brady, Milton; Yilmaz, Omer H.; Xue, Wen; Bhutkar, Arjun; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Katajisto, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Katajisto, Pekka] Karolinska Inst, Dept Biosci & Nutr, S-14183 Stockholm, Sweden; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Helsinki; Karolinska Institutet; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.; Jacks, T (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tjacks@mit.edu	Sánchez-Rivera, Francisco J./AAV-6985-2020	Sánchez-Rivera, Francisco J./0000-0002-8466-8563; Katajisto, Pekka/0000-0002-3033-4189; /0000-0003-3675-6961; Wu, Katherine/0000-0002-0472-0166; Joshi, Nikhil/0000-0002-7045-7837	Transcend Program; Janssen Pharmaceuticals; Lung Cancer Research Foundation; Howard Hughes Medical Institute; Cancer Center from the National Cancer Institute [P30-CA14051]; National Cancer Institute [K99 CA187317]; Sigrid Juselius Foundation; Hope Funds for Cancer Research; Maud Kuistila Foundation; Cancer Foundation Finland sr [160083, 140118] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA014051, K99CA187317, P01CA042063, R00CA187317] Funding Source: NIH RePORTER	Transcend Program; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lung Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Center from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Hope Funds for Cancer Research; Maud Kuistila Foundation; Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. McFadden and P. Sharp for critical reading of the manuscript and T. Papagiannakopoulos for helpful discussions; H. Clevers for Lgr5<SUP>CreER/+</SUP> mice; Janssen Pharmaceuticals for human tissue; J. Roper for mouse colon adenoma tissue; R. T. Bronson for expertise in animal pathology; Y. Soto-Feliciano and S. Levine for massively parallel sequencing expertise; L. Gilbert, M. Horlbeck and J. Weissman for Lgr5 CRISPR gene activation sgRNA sequences; A. Li for help with generation of TCGA data catalogues; M. Griffin, M. Jennings and G. Paradis for FACS support; E. Vasile for microscopy support; K. Cormier and the Hope Babette Tang (1983) Histology Facility for histology support; S. Bajpay, D. Canner, D. Garcia-Gali, R. Kohn, N. Marjanovich, K. Mercer, J. Replogle and R. Romero for help with experiments; K. Anderson, I. Baptista, A. Deconinck, J. Teixeira and K. Yee for administrative support; and the Swanson Biotechnology Center for excellent core facilities. This work was financially supported by the Transcend Program and Janssen Pharmaceuticals, the Lung Cancer Research Foundation, the Howard Hughes Medical Institute and, in part, by the Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.T. is supported by the National Cancer Institute (K99 CA187317), the Sigrid Juselius Foundation, the Hope Funds for Cancer Research and the Maud Kuistila Foundation. T.J. is a Howard Hughes Medical Institute Investigator, a David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Akama-Garren EH, 2016, SCI REP-UK, V6, DOI 10.1038/srep16836; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Cumming G., 2013, UNDERSTANDING NEW ST; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Juan J, 2014, GENE DEV, V28, P561, DOI 10.1101/gad.233627.113; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marino S, 2000, GENE DEV, V14, P994; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yeddula N, 2015, P NATL ACAD SCI USA, V112, pE6476, DOI 10.1073/pnas.1520110112; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	62	196	198	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					355	+		10.1038/nature22334	http://dx.doi.org/10.1038/nature22334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489818	Green Published, Green Accepted			2022-12-28	WOS:000401466500064
J	Fitterman, N; Singh, V				Fitterman, Nick; Singh, Varinder			Review: After coronary DES, <= 6 mo and 1 y of dual-antiplatelet therapy do not differ for CV events at 1 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fitterman, Nick] Hofstra Northwell Sch Med, Hempstead, NY 11549 USA; [Singh, Varinder] Lenox Hill Hosp, New York, NY 10021 USA	Northwell Health; Northwell Health	Fitterman, N (corresponding author), Hofstra Northwell Sch Med, Hempstead, NY 11549 USA.							Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC54	JC54		10.7326/ACPJC-2017-166-10-054	http://dx.doi.org/10.7326/ACPJC-2017-166-10-054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505638				2022-12-28	WOS:000401240200006
J	Anglesio, MS; Papadopoulos, N; Ayhan, A; Nazeran, TM; Noe, M; Horlings, HM; Lum, A; Jones, S; Senz, J; Seckin, T; Ho, J; Wu, RC; Lac, V; Ogawa, H; Tessier-Cloutier, B; Alhassan, R; Wang, A; Wang, Y; Cohen, JD; Wong, F; Hasanovic, A; Orr, N; Zhang, M; Popoli, M; McMahon, W; Wood, LD; Mattox, A; Allaire, C; Segars, J; Williams, C; Tomasetti, C; Boyd, N; Kinzler, KW; Gilks, CB; Diaz, L; Wang, TL; Vogelstein, B; Yong, PJ; Huntsman, DG; Shih, IM				Anglesio, M. S.; Papadopoulos, N.; Ayhan, A.; Nazeran, T. M.; Noe, M.; Horlings, H. M.; Lum, A.; Jones, S.; Senz, J.; Seckin, T.; Ho, J.; Wu, R. -C.; Lac, V.; Ogawa, H.; Tessier-Cloutier, B.; Alhassan, R.; Wang, A.; Wang, Y.; Cohen, J. D.; Wong, F.; Hasanovic, A.; Orr, N.; Zhang, M.; Popoli, M.; McMahon, W.; Wood, L. D.; Mattox, A.; Allaire, C.; Segars, J.; Williams, C.; Tomasetti, C.; Boyd, N.; Kinzler, K. W.; Gilks, C. B.; Diaz, L.; Wang, T. -L.; Vogelstein, B.; Yong, P. J.; Huntsman, D. G.; Shih, I. -M.			Cancer-Associated Mutations in Endometriosis without Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEAR-CELL CARCINOMA; DEEP-INFILTRATING ENDOMETRIOSIS; SOMATIC MUTATIONS; MENSTRUAL DISSEMINATION; ARID1A EXPRESSION; TUMOR PROGRESSION; OVARIAN-CANCER; PELVIC PAIN; STEM-CELLS; BURDEN	BACKGROUND Endometriosis, defined as the presence of ectopic endometrial stroma and epithelium, affects approximately 10% of reproductive-age women and can cause pelvic pain and infertility. Endometriotic lesions are considered to be benign inflammatory lesions but have cancerlike features such as local invasion and resistance to apoptosis. METHODS We analyzed deeply infiltrating endometriotic lesions from 27 patients by means of exomewide sequencing (24 patients) or cancer-driver targeted sequencing (3 patients). Mutations were validated with the use of digital genomic methods in micro-dissected epithelium and stroma. Epithelial and stromal components of lesions from an additional 12 patients were analyzed by means of a droplet digital polymerase-chain-reaction (PCR) assay for recurrent activating KRAS mutations. RESULTS Exome sequencing revealed somatic mutations in 19 of 24 patients (79%). Five patients harbored known cancer driver mutations in ARID1A, PIK3CA, KRAS, or PPP2R1A, which were validated by Safe-Sequencing System or immunohistochemical analysis. The likelihood of driver genes being affected at this rate in the absence of selection was estimated at P = 0.001 (binomial test). Targeted sequencing and a droplet digital PCR assay identified KRAS mutations in 2 of 3 patients and 3 of 12 patients, respectively, with mutations in the epithelium but not the stroma. One patient harbored two different KRAS mutations, c.35G -> T and c.35G -> C, and another carried identical KRAS c.35G -> A mutations in three distinct lesions. CONCLUSIONS We found that lesions in deep infiltrating endometriosis, which are associated with virtually no risk of malignant transformation, harbor somatic cancer driver mutations. Ten of 39 deep infiltrating lesions (26%) carried driver mutations; all the tested somatic mutations appeared to be confined to the epithelial compartment of endometriotic lesions.	[Anglesio, M. S.; Allaire, C.; Williams, C.; Yong, P. J.; Huntsman, D. G.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Anglesio, M. S.; Nazeran, T. M.; Senz, J.; Tessier-Cloutier, B.; Gilks, C. B.; Huntsman, D. G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Nazeran, T. M.; Horlings, H. M.; Ho, J.; Lac, V.; Tessier-Cloutier, B.; Wang, A.; Gilks, C. B.; Huntsman, D. G.] Vancouver Gen Hosp, Dept Anat Pathol, Vancouver, BC, Canada; [Horlings, H. M.; Lum, A.; Lac, V.; Boyd, N.; Huntsman, D. G.] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [Wong, F.; Orr, N.; Allaire, C.; Williams, C.; Yong, P. J.] BC Womens Hosp & Hlth Ctr, BC Womens Ctr Pelv Pain & Endometriosis, Vancouver, BC, Canada; [Papadopoulos, N.; Tomasetti, C.; Kinzler, K. W.; Diaz, L.; Wang, T. -L.; Vogelstein, B.; Shih, I. -M.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Papadopoulos, N.; Wang, Y.; Cohen, J. D.; Zhang, M.; Popoli, M.; McMahon, W.; Mattox, A.; Kinzler, K. W.; Diaz, L.; Vogelstein, B.] Sidney Kimmel Comprehens Canc Ctr, Ludwig Ctr, Baltimore, MD USA; [Papadopoulos, N.; Ayhan, A.; Noe, M.; Wood, L. D.; Wang, T. -L.; Vogelstein, B.; Shih, I. -M.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD USA; [Segars, J.; Shih, I. -M.] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD USA; [Jones, S.] Personal Genome Diagnost, Baltimore, MD USA; [Vogelstein, B.] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD USA; [Ayhan, A.; Ogawa, H.] Seirei Mikatahara Hosp, Dept Pathol, Hamamatsu, Shizuoka, Japan; [Ayhan, A.] Hamamatsu Univ, Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka, Japan; [Ayhan, A.] Hiroshima Univ, Sch Med, Dept Mol Pathol, Hiroshima, Japan; [Noe, M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Seckin, T.] Hofstra Univ, Lenox Hill Hospital Northwell Hlth, Dept Obstet & Gynecol, New York, NY USA; [Alhassan, R.; Hasanovic, A.] Hofstra Univ, Lenox Hill Hospital Northwell Hlth, Dept Pathol, New York, NY USA; [Wu, R. -C.] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan City, Taiwan; [Wu, R. -C.] Chang Gung Univ, Coll Med, Tao Yuan City, Taiwan	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Hamamatsu University School of Medicine; Hiroshima University; Utrecht University; Utrecht University Medical Center; Hofstra University; Hofstra University; Chang Gung Memorial Hospital	Shih, IM (corresponding author), Johns Hopkins Med Inst, Dept Gynecol, 1550 Orleans St, Baltimore, MD 21231 USA.; Huntsman, DG (corresponding author), British Columbia Canc Agcy, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.; Yong, PJ (corresponding author), BC Womens Hosp & Hlth Ctr, BC Womens Ctr Pelv Pain & Endometriosis, 4500 Oak St, Vancouver, BC V6H 3N1, Canada.; Papadopoulos, N (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Ludwig Ctr, 1650 Orleans St, Baltimore, MD 21287 USA.	npapado1@jhmi.edu; pyong@cw.bc.ca; dhuntsma@bccancer.bc.ca; ishih@jhmi.edu	Hasanovic, Adnan/ABF-1549-2020; Wood, Laura/ABF-1531-2020; AYHAN, Ayse/H-3331-2012; sdsd, shihieih/ABE-6190-2020; Huntsman, David/ABE-6082-2020; Yong, Paul J/O-3291-2017; AYHAN, Ayse/AAP-2948-2021	AYHAN, Ayse/0000-0003-0136-4271; AYHAN, Ayse/0000-0003-0136-4271; Yong, Paul/0000-0001-5521-3052; Wu, Ren-Chin/0000-0003-1439-0874; Diaz, Luis/0000-0002-7079-8914	Richard W. TeLinde Gynecologic Pathology Research Program at Johns Hopkins University; Virginia and D.K. Ludwig Fund for Cancer Research; Ephraim and Wilma Shaw Roseman Foundation; Endometriosis Foundation of America; National Institutes of Health; National Cancer Institute [P50-CA62924, CA06973, GM07184, GM07309, CA09243, CA57345, P30-CA006973, CA215483, UO1-CA200469]; Gray Family Ovarian Clear Cell Carcinoma Research Resource; Canadian Cancer Society [701603]; Canadian Institutes of Health Research [IHD-137431, MOP-142273]; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; Women's Health Research Institute (Nelly Auersperg Grant); Canadian Foundation for Women's Health (General Research Grant); BC Women's Hospital; Health Centre Foundation; BC Cancer Foundation; VGH and UBC Hospital Foundation; Jemini Foundation; Mentored Clinician-Scientist Award of the Vancouver Coastal Health Research Institute; Dutch Cancer Society translational research fellowship [KWF 2013-5869]; NATIONAL CANCER INSTITUTE [U01CA200469, R01CA057345, P50CA062924, T32CA009243, R01CA215483, P30CA006973, R37CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, T32GM007184] Funding Source: NIH RePORTER	Richard W. TeLinde Gynecologic Pathology Research Program at Johns Hopkins University; Virginia and D.K. Ludwig Fund for Cancer Research; Ephraim and Wilma Shaw Roseman Foundation; Endometriosis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gray Family Ovarian Clear Cell Carcinoma Research Resource; Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Women's Health Research Institute (Nelly Auersperg Grant); Canadian Foundation for Women's Health (General Research Grant); BC Women's Hospital; Health Centre Foundation; BC Cancer Foundation; VGH and UBC Hospital Foundation; Jemini Foundation; Mentored Clinician-Scientist Award of the Vancouver Coastal Health Research Institute; Dutch Cancer Society translational research fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Richard W. TeLinde Gynecologic Pathology Research Program at Johns Hopkins University, the Virginia and D.K. Ludwig Fund for Cancer Research, the Ephraim and Wilma Shaw Roseman Foundation, the Endometriosis Foundation of America, the National Institutes of Health and National Cancer Institute (grants P50-CA62924, CA06973, GM07184, GM07309, CA09243, CA57345, P30-CA006973, CA215483, and UO1-CA200469), the Gray Family Ovarian Clear Cell Carcinoma Research Resource, the Canadian Cancer Society (grant 701603), the Canadian Institutes of Health Research (IHD-137431 and MOP-142273), the Canadian Foundation for Innovation (John R. Evans Leaders Fund) and British Columbia Knowledge Development Fund, the Women's Health Research Institute (Nelly Auersperg Grant), and the Canadian Foundation for Women's Health (General Research Grant). The BC Women's Hospital and Health Centre Foundation provided support to the BC Women's Centre for Pelvic Pain and Endometriosis. The BC Cancer Foundation and the VGH and UBC Hospital Foundation provided funding to OVCARE: BC's Ovarian Cancer Research Team (Dr. Anglesio, Dr. Nazeran, Dr. Horlings, Ms. Lum, Ms. Senz, Ms. Ho, Ms. Lac, Dr. Tessier-Cloutier, Ms. Wang, Dr. Boyd, Dr. Gilks, Dr. Yong, and Dr. Huntsman), including donations from David and Darrell Mindell, Peter and Shelley O'Sullivan, and the Jemini Foundation to directly support this research. The Mentored Clinician-Scientist Award of the Vancouver Coastal Health Research Institute provided support to Dr. Yong. The Dr. Chew Wei Memorial Professorship in Gynecologic Oncology and the Canada Research Chairs program (Research Chair in Molecular and Genomic Pathology) provided support to Dr. Huntsman. The Dutch Cancer Society translational research fellowship (KWF 2013-5869) provided support to Dr. Horlings.	Anglesio MS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv428; Anglesio MS, 2015, J PATHOL, V236, P201, DOI 10.1002/path.4516; Ayhan A, 2012, INT J GYNECOL CANCER, V22, P1310, DOI 10.1097/IGC.0b013e31826b5dcc; Borrelli GM, 2016, MOL HUM REPROD, V22, P329, DOI 10.1093/molehr/gaw009; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Chene G, 2015, INT J GYNECOL OBSTET, V130, P27, DOI 10.1016/j.ijgo.2015.02.021; Cheng CW, 2011, J PATHOL, V224, P261, DOI 10.1002/path.2852; Cullen TS, 1896, J HOPKINS HOSP REP, V6, P133; De Graaff AA, 2013, HUM REPROD, V28, P2677, DOI 10.1093/humrep/det284; Donnez J, 2002, GYNECOL OBSTET INVES, V54, P2, DOI 10.1159/000066288; Fassbender A, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1209; FERGUSON BR, 1969, OBSTET GYNECOL, V33, P617; Ferrero S, 2015, FERTIL STERIL, V104, P771, DOI 10.1016/j.fertnstert.2015.08.031; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fung JN, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126458; Gao X, 2006, FERTIL STERIL, V86, P1561, DOI 10.1016/j.fertnstert.2006.06.015; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Jubanyik KJ, 1997, OBSTET GYN CLIN N AM, V24, P411, DOI 10.1016/S0889-8545(05)70311-9; Kato S, 2016, JNCI-J NATL CANCER I, V108, P108; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Klein S, 2014, REPROD BIOMED ONLINE, V28, P116, DOI 10.1016/j.rbmo.2013.09.020; Krimmel JD, 2016, P NATL ACAD SCI USA, V113, P6005, DOI 10.1073/pnas.1601311113; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Leyland N, 2010, J OBSTET GYNAECOL CA, V32, pS1, DOI 10.1016/S1701-2163(16)34589-3; Mao TL, 2013, AM J SURG PATHOL, V37, P1342, DOI 10.1097/PAS.0b013e3182889dc3; Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Reese K A, 1996, J Pediatr Adolesc Gynecol, V9, P125; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Russell WW, 1899, J HOPKINS HOSP B, V10, P8; Samartzis EP, 2012, MODERN PATHOL, V25, P885, DOI 10.1038/modpathol.2011.217; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sampson JA, 1927, AM J PATHOL, V3, P93; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Sato N, 2000, CANCER RES, V60, P7052; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas EJ, 2000, GYNECOL OBSTET INVES, V50, P44, DOI 10.1159/000052878; Tosti C, 2015, REPROD SCI, V22, P1053, DOI 10.1177/1933719115592713; Vercellini P, 2007, HUM REPROD, V22, P266, DOI 10.1093/humrep/del339; Vestergaard AL, 2011, MOL HUM REPROD, V17, P758, DOI 10.1093/molehr/gar049; Wei JJ, 2011, INT J GYNECOL PATHOL, V30, P553, DOI 10.1097/PGP.0b013e31821f4b85; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu RC, 2014, J PATHOL, V232, P473, DOI 10.1002/path.4315; Yamamoto S, 2012, MODERN PATHOL, V25, P615, DOI 10.1038/modpathol.2011.189	50	307	322	3	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1835	1848		10.1056/NEJMoa1614814	http://dx.doi.org/10.1056/NEJMoa1614814			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28489996	Green Accepted			2022-12-28	WOS:000400891100009
J	Siemieniuk, RAC; Harris, IA; Agoritsas, T; Poolman, RW; Brignardello-Petersen, R; Van de Velde, S; Buchbinder, R; Englund, M; Lytvyn, L; Quinlan, C; Helsingen, L; Knutsen, G; Olsen, NR; Macdonald, H; Hailey, L; Wilson, HM; Lydiatt, A; Kristiansen, A				Siemieniuk, Reed A. C.; Harris, Ian A.; Agoritsas, Thomas; Poolman, Rudolf W.; Brignardello-Petersen, Romina; Van de Velde, Stijn; Buchbinder, Rachelle; Englund, Martin; Lytvyn, Lyubov; Quinlan, Casey; Helsingen, Lise; Knutsen, Gunnar; Olsen, Nina Rydland; Macdonald, Helen; Hailey, Louise; Wilson, Hazel M.; Lydiatt, Anne; Kristiansen, Annette			Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MIDDLE-AGED PATIENTS; PARTIAL MENISCECTOMY; OARSI RECOMMENDATIONS; CONTROLLED-TRIAL; OSTEOARTHRITIS; COHORT; PAIN; POPULATION; PREVALENCE; MANAGEMENT	What is the role of arthroscopic surgery in degenerative knee disease? An expert panel produced these recommendations based on a linked systematic review triggered by a randomised trial published in The BMJ in June 2016, which found that, among patients with a degenerative medial meniscus tear, knee arthroscopy was no better than exercise therapy. The panel make a strong recommendation against arthroscopy for degenerative knee disease. Box 1 shows all of the articles and evidence linked in this Rapid Recommendation package. The infographic provides an overview of the absolute benefits and harms of arthroscopy in standard GRADE format. Table 2 below shows any evidence that has emerged since the publication of this article.	[Siemieniuk, Reed A. C.; Agoritsas, Thomas; Brignardello-Petersen, Romina] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada; [Siemieniuk, Reed A. C.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Harris, Ian A.] UNSW, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Harris, Ian A.] Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr, Liverpool, NSW 2170, Australia; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Poolman, Rudolf W.] OLVG, Joint Res, Dept Orthopaed Surg, NL-1090 HM Amsterdam, Netherlands; [Brignardello-Petersen, Romina] Univ Chile, Fac Dent, Santiago, Chile; [Van de Velde, Stijn] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Suite 41 Cabrini Med Ctr, Malvern, Vic 3144, Australia; [Englund, Martin] Lund Univ, Lund Fac Med, Dept Clin Sci, Clin Epidemiol Unit,Orthopaed, SE-22185 Lund, Sweden; [Lytvyn, Lyubov] Oslo Univ Hosp, N-0317 Oslo, Norway; [Helsingen, Lise] Univ Oslo, Inst Hlth & Soc, Clin Effectiveness Res Grp, N-0317 Oslo, Norway; [Knutsen, Gunnar] Univ Hosp North Norway, N-9038 Tromso, Norway; [Olsen, Nina Rydland] Bergen Univ Coll, Fac Hlth & Social Sci, Dept Occupat Therapy Physiotherapy & Radiog, N-5020 Bergen, Norway; [Macdonald, Helen] BMJ Editorial, BMA House, London WC1H 9JR, England; [Hailey, Louise] Oxford Univ Hosp NHS Fdn Trust, Nuffield Orthopaed Ctr, Oxford OX3 7HE, England; [Kristiansen, Annette] Univ Oslo, Dept Hlth & Sci, Oslo, Norway; [Kristiansen, Annette] Hosp Innlandet Trust, Dept Med, Gjovik, Norway	McMaster University; University of Toronto; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; University of Geneva; University of Geneva; Universidad de Chile; Norwegian Institute of Public Health (NIPH); Monash University; Cabrini Health; Monash University; Lund University; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; Western Norway University of Applied Sciences; Nuffield Orthopaedic Centre; Oxford University Hospitals NHS Foundation Trust; University of Oslo; Innlandet Hospital Trust	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada.; Siemieniuk, RAC (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	reed.siemieniuk@medportal.ca	Agoritsas, Thomas/F-4321-2014; Helsingen, Lise/ABD-6025-2021; Buchbinder, Rachelle/G-2952-2011; Helsingen, Lise/AAU-2290-2021; Poolman, Rudolf/AAM-7815-2020; Van de Velde, Stijn/F-6449-2013; Englund, Martin/J-7245-2012	Agoritsas, Thomas/0000-0002-6182-9969; Helsingen, Lise/0000-0002-2055-3978; Buchbinder, Rachelle/0000-0002-0597-0933; Poolman, Rudolf/0000-0003-3178-2247; Olsen, Nina Rydland/0000-0002-5173-1597; Van de Velde, Stijn/0000-0001-8908-3823; Hailey, Louise/0000-0001-5769-8663; Englund, Martin/0000-0003-3320-2437				Adelani MA, 2016, CLIN ORTHOP RELAT R, V474, P489, DOI 10.1007/s11999-015-4514-4; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Beaufils P, 2016, ESSKA MENISCUS CONSE; Bohensky MA, 2012, MED J AUSTRALIA, V197, P399, DOI 10.5694/mja11.11645; Brignardello-Petersen R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016114; British Orthopaedic Association British Association for Surgery of the Knee, 2015, BOA BASK RESP MED RE; Cullen Karen A, 2009, Natl Health Stat Report, P1; de Rooij M, 2016, ARTHRIT CARE RES, V68, P481, DOI 10.1002/acr.22693; Devji T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015587; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Gauffin H, 2014, OSTEOARTHR CARTILAGE, V22, P1808, DOI 10.1016/j.joca.2014.07.017; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hamilton DF, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4720; Jarvinen TLN, 2017, BRIT J SPORT MED, V51, P1502, DOI 10.1136/bjsports-2017-i3740rep; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Kise NJ, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3740; Lubowitz JH, 2008, ARTHROSCOPY, V24, P58, DOI 10.1016/j.arthro.2007.07.026; Marsh JD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009949; McGrory B, 2016, J BONE JOINT SURG AM, V98, DOI [10.2106/JBJS.ER.15.01311, 10.2106/JBJS.15.01311]; National Institute for Health and Clinical Excellence, 2007, ARTHR WASH DEBR TREA; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; Pihl K, 2016, ACTA ORTHOP, V87, P615, DOI 10.1080/17453674.2016.1228411; RA, 2016, BMJ-BRIT MED J, V354, pI5191, DOI DOI 10.1136/BMJ.I5191; Sihvonen R, 2016, ANN INTERN MED, V164, P449, DOI 10.7326/M15-0899; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Thorlund JB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2747; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	35	112	114	3	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2017	357								j1982	10.1136/bmj.j1982	http://dx.doi.org/10.1136/bmj.j1982			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UE	28490431	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000401169600001
J	Evans, JP; Powell, BC; Berg, JS				Evans, James P.; Powell, Bradford C.; Berg, Jonathan S.			Finding the Rare Pathogenic Variants in a Human Genome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POPULATION; PROMISE		[Evans, James P.; Powell, Bradford C.; Berg, Jonathan S.] Univ North Carolina Chapel Hill, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ North Carolina Chapel Hill, Dept Med, CB 7264, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Evans, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.; Evans, JP (corresponding author), Univ North Carolina Chapel Hill, Dept Med, Dept Genet, CB 7264, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu			National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006487] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Berg reports being a funded investigator on the National Human Genome Research Institute-funded GeneScreen project, which is investigating the potential use of genomic screening of a small panel of genes in generally healthy adults. No other disclosures were reported.	Adams MC, 2016, GENET MED, V18, P593, DOI 10.1038/gim.2015.136; Chen SN, 2006, JAMA-J AM MED ASSOC, V296, P1479, DOI 10.1001/jama.296.12.1479; Corpas M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1973-7; Evans JP, 2013, GENET MED, V15, P332, DOI 10.1038/gim.2013.11; Goldstein DB, 2013, NAT REV GENET, V14, P460, DOI 10.1038/nrg3455; Khoury MJ, 2013, GENET MED, V15, P437, DOI 10.1038/gim.2012.182; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Strande NT, 2016, ANNU REV GENOM HUM G, V17, P303, DOI 10.1146/annurev-genom-083115-022348	8	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1904	1905		10.1001/jama.2017.0432	http://dx.doi.org/10.1001/jama.2017.0432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492888				2022-12-28	WOS:000400842400020
J	Gaunt, M; Williamson, P				Gaunt, Matthew; Williamson, Patrick			ORGANIC CHEMISTRY Nickel steps towards selectivity	NATURE			English	Editorial Material									[Gaunt, Matthew; Williamson, Patrick] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Gaunt, M (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.	mjg32@cam.ac.uk		Gaunt, Matthew/0000-0002-7214-608X				Bertleff W., 2007, ULLMANNS ENCY IND CH; Biermann U, 2011, ANGEW CHEM INT EDIT, V50, P3854, DOI 10.1002/anie.201002767; Julia-Hernandez F, 2017, NATURE, V545, P84, DOI 10.1038/nature22316; Szilagyi M., 2012, PATTYS TOXICOLOGY, V3, P471; Vasseur A, 2016, NAT CHEM, V8, P209, DOI [10.1038/NCHEM.2445, 10.1038/nchem.2445]; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208	6	3	3	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					35	36		10.1038/545035a	http://dx.doi.org/10.1038/545035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470196				2022-12-28	WOS:000400480400022
J	Lavin, Y; Kobayashi, S; Leader, A; Amir, ED; Elefant, N; Bigenwald, C; Remark, R; Sweeney, R; Becker, CD; Levine, JH; Meinhof, K; Chow, A; Kim-Shulze, S; Wolf, A; Medaglia, C; Li, HJ; Rytlewski, JA; Emerson, RO; Solovyov, A; Greenbaum, BD; Sanders, C; Vignali, M; Beasley, MB; Flores, R; Gnjatic, S; Pe'er, D; Rahman, A; Amit, I; Merad, M				Lavin, Yonit; Kobayashi, Soma; Leader, Andrew; Amir, El-ad David; Elefant, Naama; Bigenwald, Camille; Remark, Romain; Sweeney, Robert; Becker, Christian D.; Levine, Jacob H.; Meinhof, Klaus; Chow, Andrew; Kim-Shulze, Seunghee; Wolf, Andrea; Medaglia, Chiara; Li, Hanjie; Rytlewski, Julie A.; Emerson, Ryan O.; Solovyov, Alexander; Greenbaum, Benjamin D.; Sanders, Catherine; Vignali, Marissa; Beasley, Mary Beth; Flores, Raja; Gnjatic, Sacha; Pe'er, Dana; Rahman, Adeeb; Amit, Ido; Merad, Miriam			Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses	CELL			English	Article							TERTIARY LYMPHOID STRUCTURES; FLOW-CYTOMETRIC ANALYSIS; DENDRITIC CELLS; MYELOID CELLS; GENE-EXPRESSION; T-CELLS; RNA-SEQ; CANCER; MACROPHAGES; MONOCYTES	To guide the design of immunotherapy strategies for patients with early stage lung tumors, we developed a multiscale immune profiling strategy to map the immune landscape of early lung adenocarcinoma lesions to search for tumor-driven immune changes. Utilizing a barcoding method that allows a simultaneous single-cell analysis of the tumor, noninvolved lung, and blood cells, we provide a detailed immune cell atlas of early lung tumors. We show that stage I lung adenocarcinoma lesions already harbor significantly altered T cell and NK cell compartments. Moreover, we identified changes in tumor-infiltrating myeloid cell (TIM) subsets that likely compromise anti-tumor T cell immunity. Paired single-cell analyses thus offer valuable knowledge of tumor-driven immune changes, providing a powerful tool for the rational design of immune therapies.	[Lavin, Yonit; Kobayashi, Soma; Leader, Andrew; Bigenwald, Camille; Remark, Romain; Chow, Andrew; Solovyov, Alexander; Greenbaum, Benjamin D.; Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Lavin, Yonit; Kobayashi, Soma; Leader, Andrew; Amir, El-ad David; Bigenwald, Camille; Remark, Romain; Chow, Andrew; Kim-Shulze, Seunghee; Gnjatic, Sacha; Rahman, Adeeb; Merad, Miriam] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Lavin, Yonit; Kobayashi, Soma; Leader, Andrew; Amir, El-ad David; Bigenwald, Camille; Remark, Romain; Chow, Andrew; Kim-Shulze, Seunghee; Solovyov, Alexander; Greenbaum, Benjamin D.; Gnjatic, Sacha; Rahman, Adeeb; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Becker, Christian D.; Meinhof, Klaus] Icahn Sch Med Mt Sinai, Div Pulmonol, New York, NY 10029 USA; [Solovyov, Alexander; Greenbaum, Benjamin D.; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Div Hematol Oncol, New York, NY 10029 USA; [Sweeney, Robert; Wolf, Andrea; Flores, Raja] Icahn Sch Med Mt Sinai, Dept Thorac Surg, New York, NY 10029 USA; [Sweeney, Robert; Rahman, Adeeb] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Solovyov, Alexander; Greenbaum, Benjamin D.; Beasley, Mary Beth] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Amir, El-ad David; Kim-Shulze, Seunghee; Gnjatic, Sacha; Rahman, Adeeb; Merad, Miriam] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Elefant, Naama; Medaglia, Chiara; Li, Hanjie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Levine, Jacob H.; Pe'er, Dana] Sloan Kettering Inst, Computat & Syst Biol Program, New York, NY 10065 USA; [Rytlewski, Julie A.; Emerson, Ryan O.; Sanders, Catherine; Vignali, Marissa] Adapt Biotechnol Inc, Seattle, WA 98102 USA; [Remark, Romain] Innate Pharma, 117 Ave Luminy, F-13009 Marseille, France	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Weizmann Institute of Science; Memorial Sloan Kettering Cancer Center	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA.	miriam.merad@mssm.edu	Rytlewski, Julie/O-6811-2019; wang, edwin/G-5372-2010; Li, Hanjie/G-6185-2019	Rytlewski, Julie/0000-0001-5244-6790; Li, Hanjie/0000-0002-4052-8366; Kobayashi, Soma/0000-0002-0470-4027; Chow, Andrew/0000-0003-1151-2450; Leader, Andrew/0000-0003-3738-7109; Lavin, Yonit/0000-0003-0593-3910; Gnjatic, Sacha/0000-0001-5643-9520; Pe'er, Dana/0000-0002-9259-8817	Foundation pour la Recherche Medicale [DEA20150633125]; NIH [R01 CA173861, U19AI128949, U24 AI 118644, U19 AI 117873-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA173861, R01CA154947, R01CA164729, R01CA190400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI128949, U19AI117873, U24AI118644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER	Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Merad laboratory for helpful discussions and input. We would like to thank Helene Salmon for critical review of the manuscript. We would like to thank the Human Immune Monitoring Core (HIMC) for their excellent technical support and assistance throughout the project, in particular Adeeb Rahman and the members of the CyTOF core, Oksana Mayovska and Victor Guo, and Manishkumar Patel. We would like to thank the Biorepository & Pathology Core and the Flow Cytometry facility. We would like to thank Jill Gregory for her assistance with the artwork. C.B. is funded by Foundation pour la Recherche Medicale DEA20150633125. M.M. is funded by NIH grants R01, R01 CA173861, U19AI128949, U24 AI 118644, and U19 AI 117873-01.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; [Anonymous], 2021, LANG ENV STAT COMP; Besse B, 2015, EUR J CANCER, V51, pS717, DOI 10.1016/S0959-8049(16)31938-4; Black WC, 2015, NEW ENGL J MED, V372, P388, DOI 10.1056/NEJMc1414726; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chen TJ, 2014, CURR TOP MICROBIOL, V377, P127, DOI 10.1007/82_2014_364; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Dieu-Nosjean MC, 2008, J CLIN ONCOL, V26, P4410, DOI 10.1200/JCO.2007.15.0284; Dutertre CA, 2014, CELL IMMUNOL, V291, P3, DOI 10.1016/j.cellimm.2014.08.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Forde P. M., 2016, ESMO 2016 C, V27, P1, DOI DOI 10.1093/ANN0NC/MDW435; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Germain C, 2014, AM J RESP CRIT CARE, V189, P832, DOI 10.1164/rccm.201309-1611OC; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Haniffa M, 2013, ADV IMMUNOL, V120, P1, DOI 10.1016/B978-0-12-417028-5.00001-6; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Kirsch I, 2015, MOL ONCOL, V9, P2063, DOI 10.1016/j.molonc.2015.09.003; Krijthe J.H., 2015, RTSNE T DISTRIBUTED; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lavin Y, 2013, CANCER IMMUNOL RES, V1, P201, DOI 10.1158/2326-6066.CIR-13-0117; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Naidoo J, 2017, J CLIN ONCOL, V35, P709, DOI 10.1200/JCO.2016.68.2005; Nishino M, 2016, JAMA ONCOL, V2, P1607, DOI 10.1001/jamaoncol.2016.2453; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reddy RC, 2008, J INVEST MED, V56, P522, DOI 10.2310/JIM.0b013e3181659972; Remark R, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf6925; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Wickham H, 2016, R PACKAGE VERSION 1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu K, 2015, J EXP MED, V212, P681, DOI 10.1084/jem.20141732; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu YRA, 2016, AM J RESP CELL MOL, V54, P13, DOI 10.1165/rcmb.2015-0146OC; Zhu W, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1051922; Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227	68	677	705	17	205	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					750	765		10.1016/j.cell.2017.04.014	http://dx.doi.org/10.1016/j.cell.2017.04.014			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475900	Bronze, Green Accepted			2022-12-28	WOS:000400560900018
J	Medhaug, I; Stolpe, MB; Fischer, EM; Knutti, R				Medhaug, Iselin; Stolpe, Martin B.; Fischer, Erich M.; Knutti, Reto			Reconciling controversies about the 'global warming hiatus'	NATURE			English	Article							SEA-SURFACE TEMPERATURE; OCEAN HEAT UPTAKE; MERIDIONAL OVERTURNING CIRCULATION; ATLANTIC MULTIDECADAL OSCILLATION; STRATOSPHERIC WATER-VAPOR; EARTHS ENERGY IMBALANCE; NORTH-ATLANTIC; CLIMATE-CHANGE; NATURAL VARIABILITY; THERMOHALINE CIRCULATION	Between about 1998 and 2012, a time that coincided with political negotiations for preventing climate change, the surface of Earth seemed hardly to warm. This phenomenon, often termed the 'global warming hiatus', caused doubt in the public mind about how well anthropogenic climate change and natural variability are understood. Here we show that apparently contradictory conclusions stem from different definitions of 'hiatus' and from different datasets. A combination of changes in forcing, uptake of heat by the oceans, natural variability and incomplete observational coverage reconciles models and data. Combined with stronger recent warming trends in newer datasets, we are now more confident than ever that human influence is dominant in long-term warming.	[Medhaug, Iselin; Stolpe, Martin B.; Fischer, Erich M.; Knutti, Reto] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Medhaug, I (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.	Iselin.medhaug@env.ethz.ch	Knutti, Reto/B-8763-2008; Fischer, Erich/B-6067-2011	Knutti, Reto/0000-0001-8303-6700; Fischer, Erich/0000-0003-1931-6737; Medhaug, Iselin/0000-0002-1115-8896; Hegerl, Gabriele/0000-0002-4159-1295				Abraham JP, 2013, REV GEOPHYS, V51, P450, DOI 10.1002/rog.20022; Allan RP, 2014, GEOPHYS RES LETT, V41, P5588, DOI 10.1002/2014GL060962; Amaya DJ, 2015, J GEOPHYS RES-OCEANS, V120, P6782, DOI 10.1002/2015JC010906; Andersson SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8692; Armour KC, 2016, NAT CLIM CHANGE, V6, P896, DOI 10.1038/nclimate3079; Armour KC, 2013, J CLIMATE, V26, P4518, DOI 10.1175/JCLI-D-12-00544.1; Bala G, 2013, CURR SCI INDIA, V105, P1031; Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Barcikowska MJ, 2017, J CLIMATE, V30, P721, DOI 10.1175/JCLI-D-16-0443.1; Baumberger C., 2017, WILEY INTERDISCIP RE; Bindoff N.L., 2007, CLIMATE CHANGE 2007; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Boykoff MT, 2014, NAT CLIM CHANGE, V4, P156, DOI 10.1038/nclimate2156; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Brown PT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09957; Bruhl C, 2015, J GEOPHYS RES-ATMOS, V120, P2103, DOI 10.1002/2014JD022430; Buckley MW, 2016, REV GEOPHYS, V54, P5, DOI 10.1002/2015RG000493; Cahill N, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084002; Carter B., 2006, TELEGRAPH; Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Charney J., 1979, CARBON DIOXIDE CLIMA; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Cheng LJ, 2016, OCEAN SCI, V12, P925, DOI 10.5194/os-12-925-2016; Chikamoto Y, 2016, GEOPHYS RES LETT, V43, P7143, DOI 10.1002/2016GL069544; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Cohen JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050582; Cowtan K, 2015, GEOPHYS RES LETT, V42, P6526, DOI 10.1002/2015GL064888; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Dai AG, 2015, NAT CLIM CHANGE, V5, P555, DOI 10.1038/nclimate2605; de Boisseson E, 2014, GEOPHYS RES LETT, V41, P4398, DOI 10.1002/2014GL060257; De Saedeleer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19881; Delworth TL, 2015, J CLIMATE, V28, P3834, DOI 10.1175/JCLI-D-14-00616.1; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Desbruyeres DG, 2014, GEOPHYS RES LETT, V41, P7971, DOI 10.1002/2014GL061844; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Deser C, 2010, ANNU REV MAR SCI, V2, P115, DOI 10.1146/annurev-marine-120408-151453; Dessler AE, 2013, P NATL ACAD SCI USA, V110, P18087, DOI 10.1073/pnas.1310344110; Dessler AE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049236; Dieng HB, 2015, OCEAN SCI, V11, P789, DOI 10.5194/os-11-789-2015; Dieng HB, 2015, SURV GEOPHYS, V36, P209, DOI 10.1007/s10712-015-9314-6; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Dong L, 2014, J GEOPHYS RES-ATMOS, V119, P11272, DOI 10.1002/2013JD021395; Douville H, 2015, GEOPHYS RES LETT, V42, P880, DOI 10.1002/2014GL062775; Drijfhout SS, 2014, GEOPHYS RES LETT, V41, P7868, DOI 10.1002/2014GL061456; Durack PJ, 2014, NAT CLIM CHANGE, V4, P999, DOI 10.1038/NCLIMATE2389; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; England MH, 2015, NAT CLIM CHANGE, V5, P394, DOI 10.1038/nclimate2575; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Fasullo JT, 2008, J CLIMATE, V21, P2297, DOI 10.1175/2007JCLI1935.1; Fischer EM, 2016, NAT CLIM CHANGE, V6, P986, DOI [10.1038/nclimate3110, 10.1038/NCLIMATE3110]; Flato G., 2013, CLIMATE CHANGE 2013; Foster G., 2015, VARIATIONS, V13, P6; Foster G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044022; Frankcombe LM, 2015, J CLIMATE, V28, P8184, DOI 10.1175/JCLI-D-15-0069.1; Fyfe JC, 2013, GEOPHYS RES LETT, V40, P584, DOI 10.1002/grl.50156; Fyfe JC, 2016, NAT CLIM CHANGE, V6, P224, DOI 10.1038/nclimate2938; Fyfe JC, 2013, NAT CLIM CHANGE, V3, P767, DOI 10.1038/nclimate1972; Garfinkel CI, 2017, GEOPHYS RES LETT, V44, P374, DOI 10.1002/2016GL072035; Gettelman A, 2015, CLIM DYNAM, V45, P2165, DOI 10.1007/s00382-014-2464-2; Gilford DM, 2016, J CLIMATE, V29, P595, DOI 10.1175/JCLI-D-15-0167.1; Gillett NP, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050226; Gleckler PJ, 2016, NAT CLIM CHANGE, V6, P394, DOI [10.1038/NCLIMATE2915, 10.1038/nclimate2915]; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Gregory JM, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0417; Guemas V, 2013, NAT CLIM CHANGE, V3, P649, DOI [10.1038/nclimate1863, 10.1038/NCLIMATE1863]; Han WQ, 2014, CLIM DYNAM, V43, P1357, DOI 10.1007/s00382-013-1951-1; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hathaway DH, 2015, LIVING REV SOL PHYS, V12, DOI 10.1007/lrsp-2015-4; Hawkins E, 2014, NAT CLIM CHANGE, V4, P154, DOI 10.1038/nclimate2150; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Haywood JM, 2014, ATMOS SCI LETT, V15, P92, DOI 10.1002/asl2.471; Henley BJ, 2015, CLIM DYNAM, V45, P3077, DOI 10.1007/s00382-015-2525-1; Hofmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039008; Huang B, 2016, J CLIMATE, V29, P3119, DOI 10.1175/JCLI-D-15-0430.1; Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1; Huber M, 2014, NAT GEOSCI, V7, P651, DOI [10.1038/NGEO2228, 10.1038/ngeo2228]; Hunt BG, 2011, CLIM DYNAM, V36, P509, DOI 10.1007/s00382-010-0799-x; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Johansson DJA, 2015, NAT CLIM CHANGE, V5, P449, DOI [10.1038/nclimate2573, 10.1038/NCLIMATE2573]; Johnson G. C., 2013, B AM METEOROL SOC, V94, pS50, DOI [10.1175/2013BAMSStateoftheClimate.1, DOI 10.1175/2013BAMSSTATEOFTHECLIMATE.1]; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Katsman CA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048417; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Keenlyside NS, 2008, NATURE, V453, P84, DOI 10.1038/nature06921; KELLOGG WW, 1993, CLIMATIC CHANGE, V25, P85, DOI 10.1007/BF01094085; Kennedy JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015218; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Kent EC, 2017, B AM METEOROL SOC, V98, P1601, DOI 10.1175/BAMS-D-15-00251.1; Kent EC, 2013, J GEOPHYS RES-ATMOS, V118, P1281, DOI 10.1002/jgrd.50152; Kent EC, 2010, WIRES CLIM CHANGE, V1, P718, DOI 10.1002/wcc.55; Kerr RA, 2009, SCIENCE, V326, P28, DOI 10.1126/science.326_28a; Knight J., 2009, B AM METEOROL SOC, V90, pS22, DOI DOI 10.1175/BAMS-90-8-StateoftheClimate; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudsen MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4323; Knutson TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13676; Knutti R, 2000, J CLIMATE, V13, P1997, DOI 10.1175/1520-0442(2000)013<1997:IOTTCO>2.0.CO;2; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Knutti R, 2016, NAT GEOSCI, V9, P13, DOI 10.1038/NGEO2595; Knutti R, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2015.0146; Kociuba G, 2015, J CLIMATE, V28, P20, DOI 10.1175/JCLI-D-13-00752.1; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Kucharski F, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046248; Kucharski F, 2016, CLIM DYNAM, V46, P2337, DOI 10.1007/s00382-015-2705-z; Kuhn T, 2014, GEOPHYS RES LETT, V41, P4711, DOI 10.1002/2014GL060349; Kummer JR, 2014, GEOPHYS RES LETT, V41, P3565, DOI 10.1002/2014GL060046; Laepple T, 2014, GEOPHYS RES LETT, V41, P2528, DOI 10.1002/2014GL059345; Lean JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038932; Lee SK, 2015, NAT GEOSCI, V8, P445, DOI 10.1038/NGEO2438; Lee T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032419; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Lewandowsky S, 2016, B AM METEOROL SOC, V97, P723, DOI 10.1175/BAMS-D-14-00106.1; Lewandowsky S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16784; Lewandowsky S, 2015, GLOBAL ENVIRON CHANG, V33, P1, DOI 10.1016/j.gloenvcha.2015.02.013; Lewis N, 2015, CLIM DYNAM, V45, P1009, DOI 10.1007/s00382-014-2342-y; Li C, 2015, GEOPHYS RES LETT, V42, P8131, DOI 10.1002/2015GL065327; Li JP, 2013, GEOPHYS RES LETT, V40, P5497, DOI 10.1002/2013GL057877; Li XC, 2016, NAT CLIM CHANGE, V6, P275, DOI [10.1038/NCLIMATE2840, 10.1038/nclimate2840]; Liang XF, 2016, J CLIMATE, V29, P3647, DOI 10.1175/JCLI-D-15-0626.1; Lin M, 2016, J CLIMATE, V29, P8673, DOI 10.1175/JCLI-D-16-0123.1; Liu W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10926; Llovel W, 2014, NAT CLIM CHANGE, V4, P1031, DOI 10.1038/NCLIMATE2387; Lockwood M, 2008, P ROY SOC A-MATH PHY, V464, P1387, DOI 10.1098/rspa.2007.0348; Lockwood M, 2010, P ROY SOC A-MATH PHY, V466, P303, DOI 10.1098/rspa.2009.0519; Loeb NG, 2012, NAT GEOSCI, V5, P110, DOI [10.1038/NGEO1375, 10.1038/ngeo1375]; Loeb NG, 2009, J CLIMATE, V22, P748, DOI 10.1175/2008JCLI2637.1; Luo JJ, 2012, P NATL ACAD SCI USA, V109, P18701, DOI 10.1073/pnas.1210239109; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Maher N, 2014, GEOPHYS RES LETT, V41, P5978, DOI 10.1002/2014GL060527; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; MANN ME, 1994, J GEOPHYS RES-ATMOS, V99, P25819, DOI 10.1029/94JD02396; Mann ME, 2014, GEOPHYS RES LETT, V41, P3211, DOI 10.1002/2014GL059233; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marotzke J, 2015, NATURE, V517, P565, DOI 10.1038/nature14117; Marshall J, 2001, INT J CLIMATOL, V21, P1863, DOI 10.1002/joc.693; Marvel K, 2016, NAT CLIM CHANGE, V6, P386, DOI [10.1038/NCLIMATE2888, 10.1038/nclimate2888]; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; McGregor S, 2014, NAT CLIM CHANGE, V4, P888, DOI [10.1038/nclimate2330, 10.1038/NCLIMATE2330]; Medhaug I, 2011, OCEAN SCI, V7, P389, DOI 10.5194/os-7-389-2011; Medhaug I, 2016, CLIM DYNAM, V46, P3899, DOI 10.1007/s00382-015-2811-y; Meehl GA, 2016, NAT CLIM CHANGE, V6, P1005, DOI [10.1038/NCLIMATE3107, 10.1038/nclimate3107]; Meehl GA, 2014, NAT CLIM CHANGE, V4, P898, DOI [10.1038/NCLIMATE2357, 10.1038/nclimate2357]; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Meehl GA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053423; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Middlemas EA, 2016, J CLIMATE, V29, P6245, DOI 10.1175/JCLI-D-15-0609.1; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Myhre G. D., 2013, CLIMATE CHANGE 2013, DOI [10.1017/c bo9781107415324.018, DOI 10.1017/CBO9781107415324.018]; Myhre G, 2017, ATMOS CHEM PHYS, V17, P2709, DOI 10.5194/acp-17-2709-2017; Newman M, 2016, J CLIMATE, V29, P4399, DOI 10.1175/JCLI-D-15-0508.1; Nieves V, 2015, SCIENCE, V349, P532, DOI 10.1126/science.aaa4521; Ottera OH, 2010, NAT GEOSCI, V3, P688, DOI 10.1038/NGEO955; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Outten S, 2015, J GEOPHYS RES-ATMOS, V120, P8575, DOI 10.1002/2015JD023859; Palmer MD, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034016; Palmer MD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047835; Parker DE, 2010, WIRES CLIM CHANGE, V1, P123, DOI 10.1002/wcc.21; Peterson TC, 1998, INT J CLIMATOL, V18, P1493, DOI 10.1002/(SICI)1097-0088(19981115)18:13<1493::AID-JOC329>3.0.CO;2-T; Peyser CE, 2016, GEOPHYS RES LETT, V43, P8662, DOI 10.1002/2016GL069401; Purkey SG, 2010, J CLIMATE, V23, P6336, DOI 10.1175/2010JCLI3682.1; Rajaratnam B, 2015, CLIMATIC CHANGE, V133, P129, DOI 10.1007/s10584-015-1495-y; Regayre LA, 2014, GEOPHYS RES LETT, V41, P9040, DOI 10.1002/2014GL062029; Rhein M., 2013, CLIMATE CHANGE 2013; Richardson M, 2016, NAT CLIM CHANGE, V6, P931, DOI [10.1038/NCLIMATE3066, 10.1038/nclimate3066]; Richter I, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010561; Ridley DA, 2014, GEOPHYS RES LETT, V41, P7763, DOI 10.1002/2014GL061541; Risbey JS, 2014, NAT CLIM CHANGE, V4, P835, DOI [10.1038/nclimate2310, 10.1038/NCLIMATE2310]; Roberts CD, 2015, NAT CLIM CHANGE, V5, P337, DOI 10.1038/nclimate2531; Robeson SM, 2014, GEOPHYS RES LETT, V41, P9065, DOI 10.1002/2014GL062323; Robson J, 2016, NAT GEOSCI, V9, P513, DOI [10.1038/ngeo2727, 10.1038/NGEO2727]; Roemmich D, 2015, NAT CLIM CHANGE, V5, P240, DOI [10.1038/NCLIMATE2513, 10.1038/nclimate2513]; Rohde R, 2013, GEOINFOR GEOSTAT OVE, V1, DOI 10.4172/2327-4581.1000103; Rose BEJ, 2014, GEOPHYS RES LETT, V41, P1071, DOI 10.1002/2013GL058955; Rossby CG, 1959, ATMOSPHERE SEA MOTIO, P9; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Saenko OA, 2016, CLIM DYNAM, V47, P2193, DOI 10.1007/s00382-015-2958-6; Saffioti C, 2015, GEOPHYS RES LETT, V42, P2385, DOI 10.1002/2015GL063091; Santer BD, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016263; Santer BD, 2015, GEOPHYS RES LETT, V42, P500, DOI 10.1002/2014GL062366; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Schurer AP, 2015, GEOPHYS RES LETT, V42, P5974, DOI 10.1002/2015GL064458; Sevellec F, 2016, GEOPHYS RES LETT, V43, P8169, DOI 10.1002/2016GL068950; Shindell DT, 2014, NAT CLIM CHANGE, V4, P274, DOI [10.1038/nclimate2136, 10.1038/NCLIMATE2136]; Showstack R., 2014, EOS TRANS, V95, P34, DOI DOI 10.1002/2014E0040002; Simmons AJ, 2017, Q J ROY METEOR SOC, V143, P101, DOI 10.1002/qj.2949; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Smith DM, 2016, NAT CLIM CHANGE, V6, P936, DOI [10.1038/NCLIMATE3058, 10.1038/nclimate3058]; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Storelvmo T, 2016, NAT GEOSCI, V9, P286, DOI 10.1038/NGEO2670; Stott P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014024; Stouffer RJ, 2000, J CLIMATE, V13, P513, DOI 10.1175/1520-0442(2000)013<0513:ACOSAT>2.0.CO;2; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Tandon NF, 2015, J CLIMATE, V28, P6309, DOI 10.1175/JCLI-D-14-00664.1; Thoma M, 2015, GEOPHYS RES LETT, V42, P6454, DOI 10.1002/2015GL064833; Thompson DWJ, 2008, NATURE, V453, P646, DOI 10.1038/nature06982; Thorne P, 2015, J GEOPHYS RES-ATMOS, V120, P8597, DOI 10.1002/2014JD022805; Trenberth KE, 2004, Q J ROY METEOR SOC, V130, P2677, DOI 10.1256/qj.04.83; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Trenberth KE, 2016, J CLIMATE, V29, P7495, DOI 10.1175/JCLI-D-16-0339.1; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P911, DOI [10.1038/NCLIMATE2341, 10.1038/nclimate2341]; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Trenberth KE, 2010, SCIENCE, V328, P316, DOI 10.1126/science.1187272; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047563; von Schuckmann K, 2016, NAT CLIM CHANGE, V6, P138, DOI 10.1038/NCLIMATE2876; von Schuckmann K, 2011, OCEAN SCI, V7, P783, DOI 10.5194/os-7-783-2011; Wang Y, 2017, CLIM DYNAM, V48, P2671, DOI 10.1007/s00382-016-3231-3; Watanabe M, 2014, NAT CLIM CHANGE, V4, P893, DOI [10.1038/nclimate2355, 10.1038/NCLIMATE2355]; Watanabe M, 2013, GEOPHYS RES LETT, V40, P3175, DOI 10.1002/grl.50541; WATTS RG, 1991, CLIMATIC CHANGE, V18, pR3, DOI 10.1007/BF00142966; WATTS RG, 1993, CLIMATIC CHANGE, V25, P89, DOI 10.1007/BF01094086; Whitehouse D., 2013, MET OFFICE SAYS WARM; WIGLEY TML, 1990, NATURE, V344, P324, DOI 10.1038/344324a0; Wijffels S, 2016, NAT CLIM CHANGE, V6, P116, DOI 10.1038/nclimate2924; WILD M, 2009, J GEOPHYS RES-ATMOS, V114, DOI DOI 10.1029/2008JD011470; Winton M, 2010, J CLIMATE, V23, P2333, DOI 10.1175/2009JCLI3139.1; Xie SP, 2016, NAT GEOSCI, V9, P29, DOI [10.1038/NGEO2581, 10.1038/ngeo2581]; Yan XH, 2016, EARTHS FUTURE, V4, P472, DOI 10.1002/2016EF000417; Yao SL, 2016, THEOR APPL CLIMATOL, V123, P349, DOI 10.1007/s00704-014-1358-x; Ying LX, 2015, GEOPHYS RES LETT, V42, P6471, DOI 10.1002/2015GL064884; Zhang LP, 2013, J GEOPHYS RES-OCEANS, V118, P5772, DOI 10.1002/jgrc.20390; Zhang R, 2013, J ATMOS SCI, V70, P1135, DOI 10.1175/JAS-D-12-0331.1; Zhou C, 2016, NAT GEOSCI, V9, P871, DOI [10.1038/ngeo2828, 10.1038/NGEO2828]; Zhou CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31789	235	263	280	18	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					41	+		10.1038/nature22315	http://dx.doi.org/10.1038/nature22315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470193				2022-12-28	WOS:000400480400027
J	Rosner, MH; Perazella, MA				Rosner, Mitchell H.; Perazella, Mark A.			Acute Kidney Injury in Patients with Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; TUMOR LYSIS SYNDROME; MULTIPLE-MYELOMA; ONCO-NEPHROLOGY; CAST NEPHROPATHY; LIGHT-CHAINS; PARTIAL NEPHRECTOMY; URIC-ACID; BORTEZOMIB		[Rosner, Mitchell H.] Univ Virginia Hlth Syst, Div Nephrol, Box 800133, Charlottesville, VA 22908 USA; [Perazella, Mark A.] Yale Univ, Sch Med, Sect Nephrol, West Haven, CT 06516 USA; [Perazella, Mark A.] Vet Affairs Med Ctr, West Haven, CT USA	University of Virginia; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Rosner, MH (corresponding author), Univ Virginia Hlth Syst, Div Nephrol, Box 800133, Charlottesville, VA 22908 USA.	mhr9r@virginia.edu						Adhikaree J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju509; Ando M, 2010, BONE MARROW TRANSPL, V45, P1427, DOI 10.1038/bmt.2009.377; [Anonymous], 2010, SHAR DEC MAK APPR IN; BARCOS M, 1987, CANCER, V60, P827, DOI 10.1002/1097-0142(19870815)60:4<827::AID-CNCR2820600419>3.0.CO;2-A; Basnayake K, 2010, J AM SOC NEPHROL, V21, P1165, DOI 10.1681/ASN.2009101089; Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637; Benoit DD, 2010, CRIT CARE CLIN, V26, P151, DOI 10.1016/j.ccc.2009.09.002; BOLES JM, 1984, CANCER-AM CANCER SOC, V53, P2425, DOI 10.1002/1097-0142(19840601)53:11<2425::AID-CNCR2820531111>3.0.CO;2-R; Bridoux F, 2012, ADV CHRONIC KIDNEY D, V19, P333, DOI 10.1053/j.ackd.2012.07.003; Burnette BL, 2011, NEW ENGL J MED, V364, P2365, DOI 10.1056/NEJMc1101834; Cairo MS, 2010, BRIT J HAEMATOL, V149, P578, DOI 10.1111/j.1365-2141.2010.08143.x; Canet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055870; CARDELLA CJ, 1979, CLIN NEPHROL, V12, P285; Chanan-Khan AA, 2007, BLOOD, V109, P2604, DOI 10.1182/blood-2006-09-046409; Christiansen CF, 2011, EUR J INTERN MED, V22, P399, DOI 10.1016/j.ejim.2011.05.005; Coiffier B, 2008, J CLIN ONCOL, V26, P2767, DOI 10.1200/JCO.2007.15.0177; Cortazar FB, 2016, KIDNEY INT, V90, P638, DOI 10.1016/j.kint.2016.04.008; Cortes J, 2010, J CLIN ONCOL, V28, P4207, DOI 10.1200/JCO.2009.26.8896; Cosmai L, 2016, NEPHROL DIAL TRANSPL, V31, P515, DOI 10.1093/ndt/gfv320; Da'as N, 2001, EUR J HAEMATOL, V67, P158, DOI 10.1034/j.1600-0609.2001.5790493.x; Darmon M, 2005, CRIT CARE MED, V33, P2488, DOI 10.1097/01.CCM.0000181728.13354.0A; Darmon M, 2006, CRIT CARE, V10, DOI 10.1186/cc4907; Darmon M, 2007, INTENS CARE MED, V33, P765, DOI 10.1007/s00134-007-0579-1; Darmon M, 2015, NEPHROL DIAL TRANSPL, V30, P2006, DOI 10.1093/ndt/gfv372; Dietzek A, 2015, J ONCOL PHARM PRACT, V21, P143, DOI 10.1177/1078155213518361; Dimopoulos MA, 2013, LEUKEMIA, V27, P423, DOI 10.1038/leu.2012.182; Dimopoulos MA, 2016, AM J HEMATOL, V91, P499, DOI 10.1002/ajh.24335; Dimopoulos MA, 2016, J CLIN ONCOL, V34, P1544, DOI 10.1200/JCO.2015.65.0044; Donovan PJ, 2015, J CLIN ENDOCR METAB, V100, P2024, DOI 10.1210/jc.2014-4250; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; El-Husseini A, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2010.12.029; Eleutherakis-Papaiakovou V, 2007, LEUKEMIA LYMPHOMA, V48, P337, DOI 10.1080/10428190601126602; Finkel KW, 2016, CLIN J AM SOC NEPHRO, V11, P2273, DOI 10.2215/CJN.01640216; Glavey SV, 2013, BONE MARROW TRANSPL, V48, P1543, DOI 10.1038/bmt.2013.109; Hingorani S, 2016, NEW ENGL J MED, V374, P2256, DOI 10.1056/NEJMra1404711; Hoy SM, 2016, TARGET ONCOL, V11, P255, DOI 10.1007/s11523-016-0428-7; Hutchison CA, 2012, NAT REV NEPHROL, V8, P43, DOI 10.1038/nrneph.2011.168; Hutchison CA, 2011, J AM SOC NEPHROL, V22, P1129, DOI 10.1681/ASN.2010080857; Hutchison CA, 2009, NAT REV NEPHROL, V5, P621, DOI 10.1038/nrneph.2009.151; Hutchison CA, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-55; Izzedine H, 2016, INVEST NEW DRUG, V34, P643, DOI 10.1007/s10637-016-0379-y; Izzedine H, 2014, MEDICINE, V93, P333, DOI 10.1097/MD.0000000000000207; Janus N, 2010, BRIT J CANCER, V103, P1815, DOI 10.1038/sj.bjc.6605979; Keating GM, 2014, CLIN DRUG INVEST, V34, P895, DOI 10.1007/s40261-014-0242-x; Khalil MAM, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/272961; Kim CS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-181; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Kogon A, 2010, SEMIN NEPHROL, V30, P615, DOI 10.1016/j.semnephrol.2010.09.009; Lahoti Amit, 2011, J Support Oncol, V9, P149; Lahoti A, 2010, CANCER-AM CANCER SOC, V116, P4063, DOI 10.1002/cncr.25306; Lam AQ, 2012, CLIN J AM SOC NEPHRO, V7, P1692, DOI 10.2215/CJN.03140312; Lameire N, 2011, ACTA CLIN BELG, V66, P337, DOI 10.2143/ACB.66.5.2062585; LeGrand SB, 2008, ANN INTERN MED, V149, P259, DOI 10.7326/0003-4819-149-4-200808190-00007; Liborio AB, 2011, ONCOLOGY-BASEL, V80, P160, DOI 10.1159/000329042; Lommatzsch Steven E, 2006, Ann Diagn Pathol, V10, P230, DOI 10.1016/j.anndiagpath.2005.09.015; Luciano RL, 2014, ADV CHRONIC KIDNEY D, V21, P27, DOI 10.1053/j.ackd.2013.07.004; Ludwig H, 2010, J CLIN ONCOL, V28, P4635, DOI 10.1200/JCO.2010.28.1238; LUNDBERG WB, 1977, AM J MED, V62, P636, DOI 10.1016/0002-9343(77)90427-2; Markowitz GS, 2015, CLIN J AM SOC NEPHRO, V10, P1291, DOI 10.2215/CJN.00860115; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Mazzone PJ, 2003, CURR OPIN PULM MED, V9, P313, DOI 10.1097/00063198-200307000-00012; Mirrakhimov Aibek E, 2015, World J Crit Care Med, V4, P130, DOI 10.5492/wjccm.v4.i2.130; Nasr SH, 2012, AM J KIDNEY DIS, V59, P786, DOI 10.1053/j.ajkd.2011.12.028; Neri Paola, 2016, Cancer Treat Res, V169, P169; Pargger H, 1998, INTENS CARE MED, V24, P61, DOI 10.1007/s001340050516; Parikh CR, 2008, BIOL BLOOD MARROW TR, V14, P309, DOI 10.1016/j.bbmt.2007.12.492; Parikh CR, 2006, KIDNEY INT, V69, P430, DOI 10.1038/sj.ki.5000055; Perazella MA, 2015, KIDNEY INT, V87, P909, DOI 10.1038/ki.2015.30; Perazella MA, 2012, CLIN J AM SOC NEPHRO, V7, P1713, DOI 10.2215/CJN.02780312; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; PONCE P, 1993, NEPHRON, V64, P114, DOI 10.1159/000187289; Porta C, 2015, NAT REV NEPHROL, V11, P354, DOI 10.1038/nrneph.2015.15; Pote A, 2000, AM J KIDNEY DIS, V36, P735, DOI 10.1053/ajkd.2000.17620; Reule S, 2016, J AM SOC NEPHROL, V27, P1487, DOI 10.1681/ASN.2014090876; Rosner MH, 2012, CLIN J AM SOC NEPHRO, V7, P1722, DOI 10.2215/CJN.02470312; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Salahudeen AK, 2013, CLIN J AM SOC NEPHRO, V8, P347, DOI 10.2215/CJN.03530412; SANDERS PW, 1992, J CLIN INVEST, V89, P630, DOI 10.1172/JCI115629; Scheid C, 2014, HAEMATOLOGICA, V99, P148, DOI 10.3324/haematol.2013.087585; Schmid M, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.02.018; Schmid M, 2014, UROL ONCOL-SEMIN ORI, V32, P1259, DOI 10.1016/j.urolonc.2014.05.002; Sherwood GB, 2016, CLIN CASE REP, V4, P315, DOI 10.1002/ccr3.495; Shimada M, 2009, NEPHROL DIAL TRANSPL, V24, P2960, DOI 10.1093/ndt/gfp330; Shirali AC, 2016, AM J KIDNEY DIS, V68, P287, DOI 10.1053/j.ajkd.2016.02.057; Smith ZL, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-016-0599-x; Toka HR, 2012, J AM SOC NEPHROL, V23, P1879, DOI 10.1681/ASN.2012030323; Vadhan-Raj S, 2012, ANN ONCOL, V23, P1640, DOI 10.1093/annonc/mdr490; Wanchoo R, 2016, CLIN KIDNEY J, V9, P245, DOI 10.1093/ckj/sfv149; Wilson FP, 2014, ADV CHRONIC KIDNEY D, V21, P18, DOI 10.1053/j.ackd.2013.07.001; Xu XJ, 2013, LEUKEMIA LYMPHOMA, V54, P255, DOI 10.3109/10428194.2012.715350	90	109	113	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1770	1781		10.1056/NEJMra1613984	http://dx.doi.org/10.1056/NEJMra1613984			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28467867				2022-12-28	WOS:000400442300010
J	Shohet, J; Foster, J				Shohet, Jason; Foster, Jennifer			Neuroblastoma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOMOVANILLIC-ACID; STRATEGIES		[Shohet, Jason; Foster, Jennifer] Texas Childrens Canc Ctr, 6701 Fannin St, Houston, TX 77030 USA; [Shohet, Jason] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX USA; [Foster, Jennifer] Baylor Coll Med, Sect Hematol Oncol, Dept Pediat, Houston, TX 77030 USA	Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Foster, J (corresponding author), Texas Childrens Canc Ctr, 6701 Fannin St, Houston, TX 77030 USA.; Foster, J (corresponding author), Baylor Coll Med, Sect Hematol Oncol, Dept Pediat, Houston, TX 77030 USA.	jhfoster@txch.org		Foster, Jennifer/0000-0002-2126-9768				Acharya S, 1997, CANCER, V80, P304, DOI 10.1002/(SICI)1097-0142(19970715)80:2<304::AID-CNCR19>3.0.CO;2-Y; Alvarado CS, 2000, J PEDIAT HEMATOL ONC, V22, P197, DOI 10.1097/00043426-200005000-00003; ANGSTMAN KB, 1990, AM FAM PHYSICIAN, V41, P238; Bagatell R, 2005, J CLIN ONCOL, V23, P8819, DOI 10.1200/JCO.2004.00.2931; Baker DL, 2010, NEW ENGL J MED, V363, P1313, DOI 10.1056/NEJMoa1001527; Bassiri H, 2015, TRANSL PEDIATR, V4, P226, DOI 10.3978/j.issn.2224-4336.2015.04.06; Blatt J, 1997, J PEDIATR-US, V131, P666, DOI 10.1016/S0022-3476(97)70090-8; Bowman LC, 1997, J NATL CANCER I, V89, P373, DOI 10.1093/jnci/89.5.373; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Cangemi G, 2013, PEDIATR BLOOD CANCER, V60, pE170, DOI 10.1002/pbc.24671; Chamberlain J, 1994, J Med Screen, V1, P169; Cole KA, 2012, CLIN CANCER RES, V18, P2423, DOI 10.1158/1078-0432.CCR-11-1409; De Bernardi B, 2008, BRIT J CANCER, V99, P1027, DOI 10.1038/sj.bjc.6604640; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; DuBois SG, 2016, J CLIN ONCOL, V34, P1368, DOI 10.1200/JCO.2015.65.4889; Garaventa A, 2009, EUR J CANCER, V45, P2835, DOI 10.1016/j.ejca.2009.06.010; George RE, 2005, J CLIN ONCOL, V23, P6466, DOI 10.1200/JCO.2005.05.582; HAWTHORN.HC, 1970, J PEDIATR-US, V77, P297, DOI 10.1016/S0022-3476(70)80339-0; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Iyer R, 2016, CANCER LETT, V372, P179, DOI 10.1016/j.canlet.2016.01.018; Katzenstein HM, 1998, J CLIN ONCOL, V16, P2007, DOI 10.1200/JCO.1998.16.6.2007; KUSHNER BH, 1985, J CLIN ONCOL, V3, P117, DOI 10.1200/JCO.1985.3.1.117; KUSHNER BH, 1986, CANCER-AM CANCER SOC, V57, P1887, DOI 10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7; LABROSSE EH, 1980, CANCER RES, V40, P1995; Leclair MD, 2004, J CLIN ONCOL, V22, P1689, DOI 10.1200/JCO.2004.04.069; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Maris JM, 1997, MED PEDIATR ONCOL, V28, P1, DOI 10.1002/(SICI)1096-911X(199701)28:1<1::AID-MPO1>3.0.CO;2-P; Matthay KK, 1998, J CLIN ONCOL, V16, P1256, DOI 10.1200/JCO.1998.16.4.1256; Morgenstern DA, 2013, J PEDIAT HEMATOL ONC, V35, P337, DOI 10.1097/MPH.0b013e318299d637; Mullassery D, 2014, PEDIATR HEMAT ONCOL, V31, P703, DOI 10.3109/08880018.2014.947009; National Cancer Institute, 2016, IND THER INCL 131 I; Nemecek ER, 2003, J PEDIAT HEMATOL ONC, V25, P159, DOI 10.1097/00043426-200302000-00015; Nickerson HJ, 2000, J CLIN ONCOL, V18, P477, DOI 10.1200/JCO.2000.18.3.477; Nishihira H, 2000, J CLIN ONCOL, V18, P3012, DOI 10.1200/JCO.2000.18.16.3012; Nuchtern Jed G, 2006, Semin Pediatr Surg, V15, P10, DOI 10.1053/j.sempedsurg.2005.11.003; Nuchtern JG, 2012, ANN SURG, V256, P573, DOI 10.1097/SLA.0b013e31826cbbbd; Okazaki T, 2004, PEDIATR SURG INT, V20, P27, DOI 10.1007/s00383-003-1070-x; Oue T, 2005, J PEDIATR SURG, V40, P359, DOI 10.1016/j.jpedsurg.2004.10.062; Peinemann F, 2015, COCHRANE DB SYST REV, V357; Perez CA, 2000, J CLIN ONCOL, V18, P18, DOI 10.1200/JCO.2000.18.1.18; Poplack D., 2016, PRINCIPLES PRACTICE, P772; Rubie H, 2003, BRIT J CANCER, V89, P1605, DOI 10.1038/sj.bjc.6601259; Sadilkova K, 2013, CLIN CHIM ACTA, V424, P253, DOI 10.1016/j.cca.2013.06.024; Santana VM, 2008, CANCER-AM CANCER SOC, V112, P2796, DOI 10.1002/cncr.23507; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Schmidt ML, 2005, J CLIN ONCOL, V23, P6474, DOI 10.1200/JCO.2005.05.183; Schmidt ML, 2000, J CLIN ONCOL, V18, P1260, DOI 10.1200/JCO.2000.18.6.1260; Shahar E, 2003, PEDIATR NEUROL, V28, P385, DOI 10.1016/S0887-8994(03)00010-9; Sholler GLS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127246; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; STILLER CA, 1992, INT J CANCER, V52, P538, DOI 10.1002/ijc.2910520407; STOVROFF M, 1995, J PEDIATR SURG, V30, P1218, DOI 10.1016/0022-3468(95)90027-6; Strother D, 1997, EUR J CANCER, V33, P2121, DOI 10.1016/S0959-8049(97)00293-1; STROTHER D, 1995, J PEDIAT HEMATOL ONC, V17, P254, DOI 10.1097/00043426-199508000-00007; Strother DR, 2012, J CLIN ONCOL, V30, P1842, DOI 10.1200/JCO.2011.37.9990; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yalcin B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006301.pub4; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; Yamamoto K, 2002, J CLIN ONCOL, V20, P1209, DOI 10.1200/JCO.2002.20.5.1209; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	63	38	39	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j1863	10.1136/bmj.j1863	http://dx.doi.org/10.1136/bmj.j1863			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468760				2022-12-28	WOS:000400889600004
J	Ornstein, C				Ornstein, Charles			Public Disclosure of Payments to Physicians From Industry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ornstein, Charles] ProPublica, 155 Ave Amer, New York, NY 10013 USA		Ornstein, C (corresponding author), ProPublica, 155 Ave Amer, New York, NY 10013 USA.	charles.ornstein@propublica.org			Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Mr Ornstein has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. He reports writing this piece as a senior reporter at ProPublica. Since 2015, ProPublica's health coverage has been supported by grants from the Robert Wood Johnson Foundation.	Groeger L., 2014, BIG PHARMAS BIG FINE; Jones R, MATCHING IND PAYMENT; Marshall DC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw163; Ornstein C, 2013, MEDICARES FAILURE TR; Ornstein C, 2010, DOCS PHARM PAYROLL H; Ornstein C, 2013, TOP MEDICARE PRESCRI; Weber T, 2010, MED SCH FLUNK KEEPIN	7	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1749	1750		10.1001/jama.2017.2613	http://dx.doi.org/10.1001/jama.2017.2613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464158				2022-12-28	WOS:000400440700024
J	Friedrich, MJ				Friedrich, M. J.			Massive Polio Vaccination Drive in African Nations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1941	1941		10.1001/jama.2017.5484	http://dx.doi.org/10.1001/jama.2017.5484			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510687				2022-12-28	WOS:000401315500005
J	Cyranoski, D				Cyranoski, David			THE SECRET WAR AGAINST COUNTERFEIT SCIENCE CHINA HAS A LUCRATIVE MARKET FOR FAKE RESEARCH REAGENTS. NOW SOME SCIENTISTS ARE FIGHTING BACK	NATURE			English	News Item							HEMOJUVELIN											Gutierrez OM, 2012, AM J NEPHROL, V36, P332, DOI 10.1159/000342519; Prassas I, 2014, CLIN CHEM LAB MED, V52, P765, DOI 10.1515/cclm-2013-1078; Rumjon A, 2012, AM J NEPHROL, V35, P295, DOI 10.1159/000336528	3	4	4	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					148	150		10.1038/545148a	http://dx.doi.org/10.1038/545148a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492262	Bronze			2022-12-28	WOS:000400963800010
J	Larkin, I; Loewenstein, G				Larkin, Ian; Loewenstein, George			Business Model-Related Conflict of Interests in Medicine Problems and Potential Solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OF-INTEREST; INDUSTRY		[Larkin, Ian] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, 208 Porter Hall, Pittsburgh, PA 15213 USA	University of California System; University of California Los Angeles; Carnegie Mellon University	Loewenstein, G (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, 208 Porter Hall, Pittsburgh, PA 15213 USA.	gl20@andrew.cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474				Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Government Accountability Office, 2013, USITC PUBL, P1; Government SF, 2012, GOV MID FIN PROJ STA, P1; Kirsch M, 2010, CLIN GASTROENTEROL H, V8, P666, DOI 10.1016/j.cgh.2010.05.026; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Morris M, 2016, PRACTICING VALUE BAS, P1; Mostashari F, 2014, JAMA-J AM MED ASSOC, V311, P1855, DOI 10.1001/jama.2014.4086; Rickert J., 2015, HLTH AFFAIRS	10	16	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1745	1746		10.1001/jama.2017.2275	http://dx.doi.org/10.1001/jama.2017.2275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464153				2022-12-28	WOS:000400440700022
J	Jorgensen, KK; Olsen, IC; Goll, GL; Lorentzen, M; Bolstad, N; Haavardsholm, EA; Lundin, KEA; Mork, C; Jahnsen, J; Kvien, TK				Jorgensen, Kristin K.; Olsen, Inge C.; Goll, Guro L.; Lorentzen, Merete; Bolstad, Nils; Haavardsholm, Espen A.; Lundin, Knut E. A.; Mork, Cato; Jahnsen, Jorgen; Kvien, Tore K.		NOR-SWITCH Study Grp	Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial	LANCET			English	Article							RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; INNOVATOR INFLIXIMAB; PARALLEL-GROUP; THERAPY; SAFETY; EXTRAPOLATION; PSORIASIS; EFFICACY; LESSONS	Background TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are expensive therapies. The aim of NOR-SWITCH was to examine switching from originator infliximab to the less expensive biosimilar CT-P13 regarding efficacy, safety, and immunogenicity. Methods The study is a randomised, non-inferiority, double-blind, phase 4 trial with 52 weeks of follow-up. Adult patients on stable treatment with infliximab originator treated in a hospital setting for at least 6 months were eligible for participation. Patients with informed consent were randomised in a 1:1 ratio to either continued infliximab originator or to switch to CT-P13 treatment, with unchanged dosing regimen. Data were collected at infusion visits in 40 Norwegian study centres. Patients, assessors, and patient care providers were masked to treatment allocation. The primary endpoint was disease worsening during 52-week follow-up. 394 patients in the primary per-protocol set were needed to show a non-inferiority margin of 15%, assuming 30% disease worsening in each group. This trial is registered with ClinicalTrials.gov, number NCT02148640. Findings Between Oct 24, 2014, and July 8, 2015, 482 patients were enrolled and randomised (241 to infliximab originator, 241 to CT-P13 group; one patient was excluded from the full analysis and safety set for CT-P13) and 408 were included in the per-protocol set (202 in the infliximab originator group and 206 in the CT-P13 group). 155 (32%) patients in the full analysis set had Crohn's disease, 93 (19%) had ulcerative colitis, 91 (19%) had spondyloarthritis, 77 (16%) had rheumatoid arthritis, 30 (6%) had psoriatic arthritis, and 35 (7%) had chronic plaque psoriasis. Disease worsening occurred in 53 (26%) patients in the infliximab originator group and 61 (30%) patients in the CT-P13 group (per-protocol set; adjusted treatment difference -4.4%, 95% CI -12.7 to 3.9). The frequency of adverse events was similar between groups (for serious adverse events, 24 [10%] for infliximab originator vs 21 [9%] for CT-P13; for overall adverse events, 168 [70%] vs 164 [68%]; and for adverse events leading to discontinuation, nine [4%] vs eight [3%], respectively). Interpretation The NOR-SWITCH trial showed that switching from infliximab originator to CT-P13 was not inferior to continued treatment with infliximab originator according to a prespecified non-inferiority margin of 15%. The study was not powered to show non-inferiority in individual diseases.	[Jorgensen, Kristin K.; Jahnsen, Jorgen] Akershus Univ Hosp, Dept Gastroenterol, Lorenskog, Norway; [Olsen, Inge C.; Goll, Guro L.; Haavardsholm, Espen A.; Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Box 23 Vinderen, N-0319 Oslo, Norway; [Lorentzen, Merete] Natl Hosp Norway, Oslo Univ Hosp, Dept Dermatol, Oslo, Norway; [Lundin, Knut E. A.] Natl Hosp Norway, Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway; [Bolstad, Nils] Radiumhosp, Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Haavardsholm, Espen A.; Lundin, Knut E. A.; Jahnsen, Jorgen; Kvien, Tore K.] Univ Oslo, Fac Med, Oslo, Norway; [Lundin, Knut E. A.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Mork, Cato] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, Fac Med, Trondheim, Norway	University of Oslo; Diakonhjemmet Hospital; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Kvien, TK (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Box 23 Vinderen, N-0319 Oslo, Norway.; Kvien, TK (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	t.k.kvien@medisin.uio.no	emery, paul/B-3560-2013; Jahnsen, Jorgen/GRO-3253-2022; Lundin, Knut E. A./AAW-9519-2021; Olsen, Inge Christoffer/R-9128-2019	Jahnsen, Jorgen/0000-0002-0419-2914; Lundin, Knut E. A./0000-0003-1713-5545; Olsen, Inge Christoffer/0000-0001-6889-5873; Berset, Ingrid Prytz/0000-0002-2014-8497; Gomez-Reino, Juan/0000-0001-5229-6294	Norwegian Ministry of Health and Care Services	Norwegian Ministry of Health and Care Services	Norwegian Ministry of Health and Care Services.	Ben-Horin S, 2016, CLIN GASTROENTEROL H, V14, P1685, DOI 10.1016/j.cgh.2016.05.023; Blauvelt A, 2017, BRIT J DERMATOL, V177, P23, DOI 10.1111/bjd.15067; Braun J, 2016, BIOLOGICALS, V44, P257, DOI 10.1016/j.biologicals.2016.03.006; Buer LCT, 2016, J CROHNS COLITIS, V11, DOI [10.1093/ecco-jcc/jjw166, DOI 10.1093/ECCO-JCC/JJW166]; Choe JY, 2017, ANN RHEUM DIS, V76, P58, DOI 10.1136/annrheumdis-2015-207764; Danese S, 2013, J CROHNS COLITIS, V7, P586, DOI 10.1016/j.crohns.2013.03.011; Dapavo P, 2016, J AM ACAD DERMATOL, V75, P736, DOI 10.1016/j.jaad.2016.04.068; Dorner T, 2016, ANN RHEUM DIS, V75, P974, DOI 10.1136/annrheumdis-2016-209166; Dorner T, 2015, NAT REV RHEUMATOL, V11, P713, DOI 10.1038/nrrheum.2015.110; Emery P, 2017, ANN RHEUM DIS, V76, P51, DOI 10.1136/annrheumdis-2015-207588; European Medicines Agency, 2013, ASS REP REMS; Feagan BG, 2014, BIOLOGICALS, V42, P177, DOI 10.1016/j.biologicals.2014.05.005; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gecse KB, 2016, DRUGS, V76, P1413, DOI 10.1007/s40265-016-0638-4; Glintborg B, 2016, ANN RHEUM DIS, V75, P142, DOI 10.1136/annrheumdis-2016-eular.1785; Griffiths CL, 2016, S AFR J SCI, V112, P28; HARVEY RF, 1980, LANCET, V1, P1134; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Park W, 2017, ANN RHEUM DIS, V76, P346, DOI 10.1136/annrheumdis-2015-208783; Park W, 2013, ANN RHEUM DIS, V72, P1605, DOI 10.1136/annrheumdis-2012-203091; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Putrik P, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2012-202603; Schaeverbeke T, 2016, RHEUMATOLOGY, V55, P210, DOI 10.1093/rheumatology/kev277; Schneider CK, 2013, ANN RHEUM DIS, V72, P315, DOI 10.1136/annrheumdis-2012-202941; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Smits LJT, 2016, J CROHNS COLITIS, V10, P1287, DOI 10.1093/ecco-jcc/jjw087; Weise M, 2014, BLOOD, V124, P3191, DOI 10.1182/blood-2014-06-583617; Yoo DH, 2017, ANN RHEUM DIS, V76, P355, DOI 10.1136/annrheumdis-2015-208786; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090	30	529	540	3	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2017	389	10086					2304	2316		10.1016/S0140-6736(17)30068-5	http://dx.doi.org/10.1016/S0140-6736(17)30068-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW9XM	28502609				2022-12-28	WOS:000402872700025
J	Berg, J				Berg, Jeremy			Editorial retraction	SCIENCE			English	Letter													Berg, Jeremy/GRY-6706-2022	Berg, Jeremy/0000-0002-2444-8139; Berg, Jeremy/0000-0003-3022-0963				Berg J, 2016, SCIENCE, V354, P1242, DOI 10.1126/science.aah6990; Lonnstedt OM, 2016, SCIENCE, V352, P1213, DOI 10.1126/science.aad8828	2	4	4	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2017	356	6340					812	812		10.1126/science.aan5763	http://dx.doi.org/10.1126/science.aan5763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV7LP	28469005				2022-12-28	WOS:000401957900026
J	Griffin, E				Griffin, Elizabeth			Rescue old data before it's too late	NATURE			English	Editorial Material									[Griffin, Elizabeth] Canadas Natl Res Council Observ, Victoria, BC, Canada; [Griffin, Elizabeth] RDA Data Rescue Interest Grp, Victoria, BC, Canada	National Research Council Canada	Griffin, E (corresponding author), Canadas Natl Res Council Observ, Victoria, BC, Canada.; Griffin, E (corresponding author), RDA Data Rescue Interest Grp, Victoria, BC, Canada.	elizabeth.griffin@nrc-cnrc.gc.ca							0	6	6	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					267	267		10.1038/545267a	http://dx.doi.org/10.1038/545267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28516934	Bronze			2022-12-28	WOS:000401466500031
J	Owens, B				Owens, Brian			SSIMWAVE Seeing the screen	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S12	S12		10.1038/545S12a	http://dx.doi.org/10.1038/545S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514417	Bronze			2022-12-28	WOS:000401466500008
J	Rozel, AB; Golabek, GJ; Jain, C; Tackley, PJ; Gerya, T				Rozel, A. B.; Golabek, G. J.; Jain, C.; Tackley, P. J.; Gerya, T.			Continental crust formation on early Earth controlled by intrusive magmatism	NATURE			English	Article							MANTLE CONVECTION; PLATE-TECTONICS; CORONA FORMATION; VENUS; SUBDUCTION; RHEOLOGY; ORIGIN; NOVAE; PLUME; EVOLUTION	The global geodynamic regime of early Earth, which operated before the onset of plate tectonics, remains contentious. As geological and geochemical data suggest hotter Archean mantle temperature(1,2) and more intense juvenile magmatism than in the present-day Earth(3,4), two crust-mantle interaction modes differing in melt eruption efficiency have been proposed: the Io-like heat-pipe tectonics regime dominated by volcanism(5,6) and the "Plutonic squishy lid" tectonics regime governed by intrusive magmatism, which is thought to apply to the dynamics of Venus(7-9). Both tectonics regimes are capable of producing primordial tonalite-trondhjemite-granodiorite (TTG) continental crust(5,10) but lithospheric geotherms and crust production rates as well as proportions of various TTG compositions differ greatly(9,10), which implies that the heat-pipe and Plutonic squishy lid hypotheses can be tested using natural data(11). Here we investigate the creation of primordial TTG-like continental crust using self-consistent numerical models of global thermochemical convection associated with magmatic processes. We show that the volcanism-dominated heat-pipe tectonics model results in cold crustal geotherms and is not able to produce Earth-like primordial continental crust. In contrast, the Plutonic squishy lid tectonics regime dominated by intrusive magmatism results in hotter crustal geotherms and is capable of reproducing the observed proportions of various TTG rocks. Using a systematic parameter study, we show that the typical modern eruption efficiency of less than 40 per cent(12) leads to the production of the expected amounts of the three main primordial crustal compositions previously reported from field data(4,11) (low-, medium- and high-pressure TTG). Our study thus suggests that the pre-plate-tectonics Archean Earth operated globally in the Plutonic squishy lid regime rather than in an Io-like heat-pipe regime.	[Rozel, A. B.; Jain, C.; Tackley, P. J.; Gerya, T.] Swiss Fed Inst Technol, Inst Geophys, CH-8092 Zurich, Switzerland; [Golabek, G. J.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bayreuth	Rozel, AB (corresponding author), Swiss Fed Inst Technol, Inst Geophys, CH-8092 Zurich, Switzerland.	antoine.rozel@erdw.ethz.ch	Tackley, Paul J/D-8155-2016; Gerya, Taras/V-2330-2019	Tackley, Paul J/0000-0003-4878-621X; Gerya, Taras/0000-0002-1062-2722; Rozel, Antoine/0000-0002-7408-1099; Golabek, Gregor/0000-0002-9501-8347; Jain, Charitra/0000-0002-0562-2568	European Research Council under the European Union/ERC [320639]; SNF [200020_166063]	European Research Council under the European Union/ERC(European Research Council (ERC)); SNF	We thank K. Condie, L. Moresi and M. Van Kranendonk for comments and suggestions as part of the review process. A.B.R. and C.J. received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/20072013)/ERC Grant Agreement number 320639 project iGEO. T.G. received support from the SNF projects Swiss-AlpArray and number 200020_166063.	Aittola M, 2000, PLANET SPACE SCI, V48, P1479, DOI 10.1016/S0032-0633(00)00093-3; Amestoy PR, 2000, COMPUT METHOD APPL M, V184, P501, DOI 10.1016/S0045-7825(99)00242-X; Anderson FS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2004JE002395; Armann M, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004231; Barsukov V.L., 1984, GEOKHIMIYA, V12, P1811; Basilevsky AT, 2003, REP PROG PHYS, V66, P1699, DOI 10.1088/0034-4885/66/10/R04; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Benn K, 2006, GEOPHYS MONOGR SER, V164, P1, DOI 10.1029/164GM02; BINDSCHADLER DL, 1991, J GEOPHYS RES-SOLID, V96, P5889, DOI 10.1029/90JB02742; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Cizkova H, 2012, PHYS EARTH PLANET IN, V200, P56, DOI 10.1016/j.pepi.2012.02.010; Condie KC, 2016, GEOSCI FRONT, V7, P543, DOI 10.1016/j.gsf.2016.01.006; Condie KC, 2007, GEOL SOC AM MEM, V200, P145, DOI 10.1130/2007.1200(09); CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; de Smet JH, 1999, LITHOS, V48, P153, DOI 10.1016/S0024-4937(99)00028-6; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Ernst RE, 2001, ANNU REV EARTH PL SC, V29, P489, DOI 10.1146/annurev.earth.29.1.489; Fischer R, 2016, J GEODYN, V100, P198, DOI 10.1016/j.jog.2016.03.004; Gerya TV, 2015, NATURE, V527, P221, DOI 10.1038/nature15752; Gerya TV, 2014, EARTH PLANET SC LETT, V391, P183, DOI 10.1016/j.epsl.2014.02.005; Gerya T, 2014, GONDWANA RES, V25, P442, DOI 10.1016/j.gr.2012.11.008; Griffin WL, 2007, DEV PREC G, V15, P1013, DOI 10.1016/S0166-2635(07)15082-9; Grindrod PM, 2006, ASTRON GEOPHYS, V47, P16, DOI 10.1111/j.1468-4004.2006.47316.x; HARLOW FH, 1965, PHYS FLUIDS, V8, P2182, DOI 10.1063/1.1761178; Harris LB, 2015, GEOL SOC SPEC PUBL, V401, P327, DOI 10.1144/SP401.9; Harris LB, 2014, MOD APPR SOL EARTH S, V7, P215, DOI 10.1007/978-94-007-7615-9_9; Hernlund JW, 2008, PHYS EARTH PLANET IN, V171, P48, DOI 10.1016/j.pepi.2008.07.037; HERRICK RR, 1994, GEOLOGY, V22, P703, DOI 10.1130/0091-7613(1994)022<0703:RHOV>2.3.CO;2; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; Hickman A., 2004, DEV PRECAMBRIAN GEOL, V12, P118; Hoogenboom T, 2006, ICARUS, V180, P292, DOI 10.1016/j.icarus.2005.11.001; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; James PB, 2013, J GEOPHYS RES-PLANET, V118, P859, DOI 10.1029/2012JE004237; Johnson TE, 2014, NAT GEOSCI, V7, P47, DOI [10.1038/NGEO2019, 10.1038/ngeo2019]; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Krassilnikov AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001983; Labrosse S, 2015, GEOPHYS MONOGR SER, V212, P123; Lourenco DL, 2016, EARTH PLANET SC LETT, V439, P18, DOI 10.1016/j.epsl.2016.01.024; McKinnon WB, 1997, SPACE SCI S, P969; Moore WB, 2013, NATURE, V501, P501, DOI 10.1038/nature12473; Moyen JF, 2006, GEOPHYS MONOGR SER, V164, P149, DOI 10.1029/164GM11; Moyen JF, 2011, LITHOS, V123, P21, DOI 10.1016/j.lithos.2010.09.015; Nakagawa T, 2004, PHYS EARTH PLANET IN, V146, P125, DOI 10.1016/j.pepi.2003.05.006; Nakagawa T, 2012, EARTH PLANET SC LETT, V329, P1, DOI 10.1016/j.epsl.2012.02.011; Nutman AP, 2006, ELEMENTS, V2, P223, DOI 10.2113/gselements.2.4.223; Nutman AP, 2009, GEOL SOC SPEC PUBL, V318, P127, DOI 10.1144/SP318.5; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; Rey PF, 2014, NATURE, V513, P405, DOI 10.1038/nature13728; SANDWELL DT, 1992, SCIENCE, V257, P766, DOI 10.1126/science.257.5071.766; SCHABER GG, 1992, J GEOPHYS RES-PLANET, V97, P13257, DOI 10.1029/92JE01246; Sizova E, 2015, PRECAMBRIAN RES, V271, P198, DOI 10.1016/j.precamres.2015.10.005; Smrekar SE, 1997, SCIENCE, V277, P1289, DOI 10.1126/science.277.5330.1289; STOFAN ER, 1992, J GEOPHYS RES-PLANET, V97, P13347, DOI 10.1029/92JE01314; Stofan ER, 2001, GEOPHYS RES LETT, V28, P4267, DOI 10.1029/2001GL013307; STROM RG, 1994, J GEOPHYS RES-PLANET, V99, P10899, DOI 10.1029/94JE00388; Tackley P., 2015, EUR GEOSC UN GEN ASS, V17, P13804; Tackley PJ, 2013, ICARUS, V225, P50, DOI 10.1016/j.icarus.2013.03.013; Tackley P. J., 2000, GEOCHEM GEOPHY GEOSY, V1, P1, DOI [10.1029/2000GC000036, DOI 10.1029/2000GC000036, 10.1029/200GC000036, 10.1029/2000GC000043]; Tackley PJ, 2008, PHYS EARTH PLANET IN, V171, P7, DOI 10.1016/j.pepi.2008.08.005; van Hunen J, 2012, ANNU REV EARTH PL SC, V40, P195, DOI [10.1146/annurev-earth-842711-105255, 10.1146/annurev-earth-042711-105255]; Van Kranendonk MJ, 2010, AM J SCI, V310, P1187, DOI 10.2475/10.2010.01; Van Kranendonk MJ, 2007, DEV PREC G, V15, P1105, DOI 10.1016/S0166-2635(07)15086-6; Yamazaki D, 2001, AM MINERAL, V86, P385	63	104	107	5	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					332	+		10.1038/nature22042	http://dx.doi.org/10.1038/nature22042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28482358				2022-12-28	WOS:000401466500059
J	Gulland, A				Gulland, Anne			Your vote counts: how will a soft or hard Brexit affect health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Department for Exiting the European Union, 2017, UK EX NEW PARTN EUR; General Medical Council, 2017, LIST REG MED PRACT S; Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2747; House of Commons Health Committee, 2017, BREX HLTH SOC CAR PE; House of Lords Science and Technology Select Committee, 2016, EU MEMB UK SCI 2 REP; Institute for Public Policy Research, 2017, STRIK RIGHT DEAL UK; Labour Press, 2017, COMMUNICATION    APR; O'Dowd A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j447	8	0	0	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2017	357								j2338	10.1136/bmj.j2338	http://dx.doi.org/10.1136/bmj.j2338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RN	28515124				2022-12-28	WOS:000401899700006
J	[Anonymous]				[Anonymous]			The Supply of Doctors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					2023	2023		10.1001/jama.2017.3994	http://dx.doi.org/10.1001/jama.2017.3994			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510668				2022-12-28	WOS:000401315500032
J	Tan, XJ; Anderson, RA				Tan, Xiaojun; Anderson, Richard A.			CELL BIOLOGY Keeping in touch with the ER network	SCIENCE			English	Editorial Material							MEMBRANE CONTACT SITES; EGF RECEPTOR; TRAFFICKING; DEGRADATION; AUTOPHAGY		[Tan, Xiaojun] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	raanders@wisc.edu	Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240	NCI NIH HHS [P30 CA014520] Funding Source: Medline; NIGMS NIH HHS [R35 GM134955, R01 GM057549] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burgoyne T, 2015, BBA-MOL CELL RES, V1853, P2012, DOI 10.1016/j.bbamcr.2015.01.022; Caldieri G, 2017, SCIENCE, V356, P617, DOI 10.1126/science.aah6152; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Jackson CL, 2016, DEV CELL, V39, P139, DOI 10.1016/j.devcel.2016.09.030; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tan XJ, 2016, P NATL ACAD SCI USA, V113, P10896, DOI 10.1073/pnas.1523145113; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002	14	0	0	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					584	585		10.1126/science.aan4807	http://dx.doi.org/10.1126/science.aan4807			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495716	Green Accepted			2022-12-28	WOS:000400975200023
J	Janda, CY; Dang, LT; You, CJ; Chang, JL; de Lau, W; Zhong, ZDA; Yan, KS; Marecic, O; Siepe, D; Li, XN; Moody, JD; Williams, BO; Clevers, H; Piehler, J; Baker, D; Kuo, CJ; Garcia, KC				Janda, Claudia Y.; Dang, Luke T.; You, Changjiang; Chang, Junlei; de Lau, Wim; Zhong, Zhendong A.; Yan, Kelley S.; Marecic, Owen; Siepe, Dirk; Li, Xingnan; Moody, James D.; Williams, Bart O.; Clevers, Hans; Piehler, Jacob; Baker, David; Kuo, Calvin J.; Garcia, K. Christopher			Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling	NATURE			English	Article							IN-VITRO EXPANSION; STEM-CELLS; STRUCTURAL BASIS; PROTEIN; DYNAMICS; REVEALS; GROWTH; ACTIVATION; AFFINITY; PATHWAY	Wnt proteins modulate cell proliferation and differentiation and the self-renewal of stem cells by inducing beta-catenin-dependent signalling through the Wnt receptor frizzled (FZD) and the co-receptors LRP5 and LRP6 to regulate cell fate decisions and the growth and repair of several tissues(1). The 19 mammalian Wnt proteins are cross-reactive with the 10 FZD receptors, and this has complicated the attribution of distinct biological functions to specific FZD and Wnt subtype interactions. Furthermore, Wnt proteins are modified post-translationally by palmitoylation, which is essential for their secretion, function and interaction with FZD receptors(2-4). As a result of their acylation, Wnt proteins are very hydrophobic and require detergents for purification, which presents major obstacles to the preparation and application of recombinant Wnt proteins. This hydrophobicity has hindered the determination of the molecular mechanisms of Wnt signalling activation and the functional importance of FZD subtypes, and the use of Wnt proteins as therapeutic agents. Here we develop surrogate Wnt agonists, water-soluble FZD-LRP5/LRP6 heterodimerizers, with FZD5/FZD8-specific and broadly FZD-reactive binding domains. Similar to WNT3A, these Wnt agonists elicit a characteristic beta-catenin signalling response in a FZD-selective fashion, enhance the osteogenic lineage commitment of primary mouse and human mesenchymal stem cells, and support the growth of a broad range of primary human organoid cultures. In addition, the surrogates can be systemically expressed and exhibit Wnt activity in vivo in the mouse liver, regulating metabolic liver zonation and promoting hepatocyte proliferation, resulting in hepatomegaly. These surrogates demonstrate that canonical Wnt signalling can be activated by bi-specific ligands that induce receptor heterodimerization. Furthermore, these easily produced, non-lipidated Wnt surrogate agonists facilitate functional studies of Wnt signalling and the exploration of Wnt agonists for translational applications in regenerative medicine.	[Janda, Claudia Y.; Siepe, Dirk; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Janda, Claudia Y.; Siepe, Dirk; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Dang, Luke T.; Moody, James D.; Kuo, Calvin J.] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; [Dang, Luke T.; Moody, James D.; Kuo, Calvin J.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [You, Changjiang; Piehler, Jacob] Univ Osnabruck, Dept Biol, Div Biophys, D-49076 Osnabruck, Germany; [Chang, Junlei; Yan, Kelley S.; Li, Xingnan; Kuo, Calvin J.] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [de Lau, Wim; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [de Lau, Wim; Clevers, Hans] Univ Med Ctr Utrecht, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Zhong, Zhendong A.; Williams, Bart O.] Van Andel Res Inst, Program Skeletal Dis & Tumor Microenvironm, 333 Bostwick NE, Grand Rapids, MI 49503 USA; [Zhong, Zhendong A.; Williams, Bart O.] Van Andel Res Inst, Ctr Canc & Cell Biol, 333 Bostwick NE, Grand Rapids, MI 49503 USA; [Marecic, Owen] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Marecic, Owen] Stanford Univ, Sch Med, Dept Surg, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Osnabruck; Stanford University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Van Andel Institute; Van Andel Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	You, Changjiang/L-3901-2014; You, Changjiang/AFK-2816-2022; Chang, Junlei/K-2696-2017; Williams, Bart/A-3539-2013	You, Changjiang/0000-0002-7839-6397; You, Changjiang/0000-0002-7839-6397; Chang, Junlei/0000-0002-0319-9022; Williams, Bart/0000-0002-5261-5301; Moody, James/0000-0003-2266-5348; Kuo, Calvin/0000-0002-7427-5985	National Institutes of Health (NIH) [R01 GM097015, K08DK096048, U01 DK085527, U19 AI116484, U01 CA176299]; DFG [SFB 944]; Bu,rroughs Wellcome Fund CAMS; Stinehart/Reed Foundation; Ludwig Foundation; Howard Hughes Medical Institute; European Union [668294]; NWO translational Adult Stem Cell Research grant [40-41400-98-1108]; NATIONAL CANCER INSTITUTE [U01CA217851, U01CA176299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527, K08DK096048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266, R01GM097015] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Bu,rroughs Wellcome Fund CAMS(Burroughs Wellcome Fund); Stinehart/Reed Foundation; Ludwig Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); European Union(European Commission); NWO translational Adult Stem Cell Research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff of the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory, for support and access to beamline 8.2.2, and P. Chu from the Department of Comparative Medicine Animal Histology Service Center for sample preparation. This work was supported by National Institutes of Health (NIH) R01 GM097015 (to K.C.G), K08DK096048 (to K.S.Y), U01 DK085527 (to C.J.K.), U19 AI116484 (to C.J.K.), U01 CA176299 (to C.J.K.); DFG SFB 944 (to J.P.); Bu,rroughs Wellcome Fund CAMS (to K.S.Y.); the Stinehart/Reed Foundation (to K.C.G.); the Ludwig Foundation (K.C.G., C.J.K.); the Howard Hughes Medical Institute (to K.C.G., D.B.), the European Union's Horizon 2020 research and innovation program under grant agreement no. 668294 (to H.C.), and the NWO translational Adult Stem Cell Research grant 40-41400-98-1108 (to H.C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Chang TH, 2015, ELIFE, V4, DOI 10.7554/eLife.06554; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Holmen SL, 2005, BIOCHEM BIOPH RES CO, V328, P533, DOI 10.1016/j.bbrc.2005.01.009; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lemmon MA, 1998, METH MOL B, V84, P49; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Muster B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011910; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Salazar VS, 2016, DEVELOPMENT, V143, P4352, DOI 10.1242/dev.136879; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shah SM, 2009, NEUROSCIENCE, V164, P478, DOI 10.1016/j.neuroscience.2009.08.049; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wedeking T, 2015, NANO LETT, V15, P3610, DOI 10.1021/acs.nanolett.5b01153; Wei KV, 2008, J MOL MED, V86, P161, DOI 10.1007/s00109-007-0261-7; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; You CJ, 2013, ACS CHEM BIOL, V8, P320, DOI 10.1021/cb300543t; Zhong ZD, 2014, WIRES DEV BIOL, V3, P489, DOI 10.1002/wdev.159; Zhong ZDA, 2016, METHODS MOL BIOL, V1481, P119, DOI 10.1007/978-1-4939-6393-5_13	70	164	174	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					234	+		10.1038/nature22306	http://dx.doi.org/10.1038/nature22306			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467818	Green Accepted			2022-12-28	WOS:000400963800036
J	Janne, PA; van den Heuvel, MM; Barlesi, F; Cobo, M; Mazieres, J; Crino, L; Orlov, S; Blackhall, F; Wolf, J; Garrido, P; Poltoratskiy, A; Mariani, G; Ghiorghiu, D; Kilgour, E; Smith, P; Kohlmann, A; Carlile, DJ; Lawrence, D; Bowen, K; Vansteenkiste, J				Janne, Pasi A.; van den Heuvel, Michel M.; Barlesi, Fabrice; Cobo, Manuel; Mazieres, Julien; Crino, Lucio; Orlov, Sergey; Blackhall, Fiona; Wolf, Juergen; Garrido, Pilar; Poltoratskiy, Artem; Mariani, Gabriella; Ghiorghiu, Dana; Kilgour, Elaine; Smith, Paul; Kohlmann, Alexander; Carlile, David J.; Lawrence, David; Bowen, Karin; Vansteenkiste, Johan			Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AZD6244 ARRY-142886; PHASE-II; MULTICENTER; MUTATIONS	IMPORTANCE There are no specifically approved targeted therapies for the most common genomically defined subset of non-small cell lung cancer (NSCLC), KRAS-mutant lung cancer. OBJECTIVE To compare efficacy of the mitogen-activated protein kinase kinase (MEK) inhibitor selumetinib + docetaxel with docetaxel alone as a second-line therapy for advanced KRAS-mutant NSCLC. DESIGN, SETTING, AND PARTICIPANTS Multinational, randomized clinical trial conducted at 202 sites across 25 countries from October 2013 through January 2016. Of 3323 patients with advanced NSCLC and disease progression following first-line anticancer therapy tested for a KRAS mutation, 866 were enrolled and 510 randomized. Primary reason for exclusion was ineligibility. The data cutoff date for analysis was June 7, 2016. INTERVENTIONS Patients were randomized 1: 1; 254 to receive selumetinib + docetaxel and 256 to receive placebo + docetaxel. MAIN OUTCOMES AND MEASURES Primary end point was investigator assessed progression-free survival. Secondary end points included overall survival, objective response rate, duration of response, effects on disease-related symptoms, safety, and tolerability. RESULTS Of 510 randomized patients (mean age, 61.4 years [SD, 8.3]; women, 207 [41%]), 505 patients (99%) received treatment and completed the study (251 received selumetinib + docetaxel; 254 received placebo + docetaxel). At the time of data cutoff, 447 patients (88%) had experienced a progression event and 346 deaths (68%) had occurred. Median progression-free survival was 3.9 months (interquartile range [IQR], 1.5-5.9) with selumetinib + docetaxel and 2.8 months (IQR, 1.4-5.5) with placebo + docetaxel (difference, 1.1 months; hazard ratio [HR], 0.93 [95% CI, 0.77-1.12]; P =.44). Median overall survivalwas 8.7 months (IQR, 3.6-16.8) with selumetinib + docetaxel and 7.9 months (IQR, 3.8-20.1) with placebo + docetaxel (difference, 0.9 months; HR, 1.05 [95% CI, 0.85-1.30]; P =.64). Objective response rate was 20.1% with selumetinib + docetaxel and 13.7% with placebo + docetaxel (difference, 6.4%; odds ratio, 1.61 [95% CI, 1.00-2.62]; P =.05). Median duration of response was 2.9 months (IQR, 1.7-4.8; 95% CI, 2.7-4.1) with selumetinib + docetaxel and 4.5 months (IQR, 2.3-7.3; 95% CI, 2.8-5.6) with placebo + docetaxel. Adverse events of grade 3 or higher were more frequent with selumetinib + docetaxel (169 adverse events [67%] for selumetinib + docetaxel vs 115 adverse events [45%] for placebo + docetaxel; difference, 22%). CONCLUSIONS AND RELEVANCE Among patients with previously treated advanced KRAS-mutant non-small cell lung cancer, addition of selumetinib to docetaxel did not improve progression-free survival compared with docetaxel alone.	[Janne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 450 Brookline Ave,LC4114, Boston, MA 02215 USA; [Janne, Pasi A.] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, 450 Brookline Ave,LC4114, Boston, MA 02215 USA; [van den Heuvel, Michel M.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands; [Barlesi, Fabrice] Aix Marseille Univ, AP HP, Multidisciplinary Oncol & Therapeut Innovat Dept, Marseille, France; [Cobo, Manuel] Hosp Univ Malaga, Dept Med Oncol, Malaga, Spain; Toulouse Univ Hosp, Dept Pulmonol, Toulouse, France; [Crino, Lucio] Ist Ricovero Cura Carattere Sci Meldola, Ist Sci Romagnolo Studio Cura Tumori, Meldola, Italy; [Orlov, Sergey] Pavlov Med Univ, Dept Med, St Petersburg, Russia; [Blackhall, Fiona] Manchester Univ & Christie Hosp NHS Fdn Trust, Manchester, Lancs, England; [Wolf, Juergen] Univ Hosp Cologne, Dept Internal Med, Ctr Integrated Oncol, Cologne, Germany; [Garrido, Pilar] Univ Hosp Ramon & Cajal, Dept Med Oncol, Madrid, Spain; [Mariani, Gabriella; Ghiorghiu, Dana; Kilgour, Elaine; Smith, Paul; Kohlmann, Alexander; Carlile, David J.; Lawrence, David] AstraZeneca, Cambridge, England; [Kohlmann, Alexander] AstraZeneca, Macclesfield, Cheshire, England; [Bowen, Karin] AstraZeneca, Gaithersburg, MD USA; [Vansteenkiste, Johan] Univ Leuven, Dept Resp Dis, Resp Oncol Unit, Univ Hosp Katholieke, Leuven, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Netherlands Cancer Institute; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; IRCCS Meldola (IRST); Pavlov First Saint Petersburg State Medical University; Christie NHS Foundation Trust; Christie Hospital; University of Cologne; Hospital Universitario Ramon y Cajal; AstraZeneca; AstraZeneca; KU Leuven	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 450 Brookline Ave,LC4114, Boston, MA 02215 USA.; Janne, PA (corresponding author), Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, 450 Brookline Ave,LC4114, Boston, MA 02215 USA.	pasi_janne@dfci.harvard.edu	GARRIDO, PILAR/D-5187-2017; MAZIERES, JULIEN/M-3986-2014; Mariani, Gabriella Lucia/AAA-4112-2021; van den Heuvel, Michel M/D-9491-2017; Orlov, Sergey/AAC-8379-2022; Vansteenkiste, Johan F/B-8191-2014; Blackhall, Fiona/N-2186-2015	GARRIDO, PILAR/0000-0002-5899-6125; Mariani, Gabriella Lucia/0000-0001-6882-4944; van den Heuvel, Michel M/0000-0002-6372-2153; Vansteenkiste, Johan F/0000-0002-6721-2775; Blackhall, Fiona/0000-0001-8716-3395; Orlov, Sergey/0000-0001-6080-8042	AstraZeneca; Cancer Research UK [20465] Funding Source: researchfish	AstraZeneca(AstraZeneca); Cancer Research UK(Cancer Research UK)	This study was funded by AstraZeneca. Roche Molecular Systems provided management in testing the formalin- fixed, paraffinembedded tissue samples.	[Anonymous], 1966, JAMA-J AM MED ASSOC, V197, P32, DOI [10.1001/jama.1966.03110110016005, DOI 10.1001/JAMA.1966.03110110016005]; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Burman CF, 2009, STAT MED, V28, P739, DOI 10.1002/sim.3513; Carter CA, 2016, ANN ONCOL, V27, P693, DOI 10.1093/annonc/mdw008; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Denton CL, 2011, CANCER CHEMOTH PHARM, V67, P349, DOI 10.1007/s00280-010-1323-z; Janne PA, 2015, BRIT J CANCER, V113, P199, DOI 10.1038/bjc.2015.215; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Johnson ML, 2013, CANCER-AM CANCER SOC, V119, P356, DOI 10.1002/cncr.27730; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Li D, 2016, J CLIN ONCOL S, V34; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Stone A, 2015, PHARM STAT, V14, P455, DOI 10.1002/pst.1707; Wood K, 2016, JAMA ONCOL, V2, P805, DOI 10.1001/jamaoncol.2016.0405; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	23	225	230	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1844	1853		10.1001/jama.2017.3438	http://dx.doi.org/10.1001/jama.2017.3438			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492898	Green Published			2022-12-28	WOS:000400842400015
J	Lyon, J				Lyon, Jeff			Maker of Duodenoscopes Under Scrutiny Again	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1826	1826		10.1001/jama.2017.5385	http://dx.doi.org/10.1001/jama.2017.5385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492880				2022-12-28	WOS:000400842400005
J	Galea, S; Saitz, R				Galea, Sandro; Saitz, Richard			Funding, Institutional Conflicts of Interest, and Schools of Public Health Realities and Solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALCOHOL; CONSUMPTION		[Galea, Sandro; Saitz, Richard] Boston Univ, Sch Publ Hlth, 715 Albany St,Talbot 301, Boston, MA 02118 USA	Boston University	Galea, S (corresponding author), Boston Univ, Sch Publ Hlth, 715 Albany St,Talbot 301, Boston, MA 02118 USA.	sgalea@bu.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945; /0000-0002-2535-1427	National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse; Substance Abuse and Mental Health Services Administration; NIH; ASAM; Open Society Foundations; Pew Charitable Trusts; Shatterproof; Hazelden Betty Ford Foundation; Addiction Technology Transfer Center Network	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASAM; Open Society Foundations; Pew Charitable Trusts; Shatterproof; Hazelden Betty Ford Foundation; Addiction Technology Transfer Center Network	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Saitz is and has been principal investigator of grants awarded to Boston Medical Center and Boston University from the National Institutes of Health (including the National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Administration) to study the management of unhealthy substance use, including to test the accuracy of screening and the efficacy of screening, brief intervention, and referral to treatment and the effectiveness of integrated care. He has been paid to speak or had travel reimbursed to speak or to consult for/at numerous professional and scientific organizations, all nonprofit organizations for more than a decade, such as the American Society of Addiction Medicine (ASAM), RAND, the Research Society on Alcoholism, The BMJ, the American Medical Association, the Institute for Research and Training in the Addictions, the National Council on Behavioral Healthcare, the International Conference on Treatment of Addictive Behaviors, and the International Network on Brief Intervention for Alcohol and other drugs (INEBRIA), and numerous universities and hospitals. He is an author and editor for Springer, UpToDate, the American Society of Addiction Medicine, JAMA, the BMJ, and the Massachusetts Medical Society (royalties and/or honoraria). Wolters Kluwer has supported conference travel to an editors' meeting. Systembolaget, a Swedish government agency that aims to minimize alcohol-related problems, supported transportation and lodging for a presentation on brief intervention at an INEBRIA thematic meeting in 2016. Alkermes provided medication for an NIH-funded trial of alcohol disorder treatment effectiveness. He has been paid to serve as an expert witness in malpractice cases related to the management of alcohol and other drug disorders. In 2009 he consulted for Inflexxion and Medical Directions, in 2008 and 2004for Saatchi and Saatchi Healthcare, in 2006 for Fusion Medical Education, in 2004 for the Lewin Group, in 2002 for Axis-Shield ASA and Forest Pharmaceuticals. He has also consulted regarding research for Yale University, Brandeis University, Group Health Inc, Beth Israel-Deaconess Hospital, and other universities. He spoke at a National Press Foundation event on the terminology of addiction and received no compensation but the meeting was funded by ASAM, Open Society Foundations, Pew Charitable Trusts, Shatterproof, Hazelden Betty Ford Foundation, and the Addiction Technology Transfer Center Network. Dr Galea reported no disclosures.	Adams PJ, 2007, ADDICTION, V102, P1027, DOI 10.1111/j.1360-0443.2007.01829.x; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Bero LA, 2005, TOB CONTROL, V14, P118; Drummond MB, 2015, ANN INTERN MED, V163, P61, DOI 10.7326/M15-0361; Frieden TR, 2015, NEW ENGL J MED, V373, P1748, DOI 10.1056/NEJMsa1511248; Galea S, 2016, JAMA-J AM MED ASSOC, V315, P655, DOI 10.1001/jama.2016.0198; Stockwell T, 2016, J STUD ALCOHOL DRUGS, V77, P185, DOI 10.15288/jsad.2016.77.185	7	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1735	1736		10.1001/jama.2017.1659	http://dx.doi.org/10.1001/jama.2017.1659			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6YU	28464147				2022-12-28	WOS:000400440700017
J	Bahouth, H; Shlaifer, A; Yitzhak, A; Glassberg, E				Bahouth, Hany; Shlaifer, Amir; Yitzhak, Avraham; Glassberg, Elon			Helping hands across a war-torn border: the Israeli medical effort treating casualties of the Syrian Civil War	LANCET			English	Editorial Material									[Bahouth, Hany] Rambam Hlth Care Campus, Dept Gen Surg, Haifa, Israel; [Bahouth, Hany] Rambam Hlth Care Campus, Dept Acute Care Surg, Haifa, Israel; [Shlaifer, Amir; Yitzhak, Avraham; Glassberg, Elon] Israel Def Forces, Med Corps, Surg Gen Head Quarters, Mil POB 01215, Ramat Gan, Israel; [Glassberg, Elon] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Glassberg, Elon] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA	Rambam Health Care Campus; Rambam Health Care Campus; Bar Ilan University; Uniformed Services University of the Health Sciences - USA	Glassberg, E (corresponding author), Israel Def Forces, Med Corps, Surg Gen Head Quarters, Mil POB 01215, Ramat Gan, Israel.	Medicine8280@gmail.com						[Anonymous], 2016, LANCET, V388, P2, DOI 10.1016/S0140-6736(16)30936-9; [Anonymous], 2015, THE ECONOMIST 0910; [Anonymous], 2015, GUARDIAN; Ashkenazi E., 2014, HAARETZ TEL AVI 0130; Avi B, 2016, INJURY, V47, P993, DOI 10.1016/j.injury.2015.10.078; Bar-Dayan Y, 1999, PREHOSP DISASTER MED; Committee on Medical Aspects of Automotive Safety, 1971, JAMA, V215, P277, DOI [10.1001/jama.1971.03180150059012, DOI 10.1001/JAMA.1971.03180150059012]; Glassberg E, 2015, ISR MED ASSOC J, V17, P339; Kacala A., 2015, WORLDPOST       0630; KENTISH B, 2016, INDEPENDENT; Lerner A, 2016, EUR J CLIN MICROBIOL, V35, P149, DOI 10.1007/s10096-015-2520-9; Merin O, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001693; Moon BK, 2015, REP SECR GEN CHILDR; O'Brien S., 2016, UN SECURITY COUNCIL; Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438; Ytzhak A, 2012, CRIT CARE MED, V40, P603, DOI 10.1097/CCM.0b013e318232e222; Zarocostas J, 2016, LANCET, V388, P549, DOI 10.1016/S0140-6736(16)31263-6	17	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2579	2583		10.1016/S0140-6736(17)30759-6	http://dx.doi.org/10.1016/S0140-6736(17)30759-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495107				2022-12-28	WOS:000403901800037
J	Lane, R				Lane, Richard			Orly Manor: public health leader in Israel's health system	LANCET			English	Biographical-Item																		MANOR O, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2464	2464		10.1016/S0140-6736(17)31197-2	http://dx.doi.org/10.1016/S0140-6736(17)31197-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY3VF	28495103				2022-12-28	WOS:000403901800016
J	Patel, KK; Taksler, GB; Hu, B; Rothberg, MB				Patel, Krishna K.; Taksler, Glen B.; Hu, Bo; Rothberg, Michael B.			Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; US ADULTS; PRIMARY PREVENTION; LDL CHOLESTEROL; STATIN THERAPY; TASK-FORCE; METAANALYSIS; EFFICACY; PARTICIPANTS	Background: The 2013 cholesterol management guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) recommend lipid screening in all adults older than 20 years to identify those at increased risk for atherosclerotic cardiovascular disease (ASCVD). Statins may be considered for patients with elevated 10-year risk (>5%) or a low-density lipoprotein cholesterol (LDL-C) level of 4.92 mmol/L (190 mg/dL) or greater. Objective: To describe the prevalence of elevated ASCVD risk among nondiabetic adults younger than 50 years. Design: Cross-sectional. Setting: NHANES (National Health and Nutrition Examination Survey), 1999 to 2000 through 2011 to 2012. Participants: Adults aged 30 to 49 years without known ASCVD or diabetes. Measurements: 10-year ASCVD risk was estimated by using the 2013 ACC/AHA ASCVD risk calculator. Participants were subdivided by age, sex, and history of smoking and hypertension. The percentages of adults in each subgroup with a 10-year ASCVD risk greater than 5% and of those with an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater were estimated. Low-prevalence subgroups were defined as those in which a greater than 1% prevalence of elevated cardiovascular risk could be ruled out (that is, the upper 95% confidence bound for prevalence was <= 1%). Results: Overall, 9608 NHANES participants representing 67.9 million adults were included, with approximately half (47.12%, representing 32 million adults) in low-prevalence subgroups. In the absence of smoking or hypertension, 0.09% (95% CI, 0.02% to 0.35%) of adult men younger than 40 years and 0.04% (CI, 0.0% to 0.26%) of adult women younger than 50 years had an elevated risk. Among other subgroups, 0% to 75.9% of participants had an increased risk. Overall, 2.9% (CI, 2.3% to 3.5%) had an LDL-C level of 4.92 mmol/L (190 mg/dL) or greater. Limitation: No information was available regarding cardiovascular outcomes. Conclusion: In the absence of risk factors, the prevalence of increased ASCVD risk is low among women younger than 50 and men younger than 40 years.	[Patel, Krishna K.] Univ Missouri Kansas City, St Lukes Hosp Kansas City, Mid Amer Heart Inst, Dept Cardiol, 4401 Wornall,9th Floor CV Res, Kansas City, MO 64111 USA; [Taksler, Glen B.; Hu, Bo; Rothberg, Michael B.] Cleveland Clin, Ctr Value Based Care Res, Inst Med, 9500 Euclid Ave,Desk G-10, Cleveland, OH 44195 USA	Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Cleveland Clinic Foundation	Patel, KK (corresponding author), Univ Missouri Kansas City, St Lukes Hosp Kansas City, Mid Amer Heart Inst, Dept Cardiol, 4401 Wornall,9th Floor CV Res, Kansas City, MO 64111 USA.	patelkris@umkc.edu		Patel, Krishna/0000-0003-0512-8444; Taksler, Glen/0000-0002-7566-7104	National Heart, Lung, and Blood Institute of the NIH [T32HL110837]; National Center for Advancing Translational Sciences (NIH/NCATS) [KL2TR000440]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110837] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences (NIH/NCATS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By award T32HL110837 from the National Heart, Lung, and Blood Institute of the NIH (Dr. Patel) and award KL2TR000440 from the National Center for Advancing Translational Sciences (NIH/NCATS) (Dr. Taksler).	[Anonymous], 1978, J Chronic Dis, V31, P201; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Besseling J, 2016, J AM COLL CARDIOL, V68, P252, DOI 10.1016/j.jacc.2016.04.054; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Centers for Disease Control and Prevention, 2013, CONT NHANES WEB TUT; Centers for Disease Control and Prevention (CDC), 2017, NAT HLTH NUTR EX SUR; Chou R, 2016, ANN INTERN MED, V165, P560, DOI 10.7326/M16-0946; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; DeFilippis AP, 2016, EUR HEART J; Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; KANNEL WB, 1964, ANN INTERN MED, V61, P888, DOI 10.7326/0003-4819-61-5-888; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Lloyd A, 2017, HEART, V103, P586, DOI 10.1136/heartjnl-2016-309595; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Navar-Boggan AM, 2015, J AM COLL CARDIOL, V65, P1633, DOI 10.1016/j.jacc.2015.02.025; Perak AM, 2016, CIRCULATION, V134, P9, DOI 10.1161/CIRCULATIONAHA.116.022335; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; StataCorp, 2017, STAT SURV DAT REF MA; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; U.S. Preventive Services Task Force, 2008, LIP DIS AD; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8	31	12	12	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					876	+		10.7326/M16-2052	http://dx.doi.org/10.7326/M16-2052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28505660	Green Accepted			2022-12-28	WOS:000403579000015
J	Jones, BE; Samore, MH				Jones, Barbara E.; Samore, Matthew H.			Antibiotic Overuse: Clinicians Are the Solution	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jones, Barbara E.; Samore, Matthew H.] Salt Lake City VA Hlth Syst, 633 8th Ave, Salt Lake City, UT 84103 USA; Univ Utah, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Jones, BE (corresponding author), Salt Lake City VA Hlth Syst, 633 8th Ave, Salt Lake City, UT 84103 USA.	barbara.jones@hsc.utah.edu			CDA Award from the U.S. Department of Veterans Affairs Health Services Research and Development [15-061]; Center of Innovation grant from the U.S. Department of Veterans Affairs Health Services Research and Development [150HX001240]; Centers for Disease Control and Prevention [14FED1412883, 200-2011-42039/0009]	CDA Award from the U.S. Department of Veterans Affairs Health Services Research and Development; Center of Innovation grant from the U.S. Department of Veterans Affairs Health Services Research and Development; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr. Jones is supported in part by CDA Award 15-061 from the U.S. Department of Veterans Affairs Health Services Research and Development. Dr. Samore is supported by Center of Innovation grant 150HX001240 from the U.S. Department of Veterans Affairs Health Services Research and Development. Their work is also supported by funds from the Centers for Disease Control and Prevention (14FED1412883 and 200-2011-42039/0009).	[Anonymous], 1956, BR MED J, V1, P1516; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bredemeyer M, 2016, AM FAM PHYSICIAN, V94, P1016; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Jones BE, 2015, ANN INTERN MED, V163, P73, DOI 10.7326/M14-1933; LANGER E, 1963, SCIENCE, V141, P791, DOI 10.1126/science.141.3583.791; Lewis VA, 2012, JAMA-J AM MED ASSOC, V308, P294, DOI 10.1001/jama.2012.7476; LONG PH, 1947, NEW ENGL J MED, V237, P837, DOI 10.1056/NEJM194712042372302; Podolsky SH, 2015, J LAW MED ETHICS, V43, P27, DOI 10.1111/jlme.12271; Silverman M, 2017, ANN INTERN MED, V166, P765, DOI 10.7326/M16-1131	10	6	6	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					844	+		10.7326/M17-1061	http://dx.doi.org/10.7326/M17-1061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28492844				2022-12-28	WOS:000402700200012
J	Sugimura, R; Jha, DK; Han, A; Soria-Valles, C; da Rocha, EL; Lu, YF; Goettel, JA; Serrao, E; Rowe, RG; Alleshaiah, MM; Wong, I; Sousa, P; Zhu, TN; Ditadi, A; Keller, G; Engelman, AN; Snapper, SB; Doulatov, S; Daley, GQ				Sugimura, Ryohichi; Jha, Deepak Kumar; Han, Areum; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Goettel, Jeremy A.; Serrao, Erik; Rowe, R. Grant; Alleshaiah, Mohan M.; Wong, Irene; Sousa, Patricia; Zhu, Ted N.; Ditadi, Andrea; Keller, Gordon; Engelman, Alan N.; Snapper, Scott B.; Doulatov, Sergei; Daley, George Q.			Haematopoietic stem and progenitor cells from human pluripotent stem cells	NATURE			English	Article							DIRECT INDUCTION; IN-VITRO; EXPRESSION; DIFFERENTIATION; ENDOTHELIUM; LINEAGE; GENES; RUNX1; IDENTIFICATION; FIBROBLASTS	A variety of tissue lineages can be differentiated from pluripotent stem cells by mimicking embryonic development through stepwise exposure to morphogens, or by conversion of one differentiated cell type into another by enforced expression of master transcription factors. Here, to yield functional human haematopoietic stem cells, we perform morphogen-directed differentiation of human pluripotent stem cells into haemogenic endothelium followed by screening of 26 candidate haematopoietic stem-cell-specifying transcription factors for their capacity to promote multi-lineage haematopoietic engraftment in mouse hosts. We recover seven transcription factors (ERG, HOXA5, HOXA9, HOXA10, LCOR, RUNX1 and SPI1) that are sufficient to convert haemogenic endothelium into haematopoietic stem and progenitor cells that engraft myeloid, B and T cells in primary and secondary mouse recipients. Our combined approach of morphogen-driven differentiation and transcription-factor-mediated cell fate conversion produces haematopoietic stem and progenitor cells from pluripotent stem cells and holds promise for modelling haematopoietic disease in humanized mice and for therapeutic strategies in genetic blood disorders.	[Sugimura, Ryohichi; Jha, Deepak Kumar; Han, Areum; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Rowe, R. Grant; Sousa, Patricia; Doulatov, Sergei; Daley, George Q.] Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Sugimura, Ryohichi; Jha, Deepak Kumar; Han, Areum; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Rowe, R. Grant; Sousa, Patricia; Doulatov, Sergei; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sugimura, Ryohichi; Jha, Deepak Kumar; Han, Areum; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Sousa, Patricia; Doulatov, Sergei; Daley, George Q.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sugimura, Ryohichi; Jha, Deepak Kumar; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Sousa, Patricia; Doulatov, Sergei; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Sugimura, Ryohichi; Jha, Deepak Kumar; Soria-Valles, Clara; da Rocha, Edroaldo Lummertz; Lu, Yi-Fen; Sousa, Patricia; Doulatov, Sergei; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Goettel, Jeremy A.; Snapper, Scott B.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Boston, MA 02115 USA; [Goettel, Jeremy A.; Serrao, Erik; Engelman, Alan N.; Snapper, Scott B.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Serrao, Erik; Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Alleshaiah, Mohan M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Wong, Irene] Brandeis Univ, Dept Biol, Waltham, MA 02453 USA; [Zhu, Ted N.] Harvard Univ, Comp Sci Program, Cambridge, MA 02138 USA; [Ditadi, Andrea; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Doulatov, Sergei] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Brandeis University; Harvard University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Daley, GQ (corresponding author), Boston Childrens Hosp, Dana Farber Canc Inst, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Daley, GQ (corresponding author), Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	George.Daley@childrens.harvard.edu	Jha, Deepak/AAK-2279-2020; Ditadi, Andrea/K-3461-2016; Sugimura, Rio/AAR-7280-2020	Jha, Deepak/0000-0002-6657-5662; Ditadi, Andrea/0000-0003-3283-8943; Sugimura, Rio/0000-0001-5701-3628; Lummertz da Rocha, Edroaldo/0000-0003-0537-4223; Lu, Yi-Fen/0000-0002-4066-2557; Keller, Gordon/0000-0001-9309-9297; Malleshaiah, Mohan/0000-0003-2896-8585; Wong, Irene/0000-0001-5229-2111	US National Institute of Diabetes and Digestive and Kidney Diseases [R24DK092760]; National Institute of Allergy and Infectious Diseases [R37AI039394]; National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium [UO1-HL100001]; Progenitor Cell Translation Consortium [UO1-HL134812]; Alex's Lemonade Stand Foundation; Doris Duke Medical Foundation; American Society of Hematology Scholar Fellowship; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK106311]; Crohn's and Colitis Foundation of America [CDA 352644]; NIDDK [DK034854]; Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research;  [K99/R00HL123484]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL134812, U01HL100001, R00HL123484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, P30DK034854, K01DK106311] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium; Progenitor Cell Translation Consortium; Alex's Lemonade Stand Foundation; Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); American Society of Hematology Scholar Fellowship; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Helmsley Charitable Trust; Wolpow Family Chair in IBD Treatment and Research; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Schlaeger and the Boston Children's Hospital Human ESC Core Facility, R. Mathieu from the flow cytometry core, R. Renee, A. Ratner, and S. Boswell from Harvard Medical School for RNA-seq, the orchestra team at Harvard Medical School for providing high-performance computing, D. Kaufman for providing the RUNX1c+24 hPSC line, N. Gerry for microarray and SNP array analysis, and T. North, C. Brendel and J. Powers for reading the manuscript. This work was supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (R24DK092760), the National Institute of Allergy and Infectious Diseases (R37AI039394), and the National Heart, Lung, Blood Institute Progenitor Cell Biology Consortium (UO1-HL100001) and the Progenitor Cell Translation Consortium (UO1-HL134812); Alex's Lemonade Stand Foundation; and the Doris Duke Medical Foundation. G.Q.D. is an associate member of the Broad Institute and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. R. S. is supported by an American Society of Hematology Scholar Fellowship. C.S.V. is an EMBO (ALTF 1240-2015) fellow. S. D. is supported by the K99/R00HL123484. J.A.G. is supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK106311) and the Crohn's and Colitis Foundation of America CDA 352644 (J.A.G.), S.B.S. is supported by NIDDK (DK034854), the Helmsley Charitable Trust, and the Wolpow Family Chair in IBD Treatment and Research.	ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Chan FC, 2015, BLOOD, V125, P959, DOI 10.1182/blood-2013-06-507152; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Di-Poi N, 2010, DEV BIOL, V341, P488, DOI 10.1016/j.ydbio.2010.03.006; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Ditadi A, 2016, METHODS, V101, P65, DOI 10.1016/j.ymeth.2015.10.001; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Dou DR, 2016, NAT CELL BIOL, V18, P595, DOI 10.1038/ncb3354; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Ferrell PI, 2015, STEM CELLS, V33, P1130, DOI 10.1002/stem.1940; Gillet NA, 2011, BLOOD, V117, P3113, DOI 10.1182/blood-2010-10-312926; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Hartz B, 2011, BLOOD, V118, P2362, DOI 10.1182/blood-2011-02-331918; Hu ZB, 2011, BLOOD, V117, P6498, DOI 10.1182/blood-2010-10-312512; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; McIntosh BE, 2015, STEM CELL REP, V4, P171, DOI 10.1016/j.stemcr.2014.12.005; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Ng AP, 2010, BLOOD, V115, P3966, DOI 10.1182/blood-2009-09-242107; Ng ES, 2016, NAT BIOTECHNOL, V34, P1168, DOI 10.1038/nbt.3702; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; ORKIN SH, 1983, NATURE, V301, P108, DOI 10.1038/301108a0; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Serrao E, 2016, JOVE-J VIS EXP, DOI 10.3791/53840; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith-Berdan S, 2011, CELL STEM CELL, V8, P72, DOI 10.1016/j.stem.2010.11.030; Sugimura R., 2017, HEMATOPOIETIC STEM P; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Weerkamp F, 2006, LEUKEMIA, V20, P1967, DOI 10.1038/sj.leu.2404396	57	272	287	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					432	+		10.1038/nature22370	http://dx.doi.org/10.1038/nature22370			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514439	Green Accepted, Green Submitted			2022-12-28	WOS:000401906500043
J	Drew, L				Drew, Liam			ORTHONIKA Shock absorbers for the body	NATURE			English	Editorial Material														Morgan, Branwen/0000-0001-5318-1675					0	2	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S21	S22		10.1038/545S21a	http://dx.doi.org/10.1038/545S21a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514414	Bronze			2022-12-28	WOS:000401466500020
J	Li, SZ; Sullivan, NL; Rouphael, N; Yu, TW; Banton, S; Maddur, MS; McCausland, M; Chiu, C; Canniff, J; Dubey, S; Liu, K; Tran, V; Hagan, T; Duraisingham, S; Wieland, A; Mehta, AK; Whitaker, JA; Subramaniam, S; Jones, DP; Sette, A; Vora, K; Weinberg, A; Mulligan, MJ; Nakaya, HI; Levin, M; Ahmed, R; Pulendran, B				Li, Shuzhao; Sullivan, Nicole L.; Rouphael, Nadine; Yu, Tianwei; Banton, Sophia; Maddur, Mohan S.; McCausland, Megan; Chiu, Christopher; Canniff, Jennifer; Dubey, Sheri; Liu, Ken; ViLinh Tran; Hagan, Thomas; Duraisingham, Sai; Wieland, Andreas; Mehta, Aneesh K.; Whitaker, Jennifer A.; Subramaniam, Shankar; Jones, Dean P.; Sette, Alessandro; Vora, Kalpit; Weinberg, Adriana; Mulligan, Mark J.; Nakaya, Helder I.; Levin, Myron; Ahmed, Rafi; Pulendran, Bali			Metabolic Phenotypes of Response to Vaccination in Humans	CELL			English	Article							VARICELLA-ZOSTER-VIRUS; YELLOW-FEVER VACCINE; T-CELL RESPONSES; SYSTEMS BIOLOGY; SEASONAL INFLUENZA; GENE-EXPRESSION; INNATE; ACTIVATION; IMMUNOLOGY; IMMUNITY	Herpes zoster (shingles) causes significant morbidity in immune compromised hosts and older adults. Whereas a vaccine is available for prevention of shingles, its efficacy declines with age. To help to understand the mechanisms driving vaccinal responses, we constructed a multiscale, multifactorial response network (MMRN) of immunity in healthy young and older adults immunized with the live attenuated shingles vaccine Zostavax. Vaccination induces robust antigen-specific antibody, plasmablasts, and CD4+ T cells yet limited CD8+ T cell and antiviral responses. The MMRN reveals striking associations between orthogonal datasets, such as transcriptomic and metabolomics signatures, cell populations, and cytokine levels, and identifies immune and metabolic correlates of vaccine immunity. Networks associated with inositol phosphate, glycerophospholipids, and sterol metabolism are tightly coupled with immunity. Critically, the sterol regulatory binding protein 1 and its targets are key integrators of antibody and T follicular cell responses. Our approach is broadly applicable to study human immunity and can help to identify predictors of efficacy as well as mechanisms controlling immunity to vaccination.	[Li, Shuzhao; Rouphael, Nadine; Banton, Sophia; Liu, Ken; ViLinh Tran; Mehta, Aneesh K.; Whitaker, Jennifer A.; Jones, Dean P.; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30303 USA; [Sullivan, Nicole L.; Maddur, Mohan S.; McCausland, Megan; Chiu, Christopher; Hagan, Thomas; Duraisingham, Sai; Wieland, Andreas; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Rouphael, Nadine; Mulligan, Mark J.] Emory Vaccine Ctr, Hope Clin, Decatur, GA 30030 USA; [Yu, Tianwei] Emory Univ, Rollins Sch Publ Hlth, Dept Bioinformat & Biostat, Atlanta, GA 30030 USA; [Canniff, Jennifer; Weinberg, Adriana] Univ Colorado, Anschutz Med Campus, Aurora, CO 80045 USA; [Dubey, Sheri; Vora, Kalpit] Dept Infect Dis & Vaccines, West Point, PA USA; [Dubey, Sheri; Vora, Kalpit] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ 07033 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Dept Nanoengn, Dept Bioengn,Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA; [Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Whitaker, Jennifer A.] Mayo Clin & Mayo Grad Sch Med, Dept Med, Div Infect Dis, 200 First St SW, Rochester, MN 55902 USA	Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Merck & Company; University of California System; University of California San Diego; La Jolla Institute for Immunology; Universidade de Sao Paulo; Emory University; Emory University; Mayo Clinic	Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.; Pulendran, B (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.	bpulend@emory.edu	Nakaya, Helder/AAF-1738-2020; Mulligan, Mark/V-9275-2019; Pulendran, Bali/AAW-9550-2021; Sette, Alessandro/AFO-8916-2022; Nakaya, Helder I/A-1397-2010; Mehta, Aneesh/B-8054-2012	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Yu, Tianwei/0000-0003-2502-1628; Rouphael, Nadine/0000-0002-2512-7919; Mehta, Aneesh/0000-0002-6552-9162; Li, Shuzhao/0000-0002-7386-2539	NIH [U19AI090023, U19AI057266, S10OD18006]; Medical Research Council [G0902266] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, U19AI057266, T32AI007290, R37AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; MRC [G0902266] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Mary Bower, Ildefonzo Tellez, Srilatha Edugupanti, David Rimland, and the Hope Clinic staff, who assisted with the clinical work. We also thank Emory Immunology/Flow Cytometry Core for technical assistance. This work was supported by NIH grants U19AI090023 (to B.P.), U19AI057266 (to R.A. and B.P.), and S10OD18006 (to D.P.J.).	Abendroth A, 2010, CURR TOP MICROBIOL, V342, P155, DOI 10.1007/82_2010_41; Bartel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005274; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Chiu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004008; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Frey CR, 2003, J INFECT DIS, V188, P40, DOI 10.1086/375828; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Gomi Y, 2002, J VIROL, V76, P11447, DOI 10.1128/JVI.76.22.11447-11459.2002; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mooney M, 2013, CURR OPIN IMMUNOL, V25, P551, DOI 10.1016/j.coi.2013.09.014; Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302; Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nath Artika Praveeta, 2012, Frontiers in Genetics, V3, P243, DOI 10.3389/fgene.2012.00243; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Qi Q, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005892; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zak DE, 2015, VACCINE, V33, P5241, DOI 10.1016/j.vaccine.2015.05.098; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283	54	147	150	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					862	+		10.1016/j.cell.2017.04.026	http://dx.doi.org/10.1016/j.cell.2017.04.026			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV1OM	28502771	Green Accepted, Bronze			2022-12-28	WOS:000401515900012
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: The NHS needs big, firm IT pants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Arthur C., 2017, GUARDIAN; Chinthapalli K, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2214; Gibbs S, 2015, GUARDIAN; Greenhalgh Trisha, 2010, BMJ, V341, pc5814, DOI 10.1136/bmj.c5814; Greenhalgh T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001574; HENDERSON C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1035; Owen C., 1989, Thatcheria, V24, P1; Marsh S., 2017, GUARDIAN; Murgia M, 2017, FINANCIAL TIMES; Shah S., 2016, REGISTER	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j2352	10.1136/bmj.j2352	http://dx.doi.org/10.1136/bmj.j2352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512210	Green Published, Bronze			2022-12-28	WOS:000401898900010
J	Steinberg, DI				Steinberg, Daniel I.			Review: Strategies to improve provider adoption and implementation of clinical practice guidelines were assessed	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Steinberg, Daniel I.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Steinberg, DI (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Fogerty International Center, 2017, IMPL SCI INF RES; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Ovretveit J, 2011, BMJ QUAL SAF, V20, pI18, DOI 10.1136/bmjqs.2010.045955; The Joint Commission, 2017, ANT STEW; van der Veer SN, 2010, INT J MED INFORM, V79, P305, DOI 10.1016/j.ijmedinf.2010.01.011	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC58	JC59		10.7326/ACPJC-2017-166-10-058	http://dx.doi.org/10.7326/ACPJC-2017-166-10-058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505642				2022-12-28	WOS:000401240200010
J	Voelker, R				Voelker, Rebecca			Digitized Surgical Slides	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1942	1942		10.1001/jama.2017.5540	http://dx.doi.org/10.1001/jama.2017.5540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510662				2022-12-28	WOS:000401315500007
J	Caldieri, G; Barbieri, E; Nappo, G; Raimondi, A; Bonora, M; Conte, A; Verhoef, LGGC; Confalonieri, S; Malabarba, MG; Bianchi, F; Cuomo, A; Bonaldi, T; Martini, E; Mazza, D; Pinton, P; Tacchetti, C; Polo, S; Di Fiore, PP; Sigismund, S				Caldieri, Giusi; Barbieri, Elisa; Nappo, Gilda; Raimondi, Andrea; Bonora, Massimo; Conte, Alexia; Verhoef, Lisette G. G. C.; Confalonieri, Stefano; Malabarba, Maria Grazia; Bianchi, Fabrizio; Cuomo, Alessandro; Bonaldi, Tiziana; Martini, Emanuele; Mazza, Davide; Pinton, Paolo; Tacchetti, Carlo; Polo, Simona; Di Fiore, Pier Paolo; Sigismund, Sara			Reticulon 3-dependent ER-PM contact sites control EGFR nonclathrin endocytosis	SCIENCE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; TUBULAR ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; PROTEINS; INTERNALIZATION; EXPRESSION; PATHWAY; CELLS; ENDOSOMES; PITS	The integration of endocytic routes is critical to regulate receptor signaling. A nonclathrin endocytic (NCE) pathway of the epidermal growth factor receptor (EGFR) is activated at high ligand concentrations and targets receptors to degradation, attenuating signaling. Here we performed an unbiased molecular characterization of EGFR-NCE. We identified NCE-specific regulators, including the endoplasmic reticulum (ER)-resident protein reticulon 3 (RTN3) and a specific cargo, CD147. RTN3 was critical for EGFR/CD147-NCE, promoting the creation of plasma membrane (PM)-ER contact sites that were required for the formation and/or maturation of NCE invaginations. Ca2+ release at these sites, triggered by inositol 1,4,5-trisphosphate (IP3)-dependent activation of ER Ca2+ channels, was needed for the completion of EGFR internalization. Thus, we identified a mechanism of EGFR endocytosis that relies on ER-PM contact sites and local Ca2+ signaling.	[Caldieri, Giusi; Barbieri, Elisa; Nappo, Gilda; Conte, Alexia; Verhoef, Lisette G. G. C.; Confalonieri, Stefano; Malabarba, Maria Grazia; Martini, Emanuele; Polo, Simona; Di Fiore, Pier Paolo; Sigismund, Sara] Fdn Ist FIRC Oncol Mol IFOM, Via Adamello 16, I-20139 Milan, Italy; [Malabarba, Maria Grazia; Polo, Simona; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Oncol & Ematooncol DiPO, Via Festa Perdono 7, I-20122 Milan, Italy; [Bianchi, Fabrizio; Cuomo, Alessandro; Bonaldi, Tiziana; Di Fiore, Pier Paolo] Ist Europeo Oncol, Via Ripamonti 435, I-20141 Milan, Italy; [Raimondi, Andrea; Tacchetti, Carlo] Ist Sci San Raffaele, Ctr Imaging Sperimentale, Via Olgettina 52, I-20132 Milan, Italy; [Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Lab Technol Adv Therapies Ctr, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Verhoef, Lisette G. G. C.] Ist Italiano Tecnol, Ctr Genom Sci IIT SEMM, Via Adamello 16, I-20139 Milan, Italy; [Bianchi, Fabrizio] Casa Sollievo Sofferenza, SBReMIT Inst Stem Cell Biol Regenerat Med & Innov, Viale Cappuccini Snc, I-71013 Foggia, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of Milan; IRCCS European Institute of Oncology (IEO); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; University of Ferrara; University of Ferrara; Istituto Italiano di Tecnologia - IIT; IRCCS Casa Sollievo Della Sofferenza	Di Fiore, PP; Sigismund, S (corresponding author), Fdn Ist FIRC Oncol Mol IFOM, Via Adamello 16, I-20139 Milan, Italy.; Di Fiore, PP (corresponding author), Univ Milan, Dipartimento Oncol & Ematooncol DiPO, Via Festa Perdono 7, I-20122 Milan, Italy.; Di Fiore, PP (corresponding author), Ist Europeo Oncol, Via Ripamonti 435, I-20141 Milan, Italy.	pierpaolo.difiore@ifom.eu; sara.sigismund@ifom.eu	Confalonieri, Stefano/AAQ-6786-2020; Di Fiore, Pier Paolo/K-2130-2012; Mazza, Davide/R-5340-2016; Bonora, Massimo/AAC-3609-2022; Polo, Simona/P-3509-2014; Raimondi, Andrea/AAN-2475-2020; cuomo, alessandro/AAB-7372-2019; Barbieri, Elisa/AAB-9664-2019; Sigismund, Sara/H-3687-2017; Bianchi, Fabrizio/W-7037-2019; Bianchi, Fabrizio/B-5995-2017; Pinton, Paolo/J-8025-2012; Bonaldi, Tiziana/K-5075-2016; Malabarba, Maria Grazia/L-4805-2015	Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; Mazza, Davide/0000-0003-2776-4142; Bonora, Massimo/0000-0002-5752-3318; Barbieri, Elisa/0000-0002-6180-0939; Sigismund, Sara/0000-0002-1396-4453; Bianchi, Fabrizio/0000-0001-7412-8638; Bianchi, Fabrizio/0000-0001-7412-8638; Pinton, Paolo/0000-0001-7108-6508; Bonaldi, Tiziana/0000-0003-3556-1265; Cuomo, Alessandro/0000-0002-9778-7190; TACCHETTI, CARLO/0000-0003-4602-000X; Raimondi, Andrea/0000-0002-4563-386X; Polo, Simona/0000-0001-5536-9399; Martini, Emanuele/0000-0002-3375-7726; Malabarba, Maria Grazia/0000-0002-9457-2047	Associazione Italiana per la Ricerca sul Cancro [IG15741, IG 1442, IG 15637, IG 10349, 14404, MCO 10.000]; Italian Ministry of University and Scientific Research (MIUR); Italian Ministry of Health; Monzino Foundation; Worldwide Cancer Research [16-1245]; Fondazione Italiana Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Monzino Foundation; Worldwide Cancer Research; Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank P. De Camilli for suggestions and reagents (cDNA of HRP-KDEL and E-Syt1-GFP), G. Scita for suggestions, T. Kirchhausen for TfR cDNA, N. Borgese for cerulean-17, M. Tagaya for initially providing an anti-RTN3 antibody, R. Lundmark for anti-GRAF1 antibody, D. Cairns for initial statistical analysis of SILAC, the imaging facility at IFOM, and the ALEMBIC facility at San Raffaele Institute. We thank R. Gunby and W. Maruwge for critically reading the manuscript. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro to T.B. (IG15741), P.P. (IG 1442), S.P. (IG 15637) and P.P.D.F. (IG 10349 and 14404 and MCO 10.000); the Italian Ministry of University and Scientific Research (MIUR), the Italian Ministry of Health, and the Monzino Foundation to P.P.D.F.; and Worldwide Cancer Research to S.S. (16-1245). A.Co. is supported by a fellowship from the Fondazione Italiana Ricerca sul Cancro. P.P.D.F. is on the Scientific Advisory Board of the Microsoft Research-University of Trento Centre for Computational and Systems Biology (COSBI) (Rovereto, Italy). The authors declare no competing financial interests. All data described in the paper are available in the main text and supplementary materials.	Bennett DL, 1996, J BIOL CHEM, V271, P6356, DOI 10.1074/jbc.271.11.6356; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Johannes L, 2015, NAT REV MOL CELL BIO, V16, P311, DOI 10.1038/nrm3968; Jozsef L, 2014, J BIOL CHEM, V289, P9380, DOI 10.1074/jbc.M114.548602; Kilpatrick BS, 2017, CELL REP, V18, P1636, DOI 10.1016/j.celrep.2017.01.052; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; LUND KA, 1990, J BIOL CHEM, V265, P15713; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shi Q, 2014, J NEUROSCI, V34, P13954, DOI 10.1523/JNEUROSCI.1588-14.2014; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	29	83	83	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					617	+		10.1126/science.aah6152	http://dx.doi.org/10.1126/science.aah6152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495747	Green Accepted, Green Submitted			2022-12-28	WOS:000400975200050
J	Chou, CW; Kurz, C; Hume, DB; Plessow, PN; Leibrandt, DR; Leibfried, D				Chou, Chin-wen; Kurz, Christoph; Hume, David B.; Plessow, Philipp N.; Leibrandt, David R.; Leibfried, Dietrich			Preparation and coherent manipulation of pure quantum states of a single molecular ion	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; SPIN-ROTATION CONSTANTS; GROUND-STATE; NOBEL LECTURE; AB-INITIO; SPECTROSCOPY; LASER; LOGIC; GAS; TRANSITION	Laser cooling and trapping of atoms and atomic ions has led to advances including the observation of exotic phases of matter(1,2), the development of precision sensors(3) and state-of-the-art atomic clocks(4). The same level of control in molecules could also lead to important developments such as controlled chemical reactions and sensitive probes of fundamental theories(5), but the vibrational and rotational degrees of freedom in molecules pose a challenge for controlling their quantum mechanical states. Here we use quantum-logic spectroscopy(6), which maps quantum information between two ion species, to prepare and non-destructively detect quantum mechanical states in molecular ions(7). We develop a general technique for optical pumping and preparation of the molecule into a pure initial state. This enables us to observe high-resolution spectra in a single ion (CaH+) and coherent phenomena such as Rabi flopping and Ramsey fringes. The protocol requires a single, far-off-resonant laser that is not specific to the molecule, so many other molecular ions, including polyatomic species, could be treated using the same methods in the same apparatus by changing the molecular source. Combined with the long interrogation times afforded by ion traps, a broad range of molecular ions could be studied with unprecedented control and precision. Our technique thus represents a critical step towards applications such as precision molecular spectroscopy, stringent tests of fundamental physics, quantum computing and precision control of molecular dynamics(8).	[Chou, Chin-wen; Kurz, Christoph; Hume, David B.; Leibrandt, David R.; Leibfried, Dietrich] NIST, Time & Frequency Div, Boulder, CO 80305 USA; [Plessow, Philipp N.] Karlsruhe Inst Technol, Inst Catalysis Res & Technol, Karlsruhe, Germany; [Leibrandt, David R.] Univ Colorado, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; Helmholtz Association; Karlsruhe Institute of Technology; University of Colorado System; University of Colorado Boulder	Chou, CW (corresponding author), NIST, Time & Frequency Div, Boulder, CO 80305 USA.	chin-wen.chou@nist.gov	Plessow, Philipp N/G-9609-2017	Plessow, Philipp N/0000-0001-9913-4049; Leibrandt, David Ray/0000-0003-1452-4879	US Army Research Office; NIST quantum information programme; Alexander von Humboldt foundation; state of Baden-Wurttemberg through bwHPC	US Army Research Office; NIST quantum information programme; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); state of Baden-Wurttemberg through bwHPC	We thank K. C. Cossel, Y. Wan and D. J. Wineland for comments on the manuscript. This work was supported by the US Army Research Office and the NIST quantum information programme. C. K. acknowledges support from the Alexander von Humboldt foundation. P.N.P. acknowledges support by the state of Baden-Wurttemberg through bwHPC. This is a contribution of the National Institute of Standards and Technology, not subject to US copyright.	Abe M, 2012, CHEM PHYS LETT, V521, P31, DOI 10.1016/j.cplett.2011.11.048; Amano T, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3514914; Beloy K, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.062514; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Blythe P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.183002; Bressel U, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.183003; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; DeMille D, 2015, PHYS TODAY, V68, P34, DOI 10.1063/PT.3.3020; Ding S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023028; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Gauss J, 1996, J CHEM PHYS, V105, P2804, DOI 10.1063/1.472143; Gauss J, 1997, MOL PHYS, V91, P449, DOI 10.1080/00268979709482735; Gauss J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2755664; Hanneke D, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.050101; Hansen AK, 2014, NATURE, V508, P76, DOI 10.1038/nature12996; Helgaker T, 2012, CHEM REV, V112, P543, DOI 10.1021/cr2002239; Hudson ER, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.032716; Jaszunski M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4840295; Kajita M, 2014, J MOL SPECTROSC, V300, P99, DOI 10.1016/j.jms.2014.03.009; Kajita M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032509; Karr JP, 2014, J MOL SPECTROSC, V300, P37, DOI 10.1016/j.jms.2014.03.016; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Kimura N, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.033422; Kitching J, 2011, IEEE SENS J, V11, P1749, DOI 10.1109/JSEN.2011.2157679; Koelemeij JCJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173002; Koput J, 2002, J PHYS CHEM A, V106, P9595, DOI 10.1021/jp026283u; Lazarou C, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013418; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Leibfried D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023029; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Lien CY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5783; Loh H, 2013, SCIENCE, V342, P1220, DOI 10.1126/science.1243683; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Meyer ER, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062108; Mitchell TB, 1998, SCIENCE, V282, P1290, DOI 10.1126/science.282.5392.1290; Morigi G, 2000, PHYS REV LETT, V85, P4458, DOI 10.1103/PhysRevLett.85.4458; Mur-Petit J, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022308; O'Hara KM, 1999, PHYS REV LETT, V82, P4204, DOI 10.1103/PhysRevLett.82.4204; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Pasteka LF, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.012103; POPLE JA, 1987, J CHEM PHYS, V87, P5968, DOI 10.1063/1.453520; Pupillo G., 2009, COLD MOL THEORY EXPT; Rellergert WG, 2013, NATURE, V495, P490, DOI 10.1038/nature11937; Rolik Z, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4819401; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Roos CF, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.040302; Rugango R, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035009; Schiller S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032505; Schiller S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023004; Schmidt PO, 2006, AIP CONF PROC, V862, P305, DOI 10.1063/1.2387937; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schneider T, 2010, NAT PHYS, V6, P275, DOI 10.1038/NPHYS1605; Shi M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113019; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Staanum PF, 2010, NAT PHYS, V6, P271, DOI 10.1038/NPHYS1604; Stanton J.F., 2017, CFOUR COUPLED CLUSTE; Sundholm D, 1996, J CHEM PHYS, V105, P11051, DOI 10.1063/1.472905; Team RC., 2022, LANG ENV STAT COMP; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Ubachs W, 2016, J MOL SPECTROSC, V320, P1, DOI 10.1016/j.jms.2015.12.003; Vogelius IS, 2006, J PHYS B-AT MOL OPT, V39, pS1259, DOI 10.1088/0953-4075/39/19/S31; Will SA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.225306; Wolf F, 2016, NATURE, V530, P457, DOI 10.1038/nature16513	70	93	93	5	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					203	+		10.1038/nature22338	http://dx.doi.org/10.1038/nature22338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492258	Green Submitted			2022-12-28	WOS:000400963800030
J	Lyon, J				Lyon, Jeff			Hearing Focuses on Proposed Cuts in Cancer Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1826	1826		10.1001/jama.2017.5383	http://dx.doi.org/10.1001/jama.2017.5383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492879				2022-12-28	WOS:000400842400004
J	Horton, R				Horton, Richard			Offline: Is the NHS in crisis?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1783	1783		10.1016/S0140-6736(17)31187-X	http://dx.doi.org/10.1016/S0140-6736(17)31187-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495156	Bronze			2022-12-28	WOS:000400549300009
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Outstanding Contribution to Health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2017	357								j1958	10.1136/bmj.j1958	http://dx.doi.org/10.1136/bmj.j1958			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WE	28473369				2022-12-28	WOS:000400889800001
J	Stokstad, E				Stokstad, Erik			FOOD SECURITY New crop pest takes Africa at lightning speed	SCIENCE			English	News Item																			0	88	107	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					473	474		10.1126/science.356.6337.473	http://dx.doi.org/10.1126/science.356.6337.473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473543				2022-12-28	WOS:000400545700013
J	Rialdi, A; Hultquist, J; Jimenez-Morales, D; Peralta, Z; Campisi, L; Fenouil, R; Moshkina, N; Wang, ZZ; Laffleur, B; Kaake, RM; McGregor, MJ; Haas, K; Pefanis, E; Albrecht, RA; Pache, L; Chanda, S; Jen, J; Ochando, J; Byun, M; Basu, U; Garcia-Sastre, A; Krogan, N; van Bakel, H; Marazzi, I				Rialdi, Alexander; Hultquist, Judd; Jimenez-Morales, David; Peralta, Zuleyma; Campisi, Laura; Fenouil, Romain; Moshkina, Natasha; Wang, Zhen Zhen; Laffleur, Brice; Kaake, Robyn M.; McGregor, Michael J.; Haas, Kelsey; Pefanis, Evangelos; Albrecht, Randy A.; Pache, Lars; Chanda, Sumit; Jen, Joanna; Ochando, Jordi; Byun, Minji; Basu, Uttiya; Garcia-Sastre, Adolfo; Krogan, Nevan; van Bakel, Harm; Marazzi, Ivan			The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity	CELL			English	Article							PONTOCEREBELLAR HYPOPLASIA TYPE-1; PROTEIN-PROTEIN INTERACTIONS; INFLUENZA-VIRUS; MESSENGER-RNA; EXOSC3 MUTATIONS; NUCLEAR EXOSOME; POLYMERASE-II; CEREBELLAR HYPOPLASIA; TARGETING COMPLEX; GENE-EXPRESSION	The nuclear RNA exosome is an essential multi-subunit complex that controls RNA homeostasis. Congenital mutations in RNA exosome genes are associated with neurodegenerative diseases. Little is known about the role of the RNA exosome in the cellular response to pathogens. Here, using NGS and human and mouse genetics, we show that influenza A virus (IAV) ribogenesis and growth are suppressed by impaired RNA exosome activity. Mechanistically, the nuclear RNA exosome coordinates the initial steps of viral transcription with RNAPII at host promoters. The viral polymerase complex co-opts the nuclear RNA exosome complex and cellular RNAs en route to 30 end degradation. Exosome deficiency uncouples chromatin targeting of the viral polymerase complex and the formation of cellular: viral RNA hybrids, which are essential RNA intermediates that license transcription of antisense genomic viral RNAs. Our results suggest that evolutionary arms races have shaped the cellular RNA quality control machinery.	[Rialdi, Alexander; Campisi, Laura; Moshkina, Natasha; Wang, Zhen Zhen; Albrecht, Randy A.; Garcia-Sastre, Adolfo; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Hultquist, Judd; Jimenez-Morales, David; Kaake, Robyn M.; McGregor, Michael J.; Haas, Kelsey; Krogan, Nevan] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Peralta, Zuleyma; Fenouil, Romain; van Bakel, Harm] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Laffleur, Brice; Basu, Uttiya] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Pefanis, Evangelos] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Pefanis, Evangelos] Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Pache, Lars; Chanda, Sumit] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Jen, Joanna] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Ochando, Jordi; Byun, Minji] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Marazzi, Ivan] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Columbia University; Regeneron; Regeneron; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Marazzi, I (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.	ivan.marazzi@mssm.edu	Ochando, jordi/ABE-2358-2020; Ochando, Jordi/B-6219-2008; van Bakel, Harm/N-9561-2017; Jimenez-Morales, David/AAE-9289-2019; Campisi, Laura/AAL-2064-2021	Ochando, jordi/0000-0001-7037-1681; Ochando, Jordi/0000-0001-7037-1681; van Bakel, Harm/0000-0002-1376-6916; Jimenez-Morales, David/0000-0003-4356-6461; Campisi, Laura/0000-0003-4173-4521; Byun, Minji/0000-0002-2830-4079; Hultquist, Judd/0000-0001-6424-4280; Rialdi, Alexander/0000-0001-5393-9247	NIH [2RO1AI099195, DP2 2OD008651, 1R56AI114770-01A1, 1R01AN3663134, U19AI106754 FLUOMICS]; Center for Research on Influenza Pathogenesis (CRIP), a NIAID [HHSN272201400008C]; Department of Defense [W911NF-14-1-0353]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099195, R56AI114770, U19AI106754, R01AI113186] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651, S10OD018522] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Research on Influenza Pathogenesis (CRIP), a NIAID; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Metreveli for help with virus propagations, D. Leib and S. Tripathi for sharing reagents, the Genomics and Mouse facility at Icahn School of Medicine at Mount Sinai, B. Greenbaum for discussion about virus-host interactions, the Global Health and Emerging Pathogens Institute (GHEPI) at Mount Sinai, and the entire Marazzi Lab team. I.M. thanks Dr. Charney for support. U.B. is supported by NIH grants 2RO1AI099195 and DP2 2OD008651. A.G.-S., H.v.B., R.A.A., and I.M. are partially supported by HHSN272201400008C - Center for Research on Influenza Pathogenesis (CRIP), a NIAID-funded Center of Excellence for Influenza Research and Surveillance (CEIRS). I.M. is supported in part by The Department of Defense W911NF-14-1-0353 and by NIH grant 1R56AI114770-01A1. I.M. and H.v.B. are supported by NIH grant 1R01AN3663134. I.M., R.A.A., S.C., N.K., and A.G.-S. are all supported by the NIH grant U19AI106754 FLUOMICS.	Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biancheri R, 2013, J NEUROL, V260, P1866, DOI 10.1007/s00415-013-6896-0; Boczonadi V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5287; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Eggens VRC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-23; Engreitz J, 2015, METHODS MOL BIOL, V1262, P183, DOI 10.1007/978-1-4939-2253-6_11; Giunta M, 2016, HUM MOL GENET, V25, P2985, DOI 10.1093/hmg/ddw149; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Halevy A, 2014, J NEUROL, V261, P2165, DOI 10.1007/s00415-014-7457-x; Hallais M, 2013, NAT STRUCT MOL BIOL, V20, P1358, DOI 10.1038/nsmb.2720; Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Honda A, 2001, J BIOL CHEM, V276, P31179, DOI 10.1074/jbc.M102856200; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Januszyk K, 2014, CURR OPIN STRUC BIOL, V24, P132, DOI 10.1016/j.sbi.2014.01.011; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Lukarska M, 2017, NATURE, V541, P117, DOI 10.1038/nature20594; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Madhani HD, 2013, CELL, V155, P744, DOI 10.1016/j.cell.2013.10.003; Marazzi I, 2015, CURR OPIN MICROBIOL, V26, P123, DOI 10.1016/j.mib.2015.06.009; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Ortigoza MB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002668; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Paulson M, 2002, NAT CELL BIOL, V4, P140, DOI 10.1038/ncb747; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; PLOTCH SJ, 1979, P NATL ACAD SCI USA, V76, P1618, DOI 10.1073/pnas.76.4.1618; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rudnik-Schoneborn S, 2013, NEUROLOGY, V80, P438, DOI 10.1212/WNL.0b013e31827f0f66; Sakuma T, 2014, VIRUSES-BASEL, V6, P1135, DOI 10.3390/v6031135; Shah PS, 2015, CURR OPIN MICROBIOL, V27, P62, DOI 10.1016/j.mib.2015.07.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Summers BC, 2002, J VIROL, V76, P7020, DOI 10.1128/JVI.76.14.7020-7029.2002; Teo G, 2016, PROTEOMICS, V16, P2238, DOI 10.1002/pmic.201500499; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Tollervey D, 2015, RNA, V21, P492, DOI 10.1261/rna.050989.115; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Zanni G, 2013, NEUROGENETICS, V14, P247, DOI 10.1007/s10048-013-0371-z; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	72	33	35	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					679	692		10.1016/j.cell.2017.04.021	http://dx.doi.org/10.1016/j.cell.2017.04.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475896	Green Accepted, Bronze			2022-12-28	WOS:000400560900013
J	Smith, TJ; Kahaly, GJ; Ezra, DG; Fleming, JC; Dailey, RA; Tang, RA; Harris, GJ; Antonelli, A; Salvi, M; Goldberg, RA; Gigantelli, JW; Couch, SM; Shriver, EM; Hayek, BR; Hink, EM; Woodward, RM; Gabriel, K; Magni, G; Douglas, RS				Smith, Terry J.; Kahaly, George J.; Ezra, Daniel G.; Fleming, James C.; Dailey, Roger A.; Tang, Rosa A.; Harris, Gerald J.; Antonelli, Alessandro; Salvi, Mario; Goldberg, Robert A.; Gigantelli, James W.; Couch, Steven M.; Shriver, Erin M.; Hayek, Brent R.; Hink, Eric M.; Woodward, Richard M.; Gabriel, Kathleen; Magni, Guido; Douglas, Raymond S.			Teprotumumab for Thyroid-Associated Ophthalmopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-I RECEPTOR; OF-LIFE QUESTIONNAIRE; GRAVES-DISEASE; MONOCLONAL-ANTIBODY; ORBITAL RADIOTHERAPY; PHASE-II; GO-QOL; INSULIN; GROWTH; ORBITOPATHY	BACKGROUND Thyroid-associated ophthalmopathy, a condition commonly associated with Graves' disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I receptor (IGF-IR) is a new therapeutic strategy to attenuate the underlying autoimmune pathogenesis of ophthalmopathy. METHODS We conducted a multicenter, double-masked, randomized, placebo-controlled trial to determine the efficacy and safety of teprotumumab, a human monoclonal antibody inhibitor of IGF-IR, in patients with active, moderate-to-severe ophthalmopathy. A total of 88 patients were randomly assigned to receive placebo or active drug administered intravenously once every 3 weeks for a total of eight infusions. The primary end point was the response in the study eye. This response was defined as a reduction of 2 points or more in the Clinical Activity Score (scores range from 0 to 7, with a score of >= 3 indicating active thyroid-associated ophthalmopathy) and a reduction of 2 mm or more in proptosis at week 24. Secondary end points, measured as continuous variables, included proptosis, the Clinical Activity Score, and results on the Graves' ophthalmopathy-specific quality-of-life questionnaire. Adverse events were assessed. RESULTS In the intention-to-treat population, 29 of 42 patients who received teprotumumab (69%), as compared with 9 of 45 patients who received placebo (20%), had a response at week 24 (P<0.001). Therapeutic effects were rapid; at week 6, a total of 18 of 42 patients in the teprotumumab group (43%) and 2 of 45 patients in the placebo group (4%) had a response (P<0.001). Differences between the groups increased at subsequent time points. The only drug-related adverse event was hyperglycemia in patients with diabetes; this event was controlled by adjusting medication for diabetes. CONCLUSIONS In patients with active ophthalmopathy, teprotumumab was more effective than placebo in reducing proptosis and the Clinical Activity Score.	[Smith, Terry J.; Douglas, Raymond S.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48109 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA; [Kahaly, George J.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med, Mainz, Germany; [Ezra, Daniel G.] Moorfields Eye Hosp, London, England; [Fleming, James C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Dailey, Roger A.] Oregon Hlth & Sci Univ, Oculofacial Plast Surg Div, Portland, OR 97201 USA; [Tang, Rosa A.] Neuroophthalmol Texas, Eye Wellness Ctr, Houston, TX USA; [Harris, Gerald J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Antonelli, Alessandro] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Salvi, Mario] Univ Milan, Endocrinol & Diabetol Unit, Fdn IRCCS Ca Granda, Milan, Italy; [Goldberg, Robert A.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Gigantelli, James W.] Univ Nebraska Med Ctr, Omaha, NE USA; [Couch, Steven M.] Washington Univ, Barnes Jewish Hosp, St Louis, MO 63130 USA; [Shriver, Erin M.] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA 52242 USA; [Hayek, Brent R.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Hink, Eric M.] Univ Colorado, Dept Ophthalmol, Aurora, CO USA; [Woodward, Richard M.; Gabriel, Kathleen; Magni, Guido] River Vis Dev, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johannes Gutenberg University of Mainz; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Tennessee System; University of Tennessee Health Science Center; Oregon Health & Science University; Medical College of Wisconsin; University of Pisa; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of California System; University of California Los Angeles; University of Nebraska System; University of Nebraska Medical Center; Barnes-Jewish Hospital; Washington University (WUSTL); University of Iowa; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	terrysmi@med.umich.edu	Goldberg, Robert/AAE-3046-2019; Salvi, Mario/U-8451-2019; Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685; Salvi, Mario/0000-0002-0276-0367; Douglas, Raymond S./0000-0002-3435-8161; Shriver, Erin/0000-0003-1005-4726	River Vision Development and others; FOOD AND DRUG ADMINISTRATION [R01FD004792] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021197, F31EY007003, R01EY008976, R01EY011708, P30EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI110557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	River Vision Development and others; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by River Vision Development and others; ClinicalTrials.gov number, NCT01868997.	Bahn RS, 1998, J CLIN ENDOCR METAB, V83, P998, DOI 10.1210/jc.83.3.998; Baldeschi L, 2007, OPHTHALMOLOGY, V114, P1395, DOI 10.1016/j.ophtha.2006.10.036; Bartalena L, 2012, J CLIN ENDOCR METAB, V97, P4454, DOI 10.1210/jc.2012-2389; Chen H, 2014, J CLIN ENDOCR METAB, V99, pE1635, DOI 10.1210/jc.2014-1580; Diana T, 2016, J ENDOCRINOL INVEST, V39, P1159, DOI 10.1007/s40618-016-0478-9; Douglas RS, 2008, J IMMUNOL, V181, P5768, DOI 10.4049/jimmunol.181.8.5768; Douglas RS, 2007, J IMMUNOL, V178, P3281, DOI 10.4049/jimmunol.178.5.3281; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; FELICIELLO A, 1993, LANCET, V342, P337, DOI 10.1016/0140-6736(93)91475-2; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Krieger CC, 2016, J CLIN ENDOCR METAB, V101, P2340, DOI 10.1210/jc.2016-1315; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Ma HH, 2014, BRIT J CLIN PHARMACO, V77, P917, DOI 10.1111/bcp.12228; Marcocci C, 2001, J CLIN ENDOCR METAB, V86, P3562, DOI 10.1210/jc.86.8.3562; Minich WB, 2013, J CLIN ENDOCR METAB, V98, P752, DOI 10.1210/jc.2012-1771; Morshed SA, 2015, HORM METAB RES, V47, P727, DOI 10.1055/s-0035-1559633; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Pritchard J, 2004, J IMMUNOL, V173, P3564, DOI 10.4049/jimmunol.173.5.3564; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Rootman DB, 2016, OPHTHAL PLAST RECONS; Salvi M, 2015, J CLIN ENDOCR METAB, V100, P422, DOI 10.1210/jc.2014-3014; SANDLER HM, 1989, INT J RADIAT ONCOL, V17, P823, DOI 10.1016/0360-3016(89)90073-4; Sisti E, 2015, EUR J ENDOCRINOL, V172, P269, DOI 10.1530/EJE-14-0712; Smith TJ, 2016, NEW ENGL J MED, V375, P1552, DOI 10.1056/NEJMra1510030; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Smith TJ, 2004, J CLIN ENDOCR METAB, V89, P5076, DOI 10.1210/jc.2004-0716; Stan MN, 2015, J CLIN ENDOCR METAB, V100, P432, DOI 10.1210/jc.2014-2572; Tabasum A, 2016, ENDOCRINOL DIAB META, DOI 10.1530/EDM-16-0008; Tanda ML, 2012, J CLIN ENDOCR METAB, V97, P3857, DOI 10.1210/jc.2012-2758; Terwee CB, 2001, CLIN ENDOCRINOL, V54, P391, DOI 10.1046/j.1365-2265.2001.01241.x; Terwee CB, 1998, BRIT J OPHTHALMOL, V82, P773, DOI 10.1136/bjo.82.7.773; TRAMONTANO D, 1986, ENDOCRINOLOGY, V119, P940, DOI 10.1210/endo-119-2-940; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Varewijck AJ, 2013, J CLIN ENDOCR METAB, V98, P769, DOI 10.1210/jc.2012-2270; WEIGHTMAN DR, 1993, AUTOIMMUNITY, V16, P251, DOI 10.3109/08916939309014643; Wiersinga WM, 2006, EUR J ENDOCRINOL, V155, P387, DOI 10.1530/eje.1.02230; Wu CY, 2016, OPHTHAL PLAST RECONS; Zang S, 2011, J CLIN ENDOCR METAB, V96, P320, DOI 10.1210/jc.2010-1962	39	301	321	1	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1748	1761		10.1056/NEJMoa1614949	http://dx.doi.org/10.1056/NEJMoa1614949			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28467880	Green Published, Green Accepted			2022-12-28	WOS:000400442300008
J	Xing, YH; Yao, RW; Zhang, Y; Guo, CJ; Jiang, S; Xu, G; Dong, R; Yang, L; Chen, LL				Xing, Yu-Hang; Yao, Run-Wen; Zhang, Yang; Guo, Chun-Jie; Jiang, Shan; Xu, Guang; Dong, Rui; Yang, Li; Chen, Ling-Ling			SLERT Regulates DDX21 Rings Associated with Pol I Transcription	CELL			English	Article							RNA HELICASE DDX21; RIBOSOMAL-RNA; NUCLEOLAR LOCALIZATION; GENE-EXPRESSION; POLYMERASE I; LNCRNAS; BINDING; PROTEINS; SNORNPS; II/GU	Dysregulated rRNA synthesis by RNA polymerase I (Pol I) is associated with uncontrolled cell proliferation. Here, we report a box H/ACA small nucleolar RNA (snoRNA)-ended long noncoding RNA (lncRNA) that enhances pre-rRNA transcription (SLERT). SLERT requires box H/ACA snoRNAs at both ends for its biogenesis and translocation to the nucleolus. Deletion of SLERT impairs pre-rRNA transcription and rRNA production, leading to decreased tumorigenesis. Mechanistically, SLERT interacts with DEAD-box RNA helicase DDX21 via a 143-nt non-snoRNA sequence. Super-resolution images reveal that DDX21 forms ring-shaped structures surrounding multiple Pol I complexes and suppresses pre-rRNA transcription. Binding by SLERT allosterically alters individual DDX21 molecules, loosens the DDX21 ring, and evicts DDX21 suppression on Pol I transcription. Together, our results reveal an important control of ribosome biogenesis by SLERT lncRNA and its regulatory role in DDX21 ring-shaped arrangements acting on Pol I complexes.	[Xing, Yu-Hang; Yao, Run-Wen; Zhang, Yang; Guo, Chun-Jie; Jiang, Shan; Xu, Guang; Chen, Ling-Ling] Univ Chinese Acad Sci, State Key Lab Mol Biol, Chinese Acad Sci,Shanghai Key Lab Mol Androl, Shanghai Inst Biochem & Cell Biol,CAS Ctr Excelle, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Dong, Rui; Yang, Li] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol,CAS MPG Partner Inst Comput, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Yang, Li; Chen, Ling-Ling] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Chen, LL (corresponding author), Univ Chinese Acad Sci, State Key Lab Mol Biol, Chinese Acad Sci,Shanghai Key Lab Mol Androl, Shanghai Inst Biochem & Cell Biol,CAS Ctr Excelle, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Chen, LL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	linglingchen@sibcb.ac.cn	Zhang, Yang/AFV-8861-2022; Chen, Ling-Ling/AAY-3547-2021; Yao, Runwen/AAV-5360-2020	Yao, Runwen/0000-0002-6183-0273; Dong, Rui/0000-0003-0985-6211; chen, ling ling/0000-0001-9501-0305; yang, li/0000-0001-8833-7473	CAS [XDB19020104]; MOST [2016YFA0100701, 2014CB964802]; NSFC [91440202, 91540115]	CAS(Chinese Academy of Sciences); MOST; NSFC(National Natural Science Foundation of China (NSFC))	We are grateful to G. Carmichael for reading the manuscript, D. Lafontaine for suggestions on pre-rRNA analysis, J. Chen for help in FRET assay, Y.X. He from the Core Facility Centre of the Institute of Plant Physiology and Ecology, SIBS, CAS for technical support on SIM, and all lab members for discussion. H9 cells were obtained from the WiCell Research Institute. This work was supported by CAS (XDB19020104), MOST (2016YFA0100701 and 2014CB964802), and NSFC (91440202 and 91540115).	Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9552; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; FLORESROZAS H, 1993, J BIOL CHEM, V268, P21372; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; Hacot S, 2010, CURR PROTOC CELL BIO; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Holmstrom TH, 2008, J BIOL CHEM, V283, P7046, DOI 10.1074/jbc.M709613200; Hu SB, 2015, GENE DEV, V29, P630, DOI 10.1101/gad.257048.114; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004; Nguyen LXT, 2015, J CELL PHYSIOL, V230, P1181, DOI 10.1002/jcp.24854; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; McStay B, 2016, GENE DEV, V30, P1598, DOI 10.1101/gad.283838.116; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Perlaky L, 1997, EXP CELL RES, V235, P413, DOI 10.1006/excr.1997.3686; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Seegar T., 2010, JOVE-J VIS EXP, P2149; Sloan KE, 2015, NUCLEIC ACIDS RES, V43, P553, DOI 10.1093/nar/gku1291; Valdez BC, 1996, NUCLEIC ACIDS RES, V24, P1220, DOI 10.1093/nar/24.7.1220; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Wu H, 2016, MOL CELL, V64, P534, DOI 10.1016/j.molcel.2016.10.007; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Zhang XO, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-287; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; Zhang Y, 2016, CELL REP, V15, P611, DOI 10.1016/j.celrep.2016.03.058	36	137	144	7	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					664	678		10.1016/j.cell.2017.04.011	http://dx.doi.org/10.1016/j.cell.2017.04.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475895	Bronze			2022-12-28	WOS:000400560900012
J	Huang, ZX; Ma, JY				Huang, Zhenxiao; Ma, Jingying			SPOT DIAGNOSIS Chronic purulent nasal discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Huang, Zhenxiao; Ma, Jingying] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Huang, ZX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	zhenxiaohuang@hotmail.com; rebecca7481@aliyun.com						Aribandi M, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065189; Kennedy DW, 2012, THIEME, DOI [10.1055/b-002-85513, DOI 10.1055/B-002-85513]; Seo YJ, 2011, ACTA RADIOL, V52, P790, DOI 10.1258/ar.2011.110021	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j2061	10.1136/bmj.j2061	http://dx.doi.org/10.1136/bmj.j2061			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468763	Green Published			2022-12-28	WOS:000400889600006
J	Bero, L				Bero, Lisa			Addressing Bias and Conflict of Interest Among Biomedical Researchers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bero, Lisa] Univ Sydney, Fac Pharm, Charles Perkins Ctr, D17,Sixth Floor, Sydney, NSW 2006, Australia	University of Sydney	Bero, L (corresponding author), Univ Sydney, Fac Pharm, Charles Perkins Ctr, D17,Sixth Floor, Sydney, NSW 2006, Australia.	lisa.bero@sydney.edu.au		Bero, Lisa/0000-0003-1893-6651				Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Bero LA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001221; Dunn Adam G, 2016, Res Integr Peer Rev, V1; Kearns CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001798; Lenzer J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6194; Lundh A, 2017, BMJ-BRIT MED J, V356, pj176; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Wang AT, 2010, BMJ-BRIT MED J, V340, P1344; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	9	47	48	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1723	1724		10.1001/jama.2017.3854	http://dx.doi.org/10.1001/jama.2017.3854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464166				2022-12-28	WOS:000400440700011
J	Lucas, T				Lucas, Tamara			Rafael Beyar: a meeting of medicine, science, and technology	LANCET			English	Biographical-Item																		BEYAR R, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2463	2463		10.1016/S0140-6736(17)31196-0	http://dx.doi.org/10.1016/S0140-6736(17)31196-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY3VF	28495104				2022-12-28	WOS:000403901800015
J	Skorecki, K; Horton, R				Skorecki, Karl; Horton, Richard			Israel: health and beyond	LANCET			English	Article							WORKFORCE; MEDICINE; OFFLINE; ARAB	The principle that global human identity and dignity supersede other values is a broadly accepted conviction that guides practice and policies in the realm of human health in most of the world. An assessment of the level of success that Israel has achieved in health, in the face of formidable challenges, including rapid population growth, diverse and often divided ethnic affiliations, and existential security threats, leads us to propose that extension of this principle of global human identity and dignity, together with the objective of a decent society, as overriding values beyond health to other domains of human endeavour within Israel and in its relations with neighbouring peoples, represents an entirely achievable imperative. The result will be to further advance Israel's aspiration to serve as a model for societal decency with wide international acceptance and engagement. We have identified several determinants of Israel's advancement in health, including: articulation of a clear vision, national purpose, and long-term commitment that seeks to take the health of its citizens seriously; a multi-ethnic population that brings diversity and energy to national progress; a political democracy, which is characterised by robust debate and discussion about the nation's future; national legislation governing cardinal health-care processes; cultural and religious histories that respect and revere scholarship, learning, research, and charitable donation; an expanding economy, with recent but increasing appreciation of the economic, social, and political underpinnings of health and health inequalities; a strong base of international support from the Diaspora Jewish community; and a strong desire for acceptance by the international community in key arenas, especially science and health. As a result, despite the fewer than seven decades since its establishment, Israel has achieved important milestones in health. Nevertheless, this trajectory of achievement is threatened by several serious challenges, including the capacity to sustain high-quality universal health coverage, especially for an ageing population living with multiple comorbidities in the face of a stagnant level of the percentage of treasury funding to health care at a level that is well below the average of the Organisation for Economic Co-operation and Development; ever-increasing transfer of services and care covered by the mandatory public health services basket to private programmes; insufficient progress in resolving health disparities among and between communities, populations, and regions of the country congruent with disparities in income and employment; gender inequities; a looming increase in the already alarming shortfall in health-care professionals; and failure to match inpatient and acute care facilities to manage growing needs. These challenges within Israel are magnified in the context of health disparities with the neighbouring Palestinian population, a situation in which ongoing-but fragile and limited-health cooperation and training arrangements cannot stand in for a solution that will address Palestinian national aspirations. We come away from this Series with a great sense of optimism, but with specific recommendations that are based on the foregoing challenges. We believe that by increasing the investment in the health sector, which includes investing in the societal, political, educational, and environmental underpinnings of health, far more can be achieved to move Israel to a model international leadership position in health care, education, and research, and turn health into an engine for economic wellbeing and development. Religious leadership in Israel, with its formidable political influence, can be harnessed to promote health initiatives in areas ranging from smoking cessation and healthy diet to organ transplantation, and most of all condemnation of hostility and its replacement by peaceful resolution of even the deepest conflicts. Most of all, this Series showed that there is an enormous opportunity, which Israel can lead, to leverage the universally accepted principles of health as a sanctuary against conflict and inequity, to achieve a brighter future for a deeply troubled region of the world.	[Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel; [Horton, Richard] The Lancet, London EC2Y 5AS, England	Rambam Health Care Campus; Technion Israel Institute of Technology	Skorecki, K (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Rambam Hlth Care Campus, IL-3109601 Haifa, Israel.; Horton, R (corresponding author), The Lancet, London EC2Y 5AS, England.	skorecki@technion.ac.il; richard.horton@lancet.com						[Anonymous], 1918, Cal State J Med, V16, P51; [Anonymous], 2016, HAARETZ; Arieli D, NATL HLTH INSURANCE; Atomic Energy Commission, 2016, BAS PLAN MAN HIGH LE; Atzmon I, 2017, J RELIG HEALTH, V56, P741, DOI 10.1007/s10943-014-9973-5; Bahouth H, 2017, LANCET; Balicer RD, 2017, LANCET; Barak A, 2014, ISR LAW REV, V47, P181, DOI 10.1017/S0021223714000041; Ben Noach M, 2012, NICOTINE TOB RES, V14, P648, DOI 10.1093/ntr/ntr261; Beyar R, 2017, LANCET; Blazer S, 2015, RAMBAM MAIMONIDES ME, V6, DOI 10.5041/RMMJ.10176; Chan M., 2016, EM MED TEAMS GLOB M; Chinitz D, 2016, HEALTH ECON POLICY L, V11, P215, DOI 10.1017/S1744133115000365; Clarfield AM, 2017, LANCET; Della Pergola S., 2016, AM JEWISH YB, P116; Dwolatzky T, 2017, LANCET; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Geiderman JM, 2002, ACAD EMERG MED, V9, P232, DOI 10.1111/j.1553-2712.2002.tb00255.x; Gensler HJ, 2013, ETHICS GOLDEN RULE, P84; Granek L, 2017, LANCET; Granot S., 2016, JERUSALEM POSTM 1103; Horton R, 2014, LANCET, V384, P1332, DOI 10.1016/S0140-6736(14)61782-7; Horton R, 2014, LANCET, V383, P2196, DOI 10.1016/S0140-6736(14)61046-1; Human Resources and Skills Development Canada, 2001, EMPL EQ ACT REV; Israel Frister R., 1973, ISRAEL YEARS CRISIS; Jotkowitz AB, 2017, LANCET; JTA, 2016, IR COMM MISS READ AN; Keaten J., 2016, UN HLTH AGENCY GIVES; Keshet Y, 2015, ISR J HEALTH POLICY, V4, DOI 10.1186/s13584-015-0004-0; Kleinstern G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171709; Kranzler Y, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-16; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; MARGALIT A., 1998, DECENT SOC; Muhsen K, 2017, LANCET; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; OECD, 2012, OECD RAIS STAND; Revel M., 2009, UNESCO UNIVERSAL DEC; Rubin L., 2017, LANCET; Schoenbaum SC, 2015, ISR J HEALTH POLICY, V4, DOI 10.1186/s13584-015-0030-y; Simpkin AL, 2016, NEW ENGL J MED, V375, P1713, DOI 10.1056/NEJMp1606402; State of Israel Ministry of Health, PAT BILL RIGHTS; State of Israel Ministry of Health, 2016, HIV AIDS ISR PER EP; The Israel Academy of Sciences and Humanities, REP COMM ASS STAT BI; The Society for Patient Rights in Israel, 1996, PAT RIGHTS LAW; Vogel G, 2004, SCIENCE, V303, P1128, DOI 10.1126/science.303.5661.1128; Working Party of the Royal College of Physicians, 2005, CLIN MED S1, V5, P5; World Health Organization, 2016, WORK HLTH GROWTH INV	47	10	10	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2551	2562		10.1016/S0140-6736(17)30877-2	http://dx.doi.org/10.1016/S0140-6736(17)30877-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY3VF	28495106				2022-12-28	WOS:000403901800033
J	Link, SM; Maas, DJHC; Waldburger, D; Keller, U				Link, S. M.; Maas, D. J. H. C.; Waldburger, D.; Keller, U.			Dual-comb spectroscopy of water vapor with a free-running semiconductor disk laser	SCIENCE			English	Article							FREQUENCY COMB; PHASE-CONTROL; NOISE	Dual-comb spectroscopy offers the potential for high accuracy combined with fast data acquisition. Applications are often limited, however, by the complexity of optical comb systems. Here we present dual-comb spectroscopy of water vapor using a substantially simplified single-laser system. Very good spectroscopy measurements with fast sampling rates are achieved with a free-running dual-comb mode-locked semiconductor disk laser. The absolute stability of the optical comb modes is characterized both for free-running operation and with simple microwave stabilization. This approach drastically reduces the complexity for dual-comb spectroscopy. Band-gap engineering to tune the center wavelength from the ultraviolet to the mid-infrared could optimize frequency combs for specific gas targets, further enabling dual-comb spectroscopy for a wider range of industrial applications.	[Link, S. M.; Waldburger, D.; Keller, U.] ETH, Inst Quantum Elect, Dept Phys, CH-8093 Zurich, Switzerland; [Maas, D. J. H. C.] ABB Switzerland Ltd, Corp Res, Segelhofstr 1K, CH-5405 Baden, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; ABB	Link, SM; Keller, U (corresponding author), ETH, Inst Quantum Elect, Dept Phys, CH-8093 Zurich, Switzerland.	slink@phys.ethz.ch; keller@phys.ethz.ch	Keller, Ursula/N-2437-2016	Keller, Ursula/0000-0002-1689-8041	Swiss Confederation program Nano-Tera.ch	Swiss Confederation program Nano-Tera.ch	We thank M. Kroner and A. Imamoglu for lending us the single-frequency laser (Toptica DL pro); J. Deiglmayr and F. Merkt for the wavelength meter (High-Finesse WS-7); and G. Villares, M. Rosch, and J. Faist for the frequency counter (Agilent 53220A). The authors acknowledge the support of the technology and cleanroom facility at Frontiers in Research: Space and Time (FIRST) of ETH Zurich for advanced micro-and nanotechnology. This work was financed by the Swiss Confederation program Nano-Tera.ch, which was scientifically evaluated by the Swiss National Science Foundation (SNSF). S.M.L., B. W. Tilma, M. Mangold, C. A. Zaugg, A. Klenner, and U.K. are inventors on a patent application (WO 2016/049787 A1) held and submitted by ETH Zurich that covers dual-comb mode-locking. Data can be obtained by contacting U.K. at keller@phys.ethz.ch.	Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; Bartels A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2714048; Bartels A, 2009, SCIENCE, V326, P681, DOI 10.1126/science.1179112; Coddington I, 2009, NAT PHOTONICS, V3, P351, DOI 10.1038/NPHOTON.2009.94; Coddington I, 2016, OPTICA, V3, P414, DOI [10.1364/OPTICA.3.000414, 10.1364/optica.3.000414]; Cotter D., 1984, ULTRAFAST PHENOMENA, V38, P78; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; Gaafar MA, 2016, ADV OPT PHOTONICS, V8, P370, DOI 10.1364/AOP.8.000370; Guina M., 2012, ADV OPT TECHNOL, V2012; Hartl I., 2009, C LAS EL CLEO CMN1 S; HILL KO, 1978, APPL PHYS LETT, V32, P647, DOI 10.1063/1.89881; Ideguchi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4375; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Keller U, 2006, PHYS REP, V429, P67, DOI 10.1016/j.physrep.2006.03.004; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Klenner A, 2014, OPT EXPRESS, V22, P31008, DOI 10.1364/OE.22.031008; Li J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233901; Link SM, 2016, OPT EXPRESS, V24, P1889, DOI 10.1364/OE.24.001889; Link SM, 2015, OPT EXPRESS, V23, P5521, DOI 10.1364/OE.23.005521; Liu Y, 2016, OPT EXPRESS, V24, P21392, DOI 10.1364/OE.24.021392; Ma LS, 2004, SCIENCE, V303, P1843, DOI 10.1126/science.1095092; Maas DJHC, 2007, APPL PHYS B-LASERS O, V88, P493, DOI 10.1007/s00340-007-2760-1; Mangold M, 2014, IEEE PHOTONICS J, V6, DOI 10.1109/JPHOT.2013.2295464; Mangold M, 2014, OPT EXPRESS, V22, P6099, DOI 10.1364/OE.22.006099; Rahimi-Iman A, 2016, J OPTICS-UK, V18, DOI 10.1088/2040-8978/18/9/093003; RODWELL MJW, 1989, IEEE J QUANTUM ELECT, V25, P817, DOI 10.1109/3.17346; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Schiller S, 2002, OPT LETT, V27, P766, DOI 10.1364/OL.27.000766; Schroeder PJ, 2017, P COMBUST INST, V36, P4565, DOI 10.1016/j.proci.2016.06.032; Schulz N, 2008, LASER PHOTONICS REV, V2, P160, DOI 10.1002/lpor.200710037; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Suh MG, 2016, SCIENCE, V354, P600, DOI 10.1126/science.aah6516; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Tilma BW, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.83; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Villares G, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4938213; Villares G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6192; Waldburger D, 2016, OPTICA, V3, P844, DOI 10.1364/OPTICA.3.000844; Yasui T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10786; Zaugg CA, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870048	40	133	133	5	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2017	356	6343					1164	1168		10.1126/science.aam7424	http://dx.doi.org/10.1126/science.aam7424			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6BO	28495879				2022-12-28	WOS:000403327400035
J	Scott, IU; VanVeldhuisen, PC; Ip, MS; Blodi, BA; Oden, NL; Awh, CC; Kunimoto, DY; Marcus, DM; Wroblewski, JJ; King, J				Scott, Ingrid U.; VanVeldhuisen, Paul C.; Ip, Michael S.; Blodi, Barbara A.; Oden, Neal L.; Awh, Carl C.; Kunimoto, Derek Y.; Marcus, Dennis M.; Wroblewski, John J.; King, Jacqueline		SCORE2 Investigator Grp	Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion The SCORE2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO) - Imaging in the Eye	MAY 06-11, 2017	Baltimore, MD	Assoc Res Vis & Ophthalmol			INTRAVITREAL BEVACIZUMAB; DIABETIC-RETINOPATHY; SUSTAINED BENEFITS; 12-MONTH OUTCOMES; TRAP-EYE; RANIBIZUMAB; SECONDARY; PREVALENCE	IMPORTANCE Studies have established the efficacy and safety of aflibercept for the treatment of macular edema due to central retinal vein occlusion. Bevacizumab is used off-label to treat this condition despite the absence of supporting data. OBJECTIVE To investigate whether bevacizumab is noninferior to aflibercept for the treatment of macular edema secondary to central retinal or hemiretinal vein occlusion. DESIGN, SETTING, AND PARTICIPANTS The SCORE2 randomized noninferiority clinical trial was conducted at 66 private practice or academic centers in the United States, and included 362 patients with macular edema due to central retinal or hemiretinal vein occlusion who were randomized 1: 1 to receive aflibercept or bevacizumab. The first participant was randomized on September 17, 2014, and the last month 6 visit occurred on May 6, 2016. Analyses included data available as of December 30, 2016. INTERVENTIONS Eyes were randomized to receive intravitreal injection of bevacizumab (1.25 mg; n = 182) or aflibercept (2.0 mg; n = 180) every 4 weeks through month 6. MAIN OUTCOMES AND MEASURES The primary outcome was mean change in visual acuity (VA) letter score (VALS) from the randomization visit to the 6-month follow-up visit, based on the best-corrected electronic Early Treatment Diabetic Retinopathy Study VALS (scores range from 0-100; higher scores indicate better VA). The noninferiority margin was 5 letters, and statistical testing for noninferiority was based on a 1-sided 97.5% confidence interval. RESULTS Among 362 randomized participants (mean [SD] age, 69 [12] years; 157 [43.4%] women; mean [SD] VALS at baseline, 50.3 [15.2] [approximate Snellen VA 20/100]), 348 (96.1%) completed the month 6 follow-up visit. At month 6, the mean VALS was 69.3 (a mean increase from baseline of 18.6) in the bevacizumab group and 69.3 (a mean increase from baseline of 18.9) in the aflibercept group (model-based estimate of between-group difference, -0.14; 97.5% CI, -3.07 to infinity; P = .001 for noninferiority), meeting criteria for noninferiority. Ocular adverse events in the aflibercept group included 4 participants with intraocular pressure (IOP) more than 10 mm Hg greater than baseline; ocular adverse events in the bevacizumab group included 1 participant with endophthalmitis (culture negative), 9 with IOP more than 10 mm Hg greater than baseline, 2 with IOP higher than 35 mm Hg, and 1 with angle-closure glaucoma not attributed to the study drug or procedure. CONCLUSIONS AND RELEVANCE Among patients with macular edema due to central retinal or hemiretinal vein occlusion, intravitreal bevacizumab was noninferior to aflibercept with respect to visual acuity after 6 months of treatment.	[VanVeldhuisen, Paul C.; Oden, Neal L.; King, Jacqueline] Emmes Corp, 401 N Washington St,Ste 700, Rockville, MD 20850 USA; [Scott, Ingrid U.] Penn State Coll Med, Dept Ophthalmol, Hershey, PA USA; [Scott, Ingrid U.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Ip, Michael S.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA; [Blodi, Barbara A.] Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI 53706 USA; [Awh, Carl C.] Tennessee Retina PC, Nashville, TN USA; [Kunimoto, Derek Y.] Retinal Consultants Arizona, Phoenix, AZ USA; [Marcus, Dennis M.] Southeast Retina Ctr PC, Augusta, GA USA; [Wroblewski, John J.] Cumberland Valley Retina Consultants, Hagerstown, MD USA	Emmes Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Doheny Eye Institute; University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison	VanVeldhuisen, PC (corresponding author), Emmes Corp, 401 N Washington St,Ste 700, Rockville, MD 20850 USA.	score2@emmes.com		Scott, Ingrid/0000-0002-3908-7153	National Eye Institute, National Institutes of Health, Department of Health and Human Services [U10EY023529, U10EY023533, U10EY023521]; Regeneron Inc; Allergan Inc; Research to Prevent Blindness Inc; NATIONAL EYE INSTITUTE [U10EY023533, U10EY023529] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Regeneron Inc(Regeneron); Allergan Inc(AbbVieAllergan); Research to Prevent Blindness Inc(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants U10EY023529, U10EY023533, and U10EY023521 from the National Eye Institute, National Institutes of Health, Department of Health and Human Services. Support was also provided in part by Regeneron Inc and Allergan Inc through donation of investigational drug. This work was supported in part by an unrestricted grant from Research to Prevent Blindness Inc to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; American Academy of Pediatrics, 2016, RED BOOK ONL; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Beck RW, 2007, OPHTHALMOLOGY, V114, P1804, DOI 10.1016/j.ophtha.2007.06.047; Beck RW, 2003, AM J OPHTHALMOL, V135, P194, DOI 10.1016/S0002-9394(02)01825-1; Boyer D, 2012, OPHTHALMOLOGY, V119, P1024, DOI 10.1016/j.ophtha.2012.01.042; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Heier JS, 2014, OPHTHALMOLOGY, V121, P1414, DOI 10.1016/j.ophtha.2014.01.027; Heier JS, 2014, OPHTHALMOLOGY, V121, pe1; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P278, DOI 10.1136/bjophthalmol-2012-301504; Ip MS, 2009, OPHTHALMOLOGY, V116, P1770, DOI 10.1016/j.ophtha.2009.03.022; Ip MS, 2009, OPHTHALMOLOGY, V116, pe1; Kitchens JW, 2016, OPHTHALMOLOGY, V123, P1511, DOI 10.1016/j.ophtha.2016.02.046; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Office of Inspector General Department of Health and Human Services, 2012, USITC PUBL, VOEI-03-10-00360; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Scott IU, 2012, ARCH OPHTHALMOL-CHIC, V130, P1517, DOI 10.1001/archophthalmol.2012.2728; Stewart MW, 2012, BRIT J OPHTHALMOL, V96, P1157, DOI 10.1136/bjophthalmol-2011-300654; VanderBeek BL, 2015, JAMA OPHTHALMOL, V133, P1159, DOI 10.1001/jamaophthalmol.2015.2556; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wu L, 2010, RETINA-J RET VIT DIS, V30, P1002, DOI 10.1097/IAE.0b013e3181cea68d	31	113	116	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2017	317	20					2072	2087		10.1001/jama.2017.4568	http://dx.doi.org/10.1001/jama.2017.4568			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	EV5JJ	28492910	Green Published			2022-12-28	WOS:000401800600018
J	Oliver, D				Oliver, David			BMJ ACUTE PERSPECTIVE David Oliver: The NHS's understaffing is its Achilles' heel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						House of Lords, 2017, LONG TERM SUST NHS A; Imison C., 2016, RESHAPING WORKFORCE; Jeremy Hunt Dominiczak P., 2016, DAILY TELEGRAPH; Kaffash J., 2017, PULSE; King's Fund, 2017, SUST TRANSF PLANS ST; King's Fund, 2016, KINGS FUND RESP AUT; Maybin J, 2017, UNDERSTANDING QUALIT; National Health Executive, 2015, RAT PAR LEAV NHS NEA; NHS England, 2017, NEXT STEPS NHS 5 YEA; Nuffield Trust, 2014, QUAL WATCH FOC ALL H; Queen's Nursing Institute, 2016, 2020 VIS 5 YEARS REA; Rimmer A., 2017, BMJ CAREERS; Royal College of Nursing, 2017, PAY POLL PICKS STEAM; Royal College of Physicians of London, 2016, UND UND OV; Sansom Anna, 2016, BMJ Open, V6, pe010592, DOI 10.1136/bmjopen-2015-010592; Thomas K., 2017, GUARDIAN	16	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j2192	10.1136/bmj.j2192	http://dx.doi.org/10.1136/bmj.j2192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512106	Green Published, Bronze			2022-12-28	WOS:000401898900005
J	Roth, GA; Dwyer-Lindgren, L; Bertozzi-Villa, A; Stubbs, RW; Morozoff, C; Naghavi, M; Mokdad, AH; Murray, CJL				Roth, Gregory A.; Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.			Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-DISEASE MORTALITY; LIFE EXPECTANCY; UNITED-STATES; DEATH; STROKE; DISPARITIES; DECLINE	IMPORTANCE In the United States, regional variation in cardiovascular mortality is well-known but county-level estimates for all major cardiovascular conditions have not been produced. OBJECTIVE To estimate age-standardized mortality rates from cardiovascular diseases by county. DESIGN AND SETTING Deidentified death records from the National Center for Health Statistics and population counts from the US Census Bureau, the National Center for Health Statistics, and the Human Mortality Database from 1980 through 2014 were used. Validated small area estimation models were used to estimate county-level mortality rates from all cardiovascular diseases, including ischemic heart disease, cerebrovascular disease, ischemic stroke, hemorrhagic stroke, hypertensive heart disease, cardiomyopathy, atrial fibrillation and flutter, rheumatic heart disease, aortic aneurysm, peripheral arterial disease, endocarditis, and all other cardiovascular diseases combined. EXPOSURES The 3110 counties of residence. MAIN OUTCOMES AND MEASURES Age-standardized cardiovascular disease mortality rates by county, year, sex, and cause. RESULTS From 1980 to 2014, cardiovascular diseases were the leading cause of death in the United States, although the mortality rate declined from 507.4 deaths per 100 000 persons in 1980 to 252.7 deaths per 100 000 persons in 2014, a relative decline of 50.2%(95% uncertainty interval [UI], 49.5%-50.8%). In 2014, cardiovascular diseases accounted for more than 846 000 deaths (95% UI, 827-865 thousand deaths) and 11.7 million years of life lost (95% UI, 11.6-11.9 million years of life lost). The gap in age-standardized cardiovascular disease mortality rates between counties at the 10th and 90th percentile declined 14.6% from 172.1 deaths per 100 000 persons in 1980 to 147.0 deaths per 100 000 persons in 2014 (posterior probability of decline > 99.9%). In 2014, the ratio between counties at the 90th and 10th percentile was 2.0 for ischemic heart disease (119.1 vs 235.7 deaths per 100 000 persons) and 1.7 for cerebrovascular disease (40.3 vs 68.1 deaths per 100 000 persons). For other cardiovascular disease causes, the ratio ranged from 1.4 (aortic aneurysm: 3.5 vs 5.1 deaths per 100 000 persons) to 4.2 (hypertensive heart disease: 4.3 vs 17.9 deaths per 100 000 persons). The largest concentration of counties with high cardiovascular disease mortality extended from southeastern Oklahoma along the Mississippi River Valley to eastern Kentucky. Several cardiovascular disease conditions were clustered substantially outside the South, including atrial fibrillation (Northwest), aortic aneurysm (Midwest), and endocarditis (MountainWest and Alaska). The lowest cardiovascular mortality rates were found in the counties surrounding San Francisco, California, central Colorado, northern Nebraska, central Minnesota, northeastern Virginia, and southern Florida. CONCLUSIONS AND RELEVANCE Substantial differences exist between county ischemic heart disease and stroke mortality rates. Smaller differences exist for diseases of the myocardium, atrial fibrillation, aortic and peripheral arterial disease, rheumatic heart disease, and endocarditis.	[Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA; [Roth, Gregory A.; Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Roth, GA (corresponding author), Univ Washington, Dept Med, Div Cardiol, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	rothg@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Robert Wood Johnson Foundation [72305]; National Institute on Aging [5P30AG047845-02]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grant 72305 from the Robert Wood Johnson Foundation, grant 5P30AG047845-02 from the National Institute on Aging, and a philanthropic gift from John W. Stanton and Theresa E. Gillespie. Dr Roth reports receiving funding from the Bill and Melinda Gates Foundation.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Cahill TJ, 2017, HEART, V103, P937, DOI 10.1136/heartjnl-2015-309102; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Casper M, 2016, CIRCULATION, V133, P1171, DOI 10.1161/CIRCULATIONAHA.115.018663; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Dwyer-Lindgren L, 2016, JAMA-J AM MED ASSOC, V316, P2385, DOI 10.1001/jama.2016.13645; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; FIENBERG SE, 1970, ANN MATH STAT, V41, P907, DOI 10.1214/aoms/1177696968; FINLEY JC, 1992, ARCH INTERN MED, V152, P1641, DOI 10.1001/archinte.152.8.1641; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gebreab SY, 2012, HEALTH PLACE, V18, P1006, DOI 10.1016/j.healthplace.2012.06.006; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; GOVER M, 1949, PUBLIC HEALTH REP, V64, P439, DOI 10.2307/4586913; Howard G, 2001, STROKE, V32, P2213, DOI 10.1161/hs1001.096047; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Kristensen K, 2016, J STAT SOFTW, V70, P1; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Leroux B, 2000, STAT MODELS EPIDEMIO, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3_4]; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Pletcher MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154288; Quick H, HIERARCHICAL MULTIVA; Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969; Sauer H I, 1980, Vital Health Stat 3, P1; Shrira I, 2008, NEUROEPIDEMIOLOGY, V30, P229, DOI 10.1159/000128102; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; SORLIE PD, 1987, AM J PUBLIC HEALTH, V77, P148, DOI 10.2105/AJPH.77.2.148; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; WING S, 1986, AM J PUBLIC HEALTH, V76, P1404, DOI 10.2105/AJPH.76.12.1404	33	146	147	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1976	1992		10.1001/jama.2017.4150	http://dx.doi.org/10.1001/jama.2017.4150			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510678	Green Accepted			2022-12-28	WOS:000401315500017
J	Yehia, L				Yehia, Lamis			Lucking into science	SCIENCE			English	Editorial Material								Before I embarked on my Ph.D. journey in cancer genomics, I had never thought of a career as a scientist. I had dreamed of becoming a physician for as long as I could remember. But the Fulbright scholarship I won to pursue Ph.D. training in the United States was the chance of a lifetime to continue my education beyond what would have been possible in my home country of Lebanon. I couldn't say no. In retrospect, I was clueless about what it really means to be a scientist. If I had known, I might have hesitated. But now I see that scholarship as a stroke of good fortune, which sent me along a path that helped me find my life's purpose.	[Yehia, Lamis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Yehia, L (corresponding author), Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA.	SciCareerEditor@aaas.org	Yehia, Lamis/AAI-4996-2020	Yehia, Lamis/0000-0002-6389-3059					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					654	654		10.1126/science.356.6338.654	http://dx.doi.org/10.1126/science.356.6338.654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495753				2022-12-28	WOS:000400975200057
J	Schmitt, LI; Wimmer, RD; Nakajima, M; Happ, M; Mofakham, S; Halassa, MM				Schmitt, L. Ian; Wimmer, Ralf D.; Nakajima, Miho; Happ, Michael; Mofakham, Sima; Halassa, Michael M.			Thalamic amplification of cortical connectivity sustains attentional control	NATURE			English	Article							PREFRONTAL CORTEX; MEDIODORSAL THALAMUS; SEQUENCE GENERATION; WORKING-MEMORY; DYNAMICS; INFORMATION; NETWORK; NEURONS; RAT; PROJECTIONS	Although interactions between the thalamus and cortex are critical for cognitive function(1-3), the exact contribution of the thalamus to these interactions remains unclear. Recent studies have shown diverse connectivity patterns across the thalamus(4,5), but whether this diversity translates to thalamic functions beyond relaying information to or between cortical regions(6) is unknown. Here we show, by investigating the representation of two rules used to guide attention in the mouse prefrontal cortex (PFC), that the mediodorsal thalamus sustains these representations without relaying categorical information. Specifically, mediodorsal input amplifies local PFC connectivity, enabling rule-specific neural sequences to emerge and thereby maintain rule representations. Consistent with this notion, broadly enhancing PFC excitability diminishes rule specificity and behavioural performance, whereas enhancing mediodorsal excitability improves both. Overall, our results define a previously unknown principle in neuroscience; thalamic control of functional cortical connectivity. This function, which is dissociable from categorical information relay, indicates that the thalamus has a much broader role in cognition than previously thought.	[Schmitt, L. Ian; Wimmer, Ralf D.; Nakajima, Miho; Happ, Michael; Mofakham, Sima; Halassa, Michael M.] NYU Langone Med Ctr, Dept Neurosci & Physiol, NYU Neurosci Inst, New York, NY 10016 USA; [Halassa, Michael M.] NYU, Ctr Neural Sci, 550 1St Ave, New York, NY 10016 USA	NYU Langone Medical Center; New York University	Halassa, MM (corresponding author), NYU Langone Med Ctr, Dept Neurosci & Physiol, NYU Neurosci Inst, New York, NY 10016 USA.; Halassa, MM (corresponding author), NYU, Ctr Neural Sci, 550 1St Ave, New York, NY 10016 USA.	michael.halassa@nyumc.org	Nakajima, Miho/AAU-3731-2020	Schmitt, Luke/0000-0002-1104-2666	NARSAD Young Investigator award; Swiss National Science Foundation; JSPS; NIMH; NINDS; Brain and Behavior Foundation; Sloan Foundation; Klingenstein Foundation; Human Frontiers Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107680] Funding Source: NIH RePORTER	NARSAD Young Investigator award(NARSAD); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Brain and Behavior Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. A. Movshon, D. J. Heeger, X.-J. Wang, M. A. Wilson, C. D. Brody and E. K. Miller for helpful discussions. L.I.S. is supported by a NARSAD Young Investigator award and R.D.W. by a fellowship from the Swiss National Science Foundation. M.N. is supported by a JSPS fellowship. M.M.H. is supported by grants from NIMH, NINDS, Brain and Behavior, Sloan and Klingenstein Foundations as well as the Human Frontiers Science Program.	Alcaraz F, 2016, EUR J NEUROSCI, V44, P1972, DOI 10.1111/ejn.13316; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Browning PGF, 2015, CEREB CORTEX, V25, P4519, DOI 10.1093/cercor/bhv093; Cadotte AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003355; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Dejean C, 2016, NATURE, V535, P420, DOI 10.1038/nature18630; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Duda R. O., 2001, PATTERN CLASSIFICATI, V18; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Gardner RJ, 2013, J NEUROSCI, V33, P18469, DOI 10.1523/JNEUROSCI.2197-13.2013; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; GOLOMB D, 1993, PHYS REV E, V48, P4810, DOI 10.1103/PhysRevE.48.4810; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Ito HT, 2015, NATURE, V522, P50, DOI 10.1038/nature14396; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Kuramoto E, 2017, J COMP NEUROL, V525, P166, DOI 10.1002/cne.24054; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Meyers EM, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00008; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; PREUSS TM, 1987, J COMP NEUROL, V257, P269, DOI 10.1002/cne.902570211; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Szucs A, 1998, J NEUROSCI METH, V81, P159, DOI 10.1016/S0165-0270(98)00033-8; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Wu W, 2011, J NEUROSCI METH, V195, P107, DOI 10.1016/j.jneumeth.2010.11.012; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Young ED, 2008, NEUROSCIENCE, V154, P127, DOI 10.1016/j.neuroscience.2008.01.036; Zagha E, 2015, NEURON, V88, P565, DOI 10.1016/j.neuron.2015.09.044; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P8850, DOI 10.1073/pnas.1100999108; Zhou HH, 2016, NEURON, V89, P209, DOI 10.1016/j.neuron.2015.11.034	43	295	298	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					219	+		10.1038/nature22073	http://dx.doi.org/10.1038/nature22073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467827	Green Accepted			2022-12-28	WOS:000400963800033
J	Yan, KS; Janda, CY; Chang, JL; Zheng, GXY; Larkin, KA; Luca, VC; Chia, LA; Mah, AT; Han, A; Terry, JM; Ootani, A; Roelf, K; Lee, M; Yuan, J; Li, X; Bolen, CR; Wilhelmy, J; Davies, PS; Ueno, H; von Furstenberg, RJ; Belgrader, P; Ziraldo, SB; Ordonez, H; Henning, SJ; Wong, MH; Snyder, MP; Weissman, IL; Hsueh, AJ; Mikkelsen, TS; Garcia, KC; Kuo, CJ				Yan, Kelley S.; Janda, Claudia Y.; Chang, Junlei; Zheng, Grace X. Y.; Larkin, Kathryn A.; Luca, Vincent C.; Chia, Luis A.; Mah, Amanda T.; Han, Arnold; Terry, Jessica M.; Ootani, Akifumi; Roelf, Kelly; Lee, Mark; Yuan, Jenny; Li, Xiao; Bolen, Christopher R.; Wilhelmy, Julie; Davies, Paige S.; Ueno, Hiroo; von Furstenberg, Richard J.; Belgrader, Phillip; Ziraldo, Solongo B.; Ordonez, Heather; Henning, Susan J.; Wong, Melissa H.; Snyder, Michael P.; Weissman, Irving L.; Hsueh, Aaron J.; Mikkelsen, Tarjei S.; Garcia, K. Christopher; Kuo, Calvin J.			Non-equivalence of Wnt and R-spondin ligands during Lgr5(+) intestinal stem-cell self-renewal	NATURE			English	Article							RNA-SEQ EXPERIMENTS; WNT/BETA-CATENIN; IN-VITRO; CRYPT; EXPRESSION; RECEPTORS; MARKER; GROWTH; COLON; LGR4	The canonical Wnt/beta-catenin signalling pathway governs diverse developmental, homeostatic and pathological processes. Palmitoylated Wnt ligands engage cell-surface frizzled (FZD) receptors and LRP5 and LRP6 co-receptors, enabling beta-catenin nuclear translocation and TCF/LEF-dependent gene transactivation(1-3). Mutations in Wnt downstream signalling components have revealed diverse functions thought to be carried out by Wnt ligands themselves. However, redundancy between the 19 mammalian Wnt proteins and 10 FZD receptors(1) and Wnt hydrophobicity have made it difficult to attribute these functions directly to Wnt ligands(2,3). For example, individual mutations in Wnt ligands have not revealed homeostatic phenotypes in the intestinal epithelium(4)-an archetypal canonical, Wnt pathway-dependent, rapidly self-renewing tissue, the regeneration of which is fueled by proliferative crypt Lgr5(+) intestinal stem cells (ISCs)(5-9). R-spondin ligands (RSPO1-RSPO4) engage distinct LGR4-LGR6, RNF43 and ZNRF3 receptor classes(10-13), markedly potentiate canonical Wnt/beta-catenin signalling, and induce intestinal organoid growth in vitro and Lgr5(+) ISCs in vivo(8,14-17). However, the interchangeability, functional cooperation and relative contributions of Wnt versus RSPO ligands to in vivo canonical Wnt signalling and ISC biology remain unknown. Here we identify the functional roles of Wnt and RSPO ligands in the intestinal crypt stem-cell niche. We show that the default fate of Lgr5(+) ISCs is to differentiate, unless both RSPO and Wnt ligands are present. However, gain-of-function studies using RSPO ligands and a new non-lipidated Wnt analogue reveal that these ligands have qualitatively distinct, non-interchangeable roles in ISCs. Wnt proteins are unable to induce Lgr5(+) ISC self-renewal, but instead confer a basal competency by maintaining RSPO receptor expression that enables RSPO ligands to actively drive and specify the extent of stem-cell expansion. This functionally non-equivalent yet cooperative interaction between Wnt and RSPO ligands establishes a molecular precedent for regulation of mammalian stem cells by distinct priming and self-renewal factors, with broad implications for precise control of tissue regeneration.	[Yan, Kelley S.; Chang, Junlei; Larkin, Kathryn A.; Chia, Luis A.; Mah, Amanda T.; Han, Arnold; Ootani, Akifumi; Roelf, Kelly; Lee, Mark; Yuan, Jenny; Wilhelmy, Julie; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Yan, Kelley S.] Columbia Univ, Columbia Ctr Human Dev, Div Digest & Liver Dis, Dept Med,Dept Genet & Dev,Med Ctr, New York, NY 10032 USA; [Janda, Claudia Y.; Luca, Vincent C.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Zheng, Grace X. Y.; Terry, Jessica M.; Belgrader, Phillip; Ziraldo, Solongo B.; Ordonez, Heather; Mikkelsen, Tarjei S.] 10x Genom Inc, Pleasanton, CA 94566 USA; [Han, Arnold] Columbia Univ, Columbia Ctr Translat Immunol, Dept Microbiol & Immunol, Dept Med,Div Digest & Liver Dis,Med Ctr, New York, NY 10032 USA; [Li, Xiao; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bolen, Christopher R.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Davies, Paige S.; Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA; [Ueno, Hiroo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol, Stanford, CA 94305 USA; [von Furstenberg, Richard J.; Henning, Susan J.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA; [Hsueh, Aaron J.] Stanford Univ, Sch Med, Dept Gynecol & Obstet, Stanford, CA 94305 USA	Stanford University; Columbia University; Howard Hughes Medical Institute; Stanford University; Columbia University; Stanford University; Stanford University; Oregon Health & Science University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	cjkuo@stanford.edu	Mikkelsen, Tarjei S/A-1306-2007; Chang, Junlei/K-2696-2017	Mikkelsen, Tarjei S/0000-0002-8133-3135; Chang, Junlei/0000-0002-0319-9022; Larkin, Kathryn/0000-0003-2784-8290; Kuo, Calvin/0000-0002-7427-5985; Snyder, Michael/0000-0003-0784-7987	CIRM MD Scholar Fellowships; AHA Postdoctoral Fellowship; Cancer Research Institute Irvington Fellowship; Burroughs Wellcome Fund CAMS; NIH [K08DK096048, K08DK100739, K99CA204738, R01GM097015, U01CA176299, U19AI116484, U01CA151920]; Ludwig Fund for Cancer Research; Intestinal Stem Cell Consortium - NIDDK [NIH U01DK085527, U01DK085547, U01DK085525]; NIAID; HHMI; Stinehart/Reed Foundation; AHA Innovative Science Award; NATIONAL CANCER INSTITUTE [U01CA151920, T32CA009302, K99CA204738, U01CA176299, P30CA124435, U01CA217851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI116484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100739, U01DK085525, U01DK085527, K08DK096048, R01DK068326, U01DK085547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015] Funding Source: NIH RePORTER	CIRM MD Scholar Fellowships; AHA Postdoctoral Fellowship(American Heart Association); Cancer Research Institute Irvington Fellowship; Burroughs Wellcome Fund CAMS(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Fund for Cancer Research; Intestinal Stem Cell Consortium - NIDDK; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HHMI(Howard Hughes Medical Institute); Stinehart/Reed Foundation; AHA Innovative Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to members of the Kuo laboratory, G. Struhl, R. Nusse, L. O'Brien, D. Bouley, J. Carrington and H. Clevers for discussions, R. Nusse for WNT3A-expressing cells and FZD8 CRD cDNA and S. Robine for Villin-creER mice. We thank the Stanford Histology, Functional Genomics, Confocal, Neuroscience Imaging and Stanford Shared FACS Facility Cores. This work was supported by CIRM MD Scholar Fellowships (K.S.Y. and A.O), an AHA Postdoctoral Fellowship (J.C.), a Cancer Research Institute Irvington Fellowship (V.S.L.), Burroughs Wellcome Fund CAMS (K.S.Y.), NIH K08DK096048 (K.S.Y.), NIH K08DK100739 (A.H.), NIH K99CA204738 (V.S.L.), and the Ludwig Fund for Cancer Research (C.J.K., K.C.G.). C.J.K., P.D., R.J.F., S.J.H. and M.W. were supported by the Intestinal Stem Cell Consortium (NIH U01DK085527, U01DK085547, U01DK085525), which was funded by the NIDDK and NIAID. K.C.G. was supported by HHMI, the Stinehart/Reed Foundation, and NIH R01GM097015 and C.J.K. by an AHA Innovative Science Award and NIH U01CA176299, U19AI116484 and U01CA151920.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janda C. Y., NATURE; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Storm EE, 2016, NATURE, V529, P97, DOI 10.1038/nature16466; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	43	223	238	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					238	+		10.1038/nature22313	http://dx.doi.org/10.1038/nature22313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467820	Green Accepted, Green Submitted			2022-12-28	WOS:000400963800037
J	Etemadi, A; Sinha, R; Ward, MH; Graubard, BI; Inoue-Choi, M; Dawsey, SM; Abnet, CC				Etemadi, Arash; Sinha, Rashmi; Ward, Mary H.; Graubard, Barry I.; Inoue-Choi, Maki; Dawsey, Sanford M.; Abnet, Christian C.			Mortality from different causes associated with meat, heme iron, nitrates, and nitrites in the NIH-AARP Diet and Health Study: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS MARKERS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; POOLED ANALYSIS; RED MEAT; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; LIVER-DISEASE; CURED MEATS	OBJECTIVE To determine the association of different types of meat intake and meat associated compounds with overall and cause specific mortality. DESIGN Population based cohort study. SETTING Baseline dietary data of the NIH-AARP Diet and Health Study (prospective cohort of the general population from six states and two metropolitan areas in the US) and 16 year follow-up data until 31 December 2011. PARTICIPANTS 536 969 AARP members aged 50-71 at baseline. EXPOSURES Intake of total meat, processed and unprocessed red meat (beef, lamb, and pork) and white meat (poultry and fish), heme iron, and nitrate/nitrite from processed meat based on dietary questionnaire. Adjusted Cox proportional hazards regression models were used with the lowest fifth of calorie adjusted intakes as reference categories. MAIN OUTCOME MEASURE Mortality from any cause during follow-up. RESULTS An increased risk of all cause mortality (hazard ratio for highest versus lowest fifth 1.26, 95% confidence interval 1.23 to 1.29) and death due to nine different causes associated with red meat intake was observed. Both processed and unprocessed red meat intakes were associated with all cause and cause specific mortality. Heme iron and processed meat nitrate/ nitrite were independently associated with increased risk of all cause and cause specific mortality. Mediation models estimated that the increased mortality associated with processed red meat was influenced by nitrate intake (37.0-72.0%) and to a lesser degree by heme iron (20.9-24.1%). When the total meat intake was constant, the highest fifth of white meat intake was associated with a 25% reduction in risk of all cause mortality compared with the lowest intake level. Almost all causes of death showed an inverse association with white meat intake. CONCLUSIONS The results show increased risks of all cause mortality and death due to nine different causes associated with both processed and unprocessed red meat, accounted for, in part, by heme iron and nitrate/nitrite from processed meat. They also show reduced risks associated with substituting white meat, particularly unprocessed white meat.	[Etemadi, Arash; Sinha, Rashmi; Ward, Mary H.; Graubard, Barry I.; Inoue-Choi, Maki; Dawsey, Sanford M.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Etemadi, A (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20850 USA.	arash.etemadi@nih.gov	Abnet, Christian C/C-4111-2015; Etemadi, Arash/Y-7082-2018; Inoue-Choi, Maki/K-6001-2016	Abnet, Christian C/0000-0002-3008-7843; Etemadi, Arash/0000-0002-3458-1072; Inoue-Choi, Maki/0000-0002-0070-7829	Intramural Research Program in the Division of Cancer Epidemiology and Genetics, the US National Institutes of Health (NIH), National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	Intramural Research Program in the Division of Cancer Epidemiology and Genetics, the US National Institutes of Health (NIH), National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program in the Division of Cancer Epidemiology and Genetics, the US National Institutes of Health (NIH), National Cancer Institute (NCI). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or the decision to submit the manuscript for publication.	Abete I, 2014, BRIT J NUTR, V112, P762, DOI 10.1017/S000711451400124X; Ananthakrishnan AN, 2015, CANCER EPIDEM BIOMAR, V24, P198, DOI 10.1158/1055-9965.EPI-14-0897; Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148; Bingham SA, 2002, J NUTR, V132, p3522S, DOI 10.1093/jn/132.11.3522S; BONNETT R, 1975, J CHEM SOC CHEM COMM, P884, DOI 10.1039/c39750000884; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cross Amanda J, 2012, Food Nutr Sci, V3, P905; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; Daniel CR, 2011, CANCER PREV RES, V4, P1903, DOI 10.1158/1940-6207.CAPR-11-0241; Fang X, 2015, NUTR METAB CARDIOVAS, V25, P24, DOI 10.1016/j.numecd.2014.09.002; Fletcher MT, 2009, J AGR FOOD CHEM, V57, P311, DOI 10.1021/jf8026099; Freedman ND, 2010, J NATL CANCER I, V102, P1354, DOI 10.1093/jnci/djq301; Groot MJ, 2002, J VET MED A, V49, P466, DOI 10.1046/j.1439-0442.2002.00477.x; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; Gueraud F, 2015, FREE RADICAL BIO MED, V83, P192, DOI 10.1016/j.freeradbiomed.2015.02.023; Habermeyer M, 2015, MOL NUTR FOOD RES, V59, P106, DOI 10.1002/mnfr.201400286; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hopps E, 2010, NUTR METAB CARDIOVAS, V20, P72, DOI 10.1016/j.numecd.2009.06.002; Hughes R, 2001, CARCINOGENESIS, V22, P199, DOI 10.1093/carcin/22.1.199; Inoue-Choi M, 2016, PUBLIC HEALTH NUTR, V19, P1934, DOI 10.1017/S1368980015003407; Inoue-Choi M, 2015, INT J CANCER, V137, P173, DOI 10.1002/ijc.29365; Jiang R, 2008, AM J CLIN NUTR, V87, P1002, DOI 10.1093/ajcn/87.4.1002; Jones RR, 2016, ENVIRON HEALTH PERSP, V124, P1751, DOI 10.1289/EHP191; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Larsson SC, 2014, AM J EPIDEMIOL, V179, P282, DOI 10.1093/aje/kwt261; Lee JE, 2013, AM J CLIN NUTR, V98, P1032, DOI 10.3945/ajcn.113.062638; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Lloyd J, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6601a5; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Micha R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-136; Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; PETO R, 1991, CANCER RES, V51, P6415; Rajpathak S, 2006, DIABETES CARE, V29, P1370, DOI 10.2337/dc06-0119; Ricci G, 2011, NUTRITION, V27, P672, DOI 10.1016/j.nut.2010.07.014; Rohrmann S, 2016, P NUTR SOC, V75, P233, DOI 10.1017/S0029665115004255; Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63; Romeu M, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-102; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schottker B, 2016, AGE AGEING, V45, P127, DOI 10.1093/ageing/afv159; Schottker B, 2015, J GERONTOL A-BIOL, V70, P518, DOI 10.1093/gerona/glu111; Singh PN, 2003, AM J CLIN NUTR, V78, p526S, DOI 10.1093/ajcn/78.3.526S; Sinha R, 2005, MOL NUTR FOOD RES, V49, P648, DOI 10.1002/mnfr.200500018; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Spencer EA, 2010, CANCER CAUSE CONTROL, V21, P1417, DOI 10.1007/s10552-010-9569-7; Tang YP, 2011, CURR OPIN LIPIDOL, V22, P11, DOI 10.1097/MOL.0b013e328341942c; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Varraso R, 2007, AM J EPIDEMIOL, V166, P1438, DOI 10.1093/aje/kwm235; WADE RS, 1990, CHEM RES TOXICOL, V3, P289, DOI 10.1021/tx00016a002; Wang XY, 2016, BRIT J NUTR, V116, P1188, DOI 10.1017/S000711451600297X; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; Yang W, 2014, EUR J NUTR, V53, P395, DOI 10.1007/s00394-013-0535-5; Yen ST, 2008, FOOD POLICY, V33, P631, DOI 10.1016/j.foodpol.2008.02.006; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215	61	147	150	2	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2017	357								j1957	10.1136/bmj.j1957	http://dx.doi.org/10.1136/bmj.j1957			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UA	28487287	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000401169100003
J	Mickley, GA				Mickley, G. Andrew			Completing a career	SCIENCE			English	Editorial Material									[Mickley, G. Andrew] Baldwin Wallace Univ, Berea, OH 44017 USA	Baldwin Wallace University	Mickley, GA (corresponding author), Baldwin Wallace Univ, Berea, OH 44017 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					554	554		10.1126/science.356.6337.554	http://dx.doi.org/10.1126/science.356.6337.554			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473592				2022-12-28	WOS:000400545700040
J	Chen, JH; Pelka, K; Hacohen, N				Chen, Jonathan H.; Pelka, Karin; Hacohen, Nir			Heavy Metal Enlightens Tumor Immunity	CELL			English	Editorial Material							CANCER; IMMUNOTHERAPY	A deep understanding of the immune landscape in human cancer is essential for guiding the development of immunotherapy to benefit more patients with long-lasting efficacy. Now, two studies from Lavin et al. and Chevrier et al. employ mass cytometry to study immune infiltrates in lung adenocarcinoma and clear cell renal cell carcinoma, respectively.	[Chen, Jonathan H.; Pelka, Karin; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chen, Jonathan H.; Pelka, Karin; Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Ctr Canc Res, Boston, MA 02114 USA; [Chen, Jonathan H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Hacohen, N (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Canc Res, Boston, MA 02114 USA.	nhacohen@mgh.harvard.edu			NIH/NCI [T32CA207021, 1R01CA208756]; NATIONAL CANCER INSTITUTE [R01CA208756, T32CA207021] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.H.C. is supported by NIH/NCI training grant T32CA207021. K.P. and N.H. are supported by NIH/NCI 1R01CA208756.	Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001	7	5	5	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					567	569		10.1016/j.cell.2017.04.017	http://dx.doi.org/10.1016/j.cell.2017.04.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475889	Bronze, Green Accepted			2022-12-28	WOS:000400560900004
J	Perkel, JM				Perkel, Jeffrey M.			POCKET LABORATORIES	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					119	121		10.1038/545119a	http://dx.doi.org/10.1038/545119a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470200	Bronze			2022-12-28	WOS:000400480400044
J	Rowbotham, SP; Kim, CF				Rowbotham, Samuel P.; Kim, Carla F.			Don't Stop Re-healin'! Cancer as an Ongoing Stem Cell Affair	CELL			English	Editorial Material							PROPAGATING CELLS; CARCINOMA	Tumors have long been suspected of hijacking stem cell mechanisms used for tissue maintenance and repair. Ge et al. now show that skin tumors exhibit merged chromatin profiles from distinct stem cell lineages. This "lineage infidelity'' recreates a state akin to transient wound repair that persists to maintain uncontrolled growth.	[Rowbotham, Samuel P.; Kim, Carla F.] Childrens Hosp Boston, Stem Cell Program, Div Hematol Oncol, Boston, MA 02115 USA; [Rowbotham, Samuel P.; Kim, Carla F.] Childrens Hosp Boston, Stem Cell Program, Div Pulm & Resp Dis, Boston, MA 02115 USA; [Rowbotham, Samuel P.; Kim, Carla F.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Rowbotham, Samuel P.; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Kim, CF (corresponding author), Childrens Hosp Boston, Stem Cell Program, Div Hematol Oncol, Boston, MA 02115 USA.; Kim, CF (corresponding author), Childrens Hosp Boston, Stem Cell Program, Div Pulm & Resp Dis, Boston, MA 02115 USA.; Kim, CF (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Kim, CF (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	carla.kim@childrens.harvard.edu						Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Ge YJ, 2017, CELL, V169, P636, DOI 10.1016/j.cell.2017.03.042; Imielinski M, 2017, CELL, V168, P460, DOI 10.1016/j.cell.2016.12.025; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kim TH, 2016, CELL REP, V16, P2053, DOI 10.1016/j.celrep.2016.07.056; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; White AC, 2011, P NATL ACAD SCI USA, V108, P7425, DOI 10.1073/pnas.1012670108	9	7	6	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					563	565		10.1016/j.cell.2017.04.030	http://dx.doi.org/10.1016/j.cell.2017.04.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475887	Bronze			2022-12-28	WOS:000400560900002
J	Buchanan, P				Buchanan, Paul			PATIENT COMMENTARY Redesigning patient centred hospitals: the proof is in the delivery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j2125	10.1136/bmj.j2125	http://dx.doi.org/10.1136/bmj.j2125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468754				2022-12-28	WOS:000400889600010
J	Muhsen, K; Green, MS; Soskolne, V; Neumark, Y				Muhsen, Khitam; Green, Manfred S.; Soskolne, Varda; Neumark, Yehuda			Inequalities in non-communicable diseases between the major population groups in Israel: achievements and challenges	LANCET			English	Article							SELF-RATED HEALTH; FORMER SOVIET-UNION; NATIONAL-HEALTH; LIFE EXPECTANCY; SOCIOECONOMIC INEQUALITIES; SOCIAL DETERMINANTS; BREAST-CANCER; ARAB WOMEN; JEWISH; JEWS	Israel is a high-income country with an advanced health system and universal health-care insurance. Overall, the health status has improved steadily over recent decades. We examined differences in morbidity, mortality, and risk factors for selected non-communicable diseases (NCDs) between subpopulation groups. Between 1975 and 2014, life expectancy in Israel steadily increased and is currently above the average life expectancy for the Organisation for Economic Co-operation and Development countries. Nevertheless, life expectancy has remained lower among Israeli Arabs than Israeli Jews, and this gap has recently widened. Age-adjusted mortality as a result of heart disease, stroke, or diabetes remains higher in Arabs, whereas age-adjusted incidence and mortality of cancer were higher among Jews. The prevalence of obesity and low physical activity in Israel is considerably higher among Arabs than Jews. Smoking prevalence is highest for Arab men and lowest for Arab women. Health inequalities are also evident by the indicators of socioeconomic position and in subpopulations, such as immigrants from the former Soviet Union, ultra-Orthodox Jews, and Bedouin Arabs. Despite universal health coverage and substantial improvements in the overall health of the Israeli population, substantial inequalities in NCDs persist. These differences might be explained, at least in part, by gaps in social determinants of health. The Ministry of Health has developed comprehensive programmes to reduce these inequalities between the major population groups. Sustained coordinated multisectoral efforts are needed to achieve a greater impact and to address other social inequalities.	[Muhsen, Khitam] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Green, Manfred S.] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Soskolne, Varda] Bar Ilan Univ, Sch Social Work, Ramat Gan, Israel; [Neumark, Yehuda] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Haifa; Bar Ilan University; Hebrew University of Jerusalem; Hadassah University Medical Center	Muhsen, K (corresponding author), Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	kmuhsen@post.tau.ac.il	Neumark, Yehuda/AAB-1310-2022	Green, Manfred S./0000-0002-9753-5612; Soskolne, Varda/0000-0002-1390-3335; Muhsen, Khitam/0000-0003-1086-7559				Abdul-Ghani MA, 2005, ISR MED ASSOC J, V7, P143; Abinader EG, 2000, ISR MED ASSOC J, V2, P274; Abu-Saad K, 2014, AM J HYPERTENS, V27, P1511, DOI 10.1093/ajh/hpu081; Abu-Saad K, 2012, J NUTR, V142, P2175, DOI 10.3945/jn.112.166611; Atzmon I, 2017, J RELIG HEALTH, V56, P741, DOI 10.1007/s10943-014-9973-5; Averbuch E, 2015, COPING HLTH INEQUALI; Balicer RD, 2015, HEALTH SERV RES, V50, P1891, DOI 10.1111/1475-6773.12300; Baron-Epel O, 2005, ISR MED ASSOC J, V7, P694; Baron-Epel O, 2005, SOC SCI MED, V61, P1256, DOI 10.1016/j.socscimed.2005.01.022; Baron-Epel O, 2004, EUR J PUBLIC HEALTH, V14, P384, DOI 10.1093/eurpub/14.4.384; Baron-Epel O, 2015, SUBST USE MISUSE, V50, P268, DOI 10.3109/10826084.2014.962051; Baron-Epel O, 2009, SOC SCI MED, V69, P1460, DOI 10.1016/j.socscimed.2009.08.028; Benyamini Y, 2014, WOMEN HEALTH, V54, P402, DOI 10.1080/03630242.2014.897679; BLANE D, 1995, AM J PUBLIC HEALTH, V85, P903, DOI 10.2105/AJPH.85.7.903; Blumenfeld O, 2014, PEDIATR DIABETES, V15, P422, DOI 10.1111/pedi.12101; Burck L, 2008, CHARACTERIZATION CLA; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Chernichovsky D, 2015, ASS SOCIAL CAPITAL H; Chodick G, 2008, CLIN THER, V30, P2167, DOI 10.1016/j.clinthera.2008.11.012; Clarfield AM, 2017, LANCET; Dankner R, 2015, EUR J PREV CARDIOL, V22, P1121, DOI 10.1177/2047487314548815; Dankner R, 2009, AGE AGEING, V38, P56, DOI 10.1093/ageing/afn218; Daoud N, 2009, EUR J PUBLIC HEALTH, V19, P477, DOI 10.1093/eurpub/ckp080; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dwolatzky T, 2017, LANCET; FRASER D, 1990, EUR J EPIDEMIOL, V6, P273, DOI 10.1007/BF00150432; Gendler Yulia, 2012, Harefuah, V151, P511; Gotsman I, 2015, EUR J HEART FAIL, V17, P801, DOI 10.1002/ejhf.285; Gross B, 2011, CEREBROVASC DIS, V31, P506, DOI 10.1159/000324527; Gurovich N., 2004, ULTRAORTHODOX JEWS G; Hayek S, 2017, J WOMENS HEALTH, V26, P159, DOI 10.1089/jwh.2016.5835; Hilmi A, 2013, ISR MED ASSOC J, V15, P267; Horev T, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0077-4; Israel Center for Disease Control, 2004, TRENDS INC MORT 1982; Israel Central Bureau of Statistics, 2015, STAT ABSTR ISR; Israel Central Bureau of Statistics and Ministry of Health, 2015, SOC HLTH PROF CIT TO; Israel National Insurance Institute, 2015, 2014 POV REP; Isralowitz Richard, 2014, J Ethn Subst Abuse, V13, P179, DOI 10.1080/15332640.2013.853016; Jaffe DH, 2005, ANN EPIDEMIOL, V15, P804, DOI 10.1016/j.annepidem.2004.09.014; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Kalter-Leibovici O, 2007, ISR MED ASSOC J, V9, P525; Kaluski DN, 2005, OBES REV, V6, P115, DOI 10.1111/j.1467-789X.2005.00168.x; Keinan-Boker L, 2005, ISR MED ASSOC J, V7, P219; Keinan-Boker L, 2013, EUR J CANCER PREV, V22, P112, DOI 10.1097/CEJ.0b013e3283581d3c; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Khattab N, 2011, HLTH INEQUALITY ARAB; Kopel E, 2013, NICOTINE TOB RES, V15, P562, DOI 10.1093/ntr/nts139; Kranzler Y, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-16; Kurman J, 2004, J CROSS CULT PSYCHOL, V35, P192, DOI 10.1177/0022022103262244; Lazarev I, 2014, ASIAN PAC J CANCER P, V15, P7533, DOI 10.7314/APJCP.2014.15.18.7533; Leiba A, 2013, J UROLOGY, V189, P25, DOI 10.1016/j.juro.2012.08.184; Leiba M, 2014, LEUKEMIA LYMPHOMA, V55, P2290, DOI 10.3109/10428194.2013.871276; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Ministry of Health, 2015, MIN HLTH REP SMOK IS; Ministry of Health Israel, CANC INC; Na'amnih W, 2010, INT J EPIDEMIOL, V39, P1324, DOI 10.1093/ije/dyq073; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Neumark YD, 2009, EPIDEMIOLOGY MENTAL, P131; OECD iLibrary, 2015, TACKL HARMF ALC US E; Organisation for Economic Co-operation and Development (OECD), 2015, IND IMM INT 2015; Ott JJ, 2009, B WORLD HEALTH ORGAN, V87, P20, DOI 10.2471/BLT.07.045138; PORATH A, 1995, INT J QUAL HEALTH C, V7, P281, DOI 10.1093/intqhc/7.3.281; Reges O, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000097; Reges O, 2015, EUR J PREV CARDIOL, V22, P458, DOI 10.1177/2047487314520924; Saabneh AM, 2016, EUR J PUBLIC HEALTH, V26, P433, DOI 10.1093/eurpub/ckv211; Sagar AD, 1998, ECOL ECON, V25, P249, DOI 10.1016/S0921-8009(97)00168-7; Salameh Shaden, 2008, J Cardiometab Syndr, V3, P26, DOI 10.1111/j.1559-4572.2008.07315.x; Shmueli A, 2007, ISR MED ASSOC J, V9, P703; Soskolne V, 2010, HEALTH PLACE, V16, P242, DOI 10.1016/j.healthplace.2009.10.005; Tirosh A, 2008, AM J MED QUAL, V23, P60, DOI 10.1177/1062860607307998; Vinker S, 2008, EXPERT OPIN PHARMACO, V9, P1271, DOI 10.1517/14656566.9.8.1271 ; Whitehead M., 2014, EQUITY ACTION SPECTR; YITZHAKI S, 1983, INT ECON REV, V24, P617, DOI 10.2307/2648789; Zucker I, 2016, J IMMIGR MINOR HEALT, V18, P1328, DOI 10.1007/s10903-016-0341-2	77	59	59	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2531	2541		10.1016/S0140-6736(17)30574-3	http://dx.doi.org/10.1016/S0140-6736(17)30574-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495112				2022-12-28	WOS:000403901800031
J	Kilpinen, H; Goncalves, A; Leha, A; Afzal, V; Alasoo, K; Ashford, S; Bala, S; Bensaddek, D; Casale, FP; Ulley, OJC; Danecek, P; Faulconbridge, A; Harrison, PW; Kathuria, A; McCarthy, D; McCarthy, SA; Meleckyte, R; Memari, Y; Moens, N; Soares, F; Mann, A; Streeter, I; Agu, CA; Alderton, A; Nelson, R; Harper, S; Patel, M; White, A; Patel, SR; Clarke, L; Halai, R; Kirton, CM; Kolb-Kokocinski, A; Beales, P; Birney, E; Danovi, D; Lamond, AI; Ouwehand, WH; Vallier, L; Watt, FM; Durbin, R; Stegle, O; Gaffney, DJ				Kilpinen, Helena; Goncalves, Angela; Leha, Andreas; Afzal, Vackar; Alasoo, Kaur; Ashford, Sofie; Bala, Sendu; Bensaddek, Dalila; Casale, Francesco Paolo; Ulley, Oliver J. C.; Danecek, Petr; Faulconbridge, Adam; Harrison, Peter W.; Kathuria, Annie; McCarthy, Davis; McCarthy, Shane A.; Meleckyte, Ruta; Memari, Yasin; Moens, Nathalie; Soares, Filipa; Mann, Alice; Streeter, Ian; Agu, Chukwuma A.; Alderton, Alex; Nelson, Rachel; Harper, Sarah; Patel, Minal; White, Alistair; Patel, Sharad R.; Clarke, Laura; Halai, Reena; Kirton, Christopher M.; Kolb-Kokocinski, Anja; Beales, Philip; Birney, Ewan; Danovi, Davide; Lamond, Angus I.; Ouwehand, Willem H.; Vallier, Ludovic; Watt, Fiona M.; Durbin, Richard; Stegle, Oliver; Gaffney, Daniel J.			Common genetic variation drives molecular heterogeneity in human iPSCs	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GENOME-WIDE ASSOCIATION; CANCER RISK LOCI; SUSCEPTIBILITY LOCI; COPY NUMBER; BREAST-CANCER; DNA METHYLATION; MULTIPLE COMMON; CELIAC-DISEASE; EXPRESSION	Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potential to provide improved cellular models of human disease. However, variable genetic and phenotypic characterization of many existing iPS cell lines limits their potential use for research and therapy. Here we describe the systematic generation, genotyping and phenotyping of 711 iPS cell lines derived from 301 healthy individuals by the Human Induced Pluripotent Stem Cells Initiative. Our study outlines the major sources of genetic and phenotypic variation in iPS cells and establishes their suitability as models of complex human traits and cancer. Through genome-wide profiling we find that 5-46% of the variation in different iPS cell phenotypes, including differentiation capacity and cellular morphology, arises from differences between individuals. Additionally, we assess the phenotypic consequences of genomic copy-number alterations that are repeatedly observed in iPS cells. In addition, we present a comprehensive map of common regulatory variants affecting the transcriptome of human pluripotent cells.	[Kilpinen, Helena; Casale, Francesco Paolo; Faulconbridge, Adam; Harrison, Peter W.; McCarthy, Davis; Streeter, Ian; Clarke, Laura; Birney, Ewan; Stegle, Oliver] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Goncalves, Angela; Leha, Andreas; Alasoo, Kaur; Bala, Sendu; Danecek, Petr; McCarthy, Shane A.; Memari, Yasin; Mann, Alice; Agu, Chukwuma A.; Alderton, Alex; Nelson, Rachel; Harper, Sarah; Patel, Minal; White, Alistair; Patel, Sharad R.; Halai, Reena; Kirton, Christopher M.; Kolb-Kokocinski, Anja; Ouwehand, Willem H.; Vallier, Ludovic; Durbin, Richard; Gaffney, Daniel J.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Afzal, Vackar; Bensaddek, Dalila] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland; [Ashford, Sofie; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge CB2 0XY, England; [Kathuria, Annie; Meleckyte, Ruta; Moens, Nathalie; Danovi, Davide; Watt, Fiona M.] Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, Tower Wing, London SE1 9RT, England; [McCarthy, Davis] St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [Soares, Filipa; Vallier, Ludovic] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England; [Soares, Filipa; Vallier, Ludovic] Univ Cambridge, Biomed Res Ctr, Anne McLaren Lab, Dept Surg, Cambridge CB2 0SZ, England; [Kilpinen, Helena; Beales, Philip] UCL, Inst Child Hlth, UCL Great Ormond St, London WC1N 1EH, England; [Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge Biomed Campus, Cambridge CB2 0PT, England; [Leha, Andreas] Univ Med Ctr Groningen, Dept Med Stat, Humboldtallee 32, D-37073 Gottingen, Germany	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Dundee; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; St. Vincent's Institute of Medical Research; University of Cambridge; University of Cambridge; University of London; University College London; University of Gottingen	Stegle, O (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Durbin, R; Gaffney, DJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Watt, FM (corresponding author), Kings Coll London, Guys Hosp, Ctr Stem Cells & Regenerat Med, Tower Wing, London SE1 9RT, England.	fiona.watt@kcl.ac.uk; rd@sanger.ac.uk; stegle@ebi.ac.uk; dg13@sanger.ac.uk	Stegle, Oliver/AAU-9177-2020; Leha, Andreas/W-9774-2019; Durbin, Richard/AAE-7178-2019; Alasoo, Kaur/H-7082-2019; Beales, Philip L/C-7367-2009; Danovi, Davide/P-2874-2019; Watt, Fiona/AHB-0226-2022; McCarthy, Davis James/B-5332-2018	Stegle, Oliver/0000-0002-8818-7193; Durbin, Richard/0000-0002-9130-1006; Alasoo, Kaur/0000-0002-1761-8881; Danovi, Davide/0000-0003-4119-5337; Watt, Fiona/0000-0001-9151-5154; McCarthy, Davis James/0000-0002-2218-6833; Mann, Alice/0000-0003-2402-8545; Clarke, Laura/0000-0002-5989-6898; Culley, Oliver/0000-0002-6765-9390; Faulconbridge, Adam/0000-0002-4733-3270; Patel, Sharad/0000-0003-3859-1080; Vallier, Ludovic/0000-0002-3848-2602; Birney, Ewan/0000-0001-8314-8497; Kilpinen, Helena/0000-0001-6692-6154; Gaffney, Daniel/0000-0002-1529-1862; Agu, Chukwuma/0000-0002-8368-4457; Harrison, Peter/0000-0002-4007-2899	Wellcome Trust [WT090851]; UK Medical Research Council [WT098503]; MRC eMedLab Medical Bioinformatics career development award from the UK Medical Research Council [MR/L016311/1]; Department of Health via the NIHR Biomedical Research Centre; Biotechnology and Biological Sciences Research Council [BB/M020991/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [TS/H001220/1] Funding Source: researchfish; Medical Research Council [MC_PC_12026, 1365667, G0801843, MC_PC_12009] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10151, NF-SI-0513-10008] Funding Source: researchfish; The British Council [216377911] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1296] Funding Source: researchfish; Fight for Sight [1848/49] Funding Source: researchfish; BBSRC [BB/M020991/1] Funding Source: UKRI; EPSRC [TS/H001220/1] Funding Source: UKRI; MRC [G0801843, MC_PC_12026] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC eMedLab Medical Bioinformatics career development award from the UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the NIHR Biomedical Research Centre; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The British Council; Great Ormond Street Hospital Childrens Charity; Fight for Sight; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded with a strategic award from the Wellcome Trust and UK Medical Research Council (WT098503). We thank the staff in the Cellular Genetics and Phenotyping and Sequencing core facilities at the Wellcome Trust Sanger Institute. Work at the Wellcome Trust Sanger Institute was further supported by Wellcome Trust grant WT090851. H.K. is supported by a MRC eMedLab Medical Bioinformatics career development award from the UK Medical Research Council (MR/L016311/1). F.M.W. acknowledges financial support from the Department of Health via the NIHR Biomedical Research Centre award to Guy's & St Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We acknowledge the participation of all NIHR Cambridge BioResource volunteers, and thank the NIHR Cambridge BioResource centre staff for their contribution. We thank the National Institute for Health Research and NHS Blood and Transplant. The NIHR/Wellcome Trust Cambridge Clinical Research Facility supported the volunteer recruitment. We acknowledge Life Science Technologies Corporation as the provider of Cytotune. We thank F.-J. Muller for insights regarding the PluriTest method, and the GTEx consortium for making raw data and intermediate results available.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Belinky Frida, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav006; Bensaddek D, 2016, PROTEOMICS, V16, P381, DOI 10.1002/pmic.201500264; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Burrows CK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005793; Cannavo E, 2017, NATURE, V541, P402, DOI 10.1038/nature20802; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Chen QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105393; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danecek P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155014; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DeBoever C, 2017, CELL STEM CELL, V20, P533, DOI 10.1016/j.stem.2017.03.009; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kyttala A, 2016, STEM CELL REP, V6, P200, DOI 10.1016/j.stemcr.2015.12.009; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328; Leha A, 2016, METHODS, V96, P85, DOI 10.1016/j.ymeth.2015.11.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417; Lippert C., 2014, PREPRINT; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lo JY, 2015, EXP BIOL MED, V240, P383, DOI 10.1177/1535370214566747; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Pers TH, 2015, BIOINFORMATICS, V31, P418, DOI 10.1093/bioinformatics/btu655; Purrington KS, 2014, CARCINOGENESIS, V35, P1012, DOI 10.1093/carcin/bgt404; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Spies N, 2015, ELIFE, V4, DOI 10.7554/eLife.05538; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Xu HL, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat045; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang XF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-244	93	267	273	7	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2017	546	7658					370	+		10.1038/nature22403	http://dx.doi.org/10.1038/nature22403			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5BK	28489815	Green Submitted, Green Accepted			2022-12-28	WOS:000403250900027
J	Zhang, HN; Qiao, AN; Yang, DH; Yang, LL; Dai, AT; De Graaf, C; Reedtz-Runge, S; Dharmarajan, V; Zhang, H; Han, GW; Grant, TD; Sierra, RG; Weierstall, U; Nelson, G; Liu, W; Wu, YH; Ma, LM; Cai, XQ; Lin, GY; Wu, XA; Geng, Z; Dong, YH; Song, GJ; Griffin, PR; Lau, J; Chrezov, V; Yang, HY; Hanson, MA; Stevens, RC; Zhao, Q; Jiang, HL; Wang, MW; Wu, BL				Zhang, Haonan; Qiao, Anna; Yang, Dehua; Yang, Linlin; Dai, Antao; De Graaf, Chris; Reedtz-Runge, Steffen; Dharmarajan, Venkatasubramanian; Zhang, Hui; Han, Gye Won; Grant, Thomas D.; Sierra, Raymond G.; Weierstall, Uwe; Nelson, Garrett; Liu, Wei; Wu, Yanhong; Ma, Limin; Cai, Xiaoqing; Lin, Guangyao; Wu, Xiaoai; Geng, Zhi; Dong, Yuhui; Song, Gaojie; Griffin, Patrick R.; Lau, Jesper; Chrezov, Vadim; Yang, Huaiyu; Hanson, Michael A.; Stevens, Raymond C.; Zhao, Qiang; Jiang, Hualiang; Wang, Ming-Wei; Wu, Beili			Structure of the full-length glucagon class B G-protein-coupled receptor	NATURE			English	Article							SERIAL FEMTOSECOND CRYSTALLOGRAPHY; CORTICOTROPIN-RELEASING-FACTOR; LIPIDIC CUBIC PHASE; EXTRACELLULAR DOMAINS; DRUG DISCOVERY; BINDING-SITE; LIGAND; REFINEMENT; VALIDATION; SOFTWARE	The human glucagon receptor, GCGR, belongs to the class B G-protein-coupled receptor family and plays a key role in glucose homeostasis and the pathophysiology of type 2 diabetes. Here we report the 3.0 angstrom crystal structure of full-length GCGR containing both the extracellular domain and transmembrane domain in an inactive conformation. The two domains are connected by a 12-residue segment termed the stalk, which adopts a beta-strand conformation, instead of forming an alpha-helix as observed in the previously solved structure of the GCGR transmembrane domain. The first extracellular loop exhibits a beta-hairpin conformation and interacts with the stalk to form a compact beta-sheet structure. Hydrogen-deuterium exchange, disulfide crosslinking and molecular dynamics studies suggest that the stalk and the first extracellular loop have critical roles in modulating peptide ligand binding and receptor activation. These insights into the full-length GCGR structure deepen our understanding of the signalling mechanisms of class B G-protein-coupled receptors.	[Zhang, Haonan; Qiao, Anna; Yang, Dehua; Dai, Antao; Zhang, Hui; Wu, Yanhong; Ma, Limin; Cai, Xiaoqing; Lin, Guangyao; Zhao, Qiang; Jiang, Hualiang; Wang, Ming-Wei; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhang, Haonan; Qiao, Anna; Zhang, Hui; Wu, Yanhong; Lin, Guangyao; Zhao, Qiang; Wu, Beili] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Dehua; Dai, Antao; Cai, Xiaoqing; Lin, Guangyao; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [Yang, Linlin] Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, 100 Sci Ave, Zhengzhou 450001, Peoples R China; [De Graaf, Chris] Vrije Univ Amsterdam, AIMMS, Fac Sci, Div Med Chem, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Dharmarajan, Venkatasubramanian; Lau, Jesper] Novo Nordisk AS, Novo Nordisk Pk, DK-2760 Malov, Denmark; [Dharmarajan, Venkatasubramanian; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Med, 130 Scripps Way, Jupiter, FL 33458 USA; [Han, Gye Won; Chrezov, Vadim] Univ Southern Calif, Dept Chem, Bridge Inst, 3430 S Vermont Ave, Los Angeles, CA 90089 USA; [Grant, Thomas D.] SUNY Buffalo, Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA; [Sierra, Raymond G.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Weierstall, Uwe; Nelson, Garrett] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Liu, Wei] Arizona State Univ, Biodesign Inst, Sch Mol Sci, Biodesign Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Wu, Yanhong; Lin, Guangyao; Stevens, Raymond C.; Wang, Ming-Wei; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China; [Wu, Xiaoai] Novo Nordisk Res Ctr China, 20 Life Sci Pk Rd, Beijing 102206, Peoples R China; [Geng, Zhi; Dong, Yuhui] Chinese Acad Sci, Beijing Synchrotron Radiat Facil, Inst High Energy Phys, Beijing 100049, Peoples R China; [Song, Gaojie; Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China; [Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Zhao, Qiang; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Zhao, Qiang; Wu, Beili] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhengzhou University; Vrije Universiteit Amsterdam; Novo Nordisk; Scripps Research Institute; University of Southern California; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; ShanghaiTech University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Fudan University	Jiang, HL; Wang, MW; Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Wu, BL (corresponding author), Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Wang, MW; Wu, BL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 393 Hua Xia Zhong Rd, Shanghai 201210, Peoples R China.; Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Wu, BL (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China.; Wang, MW (corresponding author), Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.	hljiang@simm.ac.cn; mwwang@simm.ac.cn; beiliwu@simm.ac.cn	Yang, Dehua/M-5789-2019; Lau, Jesper/G-3834-2011; Liu, Wei/F-1820-2011; Han, Gye Won/GLT-1531-2022; Cherezov, Vadim/L-9812-2013; Grant, Thomas/T-2921-2019; Han, Gye Won/GLQ-8724-2022; Stevens, Raymond/K-7272-2015; Grant, Thomas/GXH-9990-2022; Han, Gye Won/GLQ-8673-2022; Yang, Dehua/S-6156-2017; de Graaf, Chris/J-8549-2017	Cherezov, Vadim/0000-0002-5265-3914; Grant, Thomas/0000-0002-8583-3700; Han, Gye Won/0000-0003-4107-835X; Stevens, Raymond/0000-0002-4522-8725; Grant, Thomas/0000-0002-8583-3700; Geng, Zhi/0000-0002-5764-6190; Dong, Yuhui/0000-0002-4422-4685; de Graaf, Chris/0000-0002-1226-2150	National Basic Research Program of China [2014CB910400, 2015CB910304]; CAS Strategic Priority Research Program [XDB08020000]; CAS [QYZDB-SSW-SMC024]; National Science Foundation of China [31422017, 81525024, 81230076, 81573479]; National Health and Family Planning Commission [2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600]; National Institutes of Health [R01 GM108635, R21 DA042298, P41GM103393]; National Science Foundation STC award [1231306]; GPCR Consortium; Shanghai local government; Netherlands eScience Center (NLeSC)/NWO (Enabling Technologies project: 3D-e-Chem) [027.014.201]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM108635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA042298] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); CAS Strategic Priority Research Program; CAS(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission; Shanghai Science and Technology Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation STC award(National Science Foundation (NSF)); GPCR Consortium; Shanghai local government; Netherlands eScience Center (NLeSC)/NWO (Enabling Technologies project: 3D-e-Chem); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Basic Research Program of China grants 2014CB910400 (B.W.) and 2015CB910304 (H.J.), CAS Strategic Priority Research Program XDB08020000 and CAS grant QYZDB-SSW-SMC024 (B.W.), the National Science Foundation of China grants 31422017 (B.W.), 81525024 (Q.Z.), 81230076 (H.J.) and 81573479 (D.Y.), the National Health and Family Planning Commission grants 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001 and 2013ZX09507-002 (M.-W.W.), Shanghai Science and Technology Development Fund 15DZ2291600 (M.-W.W.), the National Institutes of Health grants R01 GM108635 (V.C.) and R21 DA042298 (W.L.), the National Science Foundation STC award 1231306 (G.N., U.W., W.L., T.D.G., V.C.), the GPCR Consortium (B.W., G.S., R.C.S.), Shanghai local government (G.S., R.C.S.), the Netherlands eScience Center (NLeSC)/NWO (Enabling Technologies project: 3D-e-Chem, grant 027.014.201) (C.d.G.), and C.d.G. participates in the European Cooperation in Science and Technology Action CM1207 (GLISTEN). The authors thank A. Walker for assistance with manuscript preparation, Y. Feng and C. Ji for technical assistance, M. Hunter, A. Batyuk, A. Ishchenko, L. Johansson, B. Stauch, M. Audet, M. Liang, M. Seaberg and P. Walter for their help with XFEL data collection, B. Yu for help with mAb1 protein sample preparation, and the special program for applied research on super computation of the NSFC-Guangdong Joint Fund (the second phase). The synchrotron radiation experiments were performed at the BL41XU of SPring-8 with approval of the Japan Synchrotron Radiation Research Institute (proposal no. 2016A2517, 2016A2518, 2016B2517 and 2016B2518). We thank the beamline staff members K. Hasegawa, H. Okumura, and H. Murakami of the BL41XU for help on X-ray data collection. Use of the LCLS, SLAC National Accelerator Laboratory, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. Parts of the sample injector used at LCLS for this research were funded by the National Institutes of Health, P41GM103393, formerly P41RR001209.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Finan B, 2016, CELL, V167, P843, DOI 10.1016/j.cell.2016.09.014; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liang MN, 2015, J SYNCHROTRON RADIAT, V22, P514, DOI 10.1107/S160057751500449X; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Mann R, 2008, MOL PHARMACOL, V74, P605, DOI 10.1124/mol.108.048017; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roberts DJ, 2011, PEPTIDES, V32, P1593, DOI 10.1016/j.peptides.2011.06.009; Siewert F, 2012, OPT EXPRESS, V20, P4525, DOI 10.1364/OE.20.004525; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Song G, 2017, NATURE; Unson CG, 2002, BIOCHEMISTRY-US, V41, P11795, DOI 10.1021/bi025711j; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; White TA, 2013, ACTA CRYSTALLOGR D, V69, P1231, DOI 10.1107/S0907444913013620; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859	44	138	143	10	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					259	+		10.1038/nature22363	http://dx.doi.org/10.1038/nature22363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28514451	Green Accepted			2022-12-28	WOS:000402823400031
J	Chung, S; Weber, F; Zhong, P; Tan, CL; Nguyen, TN; Beier, KT; Hormann, N; Chang, WC; Zhang, Z; Do, JP; Ao, SY; Krashes, MJ; Tasic, B; Cetin, A; Zeng, H; Knight, ZA; Luo, L; Dan, Y				Chung, Shinjae; Weber, Franz; Zhong, Peng; Tan, Chan Lek; Nguyen, Thuc Nghi; Beier, Kevin T.; Hormann, Nikolai; Chang, Wei-Cheng; Zhang, Zhe; Do, Johnny Phong; Ao, Shenqin Y.; Krashes, Michael J.; Tasic, Bosiljka; Cetin, Ali; Zeng, Hongkui; Knight, Zachary A. .; Luo, Liqun; Dan, Yang			Identification of preoptic sleep neurons using retrograde labelling and gene profiling	NATURE			English	Article							GABAERGIC NEURONS; REM-SLEEP; BASAL FOREBRAIN; GALANINERGIC NEURONS; RECOVERY SLEEP; NUCLEUS; CIRCUIT; HYPOTHALAMUS; DEPRIVATION; ACTIVATION	In humans and other mammalian species, lesions in the preoptic area of the hypothalamus cause profound sleep impairment(1-5), indicating a crucial role of the preoptic area in sleep generation. However, the underlying circuit mechanism remains poorly understood. Electrophysiological recordings and c-Fos immunohistochemistry have shown the existence of sleep-active neurons in the preoptic area, especially in the ventrolateral preoptic area and median preoptic nucleus(6-9). Pharmacogenetic activation of c-Fos-labelled sleep-active neurons has been shown to induce sleep(10). However, the sleep-active neurons are spatially intermingled with wake-active neurons(6,7), making it difficult to target the sleep neurons specifically for circuit analysis. Here we identify a population of preoptic area sleep neurons on the basis of their projection target and discover their molecular markers. Using a lentivirus expressing channelrhodopsin-2 or a light-activated chloride channel for retrograde labelling, bidirectional optogenetic manipulation, and optrode recording, we show that the preoptic area GABAergic neurons projecting to the tuberomammillary nucleus are both sleep active and sleep promoting. Furthermore, translating ribosome affinity purification and single-cell RNA sequencing identify candidate markers for these neurons, and optogenetic and pharmacogenetic manipulations demonstrate that several peptide markers (cholecystokinin, corticotropin-releasing hormone, and tachykinin 1) label sleep-promoting neurons. Together, these findings provide easy genetic access to sleep-promoting preoptic area neurons and a valuable entry point for dissecting the sleep control circuit.	[Chung, Shinjae; Weber, Franz; Zhong, Peng; Hormann, Nikolai; Chang, Wei-Cheng; Zhang, Zhe; Do, Johnny Phong; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Tan, Chan Lek; Knight, Zachary A. .] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Nguyen, Thuc Nghi; Ao, Shenqin Y.; Tasic, Bosiljka; Cetin, Ali; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Beier, Kevin T.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Krashes, Michael J.] NIDDKD, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Krashes, Michael J.] NIDA, NIH, Baltimore, MD 21224 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Allen Institute for Brain Science; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Dan, Y (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol,Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Core, Vector/CAF-4832-2022; Krashes, Michael/P-7677-2019	Luo, Liqun/0000-0001-5467-9264; Knight, Zachary/0000-0001-7621-1478; Dan, Yang/0000-0002-3818-877X; Nguyen, Thuc Nghi/0000-0002-6466-5883; Hormann, Nikolai/0000-0002-5952-6889; Zhang, Zhe/0000-0002-0899-8077; Beier, Kevin/0000-0002-4934-1338	Davis Postdoctoral Fellowship; Tourette Syndrome Association; EMBO Long-term Fellowship; Human Frontier Science Program Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK109533, R01DK106399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA041445, F32DA038913] Funding Source: NIH RePORTER	Davis Postdoctoral Fellowship; Tourette Syndrome Association; EMBO Long-term Fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Cox, L. Pinto for help with sleep recordings; A. Popescu for help with optrode recordings; C. Ma for help with FISH; D. Leib, C. Zimmerman, and D. Estandian for discussions on TRAP; K. Kao, G. Daly, M. Bikov, F. Virani, and G. Carrillo for technical assistance; and C. Koch for supporting the collaboration with the Allen Institute for Brain Science. This work was supported by a Davis Postdoctoral Fellowship (S.C.), Tourette Syndrome Association Grant (S.C.), EMBO Long-term Fellowship (F.W.), Human Frontier Science Program Fellowship (F.W.), and Howard Hughes Medical Institute (Y.D., L.L.).	Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Cetin A, 2014, J NEUROPHYSIOL, V111, P2150, DOI 10.1152/jn.00495.2013; Economo CV, 1930, J NERV MENT DIS, V71, P249, DOI 10.1097/00005053-193003000-00001; Franklin K. B. J., 2007, MOUSE BRAIN STEREOTA, P31; Gaus SE, 2002, NEUROSCIENCE, V115, P285, DOI 10.1016/S0306-4522(02)00308-1; Gong H, 2004, J PHYSIOL-LONDON, V556, P935, DOI 10.1113/jphysiol.2003.056622; Greco MA, 2008, BRAIN RES, V1245, P96, DOI 10.1016/j.brainres.2008.09.043; Hayashi Y, 2015, SCIENCE, V350, P957, DOI 10.1126/science.aad1023; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Kimura M, 2010, MOL PSYCHIATR, V15, P154, DOI 10.1038/mp.2009.46; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MANSBACH RS, 1983, PHYSIOL BEHAV, V30, P179, DOI 10.1016/0031-9384(83)90002-1; MCGINTY DJ, 1968, SCIENCE, V160, P1253, DOI 10.1126/science.160.3833.1253; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; SALLANON M, 1989, NEUROSCIENCE, V32, P669, DOI 10.1016/0306-4522(89)90289-3; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steininger TL, 2001, J COMP NEUROL, V429, P638; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; Takahashi K, 2009, NEUROSCIENCE, V161, P269, DOI 10.1016/j.neuroscience.2009.02.075; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Van Dort CJ, 2015, P NATL ACAD SCI USA, V112, P584, DOI 10.1073/pnas.1423136112; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143; Zhang GL, 2004, BRAIN RES, V1028, P225, DOI 10.1016/j.brainres.2004.09.017; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhang Z, 2015, NAT NEUROSCI, V18, P553, DOI 10.1038/nn.3957	45	145	147	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					477	+		10.1038/nature22350	http://dx.doi.org/10.1038/nature22350			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514446	Green Submitted, Green Accepted			2022-12-28	WOS:000401906500051
J	Jones, TD; Davies, DR; Campbell, IH; Iaffaldano, G; Yaxley, G; Kramer, SC; Wilson, CR				Jones, T. D.; Davies, D. R.; Campbell, I. H.; Iaffaldano, G.; Yaxley, G.; Kramer, S. C.; Wilson, C. R.			The concurrent emergence and causes of double volcanic hotspot tracks on the Pacific plate	NATURE			English	Article							LEAD ISOTOPES REVEAL; HAWAIIAN PLUME; MANTLE PLUMES; DEEP-MANTLE; ASYMMETRY; BASALT; GEOCHRONOLOGY; GEOCHEMISTRY; VARIABILITY; PYROXENITE	Mantle plumes are buoyant upwellings of hot rock that transport heat from Earth's core to its surface, generating anomalous regions of volcanism that are not directly associated with plate tectonic processes. The best-studied example is the Hawaiian-Emperor chain, but the emergence of two sub-parallel volcanic tracks along this chain(1), Loa and Kea, and the systematic geochemical differences between them(2,3) have remained unexplained. Here we argue that the emergence of these tracks coincides with the appearance of other double volcanic tracks on the Pacific plate and a recent azimuthal change in the motion of the plate. We propose a three-part model that explains the evolution of Hawaiian double-track volcanism: first, mantle flow beneath the rapidly moving Pacific plate strongly tilts the Hawaiian plume and leads to lateral separation between high- and low-pressure melt source regions; second, the recent azimuthal change in Pacific plate motion exposes high- and low-pressure melt products as geographically distinct volcanoes, explaining the simultaneous emergence of double-track volcanism across the Pacific; and finally, secondary pyroxenite, which is formed as eclogite melt reacts with peridotite(4), dominates the low-pressure melt region beneath Loa-track volcanism, yielding the systematic geochemical differences observed between Loa-and Kea-type lavas(3,5-9). Our results imply that the formation of double-track volcanism is transitory and can be used to identify and place temporal bounds on plate-motion changes.	[Jones, T. D.; Davies, D. R.; Campbell, I. H.; Yaxley, G.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Iaffaldano, G.] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Kramer, S. C.] Imperial Coll, Dept Earth Sci & Engn, London, England; [Wilson, C. R.] Columbia Univ, Lamont Doherty Earth Observ, New York, NY USA; [Wilson, C. R.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC USA	Australian National University; University of Copenhagen; Imperial College London; Columbia University; Carnegie Institution for Science	Jones, TD (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	tim.jones@anu.edu.au	Campbell, Ian/A-4941-2008; Jones, Timothy/ABC-7414-2020; Davies, David Rhodri/G-1551-2015; Yaxley, Greg/A-1167-2008	Campbell, Ian/0000-0001-8578-0154; Jones, Timothy/0000-0002-6824-3610; Davies, David Rhodri/0000-0002-7662-9468; Kramer, Stephan/0000-0002-9193-5092; Iaffaldano, Giampiero/0000-0003-1750-1576; Yaxley, Greg/0000-0003-0445-8812	Australian Postgraduate Award [1183a/2010]; ARC [FT140101262, DP170100058]; EPSRC [EP/L000407/1]; National Science Foundation [EAR-1141976, OCE-1358091]; Australian Commonwealth Government	Australian Postgraduate Award(Australian Government); ARC(Australian Research Council); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation(National Science Foundation (NSF)); Australian Commonwealth Government(Australian Government)	T.D.J. is funded by an Australian Postgraduate Award (1183a/2010). D.R.D. is funded by the ARC, under grant numbers FT140101262 and DP170100058. S.C.K is funded by EPSRC grant EP/L000407/1. C.R.W. is funded by the National Science Foundation under grant numbers EAR-1141976 and OCE-1358091. Numerical simulations were undertaken on the NCI National Facility in Canberra, Australia, which is supported by the Australian Commonwealth Government.	Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; Austermann J, 2011, EARTH PLANET SC LETT, V307, P289, DOI 10.1016/j.epsl.2011.04.043; Balay S, 1997, MODERN SOFTWARE TOOLS FOR SCIENTIFIC COMPUTING, P163; Ballmer MD, 2011, NAT GEOSCI, V4, P457, DOI [10.1038/NGEO1187, 10.1038/ngeo1187]; Bianco TA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000945; Chauvel C, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004123; Cheng C., 2015, SEISMIC CONSTRAINTS, P59; Clouard V, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(06); Davies DR, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003551; Fekiacova Z, 2007, EARTH PLANET SC LETT, V261, P65, DOI 10.1016/j.epsl.2007.06.005; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; FREY FA, 1993, PHILOS T R SOC A, V342, P121, DOI 10.1098/rsta.1993.0009; Frey FA, 2016, GEOCHIM COSMOCHIM AC, V185, P160, DOI 10.1016/j.gca.2016.04.010; Garcia M. O., 2015, GEOL SOC AM SPEC PAP, V511; Garcia MO, 2010, J PETROL, V51, P1507, DOI 10.1093/petrology/egq027; GRIFFITHS RW, 1989, GEOPHYS RES LETT, V16, P437, DOI 10.1029/GL016i005p00437; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Harpp KS, 2014, GEOPHYS MONOGR SER, V204, P27; Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; Herzberg C, 2011, J PETROL, V52, P113, DOI 10.1093/petrology/egq075; Hieronymus CF, 1999, NATURE, V397, P604, DOI 10.1038/17584; Hofmann AW, 2013, GEOCHEM GEOPHY GEOSY, V14, P5308, DOI 10.1002/2013GC004942; Huang SC, 2011, NAT GEOSCI, V4, P874, DOI [10.1038/NGEO1263, 10.1038/ngeo1263]; Iaffaldano G, 2014, GEOCHEM GEOPHY GEOSY, V15, P1663, DOI 10.1002/2014GC005309; Iaffaldano G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2051; JACKSON ED, 1975, EARTH PLANET SC LETT, V26, P145, DOI 10.1016/0012-821X(75)90082-5; Jackson MG, 2014, NATURE, V514, P355, DOI 10.1038/nature13794; Jackson MG, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004268; Jones TD, 2016, EARTH PLANET SC LETT, V434, P10, DOI 10.1016/j.epsl.2015.11.016; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; Kramer SC, 2012, PHYS EARTH PLANET IN, V194, P25, DOI 10.1016/j.pepi.2012.01.001; Lambart S, 2016, J GEOPHYS RES-SOL EA, V121, P5708, DOI 10.1002/2015JB012762; Lambart S, 2013, LITHOS, V160, P14, DOI 10.1016/j.lithos.2012.11.018; Norman MD, 1999, EARTH PLANET SC LETT, V168, P27, DOI 10.1016/S0012-821X(99)00043-6; O'Connor JM, 2001, EARTH PLANET SC LETT, V189, P93, DOI 10.1016/S0012-821X(01)00348-X; Payne JA, 2013, GEOLOGY, V41, P19, DOI 10.1130/G33273.1; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; TATSUMOTO M, 1978, EARTH PLANET SC LETT, V38, P63, DOI 10.1016/0012-821X(78)90126-7; Weis D, 2011, NAT GEOSCI, V4, P831, DOI [10.1038/ngeo1328, 10.1038/NGEO1328]; Wessel P, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005499; Wessel P, 2016, GEOPHYS J INT, V204, P932, DOI 10.1093/gji/ggv472; Workman RK, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000623; YASUDA A, 1994, J GEOPHYS RES-SOL EA, V99, P9401, DOI 10.1029/93JB03205; Yaxley GM, 1998, SCHWEIZ MINER PETROG, V78, P243	44	30	30	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					472	+		10.1038/nature22054	http://dx.doi.org/10.1038/nature22054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28467819				2022-12-28	WOS:000401906500050
J	Wagler, VD; Pumerantz, AW				Wagler, Vanya D.; Pumerantz, Aaron W.			Management of Acute and Recurrent Gout	ANNALS OF INTERNAL MEDICINE			English	Letter							AMERICAN-COLLEGE		[Wagler, Vanya D.; Pumerantz, Aaron W.] William Beaumont Army Med Ctr, El Paso, TX 79920 USA	William Beaumont Army Medical Center	Wagler, VD (corresponding author), William Beaumont Army Med Ctr, El Paso, TX 79920 USA.							Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Schett G, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000046; Thiele RG, 2009, ARTHRITIS RHEUM S, V59, pS1512	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					759	759		10.7326/L17-0144	http://dx.doi.org/10.7326/L17-0144			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505647				2022-12-28	WOS:000401240200028
J	Frey, D				Frey, Darren			The Enigma of Reason	SCIENCE			English	Book Review									[Frey, Darren] Paris Descartes Univ, Lab Psychol Child Dev & Educ LaPsyDE, Paris, France; [Frey, Darren] Caen Univ, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Frey, D (corresponding author), Paris Descartes Univ, Lab Psychol Child Dev & Educ LaPsyDE, Paris, France.; Frey, D (corresponding author), Caen Univ, Paris, France.	darren@post.harvard.edu						BYRNE RMJ, 1989, COGNITION, V31, P61, DOI 10.1016/0010-0277(89)90018-8; Dunning D, 2003, CURR DIR PSYCHOL SCI, V12, P83, DOI 10.1111/1467-8721.01235; Hall L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045457; Mercier H., 2017, THE ENIGMA OF REASON	4	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					589	589		10.1126/science.aan1237	http://dx.doi.org/10.1126/science.aan1237			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495719				2022-12-28	WOS:000400975200026
J	Thomas, SJ				Thomas, Stephen J.			Zika Virus Vaccines - A Full Field and Looking for the Closers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTECTION; VACCINATION		[Thomas, Stephen J.] SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Thomas, SJ (corresponding author), SUNY Upstate Med Univ, Div Infect Dis, Syracuse, NY 13210 USA.			Thomas, Stephen/0000-0002-8368-7682				Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017	7	11	14	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1883	1886		10.1056/NEJMcibr1701402	http://dx.doi.org/10.1056/NEJMcibr1701402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WR	28490001				2022-12-28	WOS:000400891100017
J	Lyon, J				Lyon, Jeff			Investigation Into Opioid Crisis Targets Drug Companies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1826	1826		10.1001/jama.2017.5130	http://dx.doi.org/10.1001/jama.2017.5130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492878				2022-12-28	WOS:000400842400003
J	Kabat, AM; Pearce, EJ				Kabat, Agnieszka M.; Pearce, Edward J.			Inflammation by way of macrophage metabolism	SCIENCE			English	Editorial Material							ACTIVATION; AUTOPHAGY; HYPOXIA		[Kabat, Agnieszka M.; Pearce, Edward J.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Stubeweg 51, D-79108 Freiburg, Germany	Max Planck Society	Pearce, EJ (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, Stubeweg 51, D-79108 Freiburg, Germany.	pearceed@ie-freiburg.mpg.de						Alvarez-Garcia O, 2017, ARTHRITIS RHEUMATOL, V69, P1418, DOI 10.1002/art.40104; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Ip W. K. E., 2017, SCIENCE, V356, P513; Joeris T, 2017, MUCOSAL IMMUNOL, V10, P845, DOI 10.1038/mi.2017.22; Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444; Ko F, 2016, EXP GERONTOL, V73, P23, DOI 10.1016/j.exger.2015.11.010; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008	15	18	19	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					488	489		10.1126/science.aan2691	http://dx.doi.org/10.1126/science.aan2691			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473549				2022-12-28	WOS:000400545700018
J	Takahashi, Y; Wu, J; Suzuki, K; Martinez-Redondo, P; Li, M; Liao, HK; Wu, MZ; Hernandez-Benitez, R; Hishida, T; Shokhirev, MN; Esteban, CR; Sancho-Martinez, I; Belmonte, JCI				Takahashi, Yuta; Wu, Jun; Suzuki, Keiichiro; Martinez-Redondo, Paloma; Li, Mo; Liao, Hsin-Kai; Wu, Min-Zu; Hernandez-Benitez, Reyna; Hishida, Tomoaki; Shokhirev, Maxim Nikolaievich; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua			Integration of CpG-free DNA induces de novo methylation of CpG islands in pluripotent stem cells	SCIENCE			English	Article							ANGELMAN-SYNDROME; COLORECTAL-CANCER; UBIQUITIN LIGASE; UBE3A; DIFFERENTIATION; SPECIFICATION; TRANSCRIPT; CONVERSION; PROMOTERS; MUTATION	CpG islands (CGIs) are primarily promoter-associated genomic regions and are mostly unmethylated within highly methylated mammalian genomes. The mechanisms by which CGIs are protected from de novo methylation remain elusive. Here we show that insertion of CpG-free DNA into targeted CGIs induces de novo methylation of the entire CGI in human pluripotent stem cells (PSCs). The methylation status is stably maintained even after CpG-free DNA removal, extensive passaging, and differentiation. By targeting the DNA mismatch repair gene MLH1 CGI, we could generate a PSC model of a cancer-related epimutation. Furthermore, we successfully corrected aberrant imprinting in induced PSCs derived from an Angelman syndrome patient. Our results provide insights into how CpG-free DNA induces de novo CGI methylation and broaden the application of targeted epigenome editing for a better understanding of human development and disease.	[Takahashi, Yuta; Wu, Jun; Suzuki, Keiichiro; Li, Mo; Liao, Hsin-Kai; Wu, Min-Zu; Hernandez-Benitez, Reyna; Hishida, Tomoaki; Esteban, Concepcion Rodriguez; Sancho-Martinez, Ignacio; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Takahashi, Yuta] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Wu, Jun; Wu, Min-Zu] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos 135, Murcia 30107, Spain; [Li, Mo; Hernandez-Benitez, Reyna] King Abdullah Univ Sci & Technol, Thuwal 239556900, Saudi Arabia; [Shokhirev, Maxim Nikolaievich] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Sancho-Martinez, Ignacio] Novartis Fdn GNF, Genom Inst, Dept Pharmacol C128, 10675 John Jay Hopkins Dr, La Jolla, CA 92121 USA	Salk Institute; University of Tsukuba; Universidad Catolica de Murcia; King Abdullah University of Science & Technology; Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019; Li, Mo/AAM-8266-2021; Liao, Hsin-Kai/H-9608-2015	Wu, Jun/0000-0001-9863-1668; Li, Mo/0000-0003-0827-8907; Suzuki, Keiichiro/0000-0001-5603-9105; Hernandez-Benitez, Reyna/0000-0003-2546-8956	Astellas Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; California Institute for Regenerative Medicine (CIRM); Fundacion Alfonso Martin Escudero; Razavi Newman Integrative Genomics and Bioinformatics Core Facility; Next Generation Sequencing (NGS) Core Facility at the Salk Institute; NIH-National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) [P30 014195]; Chapman Foundation; Leona M. and Harry B. Helmsley Charitable Trust; UCAM (iPSC); G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Astellas Foundation(Astellas Pharmaceuticals); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Fundacion Alfonso Martin Escudero; Razavi Newman Integrative Genomics and Bioinformatics Core Facility; Next Generation Sequencing (NGS) Core Facility at the Salk Institute; NIH-National Cancer Institute (NCI) Cancer Center Support Grant (CCSG); Chapman Foundation; Leona M. and Harry B. Helmsley Charitable Trust; UCAM (iPSC); G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. C. Ku and T. Nguyen for next-generation sequencing; I. Dubova and K. McIntyre for teratoma analysis; D. O'Keefe for critical reading of the manuscript; C. J. Chang, A. Goebl, E. Aizawa, N. Y. Kim, Y. Hishida, R. D. Soligalla, and M. Morales Valencia for experimental help; M. Schwarz and P. Schwarz for administrative help; and A. Fukamizu for scientific discussion. Y. T. was partially supported by Astellas Foundation, Uehara Memorial Foundation, and Mochida Memorial Foundation research fellowships. K.S. and M.L. were supported by a California Institute for Regenerative Medicine (CIRM) Training Grant fellowship. P.M.-R. was partially supported by the Fundacion Alfonso Martin Escudero. This work was supported by the Razavi Newman Integrative Genomics and Bioinformatics Core Facility and the Next Generation Sequencing (NGS) Core Facility at the Salk Institute, with funding from NIH-National Cancer Institute (NCI) Cancer Center Support Grant (CCSG) no. P30 014195, the Chapman Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust. Work in the laboratory of J.C.I.B. was supported by UCAM (iPSC work), The G. Harold and Leila Y. Mathers Charitable Foundation, The Moxie Foundation, and The Leona M. and Harry B. Helmsley Charitable Trust.	BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Dawlaty MM, 2014, DEV CELL, V29, P102, DOI 10.1016/j.devcel.2014.03.003; Egawa K, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004655; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Herzing LBK, 2002, HUM MOL GENET, V11, P1707, DOI 10.1093/hmg/11.15.1707; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Mercer AA, 2016, ELIFE, V5, DOI 10.7554/eLife.07596; Mulherkar SA, 2009, J NEUROCHEM, V110, P1955, DOI 10.1111/j.1471-4159.2009.06293.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022	34	35	36	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					503	+		10.1126/science.aag3260	http://dx.doi.org/10.1126/science.aag3260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473583	Green Accepted			2022-12-28	WOS:000400545700030
J	Voosen, P				Voosen, Paul			PLANETARY SCIENCE NASA pushes for diversity in planetary science	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					475	475		10.1126/science.356.6337.475	http://dx.doi.org/10.1126/science.356.6337.475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473544				2022-12-28	WOS:000400545700014
J	Vaughn, VM; Shuster, D; Rogers, MAM; Mann, J; Conte, ML; Saint, S; Chopra, V				Vaughn, Valerie M.; Shuster, Dmitry; Rogers, Mary A. M.; Mann, Jason; Conte, Marisa L.; Saint, Sanjay; Chopra, Vineet			Early Versus Delayed Feeding in Patients With Acute Pancreatitis A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							EARLY ENTERAL NUTRITION; MILD ACUTE-PANCREATITIS; PARENTERAL-NUTRITION; GUT; METAANALYSIS; MORTALITY; MODERATE; SUPPORT; DIET	Background: Acute pancreatitis is among the most common and costly reasons for hospitalization in the United States. Bowel rest, pain control, and intravenous fluids are the cornerstones of treatment, but early feeding might also be beneficial. Purpose: To compare length of hospital stay, mortality, and readmission in adults hospitalized with pancreatitis who received early versus delayed feeding. Data Sources: MEDLINE via Ovid, EMBASE, the Cochrane Library, CINAHL, and Web of Science through January 2017. Study Selection: Two authors independently reviewed and selected studies if they were randomized clinical trials, included adults hospitalized with acute pancreatitis, and compared early versus delayed feeding (<= 48 vs. >48 hours after hospitalization). Data Extraction: Two investigators independently extracted study data and rated risk of bias using the Cochrane Collaboration tool. Data Synthesis: Eleven randomized trials (8 peer-reviewed publications, 3 abstract-only presentations) that included 948 patients were eligible. Seven trials (3 with low risk of bias) enrolled patients with mild to moderate pancreatitis. Four trials (1 with low risk of bias) included patients with predicted severe pancreatitis. Routes used for early feeding included oral (4 studies), nasogastric (2 studies), nasojejunal (4 studies), and oral or nasoenteric (1 study). Among patients with mild to moderate pancreatitis, early feeding was associated with reduced length of stay in 4 of 7 studies (including 2 of 3 with low risk of bias). Other outcomes were heterogeneous and variably reported, but no study showed an increase in adverse events with early feeding. Among patients with severe pancreatitis, limited evidence revealed no statistically significant difference in outcomes between early and delayed feeding. Limitation: Heterogeneity of feeding protocols and outcomes, scant data, and unclear or high risk of bias in several studies. Conclusion: Limited data suggest that early feeding in patients with acute pancreatitis does not seem to increase adverse events and, for patients with mild to moderate pancreatitis, may reduce length of hospital stay.	[Vaughn, Valerie M.] Michigan Med, Div Hosp Med, Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA; [Shuster, Dmitry] Michigan Med, Dept Internal Med, Div Gastroenterol, 3912 Taubman Ctr,SPC 5362, Ann Arbor, MI 48109 USA; [Rogers, Mary A. M.; Mann, Jason; Saint, Sanjay] Michigan Med, Dept Internal Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA; [Conte, Marisa L.] Michigan Med, Taubman Hlth Sci Lib, 1135 East Catherine St, Ann Arbor, MI 48109 USA; [Chopra, Vineet] Michigan Med, Div Hosp Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA		Chopra, V (corresponding author), Michigan Med, Div Hosp Med, Med, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	vineetc@umich.edu	Saint, Sanjay/AAF-5126-2019; Vaughn, Valerie M/L-3649-2018	Chopra, Vineet/0000-0001-8670-9376; Conte, Marisa/0000-0001-7377-163X; Rogers, Mary/0000-0001-5519-3223; Vaughn, Valerie/0000-0003-4362-7842	Agency for Healthcare Research and Quality [1-K08-HS022835-01]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Chopra is supported by a career development award from the Agency for Healthcare Research and Quality (1-K08-HS022835-01).	Al Samaraee A, 2010, SURG-J R COLL SURG E, V8, P105, DOI 10.1016/j.surge.2009.10.006; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Badalov NL, 2007, AM J GASTROENTEROL, V102, pS192, DOI 10.14309/00000434-200709002-00208; Bakker OJ, 2014, NEW ENGL J MED, V371, P1983, DOI 10.1056/NEJMoa1404393; Bakker OJ, 2014, PANCREATOLOGY, V14, P340, DOI 10.1016/j.pan.2014.07.008; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; BUCHMAN AL, 1995, JPEN-PARENTER ENTER, V19, P453, DOI 10.1177/0148607195019006453; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Dua MM, 2015, J SURG RES, V199, P44, DOI 10.1016/j.jss.2015.04.054; Eckerwall GE, 2007, CLIN NUTR, V26, P758, DOI 10.1016/j.clnu.2007.04.007; Flint R S, 2003, HPB (Oxford), V5, P69, DOI 10.1080/13651820310001108; Greenberg JA, 2016, J GASTROINTEST SURG, V20, P392, DOI 10.1007/s11605-015-3023-9; HADFIELD RJ, 1995, AM J RESP CRIT CARE, V152, P1545, DOI 10.1164/ajrccm.152.5.7582291; Harrison TR, 1950, PRINCIPLES INTERNAL; Hernandez G, 1999, J CRIT CARE, V14, P73, DOI 10.1016/S0883-9441(99)90017-5; Horibe M, 2016, UNITED EUR GASTROENT, V4, P725, DOI 10.1177/2050640615612368; Karabulut U, 2014, GASTROENTEROLOGY, V146, pS621; Jiang K, 2007, WORLD J GASTROENTERO, V13, P5253, DOI 10.3748/wjg.v13.i39.5253; Kurti F, 2015, PANCREATOLOGY, V15, pS62; Larino-Noia J, 2014, PANCREATOLOGY, V14, P167, DOI 10.1016/j.pan.2014.02.008; Li JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064926; Li J, 2013, PANCREAS, V42, P88, DOI 10.1097/MPA.0b013e3182575fb5; Li W, 2010, PANCREATOLOGY, V10, P264; Li XP, 2014, MED SCI MONITOR, V20, P2327, DOI 10.12659/MSM.892770; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marta K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101691; McClave SA, 2006, JPEN-PARENTER ENTER, V30, P143, DOI 10.1177/0148607106030002143; McClave SA, 2014, CRIT CARE MED, V42, P2600, DOI 10.1097/CCM.0000000000000654; McClure RJ, 2000, ARCH DIS CHILD-FETAL, V82, pF29, DOI 10.1136/fn.82.1.F29; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Olah A, 2014, WORLD J GASTROENTERO, V20, P16123, DOI 10.3748/wjg.v20.i43.16123; Olh A, 2010, ARCH SURG-CHICAGO, V395, P309, DOI [10.1007/s00423-010-0631-4, DOI 10.1007/S00423-010-0631-4]; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Petrov MS, 2008, ALIMENT PHARM THER, V28, P704, DOI 10.1111/j.1365-2036.2008.03786.x; Petrov MS, 2013, CLIN NUTR, V32, P697, DOI 10.1016/j.clnu.2012.12.011; Powell JJ, 2000, BRIT J SURG, V87, P1375, DOI 10.1046/j.1365-2168.2000.01558.x; Stimac D, 2016, PANCREATOLOGY, V16, P523, DOI 10.1016/j.pan.2016.04.003; Teich N, 2010, PANCREAS, V39, P1088, DOI 10.1097/MPA.0b013e3181d3ce05; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Wereszczynska-Siemiatkowska U, 2013, PANCREAS, V42, P640, DOI 10.1097/MPA.0b013e318271bb61; [吴大成 WU Dacheng], 2008, [肠外与肠内营养, Parenteral & Enteral Nutrition], V15, P285; Wu Y, 1999, ANN SURG, V229, P662, DOI 10.1097/00000658-199905000-00008; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Zhao XL, 2015, NUTRITION, V31, P171, DOI 10.1016/j.nut.2014.07.002	45	52	57	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					883	+		10.7326/M16-2533	http://dx.doi.org/10.7326/M16-2533			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28505667				2022-12-28	WOS:000403579000016
J	Qaseem, A; Forciea, MA; McLean, RM; Denberg, TD				Qaseem, Amir; Forciea, Mary Ann; McLean, Robert M.; Denberg, Thomas D.		Clinical Guidelines Comm Amer Coll	Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article								Description: This guideline updates the 2008 American College of Physicians (ACP) recommendations on treatment of low bone density and osteoporosis to prevent fractures in men and women. This guideline is endorsed by the American Academy of Family Physicians. Methods: The ACP Clinical Guidelines Committee based these recommendations on a systematic review of randomized controlled trials; systematic reviews; large observational studies (for adverse events); and case reports (for rare events) that were published between 2 January 2005 and 3 June 2011. The review was updated to July 2016 by using a machine-learning method, and a limited update to October 2016 was done. Clinical outcomes evaluated were fractures and adverse events. This guideline focuses on the comparative benefits and risks of short-and long-term pharmacologic treatments for low bone density, including pharmaceutical prescriptions, calcium, vitamin D, and estrogen. Evidence was graded according to the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Target Audience and Patient Population: The target audience for this guideline includes all clinicians. The target patient population includes men and women with low bone density and osteoporosis. Recommendation 1: ACP recommends that clinicians offer pharmacologic treatment with alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk for hip and vertebral fractures in women who have known osteoporosis. (Grade: strong recommendation; high-quality evidence) Recommendation 2: ACP recommends that clinicians treat osteoporotic women with pharmacologic therapy for 5 years. (Grade: weak recommendation; low-quality evidence) Recommendation 3: ACP recommends that clinicians offer pharmacologic treatment with bisphosphonates to reduce the risk for vertebral fracture in men who have clinically recognized osteoporosis. (Grade: weak recommendation; low-quality evidence) Recommendation 4: ACP recommends against bone density monitoring during the 5-year pharmacologic treatment period for osteoporosis in women. (Grade: weak recommendation; low-quality evidence) Recommendation 5: ACP recommends against using menopausal estrogen therapy or menopausal estrogen plus progestogen therapy or raloxifene for the treatment of osteoporosis in women. (Grade: strong recommendation; moderate-quality evidence) Recommendation 6: ACP recommends that clinicians should make the decision whether to treat osteopenic women 65 years of age or older who are at a high risk for fracture based on a discussion of patient preferences, fracture risk profile, and benefits, harms, and costs of medications. (Grade: weak recommendation; low-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Forciea, Mary Ann] Univ Penn Hlth Syst, 3615 Chestnut St, Philadelphia, PA 19104 USA; [McLean, Robert M.] Yale Sch Med, 46 Prince St,Suite 302, New Haven, CT 06519 USA; [Denberg, Thomas D.] 7480 East 5th Ave, Denver, CO 80230 USA	American College of Physicians; University of Pennsylvania; Yale University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Schunemann, Holger/0000-0003-3211-8479	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	2002, BONE, V30, P836	1	355	387	9	109	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					818	+		10.7326/M15-1361	http://dx.doi.org/10.7326/M15-1361			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28492856				2022-12-28	WOS:000402700200009
J	de Carli, GJ; Pereira, TC				de Carli, Gabriel Jose; Pereira, Tiago Campos			Widen discipline span of Nature papers	NATURE			English	Letter									[de Carli, Gabriel Jose; Pereira, Tiago Campos] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Pereira, TC (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	tiagocampospereira@ffclrp.usp.br	De Carli, Gabriel Jose/AHE-2843-2022; Pereira, Tiago C/C-9076-2012	De Carli, Gabriel Jose/0000-0003-3689-4512; 					0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					289	289		10.1038/545289d	http://dx.doi.org/10.1038/545289d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516922	Bronze			2022-12-28	WOS:000401466500045
J	Koven, S				Koven, Suzanne			Letter to a Young Female Physician	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEX-DIFFERENCES		[Koven, Suzanne] Harvard Med Sch, Boston, MA 02115 USA; [Koven, Suzanne] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Koven, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Koven, S (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2015, JAMA-J AM MED ASSOC, V314, P1149, DOI 10.1001/jama.2015.10680; Lowes R, 2016, MOST FEMALE PHYS REP; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875	4	20	20	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1907	1909		10.1056/NEJMp1702010	http://dx.doi.org/10.1056/NEJMp1702010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514609				2022-12-28	WOS:000401407500004
J	Lim, JS; Ibaseta, A; Fischer, MM; Cancilla, B; O'Young, G; Cristea, S; Luca, VC; Yang, D; Jahchan, NS; Hamard, C; Antoine, M; Wislez, M; Kong, C; Cain, J; Liu, YW; Kapoun, AM; Garcia, KC; Hoey, T; Murriel, CL; Sage, J				Lim, Jing Shan; Ibaseta, Alvaro; Fischer, Marcus M.; Cancilla, Belinda; O'Young, Gilbert; Cristea, Sandra; Luca, Vincent C.; Yang, Dian; Jahchan, Nadine S.; Hamard, Cecile; Antoine, Martine; Wislez, Marie; Kong, Christina; Cain, Jennifer; Liu, Yu-Wang; Kapoun, Ann M.; Garcia, K. Christopher; Hoey, Timothy; Murriel, Christopher L.; Sage, Julien			Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer	NATURE			English	Article							SET ENRICHMENT ANALYSIS; MOUSE MODEL; NEUROENDOCRINE DIFFERENTIATION; EXPRESSION; PROTEIN; INHIBITORS; INACTIVATION; REST	The Notch signalling pathway mediates cell fate decisions(1,2) and is tumour suppressive or oncogenic depending on the context(2,3). During lung development, Notch pathway activation inhibits the differentiation of precursor cells to a neuroendocrine fate(4-6). In small-cell lung cancer, an aggressive neuroendocrine lung cancer(7), loss-of-function mutations in NOTCH genes and the inhibitory effects of ectopic Notch activation indicate that Notch signalling is tumour suppressive(8,9). Here we show that Notch signalling can be both tumour suppressive and pro-tumorigenic in small-cell lung cancer. Endogenous activation of the Notch pathway results in a neuroendocrine to non-neuroendocrine fate switch in 10-50% of tumour cells in a mouse model of small-cell lung cancer and in human tumours. This switch is mediated in part by Rest (also known as Nrsf), a transcriptional repressor that inhibits neuroendocrine gene expression. Non-neuroendocrine Notch-active small-cell lung cancer cells are slow growing, consistent with a tumour-suppressive role for Notch, but these cells are also relatively chemoresistant and provide trophic support to neuroendocrine tumour cells, consistent with a pro-tumorigenic role. Importantly, Notch blockade in combination with chemotherapy suppresses tumour growth and delays relapse in pre-clinical models. Thus, small-cell lung cancer tumours generate their own microenvironment via activation of Notch signalling in a subset of tumour cells, and the presence of these cells may serve as a biomarker for the use of Notch pathway inhibitors in combination with chemotherapy in select patients with small-cell lung cancer.	[Lim, Jing Shan; Ibaseta, Alvaro; Cristea, Sandra; Yang, Dian; Jahchan, Nadine S.; Sage, Julien] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Lim, Jing Shan; Ibaseta, Alvaro; Cristea, Sandra; Yang, Dian; Jahchan, Nadine S.; Sage, Julien] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Fischer, Marcus M.; Cancilla, Belinda; O'Young, Gilbert; Cain, Jennifer; Liu, Yu-Wang; Kapoun, Ann M.; Hoey, Timothy; Murriel, Christopher L.] OncoMed Pharmaceut Inc, Redwood City, CA 94063 USA; [Luca, Vincent C.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Luca, Vincent C.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Luca, Vincent C.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Hamard, Cecile; Antoine, Martine; Wislez, Marie] UPMC Univ Paris 06, Sorbonne Univ, GRC 04, F-75252 Paris, France; [Hamard, Cecile; Antoine, Martine; Wislez, Marie] Hop Tenon, AP HP, Serv Pneumol, F-75970 Paris, France; [Kong, Christina] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Stanford University	Sage, J (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.; Sage, J (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	julsage@stanford.edu; julsage@stanford.edu	Ibaseta, Alvaro/AAN-5333-2020	Ibaseta, Alvaro/0000-0002-9649-8258; wislez, marie/0000-0001-7518-7859	Howard Hughes Medical Institute; National Institutes of Health [R01 CA201513]; A*STAR Singapore; Soutien a la Recherche Clinique (Fondation du Souffle); Soutien a la Recherche Clinique (Fonds de Recherche en Sante Respiratoire); Legs Poix (Chancellerie des Universites de Paris); NATIONAL CANCER INSTITUTE [R01CA201513, P30CA124435, R01CA206540, R00CA204738] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR Singapore(Agency for Science Technology & Research (A*STAR)); Soutien a la Recherche Clinique (Fondation du Souffle); Soutien a la Recherche Clinique (Fonds de Recherche en Sante Respiratoire); Legs Poix (Chancellerie des Universites de Paris); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Berns for Trp53<SUP>lox</SUP> mice, S. Fre and S. Artavanis-Tsakonas for Hes1<SUP>GFP</SUP> mice, M. Winslow, M. Krasnow, T. Rando, A. Sweet-Cordero, Y. Ouadah and Sage laboratory members for suggestions on the manuscript, and P. Lovelace and J. Ho (fluorescence-activated cell sorting (FACS)), P. Chu (histology), S. Sim and the Stanford Protein and Nucleic Acid (PAN) facility for technical support. We thank the Tumorotheque des Hopitaux Universitaires de l'Est Parisien (HUEP; the East Paris University Hospitals Tumor Bio-bank) for SCLC samples and N. Rabbe-Mathiot for immunostaining support. This work was supported by the Howard Hughes Medical Institute (K.C.G.), the National Institutes of Health (J.S. R01 CA201513), A*STAR Singapore (J.S.L.), Soutien a la Recherche Clinique (Fondation du Souffle and Fonds de Recherche en Sante Respiratoire, M.W.), and the Legs Poix (Chancellerie des Universites de Paris, M.W.). J.S. is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.	Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Brahmer, 1998, Oncologist, V3, P143; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cheung AF, 2008, CANCER RES, V68, P9459, DOI 10.1158/0008-5472.CAN-08-2634; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Demitrack ES, 2015, EMBO J, V34, P2522, DOI 10.15252/embj.201490583; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hodges PE, 2002, NUCLEIC ACIDS RES, V30, P137, DOI 10.1093/nar/30.1.137; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Ito T, 2000, DEVELOPMENT, V127, P3913; Jahchan NS, 2016, CELL REP, V16, P644, DOI 10.1016/j.celrep.2016.06.021; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kaur G, 2016, CANCER LETT, V371, P225, DOI 10.1016/j.canlet.2015.12.001; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nadeau H, 2002, J NEUROPHYSIOL, V88, P409, DOI 10.1152/jn.2002.88.1.409; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pietanza MC, 2015, CLIN CANCER RES, V21, P2244, DOI 10.1158/1078-0432.CCR-14-2958; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Shi YK, 2015, THORAC CANCER, V6, P785, DOI 10.1111/1759-7714.12303; Sriuranpong V, 2001, CANCER RES, V61, P3200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021	55	214	225	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					360	+		10.1038/nature22323	http://dx.doi.org/10.1038/nature22323			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489825	Green Accepted			2022-12-28	WOS:000401466500065
J	Villareal, DT; Aguirre, L; Gurney, AB; Waters, DL; Sinacore, DR; Colombo, E; Armamento-Villareal, R; Qualls, C				Villareal, Dennis T.; Aguirre, Lina; Gurney, A. Burke; Waters, Debra L.; Sinacore, David R.; Colombo, Elizabeth; Armamento-Villareal, Reina; Qualls, Clifford			Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS; PHYSICAL PERFORMANCE; CALORIC RESTRICTION; SARCOPENIC OBESITY; FRAILTY; INTERFERENCE; ASSOCIATION; DISABILITY; CAPACITY; STRENGTH	BACKGROUND Obesity causes frailty in older adults; however, weight loss might accelerate age-related loss of muscle and bone mass and resultant sarcopenia and osteopenia. METHODS In this clinical trial involving 160 obese older adults, we evaluated the effectiveness of several exercise modes in reversing frailty and preventing reduction in muscle and bone mass induced by weight loss. Participants were randomly assigned to a weight-management program plus one of three exercise programs - aerobic training, resistance training, or combined aerobic and resistance training - or to a control group (no weight-management or exercise program). The primary outcome was the change in Physical Performance Test score from baseline to 6 months (scores range from 0 to 36 points; higher scores indicate better performance). Secondary outcomes included changes in other frailty measures, body composition, bone mineral density, and physical functions. RESULTS A total of 141 participants completed the study. The Physical Performance Test score increased more in the combination group than in the aerobic and resistance groups (27.9 to 33.4 points [21% increase] vs. 29.3 to 33.2 points [14% increase] and 28.8 to 32.7 points [14% increase], respectively; P=0.01 and P=0.02 after Bonferroni correction); the scores increased more in all exercise groups than in the control group (P<0.001 for between-group comparisons). Peak oxygen consumption (milliliters per kilogram of body weight per minute) increased more in the combination and aerobic groups (17.2 to 20.3 [17% increase] and 17.6 to 20.9 [18% increase], respectively) than in the resistance group (17.0 to 18.3 [8% increase]) (P<0.001 for both comparisons). Strength increased more in the combination and resistance groups (272 to 320 kg [18% increase] and 288 to 337 kg [19% increase], respectively) than in the aerobic group (265 to 270 kg [4% increase]) (P<0.001 for both comparisons). Body weight decreased by 9% in all exercise groups but did not change significantly in the control group. Lean mass decreased less in the combination and resistance groups than in the aerobic group (56.5 to 54.8 kg [3% decrease] and 58.1 to 57.1 kg [2% decrease], respectively, vs. 55.0 to 52.3 kg [5% decrease]), as did bone mineral density at the total hip (grams per square centimeter; 1.010 to 0.996 [1% decrease] and 1.047 to 1.041 [0.5% decrease], respectively, vs. 1.018 to 0.991 [3% decrease]) (P<0.05 for all comparisons). Exercise-related adverse events included musculoskeletal injuries. CONCLUSIONS Of the methods tested, weight loss plus combined aerobic and resistance exercise was the most effective in improving functional status of obese older adults. (Funded by the National Institutes of Health; LITOE ClinicalTrials. gov number, NCT01065636.)	[Villareal, Dennis T.; Armamento-Villareal, Reina] Baylor Coll Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA; [Villareal, Dennis T.; Armamento-Villareal, Reina] Michael E DeBakey Vet Affairs VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX USA; [Aguirre, Lina; Waters, Debra L.; Colombo, Elizabeth] New Mexico VA Hlth Care Syst, Med Care Line, Albuquerque, NM USA; [Aguirre, Lina; Colombo, Elizabeth] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Gurney, A. Burke] Univ New Mexico, Sch Med, Div Phys Therapy, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Sch Med, Dept Math & Stat, Albuquerque, NM 87131 USA; [Waters, Debra L.] Univ Otago, Sch Physiotherapy, Dept Med, Dunedin, New Zealand; [Sinacore, David R.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA	Baylor College of Medicine; University of New Mexico; University of New Mexico; University of New Mexico; University of Otago; Washington University (WUSTL)	Villareal, DT (corresponding author), Baylor Coll Med, Michael E DeBakey VA Med Ctr, 2002 Holcombe Ave, Houston, TX 77030 USA.	dennis.villareal@bcm.edu	Villareal, Reina/AAH-6028-2019; PT, David R. Sinacore/AAS-3377-2020	PT, David R. Sinacore/0000-0002-7242-3585; Zare, Morteza/0000-0001-7157-9265	National Institutes of Health [RO1-AG031176, UL1-TR000041, P30-DK020579]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449, UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (RO1-AG031176, UL1-TR000041, and P30-DK020579).	Aguirre LE, 2015, NESTLE NUTR WORKS SE, V83, P83, DOI 10.1159/000382065; Batsis JA, 2017, J AM GERIATR SOC, V65, P257, DOI 10.1111/jgs.14514; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Blaum CS, 2005, J AM GERIATR SOC, V53, P927, DOI 10.1111/j.1532-5415.2005.53300.x; Bouchonville MF, 2013, CURR OPIN ENDOCRINOL, V20, P412, DOI 10.1097/01.med.0000433071.11466.7f; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; Cadore EL, 2010, INT J SPORTS MED, V31, P689, DOI 10.1055/s-0030-1261895; Centers for Medicare and Medicaid Services, 2011, DEC MEM INT BEH THER; Dmitrienko A, 2011, STAT MED, V30, P1473, DOI 10.1002/sim.4008; Evans WJ, 2002, J GERONTOL A-BIOL, V57, pM260, DOI 10.1093/gerona/57.5.M260; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; JETTE AM, 1987, PHYS THER, V67, P1854, DOI 10.1093/ptj/67.12.1854; Lambert CP, 2005, REV ENDOCR METAB DIS, V6, P137, DOI 10.1007/s11154-005-6726-5; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Locher JL, 2016, EXP GERONTOL, V86, P4, DOI 10.1016/j.exger.2016.03.009; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Nguyen HQ, 2008, DIABETES CARE, V31, P1562, DOI 10.2337/dc08-0624; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; REUBEN DB, 1990, J AM GERIATR SOC, V38, P1105, DOI 10.1111/j.1532-5415.1990.tb01373.x; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Shah K, 2008, J AM GERIATR SOC, V56, P1157, DOI 10.1111/j.1532-5415.2008.01699.x; Shapses SA, 2012, ANNU REV NUTR, V32, P287, DOI 10.1146/annurev.nutr.012809.104655; Starr KNP, 2014, J AM MED DIR ASSOC, V15, P240, DOI 10.1016/j.jamda.2013.11.008; Svetkey LP, 2014, OBESITY, V22, P39, DOI 10.1002/oby.20506; Theou Olga, 2011, J Aging Res, V2011, P569194, DOI 10.4061/2011/569194; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; Villareal DT, 2004, OBES RES, V12, P913, DOI 10.1038/oby.2004.111; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Waters DL, 2013, EXP GERONTOL, V48, P1054, DOI 10.1016/j.exger.2013.02.005; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d	39	268	287	10	111	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1943	1955		10.1056/NEJMoa1616338	http://dx.doi.org/10.1056/NEJMoa1616338			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514618	Green Accepted			2022-12-28	WOS:000401407500008
J	Stanbrook, MB				Stanbrook, Matthew B.			Review: In COPD, injectable polyvalent pneumococcal vaccines reduce risk for community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VACCINATION; IMPACT; RATES		[Stanbrook, Matthew B.] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada.							Al-Sukhni W, 2008, VACCINE, V26, P1432, DOI 10.1016/j.vaccine.2008.01.001; Lee TA, 2007, J GEN INTERN MED, V22, P62, DOI 10.1007/s11606-007-0118-3; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Walters JA, 2010, COCHRANE DB SYST REV, V11	4	1	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC52	JC52		10.7326/ACPJC-2017-166-10-052	http://dx.doi.org/10.7326/ACPJC-2017-166-10-052			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505636				2022-12-28	WOS:000401240200004
J	Savulescu, J				Savulescu, Julian			Is it in Charlie Gard's best interest to die?	LANCET			English	Editorial Material									[Savulescu, Julian] Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England	University of Oxford	Savulescu, J (corresponding author), Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.	julian.savulescu@philosophy.ox.ac.uk						[Anonymous], 2017, BBC NEWS; Bruno MA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000039; Judiciary of England and Wales, 2017, DEC SHORT REAS REL M; Rawls J., 1951, OUTLINE DECISION PRO, V60, P177, DOI DOI 10.2307/2181696; Rawls J., 1971, THEORY JUSTICE; Savulescu J, 2006, MEDICINE, V33, P11; Wilkinson D, 2017, LANCET; Wilkinson DJC, 2011, CURR OPIN ANESTHESIO, V24, P160, DOI 10.1097/ACO.0b013e328343c5af; Yan EG, 2007, J PERINATOL, V27, P307, DOI 10.1038/sj.jp.7211694	9	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1868	1869		10.1016/S0140-6736(17)31204-7	http://dx.doi.org/10.1016/S0140-6736(17)31204-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28478974	Green Submitted			2022-12-28	WOS:000400973500008
J	Watts, G				Watts, Geoff			Profile Luca Richeldi: high hopes for rare lung diseases	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1875	1875		10.1016/S0140-6736(17)31216-3	http://dx.doi.org/10.1016/S0140-6736(17)31216-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28513440				2022-12-28	WOS:000400973500011
J	Norimatsu, Y; Hasegawa, K; Shimizu, N; Toyoshima, C				Norimatsu, Yoshiyuki; Hasegawa, Kazuya; Shimizu, Nobutaka; Toyoshima, Chikashi			Protein-phospholipid interplay revealed with crystals of a calcium pump	NATURE			English	Article							X-RAY-DIFFRACTION; MOLECULAR-DYNAMICS; MEMBRANE-PROTEIN; CA2+-ATPASE; TRANSLOCATION; RESOLUTION; MECHANISM; MULTIPLE; BILAYER; BINDING	The lipid bilayer has so far eluded visualization by conventional crystallographic methods, severely limiting our understanding of phospholipid-and protein-phospholipid interactions. Here we describe electron density maps for crystals of Ca2+-ATPase in four different states obtained by X-ray solvent contrast modulation. These maps resolve the entire first layer of phospholipids surrounding the transmembrane helices, although less than half of them are hydrogen-bonded to protein residues. Phospholipids follow the movements of associated residues, causing local distortions and changes in thickness of the bilayer. Unexpectedly, the entire protein tilts during the reaction cycle, governed primarily by a belt of Trp residues, to minimize energy costs accompanying the large perpendicular movements of the transmembrane helices. A class of Arg residues extend their side chains through the cytoplasm to exploit phospholipids as anchors for conformational switching. Thus, phospholipid-Arg/Lys and phospholipid-Trp interactions have distinct functional roles in the dynamics of ion pumps and, presumably, membrane proteins in general.	[Norimatsu, Yoshiyuki; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Hasegawa, Kazuya; Shimizu, Nobutaka] Japan Synchrotron Radiat Res Inst JASRI, Prot Crystal Anal Div, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan; [Shimizu, Nobutaka] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan	University of Tokyo; Japan Synchrotron Radiation Research Institute; High Energy Accelerator Research Organization (KEK)	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Shimizu, Nobutaka/0000-0002-3636-1663; Toyoshima, Chikashi/0000-0001-9640-0778; Norimatsu, Yoshiyuki/0000-0002-7828-6040	SPring-8 [2009B0025, 2012B1486, 2013A0049]; Ministry of Education, Culture, Sports, Science and Technology of Japan	SPring-8(SPring-8); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank H. Sakai and H. Okumura of the Japan Synchrotron Radiation Research (JASRI) and members of the Toyoshima laboratory for data collection at BL41XU of SPring-8. Thanks are also due to J. Tsueda, A. Hirata and S. Iwasawa for making crystals for this study. We are grateful to Y. Sugita at RIKEN institute for his help in molecular dynamics simulations and D. B. McIntosh for improving the manuscript. This work is a part of a long-term project (2009B0025, 2012B1486, 2013A0049) at SPring-8 and was supported by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan to C.T.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; FOURME R, 1995, J SYNCHROTRON RADIAT, V2, P36, DOI 10.1107/S0909049594006680; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1987, J BIOL CHEM, V262, P16338; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Liu YF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.040901; Lo V, 2009, ACTA CRYSTALLOGR A, V65, P312, DOI 10.1107/S0108767309019047; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mangialavori I, 2011, FEBS LETT, V585, P1153, DOI 10.1016/j.febslet.2011.03.024; Mares LJ, 2014, BIOPHYS J, V107, P1352, DOI 10.1016/j.bpj.2014.05.054; Mori T, 2010, BIOCHEMISTRY-US, V49, P945, DOI 10.1021/bi901594w; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; RICKWOOD D, 1982, ANAL BIOCHEM, V123, P23, DOI 10.1016/0003-2697(82)90618-2; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shepard W, 2000, ACTA CRYSTALLOGR D, V56, P1288, DOI 10.1107/S0907444900009574; SILVIUS Jr, 1984, BIOCHEMISTRY-US, V23, P538, DOI 10.1021/bi00298a022; Sonntag Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1307; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wood K., 2008, BIOPHYSICAL ANAL MEM, P213; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	47	92	93	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					193	+		10.1038/nature22357	http://dx.doi.org/10.1038/nature22357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467821				2022-12-28	WOS:000400963800028
J	Reardon, S				Reardon, Sara			NIH announces grant limit	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					142	143		10.1038/nature.2017.21949	http://dx.doi.org/10.1038/nature.2017.21949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492269	Bronze			2022-12-28	WOS:000400963800006
J	Yi, Z; Huang, YS; Wang, L; Zhao, YT				Yi, Zhong; Huang, Yen Shu; Wang, Lei; Zhao, Yun-Tao			CASE REVIEW A man with chest tightness and burning limbs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yi, Zhong; Huang, Yen Shu; Wang, Lei; Zhao, Yun-Tao] Aerosp Ctr Hosp, Cardiac Dept, Beijing, Peoples R China		Zhao, YT (corresponding author), Aerosp Ctr Hosp, Cardiac Dept, Beijing, Peoples R China.	raas@hsc.pku.edu.cn						Dispenzieri A, 2015, MAYO CLIN PROC, V90, P1054, DOI 10.1016/j.mayocp.2015.06.009; Falk RH, 2016, J AM COLL CARDIOL, V68, P1324, DOI 10.1016/j.jacc.2016.06.053; Martinelli N, 2011, CIRCULATION, V123, pE583, DOI 10.1161/CIRCULATIONAHA.110.011601; Quarta CC, 2012, CIRCULATION, V126, pE178, DOI 10.1161/CIRCULATIONAHA.111.069195; Ritts AJ, 2017, HEART FAIL CLIN, V13, P409, DOI 10.1016/j.hfc.2016.12.003; Sperry BW, 2016, J AM COLL CARDIOL, V67, P2941, DOI 10.1016/j.jacc.2016.03.593; Wechalekar AD, 2016, LANCET, V387, P2641, DOI 10.1016/S0140-6736(15)01274-X; Wechalekar AD, 2015, BRIT J HAEMATOL, V168, P186, DOI 10.1111/bjh.13155; Yilmaz A, 2014, HEART, V100, P662, DOI 10.1136/heartjnl-2011-301528	9	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2017	357								j1979	10.1136/bmj.j1979	http://dx.doi.org/10.1136/bmj.j1979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UK	28495887				2022-12-28	WOS:000401170200002
J	Stafford, N				Stafford, Ned			Ingeborg Rapoport Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		RAPOPORT I, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2247	10.1136/bmj.j2247	http://dx.doi.org/10.1136/bmj.j2247			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483773				2022-12-28	WOS:000401412700019
J	Patin, E; Lopez, M; Grollemund, R; Verdu, P; Harmant, C; Quach, H; Laval, G; Perry, GH; Barreiro, LB; Froment, A; Heyer, E; Massougbodji, A; Fortes-Lima, C; Migot-Nabias, F; Bellis, G; Dugoujon, JM; Pereira, JB; Fernandes, V; Pereira, L; Van der Veen, L; Mouguiama-Daouda, P; Bustamante, CD; Hombert, JM; Quintana-Murci, L				Patin, Etienne; Lopez, Marie; Grollemund, Rebecca; Verdu, Paul; Harmant, Christine; Quach, Helene; Laval, Guillaume; Perry, George H.; Barreiro, Luis B.; Froment, Alain; Heyer, Evelyne; Massougbodji, Achille; Fortes-Lima, Cesar; Migot-Nabias, Florence; Bellis, Gil; Dugoujon, Jean-Michel; Pereira, Joana B.; Fernandes, Veronica; Pereira, Luisa; Van der Veen, Lolke; Mouguiama-Daouda, Patrick; Bustamante, Carlos D.; Hombert, Jean-Marie; Quintana-Murci, Lluis			Dispersals and genetic adaptation of Bantu-speaking populations in Africa and North America	SCIENCE			English	Article							ADMIXTURE; GENOME; ANCESTRY; HISTORY; EXPANSION; SELECTION	Bantu languages are spoken by about 310 million Africans, yet the genetic history of Bantu-speaking populations remains largely unexplored. We generated genomic data for 1318 individuals from 35 populations in western central Africa, where Bantu languages originated. We found that early Bantu speakers first moved southward, through the equatorial rainforest, before spreading toward eastern and southern Africa. We also found that genetic adaptation of Bantu speakers was facilitated by admixture with local populations, particularly for the HLA and LCT loci. Finally, we identified a major contribution of western central African Bantu speakers to the ancestry of African Americans, whose genomes present no strong signals of natural selection. Together, these results highlight the contribution of Bantu-speaking peoples to the complex genetic history of Africans and African Americans.	[Patin, Etienne; Lopez, Marie; Harmant, Christine; Quach, Helene; Laval, Guillaume; Quintana-Murci, Lluis] Inst Pasteur, Human Evolut Genet, F-75015 Paris, France; [Patin, Etienne; Lopez, Marie; Harmant, Christine; Quach, Helene; Laval, Guillaume; Quintana-Murci, Lluis] CNRS, URA3012, F-75015 Paris, France; [Patin, Etienne; Lopez, Marie; Harmant, Christine; Quach, Helene; Laval, Guillaume; Quintana-Murci, Lluis] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France; [Grollemund, Rebecca] Univ Reading, Sch Biol Sci, Evolut Biol Grp, Reading RG6 6BX, Berks, England; [Grollemund, Rebecca] Univ Missouri, Dept English, Columbia, MO 65211 USA; [Grollemund, Rebecca] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Verdu, Paul; Heyer, Evelyne; Fortes-Lima, Cesar] Univ Paris Diderot, Museum Natl Hist Nat, CNRS, UMR7206,Sorbonne Paris Cite, F-75016 Paris, France; [Perry, George H.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Perry, George H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Barreiro, Luis B.] Univ Montreal, CHU St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Froment, Alain] Museum Natl Hist Nat, Inst Rech Dev, UMR 208, F-75005 Paris, France; [Massougbodji, Achille] CERPAGE, Cotonou, Benin; [Massougbodji, Achille] IRCB, 01 BP 188, Cotonou, Benin; [Fortes-Lima, Cesar; Dugoujon, Jean-Michel] CNRS, UMR 5288, Anthropol Mol & Imagerie Synthese, Univ Paul Sabatier Toulouse 3, F-31073 Toulouse 3, France; [Migot-Nabias, Florence] Inst Rech Dev, UMR 216, F-75006 Paris, France; [Migot-Nabias, Florence] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, 1Commun Univ & Etablissements COMUE, F-75006 Paris, France; [Bellis, Gil] Inst Natl Etud Demog, F-75020 Paris, France; [Pereira, Joana B.; Fernandes, Veronica; Pereira, Luisa] Univ Porto, I3S, P-4200135 Oporto, Portugal; [Pereira, Joana B.; Fernandes, Veronica; Pereira, Luisa] Univ Porto, Inst Patol & Imunol Mol, IPATIMUP, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Van der Veen, Lolke; Mouguiama-Daouda, Patrick; Hombert, Jean-Marie] CNRS, UMR 5596, Dynam Langage, Univ Lumiere Lyon 2, F-69007 Lyon, France; [Mouguiama-Daouda, Patrick] Univ Omar Bongo, Lab Langue Culture & Cognit LCC, Libreville, Gabon; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Bustamante, Carlos D.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Reading; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Lyon 2; Stanford University; Stanford University	Patin, E; Quintana-Murci, L (corresponding author), Inst Pasteur, Human Evolut Genet, F-75015 Paris, France.; Patin, E; Quintana-Murci, L (corresponding author), CNRS, URA3012, F-75015 Paris, France.; Patin, E; Quintana-Murci, L (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.	quintana@pasteur.fr	Pereira, Luisa/H-3050-2011; Fortes-Lima, Cesar A./H-4827-2013; Lima, Cesar Augusto A Fortes/M-1007-2019; Heyer, Evelyne/K-9184-2013; Barreiro, Luis/I-7772-2015; Quintana-Murci, Lluis/AAB-7468-2022; Fortes-Lima, Cesar/ABE-4823-2021; Pereira, Joana B./J-6026-2013; Fernandes, Vernonica/AAC-6824-2022	Pereira, Luisa/0000-0002-4271-1527; Fortes-Lima, Cesar A./0000-0002-9310-5009; Lima, Cesar Augusto A Fortes/0000-0002-9310-5009; Fortes-Lima, Cesar/0000-0002-9310-5009; Pereira, Joana B./0000-0002-4409-514X; Froment, Alain/0000-0001-5448-9698; Bustamante, Carlos D./0000-0002-4187-7920; Heyer, Evelyne/0000-0002-0266-3196; Barreiro, Luis/0000-0001-9456-367X; fernandes, veronica/0000-0002-3873-2034; Fortes-Lima, Cesar/0000-0002-8972-3357; Patin, Etienne/0000-0002-9911-4459; Migot-Nabias, Florence/0000-0001-9982-594X; Verdu, Paul/0000-0001-6828-268X	Institut Pasteur; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) grant AGRHUM [ANR-14-CE02-0003-01]; "Histoire du Genome des Populations Humaines Gabonaises" project (Institut Pasteur/Republic of Gabon)	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR) grant AGRHUM(French National Research Agency (ANR)); "Histoire du Genome des Populations Humaines Gabonaises" project (Institut Pasteur/Republic of Gabon)	We thank all participants who donated samples and participated in this study. We thank C. Schlebusch and G. Hellenthal for helpful discussions. We thank E. Soumonni, a historian whose advice guided the recruitment of Beninese individuals, and J.-P. Chippaux (CERPAGE, Cotonou, Benin) for his help with local authorities. We thank the African Variation Genome Project, the Data Access Committee Chair for the National Human Genome Research Institute (particularly V. Ota Wang), the Electronic Medical Records and Genomics (eMERGE) Genome-Wide Association Study, the Multiethnic Cohort Study, the Gene, Environment Association Studies consortium (GENEVA), and the Health Aging and Body Composition (Health ABC) Study for kindly providing access to their data. Detailed acknowledgments can be found elsewhere (10). This work was funded by the Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR) grant AGRHUM (ANR-14-CE02-0003-01), and the "Histoire du Genome des Populations Humaines Gabonaises" project (Institut Pasteur/Republic of Gabon). The newly generated SNP genotype data have been deposited in the European Genome-Phenome Archive under accession code EGAS00001002078.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bhatia G, 2014, AM J HUM GENET, V95, P437, DOI 10.1016/j.ajhg.2014.08.011; Bostoen K, 2015, CURR ANTHROPOL, V56, P354, DOI 10.1086/681436; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Eltis D., 2010, ATLAS TRANSATLANTIC; Grollemund R, 2015, P NATL ACAD SCI USA, V112, P13296, DOI 10.1073/pnas.1503793112; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Jin WF, 2012, GENOME RES, V22, P519, DOI 10.1101/gr.124784.111; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1448; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Montinaro F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7596; Phillipson DW, 1993, AFRICAN ARCHAEOLOGY; Pickrell JK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2140; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257	24	116	117	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					543	546		10.1126/science.aal1988	http://dx.doi.org/10.1126/science.aal1988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473590	Green Submitted			2022-12-28	WOS:000400545700039
J	Diamond, J				Diamond, Jared			ARCHAEOLOGY Of rats and resilience	NATURE			English	Editorial Material							HUMAN COLONIZATION; POLYNESIA; PACIFIC; OCEANIA		[Diamond, Jared] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Diamond, J (corresponding author), Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA.	jdiamond@geog.ucla.edu						Hiroa T.R., 1934, MANGAIAN SOC; Keegan W.F., 1987, ADV ARCHAEOL METH TH, V10, P49, DOI DOI 10.1016/B978-0-12-003110-8.50005-0; Kirch P.V., 1982, TIKOPIA PREHISTORY E; Kirch PV, 2010, ANNU REV ANTHROPOL, V39, P131, DOI 10.1146/annurev.anthro.012809.104936; Kirch PV, 2010, ARCHAEOL OCEAN, V45, P66, DOI 10.1002/j.1834-4453.2010.tb00081.x; Kirch Patrick V, 2017, TANGATATAU ROCKSHELT; KIRCH PV, 1994, ANTIQUITY, V68, P310, DOI 10.1017/S0003598X00046615; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Montenegro A, 2016, P NATL ACAD SCI USA, V113, P12685, DOI 10.1073/pnas.1612426113; Roullier C, 2013, P NATL ACAD SCI USA, V110, P2205, DOI 10.1073/pnas.1211049110; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; SPRIGGS M, 1993, ANTIQUITY, V67, P200, DOI 10.1017/S0003598X00045324; Weisler MI, 1995, PITCAIRN ISLANDS: BIOGEOGRAPHY, ECOLOGY AND PREHISTORY, P377; Williams John, 1837, NARRATIVE MISSIONARY	14	0	0	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					32	33		10.1038/545032a	http://dx.doi.org/10.1038/545032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	ET7MK	28470204				2022-12-28	WOS:000400480400020
J	McCoy, MS; Emanuel, EJ				McCoy, Matthew S.; Emanuel, Ezekiel J.			Why There Are No "Potential" Conflicts of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McCoy, Matthew S.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	McCoy, MS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	mmcco@mail.med.upenn.edu						[Anonymous], 2008, Nat Med, V14, P106, DOI 10.1038/nm0208-106; National Academies, 2014, CONFL INT MED INN EN; Thompson DF, 2009, Z EVIDENZ FORTBILD Q, V103, P136, DOI 10.1016/j.zefq.2009.02.021; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P2654, DOI 10.1001/jama.293.21.2654	5	44	46	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1721	1722		10.1001/jama.2017.2308	http://dx.doi.org/10.1001/jama.2017.2308			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464154				2022-12-28	WOS:000400440700010
J	Granek, L; Nakash, O; Carmi, R				Granek, Leeat; Nakash, Ora; Carmi, Rivka			Women and health in Israel	LANCET			English	Editorial Material							CHRONIC PAIN; PREVALENCE; DISORDERS; SECURITY; LIFE		[Granek, Leeat] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel; [Carmi, Rivka] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Nakash, Ora] Baruch Ivcher Sch Psychol, Interdisciplinary Ctr, Herzliyya, Israel	Ben Gurion University; Ben Gurion University; Reichman University	Granek, L (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, POB 653, IL-84105 Beer Sheva, Israel.	leeatg@gmail.com						Al-Krenawi A., 2009, PSYCHIAT BEHAV DISOR, P75; Aviram U, 2017, COMMUNITY MENT HLT J, V53, P550, DOI 10.1007/s10597-016-0058-7; Ayalon L, 2015, INT J SOC PSYCHIATR, V61, P386, DOI 10.1177/0020764014549082; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Charlotte H., 2013, NAT REV DRUG DISCOV, V12, P506; Elroy I, 2008, WOMENS VOICE PERCEPT; Israel AoRCCi, 2016, STAT ASS RAP CRIS CT; Israel Police, 2013, STAT ANN ISR POL 201; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kashti O., 2014, HAARETZ TEL AVI 0801; Khatib DM, 2012, HLTH AR WOM ISR POL; Kimhi S, 2014, SOCIAL ISSUES ISRAEL, V17, P94; Levav I, 2007, ISR J PSYCHIATR REL, V44, P104; Levinson D, 2007, ISR J PSYCHIATR REL, V44, P94; Ministry of Public Security, 2014, NAT VIOL IND; Mizrahi Simon S., 2015, VIOLENCE WOMEN 2015; Muhsen K, 2017, LANCET; Neville A, 2008, ISR MED ASSOC J, V10, P676; OECD, 2011, HLTH GLANC 2011 OECD; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Sa'ar A, 2011, INT SOCIOL, V26, P50, DOI 10.1177/0268580910380979; Sered S., 2000, WHAT MAKES WOMEN SIC; Solomon Z, 2009, PSYCHIAT  BEHAV DISO, P212; State of Israel Ministry of Health, 2015, IN VITRO FERT IVF TR; Wainstock T, 2013, PSYCHOSOM MED, V75, P228, DOI 10.1097/PSY.0b013e318280f5f3; Waldinger RJ, 2015, CLIN PSYCHOL SCI, V3, P516, DOI 10.1177/2167702614541261; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2006, CONST WORLD HLTH ORG	29	7	7	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2575	2578		10.1016/S0140-6736(17)30563-9	http://dx.doi.org/10.1016/S0140-6736(17)30563-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495110				2022-12-28	WOS:000403901800036
J	Rubin, L; Belmaker, I; Somekh, E; Urkin, J; Rudolf, M; Honovich, M; Bilenko, N; Grossman, Z				Rubin, Lisa; Belmaker, Ilana; Somekh, Eli; Urkin, Jacob; Rudolf, Mary; Honovich, Mira; Bilenko, Natalya; Grossman, Zachi			Maternal and child health in Israel: building lives	LANCET			English	Article							WAR-RELATED STRESS; INNOVATIVE INTERVENTION; WILD POLIOVIRUS; MENTAL-HEALTH; CARE; WOMEN; RISK; FORTIFICATION; PEDIATRICIANS; ADOLESCENTS	Israel is home to a child-oriented society that values strong family ties, universal child benefits, and free education for all children from 3 years of age to school grade 12. Alongside the universal health-care services that are guaranteed by the National Health Insurance Law and strong, community-based primary and preventive care services, these values have resulted in good maternal and child health. In 2015, infant and maternal mortality (3.1 deaths per 1000 livebirths and 2.0 deaths per 100 000 livebirths, respectively) were lower than the mean infant and maternal mortality of countries within the Organisation for Economic Co-operation and Development. Israel has already exceeded the developed regions' Sustainable Development Goal 2030 targets for maternal mortality, neonatal mortality, and mortality in children younger than 5 years in all population groups. Yet these accomplishments are marred by Israel's high prevalence of child poverty (more than 30%), particularly among Arabs (63%) and ultra-Orthodox Jews (67%). Although infant mortality has improved in all subpopulations since Israel was founded in 1948, infant mortality among Arabs is still more than twice as high as among Jews. To address these disparities in health, the Israeli Ministry of Health has created a special division and has funded an intervention programme to reduce the infant mortality among Bedouin Arabs. Other interventions include targeted and culturally appropriate health-care programmes and services for communities with a high number of at-risk children and young adults, dental health service for all children up to 15 years, and improved collaboration between health, education, and welfare services. The challenges faced by the Israeli health-care system include a growing trend towards medicalisation of prenatal care, ensuring staff are trained to treat developmental, behavioural, and psychosocial issues in children and their families, securing sustainable funding for health promotion and injury prevention programmes, expanding and improving the coordination of services for children with special needs or who are at risk, and programme assessment. Ensuring adequate funding for dedicated, preventive paediatric care and taking action on a nationwide scale to reduce child poverty are essential for maintaining health gains in children. In this Series paper, we describe the health indices, highlight disparities, and discuss the challenges in delivering and maintaining maternal and child health care in Israel.	[Rubin, Lisa; Honovich, Mira] Minist Hlth, Publ Hlth Serv, Dept Maternal & Child Hlth, Jerusalem, Israel; [Rubin, Lisa] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Bilenko, Natalya] Minist Hlth, Sub Dist Hlth Off, Ashqelon, Israel; [Bilenko, Natalya] Ben Gurion Univ Negev, Dept Publ Hlth, Fac Hlth Sci, Beer Sheva, Israel; [Belmaker, Ilana] Ben Gurion Univ Negev, Div Hlth Community, Fac Hlth Sci, Beer Sheva, Israel; [Urkin, Jacob] Clalit Hlth Serv, Tel Aviv, Israel; [Urkin, Jacob] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Pediat, Beer Sheva, Israel; [Somekh, Eli] Wolfson Med Ctr, Holon, Israel; [Somekh, Eli] Tel Aviv Univ, Sch Med, Tel Aviv, Israel; [Somekh, Eli] Israel Pediat Assoc, Tel Aviv, Israel; [Somekh, Eli] Union Natl European Paediat Societies & Assoc, European Paediat Assoc, Berlin, Germany; [Rudolf, Mary] Bar Ilan Univ, Fac Med Galilee, Dept Populat Hlth, Safed, Israel; [Rudolf, Mary] Univ Leeds, Dept Paediat & Child Hlth, Leeds, W Yorkshire, England; [Grossman, Zachi] Maccabi Hlth Serv, Tel Aviv, Israel; [Grossman, Zachi] Israel Pediat Assoc, Tel Aviv, Israel; [Grossman, Zachi] Israel Pediat Res Off Setting Network, Tel Aviv, Israel	University of Haifa; Ben Gurion University; Ben Gurion University; Clalit Health Services; Ben Gurion University; Tel Aviv University; Bar Ilan University; University of Leeds	Rubin, L (corresponding author), Minist Hlth, Publ Hlth Serv, Dept Maternal & Child Hlth, Jerusalem, Israel.; Rubin, L (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.			Rubin, Lisa/0000-0002-5819-5029				Abu-Saad K, 2016, LANCET, V388, P1983, DOI 10.1016/S0140-6736(16)31866-9; Abu-Saad K, 2012, BRIT J NUTR, V108, P1874, DOI 10.1017/S000711451100729X; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Almoshano S, 2008, ISRAELI J PEDIAT, V63, P8; Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; [Anonymous], 2014, ISR CTR DIS CONTR PU; Arazi T, 2017, PUBLICATION MYERS JD, VRR-742; Ashkenazi Y, USE EXPERIENCE CHILD; Barlev-Kotler L., 2014, PEOPLE DISABILITIES; Belmaker I, 2006, LANCET, V367, P987, DOI 10.1016/S0140-6736(06)68425-0; Ben Rabi D, 2014, HIDDEN DROPOUTS REEX; Ben Yehuda Y, 2010, ISR MED ASSOC J, V12, P598; Ben-Arieh A, 2013, APPL RESPONSES CHILD; Berger R, 2012, J ADOLESCENT HEALTH, V51, P453, DOI 10.1016/j.jadohealth.2012.02.011; Bilenko N, 2004, C PUBL HLTH PHYS UN; Bilenko N., 2010, THESIS; Bilenko N, 2010, ISR MED ASSOC J, V12, P342; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blumenfeld O, 2014, PEDIATR DIABETES, V15, P422, DOI 10.1111/pedi.12101; Breslauer D, 2014, 18 NAT C MAL FEM NUR; Breznitz Z, 2008, DIAGNOSIS ASSESSMENT; Centers for Disease Control and Prevention, MULT BIRTHS; Central Bureau of Statistics, 2016, USITC PUBL, V1632; Cohen E, 2014, CLIN SOC WORK J, V42, P336, DOI 10.1007/s10615-013-0439-0; Daoud N, 2014, ETHNIC HEALTH, V19, P385, DOI 10.1080/13557858.2013.801403; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Data Analysis Division of the Ministry of Health of Israel, 2016, SUIC IN ISR; DellaPergola S., 2011, COMM POP DEV 44 SESS; Dimitry L, 2012, CHILD CARE HLTH DEV, V38, P153, DOI 10.1111/j.1365-2214.2011.01246.x; Endblad M, 2014, NATL INSURANCE I REP; Feldman D., 2009, DISABILITY STUDIES Q, V29, P4; Gooldin Sigal, 2006, J JEWISH WOMENTS STU, V12, P151; GORODISCHER R, 1995, EARLY HUM DEV, V42, P123, DOI 10.1016/0378-3782(95)01644-I; Gottlieb N, 2011, GLOB PUBLIC HEALTH, V6, P643, DOI 10.1080/17441692.2010.482534; Grossman Z, 2014, J PEDIATR-US, V165, P1278, DOI 10.1016/j.jpeds.2014.09.016; HAGGERTY RJ, 1995, PEDIATRICS, V96, P804; Haklai Z., 2011, IVF TREATMENT; Harel-Fisch Y, 2014, YOUTH ISRAEL HLTH EM; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Israel Center for Disease Control, NAT YOUTH NUTR SURV; Israel Center for Disease Control, 2007, USITC PUBL, V302; Israel Center for Disease Control, 2011, USITC PUBL, V333, P236; Israeli Ministry of Health Public Health Service, 2016, STUD HLTH SERV COMP; Jaber L, 2014, J ATTEN DIS; Kahan-Strawczynski P., 2010, IMMIGRANT YOUTH ISRA; Kaliner E, 2014, LANCET INFECT DIS, V15, P1236; Kislev S., 2013, CHILD INJURIES ISRAE; Knessset Data Center, 2004, WAIT TIM SPEC ISR HM; Kopel E, 2014, NEW ENGL J MED, V371, P981, DOI 10.1056/NEJMp1406250; Liran D, 2013, J MATERN-FETAL NEO M, V26, P469, DOI 10.3109/14767058.2012.738262; Manor O, 2016, NATL PROGRAM QUALITY; Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709; Meyerovitch J., 2014, ANN ISR PED ASS C TE; Na'amnih W, 2014, J COMMUN GENET, V5, P395, DOI 10.1007/s12687-014-0188-y; Nakash O, 2016, J IMMIGR MINOR HEALT, V18, P1232, DOI 10.1007/s10903-016-0348-8; Naon D, 1998, RR32498 JOINT BROOKD; Naon D, 2000, RR35500 JDC BROOKD I; Naon ED, 2011, INCLUSION CHILDREN S; National Insurance Institute of Israel, BENEFITS; Oberklaid F, 2011, ISR MED ASSOC J, V13, P178; OECD, 2014, SOC GLANC 2014 HIGHL; OECD, HLTH GLANC 2015 OECD; Okun BS, 2013, DEMOG RES, V28, P1373; Porter B, 2017, ARCH DIS CHILD, V102, P795, DOI 10.1136/archdischild-2016-312468; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Ratzon R, 2011, EUR J OBSTET GYN R B, V154, P40, DOI 10.1016/j.ejogrb.2010.08.011; Raz R, 2015, J AUTISM DEV DISORD, V45, P1062, DOI 10.1007/s10803-014-2262-z; Sadeh A, 2008, PEDIATRICS, V121, P46, DOI 10.1542/peds.2007-1348; Schmid H, 2007, CHILD YOUTH SERV REV, V29, P1114, DOI 10.1016/j.childyouth.2007.03.001; Senecky Y, 2007, PEDIATR INT, V49, P472, DOI 10.1111/j.1442-200X.2007.02387.x; Shalev SA, 2017, LANCET; Shoham-Vardi I, 2010, IS ISPID JOINT C SYD, P79; Simonstein F, 2010, HEALTH POLICY, V97, P202, DOI 10.1016/j.healthpol.2010.04.004; Stein-Zamir C, 2012, EPIDEMIOL INFECT, V140, P1578, DOI 10.1017/S095026881100238X; Stein-Zamir C, 2010, ISR MED ASSOC J, V12, P296; Stoler-Liss S, 2016, BE HLTH NATION MASSI, P113; Szabo-Lael R, 2011, RISK CHILDREN YOUTH; Tasher D, 2016, J PEDIATR-US, V177, pS107, DOI 10.1016/j.jpeds.2016.04.047; Tesler R, 2016, J SCHOOL HEALTH, V86, P435, DOI 10.1111/josh.12394; The National Cancer Registry, 2015, CHILDH CANC ISR; Toledano E., 2014, SINGLE PARENT FAMILI; UNICEF, LEV TRENDS CHILD MOR; van Esso D, 2010, ARCH DIS CHILD, V95, P791, DOI 10.1136/adc.2009.178459; Vinker S, 2006, CLIN DRUG INVEST, V26, P161, DOI 10.2165/00044011-200626030-00006; Wasser J, 2015, 11 ANN C ISR HLTH PO; Weiss O, 2016, USITC PUBL, V1097; Whitehead M., 2014, EQUITY ACTION SPECTR; WHO regional office for Europe, EUR DAT HUM TECHN RE; Willis TA, 2016, PUBLIC HEALTH, V136, P101, DOI 10.1016/j.puhe.2016.04.006; Wolmer L, 2011, J AM ACAD CHILD PSY, V50, P340, DOI 10.1016/j.jaac.2011.01.002; Yizchaki L, 2010, FRONT LINE FUNCTIONI; Zemishlany Z., 2012, ISR MED ASSOC J, V14, P2	92	41	42	3	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2514	2530		10.1016/S0140-6736(17)30929-7	http://dx.doi.org/10.1016/S0140-6736(17)30929-7			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495101				2022-12-28	WOS:000403901800030
J	Kraft, WK; Adeniyi-Jones, SC; Chervoneva, I; Greenspan, JS; Abatemarco, D; Kaltenbach, K; Ehrlich, ME				Kraft, Walter K.; Adeniyi-Jones, Susan C.; Chervoneva, Inna; Greenspan, Jay S.; Abatemarco, Diane; Kaltenbach, Karol; Ehrlich, Michelle E.			Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBLINGUAL BUPRENORPHINE; PRETERM; TERM	BACKGROUND Current pharmacologic treatment of the neonatal abstinence syndrome with morphine is associated with a lengthy duration of therapy and hospitalization. Buprenorphine may be more effective than morphine for this indication. METHODS In this single-site, double-blind, double-dummy clinical trial, we randomly assigned 63 term infants (>= 37 weeks of gestation) who had been exposed to opioids in utero and who had signs of the neonatal abstinence syndrome to receive either sublingual buprenorphine or oral morphine. Infants with symptoms that were not controlled with the maximum dose of opioid were treated with adjunctive phenobarbital. The primary end point was the duration of treatment for symptoms of neonatal opioid withdrawal. Secondary clinical end points were the length of hospital stay, the percentage of infants who required supplemental treatment with phenobarbital, and safety. RESULTS The median duration of treatment was significantly shorter with buprenorphine than with morphine (15 days vs. 28 days), as was the median length of hospital stay (21 days vs. 33 days) (P<0.001 for both comparisons). Adjunctive phenobarbital was administered in 5 of 33 infants (15%) in the buprenorphine group and in 7 of 30 infants (23%) in the morphine group (P = 0.36). Rates of adverse events were similar in the two groups. CONCLUSIONS Among infants with the neonatal abstinence syndrome, treatment with sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than treatment with oral morphine, with similar rates of adverse events. (Funded by the National Institute on Drug Abuse; BBORN ClinicalTrials.gov number, NCT01452789.)	[Kraft, Walter K.; Adeniyi-Jones, Susan C.; Chervoneva, Inna; Greenspan, Jay S.; Abatemarco, Diane; Kaltenbach, Karol] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Adeniyi-Jones, Susan C.; Greenspan, Jay S.] Thomas Jefferson Univ Hosp, Nemours duPont Pediat, Philadelphia, PA 19107 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	Jefferson University; Jefferson University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kraft, WK (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Sidney Kimmel Med Coll, 1170 Main Bldg,132 S 10th St, Philadelphia, PA 19107 USA.	walter.kraft@jefferson.edu			National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002976, R01DA029076] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse; BBORN ClinicalTrials.gov number, NCT01452789.	Anagnostis Ellena A, 2011, J Pediatr Pharmacol Ther, V16, P281, DOI 10.5863/1551-6776-16.4.281; BARRETT DA, 1993, BRIT J CLIN PHARMACO, V36, P215, DOI 10.1111/j.1365-2125.1993.tb04220.x; DOBERCZAK TM, 1991, J PEDIATR-US, V118, P933, DOI 10.1016/S0022-3476(05)82214-0; Dysart K, 2007, J PERINAT MED, V35, P344, DOI 10.1515/JPM.2007.063; Gowing L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub5; Holmes AV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2929; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Kaltenbach K, 2016, J ADDICT MED, V10, P217, DOI 10.1097/ADM.0000000000000207; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kraft WK, 2008, PEDIATRICS, V122, pE601, DOI 10.1542/peds.2008-0571; Kraft WK, 2011, ADDICTION, V106, P574, DOI 10.1111/j.1360-0443.2010.03170.x; Ng CM, 2015, PHARMACOTHERAPY, V35, P670, DOI 10.1002/phar.1610; Osborn DA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002059.pub3; Patrick SW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3835; Sauberan J, 2013, J ADDICT MED, V7, P113, DOI 10.1097/ADM.0b013e318280f495; Seligman NS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.088; Short VL, 2016, BREASTFEED MED, V11, P343, DOI 10.1089/bfm.2016.0084; VANELTEREN P, 1960, B INT STATIST INST, V37, P351	18	76	77	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2341	2348		10.1056/NEJMoa1614835	http://dx.doi.org/10.1056/NEJMoa1614835			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX4UQ	28468518	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000403230800007
J	Ben-David, E; Burga, A; Kruglyak, L				Ben-David, Eyal; Burga, Alejandro; Kruglyak, Leonid			A maternal-effect selfish genetic element in Caenorhabditis elegans	SCIENCE			English	Article							PHARYNGEAL DEVELOPMENT; DIFFERENTIATION GENE; GENOME EVOLUTION; C-ELEGANS; PHA-1; ORGAN; DROSOPHILA; DIVERSITY	Selfish genetic elements spread in natural populations and have an important role in genome evolution. We discovered a selfish element causing embryonic lethality in crosses between wild strains of the nematode Caenorhabditis elegans. The element is made up of sup-35, a maternal-effect toxin that kills developing embryos, and pha-1, its zygotically expressed antidote. pha-1 has long been considered essential for pharynx development on the basis of its mutant phenotype, but this phenotype arises from a loss of suppression of sup-35 toxicity. Inactive copies of the sup-35/pha-1 element show high sequence divergence from active copies, and phylogenetic reconstruction suggests that they represent ancestral stages in the evolution of the element. Our results suggest that other essential genes identified by genetic screens may turn out to be components of selfish elements.	[Ben-David, Eyal; Burga, Alejandro; Kruglyak, Leonid] Univ Calif Los Angeles, Dept Biol Chem, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Ben-David, E; Burga, A; Kruglyak, L (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Dept Human Genet, Los Angeles, CA 90095 USA.	ebd@ucla.edu; aburga@mednet.ucla.edu; lkruglyak@mednet.ucla.edu	Ben-David, Eyal/AAV-4126-2021; Burga, Alejandro/AAJ-8745-2020	Burga, Alejandro/0000-0002-0211-4357; Ben-David, Eyal/0000-0003-0514-0400; Kruglyak, Leonid/0000-0002-8065-3057	Howard Hughes Medical Institute; NIH [R01 HG004321]; Gruss-Lipper postdoctoral fellowship from the EGL Charitable Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NCBI [PRJNA383603]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gruss-Lipper postdoctoral fellowship from the EGL Charitable Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NCBI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Kruglyak lab for their comments. Supported by the Howard Hughes Medical Institute and NIH grant R01 HG004321 (L.K.), a Gruss-Lipper postdoctoral fellowship from the EGL Charitable Foundation (E.B.-D.), and the Jane Coffin Childs Memorial Fund for Medical Research (A.B.). E.B.-D., A.B., and L.K. wrote the manuscript; all authors discussed and agreed on the final version of the manuscript. The authors declare no competing financial interests. Sequencing data are available under NCBI bioproject PRJNA383603. Phylogenetic analyses have been deposited to TreeBASE (http://purl.org/phylo/treebase/phylows/study/TB2:S20933). The liftoveR R package has been deposited in Github (https://github.com/eyalbenda/liftoveR).	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; Cook DE, 2017, NUCLEIC ACIDS RES, V45, pD650, DOI 10.1093/nar/gkw893; Cook DE, 2016, GENETICS, V204, P371, DOI 10.1534/genetics.116.191148; Dawkins Richard, 1976, SELFISH GENE; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Fay DS, 2012, GENETICS, V191, P827, DOI 10.1534/genetics.112.140814; Fay DS, 2004, DEV BIOL, V271, P11, DOI 10.1016/j.ydbio.2004.03.022; GRANATO M, 1994, DEVELOPMENT, V120, P3005; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Kuzmanov A, 2014, GENETICS, V198, P259, DOI 10.1534/genetics.114.166876; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Lorenzen MD, 2008, P NATL ACAD SCI USA, V105, P10085, DOI 10.1073/pnas.0800444105; Mango SE, 2009, ANNU REV CELL DEV BI, V25, P597, DOI 10.1146/annurev.cellbio.24.110707.175411; Mani K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000510; Okkema PG, 1997, DEVELOPMENT, V124, P3965; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Polley SRG, 2014, GENETICS, V196, P211, DOI 10.1534/genetics.113.158485; SCHNABEL H, 1991, GENETICS, V129, P69; SCHNABEL H, 1990, SCIENCE, V250, P686, DOI 10.1126/science.250.4981.686; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115; SHIN HS, 1983, NATURE, V306, P380, DOI 10.1038/306380a0; Sinkins SP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001114; van Schendel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8394; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108	32	42	43	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1051	+		10.1126/science.aan0621	http://dx.doi.org/10.1126/science.aan0621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28495877	Green Accepted, Green Submitted			2022-12-28	WOS:000402871700048
J	Orwoll, ES				Orwoll, Eric S.			Clinical Practice Guidelines for Osteoporosis: Translating Data to Patients?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Orwoll, Eric S.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Orwoll, ES (corresponding author), 3181 SW Sam Jackson Pk, Portland, OR 97239 USA.	orwoll@ohsu.edu						Black DM, 2012, NEW ENGL J MED, V366, P2051, DOI 10.1056/NEJMp1202623; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Crandall CJ, 2014, ANN INTERN MED, V161, P711, DOI 10.7326/M14-0317; Cummings SR, 2017, J BONE MINER RES, V32, P3, DOI 10.1002/jbmr.3039; Khosla S, 2016, J BONE MINER RES; Kolata Gina, 2016, NEW YORK TIMES; Leder BZ, 2015, LANCET, V386, P1147, DOI 10.1016/S0140-6736(15)61120-5; Qaseem A, 2017, ANN INTERN MED, V166, P818, DOI 10.7326/M15-1361; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045	9	1	1	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2017	166	11					852	853		10.7326/M17-0957	http://dx.doi.org/10.7326/M17-0957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW7NJ	28492858				2022-12-28	WOS:000402700200016
J	Cabezas-Wallscheid, N; Buettner, F; Sommerkamp, P; Klimmeck, D; Ladel, L; Thalheimer, FB; Pastor-Flores, D; Roma, LP; Renders, S; Zeisberger, P; Przybylla, A; Schonberger, K; Scognamiglio, R; Altamura, S; Florian, CM; Fawaz, M; Vonficht, D; Tesio, M; Collier, P; Pavlinic, D; Geiger, H; Schroeder, T; Benes, V; Dick, TP; Rieger, MA; Stegle, O; Trumpp, A				Cabezas-Wallscheid, Nina; Buettner, Florian; Sommerkamp, Pia; Klimmeck, Daniel; Ladel, Luisa; Thalheimer, Frederic B.; Pastor-Flores, Daniel; Roma, Leticia P.; Renders, Simon; Zeisberger, Petra; Przybylla, Adriana; Schoenberger, Katharina; Scognamiglio, Roberta; Altamura, Sandro; Florian, Carolina M.; Fawaz, Malak; Vonficht, Dominik; Tesio, Melania; Collier, Paul; Pavlinic, Dinko; Geiger, Hartmut; Schroeder, Timm; Benes, Vladimir; Dick, Tobias P.; Rieger, Michael A.; Stegle, Oliver; Trumpp, Andreas			Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy	CELL			English	Article							SELF-RENEWAL; PROTEIN-SYNTHESIS; C-MYC; DIFFERENTIATION; EXPRESSION; HETEROGENEITY; TRANSCRIPTOME; QUIESCENCE; RECEPTORS; REVEALS	Dormant hematopoietic stem cells (dHSCs) are atop the hematopoietic hierarchy. The molecular identity of dHSCs and the mechanisms regulating their maintenance or exit from dormancy remain uncertain. Here, we use single-cell RNA sequencing (RNA-seq) analysis to show that the transition from dormancy toward cell-cycle entry is a continuous developmental path associated with upregulation of biosynthetic processes rather than a stepwise progression. In addition, low Myc levels and high expression of a retinoic acid program are characteristic for dHSCs. To follow the behavior of dHSCs in situ, a Gprc5c-controlled reporter mouse was established. Treatment with all-trans retinoic acid antagonizes stress-induced activation of dHSCs by restricting protein translation and levels of reactive oxygen species (ROS) and Myc. Mice maintained on a vitamin A-free diet lose HSCs and show a disrupted re-entry into dormancy after exposure to inflammatory stress stimuli. Our results highlight the impact of dietary vitamin A on the regulation of cell-cycle-mediated stem cell plasticity.	[Cabezas-Wallscheid, Nina; Sommerkamp, Pia; Klimmeck, Daniel; Ladel, Luisa; Renders, Simon; Zeisberger, Petra; Przybylla, Adriana; Schoenberger, Katharina; Scognamiglio, Roberta; Vonficht, Dominik; Tesio, Melania; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Cabezas-Wallscheid, Nina; Sommerkamp, Pia; Klimmeck, Daniel; Ladel, Luisa; Renders, Simon; Zeisberger, Petra; Przybylla, Adriana; Schoenberger, Katharina; Scognamiglio, Roberta; Vonficht, Dominik; Tesio, Melania; Trumpp, Andreas] DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Cabezas-Wallscheid, Nina; Sommerkamp, Pia; Klimmeck, Daniel; Ladel, Luisa; Renders, Simon; Zeisberger, Petra; Przybylla, Adriana; Schoenberger, Katharina; Scognamiglio, Roberta; Vonficht, Dominik; Tesio, Melania; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Buettner, Florian] EBI, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Thalheimer, Frederic B.; Fawaz, Malak; Rieger, Michael A.] Goethe Univ Frankfurt, LOEWE Ctr Cell & Gene Therapy, D-60590 Frankfurt, Germany; [Thalheimer, Frederic B.; Fawaz, Malak; Rieger, Michael A.] Goethe Univ Frankfurt, Dept Med, Hematol Oncol, D-60590 Frankfurt, Germany; [Pastor-Flores, Daniel; Roma, Leticia P.; Dick, Tobias P.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Redox Regulat, D-69120 Heidelberg, Germany; [Altamura, Sandro] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, D-69120 Heidelberg, Germany; [Florian, Carolina M.; Geiger, Hartmut] Ulm Univ, Inst Mol Med Stem Cells & Aging, D-89081 Ulm, Germany; [Collier, Paul; Pavlinic, Dinko; Benes, Vladimir] EMBL, Genom Core Facil, D-69117 Heidelberg, Germany; [Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, CH-4058 Basel, Switzerland; [Trumpp, Andreas] German Canc Consortium DKTK, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ulm University; European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; German Cancer Research Center (DKFZ)	Cabezas-Wallscheid, N; Trumpp, A (corresponding author), German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany.; Cabezas-Wallscheid, N; Trumpp, A (corresponding author), DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany.; Cabezas-Wallscheid, N; Trumpp, A (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.	n.cabezas@dkfz.de; a.trumpp@dkfz.de	Buettner, Florian/ABF-1230-2020; Rieger, Michael A/L-8324-2017; Stegle, Oliver/AAU-9177-2020; Florian, M. Carolina/AAH-5309-2019; Trumpp, Andreas/Z-2141-2019	Buettner, Florian/0000-0001-5587-6761; Rieger, Michael A/0000-0002-4158-5872; Stegle, Oliver/0000-0002-8818-7193; Florian, M. Carolina/0000-0002-5791-1310; Trumpp, Andreas/0000-0002-6212-3466; TESIO, Melania/0000-0001-9291-0797; Thalheimer, Frederic B./0000-0003-0423-099X; Altamura, Sandro/0000-0002-6781-1073; Sommerkamp, Pia/0000-0002-1148-2493; Schroeder, Timm/0000-0001-9320-0252	UK Medical Research Council (MRC) via a Career Development Fellowship [MR/M01536X/1]; Deutsche Forschungsgemeinschaft (DFG) [FOR2033, SFB873]; Dietmar Hopp Foundation; MRC [MR/M01536X/1] Funding Source: UKRI	UK Medical Research Council (MRC) via a Career Development Fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar Hopp Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Sohn and all technicians of the Trumpp laboratory for technical assistance; S. Schmitt, A. Atzberger, K. Hexel, M. Eich, G. de la Cruz, C. Felbinger from the DKFZ Flow Cytometry Core facility for their assistance; K. Reifenberg, M. Socher, A. Rathgeb and all members of the DKFZ Laboratory Animal Core Facility for excellent animal welfare and husbandry. We thank A. Hotz-Wagenblatt and the microarray unit of the DKFZ Genomics and Proteomics Core Facility for their assistance. We thank A. Wilson for critical reading of the manuscript. F.B. was supported by the UK Medical Research Council (MRC) via a Career Development Fellowship (MR/M01536X/1). This work was supported by the FOR2033 and SFB873 funded by the Deutsche Forschungsgemeinschaft (DFG) and the Dietmar Hopp Foundation (all to A.T).	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Brown CC, 2015, EUR J IMMUNOL, V45, P1287, DOI 10.1002/eji.201344398; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Collins SJ, 2008, CURR OPIN HEMATOL, V15, P346, DOI 10.1097/MOH.0b013e3283007edf; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehninger A, 2014, BLOOD, V123, P3909, DOI 10.1182/blood-2013-10-531038; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fujikawa Y, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3895; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Haetscher N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9928; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; JACOBSEN SEW, 1994, J EXP MED, V179, P1665, DOI 10.1084/jem.179.5.1665; Klimmeck D, 2014, STEM CELL REP, V3, P858, DOI 10.1016/j.stemcr.2014.08.012; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lipka DB, 2014, CELL CYCLE, V13, P3476, DOI 10.4161/15384101.2014.973334; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludin A, 2014, ANTIOXID REDOX SIGN, V21, P1605, DOI 10.1089/ars.2014.5941; Masetti R, 2012, EXPERT REV ANTICANC, V12, P1191, DOI [10.1586/ERA.12.101, 10.1586/era.12.101]; Matsumoto A, 2013, BBA-GEN SUBJECTS, V1830, P2335, DOI 10.1016/j.bbagen.2012.07.004; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016; Reinisch A, 2016, NAT MED, V22, P812, DOI 10.1038/nm.4103; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Sanchez CG, 2016, CELL STEM CELL, V18, P276, DOI 10.1016/j.stem.2015.11.004; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Scognamiglio R, 2016, CELL, V164, P668, DOI 10.1016/j.cell.2015.12.033; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tesio M, 2015, J EXP MED, V212, P525, DOI 10.1084/jem.20141438; Thalheimer FB, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.010; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van der Wath RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006972; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wagner KH, 1940, H-S Z PHYSIOL CHEM, V264, P153, DOI 10.1515/bchm2.1940.264.3-4.153; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	76	226	231	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2017	169	5					807	+		10.1016/j.cell.2017.04.018	http://dx.doi.org/10.1016/j.cell.2017.04.018			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV1OM	28479188	Bronze			2022-12-28	WOS:000401515900008
J	Geller, RJ				Geller, Robert J.			Japan must admit it can't predict quakes	NATURE			English	Letter									[Geller, Robert J.] Univ Tokyo, Tokyo, Japan	University of Tokyo	Geller, RJ (corresponding author), Univ Tokyo, Tokyo, Japan.	bob@eps.s.u-tokyo.ac.jp	Geller, Robert J/A-1753-2009	Geller, Robert J/0000-0001-6628-9431				[Anonymous], 2016, JAPAN TIMES     0707; Geller RJ, 2011, NATURE, V472, P407, DOI 10.1038/nature10105; Kagan YY, 2012, SEISMOL RES LETT, V83, P951, DOI 10.1785/0220120107	3	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					289	289		10.1038/545289c	http://dx.doi.org/10.1038/545289c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516930	Bronze			2022-12-28	WOS:000401466500044
J	Hildebrand, DGC; Cicconet, M; Torres, RMI; Choi, W; Quan, TM; Moon, J; Wetzel, AW; Champion, AS; Graham, BJ; Randlett, O; Plummer, GS; Portugues, R; Bianco, IH; Saalfeld, S; Baden, AD; Lillaney, K; Burns, R; Vogelstein, JT; Schier, AF; Lee, WCA; Jeong, WK; Lichtman, JW; Engert, F				Hildebrand, David Grant Colburn; Cicconet, Marcelo; Iguel Torres, Russel M.; Choi, Woohyuk; Quan, Tran Minh; Moon, Jungmin; Wetzel, Arthur Willis; Champion, Andrew Scott; Graham, Brett Jesse; Randlett, Owen; Plummer, George Scott; Portugues, Ruben; Bianco, Isaac Henry; Saalfeld, Stephan; Baden, Alexander David; Lillaney, Kunal; Burns, Randal; Vogelstein, Joshua Tzvi; Schier, Alexander Franz; Lee, Wei-Chung Allen; Jeong, Won-Ki; Lichtman, Jeff William; Engert, Florian			Whole-brain serial-section electron microscopy in larval zebrafish	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CIRCUIT RECONSTRUCTION; SYNAPTIC ORGANIZATION; NEURAL CIRCUITS; HIGH-RESOLUTION; VISUAL-CORTEX; NETWORK; VOLUME; NEURONS; CONNECTIVITY	High-resolution serial-section electron microscopy (ssEM) makes it possible to investigate the dense meshwork of axons, dendrites, and synapses that form neuronal circuits(1). However, the imaging scale required to comprehensively reconstruct these structures is more than ten orders of magnitude smaller than the spatial extents occupied by networks of interconnected neurons(2), some of which span nearly the entire brain. Difficulties in generating and handling data for large volumes at nanoscale resolution have thus restricted vertebrate studies to fragments of circuits. These efforts were recently transformed by advances in computing, sample handling, and imaging techniques(1), but high-resolution examination of entire brains remains a challenge. Here, we present ssEM data for the complete brain of a larval zebrafish (Danio rerio) at 5.5 days post-fertilization. Our approach utilizes multiple rounds of targeted imaging at different scales to reduce acquisition time and data management requirements. The resulting dataset can be analysed to reconstruct neuronal processes, permitting us to survey all myelinated axons (the projectome). These reconstructions enable precise investigations of neuronal morphology, which reveal remarkable bilateral symmetry in myelinated reticulospinal and lateral line afferent axons. We further set the stage for whole-brain structure-function comparisons by co-registering functional reference atlases and in vivo two-photon fluorescence microscopy data from the same specimen. All obtained images and reconstructions are provided as an open-access resource.	[Hildebrand, David Grant Colburn] Harvard Univ, Grad Sch Arts & Sci, Grad Program Neurosci, Div Med Sci, Cambridge, MA 02138 USA; [Hildebrand, David Grant Colburn; Iguel Torres, Russel M.; Randlett, Owen; Plummer, George Scott; Portugues, Ruben; Bianco, Isaac Henry; Schier, Alexander Franz; Lichtman, Jeff William; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hildebrand, David Grant Colburn; Schier, Alexander Franz; Lichtman, Jeff William; Engert, Florian] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hildebrand, David Grant Colburn; Iguel Torres, Russel M.; Graham, Brett Jesse; Lee, Wei-Chung Allen] Harvard Med Sch, Boston, MA 02115 USA; [Hildebrand, David Grant Colburn; Cicconet, Marcelo] Harvard Med Sch, Image & Data Anal Core, Boston, MA 02115 USA; [Choi, Woohyuk; Quan, Tran Minh; Moon, Jungmin; Jeong, Won-Ki] UNIST, Sch Elect & Comp Engn, Ulsan, South Korea; [Wetzel, Arthur Willis] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Champion, Andrew Scott; Saalfeld, Stephan] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Baden, Alexander David; Lillaney, Kunal; Burns, Randal] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Vogelstein, Joshua Tzvi] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Vogelstein, Joshua Tzvi] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Schier, Alexander Franz] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schier, Alexander Franz] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schier, Alexander Franz] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Hildebrand, David Grant Colburn] Rockefeller Univ, Lab Neural Syst, 1230 York Ave, New York, NY 10021 USA; [Iguel Torres, Russel M.] Allen Inst Brain Sci, Seattle, WA USA; [Randlett, Owen] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Plummer, George Scott] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Portugues, Ruben] Max Planck Inst Neurobiol, Martinsried, Germany; [Bianco, Isaac Henry] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Lee, Wei-Chung Allen] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Ulsan National Institute of Science & Technology (UNIST); Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Rockefeller University; Allen Institute for Brain Science; University of Pennsylvania; Pennsylvania Medicine; Tufts University; Max Planck Society; University of London; University College London; Harvard University; Boston Children's Hospital	Hildebrand, DGC (corresponding author), Harvard Univ, Grad Sch Arts & Sci, Grad Program Neurosci, Div Med Sci, Cambridge, MA 02138 USA.; Hildebrand, DGC; Engert, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Hildebrand, DGC; Engert, F (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Hildebrand, DGC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Hildebrand, DGC (corresponding author), Harvard Med Sch, Image & Data Anal Core, Boston, MA 02115 USA.; Hildebrand, DGC (corresponding author), Rockefeller Univ, Lab Neural Syst, 1230 York Ave, New York, NY 10021 USA.	david@hildebrand.name; florian@mcb.harvard.edu	Zebrafish, UCL/A-3125-2009; Hildebrand, David G. C./L-8122-2017; Portugues, Ruben/N-4900-2019; Randlett, Owen/AAB-3136-2020; Portugues, Ruben/C-3600-2012; Vogelstein, Joshua/AAG-5489-2019; Quan, Tran Minh/AAQ-2970-2020	Hildebrand, David G. C./0000-0002-2079-3517; Portugues, Ruben/0000-0002-1495-9314; Randlett, Owen/0000-0003-0181-5239; Portugues, Ruben/0000-0002-1495-9314; Vogelstein, Joshua/0000-0003-2487-6237; Quan, Tran Minh/0000-0001-7374-9168; Plummer, George/0000-0002-1270-000X; Lee, Wei-Chung/0000-0002-4618-295X; Burns, Randal/0000-0002-2924-1997; Champion, Andrew/0000-0002-6883-0081; Bianco, Isaac/0000-0002-3149-4862; Schier, Alexander Franz/0000-0001-7645-5325	NIH through NINDS; NIMH [DP1NS082121, RC2NS069407, U01NS090449, R21NS085320]; Harvard CBS Neuroengineering Core [P30NS062685]; NIGMS via the Pittsburgh Supercomputing Center [P41GM103712]; DARPA SIMPLEX program through SPAWAR [N66001-15-C-4041]; Korea NRF through MSIP [NRF-2015M3A9A7029725]; MOE [NRF-2014R1A1A2058773]; NIH [T32MH20017, T32HL007901]; NSF [IIA-EAPSI-1317014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS082121, RC2NS069407, P30NS062685, R24NS086601, U01NS090449, R21NS085320] Funding Source: NIH RePORTER	NIH through NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard CBS Neuroengineering Core; NIGMS via the Pittsburgh Supercomputing Center; DARPA SIMPLEX program through SPAWAR; Korea NRF through MSIP; MOE(Ministry of Education, SingaporeMinistry of Higher Education & Scientific Research (MHESR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. D. Bock and K.-H. Huang for preliminary studies; L.-H. Ma, M. B. Ahrens, and D. Schoppik for dissection help; E. Raviola, H. S. Kim, J. A. Buchanan, E. J. Benecchi, and S. Ito for histology guidance; K. J. Hayworth, J. L. Morgan, N. Kasthuri, and R. Schalek for ssEM advice; T. Kazimiers and J. A. Bogovic for software assistance at the Harvard CBS Neuroengineering Core; B. L. Shanny, A. M. Roberson, M. A. Afifi, F. Gao, A. D. Wong, F. Camacho Garcia, C. S. Elkhill, T. J. Cawley, R. J. Plummer, K. M. Runci, A. Haddad, P. E. Lewis, I. Odstrcil, A. H. Cohen, and P. I. Petkova for reconstructions; and R. C. Reid, R. I. Wilson, and J. R. Sanes for valuable input. Support was provided by the NIH through NINDS and NIMH to F.E. (DP1NS082121, RC2NS069407, U01NS090449) and W.-C.A.L. (R21NS085320) and the Harvard CBS Neuroengineering Core (P30NS062685), through NIGMS to MMBioS via the Pittsburgh Supercomputing Center (P41GM103712); by the DARPA SIMPLEX program through SPAWAR to R.B. and J.T.V. (N66001-15-C-4041); by the Korea NRF through MSIP (NRF-2015M3A9A7029725) and MOE (NRF-2014R1A1A2058773) to W.-K.J.; and by the NIH (T32MH20017, T32HL007901) and the NSF (IIA-EAPSI-1317014) to D.G.C.H.	Ahrens MB, 2015, CURR OPIN NEUROBIOL, V32, P78, DOI 10.1016/j.conb.2015.01.007; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Bianco IH, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00101; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bogovic JA, 2016, I S BIOMED IMAGING, P1123, DOI 10.1109/ISBI.2016.7493463; Brand Michael, 2002, P7; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; CHALFIE M, 1985, J NEUROSCI, V5, P956; Choi H, 2014, IEEE T VIS COMPUT GR, V20, P2407, DOI 10.1109/TVCG.2014.2346322; Cicconet M., 2017, PREPRINT; da Costa NM, 2010, J NEUROSCI, V30, P13166, DOI 10.1523/JNEUROSCI.3122-10.2010; Dunn TW, 2016, NEURON, V89, P613, DOI 10.1016/j.neuron.2015.12.021; Eberle AL, 2015, J MICROSC-OXFORD, V259, P114, DOI 10.1111/jmi.12224; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Hildebrand D. G. C., 2015, WHOLE BRAIN FUNCTION; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Luft JH, ADV TECHNIQUES BIOL, P1; Ma LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1045; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; Marquart G. D., 2016, PREPRINT; Marquart GD, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00078; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; Mikula S, 2015, NAT METHODS, V12, P541, DOI 10.1038/nmeth.3361; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Morgan JL, 2016, CELL, V165, P192, DOI 10.1016/j.cell.2016.02.033; Mueller T, 2005, ATLAS EARLY ZEBRAFIS, P183; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Oteiza P., NATURE IN PRESS; Peters A., 1991, FINE STRUCTURE NERVO; Portugues R, 2014, NEURON, V81, P1328, DOI 10.1016/j.neuron.2014.01.019; Randel N, 2014, ELIFE, V3, DOI 10.7554/eLife.02730; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Saalfeld S, 2010, BIOINFORMATICS, V26, pi57, DOI 10.1093/bioinformatics/btq219; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider-Mizell CM, 2016, ELIFE, V5, DOI 10.7554/eLife.12059; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Turner MH, 2012, J PHYSIOL-LONDON, V590, P2233, DOI 10.1113/jphysiol.2011.225896; Wanner AA, 2016, NAT NEUROSCI, V19, P816, DOI 10.1038/nn.4290; Wetzel A. W., APPL IM PAT IN PRESS; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002	59	159	161	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					345	+		10.1038/nature22356	http://dx.doi.org/10.1038/nature22356			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489821	Green Submitted, Green Accepted			2022-12-28	WOS:000401466500062
J	Campbell, BH				Campbell, Bruce H.			Determination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Campbell, Bruce H.] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Campbell, BH (corresponding author), Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Milwaukee, WI 53226 USA.	bcampbell@mcw.edu						Center for Medicare Advocacy, MED DENT EXCL IS IT; Field MJ, 2000, EXTENDING MED COVERA	2	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1953	1954		10.1001/jama.2017.0629	http://dx.doi.org/10.1001/jama.2017.0629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510683				2022-12-28	WOS:000401315500013
J	Steinberg, DI				Steinberg, Daniel I.			Review: Interventions improve hospital antibiotic prescribing and reduce hospital stay but do not affect mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Steinberg, Daniel I.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Steinberg, DI (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	p.g.davey@dundee.ac.uk							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC59	JC59		10.7326/ACPJC-2017-166-10-059	http://dx.doi.org/10.7326/ACPJC-2017-166-10-059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505643				2022-12-28	WOS:000401240200011
J	Nozawa, K; Schneider, TR; Cramer, P				Nozawa, Kayo; Schneider, Thomas R.; Cramer, Patrick			Core Mediator structure at 3.4 angstrom extends model of transcription initiation complex	NATURE			English	Article							RNA-POLYMERASE-II; YEAST MEDIATOR; REQUIREMENT; ARCHITECTURE; MODULE; DOMAIN; REFINEMENT; CONTAINS; CRYSTALS; SUBUNIT	Mediator is a multiprotein co-activator that binds the transcription pre-initiation complex (PIC) and regulates RNA polymerase (Pol) II1-3. The Mediator head and middle modules form the essential core Mediator (cMed)(4-6), whereas the tail and kinase modules play regulatory roles(7). The architecture of Mediator(5,8-10) and its position on the PIC5 are known, but atomic details are limited to Mediator subcomplexes(11,12). Here we report the crystal structure of the 15-subunit cMed from Schizosaccharomyces pombe at 3.4 angstrom resolution. The structure shows an unaltered head module(13-15), and reveals the intricate middle module, which we show is globally required for transcription. Sites of known Mediator mutations cluster at the interface between the head and middle modules, and in terminal regions of the head subunits Med6 (ref. 16) and Med17 (ref. 17) that tether the middle module. The structure led to a model for Saccharomyces cerevisiae cMed that could be combined(5) with the 3.6 angstrom cryo-electron microscopy structure of the core PIC (cPIC)(18). The resulting atomic model of the cPIC-cMed complex informs on interactions of the submodules forming the middle module, called beam, knob, plank, connector, and hook. The hook is flexibly linked to Mediator by a conserved hinge(19) and contacts the transcription initiation factor IIH (TFIIH) kinase that phosphorylates the carboxy (C)-terminal domain (CTD) of Pol II and was recently positioned on the PIC20. The hook also contains residues that crosslink to the CTD and reside in a previously described cradle(5). These results provide a framework for understanding Mediator function, including its role in stimulating CTD phosphorylation by TFIIH.	[Nozawa, Kayo; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany; [Schneider, Thomas R.] Deutsch Elektronen Synchrotron DESY, European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	pcramer@mpibpc.mpg.de	Schneider, Thomas/B-7442-2011	Schneider, Thomas/0000-0001-6955-7374; Nozawa, Kayo/0000-0001-6677-7195	Human Frontier Science Program [LT000621/2012-L]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [SFB860, SPP1935]; European Research Council Advanced Investigator Grant TRANSREGULON [693023]	Human Frontier Science Program(Human Frontier Science Program); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Investigator Grant TRANSREGULON	We thank members of the Cramer laboratory, in particular C. Plaschka, S. Sainsbury, C. Engel, L. Wenzeck, and L. Lariviere. We thank K. Maier and P. Rus for 4-thiouracil sequencing (4tU-seq) data acquisition, and S. Berres and B. Schwalb for bioinformatics. We thank C.-T. Lee and H. Urlaub for mass spectrometry. We thank the staff at EMBL beamline P14 at the Deutsches Elektronen Synchrotron, in particular G. Bourenkov, and on beamline PXI at the Swiss Light Source in Villigen, Switzerland, in particular T. Tomizaki. K.N. was supported by postdoctoral fellowships from the Human Frontier Science Program (LT000621/2012-L), the Uehara Memorial Foundation and the Japan Society for the Promotion of Science. P.C. was supported by the Deutsche Forschungsgemeinschaft (SFB860, SPP1935) and the European Research Council Advanced Investigator Grant TRANSREGULON (grant agreement number 693023).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Alontaga AY, 2015, J BIOL CHEM, V290, P16550, DOI 10.1074/jbc.M115.644047; Baejen C, 2017, MOL CELL, V66, P38, DOI 10.1016/j.molcel.2017.02.009; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Deng XD, 2012, ACTA CRYSTALLOGR F, V68, P105, DOI [10.1107/S1744309111048706, 10.1107/S1744309111048706105]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eychenne T, 2016, GENE DEV, V30, P2119, DOI 10.1101/gad.285775.116; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Han SJ, 1999, MOL CELL BIOL, V19, P979; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Jeronimo C, 2016, MOL CELL, V64, P455, DOI 10.1016/j.molcel.2016.09.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee YC, 1998, MOL CELL BIOL, V18, P5364, DOI 10.1128/MCB.18.9.5364; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peiro-Chova L, 2007, GENETICS, V176, P125, DOI 10.1534/genetics.106.066829; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Plaschka C, 2016, J MOL BIOL, V428, P2569, DOI 10.1016/j.jmb.2016.01.028; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08719; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Sato S, 2016, J BIOL CHEM, V291, P26886, DOI 10.1074/jbc.M116.756098; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Tsai K. L., 2017, NATURE; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1	51	69	74	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					248	+		10.1038/nature22328	http://dx.doi.org/10.1038/nature22328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467824				2022-12-28	WOS:000400963800039
J	Lyon, J				Lyon, Jeff			Farewell to a Cancer That Never Was	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1824	1825		10.1001/jama.2017.3969	http://dx.doi.org/10.1001/jama.2017.3969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492897				2022-12-28	WOS:000400842400002
J	Rai, SK; Fung, TT; Lu, N; Keller, SF; Curhan, GC; Choi, HK				Rai, Sharan K.; Fung, Teresa T.; Lu, Na; Keller, Sarah F.; Curhan, Gary C.; Choi, Hyon K.			The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SERUM URIC-ACID; 3RD NATIONAL-HEALTH; PURINE-RICH FOODS; VITAMIN-C SUPPLEMENTATION; US GENERAL-POPULATION; BLOOD-PRESSURE; RECURRENT GOUT; WEIGHT-LOSS; PATTERNS	OBJECTIVE To prospectively examine the relation between the Dietary Approaches to Stop Hypertension (DASH) and Western diets and risk of gout (ie, the clinical endpoint of hyperuricemia) in men. DESIGN Prospective cohort study. SETTING The Health Professionals Follow-up Study. PARTICIPANTS 44 444 men with no history of gout at baseline. Using validated food frequency questionnaires, each participant was assigned a DASH dietary pattern score (based on high intake of fruits, vegetables, nuts and legumes, low fat dairy products, and whole grains, and low intake of sodium, sweetened beverages, and red and processed meats) and a Western dietary pattern score (based on high intake of red and processed meats, French fries, refined grains, sweets, and desserts). MAIN OUTCOME MEASURE Risk of incident gout meeting the preliminary American College of Rheumatology survey criteria for gout, adjusting for potential confounders, including age, body mass index, hypertension, diuretic use, and alcohol intake. RESULTS During 26 years of follow-up, 1731 confirmed cases of incident gout were documented. A higher DASH dietary pattern score was associated with a lower risk for gout (adjusted relative risk for extreme fifths 0.68, 95% confidence interval 0.57 to 0.80, P value for trend <0.001). In contrast, a higher Western dietary pattern score was associated with an increased risk for gout (1.42, 1.16 to 1.74, P=0.005). CONCLUSION The DASH diet is associated with a lower risk of gout, suggesting that its effect of lowering uric acid levels in individuals with hyperuricemia translates to a lower risk of gout. Conversely, the Western diet is associated with a higher risk of gout. The DASH diet may provide an attractive preventive dietary approach for men at risk of gout.	[Rai, Sharan K.; Lu, Na; Keller, Sarah F.; Choi, Hyon K.] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Rai, Sharan K.; Lu, Na; Curhan, Gary C.; Choi, Hyon K.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA USA; [Rai, Sharan K.; Choi, Hyon K.] Arthrit Res Canada, Richmond, BC, Canada; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Fung, Teresa T.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Curhan, Gary C.] Harvard Med Sch, Brigham & Womens Hosp, Div Renal Kidney Med, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Arthritis Research Canada; Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, HK (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.; Choi, HK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA USA.; Choi, HK (corresponding author), Arthrit Res Canada, Richmond, BC, Canada.	hchoi@partners.org			National Institutes of Health [R01AR065944, UM1CA167552]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by grants R01AR065944 and UM1CA167552 from the National Institutes of Health. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P109, DOI 10.1002/art.22466; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi HK, 2009, ARCH INTERN MED, V169, P502, DOI 10.1001/archinternmed.2008.606; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Dessein PH, 2000, ANN RHEUM DIS, V59, P539, DOI 10.1136/ard.59.7.539; Emmerson B, 1998, ANN RHEUM DIS, V57, P509, DOI 10.1136/ard.57.9.509; Fam AG, 2002, J RHEUMATOL, V29, P1350; Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Gao X, 2008, J RHEUMATOL, V35, P1853; Gao XA, 2007, HYPERTENSION, V50, P306, DOI 10.1161/HYPERTENSIONAHA.107.091041; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Huang HY, 2005, ARTHRITIS RHEUM, V52, P1843, DOI 10.1002/art.21105; Juraschek SP, 2016, ARTHRITIS RHEUMATOL, V68, P3002, DOI 10.1002/art.39813; Juraschek SP, 2011, ARTHRIT CARE RES, V63, P1295, DOI 10.1002/acr.20519; Karanja N, 2007, J AM DIET ASSOC, V107, P1530, DOI 10.1016/j.jada.2007.06.013; Karanja NM, 1999, J AM DIET ASSOC, V99, pS19, DOI 10.1016/S0002-8223(99)00412-5; Kim JO, 1978, FACTOR ANAL STAT MET, DOI [10.4135/9781412984256, DOI 10.4135/9781412984256]; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; Nguyen S, 2009, J PEDIATR-US, V154, P807, DOI 10.1016/j.jpeds.2009.01.015; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Rai SK, 2017, SEMIN ARTHRITIS RHEU, V46, P451, DOI 10.1016/j.semarthrit.2016.08.006; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Singh JA, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1067-3; Taylor EN, 2009, J AM SOC NEPHROL, V20, P2253, DOI 10.1681/ASN.2009030276; terMaaten JC, 1997, CLIN SCI, V92, P51; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Willett W., 1990, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang YQ, 2012, ANN RHEUM DIS, V71, P1448, DOI 10.1136/annrheumdis-2011-201215; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	55	109	111	4	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2017	357								j1794	10.1136/bmj.j1794	http://dx.doi.org/10.1136/bmj.j1794			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UA	28487277	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000401169100001
J	Boyle, J; Mills, P; McCaffrey, E				Boyle, Jonathan; Mills, Patricia; McCaffrey, Emily			Gerard John McCaffrey	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MCCAFFREY GJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2119	10.1136/bmj.j2119	http://dx.doi.org/10.1136/bmj.j2119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483747				2022-12-28	WOS:000401412700006
J	Zhang, YS; Khademhosseini, A				Zhang, Yu Shrike; Khademhosseini, Ali			Advances in engineering hydrogels	SCIENCE			English	Review							AQUEOUS GELATIN SOLUTIONS; STEM-CELL FATE; NANOCOMPOSITE HYDROGELS; TISSUE CONSTRUCTS; HYBRID HYDROGELS; TOUGH HYDROGELS; GROWTH; COMPLEX; FABRICATION; SCAFFOLDS	Hydrogels are formed from hydrophilic polymer chains surrounded by a water-rich environment. They have widespread applications in various fields such as biomedicine, soft electronics, sensors, and actuators. Conventional hydrogels usually possess limited mechanical strength and are prone to permanent breakage. Further, the lack of dynamic cues and structural complexity within the hydrogels has limited their functions. Recent developments include engineering hydrogels that possess improved physicochemical properties, ranging from designs of innovative chemistries and compositions to integration of dynamic modulation and sophisticated architectures. We review major advances in designing and engineering hydrogels and strategies targeting precise manipulation of their properties across multiple scales.	[Zhang, Yu Shrike; Khademhosseini, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Biomat Innovat Res Ctr,Div Biomed Engn, Cambridge, MA 02139 USA; [Zhang, Yu Shrike; Khademhosseini, Ali] MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhang, Yu Shrike; Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea; [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Konkuk University; King Abdulaziz University	Khademhosseini, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Biomat Innovat Res Ctr,Div Biomed Engn, Cambridge, MA 02139 USA.; Khademhosseini, A (corresponding author), MIT, Harvard MIT Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Khademhosseini, A (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Khademhosseini, A (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea.; Khademhosseini, A (corresponding author), King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.	alik@bwh.harvard.edu	Khademhosseini, Ali/A-9435-2010; Zhang, Yu Shrike/H-4885-2013	Khademhosseini, Ali/0000-0002-2692-1524; Zhang, Yu Shrike/0000-0002-0045-0808	National Institutes of Health [AR057837, DE021468, D005865, AR068258, AR066193, EB022403, EB021148]; Office of Naval Research Presidential Early Career Award for Scientists and Engineers (PECASE); National Cancer Institute of the National Institutes of Health Pathway to Independence Award [K99CA201603]; NATIONAL CANCER INSTITUTE [K99CA201603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068258, R01AR066193, R01AR057837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB021148, R21EB022403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research Presidential Early Career Award for Scientists and Engineers (PECASE)(Office of Naval Research); National Cancer Institute of the National Institutes of Health Pathway to Independence Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors acknowledge funding from the National Institutes of Health (grants AR057837, DE021468, D005865, AR068258, AR066193, EB022403, and EB021148) and the Office of Naval Research Presidential Early Career Award for Scientists and Engineers (PECASE). Y.S.Z. acknowledges the National Cancer Institute of the National Institutes of Health Pathway to Independence Award (K99CA201603). We greatly appreciate S. Masoud Moosavi-Basri for assistance with figure illustrations. We also thank S. Hassan, J. Seo, and W. Wang for their valuable discussions.	Annabi N, 2016, ADV MATER, V28, P40, DOI 10.1002/adma.201503255; Annabi N, 2013, BIOCHEM ENG J, V77, P110, DOI 10.1016/j.bej.2013.05.006; Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076; Appel EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7295; Avery RK, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah5533; Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q; Bekturov E. A., 1981, SPECIALITY POLYM, P99; Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g; Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Bin Imran A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6124; Blaeser A, 2016, ADV HEALTHC MATER, V5, P326, DOI 10.1002/adhm.201500677; Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Breger JC, 2015, ACS APPL MATER INTER, V7, P3398, DOI 10.1021/am508621s; Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271; Calo E, 2015, EUR POLYM J, V65, P252, DOI 10.1016/j.eurpolymj.2014.11.024; Chan KWY, 2013, NAT MATER, V12, P268, DOI [10.1038/NMAT3525, 10.1038/nmat3525]; Choi M, 2013, NAT PHOTONICS, V7, P987, DOI [10.1038/NPHOTON.2013.278, 10.1038/nphoton.2013.278]; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Colosi C, 2016, ADV MATER, V28, P677, DOI 10.1002/adma.201503310; Cui JX, 2012, CHEM COMMUN, V48, P9302, DOI 10.1039/c2cc34701f; Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111; DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/NMAT4219, 10.1038/nmat4219]; DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/NCHEM.1174, 10.1038/nchem.1174]; DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DJABOUROV M, 1988, J PHYS-PARIS, V49, P319, DOI 10.1051/jphys:01988004902031900; DJABOUROV M, 1988, J PHYS-PARIS, V49, P333, DOI 10.1051/jphys:01988004902033300; Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105; Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102; Du YA, 2010, BIOTECHNOL BIOENG, V105, P655, DOI 10.1002/bit.22552; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feinberg AW, 2015, ANNU REV BIOMED ENG, V17, P243, DOI 10.1146/annurev-bioeng-071114-040632; Gaharwar AK, 2014, ACS NANO, V8, P9833, DOI 10.1021/nn503719n; Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160; Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584; Gasperini L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0817; Ge Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31110; Geisler IM, 2012, ADV FUNCT MATER, V22, P529, DOI 10.1002/adfm.201102330; Gladman AS, 2016, NAT MATER, V15, P413, DOI [10.1038/NMAT4544, 10.1038/nmat4544]; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Gonzalez MA, 2017, ADV MATER, V29, DOI 10.1002/adma.201604743; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Hardin JO, 2015, ADV MATER, V27, P3279, DOI 10.1002/adma.201500222; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/j.addr.2012.09.009; Heo YJ, 2011, P NATL ACAD SCI USA, V108, P13399, DOI 10.1073/pnas.1104954108; Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234; Hinton TJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500758; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201501099, 10.1002/adma.201570182]; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Ionov L, 2014, MATER TODAY, V17, P494, DOI 10.1016/j.mattod.2014.07.002; Jeong KU, 2011, J MATER CHEM, V21, P6824, DOI 10.1039/c0jm03631e; Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811; Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kokkinis D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9643; Kolesky DB, 2016, P NATL ACAD SCI USA, V113, P3179, DOI 10.1073/pnas.1521342113; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kuribayashi-Shigetomi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051085; Larson C, 2016, SCIENCE, V351, P1071, DOI 10.1126/science.aac5082; Laschewsky A, 2001, MACROMOL CHEM PHYSIC, V202, P276, DOI 10.1002/1521-3935(20010101)202:2<276::AID-MACP276>3.0.CO;2-1; Leijten J, 2016, SMALL, V12, P2130, DOI 10.1002/smll.201501798; Li JY, 2014, J MATER CHEM B, V2, P6708, DOI 10.1039/c4tb01194e; Li JY, 2014, ACS MACRO LETT, V3, P520, DOI 10.1021/mz5002355; Li YC, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/9/1/012001; Lin ST, 2016, ADV MATER, V28, P4497, DOI 10.1002/adma.201504152; Liu J, 2016, LAB CHIP, V16, P1430, DOI 10.1039/c6lc00144k; Liu WJ, 2017, ADV MATER, V29, DOI 10.1002/adma.201604630; Loessner D, 2016, NAT PROTOC, V11, P727, DOI 10.1038/nprot.2016.037; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n; Ma CX, 2014, ADV MATER, V26, P5665, DOI 10.1002/adma.201402026; Ma XY, 2016, P NATL ACAD SCI USA, V113, P2206, DOI 10.1073/pnas.1524510113; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Miao SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27226; Morton SW, 2013, ADV MATER, V25, P4707, DOI 10.1002/adma.201302025; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Nakahata M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1521; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]; Ober TJ, 2015, P NATL ACAD SCI USA, V112, P12293, DOI 10.1073/pnas.1509224112; Oh JY, 2016, NATURE, V539, P411, DOI 10.1038/nature20102; Oliveira NM, 2016, CHEM MATER, V28, P3641, DOI 10.1021/acs.chemmater.5b04445; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Paul A, 2014, ACS NANO, V8, P8050, DOI 10.1021/nn5020787; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Peppas NA, 2016, NATURE, V540, P335, DOI 10.1038/540335a; Phadke A, 2012, P NATL ACAD SCI USA, V109, P4383, DOI 10.1073/pnas.1201122109; Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/NMAT3922, 10.1038/nmat3922]; Qi H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3275; Raman R, 2016, P NATL ACAD SCI USA, V113, P3497, DOI 10.1073/pnas.1516139113; Raviv D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07422; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300, DOI 10.1096/fj.00-0564fje; Saladin K. S., 1998, ANATOMY PHYSL; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Shin SR, 2016, SMALL, V12, P3677, DOI 10.1002/smll.201600178; Shin SR, 2015, ADV FUNCT MATER, V25, P4486, DOI 10.1002/adfm.201501379; Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Sun TL, 2013, NAT MATER, V12, P932, DOI [10.1038/NMAT3713, 10.1038/nmat3713]; Taubenberger AV, 2016, ACTA BIOMATER, V36, P73, DOI 10.1016/j.actbio.2016.03.017; Tibbits S, 2014, ARCHIT DESIGN, V84, P116, DOI 10.1002/ad.1710; Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804; Todhunter ME, 2015, NAT METHODS, V12, P975, DOI [10.1038/NMETH.3553, 10.1038/nmeth.3553]; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Visser J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7933; Wang E, 2013, NANO LETT, V13, P2826, DOI 10.1021/nl401088b; Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215; Watarai A, 2015, ACTA BIOMATER, V25, P65, DOI 10.1016/j.actbio.2015.07.036; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Wu ZL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2549; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]; Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yang ZM, 2007, SOFT MATTER, V3, P515, DOI 10.1039/b700138j; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yu Q, 2001, APPL PHYS LETT, V78, P2589, DOI 10.1063/1.1367010; Yuk H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12028; Yuk H, 2016, NAT MATER, V15, P190, DOI [10.1038/NMAT4463, 10.1038/nmat4463]; Zhang LD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8429; Zhang M., 2012, ANGEW CHEM INT EDIT, V124, P7117, DOI DOI 10.1002/ANGE.201203063; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang YW, 2016, ACTA ASTRONAUT, V123, P109, DOI 10.1016/j.actaastro.2016.02.021; Zhang YN, 2015, ADV FUNCT MATER, V25, P4814, DOI 10.1002/adfm.201501489; Zhang YS, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034006; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e; Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108; Zieris A, 2014, BIOMACROMOLECULES, V15, P4439, DOI 10.1021/bm5012294	142	1364	1385	333	3488	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337							eaaf3627	10.1126/science.aaf3627	http://dx.doi.org/10.1126/science.aaf3627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473537	Green Accepted			2022-12-28	WOS:000400545700027
J	Staubach, F				Staubach, Fabian			Note limitations of DNA legislation	NATURE			English	Letter									[Staubach, Fabian] Univ Freiberg, Inst Biol 1, Freiburg, Germany	University of Freiburg	Staubach, F (corresponding author), Univ Freiberg, Inst Biol 1, Freiburg, Germany.	fabian.staubach@gmail.com	Mupepele, Anne-Christine/J-3855-2014	Mupepele, Anne-Christine/0000-0002-5671-0963; Surdu, Mihai/0000-0002-1941-3193				Phillips C, 2015, FORENSIC SCI INT-GEN, V18, P49, DOI 10.1016/j.fsigen.2015.05.012; 2017, NATURE, V543, P589	2	13	13	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					30	30		10.1038/545030c	http://dx.doi.org/10.1038/545030c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470205	Bronze			2022-12-28	WOS:000400480400018
J	Tregoning, J				Tregoning, John			No researcher is too junior to fix science	NATURE			English	Editorial Material									[Tregoning, John] Imperial Coll London, London, England	Imperial College London	Tregoning, J (corresponding author), Imperial Coll London, London, England.	john.tregoning@imperial.ac.uk		Tregoning, John/0000-0001-8093-8741					0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					7	7		10.1038/545007a	http://dx.doi.org/10.1038/545007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470218	Bronze, Green Submitted			2022-12-28	WOS:000400480400004
J	Armstrong, S				Armstrong, Stephen			Patient access to health records: striving for the Swedish ideal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ONLINE ACCESS					stephen.armstrong@me.com						Hagglund M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h359; Joustra-Enquist I, SUSTAINS DIRECT ACCE; Lyttkens L., 2014, D6 1 V1 1 SUSTAINS I; Ministry of Health and Social Affairs, 2011, NAT EH STRAT ACC SEC; National Information Board, 2015, HLTH SECR OUTL VIS U; NHS England, 2015, OV 55 MILL PAT ENGL; Rexhepi H, 2016, HLTH INFORM J; Scandurra I, 2015, PROCEDIA COMPUT SCI, V64, P964, DOI 10.1016/j.procs.2015.08.614; University Health Network, 2016, MYUHN PAT PORT PAT D; Walker J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7785; Woodhead M., 2013, PULSE TODAY     0213	11	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j2069	10.1136/bmj.j2069	http://dx.doi.org/10.1136/bmj.j2069			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465316				2022-12-28	WOS:000400889500006
J	Wise, J; Samsom, M				Wise, Jacqui; Samsom, Melvin			INTERVIEW Melvin Samsom: Rebuilding hospitals for patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Armstrong S, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2069; Richards T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5765	2	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j2088	10.1136/bmj.j2088	http://dx.doi.org/10.1136/bmj.j2088			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465344				2022-12-28	WOS:000400889500008
J	Bray, BD; Steventon, A				Bray, Benjamin D.; Steventon, Adam			Data linkage studies can help to explain the weekend effect	LANCET			English	Editorial Material									[Bray, Benjamin D.] UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England; [Steventon, Adam] Hlth Fdn, Data Analyt, London, England	University of London; University College London	Bray, BD (corresponding author), UCL, Farr Inst Hlth Informat Res, London NW1 2DA, England.	benjamin.bray@kcl.ac.uk						Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Black N, 2016, JAMA-J AM MED ASSOC, V316, P2593, DOI 10.1001/jama.2016.16410; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Goddard AF, 2016, JAMA-J AM MED ASSOC, V316, P1445, DOI 10.1001/jama.2016.12029; Li LX, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2648; National Cancer Institute, CANCER MOONSHOT; Schneeweiss S, 2014, NEW ENGL J MED, V370, P2161, DOI 10.1056/NEJMp1401111; Snowden JM, 2017, BMJ QUAL SAF, V26, DOI 10.1136/bmjqs-2016-005257; Walker AS, 2017, LANCET	11	3	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					8	+		10.1016/S0140-6736(17)31195-9	http://dx.doi.org/10.1016/S0140-6736(17)31195-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28499550	hybrid			2022-12-28	WOS:000404396300007
J	Walker, AS; Mason, A; Quan, TP; Fawcett, NJ; Watkinson, P; Llewelyn, M; Stoesser, N; Finney, J; Davies, J; Wyllie, DH; Crook, DW; Peto, TEA				Walker, A. Sarah; Mason, Amy; Phuong Quan, T.; Fawcett, Nicola J.; Watkinson, Peter; Llewelyn, Martin; Stoesser, Nicole; Finney, John; Davies, Jim; Wyllie, David H.; Crook, Derrick W.; Peto, Tim E. A.			Mortality risks associated with emergency admissions during weekends and public holidays: an analysis of electronic health records	LANCET			English	Article								Background Weekend hospital admission is associated with increased mortality, but the contributions of varying illness severity and admission time to this weekend effect remain unexplored. Methods We analysed unselected emergency admissions to four Oxford University National Health Service hospitals in the UK from Jan 1, 2006, to Dec 31, 2014. The primary outcome was death within 30 days of admission (in or out of hospital), analysed using Cox models measuring time from admission. The primary exposure was day of the week of admission. We adjusted for multiple confounders including demographics, comorbidities, and admission characteristics, incorporating non-linearity and interactions. Models then considered the effect of adjusting for 15 common haematology and biochemistry test results or proxies for hospital workload. Findings 257 596 individuals underwent 503 938 emergency admissions. 18 313 (4.7%) patients admitted as weekday energency admissions and 6070 (5.1%) patients admitted as weekend emergency admissions died within 30 days (p<0.0001). 9347 individuals underwent 9707 emergency admissions on public holidays. 559 (5.8%) died within 30 days (p<0.0001 vs weekday). 15 routine haematology and biochemistry test results were highly prognostic for mortality. In 271 465 (539%) admissions with complete data, adjustment for test results explained 33% (95% CI 21 to 70) of the excess mortality associated with emergency admission on Saturdays compared with Wednesdays, 52% (lower 95% CI 34) on Sundays, and 87% (lower 95% CI 45) on public holidays after adjustment for standard patient characteristics. Excess mortality was predominantly restricted to admissions between 1100 h and 1500 h (p(interaction)=004). No hospital workload measure was independently associated with mortality (all p values >0.06). Interpretation Adjustment for routine test results substantially reduced excess mortality associated with emergency admission at weekends and public holidays. Adjustment for patient-level factors not available in our study might further reduce the residual excess mortality, particularly as this clustered around midday at weekends. Hospital workload was not associated with mortality. Together, these findings suggest that the weekend effect arises from patient-level differences at admission rather than reduced hospital staffing or services.	[Walker, A. Sarah; Mason, Amy; Phuong Quan, T.; Fawcett, Nicola J.; Watkinson, Peter; Llewelyn, Martin; Stoesser, Nicole; Finney, John; Davies, Jim; Wyllie, David H.; Crook, Derrick W.; Peto, Tim E. A.] Univ Oxford, Oxford Biomed Res Ctr, Nuffield Dept Med, Oxford, England; [Walker, A. Sarah; Mason, Amy; Phuong Quan, T.; Fawcett, Nicola J.; Llewelyn, Martin; Stoesser, Nicole; Finney, John; Wyllie, David H.; Crook, Derrick W.; Peto, Tim E. A.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Watkinson, Peter] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford, England; [Llewelyn, Martin] Univ Sussex, Brighton & Sussex Med Sch, Falmer, England; [Davies, Jim] Univ Oxford, Dept Comp Sci, Oxford, England; [Wyllie, David H.; Crook, Derrick W.] Publ Hlth England, Natl Infect Serv, London, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Brighton; University of Sussex; University of Oxford; Public Health England	Walker, AS (corresponding author), John Radcliffe Hosp, Microbiol Level 7, Oxford OX3 9DU, England.	sarah.walker@ndm.ox.ac.uk	Llewelyn, Martin/A-7194-2011; Walker, Sarah/HDM-8717-2022; Llewelyn, Martin/Y-1472-2019; Stoesser, Nicole/H-3421-2019	Llewelyn, Martin/0000-0002-6811-1124; Stoesser, Nicole/0000-0002-4508-7969; Quan, Thai/0000-0001-8566-1817; Watkinson, Peter/0000-0003-1023-3927; Davies, Jim/0000-0003-4664-6862; Mason, Amy/0000-0002-8019-0777	National Institute for Health Research Oxford Biomedical Research Centre; NIHR Research Methods Fellowship; Medical Research Council UK Clinical Research Training Fellowship; MRC [MR/M003736/1] Funding Source: UKRI; Medical Research Council [MR/M003736/1] Funding Source: researchfish	National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Research Methods Fellowship; Medical Research Council UK Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the people of Oxfordshire who contribute to the IORD, the Research Database Team, and the Patient and Public Panel. We also particularly thank Connie Junghans for comments on the manuscript, and the referees for their thoughtful and constructive reviews and suggestions which have substantially improved the analysis. This work was supported by the National Institute for Health Research Oxford Biomedical Research Centre; an NIHR Research Methods Fellowship to TPQ; and a Medical Research Council UK Clinical Research Training Fellowship to NJF. TEAP and DWC are NIHR Senior Investigators. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. IORD has Research Ethics Committee and Health Research Authority approval as a generic electronic research database (14/SC/1069, ECC5-017[a]/2009).	Academy of Medical Royal Colleges, 2012, 7 DAY CONS PRES CAR; Agency for Healthcare Research and Quality, 2017, CLASS SOFTW MORT REP; Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; [Anonymous], 2013, NHS SERVICES 7 DAY W; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Barba R, 2006, EUR J INTERN MED, V17, P322, DOI 10.1016/j.ejim.2006.01.003; Bray BD, 2016, LANCET, V388, P170, DOI 10.1016/S0140-6736(16)30443-3; Finney JM, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-7; Freedman LS, 2001, J STAT PLAN INFER, V96, P143, DOI 10.1016/S0378-3758(00)00330-X; Freemantle N, 2012, J ROY SOC MED, V105, P74, DOI 10.1258/jrsm.2012.120009; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Gan H-W, 2015, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.H4596; Handel AE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001789; Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; Lee K G, 2012, Med J Malaysia, V67, P478; Li LX, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2648; Maggs F, 2010, J ROY COLL PHYS EDIN, V40, P115, DOI 10.4997/JRCPE.2010.205; Meacock R, 2016, J HLTH SERV RES POLI; Metcalfe D, 2016, EMERG MED J, V33, P836, DOI 10.1136/emermed-2016-206049; Mohammed MA, 2016, QJM, DOI [10.1093/qjmed/hcw104, DOI 10.1093/QJMED/HCW104]; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-87; Ozdemir BA, 2016, BRIT J ANAESTH, V116, P54, DOI 10.1093/bja/aev372; Ricciardi R, 2011, ARCH SURG-CHICAGO, V146, P545, DOI 10.1001/archsurg.2011.106; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Vest-Hansen B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006731; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060	30	77	79	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					62	72		10.1016/S0140-6736(17)30782-1	http://dx.doi.org/10.1016/S0140-6736(17)30782-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ0LK	28499548	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000404396300028
J	Reis, S; Glick, SM; Urkin, J; Gilbey, P				Reis, Shmuel; Glick, Shimon M.; Urkin, Jacob; Gilbey, Peter			The medical education system in Israel	LANCET			English	Editorial Material							SCHOOL		[Reis, Shmuel] Hebrew Univ Jerusalem, Hadassah Med Sch, Ctr Med Educ, Jerusalem, Israel; [Glick, Shimon M.; Urkin, Jacob] Ben Gurion Univ Negev, Moshe Prywes Ctr Med Educ, Fac Hlth Sci, Beer Sheva, Israel; [Glick, Shimon M.] Soroka Univ, Med Ctr, Beer Sheva, Israel; [Gilbey, Peter] Bar Ilan Univ, Fac Med Galilee, Safed, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Bar Ilan University	Glick, SM (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel.	gshimon@bgu.ac.il						Balicer RD, 2017, LANCET; Benor DE, 2005, SUSTAINING CHANGE ME; Beyar R, 2017, LANCET; Bhutta ZA, 2010, LANCET, V375, P1137, DOI 10.1016/S0140-6736(10)60450-3; Clarfield AM, 2017, LANCET; Council for Higher Education, 2014, COMM EV MED STUD PRO; Epstein L, 2002, AM J PUBLIC HEALTH, V92, P1717, DOI 10.2105/AJPH.92.11.1717; Friedberg M, 2000, Educ Health (Abingdon), V13, P187; Gafni N, 2012, MED EDUC, V46, P277, DOI 10.1111/j.1365-2923.2011.04155.x; Granek L, 2017, LANCET; Holtzman KZ, 2014, ACAD MED, V89, P1558, DOI 10.1097/ACM.0000000000000488; Kark S. L., 1981, PRACTICE COMMUNITY O; Karkabi K, 2010, CLIN TEACH, V7, P126, DOI 10.1111/j.1743-498X.2010.00353.x; Margolis CZ, 2004, ACAD MED, V79, P744, DOI 10.1097/00001888-200408000-00005; Muhsen K, 2017, LANCET; Prywes M, 1994, INT HDB MED ED, P231; Reis S, 2016, ISR J HEALTH POLICY, V5, DOI 10.1186/s13584-016-0104-5; Reis S, 2009, MED TEACH, V31, P984, DOI 10.3109/01421590903092426; Schoenbaum SC, 2015, ISR J HEALTH POLICY, V4, DOI 10.1186/s13584-015-0030-y; Shalev SA, 2017, LANCET; Shvarts S., 2008, HLTH ZIONISM MARTLES; Tulchinsky TH, 2000, INTRO 21ST CENTURY S; Tulchinsky Theodore H, 2002, Public Health Rev, V30, P179; WHO, 2008, NEW DES 2007; Ziv A, 2008, MED EDUC, V42, P991, DOI 10.1111/j.1365-2923.2008.03161.x	25	4	4	3	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2570	2574		10.1016/S0140-6736(17)30822-X	http://dx.doi.org/10.1016/S0140-6736(17)30822-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495113				2022-12-28	WOS:000403901800035
J	Bosurgi, L; Cao, YG; Cabeza-Cabrerizo, M; Tucci, A; Hughes, LD; Kong, Y; Weinstein, JS; Licona-Limon, P; Schmid, ET; Pelorosso, F; Gagliani, N; Craft, JE; Flavell, RA; Ghosh, S; Rothlin, CV				Bosurgi, Lidia; Cao, Y. Grace; Cabeza-Cabrerizo, Mar; Tucci, Andrea; Hughes, Lindsey D.; Kong, Yong; Weinstein, Jason S.; Licona-Limon, Paula; Schmid, Edward T.; Pelorosso, Facundo; Gagliani, Nicola; Craft, Joseph E.; Flavell, Richard A.; Ghosh, Sourav; Rothlin, Carla V.			Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells	SCIENCE			English	Article							RECEPTOR; EXPRESSION; POLARIZATION; RECOGNITION; ACTIVATION	Tissue repair is a subset of a broad repertoire of interleukin-4 (IL-4)-and IL-13-dependent host responses during helminth infection. Here we show that IL-4 or IL-13 alone was not sufficient, but IL-4 or IL-13 together with apoptotic cells induced the tissue repair program in macrophages. Genetic ablation of sensors of apoptotic cells impaired the proliferation of tissue-resident macrophages and the induction of anti-inflammatory and tissue repair genes in the lungs after helminth infection or in the gut after induction of colitis. By contrast, the recognition of apoptotic cells was dispensable for cytokine-dependent induction of pattern recognition receptor, cell adhesion, or chemotaxis genes in macrophages. Detection of apoptotic cells can therefore spatially compartmentalize or prevent premature or ectopic activity of pleiotropic, soluble cytokines such as IL-4 or IL-13.	[Bosurgi, Lidia; Cao, Y. Grace; Cabeza-Cabrerizo, Mar; Tucci, Andrea; Hughes, Lindsey D.; Weinstein, Jason S.; Licona-Limon, Paula; Schmid, Edward T.; Craft, Joseph E.; Flavell, Richard A.; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Kong, Yong] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Pelorosso, Facundo] Univ Buenos Aires, Fac Med, Inst Farmacol, Buenos Aires, DF, Argentina; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, D-20246 Hamburg, Germany; [Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany; [Craft, Joseph E.] Yale Univ, Sch Med, Dept Internal Med Rheumatol, 333 Cedar St, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA; [Ghosh, Sourav] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [Ghosh, Sourav; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [Licona-Limon, Paula] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Yale University; Yale University; University of Buenos Aires; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Universidad Nacional Autonoma de Mexico	Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.; Ghosh, S; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	sourav.ghosh@yale.edu; carla.rothlin@yale.edu	Kong, Yong/B-5105-2014	Kong, Yong/0000-0002-2881-5274; Ghosh, Sourav/0000-0001-5990-8708; Bosurgi, Lidia/0000-0002-8775-4950; Cabeza-Cabrerizo, Mar/0000-0001-9061-058X; Cao, Y. Grace/0000-0002-7076-0270; Gagliani, Nicola/0000-0001-8514-1395	NIH [R01AI089824, R01CA212376, T32AI007019]; American Italian Cancer Foundation Post-Doctoral Fellowship; NSF [DGE-1122492]; NATIONAL CANCER INSTITUTE [R01CA212376] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089824, T32AI007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Italian Cancer Foundation Post-Doctoral Fellowship; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. Medzhitov (Department of Immunobiology, School of Medicine, Yale University) and members of the Rothlin and Ghosh laboratories for scientific discussions, G. Tokmoulina (Department of Immunobiology, School of Medicine, Yale University) for cell sorting, and T. C. Kyriakides (Yale Center for Analytical Sciences, Yale School of Public Health) for advice on statistical analyses. This research was supported by NIH grants R01AI089824 (to C.V.R.), R01CA212376 (to C.V.R. and S.G.), and T32AI007019 (to L.D.H. and E.T.S.); the American Italian Cancer Foundation Post-Doctoral Fellowship (to L.B.), and NSF grant DGE-1122492 (to L.D.H. and E.T.S.). C.V.R. is a Howard Hughes Faculty Scholar. Axl<SUP>-/-</SUP> mice were obtained from Columbia University and Mertk <SUP>/</SUP> mice from the University of North Carolina at Chapel Hill under material transfer agreements. All data and code to understand and assess the conclusions of this research are available in the main text, supplementary materials, and via the Gene Expression Omnibus database (accession number GSE98169).	Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; BROWN LF, 1993, AM J PATHOL, V142, P793; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; FADOK VA, 1992, J IMMUNOL, V148, P2207; GALIZZI JP, 1989, J BIOL CHEM, V264, P6984; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986	22	277	286	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2017	356	6342			SI		1072	+		10.1126/science.aai8132	http://dx.doi.org/10.1126/science.aai8132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9XC	28495875	Green Accepted			2022-12-28	WOS:000402871700053
J	Ni, JD; Baik, LS; Holmes, TC; Montell, C				Ni, Jinfei D.; Baik, Lisa S.; Holmes, Todd C.; Montell, Craig			A rhodopsin in the brain functions in circadian photoentrainment in Drosophila	NATURE			English	Article							R8 PHOTORECEPTOR CELLS; PACEMAKER NEURONS; LATERAL NEURONS; VISUAL-SYSTEM; CLOCK NEURONS; GENE; MELANOGASTER; CRYPTOCHROME; RHYTHM; R7	Animals partition their daily activity rhythms through their internal circadian clocks, which are synchronized by oscillating day-night cycles of light. The fruitfly Drosophila melanogaster senses day-night cycles in part through rhodopsin-dependent light reception in the compound eye and photoreceptor cells in the Hofbauer-Buchner eyelet(1). A more noteworthy light entrainment pathway is mediated by central pacemaker neurons in the brain. The Drosophila circadian clock is extremely sensitive to light. However, the only known light sensor in pacemaker neurons, the flavoprotein cryptochrome (Cry)(2,3), responds only to high levels of light in vitro(4). These observations indicate that there is an additional light-sensing pathway in fly pacemaker neurons(5). Here we describe a previously uncharacterized rhodopsin, Rh7, which contributes to circadian light entrainment by circadian pacemaker neurons in the brain. The pacemaker neurons respond to violet light, and this response depends on Rh7. Loss of either cry or rh7 caused minor defects in photoentrainment, whereas loss of both caused profound impairment. The circadian photoresponse to constant light was impaired in rh7 mutant flies, especially under dim light. The demonstration that Rh7 functions in circadian pacemaker neurons represents, to our knowledge, the first role for an opsin in the central brain.	[Ni, Jinfei D.; Montell, Craig] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Ni, Jinfei D.; Montell, Craig] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ni, Jinfei D.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Baik, Lisa S.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Holmes, Todd C.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California San Diego	Montell, C (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.; Montell, C (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	craig.montell@lifesci.ucsb.edu	Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Holmes, Todd/0000-0001-8152-8832; Baik, Lisa Soyeon/0000-0001-8184-2039	National Eye Institute [EY008117]; National Institute on Deafness and other Communication Disorders [DC007864]; National Institute of General Medical Sciences [GM102965, GM107405]; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107405, R01GM102965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007864] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Sehgal, M. Rosbash, M. Wu and P. Emery for fly stocks; A. Sehgal and S. Britt for antibodies; and E. Guzman, H. Zhou and the Next Generation Sequencing Core at the UCSB Biological Nanostructures Laboratory for help with the RNA-seq. This work was supported by grants to C.M. from the National Eye Institute (EY008117) and the National Institute on Deafness and other Communication Disorders (DC007864), and to T.C.H. from National Institute of General Medical Sciences (GM102965 and GM107405).	Blackshaw S, 1999, J NEUROSCI, V19, P3681; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; DUSHAY MS, 1990, GENETICS, V125, P557; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Jang AR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004974; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kistenpfennig C, 2012, J BIOL RHYTHM, V27, P117, DOI 10.1177/0748730411434390; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Malpel S, 2002, DEVELOPMENT, V129, P1443; MONTELL C, 1987, J NEUROSCI, V7, P1558; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Senthilan PR, 2016, PEERJ, V4, DOI 10.7717/peerj.2427; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Szular J, 2012, J BIOL RHYTHM, V27, P25, DOI 10.1177/0748730411431673; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vinayak P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003615; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZUKER CS, 1987, J NEUROSCI, V7, P1550; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	46	72	74	6	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					340	+		10.1038/nature22325	http://dx.doi.org/10.1038/nature22325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489826	Green Accepted, Green Published			2022-12-28	WOS:000401466500061
J	Kirkham, JJ; Clarke, M; Williamson, PR				Kirkham, Jamie J.; Clarke, Mike; Williamson, Paula R.			A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To assess the uptake of the rheumatoid arthritis core outcome set using a new assessment method of calculating uptake from data in clinical trial registry entries. DESIGN Review of randomised trials. SETTING ClinicalTrials.gov. SUBJECTS 273 randomised trials of drug interventions for the treatment of rheumatoid arthritis and registered in ClinicalTrials.gov between 2002 and 2016. Full publications were identified for completed studies from information in the trial registry or from an internet search using Google and the citation database Web of Science. MAIN OUTCOME MEASURE The percentage of trials reporting or planning to measure the rheumatoid arthritis core outcome set calculated from the information presented in the trial registry and compared with the percentage reporting the rheumatoid arthritis core outcome set in the resulting trial publications. RESULTS The full rheumatoid arthritis core outcome set was reported in 81% (116/143) of trials identified on the registry as completed (or terminated) for which results were found in either the published literature or the registry. For trials identified on the registry as completed (or terminated), using information only available in the registry gives an estimate for uptake of 77% (145/189). CONCLUSIONS The uptake of the rheumatoid arthritis core outcome set in clinical trials has continued to increase over time. Using the information on outcomes listed for completed or terminated studies in a trial registry provides a reasonable estimate of the uptake of a core outcome set and is a more efficient and up-to-date approach than examining the outcomes in published trial reports. The method proposed may provide an efficient approach for an up-to-date assessment of the uptake of the 300 core outcome sets already published.	[Kirkham, Jamie J.; Williamson, Paula R.] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool L69 3GL, Merseyside, England; [Clarke, Mike] Queens Univ Belfast, Ctr Publ Hlth, Northern Ireland Methodol Hub, Belfast, Antrim, North Ireland	University of Liverpool; Queens University Belfast	Kirkham, JJ (corresponding author), Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool L69 3GL, Merseyside, England.	jjk@liv.ac.uk	Williamson, Paula R/B-6425-2016; Kirkham, Jamie/AAD-4490-2019	Williamson, Paula R/0000-0001-9802-6636; Kirkham, Jamie/0000-0003-2579-9325	University of Liverpool; MRC North West Hub for Trials Methodology Research [MR/K025635/1]; MRC [G0901530, MR/K025635/1] Funding Source: UKRI; Medical Research Council [MR/K025635/1, MC_CF023241, G0901530] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10025] Funding Source: researchfish	University of Liverpool; MRC North West Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	JJK is funded by the University of Liverpool. PRW is funded by the MRC North West Hub for Trials Methodology Research (grant reference No MR/K025635/1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barnes KL, 2017, J CLIN EPIDEMIOL; BOERS M, 1994, J RHEUMATOL, V21, P86; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; COMET, COR OUTC MEAS EFF TR; European Medicines Agency, GUID CLIN INV MED PR; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Gorst SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168403; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-324; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; National Institute for Health Research, HLTH TECHN ASS HTA P; Norris SL, 2014, RES SYNTH METHODS, V5, P273, DOI 10.1002/jrsm.1113; OMERACT, OUTC MEAS RHEUM; Taggart L, 2015, TRIALS, V16, DOI [10.1186/s13063-015-0644-y, 10.1186/s13063-015-0738-6]; The European Agency for the Evaluation of Medicinal Products, UN EV MED PROD HUM U; Tugwell P, 2007, AM J MANAG CARE, V13, pS224; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; US Department of Health and Human Services, GUID IND CLIN DEV PR; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; Weston J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010075; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	22	58	61	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2017	357								j2262	10.1136/bmj.j2262	http://dx.doi.org/10.1136/bmj.j2262			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RN	28515234	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000401899700002
J	Parish, E				Parish, Emma			The impact of not having enough staff is exhausting and detrimental to patient care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ejparish@hotmail.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j2337	10.1136/bmj.j2337	http://dx.doi.org/10.1136/bmj.j2337			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512083				2022-12-28	WOS:000401898900009
J	Cheng, HM; Li, F				Cheng, Hui-Ming; Li, Feng			ENERGY STORAGE Charge delivery goes the distance	SCIENCE			English	Editorial Material							LI-S BATTERIES; ELECTRODE MATERIALS		[Cheng, Hui-Ming; Li, Feng] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Cheng, Hui-Ming] Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China; [Cheng, Hui-Ming] King Abdulaziz Univ, Ctr Excellence Environm Studies, Jeddah 21589, Saudi Arabia	Chinese Academy of Sciences; Institute of Metal Research, CAS; Tsinghua University; King Abdulaziz University	Cheng, HM (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.; Cheng, HM (corresponding author), Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China.; Cheng, HM (corresponding author), King Abdulaziz Univ, Ctr Excellence Environm Studies, Jeddah 21589, Saudi Arabia.	cheng@imr.ac.cn	Li, Feng/C-9991-2010; Cheng, Hui-Ming/B-8682-2012; LI, feng/HIR-1703-2022	Li, Feng/0000-0002-2213-9914; Cheng, Hui-Ming/0000-0002-5387-4241				Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Dudney NJ, 2015, SCIENCE, V347, P131, DOI 10.1126/science.aaa2870; Fang RP, 2016, ADV MATER, V28, P3374, DOI 10.1002/adma.201506014; Gallagher KG, 2016, J ELECTROCHEM SOC, V163, pA138, DOI 10.1149/2.0321602jes; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Hu GJ, 2016, ADV MATER, V28, P1603, DOI 10.1002/adma.201504765; Kang KS, 2006, SCIENCE, V311, P977, DOI 10.1126/science.1122152; Liang J, 2017, ENERGY STORAGE MATER, V6, pA1, DOI 10.1016/j.ensm.2017.01.001; Liu N, 2014, NAT NANOTECHNOL, V9, P187, DOI [10.1038/nnano.2014.6, 10.1038/NNANO.2014.6]; Sun HT, 2017, SCIENCE, V356, P599, DOI 10.1126/science.aam5852; Wang DW, 2008, ANGEW CHEM INT EDIT, V47, P373, DOI 10.1002/anie.200702721; Xu YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5554	12	72	74	13	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					582	583		10.1126/science.aan1472	http://dx.doi.org/10.1126/science.aan1472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495714				2022-12-28	WOS:000400975200021
J	Abram, NJ; McGregor, HV; Tierney, JE; Evans, MN; McKay, NP; Kaufman, DS				Abram, Nerilie J.; McGregor, Helen V.; Tierney, Jessica E.; Evans, Michael N.; McKay, Nicholas P.; Kaufman, Darrell S.		PAGES 2K Consortium	Early onset of industrial-era warming across the oceans and continents (vol 536, pg 411, 2016)	NATURE			English	Correction													Kaufman, Darrell/A-2471-2008; Abram, Nerilie/AAT-5171-2021	Kaufman, Darrell/0000-0002-7572-1414; 				Abram NJ, 2016, NATURE, V536, P411, DOI 10.1038/nature19082	1	0	0	5	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					252	252		10.1038/nature22349	http://dx.doi.org/10.1038/nature22349			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ4YX	28492246	Bronze			2022-12-28	WOS:000427599400002
J	Voelker, R				Voelker, Rebecca			How Much Do You Drink?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1827	1827		10.1001/jama.2017.4666	http://dx.doi.org/10.1001/jama.2017.4666			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492906				2022-12-28	WOS:000400842400006
J	Mervis, J				Mervis, Jeffrey			ENERGY RESEARCH DOE freezes millions in awards	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					471	472		10.1126/science.356.6337.471	http://dx.doi.org/10.1126/science.356.6337.471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473541				2022-12-28	WOS:000400545700011
J	Fineberg, HV				Fineberg, Harvey V.			Conflict of Interest Why Does It Matter?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fineberg, Harvey V.] Gordon & Betty Moore Fdn, 1661 Page Mill Rd, Palo Alto, CA 94304 USA		Fineberg, HV (corresponding author), Gordon & Betty Moore Fdn, 1661 Page Mill Rd, Palo Alto, CA 94304 USA.	harvey.fineberg@moore.org						Ernst J, WHATS ALL ADDRESS LA; Gallup Inc website, HON ETH PROF; Streiff MB, 2001, J CLIN EPIDEMIOL, V54, P430, DOI 10.1016/S0895-4356(00)00277-8	3	51	52	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1717	1718		10.1001/jama.2017.1869	http://dx.doi.org/10.1001/jama.2017.1869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464149				2022-12-28	WOS:000400440700008
J	MacKenzie, MJ; Bosk, E; Zeanah, CH				MacKenzie, Michael J.; Bosk, Emily; Zeanah, Charles H.			Separating Families at the Border - Consequences for Children's Health and Well-Being	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[MacKenzie, Michael J.; Bosk, Emily] Rutgers State Univ, Child Welf & Well Being Res Unit, Sch Social Work, New Brunswick, NJ 08901 USA; [Bosk, Emily] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ USA; [MacKenzie, Michael J.] Rutgers State Univ, Dept Pediat, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Zeanah, Charles H.] Tulane Univ, Sch Med, Dept Psychiat & Behav Sci, 1430 Tulane Ave, New Orleans, LA 70112 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Tulane University	MacKenzie, MJ (corresponding author), Rutgers State Univ, Child Welf & Well Being Res Unit, Sch Social Work, New Brunswick, NJ 08901 USA.		Zeanah, Charles H/AAO-3756-2020	Zeanah, Charles/0000-0002-7004-6819				Beech E., 2017, KELLY SAYS CONSIDERI; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Kopan T., 2017, CNN             0329; National Academies of Sciences Engineering and Medicine, 2016, PAR MATT SUPP PAR CH; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663	5	21	21	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2017	376	24					2314	2315		10.1056/NEJMp1703375	http://dx.doi.org/10.1056/NEJMp1703375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX4UQ	28467732				2022-12-28	WOS:000403230800003
J	Kim, SS; Rouault, H; Druckmann, S; Jayaraman, V				Kim, Sung Soo; Rouault, Herve; Druckmann, Shaul; Jayaraman, Vivek			Ring attractor dynamics in the Drosophila central brain	SCIENCE			English	Article							ANGULAR PATH-INTEGRATION; HEAD-DIRECTION SYSTEM; VISUAL-CORTEX; ORIENTATION; INHIBITION; MECHANISMS; EXCITATION; CONNECTIONS; DISSECTION; PRINCIPLES	Ring attractors are a class of recurrent networks hypothesized to underlie the representation of heading direction. Such network structures, schematized as a ring of neurons whose connectivity depends on their heading preferences, can sustain a bump-like activity pattern whose location can be updated by continuous shifts along either turn direction. We recently reported that a population of fly neurons represents the animal's heading via bump-like activity dynamics. We combined two-photon calcium imaging in head-fixed flying flies with optogenetics to overwrite the existing population representation with an artificial one, which was then maintained by the circuit with naturalistic dynamics. A network with local excitation and global inhibition enforces this unique and persistent heading representation. Ring attractor networks have long been invoked in theoretical work; our study provides physiological evidence of their existence and functional architecture.	[Kim, Sung Soo; Rouault, Herve; Druckmann, Shaul; Jayaraman, Vivek] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Druckmann, S; Jayaraman, V (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	druckmanns@janelia.hhmi.org; vivek@janelia.hhmi.org	Rouault, Hervé/AAD-7115-2022	Kim, Sung Soo/0000-0002-3508-0413; Jayaraman, Vivek/0000-0003-3680-7378	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Jenett, T. Wolff, and G. Rubin for their generous sharing of the split line SS00096 before publication, and, in particular, T. Wolff for her scientific insights; B. Pfeiffer, A. Wong, D. Anderson, and G. Rubin for generously sharing codon-optimized GCaMP6f DNA before publication; C. Dan for codon-optimized GCaMP6f flies; S. Romani for contributing to insightful discussions regarding bump jumps in the global model and the effect of input width; Janelia Fly Core and, in particular, K. Hibbard and S. Coffman, for support; J. Liu for virtual reality support; D. Flickinger and V. Goncharov for microscope design support; J. Arnold for fly holder design; Vidrio for ScanImage support; S. Rowell and E. Nielson for operational support; and A. Karpova, A. Hermundstad, M. Ahrens, S. Romani, Y. Sun, and members of V.J.'s lab for useful discussions and comments on the manuscript. Supported by the Howard Hughes Medical Institute. Code for physiological data and analyses is available at http://research.janelia.org/jayaraman/KimRouaultScience2017_Downloads.	Aksay E, 2007, NAT NEUROSCI, V10, P494, DOI 10.1038/nn1877; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Borst A, 2015, NAT NEUROSCI, V18, P1067, DOI 10.1038/nn.4050; Chaudhuri R, 2016, NAT NEUROSCI, V19, P394, DOI 10.1038/nn.4237; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Hansel D., 1998, METHODS NEURONAL MOD, P499; Kakaria KS, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00008; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Knierim JJ, 2012, ANNU REV NEUROSCI, V35, P267, DOI 10.1146/annurev-neuro-062111-150351; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mysore SP, 2010, J NEUROSCI, V30, P1727, DOI 10.1523/JNEUROSCI.3740-09.2010; Ozeki H, 2009, NEURON, V62, P578, DOI 10.1016/j.neuron.2009.03.028; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; TAUBE JS, 1990, J NEUROSCI, V10, P420; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Wimmer K, 2014, NAT NEUROSCI, V17, P431, DOI 10.1038/nn.3645; Wolff T, 2015, J COMP NEUROL, V523, P997, DOI 10.1002/cne.23705; Xie XH, 2002, PHYS REV E, V66, DOI 10.1003/PhysRevE.66.041902; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zhang K, 1996, J NEUROSCI, V16, P2112	31	140	140	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2017	356	6340					849	U111		10.1126/science.aal4835	http://dx.doi.org/10.1126/science.aal4835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV7LP	28473639				2022-12-28	WOS:000401957900039
J	Connolly, C; Lee, TH				Connolly, Ceci; Lee, Thomas H.			The Committed Perspective - Policy Principles for Regional Health Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Connolly, Ceci] Alliance Community Hlth Plans, Washington, DC 20006 USA; [Lee, Thomas H.] Press Ganey, Wakefield, MA USA; [Lee, Thomas H.] Harvard Med Sch, Boston, MA USA	Harvard University; Harvard Medical School	Connolly, C (corresponding author), Alliance Community Hlth Plans, Washington, DC 20006 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1903	1905		10.1056/NEJMp1700461	http://dx.doi.org/10.1056/NEJMp1700461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV0DB	28514608				2022-12-28	WOS:000401407500002
J	Payne, D; McCluskey, J				Payne, David; McCluskey, Jim			JIM McCLUSKEY	NATURE			English	Editorial Material									[McCluskey, Jim] Monash Univ, Clayton, Vic, Australia; [McCluskey, Jim] Univ Melbourne, Microbiol & immunol, Melbourne, Vic, Australia	Monash University; University of Melbourne									0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S36	S36		10.1038/545S36a	http://dx.doi.org/10.1038/545S36a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI0YR	28514434	Bronze			2022-12-28	WOS:000459865000003
J	Serrano, M				Serrano, Manuel			AGEING Tools to eliminate senescent cells	NATURE			English	Editorial Material							CELLULAR SENESCENCE; MICE		[Serrano, Manuel] Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr, E-28029 Madrid, Spain.	mserrano@cnio.es	Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Neves J, 2015, DEV CELL, V32, P9, DOI 10.1016/j.devcel.2014.11.028; Ovadya Y, 2014, BIOGERONTOLOGY, V15, P627, DOI 10.1007/s10522-014-9529-9; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	12	7	7	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					294	296		10.1038/nature22493	http://dx.doi.org/10.1038/nature22493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28489828				2022-12-28	WOS:000401466500050
J	McAlindon, TE; LaValley, MP; Harvey, WF; Price, LL; Driban, JB; Zhang, M; Ward, RJ				McAlindon, Timothy E.; LaValley, Michael P.; Harvey, William F.; Price, Lori Lyn; Driban, Jeffrey B.; Zhang, Ming; Ward, Robert J.			Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOSTEROID INJECTIONS; SYNOVITIS; JOINT; METAANALYSIS; PROGRESSION; ULTRASOUND; ARTHRITIS; DISEASE; LESIONS; COSTS	IMPORTANCE Synovitis is common and is associated with progression of structural characteristics of knee osteoarthritis. Intra-articular corticosteroids could reduce cartilage damage associated with synovitis but might have adverse effects on cartilage and periarticular bone. OBJECTIVE To determine the effects of intra-articular injection of 40mg of triamcinolone acetonide every 3 months on progression of cartilage loss and knee pain. DESIGN, SETTING, AND PARTICIPANTS Two-year, randomized, placebo-controlled, double-blind trial of intra-articular triamcinolone vs saline for symptomatic knee osteoarthritis with ultrasonic features of synovitis in 140 patients. Mixed-effects regression models with a random intercept were used to analyze the longitudinal repeated outcome measures. Patients fulfilling the American College of Rheumatology criteria for symptomatic knee osteoarthritis, Kellgren-Lawrence grades 2 or 3, were enrolled at Tufts Medical Center beginning February 11, 2013; all patients completed the study by January 1, 2015. INTERVENTIONS Intra-articular triamcinolone (n = 70) or saline (n = 70) every 12 weeks for 2 years. MAIN OUTCOMES AND MEASURES Annual knee magnetic resonance imaging for quantitative evaluation of cartilage volume (minimal clinically important difference not yet defined), and Western Ontario and McMaster Universities Osteoarthritis index collected every 3 months (Likert pain subscale range, 0 [no pain] to 20 [extreme pain]; minimal clinically important improvement, 3.94). RESULTS Among 140 randomized patients (mean age, 58 [SD, 8] years, 75 women [54%]), 119 (85%) completed the study. Intra-articular triamcinolone resulted in significantly greater cartilage volume loss than did saline for a mean change in index compartment cartilage thickness of -0.21mmvs -0.10mm(between-group difference, -0.11 mm; 95% CI, -0.20 to -0.03 mm); and no significant difference in pain (-1.2 vs -1.9; between-group difference, -0.6; 95% CI, -1.6 to 0.3). The saline group had 3 treatment-related adverse events compared with 5 in the triamcinolone group and had a small increase in hemoglobin A1c levels (between-group difference, -0.2%; 95% CI, -0.5% to -0.007%). CONCLUSIONS AND RELEVANCE Among patients with symptomatic knee osteoarthritis, 2 years of intra-articular triamcinolone, compared with intra-articular saline, resulted in significantly greater cartilage volume loss and no significant difference in knee pain. These findings do not support this treatment for patients with symptomatic knee osteoarthritis.	[McAlindon, Timothy E.; Harvey, William F.; Driban, Jeffrey B.; Zhang, Ming] Tufts Med Ctr, Div Rheumatol, 800 Washington St,POB 406, Boston, MA 02111 USA; [LaValley, Michael P.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Price, Lori Lyn] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Price, Lori Lyn] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Ward, Robert J.] Tufts Med Ctr, Div Musculoskeletal Imaging & Intervent, Boston, MA USA	Tufts Medical Center; Boston University; Tufts Medical Center; Tufts University; Tufts Medical Center	McAlindon, TE (corresponding author), Tufts Med Ctr, Div Rheumatol, 800 Washington St,POB 406, Boston, MA 02111 USA.	tmcalindon@tuftsmedicalcenter.org	Driban, Jeffrey/H-3486-2019; LaValley, Michael/AAA-2030-2020	Driban, Jeffrey/0000-0001-6098-4273; LaValley, Michael/0000-0002-8488-5170	National Institute for Arthritis and Musculoskeletal Disorders and Skin Diseases (NIAMS) [R01 AR051361]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001064]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051361, U01AR067168, R01AR057802] Funding Source: NIH RePORTER	National Institute for Arthritis and Musculoskeletal Disorders and Skin Diseases (NIAMS); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants R01 AR051361 from the National Institute for Arthritis and Musculoskeletal Disorders and Skin Diseases (NIAMS) and UL1TR001064 from the National Center for Advancing Translational Sciences, National Institutes of Health.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2016, SEMIN ARTHRITIS RHEU, V46, P151, DOI 10.1016/j.semarthrit.2016.04.003; Arroll B, 2004, BMJ-BRIT MED J, V328, P869, DOI 10.1136/bmj.38039.573970.7C; Atukorala I, 2016, ANN RHEUM DIS, V75, P390, DOI 10.1136/annrheumdis-2014-205894; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Bannuru RR, 2015, ANN INTERN MED, V163, P365, DOI 10.7326/M15-0623; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; Chao J, 2010, J RHEUMATOL, V37, P650, DOI 10.3899/jrheum.090575; Eckstein F, 2014, OSTEOARTHR CARTILAGE, V22, P1542, DOI 10.1016/j.joca.2014.04.016; Guermazi A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3488; Haddad IK, 2000, SAUDI MED J, V21, P675; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015; Hill CL, 2007, ANN RHEUM DIS, V66, P1599, DOI 10.1136/ard.2006.067470; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Juni P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328.pub3; Jungius KP, 2006, RADIOLOGY, V240, P482, DOI 10.1148/radiol.2401050077; Karim Z, 2004, ARTHRITIS RHEUM-US, V50, P387, DOI 10.1002/art.20054; Kellgren JH, 1962, EPIDEMIOLOGY CHRONIC, VII; Kraus VB, 2005, ARTHRITIS RHEUM, V52, P1730, DOI 10.1002/art.21100; Larsson E, 2004, RHEUMATOLOGY, V43, P428, DOI 10.1093/rheumatology/keh073; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Mapel DW, 2004, J RHEUMATOL, V31, P573; McAlindon T, 2013, JAMA-J AM MED ASSOC, V309, P155, DOI 10.1001/jama.2012.164487; PELLETIER JP, 1995, LAB INVEST, V72, P578; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Raynauld JP, 2003, ARTHRITIS RHEUM, V48, P370, DOI 10.1002/art.10777; Roemer FW, 2011, ANN RHEUM DIS, V70, P1804, DOI 10.1136/ard.2011.150243; RUBALTELLI L, 1994, J ULTRAS MED, V13, P855; Sarmanova A, 2016, OSTEOARTHR CARTILAGE, V24, P1376, DOI 10.1016/j.joca.2016.03.004; Stratford PW, 2007, OSTEOARTHR CARTILAGE, V15, P266, DOI 10.1016/j.joca.2006.09.005; Tarhan S, 2003, CLIN RHEUMATOL, V22, P181, DOI 10.1007/s10067-002-0694-x; Wada Jiro, 1993, Bulletin Hospital for Joint Diseases, V53, P45; Wernecke C, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115581163; Xu L, 2012, SEMIN ARTHRITIS RHEU, V42, P105, DOI 10.1016/j.semarthrit.2012.03.009; ZHANG M, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/634275; Zhang M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-264; Zhang YQ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.01.020	39	364	386	7	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1967	1975		10.1001/jama.2017.5283	http://dx.doi.org/10.1001/jama.2017.5283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510679	Green Published			2022-12-28	WOS:000401315500016
J	Cai, E; Marchuk, K; Beemiller, P; Beppler, C; Rubashkin, MG; Weaver, VM; Gerard, A; Liu, TL; Chen, BC; Betzig, E; Bartumeus, F; Krummel, MF				Cai, En; Marchuk, Kyle; Beemiller, Peter; Beppler, Casey; Rubashkin, Matthew G.; Weaver, Valerie M.; Gerard, Audrey; Liu, Tsung-Li; Chen, Bi-Chang; Betzig, Eric; Bartumeus, Frederic; Krummel, Matthew F.			Visualizing dynamic microvillar search and stabilization during ligand detection by T cells	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; ADHESION; MICROCLUSTERS; MOTILITY; SEGREGATION; RECEPTORS	During immune surveillance, T cells survey the surface of antigen-presenting cells. In searching for peptide-loaded major histocompatibility complexes (pMHCs), they must solve a classic trade-off between speed and sensitivity. It has long been supposed that microvilli on T cells act as sensory organs to enable search, but their strategy has been unknown. We used lattice light-sheet and quantum dot-enabled synaptic contact mapping microscopy to show that anomalous diffusion and fractal organization of microvilli survey the majority of opposing surfaces within 1 minute. Individual dwell times were long enough to discriminate pMHC half-lives and T cell receptor (TCR) accumulation selectively stabilized microvilli. Stabilization was independent of tyrosine kinase signaling and the actin cytoskeleton, suggesting selection for avid TCR microclusters. This work defines the efficient cellular search process against which ligand detection takes place.	[Cai, En; Marchuk, Kyle; Beemiller, Peter; Beppler, Casey; Gerard, Audrey; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Marchuk, Kyle; Krummel, Matthew F.] Univ Calif San Francisco, Biol Imaging Dev Ctr, San Francisco, CA 94143 USA; [Rubashkin, Matthew G.; Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Liu, Tsung-Li; Chen, Bi-Chang; Betzig, Eric] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Bartumeus, Frederic] Ctr Adv Studies Blanes CEAB CSIC, Girona 17300, Spain; [Bartumeus, Frederic] Ecol & Forestry Applicat Res Ctr CREAF, Barcelona 08193, Spain; [Bartumeus, Frederic] Inst Catala Recerca & Estudis Avancats, Barcelona 08010, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.; Krummel, MF (corresponding author), Univ Calif San Francisco, Biol Imaging Dev Ctr, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Chen, Bi-Chang/F-3480-2014; Cai, En/AAE-4726-2022	Chen, Bi-Chang/0000-0002-1876-7432; Cai, En/0000-0002-8212-8387; Beemiller, Peter/0000-0002-2736-3405; Weaver, Valerie marie/0000-0003-4786-6752; Rubashkin, Matthew/0000-0003-2907-1745	NIH [AI052116]; NCI [U01CA202241]; Department of Defense National Defense Science and Engineering Graduate (NDSEG) Fellowship; NSF [1650113]; Spanish Ministry MINECO [CGL2016-78156-C2-1-R]; NATIONAL CANCER INSTITUTE [U01CA202241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114787, R01AI052116, T32AI007334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense National Defense Science and Engineering Graduate (NDSEG) Fellowship; NSF(National Science Foundation (NSF)); Spanish Ministry MINECO(Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to L. Richie-Ehrlich for the gift of pIB2-Zap70-GFP, A. Weiss and B. Au-Yeung for the gift of ZAP70(AS)/OTI mice, and the NIH Tetramer Facility at Emory University for the monobiotinylated pMHC monomer reagents. Funding for this research was provided by NIH grant AI052116 to M.F.K., NCI grant U01CA202241 to V.M.W., a Department of Defense National Defense Science and Engineering Graduate (NDSEG) Fellowship to M.R., and NSF Graduate Research Fellowship grant 1650113 to C.B. F.B. acknowledges the Spanish Ministry MINECO (grant CGL2016-78156-C2-1-R). The data reported in this manuscript are in the main paper and in the supplementary materials. E.B. is an inventor on patent application US 20130286181 A1, submitted by Howard Hughes Medical Institute (HHMI), which covers LLS imaging. Researchers wishing to build an LLS microscope can access plans and videos for its construction after execution of a research license agreement with HHMI. The authors declare no competing financial interests. P.B., K.M., C.B., E.C., and M.F.K. designed the experiments. P.B. and M.G.R. performed the SAIM imaging experiments. P.B., E.C., and C.B. performed SCM experiments, and A.G. performed two-photon imaging. K.M., C.B., and E.C. performed the remaining experiments. T.L., B.C., and E.B. provided critical support for LLS microscopy. F.B., C.B., and K.M. performed diffusion and fractal analysis. V.W. provided financial support. M.F.K. wrote the paper together with K.M., C.B., and E.C.	Alakoskela JM, 2011, BIOPHYS J, V100, P2865, DOI 10.1016/j.bpj.2011.05.013; Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Barnsley M, 1993, FRACTALS EVERYWHERE; Beemiller P, 2012, NAT IMMUNOL, V13, P787, DOI 10.1038/ni.2364; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; GLAUERT AM, 1979, J CELL SCI, V35, P355; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hashimoto-Tane A, 2016, J EXP MED, V213, P1609, DOI 10.1084/jem.20151088; Jung YM, 2016, P NATL ACAD SCI USA, V113, pE5916, DOI 10.1073/pnas.1605399113; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Mendez V., 2013, STOCHASTIC FOUNDATIO; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Pierres A, 2009, TRENDS CELL BIOL, V19, P428, DOI 10.1016/j.tcb.2009.05.009; Ritter AT, 2015, IMMUNITY, V42, P864, DOI 10.1016/j.immuni.2015.04.013; Sage PT, 2012, J IMMUNOL, V188, P3686, DOI 10.4049/jimmunol.1102594; Seuront L., 2009, FRACTALS MULTIFRACTA; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3	35	136	136	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338							eaal3118	10.1126/science.aal3118	http://dx.doi.org/10.1126/science.aal3118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495700	Green Submitted, Green Accepted			2022-12-28	WOS:000400975200046
J	Grillo, AS; SantaMaria, AM; Kafina, MD; Cioffi, AG; Huston, NC; Han, MR; Seo, YA; Yien, YY; Nardone, C; Menon, AV; Fan, J; Svoboda, DC; Anderson, JB; Hong, JD; Nicolau, BG; Subedi, K; Gewirth, AA; Wessling-Resnick, M; Kim, J; Paw, BH; Burke, MD				Grillo, Anthony S.; SantaMaria, Anna M.; Kafina, Martin D.; Cioffi, Alexander G.; Huston, Nicholas C.; Han, Murui; Seo, Young Ah; Yien, Yvette Y.; Nardone, Christopher; Menon, Archita V.; Fan, James; Svoboda, Dillon C.; Anderson, Jacob B.; Hong, John D.; Nicolau, Bruno G.; Subedi, Kiran; Gewirth, Andrew A.; Wessling-Resnick, Marianne; Kim, Jonghan; Paw, Barry H.; Burke, Martin D.			Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals	SCIENCE			English	Article							STRUCTURAL-CHARACTERIZATION; POSITIONAL CLONING; METAL HOMEOSTASIS; MEDICAL PROGRESS; BETA-THUJAPLICIN; HINOKITIOL; INSIGHTS; CELLS; DISORDERS; COMPLEXES	Multiple human diseases ensue from a hereditary or acquired deficiency of iron-transporting protein function that diminishes transmembrane iron flux in distinct sites and directions. Because other iron-transport proteins remain active, labile iron gradients build up across the corresponding protein-deficient membranes. Here we report that a small-molecule natural product, hinokitiol, can harness such gradients to restore iron transport into, within, and/or out of cells. The same compound promotes gut iron absorption in DMT1-deficient rats and ferroportin-deficient mice, as well as hemoglobinization in DMT1-and mitoferrin-deficient zebrafish. These findings illuminate a general mechanistic framework for small molecule-mediated site-and direction-selective restoration of iron transport. They also suggest that small molecules that partially mimic the function of missing protein transporters of iron, and possibly other ions, may have potential in treating human diseases.	[Grillo, Anthony S.; Fan, James; Anderson, Jacob B.; Hong, John D.; Nicolau, Bruno G.; Subedi, Kiran; Gewirth, Andrew A.; Burke, Martin D.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [SantaMaria, Anna M.; Cioffi, Alexander G.; Nardone, Christopher; Svoboda, Dillon C.; Burke, Martin D.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Kafina, Martin D.; Huston, Nicholas C.; Yien, Yvette Y.; Paw, Barry H.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA; [Han, Murui; Menon, Archita V.; Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Seo, Young Ah] Univ Michigan, Dept Nutr Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Wessling-Resnick, Marianne] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Paw, Barry H.] Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA; [Paw, Barry H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Burke, Martin D.] Univ Illinois, Carle Illinois Coll Med, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northeastern University; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Illinois System; University of Illinois Urbana-Champaign	Burke, MD (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; Burke, MD (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Paw, BH (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA.; Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Wessling-Resnick, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.; Paw, BH (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA.; Paw, BH (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.; Burke, MD (corresponding author), Univ Illinois, Carle Illinois Coll Med, Champaign, IL 61820 USA.	wessling@hsph.harvard.edu; j.kim@neu.edu; bpaw@rics.bwh.harvard.edu; mdburke@illinois.edu	Seo, Young Ah/AAT-5022-2020; Menon, Archita/GOP-1066-2022	Seo, Young Ah/0000-0003-3884-0665; Paw, Barry/0000-0002-0492-1419; Anderson, Jacob/0000-0003-1343-3908; Menon, Archita Venguopal/0000-0002-8230-1514; SantaMaria, Anna/0000-0001-8735-0721; Hong, John/0000-0002-5563-417X	NIH [GM118185, K01 DK106156, F32 DK098866, R01 DK070838, P01 HL032262, K99ES024340, R01ES0146380, R01DK064750, R21EB023025]; Howard Hughes Medical Institute (HHMI); HHMI Exceptional Research Opportunities Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB023025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, K01DK106156, R01DK064750, F32DK098866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024340, K99ES024340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118185, R01GM080436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI Exceptional Research Opportunities Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge A. Ringel for assistance with zebrafish experiments and A. Li for assistance with octanol/water partition coefficients. We thank J. Hou, K. Muraglia, and R. Chorghade for independently repeating the results shown in Fig. 1C; fig. S2, A to C; Fig. 3, A and B; and fig. S9M. We further acknowledge D. Kosman and C. Philpott for providing yeast strains, L. Zon for the Tg(globinLCR:eGFP) transgenic zebrafish line, W. Boulanger for the generous gift of comenic acid, and J. Katzenellenbogen for use of a liquid scintillation counter. We thank M. Garrick, L. Garrick, and M. Fleming for helpful discussions. We thank D. Gray and the George L. Clark X-Ray Facility for x-ray analysis, M. Sivaguru and the Carl R. Woese Institute for Genomic Biology for assistance with confocal microscopy, B. Pilas and the Roy J. Carver Biotechnology Center for help with flow cytometry, and the University of Illinois School of Chemical Sciences microanalysis facility for ICP-MS and optical emission spectrometry. Support was provided by NIH through grants GM118185 (to M. D. B.), K01 DK106156 and F32 DK098866 (to Y.Y.Y.), R01 DK070838 and P01 HL032262 (to B.H.P.), K99ES024340 (to Y.A.S.), R01ES0146380 and R01DK064750 (to M.W.-R.), and R21EB023025 (to J. K.). M. D. B. also thanks the Howard Hughes Medical Institute (HHMI) for funding. A.S.G. was a NSF Graduate Fellow. J. B. A. was supported by the HHMI Exceptional Research Opportunities Program. M.D.B. and A.S.G. are inventors on patent application 62/101,706, submitted by the University of Illinois at Urbana-Champaign, which covers the use of small-molecule iron transporters to treat deficiencies of iron-transport proteins. Additional data reported in this paper are available in the supplementary materials. Crystallographic data for Fe(Hino)<INF>3</INF> are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC 1536565.	Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Arredondo M, 1997, AM J PHYSIOL-GASTR L, V273, pG275, DOI 10.1152/ajpgi.1997.273.2.G275; Avagyan S, 2016, HUM GENE THER, V27, P287, DOI 10.1089/hum.2016.024; Ba LA, 2009, METALLOMICS, V1, P292, DOI 10.1039/b904533c; Barret MC, 2001, INORG CHEM, V40, P4384, DOI 10.1021/ic0100368; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; BOHME G, 1980, ACTA BIOL MED GER, V39, P1153; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; BRYANT BE, 1954, J AM CHEM SOC, V76, P1696, DOI 10.1021/ja01635a072; Buss JL, 2002, ADV EXP MED BIOL, V509, P205; Chung J, 2014, J BIOL CHEM, V289, P7835, DOI 10.1074/jbc.M114.547778; Cioffi AG, 2015, J AM CHEM SOC, V137, P10096, DOI 10.1021/jacs.5b05765; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2002, BLOOD, V100, P4655, DOI 10.1182/blood-2002-04-1169; Espinoza A, 2012, BIOL TRACE ELEM RES, V146, P281, DOI 10.1007/s12011-011-9243-2; Esposito BP, 2002, BIOCHEM SOC T, V30, P729, DOI 10.1042/bst0300729; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang XP, 2006, PHARM RES-DORDR, V23, P280, DOI 10.1007/s11095-005-9258-5; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Ido Y, 1999, CELL PROLIFERAT, V32, P63, DOI 10.1046/j.1365-2184.1999.00133.x; Imai Norio, 2006, Journal of Toxicological Sciences, V31, P357, DOI 10.2131/jts.31.357; Imbrici P, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00121; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Lee MJ, 2010, BIOCHEM BIOPH RES CO, V396, P370, DOI 10.1016/j.bbrc.2010.04.099; Lesjak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102900; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meck C, 2014, MEDCHEMCOMM, V5, P842, DOI 10.1039/c4md00055b; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Murakami K, 2005, BASIC CLIN PHARMACOL, V97, P392, DOI 10.1111/j.1742-7843.2005.pto_214.x; Nomiya K, 2004, J INORG BIOCHEM, V98, P46, DOI 10.1016/j.jinorgbio.2003.07.002; Nomiya K, 2009, INORG CHIM ACTA, V362, P43, DOI 10.1016/j.ica.2008.02.061; Nozoe T, 1936, B CHEM SOC JPN, V3, P295; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Veuthey T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00082; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068	52	69	69	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					608	616		10.1126/science.aah3862	http://dx.doi.org/10.1126/science.aah3862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495746	Green Accepted			2022-12-28	WOS:000400975200049
J	Guerrini, CJ; McGuire, AL; Majumder, MA				Guerrini, Christi J.; McGuire, Amy L.; Majumder, Mary A.			DATA PRIVACY Myriad take two: Can genomic databases remain secret?	SCIENCE			English	Editorial Material									[Guerrini, Christi J.; McGuire, Amy L.; Majumder, Mary A.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Baylor College of Medicine	Guerrini, CJ (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	guerrini@bcm.edu	Guerrini, Christi/HGF-0227-2022	Guerrini, Christi/0000-0003-4430-2740	National Human Genome Research Institute (NIH) [RO1-HG006460-S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006460] Funding Source: NIH RePORTER	National Human Genome Research Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All authors contributed equally to this work. This work was funded by National Human Genome Research Institute (NIH) grant RO1-HG006460-S1. The authors declare no competing financial interests.	[Anonymous], 2016, TRADE SECRETS LAW, V3, P34; Begley S., 2016, STAT NEWS       1129; Cook-Deegan R, 2013, EUR J HUM GENET, V21, P585, DOI 10.1038/ejhg.2012.217; Evans BJ, 2014, GENET MED, V16, P504, DOI 10.1038/gim.2013.186; Feldman Robin, 2013, Stanf Technol Law Rev, V16, P623; HHS (Department of Health and Human Services), 2016, IND RIGHT HIPAA ACC; Hopkins MM, 2012, NAT BIOTECHNOL, V30, P498, DOI 10.1038/nbt.2257; Sachs Rachel E., 2016, UC DAVIS L REV, V49, P1881; Walker J, 2015, WALL STREET J	9	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					586	587		10.1126/science.aal3224	http://dx.doi.org/10.1126/science.aal3224			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495717	Green Accepted			2022-12-28	WOS:000400975200024
J	Downing, NS; Shah, ND; Aminawung, JA; Pease, AM; Zeitoun, JD; Krumholz, HM; Ross, JS				Downing, Nicholas S.; Shah, Nilay D.; Aminawung, Jenerius A.; Pease, Alison M.; Zeitoun, Jean-David; Krumholz, Harlan M.; Ross, Joseph S.			Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								IMPORTANCE Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics. These safety events can change how novel therapeutics are used in clinical practice and inform patient and clinician decision making. OBJECTIVES To characterize the frequency of postmarket safety events among novel therapeutics approved by the US Food and Drug Administration (FDA), and to examine whether any novel therapeutic characteristics known at the time of FDA approval were associated with increased risk. DESIGN AND SETTING Cohort study of all novel therapeutics approved by the FDA between January 1, 2001, and December 31, 2010, followed up through February 28, 2017. EXPOSURES Novel therapeutic characteristics known at the time of FDA approval, including drug class, therapeutic area, priority review, accelerated approval, orphan status, near-regulatory deadline approval, and regulatory review time. MAIN OUTCOMES AND MEASURES A composite of (1) withdrawals due to safety concerns, (2) FDA issuance of incremental boxed warnings added in the postmarket period, and (3) FDA issuance of safety communications. RESULTS From 2001 through 2010, the FDA approved 222 novel therapeutics (183 pharmaceuticals and 39 biologics). There were 123 new postmarket safety events (3 withdrawals, 61 boxed warnings, and 59 safety communications) during a median follow-up period of 11.7 years (interquartile range [IQR], 8.7-13.8 years), affecting 71 (32.0%) of the novel therapeutics. The median time from approval to first postmarket safety event was 4.2 years (IQR, 2.5-6.0 years), and the proportion of novel therapeutics affected by a postmarket safety event at 10 years was 30.8%(95% CI, 25.1%-37.5%). In multivariable analysis, postmarket safety events were statistically significantly more frequent among biologics (incidence rate ratio [IRR] = 1.93; 95% CI, 1.06-3.52; P =.03), therapeutics indicated for the treatment of psychiatric disease (IRR = 3.78; 95% CI, 1.77-8.06; P <.001), those receiving accelerated approval (IRR = 2.20; 95% CI, 1.15-4.21; P =.02), and those with near-regulatory deadline approval (IRR = 1.90; 95% CI, 1.19-3.05; P =.008); events were statistically significantly less frequent among those with regulatory review times less than 200 days (IRR = 0.46; 95% CI, 0.24-0.87; P =.02). CONCLUSIONS AND RELEVANCE Among 222 novel therapeutics approved by the FDA from 2001 through 2010, 32% were affected by a postmarket safety event. Biologics, psychiatric therapeutics, and accelerated and near-regulatory deadline approval were statistically significantly associated with higher rates of events, highlighting the need for continuous monitoring of the safety of novel therapeutics throughout their life cycle.	[Downing, Nicholas S.] Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Shah, Nilay D.] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA; [Aminawung, Jenerius A.; Ross, Joseph S.] Yale Sch Med, Dept Internal Med, Gen Internal Med Sect, New Haven, CT USA; [Pease, Alison M.] State Univ New York Downstate Coll Med, Brooklyn, NY USA; [Zeitoun, Jean-David] St Antoine Hosp, Dept, Paris, France; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Sch Med, Dept Internal Med, Wood Johnson Fdn Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT USA	Harvard University; Brigham & Women's Hospital; Mayo Clinic; Mayo Clinic; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Yale University; Yale University; Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Sect Gen Internal Med, POB 208093, New Haven, CT USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Cepton; Oliver Wyman; Roland Berger; McCann Health; Omnicom; Grey Healthcare; Saatchi Saatchi; Sudler; TBWA; Havas; Agipharm; Mayoly Spindler; Teva; Menarini; Pierre Fabre; Merck; AbbVie; US Food and Drug Administration; Medtronic; Johnson Johnson; Centers for Medicare & Medicaid Services; Blue Cross Blue Shield Association; Laura and John Arnold Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Cepton; Oliver Wyman; Roland Berger; McCann Health; Omnicom; Grey Healthcare; Saatchi Saatchi; Sudler; TBWA; Havas; Agipharm; Mayoly Spindler; Teva(Teva Pharmaceutical Industries); Menarini(Menarini Group); Pierre Fabre; Merck(Merck & Company); AbbVie(AbbVie); US Food and Drug Administration; Medtronic(Medtronic); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Centers for Medicare & Medicaid Services; Blue Cross Blue Shield Association; Laura and John Arnold Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Zeitoun reported receiving personal fees from Cepton, Oliver Wyman, Roland Berger, McCann Health, Omnicom, Grey Healthcare, Saatchi & Saatchi, Sudler, TBWA, Havas, Agipharm, Mayoly Spindler, Teva, Menarini, Pierre Fabre, Merck, and AbbVie. Dr Krumholz reported receiving a grant from the US Food and Drug Administration and Medtronic; having a research agreement with Johnson & Johnson (Janssen) through Yale University; serving as chair of a cardiac scientific advisory board for UnitedHealth; being a founder of Hugo; being a participant and participant representative of the IBM Watson Health Life Sciences Board; and serving as an advisory board member for Element Science. Dr Ross reported receiving grants from the US Food and Drug Administration, Medtronic, Johnson & Johnson, Centers for Medicare & Medicaid Services, Blue Cross Blue Shield Association, and the Laura and John Arnold Foundation. No other disclosures were reported.	Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; Frank C, 2014, HEALTH AFFAIR, V33, P1453, DOI 10.1377/hlthaff.2014.0122; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Lanthier M, 2013, HEALTH AFFAIR, V32, P1433, DOI 10.1377/hlthaff.2012.0541; Mott K, 2016, PHARMACOEPIDEM DR S, V25, P1023, DOI 10.1002/pds.4013; Ross JS, 2015, HEALTH AFFAIR, V34, P681, DOI 10.1377/hlthaff.2014.1160; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; U.S. Food and Drug Administration, 2011, GUID IND WARN PREC C; US Food and Drug Administration, 2007, GUID DRUG SAF INF FD; US Government Accountability Office, 2016, DRUG SAF FDA EXP MAN; Zeitoun JD, 2016, PHARMACOEPIDEM DR S, V25, P687, DOI 10.1002/pds.3910	14	172	176	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1854	1863		10.1001/jama.2017.5150	http://dx.doi.org/10.1001/jama.2017.5150			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492899	Green Published			2022-12-28	WOS:000400842400016
J	Bastable, G				Bastable, Gordon			Morag Joyce Rankine Bastable Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BASTABLE MJR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2112	10.1136/bmj.j2112	http://dx.doi.org/10.1136/bmj.j2112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483769				2022-12-28	WOS:000401412700003
J	Poels, J				Poels, Jon			Peter John Poels Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		POELS PJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2121	10.1136/bmj.j2121	http://dx.doi.org/10.1136/bmj.j2121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483924				2022-12-28	WOS:000401412700007
J	Pywell, J				Pywell, Jonathan			James Hector Macpherson Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MACPHERSON JH, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2183	10.1136/bmj.j2183	http://dx.doi.org/10.1136/bmj.j2183			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483754				2022-12-28	WOS:000401412700013
J	Zarocostas, J				Zarocostas, John			Frontline: Providing care in the midst of the Syrian crisis	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1785	1785		10.1016/S0140-6736(17)31199-6	http://dx.doi.org/10.1016/S0140-6736(17)31199-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495158				2022-12-28	WOS:000400549300011
J	Kepp, KP				Kepp, Kasper P.			Comment on "Density functional theory is straying from the path toward the exact functional"	SCIENCE			English	Editorial Material								Medvedev et al. (Reports, 6 January 2017, p. 49) argue that recent density functionals stray from the path toward exactness. This conclusion rests on very compact 1s(2) and 1s(2)2s(2) systems favored by the Hartree-Fock picture. Comparison to actual energies for the same systems indicates that the "straying" is not chemically relevant and is at best specific to the studied dense systems.	[Kepp, Kasper P.] Tech Univ Denmark, DTU Chem, Bldg 206, DK-2800 Lyngby, Denmark	Technical University of Denmark	Kepp, KP (corresponding author), Tech Univ Denmark, DTU Chem, Bldg 206, DK-2800 Lyngby, Denmark.	kpj@kemi.dtu.dk	Kepp, Kasper Planeta/G-1748-2013; Kepp, Kasper P./AAA-4626-2021	Kepp, Kasper Planeta/0000-0002-6754-7348; Kepp, Kasper P./0000-0002-6754-7348				AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Cruz FG, 1998, J PHYS CHEM A, V102, P4911, DOI 10.1021/jp980950v; de Silva P, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931628; Grimme S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811331; Haas P, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205117; Jensen KP, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2406071; Jensen KP, 2009, J PHYS CHEM A, V113, P10133, DOI 10.1021/jp9061225; Medvedev MG, 2017, SCIENCE, V355, P49, DOI [10.1126/science.aah5975, 10.1126/science.aam9550]; Peverati R, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0476; Seth M, 2012, J CHEM THEORY COMPUT, V8, P901, DOI 10.1021/ct300006h; Swart M, 2013, CHEM PHYS LETT, V580, P166, DOI 10.1016/j.cplett.2013.06.045	11	56	56	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337								10.1126/science.aam9364	http://dx.doi.org/10.1126/science.aam9364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473557	Green Submitted			2022-12-28	WOS:000400545700025
J	Stein, GE				Stein, Gila E.			Surprising states of order for linear diblock copolymers	SCIENCE			English	Editorial Material							FRANK-KASPER PHASES; PACKING; MELTS		[Stein, Gila E.] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Stein, GE (corresponding author), Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA.	gstein4@utk.edu	Stein, Gila E/P-1927-2016	Stein, Gila E/0000-0002-3973-4496	Direct For Mathematical & Physical Scien [1731292] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Ashcroft N.W., 1976, SOLID STATE PHYS; Gillard TM, 2016, P NATL ACAD SCI USA, V113, P5167, DOI 10.1073/pnas.1601692113; Grason GM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058304; Grason GM, 2006, PHYS REP, V433, P1, DOI 10.1016/j.physrep.2006.08.001; Jacobs AG, 2016, MACROMOLECULES, V49, P6462, DOI 10.1021/acs.macromol.6b00698; Kim K, 2017, SCIENCE, V356, P520, DOI 10.1126/science.aam7212; Lee S, 2014, P NATL ACAD SCI USA, V111, P17723, DOI 10.1073/pnas.1408678111; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; Lifshitz R, 2014, P NATL ACAD SCI USA, V111, P17698, DOI 10.1073/pnas.1420121111; Liu MJ, 2016, ACS MACRO LETT, V5, P1167, DOI 10.1021/acsmacrolett.6b00685; Stein GE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158302; THOMAS EL, 1987, MACROMOLECULES, V20, P2934, DOI 10.1021/ma00177a049; Xie N, 2014, ACS MACRO LETT, V3, P906, DOI 10.1021/mz500445v	13	3	3	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					487	488		10.1126/science.aan1488	http://dx.doi.org/10.1126/science.aan1488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473548				2022-12-28	WOS:000400545700017
J	DariushMozaffarian				DariushMozaffarian			Conflict of Interest and the Role of the Food Industry in Nutrition Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE; ASSOCIATION; STROKE		[DariushMozaffarian] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA	Tufts University	DariushMozaffarian (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	dariush.mozaffarian@tufts.edu			National Heart, Lung, and Blood Institute (NHLBI) [R01 HL115189]; National Institutes of Health (NIH)	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant R01 HL115189 (primary investigator, Dr Mozaffarian) from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institutes of Health (NIH).	Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Chartres N, 2016, JAMA INTERN MED, V176, P1769, DOI 10.1001/jamainternmed.2016.6721; Clancy M., 2016, AMBER WAVES; Kuchler F, 2015, FEDERAL SUPPORT NUTR; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Mandrioli D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162198; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nestle M, 2015, SODA POLITICS TAKING	9	40	43	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1755	1756		10.1001/jama.2017.3456	http://dx.doi.org/10.1001/jama.2017.3456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464165				2022-12-28	WOS:000400440700027
J	Clarfield, AM; Manor, O; Nun, GB; Shvarts, S; Azzam, ZS; Afek, A; Basis, F; Israeli, A				Clarfield, A. Mark; Manor, Orly; Nun, Gabi Bin; Shvarts, Shifra; Azzam, Zaher S.; Afek, Arnon; Basis, Fuad; Israeli, Avi			Health and health care in Israel: an introduction	LANCET			English	Article							MIDDLE-EAST; TECHNOLOGIES; PROGRESS	Starting well before Independence in 1948, and over the ensuing six decades, Israel has built a robust, relatively efficient public system of health care, resulting in good health statistics throughout the life course. Because of the initiative of people living under the British Mandate for Palestine (1922-48), the development of many of today's health services predated the state's establishment by several decades. An extensive array of high-quality services and technologies is available to all residents, largely free at point of service, via the promulgation of the 1994 National Health Insurance Law. In addition to a strong medical academic culture, well equipped (albeit crowded) hospitals, and a robust primary-care infrastructure, the country has also developed some model national projects such as a programme for community quality indicators, an annual update of the national basket of services, and a strong system of research and education. Challenges include increasing privatisation of what was once largely a public system, and the underfunding in various sectors resulting in, among other challenges, relatively few acute hospital beds. Despite substantial organisational and financial investment, disparities persist based on ethnic origin or religion, other socioeconomic factors, and, regardless of the country's small size, a geographic maldistribution of resources. The Ministry of Health continues to be involved in the ownership and administration of many general hospitals and the direct payment for some health services (eg, geriatric institutional care), activities that distract it from its main task of planning for and supervising the whole health structure. Although the health-care system itself is very well integrated in relation to the country's two main ethnic groups (Israeli Arabs and Israeli Jews), we think that health in its widest sense might help provide a bridge to peace and reconciliation between the country and its neighbours.	[Clarfield, A. Mark] Ben Gurion Univ Negev, Med Sch Int Hlth, Beer Sheva, Israel; [Shvarts, Shifra] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Nun, Gabi Bin] Ben Gurion Univ Negev, Fac Business & Management, Dept Hlth Syst Management, Beer Sheva, Israel; [Manor, Orly; Israeli, Avi] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel; [Azzam, Zaher S.; Basis, Fuad] Technion Univ, Rapaport Fac Med, Rambam Hlth Care Campus, Haifa, Israel; [Afek, Arnon] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Clarfield, AM (corresponding author), Ben Gurion Univ Negev, Med Sch Int Hlth, Bet Caroline, POB 653, IL-8410501 Beer Sheva, Israel.	markclar@bgu.ac.il	Basis, Fuad/AAN-6963-2020	Shvarts, Shifra/0000-0002-1400-8156				[Anonymous], 2016, TIMES ISRAEL JE 0812; Asiskovitch S, 2013, ISR J HEALTH POLICY, V2, DOI 10.1186/2045-4015-2-3; Atzmon I, 2014, J RELIG HLTH, DOI 10.1007/s10943-014-9973-5; Bahouth H, 2017, LANCET; Balicer RD, 2017, LANCET; Barnea T, 2000, ISRAELI PALESTINIAN; Ben Simhon M, 2013, REV SOCIAL SERVICES; Beyar R, 2017, LANCET; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Bin Nun G, 2010, HLTH SYSTEM ISRAEL; Bramley-Greenberg S, 2014, PUBLIC OPINION LEVEL; Carmel S, 1998, Ethn Health, V3, P31; Chinitz D, 1998, BRIT MED J, V317, P1005; Chinitz D, 2010, BMJ-BRIT MED J, V341, pc682; Davidovitch N, 2013, HEALTH PLACE, V20, P13, DOI 10.1016/j.healthplace.2012.11.005; Dwolatzky T, 2017, LANCET; Efrati I., 2015, HAARETZ; Golan O, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-44; Goldberg N, 2015, LEADING CAUSES DEATH; Goldfield N, PEACE BUILDING HLTH; Granek L, 2017, LANCET; Horev T., 2012, COPING HLTH INEQUALI; Horton R, 2014, LANCET, V384, P1332, DOI 10.1016/S0140-6736(14)61782-7; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Israel Central Bureau of Statistics, DRUZ POP ISR COLL DA; Israel Central Bureau of Statistics, 2014, STAT ABSTR ISR; Israel Central Bureau of Statistics, 2014, NAT HLTH EXP OP SECT; Israel Central Bureau of Statistics, 2007, WELF ISR POP PREL FI; Israel Central Bureau of Statistics, NAT EXP HLTH; Israel Central Bureau of Statistics, 2013, SOC SURV; Israel Central Bureau of Statistics, 2016, NAT HLTH INS LAW COL; Israel Central Bureau of Statistics, POP ISR 2005 2014; Israel Ministry of Health, 2014, HLTH ISR; Israel Ministry of Health, HLTH STAT ISR 2010; Israel Ministry of Health, REC GEN SCREEN AR DR; Israel Ministry of Health. Jerusalem Israel, PROC EXP LIST HLTH T; Jaffe DH, 2012, ISR J HEALTH POLICY, V1, DOI 10.1186/2045-4015-1-3; Kaidar N, 2010, INT COMP HLTH SYSTEM; Katz R, 2010, INT J AGING HUM DEV, V71, P283, DOI 10.2190/AG.71.4.b; Kleinstern G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171709; Lavee Y., 2003, MARRIAGE FAMILY REV, V35, P193, DOI DOI 10.1300/J002V35N01_11; Leventhal A, 2006, BMJ-BRIT MED J, V333, P856, DOI 10.1136/bmj.38994.420926.80; Levin A, 1998, J NATL CANCER I, V90, P807, DOI 10.1093/jnci/90.11.807; Lowenstein A, 2006, AGEING SOC, V26, P203, DOI 10.1017/S0144686X05004502; Manor O, 2014, NATL PROGRAM QUALITY; Marcus Kenneth., 2015, CASE ACAD BOYCOTTS I, P243; Muhsen K, 2017, LANCET; Muller Thomas, 2005, Ber Wiss, V28, P321, DOI 10.1002/bewi.200401074; OECD, 2012, OECD REV HLTH CAR QU; OECD, 2015, OECD FAM DAT; One World Nations Online, COUNTR WORLD AR; Porat A, QUALITY INDICATORS C; RENNERT G, 1994, INT J EPIDEMIOL, V23, P751, DOI 10.1093/ije/23.4.751; Rosen B, 2015, HEALT SYST TRANSIT, V17, P1; Rubin L., 2017, LANCET; Sachar Howard Morely, 2007, HIST ISRAEL RISE ZIO; Shani S, 2000, HEALTH POLICY, V54, P169, DOI 10.1016/S0168-8510(00)00109-3; SHARE, DAT ACC DOC; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Shuval JT, 1998, INT MIGR, V36, P3, DOI 10.1111/1468-2435.00031; Shuval JT, 2000, SOCIAL STRUCTURE HLT; Shvarts S, 2012, HADASSAH HLTH PEOPLE, P161; Shvarts S., 2002, WORKERS HLTH FUND ER, P340; Siegel J, 2017, JERUSALEM POST  0228, P4; Simon Tomer, 2014, PLoS Curr, V6, DOI 10.1371/currents.dis.806848c38f18c6b7b0037fae3cd4edc5; Simon T, 2015, INT J EMERG MANAG, V11, P169, DOI 10.1504/IJEM.2015.071049; Skorecki K, 2017, LANCET; Taub Center for Social Policy Studies in Israel, 2015, HOSP OCC RAT ISR AR; Times of Israel Staff, 2014, TIMES ISRAEL JE 0603; Tulchinsky T, 1997, J Public Health Manag Pract, V3, P57; TULCHINSKY T, 1989, AM J PUBLIC HEALTH, V79, P1648, DOI 10.2105/AJPH.79.12.1648; TULCHINSKY TH, 1990, ISRAEL J MED SCI, V26, P438; Tulchinsky TH, 1996, HLTH DIS HOLY LAND S; Watt G, 2014, LANCET, V383, pE5, DOI 10.1016/S0140-6736(13)62233-3; WHO, 2003, HLTH HUM RIGHTS PUBL; Zohar A, NATL PROGRAM HOSP QU	76	94	95	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2503	2513		10.1016/S0140-6736(17)30636-0	http://dx.doi.org/10.1016/S0140-6736(17)30636-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495109				2022-12-28	WOS:000403901800029
J	Drolet, BC				Drolet, Brian C.			Text Messaging and Protected Health Information What Is Permitted?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Drolet, Brian C.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Dept Plast Surg, Nashville, TN USA; [Drolet, Brian C.] Vanderbilt Univ, Med Ctr, Ctr Biomed Eth & Soc, Dept Biomed Informat, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Drolet, BC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Plast Surg, Med Ctr N,D-4219, Nashville, TN 37232 USA.	brian.c.drolet@gmail.com						[Anonymous], 2016, CLAR US SEC TEXT MES; [Anonymous], 2016, UPD TEXT ORD; Duggan M, CELL PHONE ACTIVITIE; Kuhlmann S, 2014, TELEMED E-HEALTH, V20, P647, DOI 10.1089/tmj.2013.0200; Shah DR, 2013, J SURG EDUC, V70, P826, DOI [10.7016/j.jsurg.2012.05.003, 10.1016/j.jsurg.2012.05.003]	5	27	27	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2017	317	23					2369	2370		10.1001/jama.2017.5646	http://dx.doi.org/10.1001/jama.2017.5646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY0NJ	28492922				2022-12-28	WOS:000403654600006
J	Sutherland, R; Townend, J; Toy, V; Upton, P; Coussens, J; Allen, M; Baratin, LM; Barth, N; Becroft, L; Boese, C; Boles, A; Boulton, C; Broderick, NGR; Janku-Capova, L; Carpenter, BM; Celerier, B; Chamberlain, C; Cooper, A; Coutts, A; Cox, S; Craw, L; Doan, ML; Eccles, J; Faulkner, D; Grieve, J; Grochowski, J; Gulley, A; Hartog, A; Howarth, J; Jacobs, K; Jeppson, T; Kato, N; Keys, S; Kirilova, M; Kometani, Y; Langridge, R; Lin, WR; Little, T; Lukacs, A; Mallyon, D; Mariani, E; Massiot, C; Mathewson, L; Melosh, B; Menzies, C; Moore, J; Morales, L; Morgan, C; Mori, H; Niemeijer, A; Nishikawa, O; Prior, D; Sauer, K; Savage, M; Schleicher, A; Schmitt, DR; Shigematsu, N; Taylor-Offord, S; Teagle, D; Tobin, H; Valdez, R; Weaver, K; Wiersberg, T; Williams, J; Woodman, N; Zimmer, M				Sutherland, Rupert; Townend, John; Toy, Virginia; Upton, Phaedra; Coussens, Jamie; Allen, Michael; Baratin, Laura-May; Barth, Nicolas; Becroft, Leeza; Boese, Carolin; Boles, Austin; Boulton, Carolyn; Broderick, Neil G. R.; Janku-Capova, Lucie; Carpenter, Brett M.; Celerier, Bernard; Chamberlain, Calum; Cooper, Alan; Coutts, Ashley; Cox, Simon; Craw, Lisa; Mai-Linh Doan; Eccles, Jennifer; Faulkner, Dan; Grieve, Jason; Grochowski, Julia; Gulley, Anton; Hartog, Arthur; Howarth, Jamie; Jacobs, Katrina; Jeppson, Tamara; Kato, Naoki; Keys, Steven; Kirilova, Martina; Kometani, Yusuke; Langridge, Rob; Lin, Weiren; Little, Timothy; Lukacs, Adrienn; Mallyon, Deirdre; Mariani, Elisabetta; Massiot, Cecile; Mathewson, Loren; Melosh, Ben; Menzies, Catriona; Moore, Jo; Morales, Luiz; Morgan, Chance; Mori, Hiroshi; Niemeijer, Andre; Nishikawa, Osamu; Prior, David; Sauer, Katrina; Savage, Martha; Schleicher, Anja; Schmitt, Douglas R.; Shigematsu, Norio; Taylor-Offord, Sam; Teagle, Damon; Tobin, Harold; Valdez, Robert; Weaver, Konrad; Wiersberg, Thomas; Williams, Jack; Woodman, Nick; Zimmer, Martin			Extreme hydrothermal conditions at an active plate-bounding fault	NATURE			English	Article							SAN-ANDREAS FAULT; ALPINE FAULT; HEAT-FLOW; SOUTH ISLAND; NEW-ZEALAND; SLIP ZONE; EARTHQUAKE; PERMEABILITY; TEMPERATURE; FRICTION	Temperature and fluid pressure conditions control rock deformation and mineralization on geological faults, and hence the distribution of earthquakes(1). Typical intraplate continental crust has hydrostatic fluid pressure and a near-surface thermal gradient of 31 +/- 15 degrees Celsius per kilometre(2,3). At temperatures above 300-450 degrees Celsius, usually found at depths greater than 10-15 kilometres, the intra-crystalline plasticity of quartz and feldspar relieves stress by aseismic creep and earthquakes are infrequent. Hydrothermal conditions control the stability of mineral phases and hence frictional-mechanical processes associated with earthquake rupture cycles, but there are few temperature and fluid pressure data from active plate-bounding faults. Here we report results from a borehole drilled into the upper part of the Alpine Fault, which is late in its cycle of stress accumulation and expected to rupture in a magnitude 8 earthquake in the coming decades(4,5). The borehole (depth 893 metres) revealed a pore fluid pressure gradient exceeding 9 +/- 1 per cent above hydrostatic levels and an average geothermal gradient of 125 +/- 55 degrees Celsius per kilometre within the hanging wall of the fault. These extreme hydrothermal conditions result from rapid fault movement, which transports rock and heat from depth, and topographically driven fluid movement that concentrates heat into valleys. Shear heating may occur within the fault but is not required to explain our observations. Our data and models show that highly anomalous fluid pressure and temperature gradients in the upper part of the seismogenic zone can be created by positive feedbacks between processes of fault slip, rock fracturing and alteration, and landscape development at plate-bounding faults.	[Sutherland, Rupert; Upton, Phaedra; Howarth, Jamie; Langridge, Rob; Massiot, Cecile] GNS Sci, POB 30368, Lower Hutt, New Zealand; [Sutherland, Rupert; Townend, John; Baratin, Laura-May; Boese, Carolin; Janku-Capova, Lucie; Chamberlain, Calum; Grochowski, Julia; Jacobs, Katrina; Keys, Steven; Little, Timothy; Massiot, Cecile; Savage, Martha; Taylor-Offord, Sam] Victoria Univ Wellington, SGEES, POB 600, Wellington, New Zealand; [Toy, Virginia; Becroft, Leeza; Cooper, Alan; Craw, Lisa; Grieve, Jason; Lukacs, Adrienn; Mathewson, Loren; Prior, David; Sauer, Katrina; Williams, Jack] Univ Otago, Dept Geol, POB 56, Dunedin 9054, New Zealand; [Coussens, Jamie; Menzies, Catriona; Teagle, Damon; Woodman, Nick] Univ Southampton, Dept Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Allen, Michael; Faulkner, Dan; Mariani, Elisabetta] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [Barth, Nicolas] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Boles, Austin] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Broderick, Neil G. R.; Coutts, Ashley; Eccles, Jennifer; Gulley, Anton] Univ Auckland, Private Bag 92019, Auckland 1142, New Zealand; [Carpenter, Brett M.] Univ Oklahoma, Sch Geol & Geophys, Norman, OK 73019 USA; [Celerier, Bernard] Univ Montpellier, CNRS, F-34095 Montpellier, France; [Cox, Simon] GNS Sci, Private Bag 1930, Dunedin 9054, New Zealand; [Mai-Linh Doan] Univ Grenoble Alpes, Univ Savoie Mont Blanc, CNRS, IRD,IFSTTAR,ISTerre, F-38000 Grenoble, France; [Hartog, Arthur] Schlumberger Fiber Opt Technol Ctr, Romsey SO51 9DL, Hants, England; [Jeppson, Tamara; Tobin, Harold] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Kato, Naoki] Osaka Univ, Dept Earth & Space Sci, Osaka 5650871, Japan; [Kometani, Yusuke] Yamaguchi Univ, Dept Geosphere Sci, Yamaguchi 7538511, Japan; [Lin, Weiren] Kyoto Univ, Grad Sch Engn, Kyoto 6158540, Japan; [Lin, Weiren] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Kochi 7838502, Japan; [Mallyon, Deirdre; Schmitt, Douglas R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2R3, Canada; [Melosh, Ben] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 0G4, Canada; [Moore, Jo] Macquarie Univ, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia; [Morales, Luiz] ETH, ScopeM, CH-8093 Zurich, Switzerland; [Mori, Hiroshi] Shinshu Univ, Dept Geol, Asahi 3-1-1, Matsumoto, Nagano, Japan; [Niemeijer, Andre] Univ Utrecht, Fac Geosci, HPT Lab, NL-3584 CD Utrecht, Netherlands; [Nishikawa, Osamu] Akita Univ, Dept Earth Sci & Technol, Akita 0108502, Japan; [Schleicher, Anja; Wiersberg, Thomas; Zimmer, Martin] GFZ German Res Ctr Geosci, D-14473 Potsdam, Germany; [Shigematsu, Norio] Geol Survey Japan, AIST, Tsukuba, Ibaraki, Japan; [Valdez, Robert] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	GNS Science - New Zealand; Victoria University Wellington; University of Otago; NERC National Oceanography Centre; University of Southampton; University of Liverpool; University of California System; University of California Riverside; University of Michigan System; University of Michigan; University of Auckland; University of Oklahoma System; University of Oklahoma - Norman; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; GNS Science - New Zealand; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Schlumberger; University of Wisconsin System; University of Wisconsin Madison; Osaka University; Yamaguchi University; Kyoto University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Alberta; McGill University; Macquarie University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Shinshu University; Utrecht University; Akita University; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; National Institute of Advanced Industrial Science & Technology (AIST); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sutherland, R (corresponding author), GNS Sci, POB 30368, Lower Hutt, New Zealand.; Sutherland, R (corresponding author), Victoria Univ Wellington, SGEES, POB 600, Wellington, New Zealand.	rupert.sutherland@vuw.ac.nz	Townend, John/B-5923-2012; Sutherland, Rupert/Y-9290-2019; Craw, Lisa/V-5681-2018; Williams, Jack/L-1239-2019; Niemeijer, Andre/AHE-5571-2022; Toy, Virginia/F-9912-2014; Niemeijer, Andre/W-5388-2019; Schmitt, Douglas R/A-4091-2010; Hartog, Arthur/AAG-8392-2020; Allen, Michael/Q-4468-2017; Célérier, Bernard/AAF-3855-2019; Lin, Weiren/AAC-2088-2020; Boulton, Carolyn/Z-1995-2019; Boles, Austin/AAK-2282-2021; Hartog, Arthur H./F-2363-2019; Shigematsu, Norio/N-2150-2018	Townend, John/0000-0002-7017-620X; Sutherland, Rupert/0000-0001-7430-0055; Craw, Lisa/0000-0002-6809-3587; Williams, Jack/0000-0001-6669-308X; Toy, Virginia/0000-0002-7621-2064; Niemeijer, Andre/0000-0003-3983-9308; Schmitt, Douglas R/0000-0001-6920-0658; Allen, Michael/0000-0001-5068-3661; Lin, Weiren/0000-0003-3228-2789; Boulton, Carolyn/0000-0003-0597-6152; Boles, Austin/0000-0003-3072-3309; Hartog, Arthur H./0000-0001-6930-4561; Moore, Jo/0000-0003-1842-5595; Menzies, Catriona/0000-0003-3268-0007; Shigematsu, Norio/0000-0001-8028-2738; Chamberlain, Calum John/0000-0003-2317-2609; Kirilova, Martina/0000-0002-1359-9193; Sauer, Katrina/0000-0001-5668-7997; Woodman, Nicholas/0000-0002-5571-0451; Boese, Carolin/0000-0002-2383-2219; Massiot, Cecile/0000-0002-7250-8554; Gulley, Anton/0000-0003-0759-1897; Janku-Capova, Lucie/0000-0003-4882-2380; Schleicher, Anja/0000-0003-4052-8654; Grochowski, Julia/0000-0002-7795-4852; Faulkner, Daniel/0000-0002-6750-3775; Townend, Jonathan/0000-0002-5881-5806; Baratin, Laura-May/0000-0003-3037-8947; Howarth, Jamie/0000-0003-4365-0292; Carpenter, Brett/0000-0002-3451-2528	Westland community; International Continental Scientific Drilling Program (ICDP); NZ Marsden Fund; GNS Science; Victoria University of Wellington; University of Otago; NZ Ministry for Business Innovation and Employment; NERC [NE/J022128/1, NE/J024449/1]; Netherlands Organization for Scientific Research VIDI grant [854.12.011]; ERC [SEISMIC 335915]; Natural Environment Research Council [NE/J022128/1, NE/H012842/1, NE/J024449/1, 1544352, 1364056] Funding Source: researchfish; NERC [NE/H012842/1] Funding Source: UKRI; Division Of Earth Sciences [1215711] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [26109004, 16H04065] Funding Source: KAKEN	Westland community; International Continental Scientific Drilling Program (ICDP); NZ Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); GNS Science; Victoria University of Wellington; University of Otago; NZ Ministry for Business Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Netherlands Organization for Scientific Research VIDI grant; ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Friend family for land access and the Westland community for support; Schlumberger for assistance with optical fibre technology; A. Benson, R. Conze, R. Marx, B. Pooley, A. Pyne and S. Yeo for engineering and site support; the CNRS University of Montpellier wireline logging group of P. Pezard, G. Henry, O. Nitsch and J. Paris; Arnold Contracting; Eco Drilling; and Webster Drilling. Funding was provided by the International Continental Scientific Drilling Program (ICDP), the NZ Marsden Fund, GNS Science, Victoria University of Wellington, University of Otago, the NZ Ministry for Business Innovation and Employment, NERC grants NE/J022128/1 and NE/J024449/1, the Netherlands Organization for Scientific Research VIDI grant 854.12.011 and the ERC starting grant SEISMIC 335915. ICDP provided expert review, staff training and technical guidance.	Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Carpenter BM, 2011, NAT GEOSCI, V4, P251, DOI [10.1038/ngeo1089, 10.1038/NGEO1089]; Chester FM, 2013, SCIENCE, V342, P1208, DOI 10.1126/science.1243719; Cochran UA, 2017, EARTH PLANET SC LETT, V464, P175, DOI 10.1016/j.epsl.2017.02.026; Cox SC, 2015, GEOFLUIDS, V15, P216, DOI 10.1111/gfl.12093; CRAW D, 1988, J METAMORPH GEOL, V6, P1, DOI 10.1111/j.1525-1314.1988.tb00405.x; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Fulton PM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019378; Hartog A, 2000, OPTICAL FIBRE SENSOR TECHNOLOGY, P241; KANAMORI H, 2004, Patent No. 671429; Kano Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026733; Kitagawa Y, 2007, TECTONOPHYSICS, V443, P183, DOI 10.1016/j.tecto.2007.01.012; Li HB, 2015, GEOLOGY, V43, P163, DOI 10.1130/G35515.1; Ma KF, 2006, NATURE, V444, P473, DOI 10.1038/nature05253; Morrow CA, 2001, J GEOPHYS RES-SOL EA, V106, P30551, DOI 10.1029/2000JB000010; Norris RJ, 2007, GEOPHYS MONOGR SER, V175, P157, DOI 10.1029/175GM09; Ohtani T, 2000, J GEOPHYS RES-SOL EA, V105, P16161, DOI 10.1029/2000JB900086; POLLACK HN, 1993, REV GEOPHYS, V31, P267, DOI 10.1029/93RG01249; Schaff DP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003011; SIBSON RH, 1982, B SEISMOL SOC AM, V72, P151; Sutherland R, 2007, GEOPHYS MONOGR SER, V175, P235, DOI 10.1029/175GM12; Sutherland R, 2012, GEOLOGY, V40, P1143, DOI 10.1130/G33614.1; Sutherland R., 2017, DEEP FAULT DRILLING; Sutherland R., 2015, GNS SCI REP, V2015, P1; Townend J, 1999, NEW ZEAL J GEOL GEOP, V42, P21, DOI 10.1080/00288306.1999.9514829; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Townend J, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018918; Upton P, 1995, NEW ZEAL J GEOL GEOP, V38, P535, DOI 10.1080/00288306.1995.9514680; Upton P, 2007, GEOPHYS MONOGR SER, V175, P253, DOI 10.1029/175GM13; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; Williams CF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019352; Xue L, 2013, SCIENCE, V340, P1555, DOI 10.1126/science.1237237; Zoback M. D., 2007, GEOPHYSICS, P649, DOI [10.1016/8978-044452748-6.00084-5, DOI 10.1016/8978-044452748-6.00084-5]	36	72	72	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2017	546	7656					137	+		10.1038/nature22355	http://dx.doi.org/10.1038/nature22355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW3CR	28514440	Green Accepted, Green Published			2022-12-28	WOS:000402372800043
J	Abbasi, J				Abbasi, Jennifer			The Paternal Epigenome Makes Its Mark	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	21	21	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2017	317	20					2049	2051		10.1001/jama.2017.1566	http://dx.doi.org/10.1001/jama.2017.1566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV5JJ	28467541				2022-12-28	WOS:000401800600001
J	Crow, JM				Crow, James Mitchell			WELCOME TO MELBOURNE, WHERE SCIENCE IS FUELLED BY A BETTER CLASS OF COFFEE.	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S33	S36		10.1038/545S33a	http://dx.doi.org/10.1038/545S33a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28514435	Bronze			2022-12-28	WOS:000401466500026
J	Shirado, H; Christakis, NA				Shirado, Hirokazu; Christakis, Nicholas A.			Locally noisy autonomous agents improve global human coordination in network experiments	NATURE			English	Article							COMPLEX NETWORKS; DECISION-MAKING; ANIMAL GROUPS; GAMES; COOPERATION; LEADERSHIP; INDIVIDUALS; AVOIDANCE; CONSENSUS; MUTATION	Coordination in groups faces a sub-optimization problem(1-6) and theory suggests that some randomness may help to achieve global optima(7-9). Here we performed experiments involving a networked colour coordination game(10) in which groups of humans interacted with autonomous software agents (known as bots). Subjects (n = 4,000) were embedded in networks (n = 230) of 20 nodes, to which we sometimes added 3 bots. The bots were programmed with varying levels of behavioural randomness and different geodesic locations. We show that bots acting with small levels of random noise and placed in central locations meaningfully improve the collective performance of human groups, accelerating the median solution time by 55.6%. This is especially the case when the coordination problem is hard. Behavioural randomness worked not only by making the task of humans to whom the bots were connected easier, but also by affecting the gameplay of the humans among themselves and hence creating further cascades of benefit in global coordination in these heterogeneous systems.	[Shirado, Hirokazu; Christakis, Nicholas A.] Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA; [Shirado, Hirokazu; Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Christakis, NA (corresponding author), Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA.; Christakis, NA (corresponding author), Yale Univ, Dept Sociol, New Haven, CT 06520 USA.; Christakis, NA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.; Christakis, NA (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	nicholas.christakis@yale.edu			Robert Wood Johnson Foundation; National Institute of Social Sciences; National Institutes of Health [P30-AG034420]; NATIONAL INSTITUTE ON AGING [P30AG034420] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Social Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Allison, F. Fu, M. Kearns, G. Kraft-Todd, A. Oswald, D. Rand and D. Spielman for comments. M. McKnight provided technical support and programming for our Breadboard platform. Support for this research was provided by grants from the Robert Wood Johnson Foundation, the National Institute of Social Sciences, and the National Institutes of Health (P30-AG034420).	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; CALVERT RL, 1992, INT POLIT SCI REV, V13, P7, DOI 10.1177/019251219201300102; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Jiang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24088; Kadri U., 2016, EPL, V116, P1; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kesting A, 2008, TRANSPORT RES C-EMER, V16, P668, DOI 10.1016/j.trc.2007.12.004; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Munger K., 2016, POLIT BEHAV; NOWAK M, 1990, THEOR POPUL BIOL, V38, P93, DOI 10.1016/0040-5809(90)90005-G; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Shirado H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3814; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Sorensen JJWH, 2016, NATURE, V532, P210, DOI 10.1038/nature17620; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Young HP, 2009, GAME ECON BEHAV, V65, P626, DOI 10.1016/j.geb.2008.02.011	30	101	102	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					370	+		10.1038/nature22332	http://dx.doi.org/10.1038/nature22332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28516927	Green Accepted			2022-12-28	WOS:000401466500067
J	Lauffenburger, JC; Franklin, JM; Choudhry, NK				Lauffenburger, Julie C.; Franklin, Jessica M.; Choudhry, Niteesh K.			Patient-Centered Medical Homes and Adherence to Chronic Disease Medications RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							INTERVENTIONS; INFARCTION		[Lauffenburger, Julie C.; Franklin, Jessica M.; Choudhry, Niteesh K.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lauffenburger, JC (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.			Lauffenburger, Julie/0000-0002-4940-4140				Choudhry NK, 2014, AM HEART J, V167, P51, DOI 10.1016/j.ahj.2013.09.014; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Fischer MA, 2014, MED CARE, V52, P1050, DOI 10.1097/MLR.0000000000000247; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					761	762		10.7326/L17-0158	http://dx.doi.org/10.7326/L17-0158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505651				2022-12-28	WOS:000401240200032
J	Lee, JS; Hu, HM; Brummett, CM; Syrjamaki, JD; Dupree, JM; Englesbe, MJ; Waljee, JF				Lee, Jay S.; Hu, Hsou M.; Brummett, Chad M.; Syrjamaki, John D.; Dupree, James M.; Englesbe, Michael J.; Waljee, Jennifer F.			Postoperative Opioid Prescribing and the Pain Scores on Hospital Consumer Assessment of Healthcare Providers and Systems Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lee, Jay S.; Hu, Hsou M.; Englesbe, Michael J.; Waljee, Jennifer F.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Brummett, Chad M.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Syrjamaki, John D.; Dupree, James M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Waljee, JF (corresponding author), Univ Michigan Hlth Syst, Sect Plast Surg, Taubman Ctr 2130, SPC 5340,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	filip@med.umich.edu	Lee, Jay Soong-Jin/Q-6416-2016	Lee, Jay Soong-Jin/0000-0002-4016-7003; Brummett, Chad/0000-0003-0974-7242	Michigan Department of Health and Human Services; National Research Service award from the National Cancer Institute [5T32 CA009672-23]; Agency for Healthcare Research and Quality [1K08 HS023313-01]; American College of Surgeons; American Foundation for Surgery of the Hand; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR060392]; National Institute on Drug Abuse [R01DA038261-05, 1R01 DA038261-01A1]; National Institutes of Health's (NIH's) Department of Health and Human Services [K23 DA038718-04, AR070600-05 CORT]; Michigan Genomics Initiative from University of Michigan School Dean's Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS023313] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060392, P50AR070600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038261, K23DA038718] Funding Source: NIH RePORTER	Michigan Department of Health and Human Services; National Research Service award from the National Cancer Institute; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Surgeons; American Foundation for Surgery of the Hand; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health's (NIH's) Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Genomics Initiative from University of Michigan School Dean's Office; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Drs Brummett, Englesbe, and Waljee receive funding from the Michigan Department of Health and Human Services. This work was supported by National Research Service award 5T32 CA009672-23 from the National Cancer Institute (Dr Lee); grant 1K08 HS023313-01 from the Agency for Healthcare Research and Quality (Dr Waljee); the American College of Surgeons (Dr Waljee); and the American Foundation for Surgery of the Hand (Dr Waljee); grant R01 AR060392 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Dr Brummett); grants R01DA038261-05 and 1R01 DA038261-01A1 from the National Institute on Drug Abuse (Dr Brummett); grants K23 DA038718-04 and P50 AR070600-05 CORT from the National Institutes of Health's (NIH's) Department of Health and Human Services (Dr Brummett); and the Michigan Genomics Initiative from University of Michigan School Dean's Office (Dr Brummett).	Centers for Medicare and Medicaid Services, 2016, FED REGISTER, V81, P79562; Hill MV, 2017, ANN SURG, V265, P709, DOI 10.1097/SLA.0000000000001993; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Tefera L, 2016, JAMA-J AM MED ASSOC, V315, P2167, DOI 10.1001/jama.2016.1652	4	62	62	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					2013	2015		10.1001/jama.2017.2827	http://dx.doi.org/10.1001/jama.2017.2827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510669	Bronze, Green Published			2022-12-28	WOS:000401315500022
J	Millstine, D; Chen, CY; Bauer, B				Millstine, Denise; Chen, Christina Y.; Bauer, Brent			Complementary and integrative medicine in the management of headache	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TENSION-TYPE HEADACHE; DOUBLE-BLIND; ALTERNATIVE MEDICINE; MANUAL THERAPY; MIGRAINE PROPHYLAXIS; PETASITES-HYBRIDUS; CONTROLLED-TRIAL; EAR ACUPUNCTURE; FATTY-ACIDS; EFFICACY	Headaches, including primary headaches such as migraine and tension-type headache, are a common clinical problem. Complementary and integrative medicine (CIM), formerly known as complementary and alternative medicine (CAM), uses evidence informed modalities to assist in the health and healing of patients. CIM commonly includes the use of nutrition, movement practices, manual therapy, traditional Chinese medicine, and mind-body strategies. This review summarizes the literature on the use of CIM for primary headache and is based on five meta-analyses, seven systematic reviews, and 34 randomized controlled trials (RCTs). The overall quality of the evidence for CIM in headache management is generally low and occasionally moderate. Available evidence suggests that traditional Chinese medicine including acupuncture, massage, yoga, biofeedback, and meditation have a positive effect on migraine and tension headaches. Spinal manipulation, chiropractic care, some supplements and botanicals, diet alteration, and hydrotherapy may also be beneficial in migraine headache. CIM has not been studied or it is not effective for cluster headache. Further research is needed to determine the most effective role for CIM in patients with headache.	[Millstine, Denise] Mayo Clin, Womens Hlth Internal Med, Dept Gen Internal Med, Integrat Med Sect, Scottsdale, AZ 85260 USA; [Chen, Christina Y.] Mayo Clin, Div Geriatr, Primary Care Internal Med, Rochester, MN 55905 USA; [Bauer, Brent] Mayo Clin, Div Gen Internal Med, Integrat Med Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic	Millstine, D (corresponding author), Mayo Clin, Womens Hlth Internal Med, Dept Gen Internal Med, Integrat Med Sect, Scottsdale, AZ 85260 USA.	Millstine.Denise@mayo.edu						Abdoli S, 2012, SCAND J CARING SCI, V26, P254, DOI 10.1111/j.1471-6712.2011.00926.x; Adams J, 2013, HEADACHE, V53, P459, DOI 10.1111/j.1526-4610.2012.02271.x; Ahn CB, 2011, J ACUPUNCT MERIDIAN, V4, P29, DOI 10.1016/S2005-2901(11)60005-8; Allais G, 2011, NEUROL SCI, V32, pS173, DOI 10.1007/s10072-011-0525-4; Bennett MH, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005219.pub3; Bhatia R, 2007, Indian J Physiol Pharmacol, V51, P333; Bond DS, 2013, CONTEMP CLIN TRIALS, V35, P133, DOI 10.1016/j.cct.2013.03.004; Bougea AM, 2013, EXPLORE-NY, V9, P91, DOI 10.1016/j.explore.2012.12.005; Bronfort G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001878.PUB2; Bryans R, 2011, J MANIP PHYSIOL THER, V34, P274, DOI 10.1016/j.jmpt.2011.04.008; Bussing A, 2012, J PAIN, V13, P1, DOI 10.1016/j.jpain.2011.10.001; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Cady RK, 2011, HEADACHE, V51, P1078, DOI 10.1111/j.1526-4610.2011.01910.x; Castien RF, 2011, CEPHALALGIA, V31, P133, DOI 10.1177/0333102410377362; Cathcart S, 2014, BEHAV COGN PSYCHOTH, V42, P1, DOI 10.1017/S1352465813000234; Ceccherelli F, 2012, ACUPUNCTURE ELECTRO, V37, P277; Cerritelli F, 2015, COMPLEMENT THER MED, V23, P149, DOI 10.1016/j.ctim.2015.01.011; Chai NC, 2014, HEADACHE, V54, P219, DOI 10.1111/head.12296; Chaibi A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008095; Chaibi A, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-67; Chaibi A, 2011, J HEADACHE PAIN, V12, P127, DOI 10.1007/s10194-011-0296-6; Chatchawan U, 2014, J ALTERN COMPLEM MED, V20, P486, DOI 10.1089/acm.2013.0176; Church D., 2013, PSYCHOLOGY, V04, P645, DOI [10.4236/psych.2013.48092, DOI 10.4236/PSYCH.2013.48092]; Conboy L, 2005, J ALTERN COMPLEM MED, V11, P977, DOI 10.1089/acm.2005.11.977; Cowan RP, 2014, HEADACHE, V54, P1097, DOI 10.1111/head.12364; Day MA, 2014, CLIN J PAIN, V30, P152, DOI 10.1097/AJP.0b013e318287a1dc; Di Lorenzo C, 2015, EUR J NEUROL, V22, P170, DOI 10.1111/ene.12550; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Diener HC, 2004, EUR NEUROL, V51, P89, DOI 10.1159/000076535; Espi-Lopez GV, 2014, EUR J PHYS REHAB MED, V50, P641; Espi-Lopez GV, 2014, J BODYW MOV THER, V18, P576, DOI 10.1016/j.jbmt.2014.01.001; Gaul C, 2009, CEPHALALGIA, V29, P1069, DOI 10.1111/j.1468-2982.2009.01841.x; Gaul C, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0516-6; Ghanbari A, 2015, NEUROREHABILITATION, V37, P157, DOI 10.3233/NRE-151248; Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106; Gouveia LO, 2009, SPINE, V34, pE405, DOI 10.1097/BRS.0b013e3181a16d63; Grossmann M, 2000, INT J CLIN PHARM TH, V38, P430; Hall A, 2017, PHYS THER, V97, P227, DOI 10.2522/ptj.20160246; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Jafarpour M, 2016, J ETHNOPHARMACOL, V179, P170, DOI 10.1016/j.jep.2015.12.040; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; John PJ, 2007, HEADACHE, V47, P654, DOI 10.1111/j.1526-4610.2007.00789.x; Jonas WB, 2016, MED ACUPUNCT, V28, P113, DOI 10.1089/acu.2016.1183; Kabat-Zinn J., 1986, CLIN J PAIN, V2, P159, DOI DOI 10.1097/00002508-198602030-00004; Kisan Ravikiran, 2014, Int J Yoga, V7, P126, DOI 10.4103/0973-6131.133891; Li Y, 2009, HEADACHE, V49, P805, DOI 10.1111/j.1526-4610.2009.01424.x; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub3; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007587.pub2; Lipton RB, 2004, NEUROLOGY, V63, P2240, DOI 10.1212/01.WNL.0000147290.68260.11; Liu YL, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-015-0535-7; Maizes V, 2009, EXPLORE-NY, V5, P277, DOI 10.1016/j.explore.2009.06.008; Mayo Clinic, MINDF EX; Menon S, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0652-7; Mesa-Jimenez JA, 2015, CEPHALALGIA, V35, P1323, DOI 10.1177/0333102415576226; Nestoriuc Y, 2008, APPL PSYCHOPHYS BIOF, V33, P125, DOI 10.1007/s10484-008-9060-3; Nestoriuc Y, 2008, J CONSULT CLIN PSYCH, V76, P379, DOI 10.1037/0022-006X.76.3.379; Neuman MG, 2015, J PHARM PHARM SCI, V18, P825, DOI 10.18433/J3BG7J; Odawara M, 2015, INT J BEHAV MED, V22, P748, DOI 10.1007/s12529-015-9469-z; Orr SL, 2016, CEPHALALGIA, V36, P1112, DOI 10.1177/0333102415590239; Peikert A, 1996, CEPHALALGIA, V16, P257, DOI 10.1046/j.1468-2982.1996.1604257.x; Peng PWH, 2012, REGION ANESTH PAIN M, V37, P372, DOI 10.1097/AAP.0b013e31824f6629; Pfaffenrath V, 1996, CEPHALALGIA, V16, P436, DOI 10.1046/j.1468-2982.1996.1606436.x; Pintov S, 1997, PEDIATR NEUROL, V17, P129, DOI 10.1016/S0887-8994(97)00086-6; Powers Thomas L, 2003, J Hosp Mark Public Relations, V15, P45; Pradalier A, 2001, CEPHALALGIA, V21, P818, DOI 10.1046/j.1468-2982.2001.00240.x; Rajapakse T, 2016, HEADACHE, V56, P808, DOI 10.1111/head.12789; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Robbins MS, 2016, HEADACHE, V56, P1093, DOI 10.1111/head.12866; Sadeghi Omid, 2015, Iran J Nurs Midwifery Res, V20, P334; Sandor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED; Sasannejad P, 2012, EUR NEUROL, V67, P288, DOI 10.1159/000335249; Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466; Soderberg EI, 2011, CLIN J PAIN, V27, P448, DOI 10.1097/AJP.0b013e318208c8fe; St Sauver JL, 2013, MAYO CLIN PROC, V88, P56, DOI 10.1016/j.mayocp.2012.08.020; Steiner TJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-31; Sujan MU, 2016, J NEUROSCI RURAL PRA, V7, P109, DOI 10.4103/0976-3147.165389; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Toro-Velasco C, 2009, J MANIP PHYSIOL THER, V32, P527, DOI 10.1016/j.jmpt.2009.08.011; Walach H, 2003, J ALTERN COMPLEM MED, V9, P837, DOI 10.1089/107555303771952181; Wang LP, 2012, PAIN MED, V13, P623, DOI 10.1111/j.1526-4637.2012.01376.x; Wells RE, 2014, HEADACHE, V54, P1484, DOI 10.1111/head.12420; Wells RE, 2011, HEADACHE, V51, P1087, DOI 10.1111/j.1526-4610.2011.01917.x; Wider B, 2015, COCHRANE DB SYST REV, V4; Yang CP, 2011, CEPHALALGIA, V31, P1510, DOI 10.1177/0333102411420585; Yang CP, 2013, CLIN J PAIN, V29, P982, DOI 10.1097/AJP.0b013e31827eb511; Yang Y, 2016, ACUPUNCT MED, V34, P76, DOI 10.1136/acupmed-2015-010903; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zheng H, 2015, ACUPUNCT MED, V33, P121, DOI 10.1136/acupmed-2014-010679	88	45	47	5	64	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2017	357								j1805	10.1136/bmj.j1805	http://dx.doi.org/10.1136/bmj.j1805			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6RJ	28512119				2022-12-28	WOS:000401898900002
J	Appleby, J				Appleby, John			DATA BRIEFING What do NHS doctors think about their work?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						Picker Institute, 2017, BRIEF NOT ISS HIGHL; Picker Institute, 2017, NHS STAFF SURV 2016	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2017	357								j2232	10.1136/bmj.j2232	http://dx.doi.org/10.1136/bmj.j2232			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UK	28495664				2022-12-28	WOS:000401170200005
J	Porter, R				Porter, Robert			Peter George Reginald Dench Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		DENCH PGR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2115	10.1136/bmj.j2115	http://dx.doi.org/10.1136/bmj.j2115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483759				2022-12-28	WOS:000401412700004
J	Burki, T				Burki, Talha			Health care in Turkey in the Erdogan era	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1786	1787		10.1016/S0140-6736(17)31200-X	http://dx.doi.org/10.1016/S0140-6736(17)31200-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495159				2022-12-28	WOS:000400549300012
J	Blakemore, R; Hochkirch, A				Blakemore, Robert; Hochkirch, Axel			Restore earthworms to rebuild topsoil	NATURE			English	Letter									[Blakemore, Robert] VermEcol, Yokohama, Kanagawa, Japan; [Hochkirch, Axel] Trier Univ, Trier, Germany	Universitat Trier	Blakemore, R (corresponding author), VermEcol, Yokohama, Kanagawa, Japan.	rob.blakemore@gmail.com	Hochkirch, Axel/A-4092-2008	Hochkirch, Axel/0000-0002-4475-0394; Blakemore, Robert/0000-0001-9797-8328				Davies J, 2017, NATURE, V543, P309, DOI 10.1038/543309a; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365	2	13	14	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					30	30		10.1038/545030b	http://dx.doi.org/10.1038/545030b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470203	Bronze			2022-12-28	WOS:000400480400017
J	Bodnar, NO; Rapoport, TA				Bodnar, Nicholas O.; Rapoport, Tom A.			Molecular Mechanism of Substrate Processing by the Cdc48 ATPase Complex	CELL			English	Article							ENDOPLASMIC-RETICULUM; PROTEOLYTIC MACHINE; QUALITY-CONTROL; GENETIC-CODE; CRYO-EM; UBIQUITIN; PROTEIN; AAA; ER; DEGRADATION	The Cdc48 ATPase and its cofactors Ufd1/Npl4 (UN) extract polyubiquitinated proteins from membranes or macromolecular complexes, but how they perform these functions is unclear. Cdc48 consists of an N-terminal domain that binds UN and two stacked hexameric ATPase rings (D1 and D2) surrounding a central pore. Here, we use purified components to elucidate how the Cdc48 complex processes substrates. After interaction of the polyubiquitin chain with UN, ATP hydrolysis by the D2 ring moves the polypeptide completely through the double ring, generating a pulling force on the substrate and causing its unfolding. ATP hydrolysis by the D1 ring is important for subsequent substrate release from the Cdc48 complex. This release requires cooperation of Cdc48 with a deubiquitinase, which trims polyubiquitin to an oligoubiquitin chain that is then also translocated through the pore. Together, these results lead to a new paradigm for the function of Cdc48 and its mammalian ortholog p97/VCP.	[Bodnar, Nicholas O.; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Bodnar, Nicholas O.; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Rapoport, TA (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu		Bodnar, Nicholas/0000-0003-2410-7542	NIH/NIGMS [R01GM052586]; NIGMS [T32GM007753]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586, T32GM007753] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alex Stein for providing reagents; the Institute for Chemistry and Chemical Biology Longwood for use of a plate reader; and Dan Finley, Alex Stein, and Ryan Baldridge for critical reading of the manuscript. This work is supported by the NIH/NIGMS Award R01GM052586 and by award #T32GM007753 from the NIGMS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. T.A.R. is a Howard Hughes Medical Institute Investigator.	Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Buchberger Alexander, 2013, Subcell Biochem, V66, P195, DOI 10.1007/978-94-007-5940-4_8; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Franz A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00073; Frey S, 2014, J CHROMATOGR A, V1337, P95, DOI 10.1016/j.chroma.2014.02.029; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Huang R, 2016, P NATL ACAD SCI USA, V113, pE4190, DOI 10.1073/pnas.1603980113; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schuller JM, 2016, FEBS LETT, V590, P595, DOI 10.1002/1873-3468.12091; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Sivaraman T, 2001, NAT STRUCT BIOL, V8, P331, DOI 10.1038/86208; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	52	166	168	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					722	735		10.1016/j.cell.2017.04.020	http://dx.doi.org/10.1016/j.cell.2017.04.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475898	Green Accepted, Bronze			2022-12-28	WOS:000400560900016
J	Fox, D				Fox, Douglas			The electric cure	NATURE			English	Editorial Material							VAGUS NERVE-STIMULATION; INFLAMMATORY RESPONSE; MESENTERIC LYMPH; ARTHRITIS; PATHWAY; DISEASE; SHOCK											Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Lorton D, 2009, BRAIN BEHAV IMMUN, V23, P276, DOI 10.1016/j.bbi.2008.10.004; Morishita K, 2015, J TRAUMA ACUTE CARE, V78, P52, DOI 10.1097/TA.0000000000000489; Morishita K, 2014, J TRAUMA ACUTE CARE, V76, P610, DOI 10.1097/TA.0000000000000137; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Olofsson P., 2015, BIOELECTRON MED, V2, P37, DOI [10.15424/bioelectronmed.2015., DOI 10.15424/BIOELECTRONMED.2015]; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	15	12	16	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					20	22		10.1038/545020a	http://dx.doi.org/10.1038/545020a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470211	Bronze			2022-12-28	WOS:000400480400011
J	Sondalle, SB; Baserga, SJ				Sondalle, Samuel B.; Baserga, Susan J.			Ribosomes Need Straight A's to Sleep	CELL			English	Editorial Material							LIVER; RNA	Like falling asleep and waking up, many biological processes in mammals cycle in a diurnal fashion. Now, Sinturel et al. demonstrate that diurnal size changes in the liver require eating during a mouse's normal awake time and that these size changes are controlled by a nuclear mechanism that modulates ribosome production.	[Sondalle, Samuel B.; Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA.	susan.baserga@yale.edu	Sondalle, Samuel/C-1283-2014	Sondalle, Samuel/0000-0002-4144-9897	NIH [R01GM115710, T32GM007205, T32HD007149, F30DK109582]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, R01GM115710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the Baserga laboratory for critically reading this preview. The authors of this work are supported by NIH grants R01GM115710 (to S.J.B.) and T32GM007205, T32HD007149, and F30DK109582 (to S.B.S.).	ATTARDI G, 1970, ANNU REV BIOCHEM, V39, P183, DOI 10.1146/annurev.bi.39.070170.001151; GLASSER SR, 1972, BIOCHEM BIOPH RES CO, V47, P951, DOI 10.1016/0006-291X(72)90585-2; MONTY KJ, 1956, J BIOPHYS BIOCHEM CY, V2, P127, DOI 10.1083/jcb.2.2.127; Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015; Sondalle SB, 2014, BBA-MOL BASIS DIS, V1842, P758, DOI 10.1016/j.bbadis.2013.11.004; STENRAM U, 1963, EXP CELL RES, P176; Wang JK, 2017, CELL METAB, V25, P102, DOI 10.1016/j.cmet.2016.10.003; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197	8	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					565	567		10.1016/j.cell.2017.04.019	http://dx.doi.org/10.1016/j.cell.2017.04.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475888	Bronze, Green Accepted			2022-12-28	WOS:000400560900003
J	Easley, TJ				Easley, Thomas J.			Medical Journals, Publishers, and Conflict of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							JAMA NETWORK FAMILY; MEMBER		[Easley, Thomas J.] Amer Med Assoc, 330 N Wabash Ave, Chicago, IL 60611 USA	American Medical Association	Easley, TJ (corresponding author), Amer Med Assoc, 330 N Wabash Ave, Chicago, IL 60611 USA.	tom.easley@ama-assn.org						[Anonymous], 1999, JAMA-J AM MED ASSOC, V281, P2240, DOI [10.1001/jama.281.23.2240, DOI 10.1001/JAMA.281.23.2240]; Bonow RO, 2015, JAMA-J AM MED ASSOC, V314, P1457, DOI 10.1001/jama.2015.12867; Disis ML, 2014, JAMA-J AM MED ASSOC, V312, P1743, DOI 10.1001/jama.2014.13944; Fontanarosa PB, 2017, JAMA-J AM MED ASSOC, V317, P812, DOI 10.1001/jama.2017.1168; Hiltzik MA, 1999, LOS ANGELES TIMES; Hoey J, 2006, NEW ENGL J MED, V354, P1982, DOI 10.1056/NEJMp068104; Kelsall D, 2017, CAN MED ASSOC J, V189, pE1, DOI 10.1503/cmaj.161478	7	10	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1759	1760		10.1001/jama.2017.3421	http://dx.doi.org/10.1001/jama.2017.3421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464164				2022-12-28	WOS:000400440700029
J	Oliver, D				Oliver, David			BMJ ACUTE PERSPECTIVE David Oliver: Fighting pyjama paralysis in hospital wards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Acute Therapies Benchmarking Conference, 2015, AC THER BENCHM C NHS; Allen C, 1999, LANCET, V354, P1229, DOI 10.1016/S0140-6736(98)10063-6; [Anonymous], 2009, NURS TIMES, P357; ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Hubbard RE, 2004, AGE AGEING, V33, P479, DOI 10.1093/ageing/afh164; Knight J, 2009, NURS TIMES, V357, P16; Kortebein P, 2008, J GERONTOL A-BIOL, V63, P1076, DOI 10.1093/gerona/63.10.1076; Mudge AM, 2011, J HOSP MED, V6, P61, DOI 10.1002/jhm.811; Royal College of Nursing, 2012, SAF STAFF OLD PEOPL; Royal College of Physicians, 2015, NAT AUD CONT CAR; Royal College of Physicians, 2012, HOSP EDG TIM ACT; Tozer J., 2017, MAIL ONLINE; WARREN M W, 1948, Geriatrics, V3, P42; WARREN MW, 1946, LANCET, V250, P841	15	14	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j2096	10.1136/bmj.j2096	http://dx.doi.org/10.1136/bmj.j2096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465317	Bronze, Green Published			2022-12-28	WOS:000400889500009
J	Steinbrook, R				Steinbrook, Robert			Physicians, Industry Payments for Food and Beverages, and Drug Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHARMACEUTICAL-INDUSTRY		[Steinbrook, Robert] Yale Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						American Medical Association, 2016, COD MED ETH; [Anonymous], OP PAYM; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Goschowski Jones R, 2016, MATCHING IND PAYMENT; Ornstein Charles, 2016, NOW THERES PROOF DOC; Steinbrook R, 2016, JAMA INTERN MED, V176, P1123, DOI 10.1001/jamainternmed.2016.2959; Steinbrook R, 2009, NEW ENGL J MED, V360, P557, DOI 10.1056/NEJMp0900143; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Winter A, 2016, PAYMENTS DRUG DEVICE	10	19	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1753	1754		10.1001/jama.2017.2477	http://dx.doi.org/10.1001/jama.2017.2477			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464155				2022-12-28	WOS:000400440700026
J	Worthen, M				Worthen, Miranda			After the Medical Error	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Worthen, Miranda] San Jose State Univ, Hlth Sci & Recreat, San Jose, CA 95192 USA	California State University System; San Jose State University	Worthen, M (corresponding author), San Jose State Univ, Hlth Sci & Recreat, San Jose, CA 95192 USA.	miranda.worthen@sjsu.edu	Worthen, Miranda/AAP-8776-2021	Worthen, Miranda/0000-0002-6494-7098				Gallagher TH, 2013, NEW ENGL J MED, V369, P1752, DOI 10.1056/NEJMsb1303119; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Kahn JS, 2015, JAMA-J AM MED ASSOC, V313, P2427, DOI 10.1001/jama.2014.6507; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Mazor KM, 2012, J CLIN ONCOL, V30, P1784, DOI 10.1200/JCO.2011.38.1384; Worthen M, 2015, J AM BOARD FAM MED, V28, P750, DOI 10.3122/jabfm.2015.06.150080	6	2	2	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1763	1764		10.1001/jama.2017.0004	http://dx.doi.org/10.1001/jama.2017.0004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464144				2022-12-28	WOS:000400440700031
J	Durfey, SNM; George, P; Adashi, EY				Durfey, Shayla N. M.; George, Paul; Adashi, Eli Y.			Permanent GME Funding for Teaching Health Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Durfey, Shayla N. M.; George, Paul; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02912 USA	Brown University	Durfey, SNM (corresponding author), Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02912 USA.	shayla_durfey@brown.edu						Brown E, 2015, TEACHING HLTH CTR GM; Chen C, 2012, ACAD MED, V87, P1752, DOI 10.1097/ACM.0b013e3182720f4d; Regenstein M, 2016, NEW ENGL J MED, V375, P612, DOI 10.1056/NEJMp1607866; Rieselbach R, 2016, HLTH AFFAIRS BLOG	4	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2017	317	22					2277	2278		10.1001/jama.2017.5298	http://dx.doi.org/10.1001/jama.2017.5298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX3RM	28472299				2022-12-28	WOS:000403149900009
J	Lincoff, AM; Nicholls, SJ; Riesmeyer, JS; Barter, PJ; Brewer, HB; Fox, KAA; Gibson, CM; Granger, C; Menon, V; Montalescot, G; Rader, D; Tall, AR; McErlean, E; Wolski, K; Ruotolo, G; Vangerow, B; Weerakkody, G; Goodman, SG; Conde, D; McGuire, DK; Nicolau, JC; Leiva-Pons, JL; Pesant, Y; Li, WM; Kandath, D; Kouz, S; Tahirkheli, N; Mason, D; Nissen, SE				Lincoff, A. Michael; Nicholls, Stephen J.; Riesmeyer, Jeffrey S.; Barter, Philip J.; Brewer, H. Bryan; Fox, Keith A. A.; Gibson, C. Michael; Granger, Christopher; Menon, Venu; Montalescot, Gilles; Rader, Daniel; Tall, Alan R.; McErlean, Ellen; Wolski, Kathy; Ruotolo, Giacomo; Vangerow, Burkhard; Weerakkody, Govinda; Goodman, Shaun G.; Conde, Diego; McGuire, Darren K.; Nicolau, Jose C.; Leiva-Pons, Jose L.; Pesant, Yves; Li, Weimin; Kandath, David; Kouz, Simon; Tahirkheli, Naeem; Mason, Denise; Nissen, Steven E.		ACCELERATE Investigators	Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; ESTER TRANSFER PROTEIN; CHOLESTEROL EFFLUX CAPACITY; C-REACTIVE PROTEIN; HDL CHOLESTEROL; HEART-DISEASE; LIPOPROTEIN CHOLESTEROL; LDL CHOLESTEROL; RANDOMIZED-TRIALS; 000 PARTICIPANTS	BACKGROUND The cholesteryl ester transfer protein inhibitor evacetrapib substantially raises the high-density lipoprotein (HDL) cholesterol level, reduces the low-density lipoprotein (LDL) cholesterol level, and enhances cellular cholesterol efflux capacity. We sought to determine the effect of evacetrapib on major adverse cardiovascular outcomes in patients with high-risk vascular disease. METHODS In a multicenter, randomized, double-blind, placebo-controlled phase 3 trial, we enrolled 12,092 patients who had at least one of the following conditions: an acute coronary syndrome within the previous 30 to 365 days, cerebrovascular atherosclerotic disease, peripheral vascular arterial disease, or diabetes mellitus with coronary artery disease. Patients were randomly assigned to receive either evacetrapib at a dose of 130 mg or matching placebo, administered daily, in addition to standard medical therapy. The primary efficacy end point was the first occurrence of any component of the composite of death from cardiovascular causes, myocardial infarction, stroke, coronary revascularization, or hospitalization for unstable angina. RESULTS At 3 months, a 31.1% decrease in the mean LDL cholesterol level was observed with evacetrapib versus a 6.0% increase with placebo, and a 133.2% increase in the mean HDL cholesterol level was seen with evacetrapib versus a 1.6% increase with placebo. After 1363 of the planned 1670 primary end-point events had occurred, the data and safety monitoring board recommended that the trial be terminated early because of a lack of efficacy. After a median of 26 months of evacetrapib or placebo, a primary end-point event occurred in 12.9% of the patients in the evacetrapib group and in 12.8% of those in the placebo group (hazard ratio, 1.01; 95% confidence interval, 0.91 to 1.11; P = 0.91). CONCLUSIONS Although the cholesteryl ester transfer protein inhibitor evacetrapib had favorable effects on established lipid biomarkers, treatment with evacetrapib did not result in a lower rate of cardiovascular events than placebo among patients with high-risk vascular disease. (Funded by Eli Lilly; ACCELERATE ClinicalTrials.gov number, NCT01687998.)	[Lincoff, A. Michael; Menon, Venu; McErlean, Ellen; Wolski, Kathy; Mason, Denise; Nissen, Steven E.] Cleveland Clin, Coordinating Ctr Clin Res, C5Res, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Nicholls, Stephen J.] Univ Adelaide, South Australian Heart & Med Res Inst, Adelaide, SA, Australia; [Barter, Philip J.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Riesmeyer, Jeffrey S.; Ruotolo, Giacomo; Vangerow, Burkhard; Weerakkody, Govinda] Eli Lilly, Indianapolis, IN USA; [Brewer, H. Bryan] Medstar Res Inst, Washington Cardiovasc Associates, Washington, DC USA; [Fox, Keith A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Granger, Christopher] Duke Univ, Med Ctr, Durham, NC USA; [Montalescot, Gilles] Univ Sorbonne Paris 6, Hop Pitie Salpetriere, AP HP, Inst Cardiol,ACTION Study Grp, Paris, France; [Rader, Daniel] Penn Heart & Vasc Ctr, Philadelphia, PA USA; [Tall, Alan R.] Columbia Univ, New York, NY USA; [Kandath, David] Saratoga Springs, Saratoga Cardiol Associates, New York, NY USA; [Goodman, Shaun G.] St Michaels Hosp, Toronto, ON, Canada; [Pesant, Yves] Rech Med St Jerome, St Jerome, PQ, Canada; [Kouz, Simon] Ctr Hosp Reg Lanaud, Ctr Sante & Serv Sociaux Nord Lanaudiere, St Charles Borromee, PQ, Canada; [Conde, Diego] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina; [McGuire, Darren K.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Nicolau, Jose C.] Univ Sao Paulo, Med Sch, Heart Inst InCor, Sao Paulo, Brazil; [Leiva-Pons, Jose L.] Hosp Cent Dr Ignacio Morones, San Luis Potosi, Mexico; [Li, Weimin] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China; [Tahirkheli, Naeem] South Oklahoma Heart Res, Oklahoma City, OK USA	Cleveland Clinic Foundation; University of Adelaide; University of New South Wales Sydney; Eli Lilly; University of Edinburgh; Harvard University; Beth Israel Deaconess Medical Center; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Columbia University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Instituto Cardiovascular de Buenos Aires (ICBA); University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Sao Paulo; Harbin Medical University	Lincoff, AM (corresponding author), Cleveland Clin, Dept Cardiovasc Med, C5Res, 9500 Euclid Ave, Cleveland, OH 44195 USA.	lincofa@ccf.org	Menon, Venu/AAF-1871-2019; McGuire, Darren K./AAL-4172-2021; Fox, keith A A/I-3742-2013; Gibson, C. Michael/AAE-8212-2019; Nicolau, Jose C/E-1487-2012; Munzel, Thomas/A-2912-2014; Boldueva, Svetlana/AAH-3862-2019; Tall, Alan/AAT-8528-2021; SILVAIN, Johanne/C-7521-2016	Nicolau, Jose C/0000-0002-9680-3689; Munzel, Thomas/0000-0001-5503-4150; Boldueva, Svetlana/0000-0002-1898-084X; Montenegro Junior, Renan/0000-0001-7287-8726; Ballantyne, Christie/0000-0002-6432-1730; gosse, philippe/0000-0002-5840-7749; ELBAZ, Meyer/0000-0002-3520-7883; Fox, Keith/0000-0002-0140-2752; Nicholls, Stephen/0000-0002-9668-4368; SILVAIN, Johanne/0000-0002-1901-2808; Howes, Laurence/0000-0002-1507-8260	Eli Lilly; AstraZeneca; Roche; CSL Behring; Esperion; AbbVie; Amgen; Cerenis; Novartis; Resverlogix; Sanofi-Regeneron; Medicines Company; Merck; Boehringer Ingelheim; Pfizer; DeZima Pharma; Bayer/Janssen; Armetheon; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; GlaxoSmithKline; Janssen Pharmaceuticals; Medtronic Foundation; Boston Scientific; Gilead Sciences; Hoffmann-La Roche; Medtronic; Verseon; Association pour le Developpement Industriel de la Reunion; Celladon; Institute of Cardiometabolism and Nutrition; Federation Francaise de Cardiologie; Merck Sharp and Dohme; Sanofi-Aventis; Berlin Chimie; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Cardiovascular Research Foundation; CME Resources, Europa; Elsevier; Fondazione Anna Maria Sechi per il Cuore; Janssen; Lead-Up; Menarini; TIMI Study Group; WebMD; MedImmune; Janssen Research and Development; Takeda Pharmaceuticals North America; Eisai; Sanofi US; Servier; Sanofi; Valeant; Dalcor; Theracos; Esperion Therapeutics; Amarin Pharma	Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Roche(Roche Holding); CSL Behring; Esperion; AbbVie(AbbVie); Amgen(Amgen); Cerenis; Novartis(Novartis); Resverlogix; Sanofi-Regeneron(Regeneron); Medicines Company; Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); DeZima Pharma(Dexcel Pharma); Bayer/Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech IncBayer AG); Armetheon; Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medtronic Foundation; Boston Scientific(Boston Scientific); Gilead Sciences(Gilead Sciences); Hoffmann-La Roche(Hoffmann-La Roche); Medtronic(Medtronic); Verseon; Association pour le Developpement Industriel de la Reunion; Celladon; Institute of Cardiometabolism and Nutrition; Federation Francaise de Cardiologie; Merck Sharp and Dohme(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Berlin Chimie; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Cardiovascular Research Foundation; CME Resources, Europa; Elsevier; Fondazione Anna Maria Sechi per il Cuore; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lead-Up; Menarini(Menarini Group); TIMI Study Group; WebMD; MedImmune(AstraZenecaMedimmune); Janssen Research and Development; Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Eisai(Eisai Co Ltd); Sanofi US; Servier(Servier); Sanofi; Valeant; Dalcor; Theracos; Esperion Therapeutics; Amarin Pharma(Dexcel Pharma)	Dr. Lincoff reports receiving grant support, through a research contract with his institution, from Eli Lilly, AstraZeneca, Roche, CSL Behring, Esperion, and AbbVie; Dr. Nicholls, receiving grant support from AstraZeneca, Amgen, Cerenis, Novartis, Esperion, Resverlogix, Sanofi-Regeneron, and the Medicines Company, fees for serving on advisory boards from AstraZeneca, Amgen, Novartis, Resverlogix, Merck, Boehringer Ingelheim, CSL Behring, Sanofi-Regeneron, and Roche, and lecture fees from Amgen and Merck; Dr. Riesmeyer, being employed by and owning stock in Eli Lilly; Dr. Barter, receiving grant support from Pfizer and Merck, fees for serving on an advisory board and lecture fees from Pfizer, Merck, and Amgen, and fees for serving on an advisory board from AstraZeneca and Sanofi-Regeneron; Dr. Brewer Jr., receiving consulting fees from Merck, AstraZeneca, Eli Lilly, Pfizer, Cerenis, and DeZima Pharma; Mr. Fox, receiving grant support and honoraria from Bayer/Janssen and AstraZeneca, and honoraria from Sanofi/Regeneron; Dr. Granger, receiving grant support from Armetheon, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Janssen Pharmaceuticals, the Medicines Company, Medtronic Foundation, Novartis, and Pfizer, lecture fees and consulting fees from AstraZeneca, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi-Sankyo, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen Pharmaceuticals, the Medicines Company, Medtronic, Novartis, Pfizer, and Verseon, and lecture fees from Bayer; Dr. Montalescot, receiving grant support, to his institution, from Association pour le Developpement Industriel de la Reunion, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Celladon, Daiichi-Sankyo, Eli Lilly, Institute of Cardiometabolism and Nutrition, Federation Francaise de Cardiologie, Medtronic, Merck Sharp and Dohme, Pfizer, Sanofi-Aventis, and the Medicines Company and consulting fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, Merck Sharp and Dohme, Pfizer, Sanofi-Aventis, the Medicines Company, Berlin Chimie, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Cardiovascular Research Foundation, CME Resources, Europa, Elsevier, Fondazione Anna Maria Sechi per il Cuore, Gilead Sciences, Janssen, Lead-Up, Menarini, TIMI Study Group, and WebMD; Mr. Tall, receiving consulting fees from Merck, CSL Behring, and MedImmune; Ms. McErlean, receiving grant support from Eli Lilly and Pfizer; Dr. Ruotolo, being employed by Eli Lilly; Dr. Vangerow, being employed by and owning equity or stock in Eli Lilly; Dr. Weerakkody, being employed by Eli Lilly; Dr. Goodman, receiving grant support, fees for serving on an advisory board, consulting fees, and lecture fees from Eli Lilly, Amgen, AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, and Sanofi-Regeneron; Dr. McGuire, receiving fees for serving on committees from Boehringer Ingelheim, Janssen Research and Development, Merck Sharp and Dohme, Eli Lilly, Novo Nordisk, GlaxoSmithKline, Takeda Pharmaceuticals North America, AstraZeneca, and Eisai, consulting fees from Boehringer Ingelheim, Sanofi US, Eli Lilly, and Novo Nordisk, fees for serving on an advisory board from Merck Sharp and Dohme, and fees for serving as clinical trials chairperson from Lexicon; Dr.; Nicolau, receiving grant support from Amgen, Sanofi, and Merck, fees for serving on advisory boards from Sanofi and Merck, and fees for serving on the NLI/Member Steering Committee for SPIRE from Pfizer; Dr. Kouz, receiving grant support, lecture fees, and fees for serving on an advisory board from Bristol-Myers Squibb, Sanofi, Servier, Novartis, AstraZeneca, Valeant, Pfizer, Bayer, Boehringer Ingelheim, Medtronic, and Amgen, grant support and lecture fees from Merck, and grant support from Dalcor, Eli Lilly, Theracos, Eisai, Esperion Therapeutics, Janssen, GlaxoSmithKline, and Amarin Pharma; and Dr. Nissen, receiving grant support from Pfizer, the Medicines Company, Amgen, Cerenis, AstraZeneca, and Esperion Therapeutics. No other potential conflict of interest relevant to this article was reported.	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Nicholls SJ, 2016, J CLIN LIPIDOL, V10, P519, DOI 10.1016/j.jacl.2015.11.014; Nicholls SJ, 2015, AM HEART J, V170, P1061, DOI 10.1016/j.ahj.2015.09.007; Nicholls SJ, 2015, J AM COLL CARDIOL, V66, P2201, DOI 10.1016/j.jacc.2015.09.013; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Saleheen D, 2015, LANCET DIABETES ENDO, V3, P507, DOI 10.1016/S2213-8587(15)00126-6; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Stone NJ, 2013, CIRCULATION S2, V129, pS1, DOI DOI 10.1161/01.CIR.0000437738.63853.7A; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; YAMASHITA S, 1988, ATHEROSCLEROSIS, V70, P7, DOI 10.1016/0021-9150(88)90094-9	35	409	423	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2017	376	20					1933	1942		10.1056/NEJMoa1609581	http://dx.doi.org/10.1056/NEJMoa1609581			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0DB	28514624	Green Published			2022-12-28	WOS:000401407500007
J	Savage, N				Savage, Neil			ENERGY Powering change	NATURE			English	Editorial Material																			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S13	S14		10.1038/545S13a	http://dx.doi.org/10.1038/545S13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514416	Bronze			2022-12-28	WOS:000401466500010
J	Horton, R				Horton, Richard			Offline: The message of mental health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1870	1870		10.1016/S0140-6736(17)31259-X	http://dx.doi.org/10.1016/S0140-6736(17)31259-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28513439	Bronze			2022-12-28	WOS:000400973500009
J	[Anonymous]				[Anonymous]			Medicolegal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1914	1914		10.1001/jama.2017.0648	http://dx.doi.org/10.1001/jama.2017.0648			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492889				2022-12-28	WOS:000400842400031
J	Sharma, DC				Sharma, Dinesh C.			Concern over India's move to cut funds for PHFI	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1784	1784		10.1016/S0140-6736(17)31198-4	http://dx.doi.org/10.1016/S0140-6736(17)31198-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495157				2022-12-28	WOS:000400549300010
J	Lucas, T				Lucas, Tamara			A personal perspective on health in Israel	LANCET			English	Editorial Material									[Lucas, Tamara] Lancet, London EC2Y 5AS, England		Lucas, T (corresponding author), Lancet, London EC2Y 5AS, England.	tamara.lucas@lancet.com						[Anonymous], 2014, LANCET; Bahouth H, 2017, LANCET; Beyar R, 2017, LANCET; Clarfield AM, 2017, LANCET; Dwolatzky T, 2017, LANCET; Granek L, 2017, LANCET; Jotkowitz AB, 2017, LANCET; Malkosh N., 1961, HISTADRUT ISRAEL ITS; Muhsen K, 2017, LANCET; Reis S, 2017, LANCET; Rubin L., 2017, LANCET; Skorecki K, 2017, LANCET	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2450	2451		10.1016/S0140-6736(17)30865-6	http://dx.doi.org/10.1016/S0140-6736(17)30865-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28495115				2022-12-28	WOS:000403901800008
J	Hattori, A; Tsunoda, M; Konuma, T; Kobayashi, M; Nagy, T; Glushka, J; Tayyari, F; Cskimming, DM; Kannan, N; Tojo, A; Edison, AS; Ito, T				Hattori, Ayuna; Tsunoda, Makoto; Konuma, Takaaki; Kobayashi, Masayuki; Nagy, Tamas; Glushka, John; Tayyari, Fariba; Cskimming, Daniel M.; Kannan, Natarajan; Tojo, Arinobu; Edison, Arthur S.; Ito, Takahiro			Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; AMINO-ACID-METABOLISM; GENE-EXPRESSION; LEUCINE SENSOR; MURINE MODEL; RNA; MUSASHI; PROLIFERATION; SURVIVAL; PATHWAY	Reprogrammed cellular metabolism is a common characteristic observed in various cancers(1,2). However, whether metabolic changes directly regulate cancer development and progression remains poorly understood. Here we show that BCAT1, a cytosolic aminotransferase for branched-chain amino acids (BCAAs), is aberrantly activated and functionally required for chronic myeloid leukaemia (CML) in humans and in mouse models of CML. BCAT1 is upregulated during progression of CML and promotes BCAA production in leukaemia cells by aminating the branched-chain keto acids. Blocking BCAT1 gene expression or enzymatic activity induces cellular differentiation and impairs the propagation of blast crisis CML both in vitro and in vivo. Stable-isotope tracer experiments combined with nuclear magnetic resonance-based metabolic analysis demonstrate the intracellular production of BCAAs by BCAT1. Direct supplementation with BCAAs ameliorates the defects caused by BCAT1 knockdown, indicating that BCAT1 exerts its oncogenic function through BCAA production in blast crisis CML cells. Importantly, BCAT1 expression not only is activated in human blast crisis CML and de novo acute myeloid leukaemia, but also predicts disease outcome in patients. As an upstream regulator of BCAT1 expression, we identified Musashi2 (MSI2), an oncogenic RNA binding protein that is required for blast crisis CML. MSI2 is physically associated with the BCAT1 transcript and positively regulates its protein expression in leukaemia. Taken together, this work reveals that altered BCAA metabolism activated through the MSI2-BCAT1 axis drives cancer progression in myeloid leukaemia.	[Hattori, Ayuna; Tayyari, Fariba; Cskimming, Daniel M.; Kannan, Natarajan; Edison, Arthur S.; Ito, Takahiro] Univ Georgia, Dept Biochem & Mol Biol, Franklin Coll Arts & Sci, Athens, GA 30602 USA; [Hattori, Ayuna; Kannan, Natarajan; Ito, Takahiro] Univ Georgia, Ctr Canc, Athens, GA 30602 USA; [Tsunoda, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Konuma, Takaaki; Kobayashi, Masayuki; Tojo, Arinobu] Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Minato Ku, Tokyo 1088639, Japan; [Nagy, Tamas] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Glushka, John; Tayyari, Fariba; Edison, Arthur S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Cskimming, Daniel M.; Kannan, Natarajan; Edison, Arthur S.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Edison, Arthur S.] Univ Georgia, Dept Genet, Franklin Coll Arts & Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Tokyo; University of Tokyo; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ito, T (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Franklin Coll Arts & Sci, Athens, GA 30602 USA.; Ito, T (corresponding author), Univ Georgia, Ctr Canc, Athens, GA 30602 USA.	ito@bmb.uga.edu	Tsunoda, Makoto/AFI-6623-2022; Ito, Takahiro/F-5006-2011	Tsunoda, Makoto/0000-0001-9596-5988; Ito, Takahiro/0000-0001-7165-0412; Edison, Arthur/0000-0002-5686-2350; Konuma, Takaaki/0000-0002-1953-8463; Kobayashi, Masayuki/0000-0002-9194-9320	University of Georgia Research Foundation; Heather Wright Cancer Research Fund; Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Projects Program; Southeast Center for Integrated Metabolomics, National Institutes of Health [U24DK097209]; Georgia Research Alliance; Grants-in-Aid for Scientific Research [16H06277, 16K19570] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114409, P41GM103390] Funding Source: NIH RePORTER	University of Georgia Research Foundation; Heather Wright Cancer Research Fund; Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Projects Program; Southeast Center for Integrated Metabolomics, National Institutes of Health; Georgia Research Alliance; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Pear, D. Baltimore and S. Lowe for plasmids, and S. Dalton, C. Jordan, B. Zimdahl, J. Ninomiya-Tsuji, K. Sai, K. Matsumoto, H. Hanafusa, T. Mizuno, Y. Kuwatsuka, Y. Minami and M. Merritt for discussions and comments on the manuscript. We also thank J. Nelson at the CTEGD Cytometry Shared Resource Laboratory, University of Georgia, for assistance in cell sorting, K. Sekimizu, C. West, M. Mandalasi and H. van der Wel for advice on radioisotope use, and K. MacKeil, J. Nist and K. Ogata for technical help. This work was supported by grants from the University of Georgia Research Foundation and the Heather Wright Cancer Research Fund (T. I.); by the Japan Society for the Promotion of Science Bilateral Open Partnership Joint Research Projects Program (M.T.); A.S.E. and the Complex Carbohydrate Research Center NMR facility were partly supported by the Southeast Center for Integrated Metabolomics, National Institutes of Health U24DK097209 and the Georgia Research Alliance.	Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Hutson SM, 1998, J NEUROCHEM, V71, P863; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537; Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Morimoto E, 2008, J PHARMACOL SCI, V108, P505, DOI 10.1254/jphs.08232FP; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Okano H, 2002, J CELL SCI, V115, P1355; Pailla K, 2000, CLIN CHEM, V46, P848; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rentas S, 2016, NATURE, V532, P508, DOI 10.1038/nature17665; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Song YT, 2012, AMINO ACIDS, V42, P1897, DOI 10.1007/s00726-011-0914-2; Song YT, 2011, J CHROMATOGR B, V879, P335, DOI 10.1016/j.jchromb.2010.12.018; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; Sutherland JM, 2013, ADV EXP MED BIOL, V786, P233, DOI 10.1007/978-94-007-6621-1_13; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884	37	191	196	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					500	+		10.1038/nature22314	http://dx.doi.org/10.1038/nature22314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514443	Green Accepted			2022-12-28	WOS:000401906500056
J	Bourzac, K				Bourzac, Katherine			THERAPEUTIC DEVELOPMENTS Masters of medicine	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					S4	S5		10.1038/545S4a	http://dx.doi.org/10.1038/545S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28514412	Bronze			2022-12-28	WOS:000401466500002
J	Garcia-Albeniz, X; Hsu, J; Bretthauer, M; Hernan, MA				Garcia-Albeniz, Xabier; Hsu, John; Bretthauer, Michael; Hernan, Miguel A.			Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							ETHNICITY; RACE		[Garcia-Albeniz, Xabier; Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Garcia-Albeniz, Xabier; Hsu, John] Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02114 USA; [Hsu, John] Harvard Med Sch, Boston, MA USA; [Bretthauer, Michael] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Hernan, Miguel A.] Harvard MIT Hlth Sci & Technol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oslo; Harvard University	Garcia-Albeniz, X (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Garcia-Albeniz, X (corresponding author), Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02114 USA.			Garcia-Albeniz, Xabier/0000-0002-9814-2343	NATIONAL INSTITUTE ON AGING [P01AG032952] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG032952] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Scott CG, 1999, SOC SECUR BULL, V62, P9; Shiels MS, 2017, LANCET, V389, P1043, DOI [10.1016/S0140-6736(17)30187-3, 10.1016/s0140-6736(17)30187-3]; Valeri L, 2016, CANCER EPIDEM BIOMAR, V25, P83, DOI 10.1158/1055-9965.EPI-15-0456	3	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					758	759		10.7326/L17-0138	http://dx.doi.org/10.7326/L17-0138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505646				2022-12-28	WOS:000401240200027
J	Hirsch, C				Hirsch, Calvin			In older men with low testosterone levels and age-associated memory impairment, testosterone did not improve memory	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] Univ Calif Davis, Davis Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Davis Med Ctr, Sacramento, CA 95817 USA.							Goldman WP, 2001, ALZ DIS ASSOC DIS, V15, P72, DOI 10.1097/00002093-200104000-00006; Jung HJ, 2016, WORLD J MENS HEALTH, V34, P194, DOI 10.5534/wjmh.2016.34.3.194; Moffat SD, 2004, NEUROLOGY, V62, P188, DOI 10.1212/WNL.62.2.188	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					JC56	JC56		10.7326/ACPJC-2017-166-10-056	http://dx.doi.org/10.7326/ACPJC-2017-166-10-056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28505640				2022-12-28	WOS:000401240200008
J	Kempen, JH; Altaweel, MM; Holbrook, JT; Sugar, EA; Thorne, JE; Jabs, DA				Kempen, John H.; Altaweel, Michael M.; Holbrook, Janet T.; Sugar, Elizabeth A.; Thorne, Jennifer E.; Jabs, Douglas A.		Writing Comm Multicenter Uvei	Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UVEITIS STEROID TREATMENT; TRIAL; RECOMMENDATIONS; GUIDELINES; THRESHOLD; BLINDNESS; HEALTH	IMPORTANCE A randomized clinical trial comparing fluocinolone acetonide implant vs systemic corticosteroids and immunosuppression for treatment of severe noninfectious intermediate, posterior, and panuveitides did not result in a significant difference in visual acuity at 2 and 4.5 years; longer-term outcomes are not known. OBJECTIVE To compare the association between intravitreous fluocinolone acetonide implant vs systemic therapy and long-term visual and other outcomes in patients with uveitis. DESIGN, SETTING, AND PARTICIPANTS Nonprespecified 7-year observational follow-up of the Multicenter Uveitis Steroid Treatment (MUST) randomized clinical trial comparing the alternative treatments. Follow-up was conducted in tertiary uveitis subspecialty practices in the United States (21), the United Kingdom (1), and Australia (1). Of 255 patients 13 years or older with intermediate, posterior, or panuveitis (active within <= 60 days) enrolled in the MUST trial between December 6, 2005, and December 9, 2008, 215 consented to ongoing follow-up through at least 7 years postrandomization (last visit, February 10, 2016). INTERVENTIONS Participants had been randomized to receive a surgically placed intravitreous fluocinolone acetonide implant or systemic corticosteroids supplemented by immunosuppression. When both eyes required treatment, both eyes were treated. MAIN OUTCOMES AND MEASURES Primary outcomewas change from baseline in best-corrected visual acuity in uveitic eyes (5 letters = 1 visual acuity chart line; potential range of change in letters read, -121 to + 101; minimal clinically important difference, 7 letters), analyzed by treatment assignment accounting for nonindependence of eyes when patients had 2 uveitic eyes. Secondary outcomes included potential systemic toxicities of corticosteroid and immunosuppressive therapy and death. RESULTS Seven-year data were obtained for 161 uveitic eyes (70% of 90 patients assigned to implant) and 167 uveitic eyes (71% of 90 patients assigned to systemic therapy) (77% female; median age at enrollment, 48 [interquartile range, 36-56] years). Change in mean visual acuity from baseline (implant, 61.7; systemic therapy, 65.0) through 7 years (implant, 55.8; systemic therapy, 66.2) favored systemic therapy by 7.2 (95% CI, 2.1-12) letters. Among protocol-specified, prospectively collected systemic adverse outcomes, the cumulative 7-year incidence in the implant and systemic therapy groups, respectively, was less than 10%, with the exceptions of hyperlipidemia (6.1% vs 11.2%), hypertension (9.8% vs 18.4%), osteopenia (41.5% vs 43.1%), fractures (11.3% vs 18.6%), hospitalization (47.6% vs 42.3%), and antibiotic-treated infection (57.4% vs 72.3%). CONCLUSIONS AND RELEVANCE In 7-year extended follow-up of a randomized trial of patients with severe intermediate, posterior, or panuveitis, those randomized to receive systemic therapy had better visual acuity than those randomized to receive intravitreous fluocinolone acetonide implants. Study interpretation is limited by loss to follow-up.	[Kempen, John H.] Massachusetts Eye & Ear, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA; [Kempen, John H.] MyungSung Christian Med Ctr, Discovery Eye Ctr, Addis Ababa, Ethiopia; [Kempen, John H.] MyungSung Med Sch, Addis Ababa, Ethiopia; [Altaweel, Michael M.] Univ Wisconsin, Fundus Photograph Reading Ctr, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Holbrook, Janet T.; Sugar, Elizabeth A.; Thorne, Jennifer E.; Jabs, Douglas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials & Evidence Synth, Baltimore, MD USA; [Holbrook, Janet T.; Thorne, Jennifer E.; Jabs, Douglas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Sugar, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Thorne, Jennifer E.] Johns Hopkins Univ Sch Med, Dept Ophthalmol, Baltimore, MD USA; [Jabs, Douglas A.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY USA; [Jabs, Douglas A.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Harvard University; Massachusetts Eye & Ear Infirmary; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kempen, JH (corresponding author), Massachusetts Eye & Ear, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	john_kempen@meei.harvard.edu		Kempen, John/0000-0002-2967-4792	National Eye Institute [U10EY014656, U10EY014660, U10EY014655]; Research to Prevent Blindness; Paul and Evanina Mackall Foundation; Lois Pope Life Foundation; NATIONAL EYE INSTITUTE [U10EY014656] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Paul and Evanina Mackall Foundation; Lois Pope Life Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Eye Institute Collaborative Agreements U10EY014656 (Dr Altaweel), U10EY014660 (Dr Holbrook), and U10EY014655 (Dr Jabs). Additional support was provided by Research to Prevent Blindness, the Paul and Evanina Mackall Foundation, and the Lois Pope Life Foundation. Bausch & Lomb provided support to the study in the form of donation of fluocinolone acetonide implants for patients randomized to implant therapy who were uninsured or otherwise unable to pay for implants or who were located at a site where implants could not be purchased (eg, in the United Kingdom).	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2011, SAS STAT US GUID VER; Arnold J, 2001, OPHTHALMOLOGY, V108, P841; Bengtsson B, 1999, ACTA OPHTHALMOL SCAN, V77, P143, DOI 10.1034/j.1600-0420.1999.770205.x; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bressler NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1329; Callanan DG, 2008, ARCH OPHTHALMOL-CHIC, V126, P1191, DOI 10.1001/archopht.126.9.1191; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Ferris FL, 1996, OPHTHALMOLOGY, V103, P181, DOI 10.1016/S0161-6420(96)30742-2; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jaffe GJ, 2006, OPHTHALMOLOGY, V113, P1020, DOI 10.1016/j.ophtha.2006.02.021; Jaffe GJ, 2005, OPHTHALMOLOGY, V112, P1192, DOI 10.1016/j.ophtha.2005.03.013; Jaffe GJ, 2000, OPHTHALMOLOGY, V107, P2024, DOI 10.1016/S0161-6420(00)00466-8; Jaffe GJ, 2008, AM J OPHTHALMOL, V145, P667, DOI 10.1016/j.ajo.2007.11.008; Kempen JH, 2016, AM J OPHTHALMOL, V164, P110, DOI 10.1016/j.ajo.2015.12.034; Kempen JH, 2015, AM J OPHTHALMOL, V160, P1133, DOI 10.1016/j.ajo.2015.09.017; Kempen JH, 2015, OPHTHALMOLOGY, V122, P1967, DOI 10.1016/j.ophtha.2015.06.042; Kempen JH, 2015, OPHTHALMOLOGY, V122, P1976, DOI 10.1016/j.ophtha.2015.06.043; Kempen JH, 2011, OPHTHALMOLOGY, V118, P1916, DOI 10.1016/j.ophtha.2011.07.027; Kempen JH, 2010, AM J OPHTHALMOL, V149, P550, DOI 10.1016/j.ajo.2009.11.019; Little R.J.A., 2002, STAT ANAL MISSING DA; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Nguyen QD, 2011, OPHTHALMOLOGY, V118, P184, DOI 10.1016/j.ophtha.2010.03.029; Nordmann JP, 2005, INVEST OPHTH VIS SCI, V46, P3169, DOI 10.1167/iovs.04-1214; Pavesio C, 2010, OPHTHALMOLOGY, V117, P567, DOI 10.1016/j.ophtha.2009.11.027; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Ryan P., 2008, STATA J, V8, P146; Sen HN, 2012, OCUL IMMUNOL INFLAMM, V20, P104, DOI 10.3109/09273948.2011.647228; STERNBERG P, 1991, ARCH OPHTHALMOL-CHIC, V109, P1242; Sugar EA, 2011, AM J OPHTHALMOL, V152, P1044, DOI 10.1016/j.ajo.2011.05.028; Suner IJ, 2009, INVEST OPHTH VIS SCI, V50, P3629, DOI 10.1167/iovs.08-3225; TENDOESSCHATE J, 1982, DOC OPHTHALMOL, V52, P279, DOI 10.1007/BF01675857; Tomkins-Netzer O, 2014, OPHTHALMOLOGY, V121, P2387, DOI 10.1016/j.ophtha.2014.07.007; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	39	61	61	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1993	2005		10.1001/jama.2017.5103	http://dx.doi.org/10.1001/jama.2017.5103			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28477440	Bronze, Green Published			2022-12-28	WOS:000401315500018
J	Wilkinson, D				Wilkinson, Dominic			Beyond resources: denying parental requests for futile treatment	LANCET			English	Editorial Material							OF-LIFE DECISIONS		[Wilkinson, Dominic] Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England; [Wilkinson, Dominic] John Radcliffe Hosp, Dept Newborn Care, Oxford, England	University of Oxford; University of Oxford	Wilkinson, D (corresponding author), Univ Oxford, Fac Philosophy, Oxford Uehiro Ctr Pract Eth, Oxford OX1 1PT, England.; Wilkinson, D (corresponding author), John Radcliffe Hosp, Dept Newborn Care, Oxford, England.	dominic.wilkinson@philosophy.ox.ac.uk			Wellcome Trust [106587] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Diekema DS, 2004, THEORETICAL MED BIOE; Forster K., 2017, INDEPENDENT; Judiciary of England and Wales, 2017, DEC SHORT REAS REL M; Larcher V, 2015, ARCH DIS CHILD, V100, pS3, DOI 10.1136/archdischild-2014-306666; Rennie JM, 2008, SEMIN FETAL NEONAT M, V13, P296, DOI 10.1016/j.siny.2008.03.007; Savulescu J., 2017, LANCET; White DB, 2016, OXFORD HDB ETHICS EN; Wilkinson D, 2016, ARCH DIS CHILD, V101, P783, DOI 10.1136/archdischild-2016-310637; Wilkinson D, 2016, BIOETHICS, V30, P109, DOI 10.1111/bioe.12162; Wilkinson DJC, 2011, CURR OPIN ANESTHESIO, V24, P160, DOI 10.1097/ACO.0b013e328343c5af	10	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2017	389	10082					1866	1867		10.1016/S0140-6736(17)31205-9	http://dx.doi.org/10.1016/S0140-6736(17)31205-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU4AZ	28478971				2022-12-28	WOS:000400973500007
J	de Kleer, K; Skrutskie, M; Leisenring, J; Davies, AG; Conrad, A; de Pater, I; Resnick, A; Bailey, V; Defrere, D; Hinz, P; Skemer, A; Spalding, E; Vaz, A; Veillet, C; Woodward, CE				de Kleer, K.; Skrutskie, M.; Leisenring, J.; Davies, A. G.; Conrad, A.; de Pater, I.; Resnick, A.; Bailey, V.; Defrere, D.; Hinz, P.; Skemer, A.; Spalding, E.; Vaz, A.; Veillet, C.; Woodward, C. E.			Multi-phase volcanic resurfacing at Loki Patera on Io	NATURE			English	Article							THERMAL EMISSION; GALILEO NIMS; AGE	The Jovian moon Io hosts the most powerful persistently active volcano in the Solar System, Loki Patera(1,2). The interior of this volcanic, caldera-like feature is composed of a warm, dark floor covering 21,500 square kilometres(3) surrounding a much cooler central 'island' 4. The temperature gradient seen across areas of the patera indicates a systematic resurfacing process(4-9), which has been seen to occur typically every one to three years since the 1980s(5,10). Analysis of past data has indicated that the resurfacing progressed around the patera in an anti-clockwise direction at a rate of one to two kilometres per day, and that it is caused either by episodic eruptions that emplace voluminous lava flows or by a cyclically overturning lava lake contained within the patera(5,8,9,11). However, spacecraft and telescope observations have been unable to map the emission from the entire patera floor at sufficient spatial resolution to establish the physical processes at play. Here we report temperature and lava cooling age maps of the entire patera floor at a spatial sampling of about two kilometres, derived from ground-based interferometric imaging of thermal emission from Loki Patera obtained on 8 March 2015 ut as the limb of Europa occulted Io. Our results indicate that Loki Patera is resurfaced by a multi-phase process in which two waves propagate and converge around the central island. The different velocities and start times of the waves indicate a non-uniformity in the lava gas content and/or crust bulk density across the patera.	[de Kleer, K.; de Pater, I.] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Skrutskie, M.] Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; [Leisenring, J.; Hinz, P.; Spalding, E.; Vaz, A.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Davies, A. G.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Conrad, A.; Veillet, C.] Univ Arizona, Large Binocular Telescope Observ, Tucson, AZ USA; [Resnick, A.] Amherst Coll, Dept Phys & Astron, Amherst, MA 01002 USA; [Bailey, V.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, Palo Alto, CA 94304 USA; [Defrere, D.] Univ Liege, Space Sci Technol & Astrophys Res STAR Inst, Liege, Wallonia, Belgium; [Skemer, A.] Univ Calif Santa Cruz, PBSci Astron & Astrophys Dept, Santa Cruz, CA 95064 USA; [Woodward, C. E.] Univ Minnesota, Minnesota Inst Astrophys, Minneapolis, MN USA	University of California System; University of California Berkeley; University of Virginia; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; Amherst College; Stanford University; University of Liege; University of California System; University of California Santa Cruz; University of Minnesota System; University of Minnesota Twin Cities	de Kleer, K (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	kdekleer@berkeley.edu	Veillet, Christian/P-5301-2018; Bailey, Vanessa P/H-2247-2018; Davies, Ashley/S-5588-2018	Veillet, Christian/0000-0003-0272-0418; Bailey, Vanessa P/0000-0002-5407-2806; Skemer, Andrew/0000-0001-6098-3924; Hinz, Philip/0000-0002-1954-4564; Spalding, Eckhart/0000-0003-3819-0076; Defrere, Denis/0000-0003-3499-2506; de Kleer, Katherine/0000-0002-9068-3428; Davies, Ashley/0000-0003-1747-8142	NASA as part of its Exoplanet Exploration program; US NSF [NSF AST-0705296]; NSF [AST-1313485]; NSF Graduate Research Fellowship [DGE-1106400]; NASA Outer Planets Research Program [OPR NNN13D466T]	NASA as part of its Exoplanet Exploration program; US NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NASA Outer Planets Research Program(National Aeronautics & Space Administration (NASA))	The Large Binocular Telescope (LBT) is an international collaboration among institutions in the United States, Italy and Germany. The LBT Corporation partners are: the University of Arizona on behalf of the Arizona university system; Istituto Nazionale di Astrofisica, Italy; LBT Beteiligungsgesellschaft, Germany, representing the Max Planck Society, the Astrophysical Institute Potsdam, and Heidelberg University; The Ohio State University; and The Research Corporation, on behalf of The University of Notre Dame, University of Minnesota and University of Virginia. The LBT Interferometer is funded by NASA as part of its Exoplanet Exploration program. The LMIRcam instrument is funded by the US NSF through grant NSF AST-0705296. A.G.D., K.d.K. and I.d.P. are partially supported by the NSF grant AST-1313485 to UC Berkeley and by the NSF Graduate Research Fellowship to K.d.K. under grant DGE-1106400. A.G.D. thanks the NASA Outer Planets Research Program for support under grant OPR NNN13D466T.	Andrae R, 2010, PREPRINT; [Anonymous], 1933, GIORNALE DELLISTITUT; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Conrad A, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/5/175; Davies A. G., 2007, VOLCANISM IO COMP EA, P217; Davies AG, 1996, ICARUS, V124, P45, DOI 10.1006/icar.1996.0189; Davies AG, 2005, ICARUS, V176, P123, DOI 10.1016/j.icarus.2005.01.015; Davies AG, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018371; de Kleer K, 2017, ICARUS, V289, P181, DOI 10.1016/j.icarus.2017.01.038; DEMBO RS, 1983, MATH PROGRAM, V26, P190, DOI 10.1007/BF02592055; Esposito S, 2011, PROC SPIE, V8149, DOI 10.1117/12.898641; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Hill JM, 2006, PROC SPIE, V6267, DOI 10.1117/12.669832; Hinz P, 2012, PROC SPIE, V8445, DOI 10.1117/12.926746; Howell RR, 2007, ICARUS, V186, P448, DOI 10.1016/j.icarus.2006.09.022; Howell RR, 1997, ICARUS, V127, P394, DOI 10.1006/icar.1997.5686; Leisenring JM, 2014, PROC SPIE, V9146, DOI 10.1117/12.2057290; Leisenring JM, 2012, PROC SPIE, V8446, DOI 10.1117/12.924814; Lim P.L., 2015, PYSYNPHOT USERS GUID; Lopes R. M. C., 2007, IO AFTER GALILEO; Lopes-Gautier R, 2000, SCIENCE, V288, P1201, DOI 10.1126/science.288.5469.1201; Maire AL, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201425185; Matson D., 2006, J GEOPHYS RES, V111, P2156; Rathbun JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014747; Rathbun JA, 2004, ICARUS, V169, P127, DOI 10.1016/j.icarus.2003.10.021; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; SPENCER JR, 1994, ICARUS, V107, P195, DOI 10.1006/icar.1994.1016; Spencer JR, 2000, SCIENCE, V288, P1198, DOI 10.1126/science.288.5469.1198; Turtle EP, 2004, ICARUS, V169, P3, DOI 10.1016/j.icarus.2003.10.014; VEEDER GJ, 1994, J GEOPHYS RES-PLANET, V99, P17095, DOI 10.1029/94JE00637; Veeder GJ, 2012, ICARUS, V219, P701, DOI 10.1016/j.icarus.2012.04.004; Veeder GJ, 2011, ICARUS, V212, P236, DOI 10.1016/j.icarus.2010.09.026	32	19	19	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					199	+		10.1038/nature22339	http://dx.doi.org/10.1038/nature22339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492251	Green Submitted			2022-12-28	WOS:000400963800029
J	Oliver, D				Oliver, David			David Oliver: Reducing acute admissions-a timely reality check	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bardsley M, 2013, EVALUATING INTEGRATE; Castle-Clarke S, 2017, THE NUFFIELD TRUST; Ham C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1678; King's Fund, 2017, SUST TRANSF PLANS; NHS England, 2017, NEW PAT CAR TEST HOS; Purdy S, 2012, INTERVENTIONS REDUCE; Royal College of Physicians, 2016, BACKGR SUST TRANSF P	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2017	357								j2082	10.1136/bmj.j2082	http://dx.doi.org/10.1136/bmj.j2082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU6UA	28487315	Bronze, Green Published			2022-12-28	WOS:000401169100004
J	Kroisel, PM; Hausler, M; Klaritsch, P; Karpf, E; Zebedin, D; Tiran, B; Pertl, B; Wagner, K				Kroisel, Peter Michael; Haeusler, Martin; Klaritsch, Phillip; Karpf, Eva; Zebedin, Doris; Tiran, Beate; Pertl, Barbara; Wagner, Klaus			Targeted enrichment sequencing in two midterm pregnancies with severe abnormalities on ultrasound	LANCET			English	Editorial Material									[Kroisel, Peter Michael; Wagner, Klaus] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Haeusler, Martin; Klaritsch, Phillip] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria; [Zebedin, Doris] Med Univ Graz, Dept Paediat Radiol, Graz, Austria; [Tiran, Beate] Med Univ Graz, Dept Lab Med, Graz, Austria; [Karpf, Eva] Med Univ Graz, Inst Pathol, Graz, Austria; [Pertl, Barbara] Ragnitz Hosp, Prenatal Ctr, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Wagner, K (corresponding author), Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria.	klaus.wagner@medunigraz.at	Klaritsch, Philipp/Q-5870-2016	Klaritsch, Philipp/0000-0002-7359-4853				Radhakrishnan N, 2011, J PEDIAT HEMATOL ONC, V33, P74, DOI 10.1097/MPH.0b013e3181fd2aae; Sahoo T, 2017, GENET MED, V19, P83, DOI 10.1038/gim.2016.69; Schumacher A, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00288; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1857	1858		10.1016/S0140-6736(17)31049-8	http://dx.doi.org/10.1016/S0140-6736(17)31049-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28495170				2022-12-28	WOS:000400549300035
J	Roberts, DW; Olson, J				Roberts, David W.; Olson, Jonathan			Fluorescein Guidance in Glioblastoma Resection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Roberts, David W.; Olson, Jonathan] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Dartmouth College	Roberts, DW (corresponding author), Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA.	david.w.roberts@dartmouth.edu			NINDS NIH HHS [R01 NS052274] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052274] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))			0	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					E36	E36		10.1056/NEJMicm1611258	http://dx.doi.org/10.1056/NEJMicm1611258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET6ZH	28467882	Green Accepted			2022-12-28	WOS:000400442300012
J	Venema, E; Mulder, MJHL; Roozenbeek, B; Broderick, JP; Yeatts, SD; Khatri, P; Berkhemer, OA; Emmer, BJ; Roos, YBWEM; Majoie, CBLM; van Oostenbrugge, RJ; van Zwam, WH; van der Lugt, A; Steyerberg, EW; Dippel, DWJ; Lingsma, HF				Venema, Esmee; Mulder, Maxim J. H. L.; Roozenbeek, Bob; Broderick, Joseph P.; Yeatts, Sharon D.; Khatri, Pooja; Berkhemer, Olvert A.; Emmer, Bart J.; Roos, Yvo B. W. E. M.; Majoie, Charles B. L. M.; van Oostenbrugge, Robert J.; van Zwam, Wim H.; van der Lugt, Aad; Steyerberg, Ewout W.; Dippel, Diederik W. J.; Lingsma, Hester F.			Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTRAVENOUS T-PA; ENDOVASCULAR THERAPY; INTERVENTIONAL MANAGEMENT; ATRIAL-FIBRILLATION; CT ANGIOGRAPHY; THROMBECTOMY; RISK; OUTCOMES; SCORE; TIME	OBJECTIVE To improve the selection of patients with acute ischaemic stroke for intra-arterial treatment using a clinical decision tool to predict individual treatment benefit. DESIGN Multivariable regression modelling with data from two randomised controlled clinical trials. SETTING 16 hospitals in the Netherlands (derivation cohort) and 58 hospitals in the United States, Canada, Australia, and Europe (validation cohort). PARTICIPANTS 500 patients from the Multicenter Randomised Clinical Trial of Endovascular Treatment for Acute Ischaemic Stroke in the Netherlands trial (derivation cohort) and 260 patients with intracranial occlusion from the Interventional Management of Stroke III trial (validation cohort). MAIN OUTCOME MEASURES The primary outcome was the modified Rankin Scale (mRS) score at 90 days after stroke. We constructed an ordinal logistic regression model to predict outcome and treatment benefit, defined as the difference between the predicted probability of good functional outcome (mRS score 0-2) with and without intra-arterial treatment. RESULTS 11 baseline clinical and radiological characteristics were included in the model. The externally validated C statistic was 0.69 (95% confidence interval 0.64 to 0.73) for the ordinal model and 0.73 (0.67 to 0.79) for the prediction of good functional outcome, indicating moderate discriminative ability. The mean predicted treatment benefit varied between patients in the combined derivation and validation cohort from -2.3% to 24.3%. There was benefit of intra-arterial treatment predicted for some individual patients from groups in which no treatment effect was found in previous subgroup analyses, such as those with no or poor collaterals. CONCLUSION The proposed clinical decision tool combines multiple baseline clinical and radiological characteristics and shows large variations in treatment benefit between patients. The tool is clinically useful as it aids in distinguishing between individual patients who may experience benefit from intra-arterial treatment for acute ischaemic stroke and those who will not.	[Venema, Esmee; Khatri, Pooja; van Oostenbrugge, Robert J.; van der Lugt, Aad; Dippel, Diederik W. J.] Erasmus MC Univ, Dept Publ Hlth, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Broderick, Joseph P.; Yeatts, Sharon D.; Berkhemer, Olvert A.; Emmer, Bart J.; van Oostenbrugge, Robert J.; Steyerberg, Ewout W.] Erasmus MC Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Venema, Esmee; Roos, Yvo B. W. E. M.; van Zwam, Wim H.; Steyerberg, Ewout W.] Erasmus MC Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands; [Roozenbeek, Bob; Majoie, Charles B. L. M.; van Zwam, Wim H.] Univ Cincinnati, Dept Neurol & Rehabil Med, Gardner Neurosci Inst, Cincinnati, OH USA; [Emmer, Bart J.; van Zwam, Wim H.; Steyerberg, Ewout W.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Roozenbeek, Bob; Khatri, Pooja; Emmer, Bart J.; van Zwam, Wim H.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Yeatts, Sharon D.; Majoie, Charles B. L. M.; van Oostenbrugge, Robert J.; Lingsma, Hester F.] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [Yeatts, Sharon D.; Khatri, Pooja; Roos, Yvo B. W. E. M.; van Zwam, Wim H.; Dippel, Diederik W. J.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Broderick, Joseph P.; Khatri, Pooja; Emmer, Bart J.; van Oostenbrugge, Robert J.; Steyerberg, Ewout W.] Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands; [Roozenbeek, Bob; Khatri, Pooja; Roos, Yvo B. W. E. M.; van Zwam, Wim H.] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; University of Cincinnati; Medical University of South Carolina; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Venema, E (corresponding author), Erasmus MC Univ, Dept Publ Hlth, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.venema@erasmusmc.nl	Roos, Yvo BWEM/B-9843-2013; Emmer, Bart/AAA-2817-2021; Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; Majoie, Charles/0000-0002-7600-9568; Emmer, Bart/0000-0001-8462-4037; Venema, Esmee/0000-0003-1631-6635	Erasmus MC Cost-Effectiveness Research; National Institutes of Health; National Institute of Neurological Disorders and Stroke [U01NS052220]; Medical University of South Carolina [U01NS054630, U01NS077304]; Genentech; EKOS; Concentric Medical; Boehringer Ingelheim; Dutch Heart Foundation; Angiocare BV; Covidien; medac; Lamepro Benelux; Penumbra; Stryker; TOP Medical	Erasmus MC Cost-Effectiveness Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical University of South Carolina; Genentech(Roche HoldingGenentech); EKOS; Concentric Medical; Boehringer Ingelheim(Boehringer Ingelheim); Dutch Heart Foundation(Netherlands Heart Foundation); Angiocare BV; Covidien; medac; Lamepro Benelux; Penumbra; Stryker; TOP Medical	This study was funded by the Erasmus MC Cost-Effectiveness Research. The Interventional Management of Stroke III (IMS III) trial was funded by National Institutes of Health and National Institute of Neurological Disorders and Stroke grant numbers: University of Cincinnati (U01NS052220) and Medical University of South Carolina (U01NS054630 and U01NS077304). Genentech supplied the study drug used for intra-arterial tissue-type plasminogen activator treatment in the endovascular group. EKOS, Concentric Medical, and Cordis supplied study catheters during protocol versions 1 to 3. In the United States, IMS III investigator meeting support was provided in part by Genentech, EKOS, and Concentric Medical. In Europe, IMS III investigator meeting support was provided in part by Boehringer Ingelheim. The Multicenter Randomised Clinical Trial of Endovascular Therapy for Acute Ischaemic Stroke in the Netherlands (MR CLEAN) was partly funded by the Dutch Heart Foundation and by unrestricted grants from Angiocare BV, Covidien, medac, Lamepro Benelux, Penumbra, Stryker, TOP Medical, and Concentric Medical.	Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P394, DOI [DOI 10.1056/NEJMOA1411587, DOI 10.1056/NEJM0A1411587, 10.1056/NEJMoa1411587]; Berkhemer OA, 2016, STROKE, V47, P768, DOI 10.1161/STROKEAHA.115.011788; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Broderick JP, 2015, STROKE, V46, P3416, DOI 10.1161/STROKEAHA.115.011397; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Demchuk AM, 2014, RADIOLOGY, V273, P202, DOI 10.1148/radiol.14132649; Flint AC, 2010, AM J NEURORADIOL, V31, P1192, DOI 10.3174/ajnr.A2050; Fransen PS, 2015, JAMA NEUROL, V73, P1; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, RADIOLOGY, V279, P888, DOI 10.1148/radiol.2016160204; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hallevi H, 2009, STROKE, V40, P1780, DOI 10.1161/STROKEAHA.108.535146; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; JOVIN TG, 2015, 8 HOURS SYMPTOM ONSE, V372, P2296, DOI DOI 10.1056/NEJMOA1503780; Kent DM, 2016, INT J EPIDEMIOL, V45, P2075, DOI 10.1093/ije/dyw118; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Lima FO, 2014, JAMA NEUROL, V71, P151, DOI 10.1001/jamaneurol.2013.5007; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Menon BK, 2016, CIRCULATION, V133, P2279, DOI 10.1161/CIRCULATIONAHA.115.019983; Muir KW, 2017, J NEUROL NEUROSUR PS, V88, P38, DOI 10.1136/jnnp-2016-314117; Mulder MJHL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013699; Ribo M, 2016, STROKE, V47, P999, DOI 10.1161/STROKEAHA.115.011721; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Scott SC, 1997, J CLIN EPIDEMIOL, V50, P45, DOI 10.1016/S0895-4356(96)00312-5; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Steyerberg EW, CLIN PREDICTION MODE; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; van der Worp HB, 2007, NEW ENGL J MED, V357, P572, DOI 10.1056/NEJMcp072057; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	40	69	70	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j1710	10.1136/bmj.j1710	http://dx.doi.org/10.1136/bmj.j1710			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468840	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000400889600002
J	Lebwohl, B; Cao, Y; Zong, G; Hu, FB; Green, PHR; Neugut, AI; Rimm, EB; Sampson, L; Dougherty, LW; Giovannucci, E; Willett, WC; Sun, Q; Chan, AT				Lebwohl, Benjamin; Cao, Yin; Zong, Geng; Hu, Frank B.; Green, Peter H. R.; Neugut, Alfred I.; Rimm, Eric B.; Sampson, Laura; Dougherty, Lauren W.; Giovannucci, Edward; Willett, Walter C.; Sun, Qi; Chan, Andrew T.			Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FREE DIET; DOUBLE-BLIND; FOOD; REPRODUCIBILITY; VALIDITY; QUESTIONNAIRE; AVAILABILITY; SENSITIVITY; SYMPTOMS; HEALTH	OBJECTIVE To examine the association of long term intake of gluten with the development of incident coronary heart disease. DESIGN Prospective cohort study. SETTING AND PARTICIPANTS 64 714 women in the Nurses' Health Study and 45 303 men in the Health Professionals Follow-up Study without a history of coronary heart disease who completed a 131 item semiquantitative food frequency questionnaire in 1986 that was updated every four years through 2010. EXPOSURE Consumption of gluten, estimated from food frequency questionnaires. MAIN OUTCOME MEASURE Development of coronary heart disease (fatal or non-fatal myocardial infarction). RESULTS During 26 years of follow-up encompassing 2 273 931 person years, 2431 women and 4098 men developed coronary heart disease. Compared with participants in the lowest fifth of gluten intake, who had a coronary heart disease incidence rate of 352 per 100 000 person years, those in the highest fifth had a rate of 277 events per 100 000 person years, leading to an unadjusted rate difference of 75 (95% confidence interval 51 to 98) fewer cases of coronary heart disease per 100 000 person years. After adjustment for known risk factors, participants in the highest fifth of estimated gluten intake had a multivariable hazard ratio for coronary heart disease of 0.95 (95% confidence interval 0.88 to 1.02; P for trend = 0.29). After additional adjustment for intake of whole grains (leaving the remaining variance of gluten corresponding to refined grains), the multivariate hazard ratio was 1.00 (0.92 to 1.09; P for trend = 0.77). In contrast, after additional adjustment for intake of refined grains (leaving the variance of gluten intake correlating with whole grain intake), estimated gluten consumption was associated with a lower risk of coronary heart disease (multivariate hazard ratio 0.85, 0.77 to 0.93; P for trend = 0.002). CONCLUSION Long term dietary intake of gluten was not associated with risk of coronary heart disease. However, the avoidance of gluten may result in reduced consumption of beneficial whole grains, which may affect cardiovascular risk. The promotion of gluten-free diets among people without celiac disease should not be encouraged.	[Lebwohl, Benjamin; Green, Peter H. R.; Neugut, Alfred I.] Columbia Univ Coll Phys & Surg, Dept Med, Celiac Dis Ctr, New York, NY USA; [Lebwohl, Benjamin; Neugut, Alfred I.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Cao, Yin; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Cao, Yin; Hu, Frank B.; Chan, Andrew T.] Harvard Med Sch, Boston, MA 02115 USA; [Cao, Yin; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Cao, Yin; Zong, Geng; Rimm, Eric B.; Sampson, Laura; Dougherty, Lauren W.; Giovannucci, Edward; Willett, Walter C.; Sun, Qi] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Hu, Frank B.; Rimm, Eric B.; Giovannucci, Edward; Willett, Walter C.; Sun, Qi; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Rimm, Eric B.; Giovannucci, Edward; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Columbia University; Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Chan, AT (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA.; Chan, AT (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Chan, AT (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ACHAN@mgh.harvard.edu	Cao, Yin/ABE-2332-2021; Zong, Geng/ABG-6946-2021	Cao, Yin/0000-0001-9835-7662; 	American Gastroenterological Association; Massachusetts General Hospital; National Institutes of Health (NIH) [K24 DK098311, UM1 CA186107, UM1 CA167552]; NIH [UM1 CA167552, R01 HL035464, R01 HL060712, R01 HL034594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	American Gastroenterological Association; Massachusetts General Hospital(General Electric); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	BL is supported by the American Gastroenterological Association's foundation research scholar award. ATC is supported by the Massachusetts General Hospital research scholars award and National Institutes of Health (NIH) grants K24 DK098311 and UM1 CA186107. WCW is supported by NIH grant UM1 CA167552, EBR by grant R01 HL035464, QS by grant R01 HL035464, and FBH by grants R01 HL060712 and R01 HL034594.	Aronsson CA, 2016, CLIN GASTROENTEROL H, V14, P403, DOI 10.1016/j.cgh.2015.09.030; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Bernstein AM, 2011, EUR J EPIDEMIOL, V26, P877, DOI 10.1007/s10654-011-9626-x; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Burden M, 2015, POSTGRAD MED J, V91, P622, DOI 10.1136/postgradmedj-2015-133395; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Davis W., 2011, WHEAT BELLY LOSE WHE; Eaton WW, 2015, AM J PSYCHIAT, V172, P219, DOI 10.1176/appi.ajp.2014.14040550; Elkan AC, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2388; Emilsson L, 2013, ALIMENT PHARM THER, V37, P905, DOI 10.1111/apt.12271; Estevez V, 2016, EUR J CLIN NUTR, V70, P1215, DOI 10.1038/ejcn.2016.139; Fasano A, 2015, GASTROENTEROLOGY, V148, P1195, DOI 10.1053/j.gastro.2014.12.049; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fuchs CS, 1999, NEW ENGL J MED, V340, P169, DOI 10.1056/NEJM199901213400301; Harvard TH, NUTRIENT TABLES; Jamnik J, 2015, J NUTR, V145, P1256, DOI 10.3945/jn.115.212829; Johnson KB, 2012, AM J PHYSIOL-HEART C, V302, pH1355, DOI 10.1152/ajpheart.00918.2011; Kasarda DD, 2013, J AGR FOOD CHEM, V61, P1155, DOI 10.1021/jf305122s; Kim HS, 2016, JAMA INTERN MED, V176, P1716, DOI 10.1001/jamainternmed.2016.5254; Larsen J, 2014, EUR J IMMUNOL, V44, P3056, DOI 10.1002/eji.201344264; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Li YP, 2015, J AM COLL CARDIOL, V66, P1538, DOI 10.1016/j.jacc.2015.07.055; Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Marietta EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078687; Miller D, 2016, JAMA INTERN MED, V176, P1717, DOI 10.1001/jamainternmed.2016.5271; NPD Group, 2013, PERC US AD TRYING CU; Perlmutter D., 2013, GRAIN BRAIN SURPRISI; Peters SL, 2014, ALIMENT PHARM THER, V39, P1104, DOI 10.1111/apt.12730; Soares FLP, 2013, J NUTR BIOCHEM, V24, P1105, DOI 10.1016/j.jnutbio.2012.08.009; Qi Jun-cong, 2005, J Zhejiang Univ Sci B, V6, P1069, DOI 10.1631/jzus.2005.B1069; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schiltz B, 2009, METAB SYNDR RELAT D, V7, P187, DOI 10.1089/met.2008.0051; See JA, 2015, NAT REV GASTRO HEPAT, V12, P580, DOI 10.1038/nrgastro.2015.156; Steppan J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000599; Vanga R, 2013, GASTROENTEROLOGY, V145, P276, DOI 10.1053/j.gastro.2013.06.027; vanOverbeek FM, 1997, EUR J GASTROEN HEPAT, V9, P1097, DOI 10.1097/00042737-199711000-00013; West J, 2004, ALIMENT PHARM THERAP, V20, P73, DOI 10.1111/j.1365-2036.2004.02008.x; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu HY, 2015, JAMA INTERN MED, V175, P373, DOI 10.1001/jamainternmed.2014.6283; Yuan C, 2017, AM J EPIDEMIOL, P1	45	98	103	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j1892	10.1136/bmj.j1892	http://dx.doi.org/10.1136/bmj.j1892			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465308	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000400889500002
J	Pizzo, PA; Lawley, TJ; Rubenstein, AH				Pizzo, Philip A.; Lawley, Thomas J.; Rubenstein, Arthur H.			Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pizzo, Philip A.] Stanford Univ, Pediat & Microbiol & Immunol, Lorry 1 Lokey Res Bldg,265 Campus Dr,G1078, Stanford, CA 94305 USA; [Lawley, Thomas J.] Emory Univ, Atlanta, GA 30322 USA; [Rubenstein, Arthur H.] Univ Penn, Philadelphia, PA 19104 USA	Stanford University; Emory University; University of Pennsylvania	Pizzo, PA (corresponding author), Stanford Univ, Pediat & Microbiol & Immunol, Lorry 1 Lokey Res Bldg,265 Campus Dr,G1078, Stanford, CA 94305 USA.	ppizzo@stanford.edu			Novozymes, A/S; Omeros Corporation; ChemoCentryx; Genentech	Novozymes, A/S; Omeros Corporation; ChemoCentryx; Genentech(Roche HoldingGenentech)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Pizzo, Lawley, and Rubenstein report receipt of personal fees from companies and organizations for academic advisory council membership, health or other advisory board membership, board of directors membership, or consulting. In addition, Dr Lawley reports receiving a portion of his institution's licensing fees from Novozymes, A/S, Omeros Corporation, ChemoCentryx, and Genentech. None of the disclosures are in conflict with this Viewpoint. No other disclosures were reported.	Association of Amercian Medical Colleges, 2008, IND FUND MED ED; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; Carlat DJ, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0725-y; Institute of Medicine, 2009, CONFLICT INTEREST ME; Korn D, 2013, JAMA-J AM MED ASSOC, V310, P2397, DOI 10.1001/jama.2013.280889; Pew Expert Task Force on Conflicts of Interest in Medicine, 2013, CONFL INT POL AC MED; Reslinski MA, 2016, NAT BIOTECHNOL, V34, P685, DOI 10.1038/nbt.3624	7	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1729	1730		10.1001/jama.2017.2573	http://dx.doi.org/10.1001/jama.2017.2573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464157				2022-12-28	WOS:000400440700014
J	Song, GJ; Yang, DH; Wang, YX; de Graaf, C; Zhou, QT; Jiang, SS; Liu, KW; Cai, XQ; Dai, AT; Lin, GY; Liu, DS; Wu, F; Wu, YR; Zhao, SW; Ye, L; Han, GW; Lau, J; Wu, BL; Hanson, MA; Liu, ZJ; Wang, MW; Stevens, RC				Song, Gaojie; Yang, Dehua; Wang, Yuxia; de Graaf, Chris; Zhou, Qingtong; Jiang, Shanshan; Liu, Kaiwen; Cai, Xiaoqing; Dai, Antao; Lin, Guangyao; Liu, Dongsheng; Wu, Fan; Wu, Yiran; Zhao, Suwen; Ye, Li; Han, Gye Won; Lau, Jesper; Wu, Beili; Hanson, Michael A.; Liu, Zhi-Jie; Wang, Ming-Wei; Stevens, Raymond C.			Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators	NATURE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CRYSTAL-STRUCTURE; FORCE-FIELD; PROTEIN; LIGAND; AGONIST; BINDING; DETERMINANTS; VALIDATION; ANTAGONIST	The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis(1). The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner(2). Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 angstrom resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR(3) and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs(4-6). Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.	[Song, Gaojie; Wang, Yuxia; Zhou, Qingtong; Liu, Kaiwen; Liu, Dongsheng; Wu, Fan; Wu, Yiran; Zhao, Suwen; Liu, Zhi-Jie; Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Dai, Antao; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China; [de Graaf, Chris] Vrije Univ Amsterdam, Fac Sci, Div Med Chem, AIMMS, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Jiang, Shanshan; Ye, Li; Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhang Heng Rd, Shanghai 201203, Peoples R China; [Liu, Kaiwen; Lin, Guangyao; Wu, Fan; Zhao, Suwen; Wu, Beili; Liu, Zhi-Jie; Wang, Ming-Wei; Stevens, Raymond C.] ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China; [Liu, Kaiwen; Wu, Fan; Wu, Beili] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Han, Gye Won] Univ Southern Calif, Bridge Inst, Dept Chem, 3430 S Vermont Ave, Los Angeles, CA 90089 USA; [Lau, Jesper] Novo Nordisk, DK-2760 Malov, Denmark; [Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA; [Liu, Zhi-Jie] Kunming Med Univ, Inst Mol & Clin Med, Kunming 650500, Peoples R China	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Vrije Universiteit Amsterdam; Fudan University; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Southern California; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Kunming Medical University	Liu, ZJ; Stevens, RC (corresponding author), ShanghaiTech Univ, iHuman Inst, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Fudan Univ, Sch Pharm, 826 Zhang Heng Rd, Shanghai 201203, Peoples R China.; Liu, ZJ; Wang, MW; Stevens, RC (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China.; Liu, ZJ (corresponding author), Kunming Med Univ, Inst Mol & Clin Med, Kunming 650500, Peoples R China.	mwwang@simm.ac.cn; stevens@shanghaitech.edu.cn	Yang, Dehua/S-6156-2017; liu, kaiwen/GVS-5259-2022; Liu, Zhi-Jie/A-3946-2012; Han, Gye Won/GLT-1531-2022; Yang, Dehua/M-5789-2019; Liu, Dongsheng/C-2128-2009; Han, Gye Won/GLQ-8673-2022; Zhou, Qingtong/AAA-1328-2020; Lau, Jesper/G-3834-2011; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8724-2022; de Graaf, Chris/J-8549-2017	Liu, Zhi-Jie/0000-0001-7279-2893; Liu, Dongsheng/0000-0002-2053-1752; Zhou, Qingtong/0000-0001-8124-3079; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; de Graaf, Chris/0000-0002-1226-2150; Zhao, Suwen/0000-0001-5609-434X	National Natural Science Foundation of China [31330019, 31500593, 81373463, 81573479]; National Health and Family Planning Commission [2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001, 2013ZX09507-002]; Shanghai Science and Technology Development Fund [15DZ2291600]; Ministry of Science and Technology of China [2014CB910400, 2015CB910104]; Netherlands eScience Center (NLeSC)/NWO Enabling Technologies project: 3D-e-Chem [027.014.201]; European Cooperation in Science and Technology Action GLISTEN [CM1207]; National Key Research and Development Program of China [2016YCF0905902]; Cloning, Cell Expression and Protein Purification Core Facilities of iHuman Institute; Shanghai Municipal Government; ShanghaiTech University; GPCR Consortium	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission; Shanghai Science and Technology Development Fund; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Netherlands eScience Center (NLeSC)/NWO Enabling Technologies project: 3D-e-Chem; European Cooperation in Science and Technology Action GLISTEN; National Key Research and Development Program of China; Cloning, Cell Expression and Protein Purification Core Facilities of iHuman Institute; Shanghai Municipal Government; ShanghaiTech University; GPCR Consortium	This work was supported by the National Natural Science Foundation of China grants 31330019 (Z.-J.L.), 31500593 (G.S.), 81373463 and 81573479 (D.Y.), the National Health and Family Planning Commission grants 2012ZX09304-011, 2013ZX09401003-005, 2013ZX09507001 and 2013ZX09507-002 (M.-W.W.), Shanghai Science and Technology Development Fund 15DZ2291600 (M.-W.W.), and Ministry of Science and Technology of China grants 2014CB910400 (Z.-J.L.) and 2015CB910104 (Z.-J.L.), the Netherlands eScience Center (NLeSC)/NWO Enabling Technologies project: 3D-e-Chem, grant 027.014.201 (C.d.G.), the European Cooperation in Science and Technology Action CM1207 GLISTEN (C.d.G.), and National Key Research and Development Program of China 2016YCF0905902 (S.Z.). We thank the Cloning, Cell Expression and Protein Purification Core Facilities of iHuman Institute for their support. We thank L. Qu, Y. Feng and C. Ji for their technical assistance, Y. Liu, H. Tao, S. Qin, W. Shui, F. Ni, C. Zhang, J. Cheng, Q. Zhao and V. Cherezov for discussions or contributions at the early stages of this project, and A. Walker and S. Reedtz-Runge for critical review of the manuscript. We thank the Shanghai Municipal Government, ShanghaiTech University and GPCR Consortium for financial support. The synchrotron radiation experiments were performed at the BL41XU of Spring-8 with approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2016B2708 and 2016B2724), and beamline BL17U1 (Shanghai Synchrotron Radiation Facility [SSRF], China). Computational resources were supported by the Shanghai Supercomputer Center, and the Supercomputing Center of ShanghaiTech University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bueno AB, 2016, J BIOL CHEM, V291, P10700, DOI 10.1074/jbc.M115.696039; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Cordomi A, 2015, BIOCHEM PHARMACOL, V96, P237, DOI 10.1016/j.bcp.2015.05.015; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guzman-Perez A, 2013, BIOORG MED CHEM LETT, V23, P3051, DOI 10.1016/j.bmcl.2013.03.014; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Lau J, 2007, J MED CHEM, V50, P113, DOI 10.1021/jm058026u; Lv XC, 2016, PROTEIN CELL, V7, P325, DOI 10.1007/s13238-016-0263-8; Mann RJ, 2010, PEPTIDES, V31, P2289, DOI 10.1016/j.peptides.2010.09.015; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitternacht Simon, 2016, F1000Res, V5, P189, DOI 10.12688/f1000research.7931.1; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spyridaki K, 2014, J BIOL CHEM, V289, P18966, DOI 10.1074/jbc.M113.544460; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiong YS, 2012, J MED CHEM, V55, P6137, DOI 10.1021/jm300579z; Yang DH, 2016, J BIOL CHEM, V291, P12991, DOI 10.1074/jbc.M116.721977; Yu WB, 2012, J COMPUT CHEM, V33, P2451, DOI 10.1002/jcc.23067; Zhang DD, 2015, NATURE, V520, P317, DOI 10.1038/nature14287; Zhang H., NATURE; Zhu K, 2014, J CHEM INF MODEL, V54, P1932, DOI 10.1021/ci500118s	49	141	143	6	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2017	546	7657					312	+		10.1038/nature22378	http://dx.doi.org/10.1038/nature22378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9FY	28514449				2022-12-28	WOS:000402823400042
J	Demotes-Mainard, J				Demotes-Mainard, Jacques			Boost multinational clinical research	NATURE			English	Letter									[Demotes-Mainard, Jacques] European Clin Res Infrastruct Network, Paris, France		Demotes-Mainard, J (corresponding author), European Clin Res Infrastruct Network, Paris, France.	jacques.demotes@ecrin.org							0	1	1	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					289	289		10.1038/545289b	http://dx.doi.org/10.1038/545289b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516925	Bronze			2022-12-28	WOS:000401466500043
J	Lewis, GD; Malhotra, R; Hernandez, AF; McNulty, SE; Smith, A; Felker, GM; Tang, WHW; Larue, SJ; Redfield, MM; Semigran, MJ; Givertz, MM; Van Buren, P; Whellan, D; Anstrom, KJ; Shah, MR; Desvigne-Nickens, P; Butler, J; Braunwald, E				Lewis, Gregory D.; Malhotra, Rajeev; Hernandez, Adrian F.; McNulty, Steven E.; Smith, Andrew; Felker, G. Michael; Tang, W. H. Wilson; Larue, Shane J.; Redfield, Margaret M.; Semigran, Marc J.; Givertz, Michael M.; Van Buren, Peter; Whellan, David; Anstrom, Kevin J.; Shah, Monica R.; Desvigne-Nickens, Patrice; Butler, Javed; Braunwald, Eugene		NHLBI Heart Failure Clinical Res	Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency The IRONOUT HF Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FERRIC CARBOXYMALTOSE; MEDICAL PROGRESS; ANEMIA; HEPCIDIN; METABOLISM; INFLAMMATION; THERAPY; PEPTIDE; PROTEIN; VO2	IMPORTANCE Iron deficiency is present in approximately 50% of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) and is an independent predictor of reduced functional capacity and mortality. However, the efficacy of inexpensive readily available oral iron supplementation in heart failure is unknown. OBJECTIVE To test whether therapy with oral iron improves peak exercise capacity in patients with HFrEF and iron deficiency. DESIGN, SETTING, AND PARTICIPANTS Phase 2, double-blind, placebo-controlled randomized clinical trial of patients with HFrEF (< 40%) and iron deficiency, defined as a serum ferritin level of 15 to 100 ng/mL or a serum ferritin level of 101 to 299 ng/mL with transferrin saturation of less than 20%. Participants were enrolled between September 2014 and November 2015 at 23 US sites. INTERVENTIONS Oral iron polysaccharide (n = 111) or placebo (n = 114), 150mg twice daily for 16 weeks. MAIN OUTCOMES AND MEASURES The primary end pointwas a change in peak oxygen uptake (V. O2) from baseline to 16 weeks. Secondary end points were change in 6-minute walk distance, plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, and health status as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ, range 0-100, higher scores reflect better quality of life). RESULTS Among 225 randomized participants (median age, 63 years; 36% women) 203 completed the study. The median baseline peak V. O2 was 1196 mL/min (interquartile range [IQR], 887-1448 mL/min) in the oral iron group and 1167 mL/min (IQR, 887-1449 mL/min) in the placebo group. The primary end point, change in peak V. O2 at 16 weeks, did not significantly differ between the oral iron and placebo groups (+ 23 mL/min vs -2 mL/min; difference, 21 mL/min [95% CI, -34 to + 76 mL/min]; P =.46). Similarly, at 16 weeks, there were no significant differences between treatment groups in changes in 6-minute walk distance (-13 m; 95% CI, -32 to 6 m), NT-proBNP levels (159; 95% CI, -280 to 599 pg/mL), or KCCQ score (1; 95% CI, -2.4 to 4.4), all P >.05. CONCLUSIONS AND RELEVANCE Among participants with HFrEF with iron deficiency, high-dose oral iron did not improve exercise capacity over 16 weeks. These results do not support use of oral iron supplementation in patients with HFrEF.	[Lewis, Gregory D.; Malhotra, Rajeev; Semigran, Marc J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hernandez, Adrian F.; McNulty, Steven E.; Anstrom, Kevin J.] Duke Clin Res Inst, Durham, NC USA; [Smith, Andrew] Emory Univ, Atlanta, GA 30322 USA; [Felker, G. Michael] Duke Univ, Duke Heart Ctr, Sch Med, Durham, NC USA; [Tang, W. H. Wilson] Cleveland Clin, Cleveland, OH 44106 USA; [Larue, Shane J.] Washington Univ, Sch Med, St Louis, MO USA; [Redfield, Margaret M.] Mayo Clin, Rochester, MN USA; [Givertz, Michael M.; Braunwald, Eugene] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Van Buren, Peter] Univ Vermont, Med Ctr, Burlington, VT 05405 USA; [Whellan, David] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Shah, Monica R.; Desvigne-Nickens, Patrice] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Butler, Javed] Stony Brook Med Ctr, Stony Brook, NY USA	Harvard University; Massachusetts General Hospital; Duke University; Emory University; Duke University; Cleveland Clinic Foundation; Washington University (WUSTL); Mayo Clinic; Harvard University; Brigham & Women's Hospital; University of Vermont; University of Vermont Medical Center; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Lewis, GD (corresponding author), Massachusetts Gen Hosp, Pulm Crit Care Unit, Cardiol Div, 55 Fruit St,Bigelow 800, Boston, MA 02114 USA.	glewis@partners.org	Hernandez, Adrian F/A-7818-2016; Tang, Wai Hong Wilson/I-1238-2013; Girelli, Domenico/B-1183-2008; Felker, Michael/AAX-2288-2021	Hernandez, Adrian F/0000-0003-3387-9616; Girelli, Domenico/0000-0001-9684-1899; Tang, W. H. Wilson/0000-0002-8335-735X; Malhotra, Rajeev/0000-0003-0120-4630	NHLBI [U10 HL084904, U10HL110337, U10HL110302, U10HL110312, U10HL110262, U10HL110297, U10HL110342, U10 HL110309, U10 HL110336, U10 HL110338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110338, U10HL110336, U10HL110309, U10HL110312, U10HL110262, U10HL110302, U10HL084904, U10HL110297, U10HL110337, U10HL110342, K08HL111210] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the following NHLBI grants U10 HL084904 (awarded to the coordinating center) and U10HL110337, U10HL110302, U10HL110312, U10HL110262, U10HL110297, U10HL110342, U10 HL110309, U10 HL110336, and U10 HL110338 (awarded to the regional clinical centers).	Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Beck-da-Silva L, 2013, INT J CARDIOL, V168, P3439, DOI 10.1016/j.ijcard.2013.04.181; Chatterjee NA, 2013, CIRC-HEART FAIL, V6, P499, DOI 10.1161/CIRCHEARTFAILURE.112.000157; Choi Hyoung Soo, 2012, Korean J Hematol, V47, P286, DOI 10.5045/kjh.2012.47.4.286; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Franchini M, 2010, CLIN CHIM ACTA, V411, P1565, DOI 10.1016/j.cca.2010.07.003; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Georgieva Z, 1997, CLIN HEMORHEOL MICRO, V17, P21; Glassman E, 1992, ANNA J, V19, P277; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Jacobs P, 1993, J Clin Apher, V8, P89, DOI 10.1002/jca.2920080207; Jankowska EA, 2011, J CARD FAIL, V17, P899, DOI 10.1016/j.cardfail.2011.08.003; Jankowska Ewa A, 2010, Heart Fail Clin, V6, P295, DOI 10.1016/j.hfc.2010.03.003; Klip IT, 2013, AM HEART J, V165, P575, DOI 10.1016/j.ahj.2013.01.017; Lewis GD, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.000345; Malhotra R, 2016, JACC-HEART FAIL, V4, P607, DOI 10.1016/j.jchf.2016.03.022; Melenovsky V, 2017, EUR J HEART FAIL, V19, P522, DOI 10.1002/ejhf.640; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Pasricha SR, 2014, BLOOD, V123, P611, DOI 10.1182/blood-2013-12-543405; Ponikowski P, 2015, EUR HEART J, V36, P657, DOI 10.1093/eurheartj/ehu385; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; van Santen S, 2011, ARTHRITIS RHEUM-US, V63, P3672, DOI 10.1002/art.30623; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WINGARD RL, 1995, AM J KIDNEY DIS, V25, P433, DOI 10.1016/0272-6386(95)90105-1	31	214	225	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1958	1966		10.1001/jama.2017.5427	http://dx.doi.org/10.1001/jama.2017.5427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510680	Green Accepted			2022-12-28	WOS:000401315500015
J	Kobayashi, Y; Misumi, O; Odahara, M; Ishibashi, K; Hirono, M; Hidaka, K; Endo, M; Sugiyama, H; Iwasaki, H; Kuroiwa, T; Shikanai, T; Nishimura, Y				Kobayashi, Yusuke; Misumi, Osami; Odahara, Masaki; Ishibashi, Kota; Hirono, Masafumi; Hidaka, Kumi; Endo, Masayuki; Sugiyama, Hiroshi; Iwasaki, Hiroshi; Kuroiwa, Tsuneyoshi; Shikanai, Toshiharu; Nishimura, Yoshiki			Holliday junction resolvases mediate chloroplast nucleoid segregation	SCIENCE			English	Article							ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; RECOMBINATION; ENDONUCLEASE; DNA; PROTEIN; IDENTIFICATION; RESOLUTION; GENOME; YEAST	Holliday junctions, four-stranded DNA structures formed during homologous recombination, are disentangled by resolvases that have been found in prokaryotes and eukaryotes but not in plant organelles. Here, we identify monokaryotic chloroplast 1 (MOC1) as a Holliday junction resolvase in chloroplasts by analyzing a green alga Chlamydomonas reinhardtii mutant defective in chloroplast nucleoid (DNA-protein complex) segregation. MOC1 is structurally similar to a bacterial Holliday junction resolvase, resistance to ultraviolet (Ruv) C, and genetically conserved among green plants. Reduced or no expression of MOC1 in Arabidopsis thaliana leads to growth defects and aberrant chloroplast nucleoid segregation. In vitro biochemical analysis and high-speed atomic force microscopic analysis revealed that A. thaliana MOC 1 (AtMOC1) binds and cleaves the core of Holliday junctions symmetrically. MOC1 may mediate chloroplast nucleoid segregation in green plants by resolving Holliday junctions.	[Kobayashi, Yusuke; Ishibashi, Kota; Shikanai, Toshiharu; Nishimura, Yoshiki] Kyoto Univ, Lab Plant Mol Genet, Dept Bot, Oiwake Cho, Kyoto 6068502, Japan; [Misumi, Osami] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Dept Biol Sci & Chem, Fac Sci, Yamaguchi 7538512, Japan; [Odahara, Masaki] Rikkyo St Pauls Univ, Dept Life Sci, Coll Sci, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Hirono, Masafumi] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan; [Hidaka, Kumi; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Endo, Masayuki; Sugiyama, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Sakyo Ku, Kyoto 6068501, Japan; [Iwasaki, Hiroshi] Tokyo Inst Technol, Dept Biol Sci, Sch & Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo, Japan; [Kuroiwa, Tsuneyoshi] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan	Kyoto University; Yamaguchi University; Rikkyo University; Hosei University; Kyoto University; Kyoto University; Tokyo Institute of Technology; Japan Womens University	Nishimura, Y (corresponding author), Kyoto Univ, Lab Plant Mol Genet, Dept Bot, Oiwake Cho, Kyoto 6068502, Japan.	yoshiki@pmg.bot.kyoto-u.ac.jp	Iwasaki, Hiroshi/Y-7946-2018; Endo, Masayuki/J-5874-2014; HIRONO, MASAFUMI/G-4948-2014; Endo, Masayuki/AAO-2986-2020; Shikanai, Toshiharu/AAK-9112-2020; Sugiyama, Hiroshi/C-7687-2011; Odahara, Masaki/AAM-7784-2020	Iwasaki, Hiroshi/0000-0002-0153-6873; Endo, Masayuki/0000-0003-0957-3764; HIRONO, MASAFUMI/0000-0002-2497-4227; Endo, Masayuki/0000-0003-0957-3764; Sugiyama, Hiroshi/0000-0001-8923-5946; Nishimura, Yoshiki/0000-0001-8686-9206; Odahara, Masaki/0000-0002-3752-5447	Ministry of Education, Culture, Sports, Science, and Technology of Japan [16K14768, 17H05840]; Kyoto University; Next Generation World-Leading Researchers [GS015];  [26.786]; Grants-in-Aid for Scientific Research [15H05974, 15H03837] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto University; Next Generation World-Leading Researchers; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Shinagawa and H. Kuroiwa for advice; N. Harada, T. Otani, and T. Emura for technical assistance; and T. Nakagawa (Shimane University) for vectors. Supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan grants to Y.N. (16K14768 and 17H05840), the Core Stage Back-up program from Kyoto University, a funding Program for Next Generation World-Leading Researchers (GS015), and a grant-in-aid for Japan Society for the Promotion of Science Fellows (grant 26.786 to Y.K.). The supplementary materials contain additional data. Y.K., O.M., M.O., K.I., T.K., M.E., M.H., H.S., H. I, T.S., and Y.N. conceived and designed the experiments. Y.K., O.M., M.H., and K.H. performed the experiments. Y.K. and Y.N. wrote the paper.	ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Ehara T., 1990, CURRENT RES PHOTOSYN, V1990, P2535; Endo M, 2014, ACCOUNTS CHEM RES, V47, P1645, DOI 10.1021/ar400299m; Gillham N.W., 1994, ORGANELLE GENES GENO; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; IWASAKI H, 1991, EMBO J, V10, P4381, DOI 10.1002/j.1460-2075.1991.tb05016.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Kuroiwa T., 1981, PLANT CELL PHYSL, V22, P16; KUROIWA T, 1991, INT REV CYTOL, V128, P1; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Misumi O, 2001, J PLANT RES, V114, P125, DOI 10.1007/PL00013975; Misumi O, 1999, PROTOPLASMA, V209, P273, DOI 10.1007/BF01453455; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; Odom OW, 2008, PLANT J, V53, P842, DOI 10.1111/j.1365-313X.2007.03376.x; Oldenburg DJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00883; SAITO A, 1995, P NATL ACAD SCI USA, V92, P7470, DOI 10.1073/pnas.92.16.7470; Shida T, 1996, J BIOL CHEM, V271, P26105, DOI 10.1074/jbc.271.42.26105; Terasawa K, 2005, PLANT CELL PHYSIOL, V46, P649, DOI 10.1093/pcp/pci070; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang YT, 2012, J BIOCHEM, V151, P317, DOI 10.1093/jb/mvr145	30	24	24	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					631	634		10.1126/science.aan0038	http://dx.doi.org/10.1126/science.aan0038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU4BQ	28495749				2022-12-28	WOS:000400975200053
J	Yu, PC; Wilhelm, K; Dubrac, A; Tung, JK; Alves, TC; Fang, JS; Xie, Y; Zhu, J; Chen, ZH; De Smet, F; Zhang, JS; Jin, SW; Sun, LL; Sun, HY; Kibbey, RG; Hirschi, KK; Hay, N; Carmeliet, P; Chittenden, TW; Eichmann, A; Potente, M; Simons, M				Yu, Pengchun; Wilhelm, Kerstin; Dubrac, Alexandre; Tung, Joe K.; Alves, Tiago C.; Fang, Jennifer S.; Xie, Yi; Zhu, Jie; Chen, Zehua; De Smet, Frederik; Zhang, Jiasheng; Jin, Suk-Won; Sun, Lele; Sun, Hongye; Kibbey, Richard G.; Hirschi, Karen K.; Hay, Nissim; Carmeliet, Peter; Chittenden, Thomas W.; Eichmann, Anne; Potente, Michael; Simons, Michael			FGF-dependent metabolic control of vascular development	NATURE			English	Article							ENDOTHELIAL-CELL METABOLISM; GENE-EXPRESSION; GROWTH-FACTOR; LYMPHANGIOGENESIS; MAINTENANCE; MECHANISMS	Blood and lymphatic vasculatures are intimately involved in tissue oxygenation and fluid homeostasis maintenance. Assembly of these vascular networks involves sprouting, migration and proliferation of endothelial cells. Recent studies have suggested that changes in cellular metabolism are important to these processes(1). Although much is known about vascular endothelial growth factor (VEGF)-dependent regulation of vascular development and metabolism(2,3), little is understood about the role of fibroblast growth factors (FGFs) in this context(4). Here we identify FGF receptor (FGFR) signalling as a critical regulator of vascular development. This is achieved by FGF-dependent control of c-MYC (MYC) expression that, in turn, regulates expression of the glycolytic enzyme hexokinase 2 (HK2). A decrease in HK2 levels in the absence of FGF signalling inputs results in decreased glycolysis, leading to impaired endothelial cell proliferation and migration. Pan-endothelial-and lymphatic-specific Hk2 knockouts phenocopy blood and/or lymphatic vascular defects seen in Fgfr1/Fgfr3 double mutant mice, while HK2 overexpression partly rescues the defects caused by suppression of FGF signalling. Thus, FGF-dependent regulation of endothelial glycolysis is a pivotal process in developmental and adult vascular growth and development.	[Yu, Pengchun; Dubrac, Alexandre; Tung, Joe K.; Fang, Jennifer S.; Xie, Yi; Zhang, Jiasheng; Jin, Suk-Won; Hirschi, Karen K.; Eichmann, Anne; Simons, Michael] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06511 USA; [Wilhelm, Kerstin; Potente, Michael] Max Plank Inst Heart & Lung Res, Angiogenesis & Metab Lab, D-61231 Bad Nauheim, Germany; [Alves, Tiago C.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, 333 Cedar St, New Haven, CT 06520 USA; [Zhu, Jie] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA; [Chen, Zehua; Chittenden, Thomas W.] WuXi NextCODE Genom, Computat Stat & Bioinformat Grp, Adv Artificial Intelligence Res Lab, Cambridge, MA 02142 USA; [De Smet, Frederik] VIB KU Leuven, Switch Lab, B-3000 Leuven, Belgium; [De Smet, Frederik] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Jin, Suk-Won] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea; [Sun, Lele; Sun, Hongye] WuXi NextCODE Genom, Genom Lab, 288 Fute Zhong Rd, Shanghai 200131, Peoples R China; [Hay, Nissim] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Leuven, Belgium; [Eichmann, Anne] Paris Cardiovasc Res Ctr, U970, 56 Rue Leblanc, F-75015 Paris, France; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Max Planck Society; Yale University; Yale University; Flanders Institute for Biotechnology (VIB); Harvard University; Dana-Farber Cancer Institute; Gwangju Institute of Science & Technology (GIST); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; KU Leuven; Flanders Institute for Biotechnology (VIB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Yale University	Simons, M (corresponding author), Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06511 USA.; Simons, M (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	michael.simons@yale.edu	Wilhelm, Kerstin/AAX-5025-2020; Xie, Yi/G-8502-2015; Carmeliet, Peter/AAQ-5140-2020; De Smet, Frederik/Q-7808-2016; Dubrac, Alexandre/AAQ-9515-2021; Fang, Jennifer S./AAK-8044-2020	Wilhelm, Kerstin/0000-0001-8159-2850; Carmeliet, Peter/0000-0001-7961-1821; De Smet, Frederik/0000-0002-6669-3335; Dubrac, Alexandre/0000-0002-3829-2577; Fang, Jennifer S./0000-0001-5703-2239; Potente, Michael/0000-0002-5689-0036; Yu, Pengchun/0000-0002-3657-9048; Tung, Joe/0000-0001-7162-3975	American Heart Association [15POST25830021]; Brown-Coxe Fellowship from Yale University; Research Foundation Flanders (FWO); Flemish Government [IUAP P7/03]; FWO [G.0598.12, G.0532.10, G.0817.11, G.0834.13, 1.5.202.10.]; Leducq Transatlantic Network ARTEMIS; AXA Research Fund [1465]; Foundation against Cancer; European Research Council (ERC) Advanced Research Grant [EU-ERC269073]; Max Planck Society; ERC Starting Grant ANGIOMET [311546]; Deutsche Forschungsgemeinschaft [SFB 834]; Excellence Cluster Cardiopulmonary System [EXC 147/1]; LOEWE grant Ub-Net; DZHK (German Center for Cardiovascular Research); European Molecular Biology Organization Young Investigator Programme; National Institutes of Health [HL053793, HL084619]; ARTEMIS Leducq Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA206167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793, R01HL125811, R01HL084619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [UH3EB017103, UG3EB025765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016927] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Brown-Coxe Fellowship from Yale University; Research Foundation Flanders (FWO)(FWO); Flemish Government(European Commission); FWO(FWO); Leducq Transatlantic Network ARTEMIS(Leducq Foundation); AXA Research Fund(AXA Research Fund); Foundation against Cancer; European Research Council (ERC) Advanced Research Grant(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC Starting Grant ANGIOMET; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); LOEWE grant Ub-Net; DZHK (German Center for Cardiovascular Research); European Molecular Biology Organization Young Investigator Programme(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARTEMIS Leducq Transatlantic Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Adams for Cdh5-CreER<SUP>T2</SUP>, T. Makinen for Prox1-CreER<SUP>T2(BAC)</SUP>, G. Oliver for Prox1-CreER<SUP>T2(KI)</SUP>, as well as F. Vaccarino and S. Tomasi for Fgfr1<SUP>flox/flox</SUP>; Fgfr<SUP>3+/-</SUP> mice. We also thank H. Ardehali for providing HK2 adenovirus, B. G. Coon for generating CRISPR-Cas9 lentivirus, K. van den Dries for real-time imaging and analysis of cell motility, G. Eelen and A. Quaegebeur for metabolic analysis, T. Yarovinsky for instruction and assistance on the flow cytometry, A. Kuo for help with the Seahorse metabolic analyser and F. Zhuo for schematic illustrations. P.Y. is funded by an American Heart Association Postdoctoral Fellowship (15POST25830021). J.Z. was funded by the Brown-Coxe Fellowship from Yale University. F.D.S. was supported as a postdoctoral researcher by the Research Foundation Flanders (FWO). P.C. is funded by IUAP P7/03, long-term structural Methusalem funding by the Flemish Government, FWO G.0598.12, G.0532.10, G.0817.11, G.0834.13, 1.5.202.10. N Krediet aan navorsers, Leducq Transatlantic Network ARTEMIS, AXA Research Fund (1465) and Foundation against Cancer, European Research Council (ERC) Advanced Research Grant (EU-ERC269073, PC). M.P. is supported by the Max Planck Society, a ERC Starting Grant ANGIOMET (311546), the Deutsche Forschungsgemeinschaft (SFB 834), the Excellence Cluster Cardiopulmonary System (EXC 147/1), the LOEWE grant Ub-Net, the DZHK (German Center for Cardiovascular Research), and the European Molecular Biology Organization Young Investigator Programme. M.S. is supported by National Institutes of Health grants HL053793, HL084619 and ARTEMIS Leducq Transatlantic Network.	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chittenden TW, 2012, BIOINFORMATICS, V28, P726, DOI 10.1093/bioinformatics/bts011; Chittenden TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015581; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubrac A, 2016, CIRCULATION, V133, P409, DOI 10.1161/CIRCULATIONAHA.115.017537; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Herbert C, 2013, CANCER CELL, V23, P489, DOI 10.1016/j.ccr.2013.02.018; Ichise T, 2014, J CELL SCI, V127, P845, DOI 10.1242/jcs.137836; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Oladipupo SS, 2014, P NATL ACAD SCI USA, V111, P13379, DOI 10.1073/pnas.1324235111; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Rash BG, 2011, J NEUROSCI, V31, P15604, DOI 10.1523/JNEUROSCI.4439-11.2011; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Tang ZS, 2011, JOVE-J VIS EXP, DOI 10.3791/3077; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	33	179	187	4	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					224	+		10.1038/nature22322	http://dx.doi.org/10.1038/nature22322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467822	Green Accepted			2022-12-28	WOS:000400963800034
J	Lin, JS; Bowles, EJA; Williams, SB; Morrison, CC				Lin, Jennifer S.; Bowles, Erin J. Aiello; Williams, Selvi B.; Morrison, Caitlin C.			Screening for Thyroid Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL NECK DISSECTION; FINE-NEEDLE-ASPIRATION; LYMPH-NODE DISSECTION; 2ND PRIMARY MALIGNANCY; RADIOACTIVE IODINE ABLATION; PAPILLARY MICROCARCINOMA; SURGICAL-TREATMENT; UNITED-STATES; CARCINOMA; RISK	IMPORTANCE The incidence of detected thyroid cancer cases has been increasing in the United States since 1975. The majority of thyroid cancers are differentiated cancers with excellent prognosis and long-term survival. OBJECTIVE To systematically review the benefits and harms associated with thyroid cancer screening and treatment of early thyroid cancer in asymptomatic adults to inform the US Preventive Services Task Force. DATA SOURCES Searches of MEDLINE, PubMed, and the Cochrane Central Register of Controlled Trials for relevant studies published from January 1966 through January 2016, with active surveillance through December 2016. STUDY SELECTION English-language studies conducted in asymptomatic adult populations. DATA EXTRACTION AND SYNTHESIS Two reviewers independently appraised the articles and extracted relevant study data from fair-or good-quality studies. Random-effects meta-analyses were conducted to pool surgical harms. MAIN OUTCOMES AND MEASURES Thyroid cancer morbidity and mortality, test accuracy to detect thyroid nodules or thyroid cancer, and harms resulting from screening (including overdiagnosis) or treatment of thyroid cancer. RESULTS Of 10 424 abstracts, 707 full-text articles were reviewed, and 67 studies were included for this review. No fair-to good-quality studies directly examined the benefit of thyroid cancer screening. In 2 studies (n = 354), neck palpation was not sensitive to detect thyroid nodules. In 2 methodologically limited studies (n = 243), a combination of selected high-risk sonographic features was specific for thyroid malignancy. Three studies (n = 5894) directly addressed the harms of thyroid cancer screening, none of which suggested any serious harms from screening or ultrasound-guided fine-needle aspiration. No screening studies directly examined the risk of overdiagnosis. Two observational studies (n = 39 211) included cohorts of persons treated for well-differentiated thyroid cancer and persons with no surgery or surveillance; however, these studies did not adjust for confounders and therefore were not designed to determine if earlier or immediate treatment vs delayed or no surgical treatment improves patient outcomes. Based on 36 studies (n = 43 295), the 95% CI for the rate of surgical harm was 2.12 to 5.93 cases of permanent hypoparathyroidism per 100 thyroidectomies and 0.99 to 2.13 cases of recurrent laryngeal nerve palsy per 100 operations. Based on 16 studies (n = 291 796), treatment of differentiated thyroid cancer with radioactive iodine is associated with a small increase in risk of second primary malignancies and with increased risk of permanent adverse effects on the salivary gland, such as dry mouth. CONCLUSIONS AND RELEVANCE Although ultrasonography of the neck using high-risk sonographic characteristics plus follow-up cytology from fine-needle aspiration can identify thyroid cancers, it is unclear if population-based or targeted screening can decrease mortality rates or improve important patient health outcomes. Screening that results in the identification of indolent thyroid cancers, and treatment of these overdiagnosed cancers, may increase the risk of patient harms.	[Lin, Jennifer S.; Williams, Selvi B.] Kaiser Permanente Res Affiliates Evidence Based P, Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Bowles, Erin J. Aiello; Morrison, Caitlin C.] Kaiser Permanente Res Affiliates Evidence Based P, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA	Kaiser Permanente; Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org			Agency for Healthcare Research and Quality (AHRQ) [HHSA-290-2012-00015-I-357 EPC4]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded under contract number HHSA-290-2012-00015-I-357 EPC4, Task Order 4, from the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	Abu-Yousef MM, 2011, ULTRASOUND Q, V27, P157, DOI 10.1097/RUQ.0b013e31822b5681; Ahn D, 2014, AURIS NASUS LARYNX, V41, P63, DOI 10.1016/j.anl.2013.06.002; Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Boute P, 2013, EUR ANN OTORHINOLARY, V130, P245, DOI 10.1016/j.anorl.2012.10.004; BRANDER A, 1989, RADIOLOGY, V173, P507, DOI 10.1148/radiology.173.2.2678263; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; Brito JP, 2014, J CLIN ENDOCR METAB, V99, P1253, DOI 10.1210/jc.2013-2928; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Bucci A, 2001, J CLIN ENDOCR METAB, V86, P3711, DOI 10.1210/jc.86.8.3711; Caliskan M, 2012, ENDOCR J, V59, P305, DOI 10.1507/endocrj.EJ11-0366; Calo PG, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/625193; Carter SM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h869; Chang YW, 2016, ASIAN J SURG, V39, P197, DOI 10.1016/j.asjsur.2015.02.006; Chaplin JM, 1999, AUST NZ J SURG, V65, P625, DOI 10.1046/j.1440-1622.1999.01651.x; Chung WY, 2001, SURG TODAY, V31, P763, DOI 10.1007/s005950170044; Cirocchi R, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-70; Conzo G, 2014, SURGERY, V155, P998, DOI 10.1016/j.surg.2014.02.010; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, ARCH OTOLARYNGOL, V136, P440, DOI 10.1001/archoto.2010.55; Del Rio P, 2015, TUMORI, V101, P144, DOI 10.5301/tj.5000223; Donatini G, 2016, WORLD J SURG, V40, P510, DOI 10.1007/s00268-015-3327-7; Durante C, 2015, JAMA-J AM MED ASSOC, V313, P926, DOI 10.1001/jama.2015.0956; Francis DO, 2014, OTOLARYNG HEAD NECK, V150, P548, DOI 10.1177/0194599814521381; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; Grewal RK, 2009, J NUCL MED, V50, P1605, DOI 10.2967/jnumed.108.061382; Hakala TT, 2016, INT J CLIN ONCOL, V21, P231, DOI 10.1007/s10147-015-0904-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartl DM, 2013, WORLD J SURG, V37, P1951, DOI 10.1007/s00268-013-2089-3; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Ho AS, 2015, CANCER-AM CANCER SOC, V121, P1793, DOI 10.1002/cncr.29289; Hobbs HA, 2014, AM J ROENTGENOL, V202, P602, DOI 10.2214/AJR.13.11219; Holzer S, 2000, CANCER, V89, P192, DOI 10.1002/1097-0142(20000701)89:1<192::AID-CNCR26>3.0.CO;2-7; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Hundahl SA, 2000, CANCER-AM CANCER SOC, V89, P202, DOI 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A; Hyer S, 2007, CLIN ONCOL-UK, V19, P83, DOI 10.1016/j.clon.2006.11.005; Hyun SM, 2012, ANN SURG ONCOL, V19, P591, DOI 10.1245/s10434-011-1995-6; Ish-Shalom S, 2008, EUR J ENDOCRINOL, V158, P677, DOI 10.1530/EJE-07-0634; ISHIDA T, 1988, JPN J CLIN ONCOL, V18, P289; Ito Y, 2005, WORLD J SURG, V29, P1544, DOI 10.1007/s00268-005-0086-x; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jeong SY, 2013, THYROID, V23, P609, DOI 10.1089/thy.2012.0106; Khang AR, 2015, CLIN ENDOCRINOL, V83, P117, DOI 10.1111/cen.12581; Kim BS, 2014, SURG LAPARO ENDO PER, V24, P67, DOI 10.1097/SLE.0b013e3182a4bfec; Kim JY, 2008, J ULTRAS MED, V27, P215, DOI 10.7863/jum.2008.27.2.215; Kim SJ, 2010, ACTA RADIOL, V51, P475, DOI 10.3109/02841851003641834; Kim WW, 2011, WORLD J SURG, V35, P779, DOI 10.1007/s00268-011-0960-7; Kwan WYW, 2015, ANZ J SURG, V85, P274, DOI 10.1111/ans.12343; La Vecchia C, 2015, INT J CANCER, V136, P2740, DOI 10.1002/ijc.29310; Lang BHH, 2012, SURGERY, V151, P844, DOI 10.1016/j.surg.2011.12.019; Lang BHH, 2011, ANN SURG ONCOL, V18, P3559, DOI 10.1245/s10434-011-1777-1; Lee HK, 2003, YONSEI MED J, V44, P1040, DOI 10.3349/ymj.2003.44.6.1040; Lee YS, 2014, J KOREAN MED SCI, V29, P676, DOI 10.3346/jkms.2014.29.5.676; Lee YS, 2010, J KOREAN MED SCI, V25, P541, DOI 10.3346/jkms.2010.25.4.541; Lin CM, 2014, EUR J NUCL MED MOL I, V41, P253, DOI 10.1007/s00259-013-2541-5; Lin CY, 2016, J NUCL MED, V57, P685, DOI 10.2967/jnumed.115.164830; Lin JS, 2016, SCREENING THYROID CA; Moo TAS, 2009, ANN SURG, V250, P403, DOI 10.1097/SLA.0b013e3181b3adab; National Cancer Institute (NCI), 2014, CANC STAT FACTS THYR; Noguchi S, 2008, WORLD J SURG, V32, P747, DOI 10.1007/s00268-007-9453-0; Oda H, 2016, THYROID, V26, P150, DOI 10.1089/thy.2015.0313; Palestini N, 2008, LANGENBECK ARCH SURG, V393, P693, DOI 10.1007/s00423-008-0360-0; Raffaelli M, 2012, SURGERY, V152, P957, DOI 10.1016/j.surg.2012.08.053; Raj MD, 2010, ANZ J SURG, V80, P827, DOI 10.1111/j.1445-2197.2010.05343.x; RON E, 1984, ISRAEL J MED SCI, V20, P1164; Ronckers CM, 2005, INT J CANCER, V117, P281, DOI 10.1002/ijc.21064; Ryu CH, 2015, J NUCL MED, V56, P1480, DOI 10.2967/jnumed.115.161463; Seo GH, 2015, THYROID, V25, P927, DOI 10.1089/thy.2014.0557; Shah MD, 2006, J OTOLARYNGOL, V35, P209, DOI 10.2310/7070.2006.0011; SHIMAOKA K, 1982, NEW YORK STATE J MED, V82, P1184; SHINDO ML, 1995, LARYNGOSCOPE, V105, P1173, DOI 10.1288/00005537-199511000-00006; Sim R, 1998, J ROY COLL SURG EDIN, V43, P239; So YK, 2010, SURGERY, V148, P526, DOI 10.1016/j.surg.2010.01.003; Solans R, 2001, J NUCL MED, V42, P738; Son YI, 2008, ANN SURG ONCOL, V15, P2020, DOI 10.1245/s10434-008-9928-8; Spear SA, 2008, MIL MED, V173, P399, DOI 10.7205/MILMED.173.4.399; Suehiro F, 2006, SURG TODAY, V36, P947, DOI 10.1007/s00595-006-3293-7; Sywak M, 2006, SURGERY, V140, P1000, DOI 10.1016/j.surg.2006.08.001; Tartaglia F, 2014, INT J SURG, V12, pS57, DOI 10.1016/j.ijsu.2014.05.053; Tuttle M., 2011, CLINCOOPATHOLOGIC ST; US Preventive Services Task Force, 2008, AHRQ PUBL; Viola D, 2015, J CLIN ENDOCR METAB, V100, P1316, DOI 10.1210/jc.2014-3825; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu JX, 2015, THYROID, V25, P133, DOI 10.1089/thy.2014.0343; Xing MM, 2012, THYROID CARCINOMA; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116; Yu XM, 2011, ANN SURG, V254, P653, DOI 10.1097/SLA.0b013e318230036d; Zerey M, 2009, AM SURGEON, V75, P20	95	80	83	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1888	1903		10.1001/jama.2017.0562	http://dx.doi.org/10.1001/jama.2017.0562			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492904				2022-12-28	WOS:000400842400019
J	Clery, D				Clery, Daniel			FAST AND CURIOUS	SCIENCE			English	Editorial Material														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					476	479		10.1126/science.356.6337.476	http://dx.doi.org/10.1126/science.356.6337.476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET8JM	28473545				2022-12-28	WOS:000400545700015
J	Ip, WKE; Hoshi, N; Shouval, DS; Snapper, S; Medzhitov, R				Ip, W. K. Eddie; Hoshi, Namiko; Shouval, Dror S.; Snapper, Scott; Medzhitov, Ruslan			Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages	SCIENCE			English	Article							MECHANISTIC TARGET; DENDRITIC CELLS; GROWTH-CONTROL; MTORC1; AUTOPHAGY; INNATE; INHIBITION; COMMITMENT; ACTIVATION; IL-1-BETA	Interleukin 10 (IL-10) is an anti-inflammatory cytokine that plays a critical role in the control of immune responses. However, its mechanisms of action remain poorly understood. Here, we show that IL-10 opposes the switch to the metabolic program induced by inflammatory stimuli in macrophages. Specifically, we show that IL-10 inhibits lipopolysaccharide-induced glucose uptake and glycolysis and promotes oxidative phosphorylation. Furthermore, IL-10 suppresses mammalian target of rapamycin (mTOR) activity through the induction of an mTOR inhibitor, DDIT4. Consequently, IL-10 promotes mitophagy that eliminates dysfunctional mitochondria characterized by low membrane potential and a high level of reactive oxygen species. In the absence of IL-10 signaling, macrophages accumulate damaged mitochondria in a mouse model of colitis and inflammatory bowel disease patients, and this results in dysregulated activation of the NLRP3 inflammasome and production of IL-1 beta.	[Ip, W. K. Eddie; Hoshi, Namiko; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; [Ip, W. K. Eddie; Hoshi, Namiko; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Shouval, Dror S.; Snapper, Scott] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Hoshi, Namiko] Kobe Univ, Div Gastroenterol, Grad Sch Med, Kobe, Hyogo, Japan; [Shouval, Dror S.] Edmond & Lily Safra Childrens Hosp, Div Pediat Gastroenterol & Nutr, Sheba Med Ctr, Tel Hashomer, Israel; [Shouval, Dror S.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School; Kobe University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.; Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu	Ip, W. K. Eddie/C-3042-2012; Hoshi, Namiko/V-8370-2019	Ip, W. K. Eddie/0000-0003-1953-972X; Hoshi, Namiko/0000-0003-2768-3991	Helmsley Charitable Trust; Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung; NIH [R01 AI046688, DK071754, CA157461]; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754, P30DK034854] Funding Source: NIH RePORTER	Helmsley Charitable Trust; Blavatnik Family Foundation; Else Kroner-Fresenius-Stiftung; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Medzhitov lab for discussions and D. M. Sabatini for helpful suggestions. We thank R. Flavell (Yale University) for Casp1<SUP>-/-</SUP> mice, D. Mizushima for Atg5<SUP>flox/flox</SUP> mice (Tokyo Medical and Dental University), H. Virgin (Washington University) for Atg5<SUP>flox/flox</SUP> LysM-Cre mice, L. Ellisen (Massachusetts General Hospital) for bone-marrow cells from Ddit4<SUP>-/-</SUP> mice, S. Kaech (Yale University) for the use of Seahorse Analyzer, M. Staron and P.-C. Ho for assistance with Seahorse assays, the Yale Stem Cell Center for RNA-seq, Y. Kong for RNA-seq analysis, N. Allen and I. Brodsky for retroviral vector pMSCV-NLRP3/IRES-GFP, and C. Annicelli and S. Cronin for animal care. All data reported in this manuscript are tabulated in the main paper and supplementary materials. This work was supported by Helmsley Charitable Trust, Blavatnik Family Foundation, Else Kroner-Fresenius-Stiftung, and grants from the NIH (R01 AI046688, DK071754, and CA157461 to R.M.). R.M. is an investigator of the Howard Hughes Medical Institute.	Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Baseler WA, 2016, REDOX BIOL, V10, P12, DOI 10.1016/j.redox.2016.09.005; Begue B, 2011, AM J GASTROENTEROL, V106, P1544, DOI 10.1038/ajg.2011.112; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Ohtani M, 2012, J IMMUNOL, V188, P4736, DOI 10.4049/jimmunol.1200069; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	39	617	654	21	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2017	356	6337					513	519		10.1126/science.aal3535	http://dx.doi.org/10.1126/science.aal3535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET8JM	28473584	Green Accepted			2022-12-28	WOS:000400545700032
J	Birkhead, T; Montgomerie, R				Birkhead, Tim; Montgomerie, Robert			One submission to all journals	NATURE			English	Letter									[Birkhead, Tim] Univ Sheffield, Sheffield, S Yorkshire, England; [Montgomerie, Robert] Queens Univ, Kingston, ON, Canada	University of Sheffield; Queens University - Canada	Birkhead, T (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.	t.r.birkhead@sheffield.ac.uk						Guo QM, 2016, NATURE, V540, P525, DOI 10.1038/540525d; Moore JP, 2017, NATURE, V542, P31, DOI 10.1038/542031e	2	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					30	30		10.1038/545030a	http://dx.doi.org/10.1038/545030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470194	Bronze			2022-12-28	WOS:000400480400016
J	Risbey, JS; Lewandowsky, S				Risbey, James S.; Lewandowsky, Stephan			CLIMATE SCIENCE The 'pause' unpacked	NATURE			English	Editorial Material									[Risbey, James S.] Oceans & Atmosphere Commonwealth Sci & Ind Res Or, Hobart, Tas 7001, Australia; [Lewandowsky, Stephan] Univ Bristol, Sch Expt Psychol, Clifton BS8 1TU, England; [Lewandowsky, Stephan] Univ Bristol, Cabot Inst, Clifton BS8 1TU, England; [Lewandowsky, Stephan] Univ Western Australia, Sch Psychol Sci, Crawley, England	University of Bristol; University of Bristol; University of Western Australia	Risbey, JS (corresponding author), Oceans & Atmosphere Commonwealth Sci & Ind Res Or, Hobart, Tas 7001, Australia.	james.risbey@csiro.au; stephan.lewandowsky@bristol.ac.uk	Risbey, James/M-8419-2013; Lewandowsky, Stephan/L-4272-2019	Risbey, James/0000-0003-3202-9142; Lewandowsky, Stephan/0000-0003-1655-2013				Cahill N., 2017, ENVIRON RES LETT, V12; Cahill N, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/084002; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Lewandowsky S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16784; Mann ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep19831; Medhaug I, 2017, NATURE, V545, P41, DOI 10.1038/nature22315; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Risbey JS, 2014, NAT CLIM CHANGE, V4, P835, DOI [10.1038/nclimate2310, 10.1038/NCLIMATE2310]	9	11	11	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					37	39		10.1038/545037a	http://dx.doi.org/10.1038/545037a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ET7MK	28470197				2022-12-28	WOS:000400480400024
J	Sinturel, F; Gerber, A; Mauvoisin, D; Wang, JK; Gatfield, D; Stubblefield, JJ; Green, CB; Gachon, F; Schibler, U				Sinturel, Flore; Gerber, Alan; Mauvoisin, Daniel; Wang, Jingkui; Gatfield, David; Stubblefield, Jeremy J.; Green, Carla B.; Gachon, Frederic; Schibler, Ueli			Diurnal Oscillations in Liver Mass and Cell Size Accompany Ribosome Assembly Cycles	CELL			English	Article							CIRCADIAN TRANSCRIPTION; POLY(A) POLYMERASE; RNA DEGRADATION; MESSENGER-RNA; POLYADENYLATION; RHYTHMS; CLOCK; SURVEILLANCE; ADENYLATION; METABOLISM	The liver plays a pivotal role in metabolism and xenobiotic detoxification, processes that must be particularly efficient when animals are active and feed. A major question is how the liver adapts to these diurnal changes in physiology. Here, we show that, in mice, liver mass, hepatocyte size, and protein levels follow a daily rhythm, whose amplitude depends on both feeding-fasting and light-dark cycles. Correlative evidence suggests that the daily oscillation in global protein accumulation depends on a similar fluctuation in ribosome number. Whereas rRNA genes are transcribed at similar rates throughout the day, some newly synthesized rRNAs are polyadenylated and degraded in the nucleus in a robustly diurnal fashion with a phase opposite to that of ribosomal protein synthesis. Based on studies with cultured fibroblasts, we propose that rRNAs not packaged into complete ribosomal subunits are polyadenylated by the poly(A) polymerase PAPD5 and degraded by the nuclear exosome.	[Sinturel, Flore; Gerber, Alan; Schibler, Ueli] Univ Geneva, Sci 3, Dept Mol Biol, iGE3, CH-1211 Geneva, Switzerland; [Mauvoisin, Daniel; Wang, Jingkui] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Mauvoisin, Daniel; Gachon, Frederic] Nestle Inst Hlth Sci, Dept Diabet & Circadian Rhythms, CH-1015 Lausanne, Switzerland; [Wang, Jingkui] IMP Res Inst Mol Pathol, Campus Vienna Bioctr 1, A-1030 Vienna, Austria; [Gatfield, David] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Stubblefield, Jeremy J.; Green, Carla B.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Gachon, Frederic] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Sinturel, Flore] Univ Geneva, Fac Med, Diabet Ctr, Dept Cellular Physiol & Metab,iGE3, Geneva, Switzerland; [Gerber, Alan] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Nestle SA; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Lausanne; University of Texas System; University of Texas Southwestern Medical Center Dallas; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Rockefeller University	Schibler, U (corresponding author), Univ Geneva, Sci 3, Dept Mol Biol, iGE3, CH-1211 Geneva, Switzerland.; Gachon, F (corresponding author), Nestle Inst Hlth Sci, Dept Diabet & Circadian Rhythms, CH-1015 Lausanne, Switzerland.; Gachon, F (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	frederic.gachon@rd.nestle.com; ueli.schibler@unige.ch	Gachon, Frédéric/H-3111-2019; Mauvoisin, Daniel/V-3928-2017; Gatfield, David/C-2354-2011; Mauvoisin, Daniel/ABD-7813-2020; Sinturel, Flore/AAA-5420-2019	Gachon, Frédéric/0000-0002-9279-9707; Mauvoisin, Daniel/0000-0003-0571-0741; Gatfield, David/0000-0001-5114-2824; Mauvoisin, Daniel/0000-0003-0571-0741; Gerber, Alan/0000-0003-3909-3606; Sinturel, Flore/0000-0003-3210-0113	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC-2009-AdG-TIMESIGNAL-250117, ERC-2010-StG-CIRCATRANS-260988]; State of Geneva; Louis Jeantet Foundation of Medicine; EMBO [ALTF 1464-2012]; NIH [R01GM111387, R01GM112991, R01AG045795]; SNF [157528]; NCCR RNA Disease; Leenaards Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111387, R01GM112991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045795] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SNF; NCCR RNA Disease; Leenaards Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Andre Liani and Yves-Alain Poget for designing and engineering the automated feeding machines; Pascal Gos for help in using them; Dr. Ingrid Grummt, DKFZ, Heidelberg, for providing anti-RNA polymerase I antibodies; and Nicolas Roggli for the artwork. Dr. Charna Dibner, the current employer of F.S., Geneva Medical School, has generously allocated her time for conducting the revisions. We thank Jessica Sordet-Dessimoz, Histology Core Facility, EPFL, for her assistance in the immunohistochemistry experiments. Work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565 and SNF 31-128656/1), the European Research Council (ERC-2009-AdG-TIMESIGNAL-250117), the State of Geneva, and the Louis Jeantet Foundation of Medicine. F.S. was funded in part by a long-term EMBO fellowship (ALTF 1464-2012). Work in the laboratory of C.B.G. was funded by the NIH (R01GM111387, R01GM112991, and R01AG045795). D.G. acknowledges funding by SNF professorship grant 157528 and the NCCR RNA & Disease. F.G. acknowledges funding by the European Research Council (through individual starting grants ERC-2010-StG-CIRCATRANS-260988) and the Leenaards Foundation (to F.G. and D.G.). F.G. and D.M. are Nestle Institute of Health Sciences SA employees.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Boele J, 2014, P NATL ACAD SCI USA, V111, P11467, DOI 10.1073/pnas.1317751111; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; FISHER HARVEY I., 1957, CONDOR, V59, P364, DOI 10.2307/1365247; FISHMAN B, 1969, P NATL ACAD SCI USA, V64, P677, DOI 10.1073/pnas.64.2.677; Gerber A, 2013, CELL, V152, P492, DOI 10.1016/j.cell.2012.12.027; Gerhart-Hines Z, 2015, ENDOCR REV, V36, P289, DOI 10.1210/er.2015-1007; Gotic I, 2016, GENE DEV, V30, P2005, DOI 10.1101/gad.287094.116; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Janich P, 2015, GENOME RES, V25, P1848, DOI 10.1101/gr.195404.115; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kojima S, 2012, GENE DEV, V26, P2724, DOI 10.1101/gad.208306.112; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LEUNG NWY, 1986, J HEPATOL, V2, P157, DOI 10.1016/S0168-8278(86)80074-5; LOEB JN, 1965, SCIENCE, V149, P1093, DOI 10.1126/science.149.3688.1093; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Mohanty BK, 2011, WIRES RNA, V2, P256, DOI 10.1002/wrna.51; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; SCHMIDT EE, 1995, J CELL BIOL, V128, P467, DOI 10.1083/jcb.128.4.467; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Shukla S, 2016, NAT STRUCT MOL BIOL, V23, P286, DOI 10.1038/nsmb.3184; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Slomovic S, 2010, P NATL ACAD SCI USA, V107, P7407, DOI 10.1073/pnas.0910621107; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sudo H, 2016, FEBS LETT, V590, P2963, DOI 10.1002/1873-3468.12314; UCHIYAMA Y, 1990, J GASTROEN HEPATOL, V5, P321, DOI 10.1111/j.1440-1746.1990.tb01634.x; Udoh US, 2015, AM J PHYSIOL-GASTR L, V308, pG964, DOI 10.1152/ajpgi.00081.2015; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang JK, 2017, CELL METAB, V25, P102, DOI 10.1016/j.cmet.2016.10.003; Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709; WILSON WO, 1969, POULTRY SCI, V48, P477, DOI 10.3382/ps.0480477; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	50	108	112	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					651	663		10.1016/j.cell.2017.04.015	http://dx.doi.org/10.1016/j.cell.2017.04.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475894	Green Accepted, Bronze			2022-12-28	WOS:000400560900011
J	Pease, AM; Krumholz, HM; Downing, NS; Aminawung, JA; Shah, ND; Ross, JS				Pease, Alison M.; Krumholz, Harlan M.; Downing, Nicholas S.; Aminawung, Jenerius A.; Shah, Nilay D.; Ross, Joseph S.			Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURROGATE END-POINTS; LIFE-CYCLE	Objective To characterize the prospective controlled clinical studies for all novel drugs that were initially approved by the Food and Drug Administration on the basis of limited evidence. Design Systematic review. Data sources Drugs@FDA database and PubMed. Study inclusion All prospective controlled clinical studies published after approval for all novel drugs initially approved by the FDA between 2005 and 2012 on the basis of a single pivotal trial, pivotal trials that used surrogate markers of disease as primary endpoints, or both. Results Between 2005 and 2012 the FDA approved 117 novel drugs for 123 indications on the basis of a single pivotal trial, pivotal trials that used surrogate markers of disease, or both (single surrogate trials). We identified 758 published controlled studies over a median of 5.5 years (interquartile range 3.4-8.2) after approval, most of which (554 of 758; 73.1%) were studies for indications approved on the basis of surrogate markers of disease. Most postapproval studies used active comparators-67 of 77 (87.0%) indications approved on the basis of single pivotal trials, 365 of 554 (65.9%) approvals based on surrogate marker trials, and 100 of 127 (78.7%) approvals based on single surrogate trials-and examined surrogate markers of efficacy as primary endpoints-51 of 77 (66.2%), 512 of 554 (92.4%), and 110 of 127 (86.6%), respectively. Overall, no postapproval studies were identified for 43 of the 123 (35.0%) approved indications. The median total number of postapproval studies identified was 1 (interquartile range 0-2) for indications approved on the basis of a single pivotal trial, 3 (1-8) for indications approved on the basis of pivotal trials that used surrogate markers of disease as primary endpoints, and 1 (0-2) for single surrogate trial approvals, and the median aggregate number of patients enrolled in postapproval studies was 90 (0-509), 533 (122-3633), and 38 (0-666), respectively. The proportion of approved indications with one or more randomized, controlled, double blind study using a clinical outcome for the primary endpoint that was published after approval and showed superior efficacy was 18.2% (6 of 33), 2.0% (1 of 49), and 4.9% (2 of 41), respectively. Conclusions The quantity and quality of postapproval clinical evidence varied substantially for novel drugs first approved by the FDA on the basis of limited evidence, with few controlled studies published after approval that confirmed efficacy using clinical outcomes for the original FDA approved indication.	[Pease, Alison M.; Ross, Joseph S.] State Univ New York, Downstate Coll Med, Brooklyn, NY USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Hlth, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Downing, Nicholas S.] Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Aminawung, Jenerius A.; Ross, Joseph S.] Yale Sch Med, Gen Internal Med Sect, Dept Internal Med, New Haven, CT USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Sci Res, Rochester, MN USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Yale University; Mayo Clinic	Ross, JS (corresponding author), State Univ New York, Downstate Coll Med, Brooklyn, NY USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Robert E Leet and Clara Guthrie Patterson Trust Awards Program in Clinical Research, Bank of America, NA; SUNY Downstate College of Medicine Alumni Fund Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Robert E Leet and Clara Guthrie Patterson Trust Awards Program in Clinical Research, Bank of America, NA; SUNY Downstate College of Medicine Alumni Fund Summer Research Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported in part by the Robert E Leet and Clara Guthrie Patterson Trust Awards Program in Clinical Research, Bank of America, NA, Trustee. The sponsor had no role in the design of the study, analysis or interpretation of findings, or drafting the manuscript and did not review or approve the manuscript before submission. The authors assume full responsibility for the accuracy and completeness of the ideas presented. AMP was supported in part by the SUNY Downstate College of Medicine Alumni Fund Summer Research Fellowship. Ethical approval: The Yale University Institutional Review Board approved this study and considered it non-human subjects research.	Anderson GM, 2008, JAMA-J AM MED ASSOC, V299, P1598, DOI 10.1001/jama.299.13.1598; Avorn J, 2015, NEW ENGL J MED, V372, P2473, DOI 10.1056/NEJMp1506964; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bognet RA, 2006, J AM ACAD DERMATOL, V55, P721, DOI 10.1016/j.jaad.2006.06.025; Carpenter D, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1107201, 10.1056/nejmp1107201]; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Ciani O, 2017, VALUE HEALTH, V20, P487, DOI 10.1016/j.jval.2016.10.011; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P2459, DOI 10.1001/jama.2013.278904; Food and Drug Administration (FDA), STAT CTR DRUG EV RES; Healy D., 2012, PHARMAGEDDON; Institute of Medicine, 2010, EVALUATION BIOMARKER; Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Institute of Medicine, 2007, FUT DRUG SAF PROM PR; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kim C, 2015, JAMA INTERN MED, V175, P1992, DOI 10.1001/jamainternmed.2015.5868; Krumholz HM, 2016, CIRC-CARDIOVASC QUAL, V9, P343, DOI 10.1161/CIRCOUTCOMES.116.003094; Krumholz HM, 2015, CIRC-CARDIOVASC QUAL, V8, P457, DOI 10.1161/CIRCOUTCOMES.115.002245; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Schwartz LM, 2011, ARCH INTERN MED, V171, P1463, DOI 10.1001/archinternmed.2011.396; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; Sotos J., 2016, WALL STREET J; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; US Food and Drug Administration (FDA), GUID IND PROV CLIN E; US Food and Drug Administration (FDA), FDA PROD APPR; US Food and Drug Administration (FDA), FDAS SENT IN BACKGR; US Food and Drug Administration (FDA), GUID IND POSTM STUD; US Food And Drugs Administration (FDA), POSTM DRUG BIOL SAF; US Government Accountability Office, FDA NEEDS ENH ITS OV; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; World Health Organization (WHO) Collaborating Center for Drug Statistics Methodology, ATC DDD IND 2017	34	67	68	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2017	357								j1680	10.1136/bmj.j1680	http://dx.doi.org/10.1136/bmj.j1680			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WC	28468750	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000400889600001
J	Fry, J; Fry, ENS				Fry, John; Fry, E. N. S.			Edwin Norman Sargood Fry OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j2037	10.1136/bmj.j2037	http://dx.doi.org/10.1136/bmj.j2037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WB	28465361				2022-12-28	WOS:000400889500004
J	Larkin, I; Ang, D; Steinhart, J; Chao, M; Patterson, M; Sah, S; Wu, TN; Schoenbaum, M; Hutchins, D; Brennan, T; Loewenstein, G				Larkin, Ian; Ang, Desmond; Steinhart, Jonathan; Chao, Matthew; Patterson, Mark; Sah, Sunita; Wu, Tina; Schoenbaum, Michael; Hutchins, David; Brennan, Troyen; Loewenstein, George			Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-INTEREST-POLICIES; DIFFERENCE	IMPORTANCE In an effort to regulate physician conflicts of interest, some US academic medical centers (AMCs) enacted policies restricting pharmaceutical representative sales visits to physicians (known as detailing) between 2006 and 2012. Little is known about the effect of these policies on physician prescribing. OBJECTIVE To analyze the association between detailing policies enacted at AMCs and physician prescribing of actively detailed and not detailed drugs. DESIGN, SETTING, AND PARTICIPANTS The study used a difference-in-differences multivariable regression analysis to compare changes in prescribing by physicians before and after implementation of detailing policies at AMCs in 5 states (California, Illinois, Massachusetts, Pennsylvania, and New York) that made up the intervention group with changes in prescribing by a matched control group of similar physicians not subject to a detailing policy. EXPOSURES Academic medical center implementation of policies regulating pharmaceutical salesperson visits to attending physicians. MAIN OUTCOMES AND MEASURES The monthly within-drug class market share of prescriptions written by an individual physician for detailed and nondetailed drugs in 8 drug classes (lipid-lowering drugs, gastroesophageal reflux disease drugs, diabetes drugs, antihypertensive drugs, hypnotic drugs approved for the treatment of insomnia [sleep aids], attention-deficit/hyperactivity disorder drugs, antidepressant drugs, and antipsychotic drugs) comparing the 10- to 36-month period before implementation of the detailing policies with the 12- to 36-month period after implementation, depending on data availability. RESULTS The analysis included 16 121 483 prescriptions written between January 2006 and June 2012 by 2126 attending physicians at the 19 intervention group AMCs and by 24 593 matched control group physicians. The sample mean market share at the physician-drug-month level for detailed and nondetailed drugs prior to enactment of policies was 19.3% and 14.2%, respectively. Exposure to an AMC detailing policywas associated with a decrease in the market share of detailed drugs of 1.67 percentage points (95% CI, -2.18 to -1.18 percentage points; P<.001) and an increase in the market share of nondetailed drugs of 0.84 percentage points (95% CI, 0.54 to 1.14 percentage points; P<.001). Associations were statistically significant for 6 of 8 study drug classes for detailed drugs (lipid-lowering drugs, gastroesophageal reflux disease drugs, antihypertensive drugs, sleep aids, attention-deficit/hyperactivity disorder drugs, and antidepressant drugs) and for 9 of the 19 AMCs that implemented policies. Eleven of the 19 AMCs regulated salesperson gifts to physicians, restricted salesperson access to facilities, and incorporated explicit enforcement mechanisms. For 8 of these 11 AMCs, there was a significant change in prescribing. In contrast, there was a significant change at only 1 of 8 AMCs that did not enact policies in all 3 areas. CONCLUSIONS AND RELEVANCE Implementation of policies at AMCs that restricted pharmaceutical detailing between 2006 and 2012 was associated with modest but significant reductions in prescribing of detailed drugs across 6 of 8 major drug classes; however, changes were not seen in all of the AMCs that enacted policies.	[Larkin, Ian] Univ Calif Los Angeles, Los Angeles, CA USA; [Ang, Desmond] Univ Calif San Diego, San Diego, CA 92103 USA; [Steinhart, Jonathan] Austrian Inst Technol, Seibersdorf, Austria; [Steinhart, Jonathan] Johannes Kepler Univ Linz, Linz, Austria; [Chao, Matthew] Williams Coll, Williamstown, MA 01267 USA; [Patterson, Mark; Loewenstein, George] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Sah, Sunita] Cornell Univ, Ithaca, NY USA; [Wu, Tina] NYU, Langone Sch Med, New York, NY USA; [Schoenbaum, Michael] NIMH, Bethesda, MD 20892 USA; [Hutchins, David; Brennan, Troyen] CVS Caremark, Woonsocket, RI USA	University of California System; University of California Los Angeles; University of California System; University of California San Diego; Austrian Institute of Technology (AIT); Johannes Kepler University Linz; Williams College; Carnegie Mellon University; Cornell University; New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Larkin, I (corresponding author), Univ Calif Los Angeles, Anderson Sch Management, 110 Westwood Plaza, Los Angeles, CA 90095 USA.	ian.larkin@anderson.ucla.edu	Schoenbaum, Michael/GRR-3988-2022; Loewenstein, George/G-7616-2014; Sah, Sunita/J-4613-2014	Loewenstein, George/0000-0003-2790-0474; Wu, Tina/0000-0003-4902-2916; Sah, Sunita/0000-0003-1671-4414; Chao, Matthew/0000-0002-4757-2001	Division of Research and Faculty Development at Harvard Business School; National Science Foundation; National Institute of Mental Health	Division of Research and Faculty Development at Harvard Business School; National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Licenses for some of the data used in the study were purchased by Dr Larkin with support from the Division of Research and Faculty Development at Harvard Business School. Mr Ang and Dr Chao were supported by the National Science Foundation. This study was supported by a contract from the National Institute of Mental Health awarded to Dr Loewenstein and by the provision of data and assistance from CVS Caremark.	American Board of Medical Specialties, ACCR MED SCH US CAN; American Medical Student Association, AM MED STUD ASS SCOR; Anderson TS, 2015, MED CARE, V53, P338, DOI 10.1097/MLR.0000000000000329; [Anonymous], OR BOOK DAT FIL; Chressanthis GA, 2012, J CLIN HYPERTENS, V14, P435, DOI 10.1111/j.1751-7176.2012.00651.x; DeJong C, 2016, JAMA INTERN MED, V176, P1114, DOI 10.1001/jamainternmed.2016.2765; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Drugs.com, TOP 200 DRUGS 2010 S; Epstein AJ, 2013, MED CARE, V51, P199, DOI 10.1097/MLR.0b013e318277eb19; Essick C, 2013, BMJ-BRIT MED J, V346, pf264; Generic Pharmaceutical Association, 2011, EC AN GEN DRUG US US; Henry J. Kaiser Family Foundation, TOTAL NUMBER RETAIL; Institute on Medicine as a Profession, CONFL INT POL DAT; Larkin I, 2014, HEALTH AFFAIR, V33, P1014, DOI 10.1377/hlthaff.2013.0939; Perlis RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155474; PhRMA, 2002, 2002 PHRMA COD INT H; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinbrook R, 2006, NEW ENGL J MED, V354, P2745, DOI 10.1056/NEJMp068125; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709	21	52	52	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1785	1795		10.1001/jama.2017.4039	http://dx.doi.org/10.1001/jama.2017.4039			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464141	Green Published			2022-12-28	WOS:000400440700036
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Can't we take mental illness seriously without Prince Harry?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Barr B, 2016, J EPIDEMIOL COMMUN H, V70, P339, DOI 10.1136/jech-2015-206209; Brogan S., 2015, ROYAL TOUCH EARLY MO; Gentleman A., 2013, GUARDIAN; Wessely S., 2017, DAILY TELEGRAPH	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2017	357								j2078	10.1136/bmj.j2078	http://dx.doi.org/10.1136/bmj.j2078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU2WB	28465422	Green Published, Bronze			2022-12-28	WOS:000400889500007
J	Hida, T; Nokihara, H; Kondo, M; Kim, YH; Azuma, K; Seto, T; Takiguchi, Y; Nishio, M; Yoshioka, H; Imamura, F; Hotta, K; Watanabe, S; Goto, K; Satouchi, M; Kozuki, T; Shukuya, T; Nakagawa, K; Mitsudomi, T; Yamamoto, N; Asakawa, T; Asabe, R; Tanaka, T; Tamura, T				Hida, Toyoaki; Nokihara, Hiroshi; Kondo, Masashi; Kim, Young Hak; Azuma, Koichi; Seto, Takashi; Takiguchi, Yuichi; Nishio, Makoto; Yoshioka, Hiroshige; Imamura, Fumio; Hotta, Katsuyuki; Watanabe, Satoshi; Goto, Koichi; Satouchi, Miyako; Kozuki, Toshiyuki; Shukuya, Takehito; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Yamamoto, Nobuyuki; Asakawa, Takashi; Asabe, Ryoichi; Tanaka, Tomohiro; Tamura, Tomohide			Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial	LANCET			English	Article							ANAPLASTIC LYMPHOMA KINASE; ADVANCED NSCLC; CHEMOTHERAPY; INHIBITORS; CH5424802; AF-001JP; SAFETY	Background Alectinib, a potent, highly selective, CNS-active inhibitor of anaplastic lymphoma kinase (ALK), showed promising efficacy and tolerability in the single-arm phase 1/2 AF-001JP trial in Japanese patients with ALK-positive non-small-cell lung cancer. Given those promising results, we did a phase 3 trial to directly compare the efficacy and safety of alectinib and crizotinib. Methods J-ALEX was a randomised, open-label, phase 3 trial that recruited ALK inhibitor-naive Japanese patients with ALK-positive non-small-cell lung cancer, who were chemotherapy-naive or had received one previous chemotherapy regimen, from 41 study sites in Japan. Patients were randomly assigned (1: 1) via an interactive web response system using a permuted-block method stratified by Eastern Cooperative Oncology Group performance status, treatment line, and disease stage to receive oral alectinib 300 mg twice daily or crizotinib 250 mg twice daily until progressive disease, unacceptable toxicity, death, or withdrawal. The primary endpoint was progression-free survival assessed by an independent review facility. The efficacy analysis was done in the intention-to-treat population, and safety analyses were done in all patients who received at least one dose of the study drug. The study is ongoing and patient recruitment is closed. This study is registered with the Japan Pharmaceutical Information Center (number JapicCTI-132316). Findings Between Nov 18, 2013, and Aug 4, 2015, 207 patients were recruited and assigned to the alectinib (n=103) or crizotinib (n=104) groups. At data cutoff for the second interim analysis, 24 patients in the alectinib group had discontinued treatment compared with 61 in the crizotinib group, mostly due to lack of efficacy or adverse events. At the second interim analysis (data cutoff date Dec 3, 2015), an independent data monitoring committee determined that the primary endpoint of the study had been met (hazard ratio 0.34 [99.7% CI 0.17-0.71], stratified log-rank p< 0.0001) and recommended an immediate release of the data. Median progression-free survival had not yet been reached with alectinib (95% CI 20.3-not estimated) and was 10.2 months (8.2-12.0) with crizotinib. Grade 3 or 4 adverse events occurred at a greater frequency with crizotinib (54 [52%] of 104) than alectinib (27 [26%] of 103). Dose interruptions due to adverse events were also more prevalent with crizotinib (77 [74%] of 104) than with alectinib (30 [29%] of 103), and more patients receiving crizotinib (21 [20%]) than alectinib (nine [9%]) discontinued the study drug because of an adverse event. No adverse events with a fatal outcome occurred in either treatment group. Interpretation These results provide the first head-to-head comparison of alectinib and crizotinib and have the potential to change the standard of care for the first-line treatment of ALK-positive non-small-cell lung cancer. The dose of alectinib (300 mg twice daily) used in this study is lower than the approved dose in countries other than Japan; however, this limitation is being addressed in the ongoing ALEX study.	[Hida, Toyoaki] Aichi Canc Ctr, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Nokihara, Hiroshi] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan; [Kondo, Masashi] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan; [Kim, Young Hak] Kyoto Univ, Dept Resp Med, Kyoto, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Inst Div Respirol Neurol & Rheumatol, Kurume, Fukuoka, Japan; [Seto, Takashi] Natl Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan; [Nishio, Makoto] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan; [Yoshioka, Hiroshige] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Oncol, Osaka, Japan; [Hotta, Katsuyuki] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Watanabe, Satoshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, Niigata, Japan; [Goto, Koichi] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Satouchi, Miyako] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan; [Kozuki, Toshiyuki] Shikoku Canc Ctr, Dept Thorac Oncol & Med, Matsuyama, Ehime, Japan; [Shukuya, Takehito] Juntendo Univ, Dept Resp Med, Tokyo, Japan; [Nakagawa, Kazuhiko] Kindai Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Mitsudomi, Tetsuya] Kindai Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan; [Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan; [Asakawa, Takashi; Tanaka, Tomohiro] Chugai Pharmaceut, Clin Sci & Strategy Dept, Tokyo, Japan; [Asabe, Ryoichi] Chugai Pharmaceut, Clin Study Management Dept, Tokyo, Japan; [Tamura, Tomohide] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan	Aichi Cancer Center; National Cancer Center - Japan; Nagoya University; Kyoto University; Kurume University; Kyushu Cancer Center; Chiba University; Japanese Foundation for Cancer Research; Kurashiki Central Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases; Okayama University; Niigata University; National Cancer Center - Japan; Hyogo Cancer Center; Juntendo University; Kindai University (Kinki University); Kindai University (Kinki University); Wakayama Medical University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Roche Holding; St. Luke's International Hospital	Tamura, T (corresponding author), St Lukes Int Hosp, Thorac Ctr, Chuo Ku, Tokyo 1048560, Japan.	tamuratomohide@gmail.com			Chugai Pharmaceutical	Chugai Pharmaceutical	We thank the participants of the study and their families; investigators and study teams; Masahiro Fukuoka, Satoshi Oizumi, Seiichiro Yamamoto, and members of the independent data monitoring committee for their role in this trial; LSI Medience, SRL, Micron, and Bell Medical Solutions for their role in the undertaking of this study; Hiroshi Kuriki of Chugai Pharmaceutical for his substantial contribution to data analysis and interpretation; and Ali Zeaiter for his contribution to the design and data interpretation of the study. Third-party medical writing assistance, under the direction of the authors, was provided by Louise Clarke and Fiona Fernando of Gardiner-Caldwell Communications, and was funded by Chugai Pharmaceutical.	Costa DB, 2011, J CLIN ONCOL, V29, pE443, DOI 10.1200/JCO.2010.34.1313; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; European Medicines Agency, CRIZ EU PRESCR INF; Freidlin B, 2009, CLIN TRIALS, V6, P119, DOI 10.1177/1740774509102310; Gadgeel SM, 2014, LANCET ONCOL, V15, P1119, DOI 10.1016/S1470-2045(14)70362-6; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Harada M, 2014, JAPAN J LUNG CANC, P54; International Association for the Study of Lung Cancer, 2013, IASLC ATL ALK TEST L; Kinoshita K, 2012, BIOORGAN MED CHEM, V20, P1271, DOI 10.1016/j.bmc.2011.12.021; Kodama T, 2014, CANCER LETT, V351, P215, DOI 10.1016/j.canlet.2014.05.020; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Okamoto I, 2015, ANN ONCOL, V26, P37; Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443; Pharmaceuticals and Medical Devices Agency, 2012, REP DEL RES; Pharmaceuticals and Medical Devices Agency, 2014, REP DEL RES; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2016, J CLIN ONCOL, V34, P2858, DOI 10.1200/JCO.2015.63.5888; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Takamochi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069794; Takeuchi K, 2016, ANN ONCOL, V27, P185, DOI 10.1093/annonc/mdv501; Takezawa K, 2011, CLIN CANCER RES, V17, P2140, DOI 10.1158/1078-0432.CCR-10-2798; US Food and Drug Administration, 2014, CRIZ US PRESCR INF; Yuan DM, 2015, TUMOR BIOL, V36, P9031, DOI 10.1007/s13277-015-3657-y	28	543	578	1	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					29	39		10.1016/S0140-6736(17)30565-2	http://dx.doi.org/10.1016/S0140-6736(17)30565-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ0LK	28501140				2022-12-28	WOS:000404396300025
J	Sivaprasad, S; Prevost, AT; Vasconcelos, JC; Riddell, A; Murphy, C; Kelly, J; Bainbridge, J; Tudor-Edwards, R; Hopkins, D; Hykin, P				Sivaprasad, Sobha; Prevost, A. Toby; Vasconcelos, Joana C.; Riddell, Amy; Murphy, Caroline; Kelly, Joanna; Bainbridge, James; Tudor-Edwards, Rhiannon; Hopkins, David; Hykin, Philip		CLARITY Study Grp	Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial	LANCET			English	Article							LASER; RANIBIZUMAB	Background Proliferative diabetic retinopathy is the most common cause of severe sight impairment in people with diabetes. Proliferative diabetic retinopathy has been managed by panretinal laser photocoagulation (PRP) for the past 40 years. We report the 1 year safety and efficacy of intravitreal aflibercept. Methods In this phase 2b, single-blind, non-inferiority trial (CLARITY), adults (aged >= 18 years) with type 1 or 2 diabetes and previously untreated or post-laser treated active proliferative diabetic retinopathy were recruited from 22 UK ophthalmic centres. Patients were randomly assigned (1: 1) to repeated intravitreal aflibercept (2 mg/0.05 mL at baseline, 4 weeks, and 8 weeks, and from week 12 patients were reviewed every 4 weeks and aflibercept injections were given as needed) or PRP standard care (single spot or mutlispot laser at baseline, fractionated fortnightly thereafter, and from week 12 patients were assessed every 8 weeks and treated with PRP as needed) for 52 weeks. Randomisation was by minimisation with a web-based computer generated system. Primary outcome assessors were masked optometrists. The treating ophthalmologists and participants were not masked. The primary outcome was defined as a change in best-corrected visual acuity at 52 weeks with a linear mixed-effect model that estimated adjusted treatment effects at both 12 weeks and 52 weeks, having excluded fluctuations in best corrected visual acuity owing to vitreous haemorrhage. This modified intention-to-treat analysis was reapplied to the per protocol participants. The non-inferiority margin was prespecified as -5 Early Treatment Diabetic Retinopathy Study letters. Safety was assessed in all participants. This trial is registered with ISRCTN registry, number 32207582. Findings We recruited 232 participants (116 per group) between Aug 22, 2014 and Nov 30, 2015. 221 participants (112 in aflibercept group, 109 in PRP group) contributed to the modified intention-to-treat model, and 210 participants (104 in aflibercept group and 106 in PRP group) within per protocol. Aflibercept was non-inferior and superior to PRP in both the modified intention-to-treat population (mean best corrected visual acuity difference 3.9 letters [95% CI 2.3-5.6], p<0.0001) and the per-protocol population (4.0 letters [2.4-5.7], p<0.0001). There were no safety concerns. The 95% CI adjusted difference between groups was more than the prespecified acceptable margin of -5 letters at both 12 weeks and 52 weeks. Interpretation Patients with proliferative diabetic retinopathy who were treated with intravitreal aflibercept had an improved outcome at 1 year compared with those treated with PRP standard care. Funding The Efficacy and Mechanism Evaluation Programme, a Medical Research Council and National Institute for Health Research partnership.	[Sivaprasad, Sobha; Hykin, Philip] Moorfields Biomed Res Ctr, Natl Inst Hlth Res, London EC1V 2PD, England; [Prevost, A. Toby; Vasconcelos, Joana C.] Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London, England; [Riddell, Amy; Murphy, Caroline; Kelly, Joanna] Kings Coll London, Kings Hlth Partners, Kings Clin Trials Unit, London, England; [Bainbridge, James] UCL, Inst Ophthalmol, London, England; [Tudor-Edwards, Rhiannon] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales; [Hopkins, David] Kings Coll Hosp NHS Fdn Trust, Dept Diabet & Endocrinol, London, England	Imperial College London; University of London; King's College London; University of London; University College London; Bangor University; King's College Hospital NHS Foundation Trust	Sivaprasad, S (corresponding author), Moorfields Biomed Res Ctr, Natl Inst Hlth Res, London EC1V 2PD, England.	Sobha.sivaprasad@moorfields.nhs.uk	Hopkins, David/AAP-4541-2020; Sivaprasad, S./D-6876-2015	Hopkins, David/0000-0002-0451-0900; Sivaprasad, S./0000-0001-8952-0659; Lotery, Andrew/0000-0001-5541-4305; Bainbridge, James/0000-0003-1318-8201; Chakravarthy, Usha/0000-0002-2606-3734; Talks, James/0000-0001-6126-6476; Amoaku, Winfried/0000-0001-5028-7984; Prevost, A. Toby/0000-0003-1723-0796; Burton, Ben/0000-0001-9579-9078; Nicholson, Luke/0000-0001-6685-4402	Efficacy and Mechanism Evaluation Programme; Medical Research Council; National Institute for Health Research; National Institute for Health Research [NIHR-RP-011-003] Funding Source: researchfish	Efficacy and Mechanism Evaluation Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Efficacy and Mechanism Evaluation Programme, a Medical Research Council and National Institute for Health Research partnership.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Brown DM, 2015, OPHTHALMOLOGY, V122, P2044, DOI 10.1016/j.ophtha.2015.06.017; Brucker AJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P132, DOI 10.1001/archophthalmol.2008.565; Driver and Vehicle Licensing Agency, VIS DIS ASS FITN DRI; FLYNN HW, 1992, OPHTHALMOLOGY, V99, P1351; Gonzalez VH, 2009, BRIT J OPHTHALMOL, V93, P1474, DOI 10.1136/bjo.2008.155663; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Kanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17946; Muqit MMK, 2010, EYE, V24, P1136, DOI 10.1038/eye.2009.308; Muqit MMK, 2013, BRIT J OPHTHALMOL, V97, P220, DOI 10.1136/bjophthalmol-2012-302189; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Preti RC, 2013, BRIT J OPHTHALMOL, V97, P885, DOI 10.1136/bjophthalmol-2012-302675; Simunovic MP, 2015, RETINA-J RET VIT DIS, V35, P1931, DOI 10.1097/IAE.0000000000000723; Sivaprasad S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008405; Subash M, 2016, JAMA OPHTHALMOL, V134, P666, DOI 10.1001/jamaophthalmol.2016.0629; Weidle UH, 2012, CANCER GENOM PROTEOM, V9, P357; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; White IR, 2012, CLIN TRIALS, V939, P6	23	182	186	2	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2017	389	10085					2193	2203		10.1016/S0140-6736(17)31193-5	http://dx.doi.org/10.1016/S0140-6736(17)31193-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW5JC	28494920	Green Submitted, Bronze			2022-12-28	WOS:000402540800027
J	Philip, M; Fairchild, L; Sun, L; Horste, EL; Amara, SC; Shakiba, M; Scott, AC; Viale, A; Lauer, P; Erghoub, TM; Hellmann, MD; Wolchok, JD; Leslie, CS; Schietinger, A				Philip, Mary; Fairchild, Lauren; Sun, Liping; Horste, Ellen L.; Amara, Steven C.; Shakiba, Mojdeh; Scott, Andrew C. .; Viale, Agnes; Lauer, Peter; Erghoub, Taha M.; Hellmann, Matthew D.; Wolchok, Jedd D.; Leslie, Christina S.; Schietinger, Andrea			Chromatin states define tumour-specific T cell dysfunction and reprogramming	NATURE			English	Article							DIFFERENTIAL EXPRESSION; TRANSCRIPTIONAL CONTROL; CANCER; EFFECTOR; LANDSCAPE; PROTEINS; BLOCKADE; ANTIGEN; BIAS	Tumour-specific CD8 T cells in solid tumours are dysfunctional, allowing tumours to progress. The epigenetic regulation of T cell dysfunction and therapeutic reprogrammability (for example, to immune checkpoint blockade) is not well understood. Here we show that T cells in mouse tumours differentiate through two discrete chromatin states: a plastic dysfunctional state from which T cells can be rescued, and a fixed dysfunctional state in which the cells are resistant to reprogramming. We identified surface markers associated with each chromatin state that distinguished reprogrammable from non-reprogrammable PD1(hi) dysfunctional T cells within heterogeneous T cell populations from tumours in mice; these surface markers were also expressed on human PD1(hi) tumour-infiltrating CD8 T cells. Our study has important implications for cancer immunotherapy as we define key transcription factors and epigenetic programs underlying T cell dysfunction and surface markers that predict therapeutic reprogrammability.	[Philip, Mary; Horste, Ellen L.; Amara, Steven C.; Shakiba, Mojdeh; Scott, Andrew C. .; Schietinger, Andrea] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Fairchild, Lauren; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Philip, Mary] Weill Cornell Med Coll, Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [Sun, Liping; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, Integrated Genom Operat, New York, NY 10065 USA; [Shakiba, Mojdeh; Scott, Andrew C. .; Erghoub, Taha M.; Hellmann, Matthew D.; Wolchok, Jedd D.; Schietinger, Andrea] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA; [Lauer, Peter] Aduro Biotech Inc, Berkeley, CA 94720 USA; [Erghoub, Taha M.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Melanoma & Immunotherapeut Serv, New York, NY 10065 USA; [Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Schietinger, A (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.; Schietinger, A (corresponding author), Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA.	schietia@mskcc.org		Scott, Andrew/0000-0002-3090-9704	NIH-NCI grants [R00 CA172371, K08 CA158069, U54 CA209975]; NHGRI [U01 HG007893]; V Foundation for Cancer Research; William and Ella Owens Medical Research Foundation; Josie Robertson Young Investigator Award; MSKCC Core Grant [P30 CA008748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NATIONAL CANCER INSTITUTE [P30CA008748, K08CA158069, U54CA209975, R00CA172371] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER	NIH-NCI grants; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); V Foundation for Cancer Research; William and Ella Owens Medical Research Foundation; Josie Robertson Young Investigator Award; MSKCC Core Grant; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. van der Veeken, V. Krisnawan, Y. Pritykin, and B. Gasmi for discussions and technical support; S. Reiner for discussions; and the MSKCC Flow Cytometry Core and Animal Facility. T.M., M.H., J.D.W., and A.S. are members of the Parker Institute for Cancer Immunotherapy. This work was supported by NIH-NCI grants R00 CA172371 (to A.S.), K08 CA158069 (to M.P.), and U54 CA209975 (to C.S.L. and A.S.), NHGRI grant U01 HG007893 (to C.S.L.), V Foundation for Cancer Research (to A.S.), the William and Ella Owens Medical Research Foundation (to A.S.), the Josie Robertson Young Investigator Award (to A.S.), and the MSKCC Core Grant P30 CA008748. The Integrated Genomics Operation Core was supported by Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; Denas O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1245-6; Denton AE, 2011, P NATL ACAD SCI USA, V108, P15306, DOI 10.1073/pnas.1112520108; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HELLSTROM I, 1968, NATURE, V220, P1352, DOI 10.1038/2201352a0; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kelderman S, 2014, MOL ONCOL, V8, P1132, DOI 10.1016/j.molonc.2014.07.011; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li YF, 2010, J IMMUNOL, V184, P452, DOI 10.4049/jimmunol.0901101; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stahl S, 2009, IMMUNOL LETT, V123, P31, DOI 10.1016/j.imlet.2009.01.011; Staveley-O'Carroll K, 2003, J IMMUNOL, V171, P697, DOI 10.4049/jimmunol.171.2.697; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Waugh KA, 2016, J IMMUNOL, V197, P1477, DOI 10.4049/jimmunol.1600589; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zigler CM, 2011, ANN APPL STAT, V5, P1876, DOI 10.1214/11-AOAS477	50	430	436	7	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					452	+		10.1038/nature22367	http://dx.doi.org/10.1038/nature22367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28514453	Green Accepted			2022-12-28	WOS:000401906500046
J	Flock, T; Hauser, AS; Lund, N; Gloriam, DE; Balaji, S; Babu, MM				Flock, Tilman; Hauser, Alexander S.; Lund, Nadia; Gloriam, David E.; Balaji, Santhanam; Babu, M. Madan			Selectivity determinants of GPCR-G-protein binding	NATURE			English	Article							COUPLED RECEPTORS; BIOLOGICAL NETWORKS; SIGNALING SYSTEM; IUPHAR/BPS GUIDE; SEQUENCE; REPERTOIRE; ACTIVATION; FAMILIES; TREES; CONSERVATION	The selective coupling of G-protein-coupled receptors (GPCRs) to specific G proteins is critical to trigger the appropriate physiological response. However, the determinants of selective binding have remained elusive. Here we reveal the existence of a selectivity barcode (that is, patterns of amino acids) on each of the 16 human G proteins that is recognized by distinct regions on the approximately 800 human receptors. Although universally conserved positions in the barcode allow the receptors to bind and activate G proteins in a similar manner, different receptors recognize the unique positions of the G-protein barcode through distinct residues, like multiple keys (receptors) opening the same lock (G protein) using non-identical cuts. Considering the evolutionary history of GPCRs allows the identification of these selectivity-determining residues. These findings lay the foundation for understanding the molecular basis of coupling selectivity within individual receptors and G proteins.	[Flock, Tilman; Balaji, Santhanam; Babu, M. Madan] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Flock, Tilman] Fitzwilliam Coll, Cambridge CB3 0DG, England; [Hauser, Alexander S.; Lund, Nadia; Gloriam, David E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark	MRC Laboratory Molecular Biology; University of Cambridge; University of Copenhagen	Flock, T; Babu, MM (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Flock, T (corresponding author), Fitzwilliam Coll, Cambridge CB3 0DG, England.	tf284@cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Hauser, Alexander/AAV-3436-2020; Gloriam, David E./A-1904-2011; Mohan, Babu P./I-7362-2019	Hauser, Alexander/0000-0003-1098-6419; Gloriam, David E./0000-0002-4299-7561; /0000-0003-3398-0968	Medical Research Council [MC_U105185859]; Boehringer Ingelheim Fond; European Research Council [DE-ORPHAN 639125]; Lundbeck Foundation [R163-2013-16327]; European Research Council; MRC [MC_U105185859] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fond(Boehringer Ingelheim); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank U. F. Lang, D. Veprintsev, C. Ravarani, H. Harbrecht, G. De Baets, D. Prado, X. Deupi, C. G. Tate and N. S. Latysheva for their comments on this work, and J. Westmoreland for assistance with Fig. 6. We thank S. Chavali and B. Lang for help with compiling mutation and expression data. We thank M. Mounir and C. Munk for help with the GPCRdb web service. This work was supported by the Medical Research Council (MC_U105185859; M.M.B., T.F., S.B.), the Boehringer Ingelheim Fond (T.F.), European Research Council (DE-ORPHAN 639125; D.E.G., A.S.H., N.L.) and the Lundbeck Foundation (R163-2013-16327; D.E.G.). T.F. is a Research Fellow of Fitzwilliam College, University of Cambridge, UK. M.M.B. is a Lister Institute Research Prize Fellow and is supported by a European Research Council Consolidator Grant.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Anantharaman V, 2011, GENE, V475, P63, DOI 10.1016/j.gene.2010.12.001; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Mendoza A, 2014, GENOME BIOL EVOL, V6, P606, DOI 10.1093/gbe/evu038; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Furness SGB, 2016, CELL, V167, P739, DOI 10.1016/j.cell.2016.09.021; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Komatsuzaki K, 1997, FEBS LETT, V406, P165, DOI 10.1016/S0014-5793(97)00257-3; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krishnan A, 2015, MOL PHYLOGENET EVOL, V91, P27, DOI 10.1016/j.ympev.2015.05.009; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li FX, 2004, J PHARMACOL EXP THER, V308, P1111, DOI 10.1124/jpet.103.060145; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Mirny LA, 2002, GENOME BIOL, V3; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Rose AS, 2014, J AM CHEM SOC, V136, P11244, DOI 10.1021/ja5055109; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; RUAT M, 1993, BIOCHEM BIOPH RES CO, V193, P268, DOI 10.1006/bbrc.1993.1619; Sasamura H, 2000, MOL CELL ENDOCRINOL, V170, P113, DOI 10.1016/S0303-7207(00)00333-6; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-217; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Sun DW, 2015, NAT STRUCT MOL BIOL, V22, P686, DOI 10.1038/nsmb.3070; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wichard JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016811; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Wuster A, 2010, BIOINFORMATICS, V26, P2906, DOI 10.1093/bioinformatics/btq552	61	203	206	6	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					317	+		10.1038/nature22070	http://dx.doi.org/10.1038/nature22070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489817	Green Accepted			2022-12-28	WOS:000401466500056
J	Tang, AT; Hoi, JPC; Kotzin, JJ; Yang, YQ; Hong, CC; Hobson, N; Girard, R; Zeineddine, HA; Lightle, R; Moore, T; Cao, Y; Shenkar, R; Chen, M; Mericko, P; Yang, JS; Li, L; Tanes, C; Kobuley, D; Vosa, U; Whitehead, KJ; Li, DY; Franke, L; Hart, B; Schwaninger, M; Henao-Mejia, J; Morrison, L; Kim, H; Awad, IA; Zheng, XJ; Kahn, ML				Tang, Alan T.; Hoi, Jaesung P. C.; Kotzin, Jonathan J.; Yang, Yiqing; Hong, Courtney C.; Hobson, Nicholas; Girard, Romuald; Zeineddine, Hussein A.; Lightle, Rhonda; Moore, Thomas; Cao, Ying; Shenkar, Robert; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Li, Li; Tanes, Ceylan; Kobuley, Dmytro; Vosa, Urmo; Whitehead, Kevin J.; Li, Dean Y.; Franke, Lude; Hart, Blaine; Schwaninger, Markus; Henao-Mejia, Jorge; Morrison, Leslie; Kim, Helen; Awad, Issam A.; Zheng, Xiangjian; Kahn, Mark L.			Endothelial TLR4 and the microbiome drive cerebral cavernous malformations	NATURE			English	Article							LPS; RECEPTOR; ANGIOGENESIS; BACTERIA; LIPOPOLYSACCHARIDE; INTERFACE; STABILITY; INSIGHTS; GENES; HOST	Cerebral cavernous malformations (CCMs) are a cause of stroke and seizure for which no effective medical therapies yet exist. CCMs arise from the loss of an adaptor complex that negatively regulates MEKK3-KLF2/4 signalling in brain endothelial cells, but upstream activators of this disease pathway have yet to be identified. Here we identify endothelial Toll-like receptor 4 (TLR4) and the gut microbiome as critical stimulants of CCM formation. Activation of TLR4 by Gram-negative bacteria or lipopolysaccharide accelerates CCM formation, and genetic or pharmacologic blockade of TLR4 signalling prevents CCM formation in mice. Polymorphisms that increase expression of the TLR4 gene or the gene encoding its co-receptor CD14 are associated with higher CCM lesion burden in humans. Germ-free mice are protected from CCM formation, and a single course of antibiotics permanently alters CCM susceptibility in mice. These studies identify unexpected roles for the microbiome and innate immune signalling in the pathogenesis of a cerebrovascular disease, as well as strategies for its treatment.	[Tang, Alan T.; Yang, Yiqing; Hong, Courtney C.; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Li, Li; Kahn, Mark L.] Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Tang, Alan T.; Yang, Yiqing; Hong, Courtney C.; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Li, Li; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Hoi, Jaesung P. C.; Zheng, Xiangjian] Centenary Inst, Lab Cardiovasc Signaling, Sydney, NSW 2050, Australia; [Kotzin, Jonathan J.; Henao-Mejia, Jorge] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kotzin, Jonathan J.; Kobuley, Dmytro; Henao-Mejia, Jorge] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Hobson, Nicholas; Girard, Romuald; Zeineddine, Hussein A.; Lightle, Rhonda; Moore, Thomas; Cao, Ying; Shenkar, Robert; Awad, Issam A.] Univ Chicago, Dept Surg, Sch Med & Biol Sci, Neurovasc Surg Program, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Tanes, Ceylan] Childrens Hosp Philadelphia, CHOP Microbiome Ctr, Philadelphia, PA 19104 USA; [Kobuley, Dmytro] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Vosa, Urmo; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Whitehead, Kevin J.; Li, Dean Y.] Univ Utah, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Whitehead, Kevin J.; Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA; [Hart, Blaine; Morrison, Leslie] Univ New Mexico, Dept Neurol & Pediat, Albuquerque, NM 87131 USA; [Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, D-23562 Lubeck, Germany; [Henao-Mejia, Jorge] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Kim, Helen] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Zheng, Xiangjian] Univ Sydney, Sydney Med Sch, Fac Med, Sydney, NSW 2050, Australia; [Zheng, Xiangjian] Tianjian Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin, Peoples R China	University of Pennsylvania; University of Pennsylvania; University of Sydney; Centenary Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Chicago; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Groningen; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of New Mexico; University of Lubeck; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Francisco; University of Sydney; Tianjin Medical University	Kahn, ML (corresponding author), Univ Penn, Dept Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Kahn, ML (corresponding author), Univ Penn, Cardiovasc Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	markkahn@mail.med.upenn.edu	Shenkar, Robert/AAC-7065-2020; Võsa, Urmo/AAJ-5928-2020; Franke, Lude/P-7036-2016	Võsa, Urmo/0000-0003-3476-1652; Hong, Courtney/0000-0003-0515-6816; Kim, Helen/0000-0002-1937-354X; Franke, Lude/0000-0002-5159-8802; Choi, Jaesung Peter/0000-0002-0135-8632; Girard, Romuald/0000-0002-5893-9315; Schwaninger, Markus/0000-0002-4510-9718	National Institute of Health [R01HL094326, P01NS092521, R01NS075168, T32HL07439, F30NS100252, T32DK007780]; DFG [SCHWD-416/5-2, U54NS065705]; Penn-CHOP Microbiome Pilot & Feasibility Award Grant; Australian NHMRC [161558]; FOGARTY INTERNATIONAL CENTER [F06TW002300] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102138, T32HL007439, R01HL094326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI128060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780, P30DK019525, R21DK111755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS092521, F30NS100252, U54NS065705, R01NS100949, R01NS075168] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Penn-CHOP Microbiome Pilot & Feasibility Award Grant; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Goddard, other laboratory members, and K. Szigety for their comments during this work. We appreciate the guidance of our colleagues: G. Wu, R. Bushman, and Y. Choi. We acknowledge valuable technical assistance with B. fragilis culture from O. Jensen and J. Zhu; 16S sequencing and analysis by D. Kim, L. Mattei, and K. Bittinger from the PennCHOP Microbiome Core; germ-free mouse husbandry from K. Rickershauser and the Penn Gnotobiotic Mouse Facility; KRIT1 Q455X screening and Affymetrix genotyping of human samples from D. Guo and L. Pawlikowska; MRI images from M. Bartlett; patient data analysis from J. Nelson; data sorting from Y. Tang; artwork from L. Guo. We thank A. Ackers and Angioma Alliance for patient enrollment. These studies were supported by National Institute of Health grants R01HL094326 (M.L K.), P01NS092521 (M.L.K. and I.A.A.), R01NS075168 (K.J.W.), T32HL07439 (A.T.T.), F30NS100252 (A.T.T.), T32DK007780 (J.K.), DFG grant SCHWD-416/5-2 (M.S.), U54NS065705 (H.K., L.M., B.H.), a Penn-CHOP Microbiome Pilot & Feasibility Award Grant (M.L.K.), and Australian NHMRC project grant 161558 (X.Z.).	Alcock D, 1990, Can J Nurs Res, V22, P7; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choquet H, 2014, CEREBROVASC DIS, V38, P440, DOI 10.1159/000369200; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Cullere X, 2015, P NATL ACAD SCI USA, V112, P14284, DOI 10.1073/pnas.1510495112; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Denier C, 2004, ANN NEUROL, V55, P213, DOI 10.1002/ana.10804; Denier C, 2006, ANN NEUROL, V60, P550, DOI 10.1002/ana.20947; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8937; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Girard R, 2016, J NEUROSCI METH, V271, P14, DOI 10.1016/j.jneumeth.2016.06.021; Hang J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-31; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Kalis C, 2003, EUR J IMMUNOL, V33, P798, DOI 10.1002/eji.200323431; Kibe R, 2007, MICROBIOL IMMUNOL, V51, P349, DOI 10.1111/j.1348-0421.2007.tb03916.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang XY, 2015, STRUCTURE, V23, P1087, DOI 10.1016/j.str.2015.04.003; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	65	168	177	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					305	+		10.1038/nature22075	http://dx.doi.org/10.1038/nature22075			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28489816	Green Submitted, Green Accepted			2022-12-28	WOS:000401466500054
J	Toschek, P				Toschek, Peter			Hans Dehmelt (1922-2017) OBITUARY	NATURE			English	Biographical-Item									[Toschek, Peter] Hamburg Univ, Phys, Hamburg, Germany	University of Hamburg	Toschek, P (corresponding author), Hamburg Univ, Phys, Hamburg, Germany.	ptoschek@physnet.uni-hamburg.de							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					290	290		10.1038/545290a	http://dx.doi.org/10.1038/545290a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV0WF	28516929	Bronze			2022-12-28	WOS:000401466500047
J	Gronvall, GK				Gronvall, Gigi Kwik			Biosecurity Dilemmas Dreaded Diseases, Ethical Responses, and the Health of Nations	SCIENCE			English	Book Review									[Gronvall, Gigi Kwik] Johns Hopkins Univ, Ctr Hlth Secur, Baltimore, MD 21218 USA	Johns Hopkins University	Gronvall, GK (corresponding author), Johns Hopkins Univ, Ctr Hlth Secur, Baltimore, MD 21218 USA.	ggronvall@jhu.edu						Enemark C., 2017, BIOSECURITY DILEMMAS; Zilinskas RA, 2012, NAT MED, V18, P850, DOI 10.1038/nm0612-850	2	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2017	356	6338					588	588		10.1126/science.aan1118	http://dx.doi.org/10.1126/science.aan1118			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EU4BQ	28495718				2022-12-28	WOS:000400975200025
J	Guo, ZCV; Inagaki, HK; Daie, K; Druckmann, S; Gerfen, CR; Svoboda, K				Guo, Zengcai V.; Inagaki, Hidehiko K.; Daie, Kayvon; Druckmann, Shaul; Gerfen, Charles R.; Svoboda, Karel			Maintenance of persistent activity in a frontal thalamocortical loop	NATURE			English	Article							BASAL GANGLIA; PREFRONTAL CORTEX; WORKING-MEMORY; MOTOR CORTEX; TRANSGENIC MICE; SINGLE NEURONS; THALAMUS; RAT; MOVEMENT; NUCLEUS	Persistent neural activity maintains information that connects past and future events. Models of persistent activity often invoke reverberations within local cortical circuits, but long-range circuits could also contribute. Neurons in the mouse anterior lateral motor cortex (ALM) have been shown to have selective persistent activity that instructs future actions. The ALM is connected bidirectionally with parts of the thalamus, including the ventral medial and ventral anterior-lateral nuclei. We recorded spikes from the ALM and thalamus during tactile discrimination with a delayed directional response. Here we show that, similar to ALM neurons, thalamic neurons exhibited selective persistent delay activity that predicted movement direction. Unilateral photoinhibition of delay activity in the ALM or thalamus produced contralesional neglect. Photoinhibition of the thalamus caused a short-latency and near-complete collapse of ALM activity. Similarly, photoinhibition of the ALM diminished thalamic activity. Our results show that the thalamus is a circuit hub in motor preparation and suggest that persistent activity requires reciprocal excitation across multiple brain areas.	[Guo, Zengcai V.; Inagaki, Hidehiko K.; Daie, Kayvon; Druckmann, Shaul; Svoboda, Karel] HHMI, Janelia Res Campus, Ashburn, VA 20147 USA; [Gerfen, Charles R.] NIMH, Lab Syst Neurosci, Bethesda, MD 20892 USA; [Guo, Zengcai V.] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Tsinghua University	Svoboda, K (corresponding author), HHMI, Janelia Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org		Inagaki, Hidehiko/0000-0003-4580-2763	Howard Hughes Medical Institute; Simons Collaboration on the Global Brain; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002497] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Collaboration on the Global Brain; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank N. Li, J. Yu, J. Goldberg, X.-J. Wang, A. Hantman, J. Phillips, G. Shepherd and N. Yamawaki for comments on the manuscript, L. Walendy, T. Pluntke and M. Inagaki for animal training, T. Harris, B. Barbarits, J. J. Jun and W.-L. Sun for help with silicon probe recordings and spike sorting, M. Economo for help with image processing and A. Hu for help with histology. This work was funded by the Howard Hughes Medical Institute. H.K.I. and K.D. are Helen Hay Whitney Foundation postdoctoral fellows. K.D. is supported by the Simons Collaboration on the Global Brain.	Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chen JD, 2015, SCIENCE, V350, P554, DOI 10.1126/science.aac6472; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; DICHIARA G, 1979, NEUROSCIENCE, V4, P1453, DOI 10.1016/0306-4522(79)90050-2; Duan CA, 2015, NEURON, V86, P1491, DOI 10.1016/j.neuron.2015.05.042; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Fried I, 2011, NEURON, V69, P548, DOI 10.1016/j.neuron.2010.11.045; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Giber K, 2015, NAT NEUROSCI, V18, P562, DOI 10.1038/nn.3951; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Goldberg JH, 2013, TRENDS NEUROSCI, V36, P695, DOI 10.1016/j.tins.2013.09.001; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gulcebi MI, 2012, BRAIN RES BULL, V87, P312, DOI 10.1016/j.brainresbull.2011.11.005; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; HERKENHAM M, 1979, J COMP NEUROL, V183, P487, DOI 10.1002/cne.901830304; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hunnicutt BJ, 2014, NAT NEUROSCI, V17, P1276, DOI 10.1038/nn.3780; ISSEROFF A, 1982, BRAIN RES, V232, P97, DOI 10.1016/0006-8993(82)90613-8; Krupa DJ, 1999, P NATL ACAD SCI USA, V96, P8200, DOI 10.1073/pnas.96.14.8200; Kuramoto E, 2015, CEREB CORTEX, V25, P221, DOI 10.1093/cercor/bht216; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Liu D, 2014, SCIENCE, V346, P458, DOI 10.1126/science.1256573; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Reinhold K, 2015, NAT NEUROSCI, V18, P1789, DOI 10.1038/nn.4153; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rossi MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071598; Saalmann YB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00083; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sherman SM, 2013, FUNCTIONAL CONNECTIO, DOI DOI 10.7551/MITPRESS/9780262019309.001.0001; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Tanaka M, 2007, J NEUROSCI, V27, P12109, DOI 10.1523/JNEUROSCI.1873-07.2007; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Teeters JL, 2015, NEURON, V88, P629, DOI 10.1016/j.neuron.2015.10.025; Tsuriel S, 2015, NAT METHODS, V12, P547, DOI 10.1038/nmeth.3367; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Viswanathan S, 2015, NAT METHODS, V12, P568, DOI 10.1038/nmeth.3365; Vue TY, 2009, J NEUROSCI, V29, P4484, DOI 10.1523/JNEUROSCI.0656-09.2009; Wan Y, 2009, IEEE T VIS COMPUT GR, V15, P1489, DOI 10.1109/TVCG.2009.118; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yu JN, 2016, NAT NEUROSCI, V19, P1647, DOI 10.1038/nn.4412; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	60	236	236	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					181	+		10.1038/nature22324	http://dx.doi.org/10.1038/nature22324			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467817	Green Accepted			2022-12-28	WOS:000400963800026
J	Ooi, JD; Petersen, J; Tan, YH; Huynh, M; Willett, ZJ; Ramarathinam, SH; Eggenhuizen, PJ; Loh, KL; Watson, KA; Gan, PY; Likhan, MAA; Dudek, NL; Handel, A; Hudson, BG; Fugger, L; Power, DA; Holt, SG; Coates, PT; Gregersen, JW; Purcell, AW; Holdsworth, SR; La Gruta, NL; Reid, HH; Rossjohn, J; Kitching, AR				Ooi, Joshua D.; Petersen, Jan; Tan, Yu H.; Huynh, Megan; Willett, Zoe J.; Ramarathinam, Sri H.; Eggenhuizen, Peter J.; Loh, Khai L.; Watson, Katherine A.; Gan, Poh Y.; Likhan, Maliha A. A.; Dudek, Nadine L.; Handel, Andreas; Hudson, Billy G.; Fugger, Lars; Power, David A.; Holt, Stephen G.; Coates, P. Toby; Gregersen, Jon W.; Purcell, Anthony W.; Holdsworth, Stephen R.; La Gruta, Nicole L.; Reid, Hugh H.; Rossjohn, Jamie; Kitching, A. Richard			Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells	NATURE			English	Article							GOODPASTURE AUTOANTIGEN; PEPTIDES; COLLAGEN; DISEASE; COMPLEX; BINDING; PROTEIN	Susceptibility and protection against human autoimmune diseases, including type I diabetes, multiple sclerosis, and Goodpasture disease, is associated with particular human leukocyte antigen (HLA) alleles. However, the mechanisms underpinning such HLA-mediated effects on self-tolerance remain unclear. Here we investigate the molecular mechanism of Goodpasture disease, an HLA-linked autoimmune renal disorder characterized by an immunodominant CD4(+) T-cell self-epitope derived from the alpha 3 chain of type IV collagen (alpha 3(135-145))(1-4). While HLA-DR15 confers a markedly increased disease risk, the protective HLA-DR1 allele is dominantly protective in trans with HLA-DR15 (ref. 2). We show that autoreactive alpha 3(135-145)-specific T cells expand in patients with Goodpasture disease and, in alpha 3(135-145)-immunized HLA-DR15 transgenic mice, alpha 3(135-145)-specific T cells infiltrate the kidney and mice develop Goodpasture disease. HLA-DR15 and HLA-DR1 exhibit distinct peptide repertoires and binding preferences and present the alpha 3(135-145) epitope in different binding registers. HLA-DR15-alpha 3(135-145) tetramer(+) T cells in HLA-DR15 transgenic mice exhibit a conventional T-cell phenotype (T-conv) that secretes pro-inflammatory cytokines. In contrast, HLA-DR1-alpha 3(135-145) tetramer(+) T cells in HLA-DR1 and HLA-DR15/DR1 transgenic mice are predominantly CD4(+) Foxp3(+) regulatory T cells (T-reg cells) expressing tolerogenic cytokines. HLA-DR1-induced T-reg cells confer resistance to disease in HLA-DR15/DR1 transgenic mice. HLA-DR15(+) and HLA-DR1(+) healthy human donors display altered alpha 3(135-145)-specific T-cell antigen receptor usage, HLA-DR15-alpha 3(135-145) tetramer(+) Foxp3-T-conv and HLA-DR1-alpha 3(135-145) tetramer(+) Foxp3(+) CD25(hi)CD127(lo) T-reg dominant phenotypes. Moreover, patients with Goodpasture disease display a clonally expanded alpha 3(135-145)-specific CD4(+) T-cell repertoire. Accordingly, we provide a mechanistic basis for the dominantly protective effect of HLA in autoimmune disease, whereby HLA polymorphism shapes the relative abundance of self-epitope specific T-reg cells that leads to protection or causation of autoimmunity.	[Ooi, Joshua D.; Huynh, Megan; Willett, Zoe J.; Eggenhuizen, Peter J.; Gan, Poh Y.; Likhan, Maliha A. A.; Holdsworth, Stephen R.; Kitching, A. Richard] Monash Univ, Dept Med, Monash Med Ctr, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia; [Petersen, Jan; Tan, Yu H.; Ramarathinam, Sri H.; Loh, Khai L.; Dudek, Nadine L.; Purcell, Anthony W.; La Gruta, Nicole L.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Petersen, Jan; Tan, Yu H.; Ramarathinam, Sri H.; Loh, Khai L.; Dudek, Nadine L.; Purcell, Anthony W.; La Gruta, Nicole L.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Watson, Katherine A.; La Gruta, Nicole L.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3010, Australia; [Handel, Andreas] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Fugger, Lars] Univ Oxford, Oxford Ctr Neuroinflammat, Nuffield Dept Clin Neurosci, John Radcliffe Hosp, Oxford OX3 9DS, England; [Fugger, Lars] Univ Oxford, MRC Human Immunol Unit, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX3 9DS, England; [Power, David A.] Austin Hlth, Dept Nephrol, Heidelberg, Vic 3084, Australia; [Power, David A.; Holt, Stephen G.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Holt, Stephen G.] Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic 3050, Australia; [Coates, P. Toby] Royal Adelaide Hosp, Cent Northern Adelaide Renal & Transplantat Serv, Adelaide, SA 5000, Australia; [Gregersen, Jon W.] Viborg Reg Hosp, Dept Med, DK-8800 Viborg, Denmark; [Holdsworth, Stephen R.; Kitching, A. Richard] Monash Hlth, Dept Nephrol, Clayton, Vic 3168, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Kitching, A. Richard] Monash Univ, NHMRC Ctr Personalised Immunol, Clayton, Vic 3168, Australia; [Kitching, A. Richard] Monash Hlth, Dept Pediat Nephrol, Clayton, Vic 3168, Australia; [Watson, Katherine A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Monash University; University of Melbourne; University System of Georgia; University of Georgia; Vanderbilt University; University of Oxford; University of Oxford; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Royal Adelaide Hospital; Aarhus University; Cardiff University; Monash University; Walter & Eliza Hall Institute	Kitching, AR (corresponding author), Monash Univ, Dept Med, Monash Med Ctr, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Kitching, AR (corresponding author), Monash Hlth, Dept Nephrol, Clayton, Vic 3168, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Kitching, AR (corresponding author), Monash Univ, NHMRC Ctr Personalised Immunol, Clayton, Vic 3168, Australia.; Kitching, AR (corresponding author), Monash Hlth, Dept Pediat Nephrol, Clayton, Vic 3168, Australia.	hugh.reid@monash.edu; jamie.rossjohn@monash.edu; richard.kitching@monash.edu	Holt, Stephen/AAU-7808-2020; Power, David/AAM-6012-2021; Kitching, A Richard/B-6947-2013; Rossjohn, Jamie/F-9032-2013; Purcell, Anthony/AAH-1942-2019; Ramarathinam, Sri H/G-2278-2012; Power, David/L-4387-2019	Holt, Stephen/0000-0001-5004-5539; Power, David/0000-0003-3983-0581; Kitching, A Richard/0000-0002-2713-2391; Rossjohn, Jamie/0000-0002-2020-7522; Purcell, Anthony/0000-0003-0532-8331; Ramarathinam, Sri H/0000-0002-2787-1282; La Gruta, Nicole/0000-0001-5358-9363; Loh, Khai Lee/0000-0002-2211-2404; Eggenhuizen, Peter/0000-0002-7102-3547; Handel, Andreas/0000-0002-4622-1146; Gan, Poh Yi/0000-0001-8373-7144; Hudson, Billy/0000-0002-5420-4100; Alikhan, Maliha/0000-0002-2578-3457	National Health and Medical Research Council of Australia (NHMRC) [1048575, 1079648, 334067, 1071916]; Sylvia and Charles Viertel Senior Medical Research Fellowship; NHMRC Senior Research Fellowship; Australian Research Council Laureate Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Laureate Fellowship(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff of the Australian Synchrotron (beamline MX1 and MX2) for assistance with data collection and donors of the Australian Bone Marrow Donor Registry for blood samples. This study was supported by grants from the National Health and Medical Research Council of Australia (NHMRC), 1048575 and 1079648 to A.R.K., 334067 to A.R.K. and S.R.H., and 1071916 to N.L.L.G. N.L.L.G. is supported by a Sylvia and Charles Viertel Senior Medical Research Fellowship. A.W.P. is supported by an NHMRC Senior Research Fellowship. J.R. is supported by an Australian Research Council Laureate Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Apostolopoulos J, 2006, J IMMUNOL METHODS, V308, P167, DOI 10.1016/j.jim.2005.10.011; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Cairns LS, 2003, J AM SOC NEPHROL, V14, P2801, DOI 10.1097/01.ASN.0000091588.80007.0E; Clement CC, 2016, J BIOL CHEM, V291, P5576, DOI 10.1074/jbc.M115.655738; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Dudek NL, 2016, METHODS MOL BIOL, V1394, P189, DOI 10.1007/978-1-4939-3341-9_14; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li YL, 2000, J MOL BIOL, V304, P177, DOI 10.1006/jmbi.2000.4198; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohme M, 2013, BRAIN, V136, P1783, DOI 10.1093/brain/awt108; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ooi JD, 2013, J AM SOC NEPHROL, V24, P419, DOI 10.1681/ASN.2012070705; Ooi JD, 2009, J AM SOC NEPHROL, V20, P980, DOI 10.1681/ASN.2008080891; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Phelps RG, 1999, KIDNEY INT, V56, P1638, DOI 10.1046/j.1523-1755.1999.00720.x; Salama AD, 2003, KIDNEY INT, V64, P1685, DOI 10.1046/j.1523-1755.2003.00259.x; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Schittenhelm RB, 2014, TISSUE ANTIGENS, V83, P174, DOI 10.1111/tan.12282; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; van der Horst-Bruinsma IE, 1999, HUM IMMUNOL, V60, P152, DOI 10.1016/S0198-8859(98)00101-3; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; VOGT AB, 1994, J IMMUNOL, V153, P1665; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zou J, 2008, J AM SOC NEPHROL, V19, P396, DOI 10.1681/ASN.2007050546	37	127	130	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					243	+		10.1038/nature22329	http://dx.doi.org/10.1038/nature22329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28467828	Green Accepted			2022-12-28	WOS:000400963800038
J	Pritchard, HD				Pritchard, Hamish D.			RETRACTED: Asia's glaciers are a regionally important buffer against drought (Publication with Expression of Concern. See vol. 550, 2017) (Retracted article. See vol. 555, 2018)	NATURE			English	Article; Retracted Publication							PRECIPITATION DATA; MASS-LOSS; CLIMATE; RIVER; HIMALAYA; YIELD; BASIN; MELT; DAM	The high mountains of Asia-encompassing the Himalayas, the Hindu Kush, Karakoram, Pamir Alai, Kunlun Shan, and Tian Shan mountains-have the highest concentration of glaciers globally, and 800 million people depend in part on meltwater from them. Water stress makes this region vulnerable economically and socially to drought, but glaciers are a uniquely drought-resilient source of water. Here I show that these glaciers provide summer meltwater to rivers and aquifers that is sufficient for the basic needs of 136 million people, or most of the annual municipal and industrial needs of Pakistan, Tajikistan, Turkmenistan, Uzbekistan and Kyrgyzstan. During drought summers, meltwater dominates water inputs to the upper Indus and Aral river basins. Uncertainties in mountain precipitation are poorly known, but, given the magnitude of this water supply, predicted glacier loss would add considerably to drought-related water stress. Such additional water stress increases the risk of social instability, conflict and sudden, uncontrolled population migrations triggered by water scarcity, which is already associated with the large and rapidly growing populations and hydroeconomies of these basins.	[Pritchard, Hamish D.] British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Pritchard, HD (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	hprit@bas.ac.uk	Pritchard, Hamish Daniel/AAU-4696-2021		Natural Environment Research Council [bas0100034, NE/R000107/1] Funding Source: researchfish; NERC [NE/R000107/1, bas0100034] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abbaspour KC, 2007, J HYDROL, V333, P413, DOI 10.1016/j.jhydrol.2006.09.014; Abeysingha NS, 2015, CURR SCI INDIA, V108, P2202; [Anonymous], 2013, NAT CAP RISK TOP 100; [Anonymous], 2015, ISS MAN WAT CHALL PO; [Anonymous], 2016, UNEP ENV DAT EXPL CO; Arendt A., 2015, RANDOLPH GLACIER INV; Arnold J.G., 2012, SOIL WATER ASSESSMEN; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Dahri ZH, 2016, SCI TOTAL ENVIRON, V548, P289, DOI 10.1016/j.scitotenv.2016.01.001; Dyurgerov M. B., 2005, 58 UNSTAAR U COL; Farinotti D, 2015, NAT GEOSCI, V8, P716, DOI 10.1038/NGEO2513; Frey H, 2014, CRYOSPHERE, V8, P2313, DOI 10.5194/tc-8-2313-2014; Gassert F., 2013, AQUEDUCT GLOBAL MAPS; Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1; Hijioka Y, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1327; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; IPCC, 2013, CLIMATE CHANGE 2022; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Laghari AN, 2012, HYDROL EARTH SYST SC, V16, P1063, DOI 10.5194/hess-16-1063-2012; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Leon L. F., 2008, Open Hydrology Journal, V2, P1, DOI 10.2174/1874378100802010001; Malsy M, 2015, ENVIRON EARTH SCI, V73, P787, DOI 10.1007/s12665-014-3107-y; National Research Council, 2012, HIM GLAC CLIM CHANG, DOI 10.17226/13449; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Qi W, 2016, HYDROL EARTH SYST SC, V20, P903, DOI 10.5194/hess-20-903-2016; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sakai A, 2015, CRYOSPHERE, V9, P865, DOI 10.5194/tc-9-865-2015; Savoskul O. S., 2013, Research Report - International Water Management Institute; Schaner N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034029; Schleussner CF, 2016, P NATL ACAD SCI USA, V113, P9216, DOI 10.1073/pnas.1601611113; Singh P, 2005, J HYDROL, V300, P140, DOI 10.1016/j.jhydrol.2004.06.005; Singh P, 2002, HYDROLOG SCI J, V47, P93, DOI 10.1080/02626660209492910; Srinivasan R, 2010, T ASABE, V53, P1533; Strauch M, 2017, CLIMATIC CHANGE, V141, P547, DOI 10.1007/s10584-016-1706-1; Van Liew MW, 2003, J AM WATER RESOUR AS, V39, P413, DOI 10.1111/j.1752-1688.2003.tb04395.x; World Economic Forum, 2016, GLOB RISKS REP 2016; Wu KS, 2007, J HYDROL, V337, P187, DOI 10.1016/j.jhydrol.2007.01.030; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zemp M, 2015, J GLACIOL, V61, P745, DOI 10.3189/2015JoG15J017	44	114	124	2	124	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 11	2017	545	7653					169	+		10.1038/nature22062	http://dx.doi.org/10.1038/nature22062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU3XG	28492255				2022-12-28	WOS:000400963800024
J	Bishop, C				Bishop, Christine			Donald James Fairclough Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		FAIRCLOUGH DJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2117	10.1136/bmj.j2117	http://dx.doi.org/10.1136/bmj.j2117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483751				2022-12-28	WOS:000401412700005
J	Davies, A				Davies, Angela			Myrtle Summerly Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SUMMERLY M, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2017	357								j2181	10.1136/bmj.j2181	http://dx.doi.org/10.1136/bmj.j2181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV0FA	28483760				2022-12-28	WOS:000401412700011
J	Chanchlani, N; Davis, F; Devarajan, K				Chanchlani, Neil; Davis, Fiona; Devarajan, Kalyaan			10-MINUTE CONSULTATION Ongoing vomiting in an infant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chanchlani, Neil] Royal Free London NHS Fdn Trust, Paediat, London, England; [Davis, Fiona] East Hill Surg, Colchester, Essex, England; [Devarajan, Kalyaan] Colchester Gen Hosp, Colchester, Essex, England	University of London; University College London; Royal Free London NHS Foundation Trust	Chanchlani, N (corresponding author), Royal Free London NHS Fdn Trust, Paediat, London, England.	nchanchlani@doctors.org.uk		Chanchlani, Neil/0000-0003-0207-6706				Czinn SJ, 2013, PEDIATR DRUGS, V15, P19, DOI 10.1007/s40272-012-0004-2; Davies I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7703; MHRA, DOMP RISKS CARD SID; Moreno M, 2014, JAMA PEDIATR, V168, P976, DOI 10.1001/jamapediatrics.2013.3373; National Institute for Health and Care Excellence, 2015, GASTR OES REFL DIS R; Onyeador N, 2014, ARCH DIS CHILDHOOD-E, V99, P190, DOI 10.1136/archdischild-2013-305253; Puntis JW, 2015, ARCH DIS CHILD, V100, P989, DOI 10.1136/archdischild-2014-306232; Ruigomez A, 2010, SCAND J GASTROENTERO, V45, P139, DOI 10.3109/00365520903428606; Shields B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5931; Sun H, 2015, J PAEDIATR CHILD H, V51, P515, DOI 10.1111/jpc.12760; Tighe M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008550.pub2	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2017	357								j1802	10.1136/bmj.j1802	http://dx.doi.org/10.1136/bmj.j1802			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WD	28473311				2022-12-28	WOS:000400889700001
J	Gainor, JF; Shaw, AT				Gainor, Justin F.; Shaw, Alice T.			J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer	LANCET			English	Editorial Material							PROGRESSION-FREE; OPEN-LABEL; CERITINIB; CHEMOTHERAPY; SURVIVAL		[Gainor, Justin F.; Shaw, Alice T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Gainor, JF (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jgainor@partners.org	Gainor, Justin/T-5411-2019		Ariad Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Loxo Oncology; Merck; Novartis; Theravance Biopharma; Genentech/Roche; Pfizer; Daiichi Sankyo; Taiho; EMD Serono; Blueprint Medicines; Ignyta; Foundation Medicine	Ariad Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Genentech(Roche HoldingGenentech); Loxo Oncology; Merck(Merck & Company); Novartis(Novartis); Theravance Biopharma; Genentech/Roche(Roche HoldingGenentech); Pfizer(Pfizer); Daiichi Sankyo(Daiichi Sankyo Company Limited); Taiho; EMD Serono; Blueprint Medicines; Ignyta; Foundation Medicine	JFG reports personal fees from Ariad Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Loxo Oncology, Merck, Novartis, and Theravance Biopharma; has served on advisory boards for Boehringer Ingelheim, Bristol-Myers Squibb, Genentech/Roche, Loxo Oncology, and Theravance Biopharma; and has received honoraria from Merck and Novartis for work in non-small-cell lung cancer, including the development of ALK inhibitors. ATS reports personal fees from Genentech/Roche, Pfizer, Novartis, Ariad Pharmaceuticals, Daiichi Sankyo, Taiho, EMD Serono, Blueprint Medicines, Ignyta, Loxo Oncology, and Foundation Medicine; and has served on advisory boards for Genentech/Roche, Pfizer, Novartis, Ariad Pharmaceuticals, Daiichi Sankyo, Taiho, EMD Serono, Blueprint Medicines, Ignyta, Loxo Oncology, and Foundation Medicine, for work in non-small-cell lung cancer, including development of alectinib and other ALK inhibitors.	Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Gainor JF, 2015, CLIN CANCER RES, V21, P2745, DOI 10.1158/1078-0432.CCR-14-3009; Hida T, 2017, LANCET; Kim Y, 2016, 17 WORLD C LUNG CANC; Ou SHI, 2016, J CLIN ONCOL, V34, P661, DOI 10.1200/JCO.2015.63.9443; Pfizer Inc, 2011, CRIZ PACK INS; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Solomon B.J., 2014, NEW ENGL J MED, V371, P2167, DOI 10.1056/NEJMoa1408440; Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X; Watanabe S, 2016, CLIN LUNG CANCER, V17, P528, DOI 10.1016/j.cllc.2016.05.001	13	6	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					3	4		10.1016/S0140-6736(17)31074-7	http://dx.doi.org/10.1016/S0140-6736(17)31074-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28501139				2022-12-28	WOS:000404396300004
J	Ridker, PM; Cook, NR				Ridker, Paul M.; Cook, Nancy R.			Cholesterol Evaluation in Young Adults: Absence of Clinical Trial Evidence Is Not a Reason to Delay Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FAMILIAL HYPERCHOLESTEROLEMIA; PREVALENCE		[Ridker, Paul M.; Cook, Nancy R.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.; Cook, Nancy R.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768				Chou R, 2016, ANN INTERN MED, V165, P560, DOI 10.7326/M16-0946; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Hingorani AD, 2017, NEW ENGL J MED, V376, P499, DOI 10.1056/NEJMc1615365; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Patel KK, 2017, ANN INTERN MED, V166, P876, DOI 10.7326/M16-2052; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; U.S. Preventive Services Task Force, 2017, LIP DIS AD CHOL DYSL	10	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2017	166	12					901	+		10.7326/M17-0855	http://dx.doi.org/10.7326/M17-0855			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX9LG	28505631				2022-12-28	WOS:000403579000021
J	Anenberg, SC; Miller, J; Injares, RM; Du, L; Henze, DK; Lacey, F; Malley, CS; Emberson, L; Franco, V; Klimont, Z; Heyes, C				Anenberg, Susan C.; Miller, Joshua; Injares, Ray M.; Du, Li; Henze, Daven K.; Lacey, Forrest; Malley, Christopher S.; Emberson, Lisa; Franco, Vicente; Klimont, Zbigniew; Heyes, Chris			Impacts and mitigation of excess diesel-related NOx emissions in 11 major vehicle markets	NATURE			English	Article							FINE PARTICULATE MATTER; TERM OZONE EXPOSURE; FUTURE AIR-QUALITY; GLOBAL BURDEN; PASSENGER CARS; CO-BENEFITS; MORTALITY; CLIMATE; HEALTH; DISEASE	Vehicle emissions contribute to fine particulate matter (PM2.5) and tropospheric ozone air pollution, affecting human health(1-5), crop yields(5,6) and climate(5,7) worldwide. On-road diesel vehicles produce approximately 20 per cent of global anthropogenic emissions of nitrogen oxides (NOx), which are key PM2.5 and ozone precursors(8,9). Regulated NOx emission limits in leading markets have been progressively tightened, but current diesel vehicles emit far more NOx under real-world operating conditions than during laboratory certification testing(10-20). Here we show that across 11 markets, representing approximately 80 per cent of global diesel vehicle sales, nearly one-third of on-road heavy-duty diesel vehicle emissions and over half of on-road light-duty diesel vehicle emissions are in excess of certification limits. These excess emissions (totalling 4.6 million tons) are associated with about 38,000 PM2.5- and ozone-related premature deaths globally in 2015, including about 10 per cent of all ozone-related premature deaths in the 28 European Union member states. Heavy-duty vehicles are the dominant contributor to excess diesel NOx emissions and associated health impacts in almost all regions. Adopting and enforcing next-generation standards (more stringent than Euro 6/VI) could nearly eliminate real-world diesel-related NOx emissions in these markets, avoiding approximately 174,000 global PM2.5- and ozone-related premature deaths in 2040. Most of these benefits can be achieved by implementing Euro VI standards where they have not yet been adopted for heavy-duty vehicles.	[Anenberg, Susan C.] Environm Hlth Analyt LLC, Washington, DC 20015 USA; [Miller, Joshua; Injares, Ray M.; Du, Li; Franco, Vicente] Int Council Clean Transportat, Washington, DC 20005 USA; [Henze, Daven K.; Lacey, Forrest] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Malley, Christopher S.; Emberson, Lisa] Univ York, Stockholm Environm Inst, York, N Yorkshire, England; [Klimont, Zbigniew; Heyes, Chris] Int Inst Appl Syst Anal, Laxenburg, Austria; [Lacey, Forrest] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Franco, Vicente] European Commiss, Directorate Gen Environm, Brussels, Belgium	University of Colorado System; University of Colorado Boulder; University of York - UK; International Institute for Applied Systems Analysis (IIASA); National Center Atmospheric Research (NCAR) - USA	Anenberg, SC (corresponding author), Environm Hlth Analyt LLC, Washington, DC 20015 USA.; Miller, J (corresponding author), Int Council Clean Transportat, Washington, DC 20005 USA.	susan.anenberg@envhealthanalytics.com; josh@theicct.org	Emberson, Lisa/ABA-8711-2021; Klimont, Zbigniew/P-7641-2015; Klimont, Zbigniew/O-6683-2019	Klimont, Zbigniew/0000-0003-2630-198X; Klimont, Zbigniew/0000-0003-2630-198X; Minjares, Ray/0000-0003-2037-6198; Franco, Vicente/0000-0001-5690-7515; Lacey, Forrest/0000-0003-4578-8375; Anenberg, Susan/0000-0002-9668-603X	Hewlett Foundation; ClimateWorks Foundation; European Climate Foundation; Energy Foundation China; NASA Health and Air Quality Applied System Team	Hewlett Foundation; ClimateWorks Foundation; European Climate Foundation; Energy Foundation China; NASA Health and Air Quality Applied System Team	Support was provided by the Hewlett Foundation, the ClimateWorks Foundation, the European Climate Foundation, Energy Foundation China and the NASA Health and Air Quality Applied System Team. We are grateful to F. Posada, T. Dallman, J. German, R. Muncrief, A. Bandivadekar, H. He, D. Rutherford and F. Kamakate for assistance with regional diesel NO<INF>x</INF> emissions inventories; G. Bishop for access to US remote sensing data; J. Apte and N. Fann for discussions on the health impact methodology; and R. van Dingenen for assistance with the crop impact methodology.	Anenberg SC, 2012, ENVIRON HEALTH PERSP, V120, P831, DOI 10.1289/ehp.1104301; Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; [Anonymous], 2011, CTR ALT FUELS ENG EM; [Anonymous], 2011, INTEGRATED ASSESSMEN; Apte JS, 2015, ENVIRON SCI TECHNOL, V49, P8057, DOI 10.1021/acs.est.5b01236; Barrett SRH, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114005; Bey I, 2001, J GEOPHYS RES-ATMOS, V106, P23073, DOI 10.1029/2001JD000807; Bhalla K., TRANSP HLTH GLOB BUR; Bishop GA, 2008, ENVIRON SCI TECHNOL, V42, P1651, DOI 10.1021/es702413b; Bishop GA, 2015, ENVIRON SCI TECHNOL, V49, P11234, DOI 10.1021/acs.est.5b02392; Bishop GA, 2013, ENVIRON SCI TECHNOL, V47, P9523, DOI 10.1021/es401487b; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; California Air Resources Board (CARB), 2014, OPT RED NOX EM STAND; Carslaw DC, 2013, ATMOS ENVIRON, V81, P339, DOI 10.1016/j.atmosenv.2013.09.026; Carslaw DC, 2011, ATMOS ENVIRON, V45, P7053, DOI 10.1016/j.atmosenv.2011.09.063; Chambliss SE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104009; Chen YC, 2016, ENVIRON SCI TECHNOL, V50, P3327, DOI 10.1021/acs.est.5b04704; Chowdhury S, 2016, ENVIRON INT, V91, P283, DOI 10.1016/j.envint.2016.03.004; Crippa M, 2016, ATMOS CHEM PHYS, V16, P3825, DOI 10.5194/acp-16-3825-2016; ECLIPSE Emissions Inventory The International Institute for Applied Systems Analysis, 2016, GLOB EM FIELDS AIR P; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Franco V, 2014, ICCT INT COUNCIL CLE, V49, P847; Fry MM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017134; German J. U. S., 2014, U S TIER 3 VEHICLE E; Guo JD, 2014, ATMOS ENVIRON, V99, P1, DOI 10.1016/j.atmosenv.2014.07.032; Heijne V., 2016, EMISSION FACTORS DIE; Henze DK, 2007, ATMOS CHEM PHYS, V7, P2413, DOI 10.5194/acp-7-2413-2007; Henze DK, 2012, ENVIRON SCI TECHNOL, V46, P9511, DOI 10.1021/es301993s; Holland SP, 2016, ENVIRON SCI TECHNOL, V50, P1111, DOI 10.1021/acs.est.5b05190; Hou LF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090891; Huo H, 2012, ATMOS ENVIRON, V54, P159, DOI 10.1016/j.atmosenv.2012.01.068; International Council on Clean Transportation (ICCT), 2016, DEF BRAZ PROC P 7 CA; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kadijk G., 2015, 2015R10838 TNO; Kadijk G., 2015, 2015R10702 TNO; Kodjak D., 2015, POLICIES REDUCE FUEL; Kubota Y., 2016, SOME JAPANESE CAR DI; Lamarque JF, 2010, ATMOS CHEM PHYS, V10, P7017, DOI 10.5194/acp-10-7017-2010; Lapina K, 2016, ENVIRON SCI TECHNOL, V50, P806, DOI 10.1021/acs.est.5b04887; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lowell D, 2012, URBAN CYCLE NOX EMIS; Miller J., RDE IMPACT IMPROVED; Misra C., 2017, ENV SCI TECHNOL; Mock P., 2015, FUTURE VEHICLE EMISS; Muncrief R., COMP REAL WORLD CYCL; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Ntziachristos L, 2016, ATMOS ENVIRON, V141, P542, DOI 10.1016/j.atmosenv.2016.07.036; Oldenkamp R, 2016, ENVIRON POLLUT, V212, P121, DOI 10.1016/j.envpol.2016.01.053; Punger EM, 2013, AIR QUAL ATMOS HLTH, V6, P563, DOI 10.1007/s11869-013-0197-8; Quiros D.C., 2016, EMISS CONTROL SCI TE, V2, P156, DOI [DOI 10.1007/S40825-016-0044-0, 10.1007, 10.1007/s40825-016-0044-0]; Sarofim MC, 2017, ENVIRON RESOUR ECON, V66, P45, DOI 10.1007/s10640-015-9937-6; Shindell D, 2011, NAT CLIM CHANGE, V1, P59, DOI [10.1038/NCLIMATE1066, 10.1038/nclimate1066]; Silva RA, 2016, ENVIRON HEALTH PERSP, V124, P1776, DOI 10.1289/EHP177; Spurr RJD, 2001, J QUANT SPECTROSC RA, V68, P689, DOI 10.1016/S0022-4073(00)00055-8; Stohl A, 2015, ATMOS CHEM PHYS, V15, P10529, DOI 10.5194/acp-15-10529-2015; Thompson G., 2014, FINAL REPORT IN USE; Transport Research Laboratory (TRL), 2009, ROAD VEH EM FACT 200; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; U.S. EPA (Environmental Protection Agency), 2008, EPA600R08082F; Unger N, 2010, P NATL ACAD SCI USA, V107, P3382, DOI 10.1073/pnas.0906548107; United Kingdom Department for Transport, 2016, VEH EM TEST PROGR MO; United States Energy Information Administration (US EIA), 2016, TABL LIGHT DUT VEH S; United States Environmental Protection Agency, 2015, NOT VIOL 18 SEP 2015; United States Environmental Protection Agency (US EPA), 2015, MOVES 2014A LAT VERS; US EPA, 2016, EPA600R15068; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; van Donkelaar A, 2016, ENVIRON SCI TECHNOL, V50, P3762, DOI 10.1021/acs.est.5b05833; Velders GJM, 2011, ATMOS ENVIRON, V45, P3025, DOI 10.1016/j.atmosenv.2011.03.023; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/NCLIMATE2009, 10.1038/nclimate2009]; Wu Y, 2012, ATMOS CHEM PHYS, V12, P9365, DOI 10.5194/acp-12-9365-2012; Yao ZL, 2015, ATMOS ENVIRON, V123, P1, DOI 10.1016/j.atmosenv.2015.10.056; Zhang SJ, 2014, APPL ENERG, V132, P118, DOI 10.1016/j.apenergy.2014.07.008	73	317	333	24	380	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2017	545	7655					467	+		10.1038/nature22086	http://dx.doi.org/10.1038/nature22086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV6TH	28505629	Green Accepted			2022-12-28	WOS:000401906500049
J	Spielman, IB				Spielman, Ian B.			ATOMIC PHYSICS Quantum theory verified by experiment	NATURE			English	Editorial Material									[Spielman, Ian B.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Spielman, Ian B.] Univ Maryland, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Spielman, IB (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.; Spielman, IB (corresponding author), Univ Maryland, Gaithersburg, MD 20899 USA.	spielman@jqi.umd.edu			Intramural NIST DOC [9999-NIST] Funding Source: Medline	Intramural NIST DOC		Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Gritsev V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.174511; Meystre P., 2001, ATOM OPTICS; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Schweigler T, 2017, NATURE, V545, P323, DOI 10.1038/nature22310	7	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2017	545	7654					293	294		10.1038/545293a	http://dx.doi.org/10.1038/545293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV0WF	28516919	Green Accepted			2022-12-28	WOS:000401466500049
J	Leung, FW				Leung, Felix W.			Trends in Use of Sedation for Low-Risk Endoscopy Looking Beyond Monitored Anesthesia Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WATER EXCHANGE; CONTROLLED-TRIAL; GASTROENTEROLOGY; COLONOSCOPIES		[Leung, Felix W.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Leung, Felix W.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Leung, FW (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, 16111 Plummer St,111G, North Hills, CA 91343 USA.	felix.leung@va.gov			VA Medical Center research funds	VA Medical Center research funds	This work was supported in part by VA Medical Center research funds.	Adams MA, 2017, JAMA INTERN MED, V177, P436, DOI 10.1001/jamainternmed.2016.8566; Cadoni S, 2015, CLIN GASTROENTEROL H, V13, P1972, DOI 10.1016/j.cgh.2015.04.178; Hsieh YH, 2014, AM J GASTROENTEROL, V109, P1390, DOI 10.1038/ajg.2014.126; Leung Felix W, 2011, J Interv Gastroenterol, V1, P172; Leung FW, 2010, GASTROINTEST ENDOSC, V72, P693, DOI 10.1016/j.gie.2010.05.020; Lichtenstein DR, 2008, GASTROINTEST ENDOSC, V68, P815, DOI 10.1016/j.gie.2008.09.029; Liu HS, 2012, JAMA-J AM MED ASSOC, V307, P1178, DOI 10.1001/jama.2012.270; Luo H, 2013, GASTROINTEST ENDOSC, V77, P767, DOI 10.1016/j.gie.2012.12.007; Nakshabendi R, 2016, ANN GASTROENTEROL, V29, P50; Predmore Z, 2017, AM J GASTROENTEROL, V112, P297, DOI 10.1038/ajg.2016.266	10	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					2006	2007		10.1001/jama.2017.4114	http://dx.doi.org/10.1001/jama.2017.4114			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510664				2022-12-28	WOS:000401315500019
J	Voelker, R				Voelker, Rebecca			Tardive Dyskinesia Drug Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1942	1942		10.1001/jama.2017.5537	http://dx.doi.org/10.1001/jama.2017.5537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28510661				2022-12-28	WOS:000401315500006
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Barry, MJ; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Siu, AL; Tseng, CW				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Siu, Albert L.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Thyroid Cancer US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEEDLE-ASPIRATION BIOPSY; PAPILLARY MICROCARCINOMA; RADIOIODINE THERAPY; GLAND; SALIVARY; POPULATION; CARCINOMAS; MANAGEMENT; RISK	IMPORTANCE The incidence of thyroid cancer detection has increased by 4.5% per year over the last 10 years, faster than for any other cancer, but without a corresponding change in the mortality rate. In 2013, the incidence rate of thyroid cancer in the United States was 15.3 cases per 100 000 persons. Most cases of thyroid cancer have a good prognosis; the 5-year survival rate for thyroid cancer overall is 98.1%. OBJECTIVE To update the US Preventive Services Task Force (USPSTF) recommendation on screening for thyroid cancer. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of screening for thyroid cancer in asymptomatic adults, the diagnostic accuracy of screening (including neck palpation and ultrasound), and the benefits and harms of treatment of screen-detected thyroid cancer. FINDINGS The USPSTF found inadequate direct evidence on the benefits of screening but determined that the magnitude of the overall benefits of screening and treatment can be bounded as no greater than small, given the relative rarity of thyroid cancer, the apparent lack of difference in outcomes between patients who are treated vs monitored (for the most common tumor types), and observational evidence showing no change in mortality over time after introduction of a mass screening program. The USPSTF found inadequate direct evidence on the harms of screening but determined that the overall magnitude of the harms of screening and treatment can be bounded as at least moderate, given adequate evidence of harms of treatment and indirect evidence that overdiagnosis and overtreatment are likely to be substantial with population-based screening. The USPSTF therefore determined that the net benefit of screening for thyroid cancer is negative. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (D recommendation)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Siu, Albert L.] Mt Sinai Hosp, New York, NY 10029 USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA	University of California System; University of California San Francisco; Kaiser Permanente; University of Iowa; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Pacific Health Research & Education Institute; University of Hawaii System	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Abu-Yousef MM, 2011, ULTRASOUND Q, V27, P157, DOI 10.1097/RUQ.0b013e31822b5681; Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; BRANDER A, 1989, RADIOLOGY, V173, P507, DOI 10.1148/radiology.173.2.2678263; BRANDER A, 1991, RADIOLOGY, V181, P683, DOI 10.1148/radiology.181.3.1947082; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Cooper DS, 2010, THYROID, V20, P942, DOI 10.1089/thy.2009.0110.cxn2; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2010, ARCH OTOLARYNGOL, V136, P440, DOI 10.1001/archoto.2010.55; Gharib H, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161208.GL; Grewal RK, 2009, J NUCL MED, V50, P1605, DOI 10.2967/jnumed.108.061382; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Howlader N., 2016, SEER CANC STAT REV 1; Hyer S, 2007, CLIN ONCOL-UK, V19, P83, DOI 10.1016/j.clon.2006.11.005; Ish-Shalom S, 2008, EUR J ENDOCRINOL, V158, P677, DOI 10.1530/EJE-07-0634; Ito Y, 2005, WORLD J SURG, V29, P1544, DOI 10.1007/s00268-005-0086-x; Ito Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875; Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367; Ito Y, 2010, WORLD J SURG, V34, P28, DOI 10.1007/s00268-009-0303-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jeong SY, 2013, THYROID, V23, P609, DOI 10.1089/thy.2012.0106; Kim JY, 2008, J ULTRAS MED, V27, P215, DOI 10.7863/jum.2008.27.2.215; Kim SJ, 2010, ACTA RADIOL, V51, P475, DOI 10.3109/02841851003641834; Lee YS, 2014, J KOREAN MED SCI, V29, P676, DOI 10.3346/jkms.2014.29.5.676; Lin JS, 2017, JAMA-J AM MED ASSOC, V317, P1888, DOI 10.1001/jama.2017.0562; Lin JS, 2017, AHRQ PUBLICATION; Oda H, 2016, THYROID, V26, P150, DOI 10.1089/thy.2015.0313; Ridley J, 2016, CAN FAM PHYSICIAN, V62, P307; Ryu CH, 2015, J NUCL MED, V56, P1480, DOI 10.2967/jnumed.115.161463; Solans R, 2001, J NUCL MED, V42, P738; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18	30	140	146	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1882	1887		10.1001/jama.2017.4011	http://dx.doi.org/10.1001/jama.2017.4011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28492905				2022-12-28	WOS:000400842400018
J	Buck, MD; Sowell, RT; Kaech, SM; Pearce, EL				Buck, Michael D.; Sowell, Ryan T.; Kaech, Susan M.; Pearce, Erika L.			Metabolic Instruction of Immunity	CELL			English	Review							CD8(+) T-CELLS; GERMINAL CENTER HYPOXIA; FATTY-ACID-METABOLISM; REGULATORY T; GLYCOLYTIC METABOLISM; INTERLEUKIN-10 RECEPTOR; TUMOR MICROENVIRONMENT; AEROBIC GLYCOLYSIS; EFFECTOR FUNCTION; DENDRITIC CELL	Choices have consequences. Immune cells survey and migrate throughout the body and sometimes take residence in niche environments with distinct communities of cells, extracellular matrix, and nutrients that may differ from those in which they matured. Imbedded in immune cell physiology are metabolic pathways and metabolites that not only provide energy and substrates for growth and survival, but also instruct effector functions, differentiation, and gene expression. This review of immunometabolism will reference the most recent literature to cover the choices that environments impose on the metabolism and function of immune cells and highlight their consequences during homeostasis and disease.	[Buck, Michael D.; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany; [Buck, Michael D.] Washington Univ, Sch Med, Div Biol, St Louis, MO 63110 USA; [Buck, Michael D.] Washington Univ, Sch Med, Biomed Sci Immunol Program, St Louis, MO 63110 USA; [Sowell, Ryan T.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Max Planck Society; Washington University (WUSTL); Washington University (WUSTL); Yale University	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.; Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	susan.kaech@yale.edu; pearce@ie-freiburg.mpg.de		Buck, Michael/0000-0002-9611-1199	NIH [R01CA181125, R01AI091965, R37AI066232, R01CA195720, R01CA196660, P50CA196530]; NIH (Ruth L. Kirschtein National Research Service) [5T32HL007974]; Burroughs Wellcome Fund (Investigator in the Pathogenesis of Infectious Disease Award); MRA Team Science Award; Max Planck Society; National Science Foundation [DGE-1143954]; NATIONAL CANCER INSTITUTE [R01CA181125, P50CA196530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, R01AI091965, R37AI066232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Ruth L. Kirschtein National Research Service)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund (Investigator in the Pathogenesis of Infectious Disease Award)(Burroughs Wellcome Fund); MRA Team Science Award; Max Planck Society(Max Planck SocietyFoundation CELLEX); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Edward Pearce and members of the Pearce laboratories for their insight and critical reading of the manuscript. This work was supported by grants from the NIH (R01CA181125 and R01AI091965 to E.L.P.; R37AI066232, R01CA195720, R01CA196660, P50CA196530 [PI, Roy S. Herbst] to S.M.K.; Ruth L. Kirschtein National Research Service Award 5T32HL007974 to R.T.S.), the Burroughs Wellcome Fund (Investigator in the Pathogenesis of Infectious Disease Award to E.L.P.), the MRA Team Science Award (to S.M.K.), the Max Planck Society, and the National Science Foundation Graduate Research Fellowship (DGE-1143954 to M.D.B.). We regret that we are unable to cite all relevant studies due to space limitations. E.L.P. is on the scientific advisory board of Immunomet.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Adams JL, 2015, NAT REV DRUG DISCOV, V14, P603, DOI 10.1038/nrd4596; Adams WC, 2016, CELL REP, V17, P3142, DOI 10.1016/j.celrep.2016.11.065; Allen BG, 2014, REDOX BIOL, V2, P963, DOI 10.1016/j.redox.2014.08.002; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Champagne DP, 2016, IMMUNITY, V44, P1299, DOI 10.1016/j.immuni.2016.02.018; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Condamine T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8943; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; de Silly RV, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232236; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2007, J IMMUNOL, V179, P4953, DOI 10.4049/jimmunol.179.8.4953; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Haas R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002202; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Hand TW, 2016, TRENDS ENDOCRIN MET, V27, P831, DOI 10.1016/j.tem.2016.08.003; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hsu YL, 2016, ONCOTARGET, V7, P27584, DOI 10.18632/oncotarget.8488; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunisawa J, 2015, CELL REP, V13, P122, DOI 10.1016/j.celrep.2015.08.063; Kurashima Y., 2017, ANN REV IMMUNOL; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Lee GK, 2002, IMMUNOLOGY, V107, P452, DOI 10.1046/j.1365-2567.2002.01526.x; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu GW, 2014, CANCER RES, V74, P727, DOI 10.1158/0008-5472.CAN-13-2584; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Man K, 2017, CELL METAB, V25, P11, DOI 10.1016/j.cmet.2016.08.016; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moon JS, 2016, NAT MED, V22, P1002, DOI 10.1038/nm.4153; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Perez-Escuredo J, 2016, CELL CYCLE, V15, P72, DOI 10.1080/15384101.2015.1120930; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; Rao S, 2017, CELL, V168, P503, DOI 10.1016/j.cell.2017.01.006; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Ribas A, 2015, NEW ENGL J MED, V373, P1490, DOI 10.1056/NEJMp1510079; Rodriguez PC, 2004, CANCER RES, V64, P5839, DOI 10.1158/0008-5472.CAN-04-0465; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schultz O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014328; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Torres A, 2016, J LEUKOCYTE BIOL, V99, P387, DOI 10.1189/jlb.4A0615-252R; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wilhelm C, 2016, J EXP MED, V213, P1409, DOI 10.1084/jem.20151448; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	145	590	606	8	234	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					570	586		10.1016/j.cell.2017.04.004	http://dx.doi.org/10.1016/j.cell.2017.04.004			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475890	Green Accepted, Bronze			2022-12-28	WOS:000400560900005
J	del Toro, D; Ruff, T; Cederfjall, E; Villalba, A; Seyit-Bremer, G; Borrell, V; Klein, R				del Toro, Daniel; Ruff, Tobias; Cederfjaell, Erik; Villalba, Ana; Seyit-Bremer, Goenuel; Borrell, Victor; Klein, Ruediger			Regulation of Cerebral Cortex Folding by Controlling Neuronal Migration via FLRT Adhesion Molecules	CELL			English	Article							RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; NEOCORTEX; MECHANISMS; EXPRESSION; EXPANSION; FERRET; GENE; AMPLIFICATION; PROGENITORS	The folding of the mammalian cerebral cortex into sulci and gyri is thought to be favored by the amplification of basal progenitor cells and their tangential migration. Here, we provide a molecular mechanism for the role of migration in this process by showing that changes in intercellular adhesion of migrating cortical neurons result in cortical folding. Mice with deletions of FLRT1 and FLRT3 adhesion molecules develop macroscopic sulci with preserved layered organization and radial glial morphology. Cortex folding in these mutants does not require progenitor cell amplification but is dependent on changes in neuron migration. Analyses and simulations suggest that sulcus formation in the absence of FLRT1/3 results from reduced intercellular adhesion, increased neuron migration, and clustering in the cortical plate. Notably, FLRT1/3 expression is low in the human cortex and in future sulcus areas of ferrets, suggesting that intercellular adhesion is a key regulator of cortical folding across species.	[del Toro, Daniel; Ruff, Tobias; Cederfjaell, Erik; Seyit-Bremer, Goenuel; Klein, Ruediger] Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany; [Villalba, Ana; Borrell, Victor] CSIC, Inst Neurociencias, Sant Joan dAlacant 03550, Spain; [Villalba, Ana; Borrell, Victor] Univ Miguel Hernandez, Sant Joan dAlacant 03550, Spain; [Klein, Ruediger] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; University of Munich	Klein, R (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.; Klein, R (corresponding author), Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.	rklein@neuro.mpg.de	, Dani/AAM-5274-2021; Cederfjäll, Erik/A-8042-2011; Borrell, Victor/U-1802-2017; Ruff, Tobias/X-9619-2019; Klein, Ruediger/C-6147-2008	, Dani/0000-0002-7416-2155; Cederfjäll, Erik/0000-0003-4253-0686; Borrell, Victor/0000-0002-7833-3978; Ruff, Tobias/0000-0003-3565-5480; Klein, Ruediger/0000-0002-3109-0163; Villalba Requena, Ana/0000-0002-5615-5277	Boehringer Ingelheim; Alexander von Humboldt Foundation; predoctoral Severo Ochoa contract; Spanish Ministry of Economy and Competitiveness (MINECO) [SVP-2014-068671]; Max Planck Society; Deutsche Forschungsgemeinschaft (Synergy); European Research Council (CORTEXFOLDING) [309633]; MINECO [SAF2015-69168-R]	Boehringer Ingelheim(Boehringer Ingelheim); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); predoctoral Severo Ochoa contract; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (Synergy); European Research Council (CORTEXFOLDING); MINECO(Spanish Government)	We thank M. Gotz for her insightful comments during the course of this study, R. Portugues and A. Boehm for help with the computational model, S. Falk for help with setting up time-lapse experiments, R. Kasper for technical help with the time-lapse setup, A. Yeroslaviz and B. Habermann for help with gene expression analysis, T. Gaitanos for help with Cell Profiler, T. Iwasato for the Supernova system, and H. Kucukdereli and A. Kist for help with Python programming. T.R., a member of the graduate program IMPRS-LS, was funded by a Boehringer Ingelheim Ph.D. fellowship. E.C. was supported by a postdoctoral research fellowship from the Alexander von Humboldt Foundation, and A.V. was supported by a predoctoral Severo Ochoa contract with the Spanish Ministry of Economy and Competitiveness (MINECO, SVP-2014-068671). This work was funded by the Max Planck Society and the Deutsche Forschungsgemeinschaft (Synergy) (to R.K.) and by the European Research Council (CORTEXFOLDING, 309633) and MINECO (SAF2015-69168-R to V.B.).	Beaudin SA, 2013, CEREB CORTEX, V23, P460, DOI 10.1093/cercor/bhs038; Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Buchholz J., 2009, MATLAB PARTICLES 2 0; Cooper JA, 2013, J CELL BIOL, V202, P725, DOI 10.1083/jcb.201305021; de Juan Romero C, 2015, EMBO J, V34, P1859, DOI 10.15252/embj.201591176; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; Dimidschstein J, 2013, NEURON, V79, P1123, DOI 10.1016/j.neuron.2013.07.015; Egea J, 2008, GENE DEV, V22, P3349, DOI 10.1101/gad.486708; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gertz CC, 2015, J NEUROSCI, V35, P14307, DOI 10.1523/JNEUROSCI.2198-15.2015; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Jackson VA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11184; Jackson VA, 2015, STRUCTURE, V23, P774, DOI 10.1016/j.str.2015.01.013; Ju X.-C., 2016, HOMINOID SPECIFIC GE, V5; Kawauchi T, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00394; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Lewitus E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002000; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masuda K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15370; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mizuno H, 2014, NEURON, V82, P365, DOI 10.1016/j.neuron.2014.02.026; Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67; Morgan-Smith M., 2014, GSK 3 SIGNALING DEV, V3; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Nonaka-Kinoshita M, 2013, EMBO J, V32, P1817, DOI 10.1038/emboj.2013.96; Pilz GA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3125; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013; Reillo I., ROLE INTERMEDIATE RA, V21, P1674; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SMART IHM, 1986, J ANAT, V147, P27; Solecki DJ, 2012, CURR OPIN NEUROBIOL, V22, P791, DOI 10.1016/j.conb.2012.04.010; Stahl R, 2013, CELL, V153, P535, DOI 10.1016/j.cell.2013.03.027; Striedter GF, 2015, ANNU REV NEUROSCI, V38, P291, DOI 10.1146/annurev-neuro-071714-034128; Tabata H, 2016, MED MOL MORPHOL, V49, P63, DOI 10.1007/s00795-015-0127-y; Thomson RE, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-4; Toda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29578; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang L, 2016, NAT NEUROSCI, V19, P1115, DOI 10.1038/nn0816-1115b; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723	56	80	80	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2017	169	4					621	635		10.1016/j.cell.2017.04.012	http://dx.doi.org/10.1016/j.cell.2017.04.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET8PD	28475893	Bronze			2022-12-28	WOS:000400560900009
J	Holtz, TR				Holtz, Thomas R.			Share names for dinosaur divisions	NATURE			English	Letter									[Holtz, Thomas R.] Univ Maryland, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Holtz, TR (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	tholtz@umd.edu		Holtz, Thomas/0000-0002-2906-4900				Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; 2017, NATURE, V543, P501	2	3	3	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					30	30		10.1038/545030d	http://dx.doi.org/10.1038/545030d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28470208	Bronze			2022-12-28	WOS:000400480400019
J	Flier, JS				Flier, Jeffrey S.			Conflict of Interest Among Medical School Faculty Achieving a Coherent and Objective Approach	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Flier, Jeffrey S.] Harvard Med Sch, 200 Longwood Ave,Goldenson 542, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Flier, JS (corresponding author), Harvard Med Sch, 200 Longwood Ave,Goldenson 542, Boston, MA 02115 USA.	jeffrey_flier@hms.harvard.edu	Flier, jeffrey/AAG-6223-2019					Flier JS, 2017, MOL METAB, V6, P2, DOI 10.1016/j.molmet.2016.11.006; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1860, DOI 10.1056/NEJMms1502493; Steinbrook R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2942; Stossel TP, 2015, PHARMACOPHOBIA CONFL; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812	5	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1731	1732		10.1001/jama.2017.1751	http://dx.doi.org/10.1001/jama.2017.1751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464148				2022-12-28	WOS:000400440700015
J	Wayne, DB; Green, M; Neilson, EG				Wayne, Diane B.; Green, Marianne; Neilson, Eric G.			Teaching Medical Students About Conflicts of Interest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wayne, Diane B.; Green, Marianne; Neilson, Eric G.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Wayne, Diane B.; Green, Marianne] Northwestern Univ, Dept Med Educ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Neilson, EG (corresponding author), Northwestern Univ, Feinberg Sch Med, Arthur J Rubloff Bldg,Ste 12-109,420 E Super St, Chicago, IL 60611 USA.	egneilson@northwestern.edu						American Medical Student Association, AMSA SCOR 2017; Austad KE, 2013, J GEN INTERN MED, V28, P1064, DOI 10.1007/s11606-013-2361-0; Coller BS, 2002, AM J MED, V112, P744, DOI 10.1016/S0002-9343(02)01159-2; Cruess SR, 2004, VIRTUAL MENTOR, V6, DOI [10.1001/virtualmentor.2004.6.4.msoc1-0404, DOI 10.1001/VIRTUALMENT0R.2004.6.4]; Institute of Medicine, 2009, CONFLICT INTEREST ME; Institute on Medicine as a Profession, CONFL INT OV; Pharmaceutical Research and Manufacturers of America, PHARM COD INT HEALTH; Stevens RA, 2002, MT SINAI J MED, V69, P357	8	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1733	1734		10.1001/jama.2017.2079	http://dx.doi.org/10.1001/jama.2017.2079			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464151				2022-12-28	WOS:000400440700016
J	Zuger, A				Zuger, Abigail			What Do Patients Think About Physicians' Conflicts of Interest? Watching Transparency Evolve	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FINANCIAL INCENTIVES		[Zuger, Abigail] Mt Sinai St Lukes Hosp, Dept Med, 1000 10th Ave,2T, New York, NY 10019 USA; [Zuger, Abigail] Mt Sinai West Hosp, 1000 10th Ave,2T, New York, NY 10019 USA	Mount Sinai St. Luke's; Mount Sinai West	Zuger, A (corresponding author), Mt Sinai St Lukes Hosp, Dept Med, 1000 10th Ave,2T, New York, NY 10019 USA.; Zuger, A (corresponding author), Mt Sinai West Hosp, 1000 10th Ave,2T, New York, NY 10019 USA.	abigail.zuger@mountsinai.org						Boxill R., 1969, SHAW AND THE DOCTORS, P146; JONSEN AR, 1983, NEW ENGL J MED, V308, P1531, DOI 10.1056/NEJM198306233082511; Lenzer J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4608; Levinson W, 2005, ARCH INTERN MED, V165, P625, DOI 10.1001/archinte.165.6.625; Pearson SD, 2006, ARCH INTERN MED, V166, P623, DOI 10.1001/archinte.166.6.623; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1860, DOI 10.1056/NEJMms1502493; Shaw GB, 1913, THE DOCTORS DILEMMA, pxiii	7	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2017	317	17					1747	+		10.1001/jama.2017.2995	http://dx.doi.org/10.1001/jama.2017.2995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6YU	28464162				2022-12-28	WOS:000400440700023
J	Medvedev, MG; Bushmarinov, IS; Sun, JW; Perdew, JP; Lyssenko, KA				Medvedev, Michael G.; Bushmarinov, Ivan S.; Sun, Jianwei; Perdew, John P.; Lyssenko, Konstantin A.			Density functional theory is straying from the path toward the exact functional	SCIENCE			English	Article							EXCHANGE-CORRELATION FUNCTIONALS; THERMOCHEMISTRY; PARAMETRIZATION; APPROXIMATIONS	The theorems at the core of density functional theory (DFT) state that the energy of a many-electron system in its ground state is fully defined by its electron density distribution. This connection is made via the exact functional for the energy, which minimizes at the exact density. For years, DFT development focused on energies, implicitly assuming that functionals producing better energies become better approximations of the exact functional. We examined the other side of the coin: the energy-minimizing electron densities for atomic species, as produced by 128 historical and modern DFT functionals. We found that these densities became closer to the exact ones, reflecting theoretical advances, until the early 2000s, when this trend was reversed by unconstrained functionals sacrificing physical rigor for the flexibility of empirical fitting.	[Medvedev, Michael G.; Bushmarinov, Ivan S.; Lyssenko, Konstantin A.] RAS, AN Nesmeyanov Inst Organoelement Cpds, Xray Struct Lab, Moscow 119991, Russia; [Medvedev, Michael G.] RAS, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; [Medvedev, Michael G.] RAS, Higher Chem Coll, Moscow 125047, Russia; [Sun, Jianwei; Perdew, John P.] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Perdew, John P.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Medvedev, Michael G.; Bushmarinov, Ivan S.; Perdew, John P.; Lyssenko, Konstantin A.] Univ Texas, El Paso, TX 79968 USA	Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Texas System; University of Texas El Paso	Medvedev, MG; Bushmarinov, IS (corresponding author), RAS, AN Nesmeyanov Inst Organoelement Cpds, Xray Struct Lab, Moscow 119991, Russia.; Medvedev, MG (corresponding author), RAS, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia.; Medvedev, MG (corresponding author), RAS, Higher Chem Coll, Moscow 125047, Russia.; Medvedev, MG; Bushmarinov, IS (corresponding author), Univ Texas, El Paso, TX 79968 USA.	medvedev.m.g@gmail.com; ib@xrlab.ru	Lyssenko, Konstantin/J-9721-2013; Medvedev, Michael G./N-3097-2016	Lyssenko, Konstantin/0000-0002-3500-1287; Medvedev, Michael G./0000-0001-7070-4052	Russian Science Foundation [14-13-00884]; NSF [DMR-1305135, DMR-1607868]; Humboldt Foundation; MultiWFN program [29]; Russian Science Foundation [17-13-00069] Funding Source: Russian Science Foundation; Division Of Materials Research [1607868] Funding Source: National Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); NSF(National Science Foundation (NSF)); Humboldt Foundation(Alexander von Humboldt Foundation); MultiWFN program; Russian Science Foundation(Russian Science Foundation (RSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by Russian Science Foundation grant 14-13-00884 (M.G.M., I.S.B., and K.A.L.), NSF grants DMR-1305135 and DMR-1607868 (with contributions from Chemical Theory, Modeling, and Computation) (J.P.P. and J.S.), and the Humboldt Foundation (J.P.P.). The calculations were performed on the IBM Blue Gene/P supercomputer at Moscow State University's Faculty of Computational Mathematics and Cybernetics and on the Lomonosov (28) supercomputer of the Supercomputing Center of Lomonosov Moscow State University. We thank M. V. Panova, A. O. Dmitrienko, I. V. Ananyev, I. V. Fedyanin, and E. A. Lapshin for discussions and T. Lu for help with his MultiWFN program (29).	Becke AD, 1996, J CHEM PHYS, V104, P1040, DOI 10.1063/1.470829; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bochevarov AD, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2821123; Boese AD, 2001, J CHEM PHYS, V114, P5497, DOI 10.1063/1.1347371; Boyd R. J., 1995, RECENT ADV DENSITY F, V1, P369; Csonka GI, 1997, J COMPUT CHEM, V18, P1534, DOI 10.1002/(SICI)1096-987X(199709)18:12<1534::AID-JCC10>3.0.CO;2-K; Frisch M. J, GAUSSIAN 09 REVISION; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Grabowski I, 2014, MOL PHYS, V112, P700, DOI 10.1080/00268976.2013.854424; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897; Kim MC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.073003; LEVY M, 1979, P NATL ACAD SCI USA, V76, P6062, DOI 10.1073/pnas.76.12.6062; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Medvedev MG, 2016, CHEM COMMUN, V52, P6593, DOI 10.1039/c6cc01305h; Perdew JP, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.026403; Perdew JP, 1996, J CHEM PHYS, V105, P9982, DOI 10.1063/1.472933; Perdew JP, 2001, AIP CONF PROC, V577, P1, DOI 10.1063/1.1390175; Peterson KA, 2002, J CHEM PHYS, V117, P10548, DOI 10.1063/1.1520138; Peverati R, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0476; Poater J, 2001, J COMPUT CHEM, V22, P1666, DOI 10.1002/jcc.1122; Polo V, 2002, THEOR CHEM ACC, V107, P291, DOI 10.1007/s00214-002-0331-4; Rykounov AA, 2011, ACTA CRYSTALLOGR B, V67, P425, DOI 10.1107/S0108768111033015; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; Sun JW, 2016, NAT CHEM, V8, P831, DOI [10.1038/NCHEM.2535, 10.1038/nchem.2535]; Sun JW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.036402; Tao JM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.146401; Tognetti V, 2011, J PHYS CHEM A, V115, P5505, DOI 10.1021/jp2031384; Wilson PJ, 2001, J CHEM PHYS, V115, P9233, DOI 10.1063/1.1412605	29	579	593	21	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2017	355	6320					49	+		10.1126/science.aah5975	http://dx.doi.org/10.1126/science.aah5975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4KK	28473558				2022-12-28	WOS:000391739900039
